{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "cc8f9942",
   "metadata": {},
   "source": [
    "# Objectif:\n",
    "\n",
    "On souhaite évaluer le nombre de publications qui sont le résultat d'études cliniques liées à l'INSERM.\n",
    "\n",
    "En particulier, on souhaite identifier les études cliniques qui ne donnent lieu à aucune publication et essayer de comprendre les raisons de cette absence de publication."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f4027005",
   "metadata": {},
   "source": [
    "# Organisation :\n",
    "- On récupère via l'API de *ClinicalTrial* les *ID* (**NCTId**) des études cliniques qui ont pour sponsors l'*INSERM*, l'*ANRS* etc.\n",
    "\n",
    "- A partir de ces **NCTIds**, on récupère sur *ClinicalTrial* les **PMIDs** des publications liées à ces études.  \n",
    "    Ces publications sont de 2 types:\n",
    "    1. Elles ont été uploadées sur *CT* par les auteurs de l'étude: `BACKGROUND, RESULT`\n",
    "    2. Elles ont été automatiquement récupérés sur PubMed par *CT*: `DERIVED`\n",
    "- A partir de ces **NCTIds**, on récupère sur *PubMed* les **PMIDs** des publications liées à ces études.  \n",
    "    On retrouve général un peu plus de publications que le traitement automatique réalisé par *CT*. \n",
    "\n",
    "- Pour chaque **NCTIds**, on fusionne l'ensemble des **PMIDs** retournées par *CT* et *PubMed*.\n",
    "\n",
    "- A partir de cet ensemble de **PMIDs**, on récupère les infos liés : `titre, auteurs, doi`..."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "65464cb1-f3cd-42cd-9f89-9aa323196250",
   "metadata": {},
   "source": [
    "# Extraction des NCTIds dans ClinicalTrial:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "338bf2ef-bbcc-427a-8840-0f2b91b17292",
   "metadata": {},
   "source": [
    "## API v1:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "548c1a1f-38fd-455f-abd2-6111b492a446",
   "metadata": {},
   "source": [
    "Pour faciliter la récupération des données via l'API v1 de ClinicalTrial, on utilise le wrapper Python: [pytrials](https://github.com/jvfe/pytrials)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7de1cbc9-3b95-40cf-8ceb-73efdc8e9661",
   "metadata": {},
   "source": [
    "Installer ***pytrials***:\n",
    "- Dans Conda Navigator, se placer dans le meme environnement que celui qui execute Jupyter\n",
    "- Lancer Powershell Prompt dans cet environnement\n",
    "- Taper: `pip install pytrials`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "2ae35742-d8a3-448b-b616-636604a16a50",
   "metadata": {},
   "outputs": [],
   "source": [
    "from pytrials.client import ClinicalTrials\n",
    "import urllib.parse"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "e22ac03f-cafe-4757-9c41-4bf21940f058",
   "metadata": {},
   "outputs": [],
   "source": [
    "ct = ClinicalTrials()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f5f94dc3-f00c-4a26-b360-63d46912aab4",
   "metadata": {},
   "source": [
    "### Création de la requête:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "479b8333-7891-4eac-a718-775fb3da2616",
   "metadata": {},
   "source": [
    "On crée la requête qui sera envoyé à l'API de ClinicalTrial"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "979cef8b-2f59-4ffc-b8e1-713c2df54f7d",
   "metadata": {},
   "source": [
    "#### Sponsors:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "fa86d5bc-e8ba-498a-a20d-ba223e05ef89",
   "metadata": {},
   "outputs": [],
   "source": [
    "sponsors = [\n",
    "    'anrs',\n",
    "    'inserm',\n",
    "    'institut national de la santé et de la recherche médicale',\n",
    "    'french national agency for research on aids and viral hepatitis',\n",
    "]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "11a94424-1569-4107-ba6d-6310db1079ea",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'(AREA[LeadSponsorName]anrs OR AREA[LeadSponsorName]inserm OR AREA[LeadSponsorName]institut national de la santé et de la recherche médicale OR AREA[LeadSponsorName]french national agency for research on aids and viral hepatitis)'"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sponsors_expr = [f'AREA[LeadSponsorName]{sponsor}' for sponsor in sponsors]\n",
    "\n",
    "# Add OR keyword\n",
    "sponsors_expr = ' OR '.join(sponsors_expr)\n",
    "\n",
    "# Add parenthesis for correct interpretation of OR expression\n",
    "sponsors_expr = f'({sponsors_expr})'\n",
    "\n",
    "sponsors_expr"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f673c610-bd07-4441-8954-bb9471b3eb4d",
   "metadata": {},
   "source": [
    "#### Status:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "b7faf8d7-45d7-42c9-8769-05b4b161b0d8",
   "metadata": {},
   "outputs": [],
   "source": [
    "status = 'completed'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "718888a1-e9b7-48e6-bb19-d40adbeb12a2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'AREA[OverallStatus]completed'"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "status_expr = f'AREA[OverallStatus]{status}'\n",
    "status_expr"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a0fba5e7-f5ac-4522-87f4-59750f158c9c",
   "metadata": {},
   "source": [
    "#### Search Expression:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "2a93eed1-3da5-483b-9641-93e073d72eb3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'(AREA[LeadSponsorName]anrs OR AREA[LeadSponsorName]inserm OR AREA[LeadSponsorName]institut national de la santé et de la recherche médicale OR AREA[LeadSponsorName]french national agency for research on aids and viral hepatitis) AND AREA[OverallStatus]completed'"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "search_expr = ' AND '.join([sponsors_expr, status_expr])\n",
    "search_expr"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5317cc15-f232-43d2-84a0-dffd039866ff",
   "metadata": {},
   "source": [
    "#### URL encode: "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "74564518-2bff-4de8-854e-5690d8b3be95",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'%28AREA%5BLeadSponsorName%5Danrs+OR+AREA%5BLeadSponsorName%5Dinserm+OR+AREA%5BLeadSponsorName%5Dinstitut+national+de+la+sant%C3%A9+et+de+la+recherche+m%C3%A9dicale+OR+AREA%5BLeadSponsorName%5Dfrench+national+agency+for+research+on+aids+and+viral+hepatitis%29+AND+AREA%5BOverallStatus%5Dcompleted'"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "search_expr_url_encode = urllib.parse.quote_plus(search_expr)\n",
    "search_expr_url_encode"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4ba1adce-a84f-494b-8724-ee555d5c7d57",
   "metadata": {},
   "source": [
    "#### Fields:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c5114e6f-8606-4109-ac13-62d2cf22975a",
   "metadata": {},
   "source": [
    "Les champs que l'on veut récupérer:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "af5a1984-b35d-4af6-85ca-d276ffe37af5",
   "metadata": {},
   "outputs": [],
   "source": [
    "fields = [\n",
    "    'NCTId',\n",
    "    'BriefTitle',\n",
    "    'OverallStatus',\n",
    "    'StudyType',\n",
    "    'LeadSponsorName',\n",
    "    'CollaboratorName',\n",
    "    'OrgStudyId',\n",
    "    'SecondaryId',\n",
    "    'StudyFirstPostDate',\n",
    "    'ReferencePMID',\n",
    "    'ReferenceCitation',\n",
    "    'ReferenceType',\n",
    "]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "67d2fde1-5386-4773-b10a-90a8ff153dc5",
   "metadata": {},
   "source": [
    "### Envoi de la requête :"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "ee115e0b-e412-4465-994e-b25dd746c5f9",
   "metadata": {},
   "outputs": [],
   "source": [
    "study_fields = ct.get_study_fields(\n",
    "    search_expr=search_expr_url_encode,\n",
    "    fields=fields,\n",
    "    max_studies=1000,\n",
    "    fmt='csv',\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "0a86dcfc-d52b-4d7c-8041-b3ffac03b982",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "NStudiesReturned: 289\n"
     ]
    }
   ],
   "source": [
    "print(f'NStudiesReturned: {len(study_fields[1:])}')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "17dec420-05d4-4724-b626-931f5f23c115",
   "metadata": {},
   "source": [
    "### Lire le résultat de la requête dans Pandas :"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "3de5e52f-2e18-4c00-85f2-75b4c3249706",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "34aced60-0e4c-4fec-8379-37026be31837",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OrgStudyId</th>\n",
       "      <th>SecondaryId</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>ReferencePMID</th>\n",
       "      <th>ReferenceCitation</th>\n",
       "      <th>ReferenceType</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Rank</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03671291</td>\n",
       "      <td>Missed Opportunities to Pre-exposure Prophylax...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>University Hospital, Marseille|University Hosp...</td>\n",
       "      <td>ANRS 95041 Missed Opportunity</td>\n",
       "      <td></td>\n",
       "      <td>September 14, 2018</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT01494961</td>\n",
       "      <td>Couple-oriented Prenatal HIV Counseling in Low...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>Elizabeth Glaser Pediatric AIDS Foundation</td>\n",
       "      <td>ANRS 12127 Prenahtest</td>\n",
       "      <td></td>\n",
       "      <td>December 19, 2011</td>\n",
       "      <td>20403152|21857289|34329355|29178852|23343912</td>\n",
       "      <td>Orne-Gliemann J, Tchendjou PT, Miric M, Gadgil...</td>\n",
       "      <td>result|result|derived|derived|derived</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT01463956</td>\n",
       "      <td>Efficacy of PegInterferon-Ribavirin-Boceprevir...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>Merck Sharp &amp; Dohme LLC</td>\n",
       "      <td>2011- 001089 -17</td>\n",
       "      <td></td>\n",
       "      <td>November 2, 2011</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT01426243</td>\n",
       "      <td>The Yellow Fever Vaccine Immunity in HIV Infec...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td></td>\n",
       "      <td>2009-014921-17</td>\n",
       "      <td></td>\n",
       "      <td>August 31, 2011</td>\n",
       "      <td>30096071</td>\n",
       "      <td>Colin de Verdiere N, Durier C, Samri A, Meiffr...</td>\n",
       "      <td>derived</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT01413152</td>\n",
       "      <td>Residual Risk Assessment Of HIV Transmission</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td></td>\n",
       "      <td>AOO 370-41</td>\n",
       "      <td></td>\n",
       "      <td>August 10, 2011</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>285</th>\n",
       "      <td>NCT00265642</td>\n",
       "      <td>Evaluation of Irbesartan on Hepatic Fibrosis i...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Sanofi</td>\n",
       "      <td>2005-006027-37</td>\n",
       "      <td>ANRS HC 19 Fibrosar</td>\n",
       "      <td>December 15, 2005</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>286</th>\n",
       "      <td>NCT00116454</td>\n",
       "      <td>Trial for Hepatocellular Carcinoma Adjuvant Tr...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td></td>\n",
       "      <td>2004-003883-31</td>\n",
       "      <td>ANRS HC06 LIPIOCIS</td>\n",
       "      <td>June 30, 2005</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>287</th>\n",
       "      <td>NCT05349162</td>\n",
       "      <td>Epicardial vs. Transvenous ICDs in Children</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Paris Cardiovascular Research Center (Inserm U...</td>\n",
       "      <td>Hôpital Necker-Enfants Malades</td>\n",
       "      <td>134526</td>\n",
       "      <td></td>\n",
       "      <td>April 27, 2022</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>288</th>\n",
       "      <td>NCT04842851</td>\n",
       "      <td>Cardiac Resynchronization Therapy in Congenita...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Paris Cardiovascular Research Center (Inserm U...</td>\n",
       "      <td>Marie Lannelongue Hospital, Le Plessis Robinso...</td>\n",
       "      <td>2219047</td>\n",
       "      <td></td>\n",
       "      <td>April 13, 2021</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>289</th>\n",
       "      <td>NCT05199831</td>\n",
       "      <td>Situational Analysis of HIV-related Disability...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Programme PAC-CI, Site ANRS-MIE de Côte d'Ivoire</td>\n",
       "      <td>Institute of Research for Development, France|...</td>\n",
       "      <td>VIRAGE</td>\n",
       "      <td></td>\n",
       "      <td>January 20, 2022</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>289 rows × 12 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "            NCTId                                         BriefTitle  \\\n",
       "Rank                                                                   \n",
       "1     NCT03671291  Missed Opportunities to Pre-exposure Prophylax...   \n",
       "2     NCT01494961  Couple-oriented Prenatal HIV Counseling in Low...   \n",
       "3     NCT01463956  Efficacy of PegInterferon-Ribavirin-Boceprevir...   \n",
       "4     NCT01426243  The Yellow Fever Vaccine Immunity in HIV Infec...   \n",
       "5     NCT01413152       Residual Risk Assessment Of HIV Transmission   \n",
       "...           ...                                                ...   \n",
       "285   NCT00265642  Evaluation of Irbesartan on Hepatic Fibrosis i...   \n",
       "286   NCT00116454  Trial for Hepatocellular Carcinoma Adjuvant Tr...   \n",
       "287   NCT05349162        Epicardial vs. Transvenous ICDs in Children   \n",
       "288   NCT04842851  Cardiac Resynchronization Therapy in Congenita...   \n",
       "289   NCT05199831  Situational Analysis of HIV-related Disability...   \n",
       "\n",
       "     OverallStatus       StudyType  \\\n",
       "Rank                                 \n",
       "1        Completed  Interventional   \n",
       "2        Completed  Interventional   \n",
       "3        Completed  Interventional   \n",
       "4        Completed  Interventional   \n",
       "5        Completed  Interventional   \n",
       "...            ...             ...   \n",
       "285      Completed  Interventional   \n",
       "286      Completed  Interventional   \n",
       "287      Completed   Observational   \n",
       "288      Completed   Observational   \n",
       "289      Completed   Observational   \n",
       "\n",
       "                                        LeadSponsorName  \\\n",
       "Rank                                                      \n",
       "1     French National Agency for Research on AIDS an...   \n",
       "2     French National Agency for Research on AIDS an...   \n",
       "3     French National Agency for Research on AIDS an...   \n",
       "4     French National Agency for Research on AIDS an...   \n",
       "5     French National Agency for Research on AIDS an...   \n",
       "...                                                 ...   \n",
       "285                  ANRS, Emerging Infectious Diseases   \n",
       "286                  ANRS, Emerging Infectious Diseases   \n",
       "287   Paris Cardiovascular Research Center (Inserm U...   \n",
       "288   Paris Cardiovascular Research Center (Inserm U...   \n",
       "289    Programme PAC-CI, Site ANRS-MIE de Côte d'Ivoire   \n",
       "\n",
       "                                       CollaboratorName  \\\n",
       "Rank                                                      \n",
       "1     University Hospital, Marseille|University Hosp...   \n",
       "2            Elizabeth Glaser Pediatric AIDS Foundation   \n",
       "3                               Merck Sharp & Dohme LLC   \n",
       "4                                                         \n",
       "5                                                         \n",
       "...                                                 ...   \n",
       "285                                              Sanofi   \n",
       "286                                                       \n",
       "287                      Hôpital Necker-Enfants Malades   \n",
       "288   Marie Lannelongue Hospital, Le Plessis Robinso...   \n",
       "289   Institute of Research for Development, France|...   \n",
       "\n",
       "                         OrgStudyId          SecondaryId  StudyFirstPostDate  \\\n",
       "Rank                                                                           \n",
       "1     ANRS 95041 Missed Opportunity                       September 14, 2018   \n",
       "2             ANRS 12127 Prenahtest                        December 19, 2011   \n",
       "3                  2011- 001089 -17                         November 2, 2011   \n",
       "4                    2009-014921-17                          August 31, 2011   \n",
       "5                        AOO 370-41                          August 10, 2011   \n",
       "...                             ...                  ...                 ...   \n",
       "285                  2005-006027-37  ANRS HC 19 Fibrosar   December 15, 2005   \n",
       "286                  2004-003883-31   ANRS HC06 LIPIOCIS       June 30, 2005   \n",
       "287                          134526                           April 27, 2022   \n",
       "288                         2219047                           April 13, 2021   \n",
       "289                          VIRAGE                         January 20, 2022   \n",
       "\n",
       "                                     ReferencePMID  \\\n",
       "Rank                                                 \n",
       "1                                                    \n",
       "2     20403152|21857289|34329355|29178852|23343912   \n",
       "3                                                    \n",
       "4                                         30096071   \n",
       "5                                                    \n",
       "...                                            ...   \n",
       "285                                                  \n",
       "286                                                  \n",
       "287                                                  \n",
       "288                                                  \n",
       "289                                                  \n",
       "\n",
       "                                      ReferenceCitation  \\\n",
       "Rank                                                      \n",
       "1                                                         \n",
       "2     Orne-Gliemann J, Tchendjou PT, Miric M, Gadgil...   \n",
       "3                                                         \n",
       "4     Colin de Verdiere N, Durier C, Samri A, Meiffr...   \n",
       "5                                                         \n",
       "...                                                 ...   \n",
       "285                                                       \n",
       "286                                                       \n",
       "287                                                       \n",
       "288                                                       \n",
       "289                                                       \n",
       "\n",
       "                              ReferenceType  \n",
       "Rank                                         \n",
       "1                                            \n",
       "2     result|result|derived|derived|derived  \n",
       "3                                            \n",
       "4                                   derived  \n",
       "5                                            \n",
       "...                                     ...  \n",
       "285                                          \n",
       "286                                          \n",
       "287                                          \n",
       "288                                          \n",
       "289                                          \n",
       "\n",
       "[289 rows x 12 columns]"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.DataFrame.from_records(\n",
    "    study_fields[1:], index='Rank', columns=study_fields[0]\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "21b09539-cd2a-44e6-85bd-fd1a77c2eac7",
   "metadata": {},
   "source": [
    "## API v2:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e47cc848-f6eb-4c27-8f79-c31d2b6f6a27",
   "metadata": {},
   "source": [
    "L'API v1 ne sera plus supporté a [partir de mi-2024](https://clinicaltrials.gov/data-api/api) :"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ccb8b923-cd0d-4704-af4d-537bc9ff9448",
   "metadata": {},
   "source": [
    ">***Notice to API users:  \n",
    ">The new ClinicalTrials.gov API, version 2.0 is available. Classic API users are strongly encouraged to switch to the modernized API. We will continue to support the classic API until mid-2024 and are planning blackouts for the spring to help with the transition to the modernized API.***"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4760cf2e-125c-4961-bde4-5939a55a9159",
   "metadata": {},
   "source": [
    "De plus, l'API v2 supporte un nouveau champs **\"HasResults\"**, qui pour l'instant n'est que très peu utilisé mais qui pourrait être utile à l'avenir.\n",
    "\n",
    "En contre-partie, l'export des données sous forme de CSV est limité à un certain nombre de champs visible sur cette page: https://clinicaltrials.gov/data-api/about-api/csv-download\n",
    "\n",
    "On est donc obligé d'utiliser l'export de données sous forme de JSON."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cc42bfa7-3115-410a-8244-d1ad36551a3f",
   "metadata": {},
   "source": [
    "### Création de la requête:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0f8d8cb3-4485-4899-9080-09fa01fa4e46",
   "metadata": {},
   "source": [
    "`pytrials` n'étant pas compatible avec la v2, on envoie la requête manuellement en utilisant [Requests](https://requests.readthedocs.io/en/latest/) "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a5fed10d-6587-43fd-8e93-9dfd937db9e0",
   "metadata": {},
   "source": [
    "#### Format:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "c9c74f1a-8345-44a7-8a5e-e034ed6bac96",
   "metadata": {},
   "outputs": [],
   "source": [
    "format = 'json'"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "00b5564b-8a48-4fba-b0eb-f396af6c2f93",
   "metadata": {},
   "source": [
    "#### Sponsors:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "28745196-a342-47e7-9b95-d1f214ba4372",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['anrs',\n",
       " 'inserm',\n",
       " 'institut national de la santé et de la recherche médicale',\n",
       " 'french national agency for research on aids and viral hepatitis']"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sponsors"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "97255a51-e80a-4ded-878e-116f62b761d9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'anrs+OR+inserm+OR+institut+national+de+la+sant%C3%A9+et+de+la+recherche+m%C3%A9dicale+OR+french+national+agency+for+research+on+aids+and+viral+hepatitis'"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sponsors_expr_v2 = ' OR '.join(sponsors)\n",
    "sponsors_expr_v2 = urllib.parse.quote_plus(sponsors_expr_v2)\n",
    "sponsors_expr_v2"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f2014ccb-b5ba-4bdb-90e0-040900c08c87",
   "metadata": {},
   "source": [
    "#### Overall_status:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "380fae7f-a745-4cfc-93f2-53d64f75717c",
   "metadata": {},
   "outputs": [],
   "source": [
    "overall_status = 'COMPLETED'"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7a1431ad-b7a8-4c7c-8f97-cfa13cc1aa61",
   "metadata": {},
   "source": [
    "#### Fields:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "98e9a105-7e78-47cc-b572-b42a67b3aaa7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['NCTId',\n",
       " 'BriefTitle',\n",
       " 'OverallStatus',\n",
       " 'StudyType',\n",
       " 'LeadSponsorName',\n",
       " 'CollaboratorName',\n",
       " 'StudyFirstPostDate',\n",
       " 'StartDate',\n",
       " 'CompletionDate',\n",
       " 'ReferencePMID',\n",
       " 'ReferenceCitation',\n",
       " 'ReferenceType',\n",
       " 'hasResults']"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "fields_v2 = [\n",
    "    'NCTId',\n",
    "    'BriefTitle',\n",
    "    # 'OfficialTitle',\n",
    "    'OverallStatus',\n",
    "    'StudyType',\n",
    "    'LeadSponsorName',\n",
    "    'CollaboratorName',\n",
    "    # 'OrgStudyId',\n",
    "    # 'SecondaryId',\n",
    "    'StudyFirstPostDate',\n",
    "    'StartDate',\n",
    "    # 'PrimaryCompletionDate',\n",
    "    'CompletionDate',\n",
    "    'ReferencePMID',\n",
    "    'ReferenceCitation',\n",
    "    'ReferenceType',\n",
    "    'hasResults',\n",
    "]\n",
    "fields_v2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "7830602f-81b0-425c-bc69-f4f96db82948",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'NCTId%2CBriefTitle%2COverallStatus%2CStudyType%2CLeadSponsorName%2CCollaboratorName%2CStudyFirstPostDate%2CStartDate%2CCompletionDate%2CReferencePMID%2CReferenceCitation%2CReferenceType%2ChasResults'"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "fields_expr_v2 = ','.join(fields_v2)\n",
    "fields_expr_v2 = urllib.parse.quote_plus(fields_expr_v2)\n",
    "fields_expr_v2"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fcd86e2b-ebad-4806-b5f4-c9e283db79f4",
   "metadata": {},
   "source": [
    "#### Nombre de résultats max :"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "fd0b7d3d-0a8b-43bc-a078-00464b940972",
   "metadata": {},
   "outputs": [],
   "source": [
    "count_total = 'true'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "46cc35ff-1519-4433-a6bc-a49bc4c28e1a",
   "metadata": {},
   "outputs": [],
   "source": [
    "page_size = 1000"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c6c28d63-9bcf-4de6-bea0-4d143fcc002d",
   "metadata": {},
   "source": [
    "#### URL api:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "42d61bdd-b160-45b2-a782-d3b1f887d631",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'https://clinicaltrials.gov/api/v2/studies?format=json&query.lead=anrs+OR+inserm+OR+institut+national+de+la+sant%C3%A9+et+de+la+recherche+m%C3%A9dicale+OR+french+national+agency+for+research+on+aids+and+viral+hepatitis&filter.overallStatus=COMPLETED&fields=NCTId%2CBriefTitle%2COverallStatus%2CStudyType%2CLeadSponsorName%2CCollaboratorName%2CStudyFirstPostDate%2CStartDate%2CCompletionDate%2CReferencePMID%2CReferenceCitation%2CReferenceType%2ChasResults&countTotal=true&pageSize=1000'"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "query_url = f'https://clinicaltrials.gov/api/v2/studies?format={format}&query.lead={sponsors_expr_v2}&filter.overallStatus={overall_status}&fields={fields_expr_v2}&countTotal={count_total}&pageSize={page_size}'\n",
    "query_url"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "da875083-d048-4247-bba1-e71f88d23d6b",
   "metadata": {},
   "source": [
    "### Envoi de la requête :"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "5c83ef54-aa5b-417b-9948-0917421dbb92",
   "metadata": {},
   "outputs": [],
   "source": [
    "import requests"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "bfa9259e-3c18-458b-9286-9e16a08123da",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<Response [200]>"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "response = requests.get(query_url)\n",
    "response.raise_for_status()\n",
    "response"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "83cb6e68-fe6d-4fd8-90f8-bcd57450af69",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Studies returned: 289\n"
     ]
    }
   ],
   "source": [
    "print(f'Studies returned: {response.json()[\"totalCount\"]}')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "044debef-36e1-4a84-a483-1e2804c4f79d",
   "metadata": {},
   "source": [
    "### Traitement du JSON retourné:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "9032d2aa-2d5c-4b9f-ba47-a0e591129dc9",
   "metadata": {},
   "outputs": [],
   "source": [
    "import json"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "e105fd04-80ac-436b-846c-def4df8c2591",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{\n",
      "  \"totalCount\": 289,\n",
      "  \"studies\": [\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02014727\",\n",
      "          \"briefTitle\": \"Safety and Immunogenicity of Recombinant Pichia Pastoris AMA1-DiCo Candidate Malaria Vaccine With GLA-SE and Alhydrogel \\u00ae as Adjuvant in Healthy Malaria Non-Exposed European and Malaria Exposed African Adults\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-07\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2013-12-18\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"EVI Industries, Inc.\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"BPRC\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Recherche Clinique Paris Descartes Necker Cochin Sainte Anne\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Centre national de recherche et de formation sur le paludisme\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"28947345\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Sirima SB, Durier C, Kara L, Houard S, Gansane A, Loulergue P, Bahuaud M, Benhamouda N, Nebie I, Faber B, Remarque E, Launay O; AMA1-DiCo Study Group. Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel(R) in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial. Vaccine. 2017 Oct 27;35(45):6218-6227. doi: 10.1016/j.vaccine.2017.09.027. Epub 2017 Sep 22.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00117494\",\n",
      "          \"briefTitle\": \"Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2005-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2007-06\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-07-07\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"22739396\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Bittar R, Giral P, Aslangul E, Assoumou L, Valantin MA, Kalmykova O, Federspiel MC, Cherfils C, Costagliola D, Bonnefont-Rousselot D; French National Agency for AIDS and Viral Hepatitis Research (ANRS) 126 study group. Effects of rosuvastatin versus pravastatin on low-density lipoprotein diameter in HIV-1-infected patients receiving ritonavir-boosted protease inhibitor. AIDS. 2012 Sep 10;26(14):1801-5. doi: 10.1097/QAD.0b013e328357063c.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22318219\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Bittar R, Giral P, Aslangul E, Assoumou L, Valantin MA, Kalmykova O, Fesel-Fouquier V, Costagliola D, Bonnefont-Rousselot D; ANRS 126 study group. Determinants of low-density lipoprotein particle diameter during antiretroviral therapy including protease inhibitors in HIV-1-infected patients. Antivir Ther. 2012;17(5):855-60. doi: 10.3851/IMP2065. Epub 2012 Feb 9.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00536627\",\n",
      "          \"briefTitle\": \"Efficacy and Tolerance of Naked DNA Vaccine in Patients With Chronic B Hepatitis\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2008-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2010-11\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2007-09-28\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"16310901\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Mancini-Bourgine M, Fontaine H, Brechot C, Pol S, Michel ML. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. Vaccine. 2006 May 22;24(21):4482-9. doi: 10.1016/j.vaccine.2005.08.013. Epub 2005 Aug 18.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"15382173\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Mancini-Bourgine M, Fontaine H, Scott-Algara D, Pol S, Brechot C, Michel ML. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers. Hepatology. 2004 Oct;40(4):874-82. doi: 10.1002/hep.20408.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24555998\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Fontaine H, Kahi S, Chazallon C, Bourgine M, Varaut A, Buffet C, Godon O, Meritet JF, Saidi Y, Michel ML, Scott-Algara D, Aboulker JP, Pol S; ANRS HB02 study group. Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN. Gut. 2015 Jan;64(1):139-47. doi: 10.1136/gutjnl-2013-305707. Epub 2014 Feb 20.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24394187\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Godon O, Fontaine H, Kahi S, Meritet JF, Scott-Algara D, Pol S, Michel ML, Bourgine M; ANRS HB02 study group. Immunological and antiviral responses after therapeutic DNA immunization in chronic hepatitis B patients efficiently treated by analogues. Mol Ther. 2014 Mar;22(3):675-684. doi: 10.1038/mt.2013.274. Epub 2013 Dec 5.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01033760\",\n",
      "          \"briefTitle\": \"Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2010-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2013-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2009-12-16\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Gilead Sciences\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Merck Sharp & Dohme LLC\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Pfizer\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Janssen-Cilag Ltd.\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"28708873\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Cheret A, Durier C, Melard A, Ploquin M, Heitzmann J, Lecuroux C, Avettand-Fenoel V, David L, Pialoux G, Chennebault JM, Muller-Trutwin M, Goujard C, Rouzioux C, Meyer L; ANRS OPTIPRIM study group. Impact of early cART on HIV blood and semen compartments at the time of primary infection. PLoS One. 2017 Jul 14;12(7):e0180191. doi: 10.1371/journal.pone.0180191. eCollection 2017.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"25701561\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Cheret A, Nembot G, Melard A, Lascoux C, Slama L, Miailhes P, Yeni P, Abel S, Avettand-Fenoel V, Venet A, Chaix ML, Molina JM, Katlama C, Goujard C, Tamalet C, Raffi F, Lafeuillade A, Reynes J, Ravaux I, Hoen B, Delfraissy JF, Meyer L, Rouzioux C; OPTIPRIM ANRS Study Group. Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial. Lancet Infect Dis. 2015 Apr;15(4):387-96. doi: 10.1016/S1473-3099(15)70021-6. Epub 2015 Feb 18.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT05349162\",\n",
      "          \"briefTitle\": \"Epicardial vs. Transvenous ICDs in Children\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2003-01-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2022-04-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2022-04-27\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Paris Cardiovascular Research Center (Inserm U970)\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"H\\u00f4pital Necker-Enfants Malades\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01164462\",\n",
      "          \"briefTitle\": \"Feasibility and Limitations of Offering Community Based Rapid HIV Testing to Men Who Have Sex With Men (MSM)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2010-03\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2011-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2010-07-16\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02777229\",\n",
      "          \"briefTitle\": \"Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited Settings\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2016-07\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2021-07\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2016-05-19\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Institut de Recherche pour le Developpement\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"UNITAID\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"33355914\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Bousmah MA, Nishimwe ML, Tovar-Sanchez T, Lantche Wandji M, Mpoudi-Etame M, Maradan G, Omgba Bassega P, Varloteaux M, Montoyo A, Kouanfack C, Delaporte E, Boyer S; New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries (NAMSAL) ANRS 12313 Study Group. Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial). Pharmacoeconomics. 2021 Mar;39(3):331-343. doi: 10.1007/s40273-020-00987-3. Epub 2020 Dec 23.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"33010241\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Calmy A, Tovar Sanchez T, Kouanfack C, Mpoudi-Etame M, Leroy S, Perrineau S, Lantche Wandji M, Tetsa Tata D, Omgba Bassega P, Abong Bwenda T, Varloteaux M, Tongo M, Mpoudi-Ngole E, Montoyo A, Mercier N, LeMoing V, Peeters M, Reynes J, Delaporte E; New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries (NAMSAL) ANRS 12313 Study Group. Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon. Lancet HIV. 2020 Oct;7(10):e677-e687. doi: 10.1016/S2352-3018(20)30238-1.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"31339676\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"NAMSAL ANRS 12313 Study Group; Kouanfack C, Mpoudi-Etame M, Omgba Bassega P, Eymard-Duvernay S, Leroy S, Boyer S, Peeters M, Calmy A, Delaporte E. Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1. N Engl J Med. 2019 Aug 29;381(9):816-826. doi: 10.1056/NEJMoa1904340. Epub 2019 Jul 24.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00480792\",\n",
      "          \"briefTitle\": \"Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2007-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-09\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2007-05-31\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"MCM Vaccines B.V.\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"27064975\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Launay O, Rosenberg AR, Rey D, Pouget N, Michel ML, Reynes J, Neau D, Raffi F, Piroth L, Carrat F; ANRS HB03 VIHVAC-B (Trial Comparing 3 Strategies of Vaccination Against the Virus of Hepatitis B in HIV-Infected Patients) Group. Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial. JAMA Intern Med. 2016 May 1;176(5):603-10. doi: 10.1001/jamainternmed.2016.0741.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21486976\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Launay O, van der Vliet D, Rosenberg AR, Michel ML, Piroth L, Rey D, Colin de Verdiere N, Slama L, Martin K, Lortholary O, Carrat F; ANRS HB03 VIHVAC-B Trial. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial. JAMA. 2011 Apr 13;305(14):1432-40. doi: 10.1001/jama.2011.351.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01095744\",\n",
      "          \"briefTitle\": \"Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-03\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-05\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2010-03-30\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01489592\",\n",
      "          \"briefTitle\": \"Effect of Curcumin on Iron Metabolism in Healthy Volunteer\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2011-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-03\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2011-12-09\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"20169331\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Fatih N, Camberlein E, Island ML, Corlu A, Abgueguen E, Detivaud L, Leroyer P, Brissot P, Loreal O. Natural and synthetic STAT3 inhibitors reduce hepcidin expression in differentiated mouse hepatocytes expressing the active phosphorylated STAT3 form. J Mol Med (Berl). 2010 May;88(5):477-86. doi: 10.1007/s00109-009-0588-3. Epub 2010 Feb 19.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"15974953\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Loreal O, Haziza-Pigeon C, Troadec MB, Detivaud L, Turlin B, Courselaud B, Ilyin G, Brissot P. Hepcidin in iron metabolism. Curr Protein Pept Sci. 2005 Jun;6(3):279-91. doi: 10.2174/1389203054065392.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"16946298\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stolte J, Hentze MW, Muckenthaler MU. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood. 2007 Jan 1;109(1):353-8. doi: 10.1182/blood-2006-07-033969. Epub 2006 Aug 31.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"15501961\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, Marczylo TH, Morgan B, Hemingway D, Plummer SM, Pirmohamed M, Gescher AJ, Steward WP. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res. 2004 Oct 15;10(20):6847-54. doi: 10.1158/1078-0432.CCR-04-0744.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"18559556\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Vareed SK, Kakarala M, Ruffin MT, Crowell JA, Normolle DP, Djuric Z, Brenner DE. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1411-7. doi: 10.1158/1055-9965.EPI-07-2693.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01453192\",\n",
      "          \"briefTitle\": \"Renal Transplantation and Raltegravir in HIV-Infected Patients\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2011-12\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-11\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2011-10-17\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Merck Sharp & Dohme LLC\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00460382\",\n",
      "          \"briefTitle\": \"Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2007-05\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2009-09\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2007-04-13\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Merck Sharp & Dohme LLC\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Janssen-Cilag Tibotec\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02486731\",\n",
      "          \"briefTitle\": \"Hormonal Sensitivity in Patients With Noonan and LEOPARD Syndromes\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2015-12-16\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2015-07-01\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02116374\",\n",
      "          \"briefTitle\": \"Physiopathology Study of the Microbiota Biodiversity of HIV Seropositive Patients\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-12\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-06\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-04-16\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02497274\",\n",
      "          \"briefTitle\": \"Obesity and Lipids: a Matter of Taste?\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2016-01-11\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2019-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2015-07-14\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01022476\",\n",
      "          \"briefTitle\": \"Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2010-05\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2013-05\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2009-12-01\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Merck Sharp & Dohme LLC\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00528060\",\n",
      "          \"briefTitle\": \"Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2008-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2008-11\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2007-09-11\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Bristol-Myers Squibb\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Gilead Sciences\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"23459496\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Parienti JJ, Barrail-Tran A, Duval X, Nembot G, Descamps D, Vigan M, Vrijens B, Panhard X, Taburet AM, Mentre F, Goujard C. Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial. Antimicrob Agents Chemother. 2013 May;57(5):2265-71. doi: 10.1128/AAC.02605-12. Epub 2013 Mar 4.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02078076\",\n",
      "          \"briefTitle\": \"IRM Cardiaque en Respiration Libre Pour Des Patients Atteints de Dystrophinopathie s\\u00e9v\\u00e8re\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2013-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-11\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-03-05\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT04008927\",\n",
      "          \"briefTitle\": \"A Community-based Intervention Among Active Drug Users in Montpellier\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2020-09-18\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2021-09-10\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2019-07-05\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"27168667\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Blackburn NA, Patel RC, Zibbell JE. Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014. Public Health Rep. 2016 May-Jun;131 Suppl 2(Suppl 2):91-7. doi: 10.1177/00333549161310S214.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26806260\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Chevaliez S, Poiteau L, Rosa I, Soulier A, Roudot-Thoraval F, Laperche S, Hezode C, Pawlotsky JM. Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care. Clin Microbiol Infect. 2016 May;22(5):459.e1-6. doi: 10.1016/j.cmi.2016.01.009. Epub 2016 Jan 22.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22310560\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012 Mar;50(3):217-26. doi: 10.1097/MLR.0b013e3182408812.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"29432973\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Des Jarlais D, Khue PM, Feelemyer J, Arasteh K, Thi Huong D, Thi Hai Oanh K, Thi Giang H, Thi Tuyet Thanh N, Vinh VH, Heckathorn DD, Moles JP, Vallo R, Quillet C, Rapoud D, Michel L, Laureillard D, Hammett T, Nagot N. Using dual capture/recapture studies to estimate the population size of persons who inject drugs (PWID) in the city of Hai Phong, Vietnam. Drug Alcohol Depend. 2018 Apr 1;185:106-111. doi: 10.1016/j.drugalcdep.2017.11.033. Epub 2018 Feb 2.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27178119\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Des Jarlais D, Duong HT, Pham Minh K, Khuat OH, Nham TT, Arasteh K, Feelemyer J, Heckathorn DD, Peries M, Moles JP, Laureillard D, Nagot N; (The Drive Study Team). Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. AIDS Care. 2016 Oct;28(10):1312-5. doi: 10.1080/09540121.2016.1178698. Epub 2016 May 13.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27537841\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Dore GJ, Altice F, Litwin AH, Dalgard O, Gane EJ, Shibolet O, Luetkemeyer A, Nahass R, Peng CY, Conway B, Grebely J, Howe AY, Gendrano IN, Chen E, Huang HC, Dutko FJ, Nickle DC, Nguyen BY, Wahl J, Barr E, Robertson MN, Platt HL; C-EDGE CO-STAR Study Group. Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial. Ann Intern Med. 2016 Nov 1;165(9):625-634. doi: 10.7326/M16-0816. Epub 2016 Aug 9.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28004616\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Leon L, Kasereka S, Barin F, Larsen C, Weill-Barillet L, Pascal X, Chevaliez S, Pillonel J, Jauffret-Roustide M, LE Strat Y. Age- and time-dependent prevalence and incidence of hepatitis C virus infection in drug users in France, 2004-2011: model-based estimation from two national cross-sectional serosurveys. Epidemiol Infect. 2017 Apr;145(5):895-907. doi: 10.1017/S0950268816002934. Epub 2016 Dec 22.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"35774932\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Nagot N, D'Ottavi M, Quillet C, Debellefontaine A, Castellani J, Langendorfer N, Hanslik B, Guichard S, Baglioni R, Faucherre V, Tuaillon E, Pageaux GP, Laureillard D, Donnadieu-Rigole H. Reaching Hard-to-Reach People Who Use Drugs: A Community-Based Strategy for the Elimination of Hepatitis C. Open Forum Infect Dis. 2022 Apr 14;9(6):ofac181. doi: 10.1093/ofid/ofac181. eCollection 2022 Jun.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01331876\",\n",
      "          \"briefTitle\": \"Modification of Cerebral Activity of Obsessive Compulsive Disorder (OCD) Patients During Cognitive and Behavioral Therapy\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-07\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2011-04-08\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00820820\",\n",
      "          \"briefTitle\": \"IDA (Immunoth\\u00e9rapie de la Dermatite Atopique) Adult - Immunotherapy in Atopic Dermatitis\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-01-09\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-03-26\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2009-01-12\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Ministry of Health, France\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02273765\",\n",
      "          \"briefTitle\": \"Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2015-09-11\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-11-28\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-10-24\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Merck Sharp & Dohme LLC\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Ministry of Health, Brazil\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"33667406\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"De Castro N, Marcy O, Chazallon C, Messou E, Eholie S, N'takpe JB, Bhatt N, Khosa C, Timana Massango I, Laureillard D, Chau GD, Domergue A, Veloso V, Escada R, Wagner Cardoso S, Delaugerre C, Anglaret X, Molina JM, Grinsztejn B; ANRS 12300 Reflate TB2 study group. Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial. Lancet Infect Dis. 2021 Jun;21(6):813-822. doi: 10.1016/S1473-3099(20)30869-0. Epub 2021 Mar 2.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02107365\",\n",
      "          \"briefTitle\": \"Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2013-11\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-04-08\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Bristol-Myers Squibb\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00113282\",\n",
      "          \"briefTitle\": \"Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2004-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2008-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-06-08\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Chiron Corporation\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01055873\",\n",
      "          \"briefTitle\": \"Immunology of the Infection Perinatal\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2007-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2009-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2010-01-26\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Institut Pasteur\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University of Paris 5 - Rene Descartes\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"H\\u00f4pital Necker-Enfants Malades\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"22427678\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Avettand-Fenoel V, Blanche S, Le Chenadec J, Scott-Algara D, Dollfus C, Viard JP, Bouallag N, Benmebarek Y, Riviere Y, Warszawski J, Rouzioux C, Buseyne F. Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study. J Infect Dis. 2012 May 15;205(10):1520-8. doi: 10.1093/infdis/jis233. Epub 2012 Mar 15.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT05199831\",\n",
      "          \"briefTitle\": \"Situational Analysis of HIV-related Disability in the Context of Ivory Coast\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2021-02-05\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2022-08-10\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2022-01-20\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Programme PAC-CI, Site ANRS-MIE de C\\u00f4te d'Ivoire\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Institute of Research for Development, France\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Institut de Sante Publique, d'Epidemiologie et de Developpement\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University of Toronto\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Universit\\u00e9 de Lille\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01359774\",\n",
      "          \"briefTitle\": \"31P-MRS and Huntington Disease\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2011-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2011-05-25\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"21285522\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Mochel F, Haller RG. Energy deficit in Huntington disease: why it matters. J Clin Invest. 2011 Feb;121(2):493-9. doi: 10.1172/JCI45691. Epub 2011 Feb 1.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"17653274\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Mochel F, Charles P, Seguin F, Barritault J, Coussieu C, Perin L, Le Bouc Y, Gervais C, Carcelain G, Vassault A, Feingold J, Rabier D, Durr A. Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. PLoS One. 2007 Jul 25;2(7):e647. doi: 10.1371/journal.pone.0000647.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21320997\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Mochel F, Benaich S, Rabier D, Durr A. Validation of plasma branched chain amino acids as biomarkers in Huntington disease. Arch Neurol. 2011 Feb;68(2):265-7. doi: 10.1001/archneurol.2010.358. No abstract available.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02099474\",\n",
      "          \"briefTitle\": \"Evaluation of Raltegravir During the Third Trimester of Pregnancy\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-06-30\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-03-31\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"32661003\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Zheng Y, Hirt D, Delmas S, Lui G, Benaboud S, Lechedanec J, Treluyer JM, Chenevier-Gobeaux C, Arezes E, Gelley A, Amri I, Urien S, Bouazza N, Foissac F, Warszawski J, Ghosn J. Effect of Pregnancy on Unbound Raltegravir Concentrations in the ANRS 160 RalFe Trial. Antimicrob Agents Chemother. 2020 Sep 21;64(10):e00759-20. doi: 10.1128/AAC.00759-20. Print 2020 Sep 21.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03546127\",\n",
      "          \"briefTitle\": \"Molecular Profiling to Improve Outcome of Patients in Cancer. A Pilot Study\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2017-05-23\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-09-21\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2018-06-06\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Institut Bergoni\\u00e9\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Plateforme labellis\\u00e9e Inca - Institut Bergoni\\u00e9, Bordeaux\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Plateforme labellis\\u00e9e Inca - H\\u00f4pital Europ\\u00e9en Georges Pompidou, Paris\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"CNRGH, Evry\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"EUCLID Clinical Trial Platform\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT04315948\",\n",
      "          \"briefTitle\": \"Trial of Treatments for COVID-19 in Hospitalized Adults\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2020-03-22\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2023-09-25\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2020-03-20\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"32958495\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Ader F; Discovery French Trial Management Team. Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults. BMJ Open. 2020 Sep 21;10(9):e041437. doi: 10.1136/bmjopen-2020-041437.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"34763056\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"EU-Response investigators group; Diallo A, Troseid M, Simensen VC, Boston A, Demotes J, Olsen IC, Chung F, Paiva JA, Hites M, Ader F, Arribas JR, Baratt-Due A, Melien O, Tacconelli E, Staub T, Greil R, Tsiodras S, Briel M, Esperou H, Mentre F, Eustace J, Saillard J, Delmas C, LeMestre S, Dumousseaux M, Costagliola D, Rottingen JA, Yazdanpanah Y. Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group. Clin Microbiol Infect. 2022 Jan;28(1):1-5. doi: 10.1016/j.cmi.2021.10.011. Epub 2021 Nov 8. No abstract available.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"35623577\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Troseid M, Hentzien M, Ader F, Cardoso SW, Arribas JR, Molina JM, Mueller N, Hites M, Bonnet F, Manuel O, Costagliola D, Grinsztejn B, Olsen IC, Yazdapanah Y, Calmy A; EU RESPONSE; COMBINE. Immunocompromised patients have been neglected in COVID-19 trials: a call for action. Clin Microbiol Infect. 2022 Sep;28(9):1182-1183. doi: 10.1016/j.cmi.2022.05.005. Epub 2022 May 25. No abstract available.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"36680782\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Terzic V, Levoyer L, Figarella M, Bigagli E, Mercier N, De Gastines L, Gibowski S, Troseid M, Demotes J, Olsen IC, Hites M, Ader F, Lopez JRA, Mentre F, Esperou H, Costagliola D, Rottingen JA, Poissy J, Roze JC, Warris A, O'Leary J, Fernandes RM, Assoumou L, Hankard R, Turner MA, Yazdanpanah Y, Diallo A; EU-Response safety group; c4c safety group. Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia. Br J Clin Pharmacol. 2023 Apr;89(4):1318-1328. doi: 10.1111/bcp.15669. Epub 2023 Feb 8.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"36828006\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Amstutz A, Speich B, Mentre F, Rueegg CS, Belhadi D, Assoumou L, Burdet C, Murthy S, Dodd LE, Wang Y, Tikkinen KAO, Ader F, Hites M, Bouscambert M, Trabaud MA, Fralick M, Lee TC, Pinto R, Barratt-Due A, Lund-Johansen F, Muller F, Nevalainen OPO, Cao B, Bonnett T, Griessbach A, Taji Heravi A, Schonenberger C, Janiaud P, Werlen L, Aghlmandi S, Schandelmaier S, Yazdanpanah Y, Costagliola D, Olsen IC, Briel M. Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials. Lancet Respir Med. 2023 May;11(5):453-464. doi: 10.1016/S2213-2600(22)00528-8. Epub 2023 Feb 21. Erratum In: Lancet Respir Med. 2023 Aug;11(8):e77.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"32473020\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Le MP, Peiffer-Smadja N, Guedj J, Neant N, Mentre F, Ader F, Yazdanpanah Y, Peytavin G. Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial. J Antimicrob Chemother. 2020 Sep 1;75(9):2376-2380. doi: 10.1093/jac/dkaa191.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"33089306\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Le MP, Peiffer-Smadja N, Guedj J, Neant N, Mentre F, Ader F, Yazdanpanah Y, Peytavin G; C-20-15 DisCoVeRy French Steering Committee. Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response. J Antimicrob Chemother. 2021 Jan 1;76(1):277-279. doi: 10.1093/jac/dkaa415. No abstract available.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"37269068\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Mercier N, Belhadi D, DeChanet A, Delmas C, Saillard J, Dumousseaux M, Le Mestre S, Fougerou-Leurent C, Ferrane A, Burdet C, Esperou H, Ader F, Hites M, Peiffer-Smadja N, Poissy J, Andrejak C, Paiva JA, Tacconelli E, Staub T, Greil R, Costagliola D, Mentre F, Yazdanpanah Y, Diallo A; DisCoVeRy Safety Working group. Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial. Pharmacol Res Perspect. 2023 Jun;11(3):e01072. doi: 10.1002/prp2.1072.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"37302469\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Fougerou-Leurent C, Delmas C, Saillard J, Dumousseaux M, Ferrane A, Mercier N, Terzic V, Le Mestre S, Dechanet A, Belhadi D, Metois A, Burdet C, Mentre F, Noret M, Diallo A, Petrov-Sanchez V, Couffin-Cadiergues S, Hites M, Ader F, Esperou H. Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20-15 DisCoVeRy study. Contemp Clin Trials. 2023 Aug;131:107267. doi: 10.1016/j.cct.2023.107267. Epub 2023 Jun 9.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"33264556\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"WHO Solidarity Trial Consortium; Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, Alejandria MM, Hernandez Garcia C, Kieny MP, Malekzadeh R, Murthy S, Reddy KS, Roses Periago M, Abi Hanna P, Ader F, Al-Bader AM, Alhasawi A, Allum E, Alotaibi A, Alvarez-Moreno CA, Appadoo S, Asiri A, Aukrust P, Barratt-Due A, Bellani S, Branca M, Cappel-Porter HBC, Cerrato N, Chow TS, Como N, Eustace J, Garcia PJ, Godbole S, Gotuzzo E, Griskevicius L, Hamra R, Hassan M, Hassany M, Hutton D, Irmansyah I, Jancoriene L, Kirwan J, Kumar S, Lennon P, Lopardo G, Lydon P, Magrini N, Maguire T, Manevska S, Manuel O, McGinty S, Medina MT, Mesa Rubio ML, Miranda-Montoya MC, Nel J, Nunes EP, Perola M, Portoles A, Rasmin MR, Raza A, Rees H, Reges PPS, Rogers CA, Salami K, Salvadori MI, Sinani N, Sterne JAC, Stevanovikj M, Tacconelli E, Tikkinen KAO, Trelle S, Zaid H, Rottingen JA, Swaminathan S. Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"34048876\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Ader F, Peiffer-Smadja N, Poissy J, Bouscambert-Duchamp M, Belhadi D, Diallo A, Delmas C, Saillard J, Dechanet A, Mercier N, Dupont A, Alfaiate T, Lescure FX, Raffi F, Goehringer F, Kimmoun A, Jaureguiberry S, Reignier J, Nseir S, Danion F, Clere-Jehl R, Bouiller K, Navellou JC, Tolsma V, Cabie A, Dubost C, Courjon J, Leroy S, Mootien J, Gaci R, Mourvillier B, Faure E, Pourcher V, Gallien S, Launay O, Lacombe K, Lanoix JP, Makinson A, Martin-Blondel G, Bouadma L, Botelho-Nevers E, Gagneux-Brunon A, Epaulard O, Piroth L, Wallet F, Richard JC, Reuter J, Staub T, Lina B, Noret M, Andrejak C, Le MP, Peytavin G, Hites M, Costagliola D, Yazdanpanah Y, Burdet C, Mentre F; DisCoVeRy study group. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-beta-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec;27(12):1826-1837. doi: 10.1016/j.cmi.2021.05.020. Epub 2021 May 26.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"34534511\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Poissy J, Belhadi D, Diallo A, Le MP, Peytavin G, Staub T, Greil R, Guedj J, Paiva JA, Costagliola D, Yazdanpanah Y, Burdet C, Mentre F; DisCoVeRy Study Group. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial. Lancet Infect Dis. 2022 Feb;22(2):209-221. doi: 10.1016/S1473-3099(21)00485-0. Epub 2021 Sep 14.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"35233617\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Lingas G, Neant N, Gaymard A, Belhadi D, Peytavin G, Hites M, Staub T, Greil R, Paiva JA, Poissy J, Peiffer-Smadja N, Costagliola D, Yazdanpanah Y, Wallet F, Gagneux-Brunon A, Mentre F, Ader F, Burdet C, Guedj J, Bouscambert-Duchamp M. Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial. J Antimicrob Chemother. 2022 Apr 27;77(5):1404-1412. doi: 10.1093/jac/dkac048.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"35643099\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Mentre F, Burdet C; DisCoVeRy Study Group. Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19. Lancet Infect Dis. 2022 Jun;22(6):764-765. doi: 10.1016/S1473-3099(22)00295-X. No abstract available.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"35533972\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Ader F; DisCoVeRy Study Group. An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-beta-1a, and hydroxychloroquine in hospitalized patients with COVID-19: final results. Clin Microbiol Infect. 2022 Sep;28(9):1293-1296. doi: 10.1016/j.cmi.2022.04.016. Epub 2022 May 7. No abstract available.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"37728045\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Neant N, Lingas G, Gaymard A, Belhadi D, Hites M, Staub T, Greil R, Paiva JA, Poissy J, Peiffer-Smadja N, Costagliola D, Yazdanpanah Y, Bouscambert-Duchamp M, Gagneux-Brunon A, Ader F, Mentre F, Wallet F, Burdet C, Guedj J; DisCoVeRy study group. Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients. CPT Pharmacometrics Syst Pharmacol. 2023 Dec;12(12):2027-2037. doi: 10.1002/psp4.13051. Epub 2023 Oct 11.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"35512728\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"WHO Solidarity Trial Consortium. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses. Lancet. 2022 May 21;399(10339):1941-1953. doi: 10.1016/S0140-6736(22)00519-0. Epub 2022 May 2. Erratum In: Lancet. 2022 Oct 29;400(10362):1512. Lancet. 2024 Jan 13;403(10422):146.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"34473343\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"34350582\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Ansems K, Grundeis F, Dahms K, Mikolajewska A, Thieme V, Piechotta V, Metzendorf MI, Stegemann M, Benstoem C, Fichtner F. Remdesivir for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Aug 5;8(8):CD014962. doi: 10.1002/14651858.CD014962.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"32304640\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Taccone FS, Gorham J, Vincent JL. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base. Lancet Respir Med. 2020 Jun;8(6):539-541. doi: 10.1016/S2213-2600(20)30172-7. Epub 2020 Apr 15. No abstract available.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02987530\",\n",
      "          \"briefTitle\": \"National Multicenter Trial Evaluating Two Treatments in Patients With Primary Human Immunodeficiency Virus (HIV-1) Infection\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2017-04-11\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2020-01-31\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2016-12-09\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT05311865\",\n",
      "          \"briefTitle\": \"Transmission of Covid-19 During Clubbing Events in Closed Places\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2021-09-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2022-02-26\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2022-04-05\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Cerballiance\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Kappa Sant\\u00e9\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00122616\",\n",
      "          \"briefTitle\": \"Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2003-11\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2009-03\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-07-22\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Hoffmann-La Roche\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"23800784\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Chapplain JM, Bellissant E, Guyader D, Molina JM, Poizot-Martin I, Perre P, Pialoux G, Turlin B, Mouchel C, Renault A, Michelet C; ANRS HC-12 Study Group. The effects of a maintenance therapy with peg-interferon alpha-2a on liver fibrosis in HIV/HCV co-infected patients: a randomized controlled trial. J Infect. 2013 Oct;67(4):313-21. doi: 10.1016/j.jinf.2013.05.007. Epub 2013 Jun 22.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02428816\",\n",
      "          \"briefTitle\": \"Evaluation of a Multimodal Neuroimaging Method for Diagnosis in Parkinsonian Syndromes\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2013-01-24\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-07-28\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2015-04-29\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02453048\",\n",
      "          \"briefTitle\": \"Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2015-09\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2015-05-25\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"24421886\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Thorstensson R, Trollfors B, Al-Tawil N, Jahnmatz M, Bergstrom J, Ljungman M, Torner A, Wehlin L, Van Broekhoven A, Bosman F, Debrie AS, Mielcarek N, Locht C. A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. PLoS One. 2014 Jan 8;9(1):e83449. doi: 10.1371/journal.pone.0083449. eCollection 2014.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24793938\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Jahnmatz M, Amu S, Ljungman M, Wehlin L, Chiodi F, Mielcarek N, Locht C, Thorstensson R. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial. Vaccine. 2014 Jun 5;32(27):3350-6. doi: 10.1016/j.vaccine.2014.04.048. Epub 2014 Apr 29.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24950361\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Feunou PF, Kammoun H, Debrie AS, Locht C. Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice. Vaccine. 2014 Jul 23;32(34):4281-8. doi: 10.1016/j.vaccine.2014.06.019. Epub 2014 Jun 17.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22814407\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Kammoun H, Feunou PF, Foligne B, Debrie AS, Raze D, Mielcarek N, Locht C. Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice. Vaccine. 2012 Aug 31;30(40):5864-70. doi: 10.1016/j.vaccine.2012.07.005. Epub 2012 Jul 17.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21430219\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Fedele G, Bianco M, Debrie AS, Locht C, Ausiello CM. Attenuated Bordetella pertussis vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1/Th17 response. J Immunol. 2011 May 1;186(9):5388-96. doi: 10.4049/jimmunol.1003765. Epub 2011 Mar 23.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21147936\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Skerry CM, Mahon BP. A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model. Clin Vaccine Immunol. 2011 Feb;18(2):187-93. doi: 10.1128/CVI.00371-10. Epub 2010 Dec 8.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20708998\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Feunou PF, Kammoun H, Debrie AS, Mielcarek N, Locht C. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1. Vaccine. 2010 Oct 8;28(43):7047-53. doi: 10.1016/j.vaccine.2010.08.017. Epub 2010 Aug 13.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20419113\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Feunou PF, Bertout J, Locht C. T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis. PLoS One. 2010 Apr 15;5(4):e10178. doi: 10.1371/journal.pone.0010178.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20107007\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Mielcarek N, Debrie AS, Mahieux S, Locht C. Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice. Clin Vaccine Immunol. 2010 Mar;17(3):317-24. doi: 10.1128/CVI.00322-09. Epub 2010 Jan 27.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"19625486\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Skerry CM, Cassidy JP, English K, Feunou-Feunou P, Locht C, Mahon BP. A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice. Clin Vaccine Immunol. 2009 Sep;16(9):1344-51. doi: 10.1128/CVI.00082-09. Epub 2009 Jul 22.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"18762220\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Feunou PF, Ismaili J, Debrie AS, Huot L, Hot D, Raze D, Lemoine Y, Locht C. Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1. Vaccine. 2008 Oct 23;26(45):5722-7. doi: 10.1016/j.vaccine.2008.08.018. Epub 2008 Aug 30.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"32687804\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Jahnmatz M, Richert L, Al-Tawil N, Storsaeter J, Colin C, Bauduin C, Thalen M, Solovay K, Rubin K, Mielcarek N, Thorstensson R, Locht C; BPZE1 study team. Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study. Lancet Infect Dis. 2020 Nov;20(11):1290-1301. doi: 10.1016/S1473-3099(20)30274-7. Epub 2020 Jul 17. Erratum In: Lancet Infect Dis. 2020 Sep;20(9):e215.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"31945015\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Lin A, Apostolovic D, Jahnmatz M, Liang F, Ols S, Tecleab T, Wu C, van Hage M, Solovay K, Rubin K, Locht C, Thorstensson R, Thalen M, Lore K. Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans. J Clin Invest. 2020 May 1;130(5):2332-2346. doi: 10.1172/JCI135020.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": true\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00120757\",\n",
      "          \"briefTitle\": \"Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2004-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2008-11\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-07-19\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"22353022\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Rozenberg S, Lanoy E, Bentata M, Viard JP, Valantin MA, Missy P, Darasteanu I, Roux C, Kolta S, Costagliola D; ANRS 120 Fosivir Study Group. Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120). AIDS Res Hum Retroviruses. 2012 Sep;28(9):972-80. doi: 10.1089/AID.2011.0224. Epub 2012 Mar 23.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02566148\",\n",
      "          \"briefTitle\": \"Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2013-05\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2015-10-02\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Ministry of Health, France\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Institut de Recherche pour le Developpement\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Institut national de prevention et d'education pour la sante\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"29982518\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Vignier N, Dray Spira R, Pannetier J, Ravalihasy A, Gosselin A, Lert F, Lydie N, Bouchaud O, Desgrees Du Lou A, Chauvin P; PARCOURS Study Group. Refusal to provide healthcare to sub-Saharan migrants in France: a comparison according to their HIV and HBV status. Eur J Public Health. 2018 Oct 1;28(5):904-910. doi: 10.1093/eurpub/cky118.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"29437866\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Gosselin A, Desgrees du Lou A, Lelievre E; PARCOURS Study Group. How to use sequence analysis for life course epidemiology? An example on HIV-positive Sub-Saharan migrants in France. J Epidemiol Community Health. 2018 Jun;72(6):507-512. doi: 10.1136/jech-2017-209739. Epub 2018 Feb 2.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"29307383\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Pannetier J, Ravalihasy A, Lydie N, Lert F, Desgrees du Lou A; Parcours study group. Prevalence and circumstances of forced sex and post-migration HIV acquisition in sub-Saharan African migrant women in France: an analysis of the ANRS-PARCOURS retrospective population-based study. Lancet Public Health. 2018 Jan;3(1):e16-e23. doi: 10.1016/S2468-2667(17)30211-6. Epub 2017 Nov 23.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00640263\",\n",
      "          \"briefTitle\": \"Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-12\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2014-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2008-03-21\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"European and Developing Countries Clinical Trials Partnership (EDCTP)\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"The Research Council of Norway\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Swedish International Development Cooperation Agency (SIDA)\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Universit\\u00e9 Montpellier\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University of Bergen\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"17825642\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Kourtis AP, Jamieson DJ, de Vincenzi I, Taylor A, Thigpen MC, Dao H, Farley T, Fowler MG. Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments. Am J Obstet Gynecol. 2007 Sep;197(3 Suppl):S113-22. doi: 10.1016/j.ajog.2007.03.003.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"32991450\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Birungi N, Fadnes LT, Engebretsen IMS, Tumwine JK, Astrom AN; for ANRS 12174 AND 12341 study groups. Antiretroviral treatment and its impact on oral health outcomes in 5 to 7 year old Ugandan children: A 6 year follow-up visit from the ANRS 12174 randomized trial. Medicine (Baltimore). 2020 Sep 25;99(39):e22352. doi: 10.1097/MD.0000000000022352.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"32228542\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Birungi N, Fadnes LT, Engebretsen IMS, Lie SA, Tumwine JK, Astrom AN; ANRS 12174 and 12341 study groups. Caries experience and oral health related quality of life in a cohort of Ugandan HIV-1 exposed uninfected children compared with a matched cohort of HIV unexposed uninfected children. BMC Public Health. 2020 Mar 30;20(1):423. doi: 10.1186/s12889-020-08564-1.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"32067040\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Montoya-Ferrer A, Sanosyan A, Fayd'herbe de Maudave A, Pisoni A, Bollore K, Moles JP, Peries M, Tylleskar T, Tumwine JK, Ndeezi G, Gorgolas M, Nagot N, van de Perre P, Tuaillon E. Clinical and Biological Factors Associated With Early Epstein-Barr Virus Infection in Human Immunodeficiency Virus-Exposed Uninfected Infants in Eastern Uganda. Clin Infect Dis. 2021 Mar 15;72(6):1026-1032. doi: 10.1093/cid/ciaa161.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"31994250\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Birungi N, Fadnes LT, Engebretsen IMS, Lie SA, Tumwine JK, Astrom AN; ANRS 12174 and 12341 study groups. Association of maternal HIV-1 severity with dental caries: an observational study of uninfected 5- to 7-yr-old children of HIV-1-infected mothers without severe immune suppression. Eur J Oral Sci. 2020 Feb;128(1):46-54. doi: 10.1111/eos.12669. Epub 2020 Jan 29.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"31633158\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Kariyawasam D, Peries M, Foissac F, Eymard-Duvernay S, Tylleskar T, Singata-Madliki M, Kankasa C, Meda N, Tumwine J, Mwiya M, Engebretsen I, Fluck CE, Hartmann MF, Wudy SA, Hirt D, Treluyer JM, Moles JP, Blanche S, Van De Perre P, Polak M, Nagot N; ANRS 12174 Trial Group. Lopinavir-Ritonavir Impairs Adrenal Function in Infants. Clin Infect Dis. 2020 Aug 14;71(4):1030-1039. doi: 10.1093/cid/ciz888.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"30814028\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Blanche S, Tylleskar T, Peries M, Kankasa C, Engebretsen I, Meda N, Tumwine JK, Singata-Madliki M, Mwiya M, Van de Perre P, Nagot N; ANRS 12174 Trial Group. Growth in HIV-1-exposed but uninfected infants treated with lopinavir-ritonavir versus lamivudine: a secondary analysis of the ANRS 12174 trial. Lancet HIV. 2019 May;6(5):e307-e314. doi: 10.1016/S2352-3018(18)30361-8. Epub 2019 Feb 24.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28469697\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Some EN, Engebretsen IMS, Nagot N, Meda N, Lombard C, Vallo R, Peries M, Kankasa C, Tumwine JK, Hofmeyr GJ, Singata M, Harper K, Van De Perre P, Tylleskar T; ANRS 12174 Trial Group. Breastfeeding patterns and its determinants among mothers living with Human Immuno-deficiency Virus -1 in four African countries participating in the ANRS 12174 trial. Int Breastfeed J. 2017 May 2;12:22. doi: 10.1186/s13006-017-0112-2. eCollection 2016.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27895016\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Foissac F, Blume J, Treluyer JM, Tylleskar T, Kankasa C, Meda N, Tumwine JK, Singata-Madliki M, Harper K, Illamola SM, Bouazza N, Nagot N, Van de Perre P, Blanche S, Hirt D. Are Prophylactic and Therapeutic Target Concentrations Different?: the Case of Lopinavir-Ritonavir or Lamivudine Administered to Infants for Prevention of Mother-to-Child HIV-1 Transmission during Breastfeeding. Antimicrob Agents Chemother. 2017 Jan 24;61(2):e01869-16. doi: 10.1128/AAC.01869-16. Print 2017 Feb.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26603917\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Nagot N, Kankasa C, Tumwine JK, Meda N, Hofmeyr GJ, Vallo R, Mwiya M, Kwagala M, Traore H, Sunday A, Singata M, Siuluta C, Some E, Rutagwera D, Neboua D, Ndeezi G, Jackson D, Marechal V, Neveu D, Engebretsen IMS, Lombard C, Blanche S, Sommerfelt H, Rekacewicz C, Tylleskar T, Van de Perre P; ANRS 12174 Trial Group. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. Lancet. 2016 Feb 6;387(10018):566-573. doi: 10.1016/S0140-6736(15)00984-8. Epub 2015 Nov 19. Erratum In: Lancet. 2019 Jun 22;393(10190):2492.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23039034\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Nagot N, Kankasa C, Meda N, Hofmeyr J, Nikodem C, Tumwine JK, Karamagi C, Sommerfelt H, Neveu D, Tylleskar T, Van de Perre P; PROMISE-PEP group. Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding: the PROMISE-PEP trial Protocol ANRS 12174. BMC Infect Dis. 2012 Oct 6;12:246. doi: 10.1186/1471-2334-12-246.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01693835\",\n",
      "          \"briefTitle\": \"\\\"Cancersensor\\\": Circadian Rhythms\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-08\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2014-06\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-09-26\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT04470648\",\n",
      "          \"briefTitle\": \"COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2020-07-22\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2021-08-22\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2020-07-14\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Samusocial de Paris\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Assistance Publique - H\\u00f4pitaux de Paris\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"32070465\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Bernard Stoecklin S, Rolland P, Silue Y, Mailles A, Campese C, Simondon A, Mechain M, Meurice L, Nguyen M, Bassi C, Yamani E, Behillil S, Ismael S, Nguyen D, Malvy D, Lescure FX, Georges S, Lazarus C, Tabai A, Stempfelet M, Enouf V, Coignard B, Levy-Bruhl D; Investigation team. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro Surveill. 2020 Feb;25(6):2000094. doi: 10.2807/1560-7917.ES.2020.25.6.2000094.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"32224310\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Lescure FX, Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S, Gaymard A, Bouscambert-Duchamp M, Donati F, Le Hingrat Q, Enouf V, Houhou-Fidouh N, Valette M, Mailles A, Lucet JC, Mentre F, Duval X, Descamps D, Malvy D, Timsit JF, Lina B, van-der-Werf S, Yazdanpanah Y. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020 Jun;20(6):697-706. doi: 10.1016/S1473-3099(20)30200-0. Epub 2020 Mar 27. Erratum In: Lancet Infect Dis. 2020 May 19;: Lancet Infect Dis. 2020 Jun;20(6):e116.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"32371096\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Deslandes A, Berti V, Tandjaoui-Lambotte Y, Alloui C, Carbonnelle E, Zahar JR, Brichler S, Cohen Y. SARS-CoV-2 was already spreading in France in late December 2019. Int J Antimicrob Agents. 2020 Jun;55(6):106006. doi: 10.1016/j.ijantimicag.2020.106006. Epub 2020 May 3.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"31978945\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W; China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"32046819\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveill. 2020 Feb;25(5):2000062. doi: 10.2807/1560-7917.ES.2020.25.5.2000062.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"31995857\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"32109013\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"32338732\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Baggett TP, Keyes H, Sporn N, Gaeta JM. Prevalence of SARS-CoV-2 Infection in Residents of a Large Homeless Shelter in Boston. JAMA. 2020 Jun 2;323(21):2191-2192. doi: 10.1001/jama.2020.6887.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02573948\",\n",
      "          \"briefTitle\": \"Feasibility of Interventions on People Who Inject Drugs in Vietnam\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-09\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-06\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2015-10-12\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"National Institute on Drug Abuse (NIDA)\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"26080690\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Elliott JC, Hasin DS, Stohl M, Des Jarlais DC. HIV, Hepatitis C, and Abstinence from Alcohol Among Injection and Non-injection Drug Users. AIDS Behav. 2016 Mar;20(3):548-54. doi: 10.1007/s10461-015-1113-z.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26075647\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Perlman DC, Des Jarlais DC, Feelemyer J. Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs? J Addict Dis. 2015;34(2-3):198-205. doi: 10.1080/10550887.2015.1059111.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26050614\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Perlman DC, Jordan AE, Uuskula A, Huong DT, Masson CL, Schackman BR, Des Jarlais DC. An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential. Int J Drug Policy. 2015 Nov;26(11):1056-63. doi: 10.1016/j.drugpo.2015.04.015. Epub 2015 Apr 27.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26032121\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Hatzakis A, Sypsa V, Paraskevis D, Nikolopoulos G, Tsiara C, Micha K, Panopoulos A, Malliori M, Psichogiou M, Pharris A, Wiessing L, van de Laar M, Donoghoe M, Heckathorn DD, Friedman SR, Des Jarlais DC. Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme. Addiction. 2015 Sep;110(9):1453-67. doi: 10.1111/add.12999. Epub 2015 Jul 14.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"25540950\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Des Jarlais DC. AIDS, people who use drugs, and altruism: reflection on a personal image. Subst Use Misuse. 2015 Mar;50(4):532-3. doi: 10.3109/10826084.2015.978185. Epub 2014 Dec 26. No abstract available.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28800503\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Michel L, Des Jarlais DC, Duong Thi H, Khuat Thi Hai O, Pham Minh K, Peries M, Vallo R, Nham Thi Tuyet T, Hoang Thi G, Le Sao M, Feelemyer J, Vu Hai V, Moles JP, Laureillard D, Nagot N; DRIVE Study Team. Intravenous heroin use in Haiphong, Vietnam: Need for comprehensive care including methamphetamine use-related interventions. Drug Alcohol Depend. 2017 Oct 1;179:198-204. doi: 10.1016/j.drugalcdep.2017.07.004. Epub 2017 Aug 2.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27178119\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Des Jarlais D, Duong HT, Pham Minh K, Khuat OH, Nham TT, Arasteh K, Feelemyer J, Heckathorn DD, Peries M, Moles JP, Laureillard D, Nagot N; (The Drive Study Team). Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. AIDS Care. 2016 Oct;28(10):1312-5. doi: 10.1080/09540121.2016.1178698. Epub 2016 May 13.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27006257\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Des Jarlais DC, Thi Huong D, Thi Hai Oanh K, Khue Pham M, Thi Giang H, Thi Tuyet Thanh N, Arasteh K, Feelemyer J, Hammett T, Peries M, Michel L, Vu Hai V, Roustide MJ, Moles JP, Laureillard D, Nagot N; DRIVE Study Team. Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam. Int J Drug Policy. 2016 Jun;32:50-6. doi: 10.1016/j.drugpo.2016.02.021. Epub 2016 Feb 27.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28612212\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Duong HT, Jarlais DD, Khuat OHT, Arasteh K, Feelemyer J, Khue PM, Giang HT, Laureillard D, Hai VV, Vallo R, Michel L, Moles JP, Nagot N; Drive Study Group. Risk Behaviors for HIV and HCV Infection Among People Who Inject Drugs in Hai Phong, Viet Nam, 2014. AIDS Behav. 2018 Jul;22(7):2161-2171. doi: 10.1007/s10461-017-1814-6.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": true\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01693848\",\n",
      "          \"briefTitle\": \"\\\"Cancersensor\\\" Metastasis Resection\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-09\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2014-11\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-09-26\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01895920\",\n",
      "          \"briefTitle\": \"Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread?\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2013-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2013-07-11\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01039220\",\n",
      "          \"briefTitle\": \"Incidence of H1N1v Influenza-like Illness and Risk Factors for Serious Influenza Forms in HIV Infected Patients\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-12\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2010-11\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2009-12-24\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00820118\",\n",
      "          \"briefTitle\": \"Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-05\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-05\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2009-01-09\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"26568566\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Piroth L, Moinot L, Yeni P, Avettand-Fenoel V, Reynes J, Girard PM, Marchou B, Georget A, Rouzioux C, Autran B, Duvillard L, Chene G, Fagard C; ANRS 141 TIPI Trial Study Group. Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial). J Antimicrob Chemother. 2016 Feb;71(2):490-6. doi: 10.1093/jac/dkv369. Epub 2015 Nov 14.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01801618\",\n",
      "          \"briefTitle\": \"National Evaluation of PI-based 2nd Line Efficacy in Cambodia\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2013-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2014-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2013-03-01\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02405013\",\n",
      "          \"briefTitle\": \"Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2015-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-11\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2015-04-01\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01779713\",\n",
      "          \"briefTitle\": \"Transcriptomic Signature of Vasospasm Consecutive to Sub-arachnoid Aneurismal Hemorrhage\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2013-02-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-07-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2013-01-30\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"30354977\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Pulcrano-Nicolas AS, Proust C, Clarencon F, Jacquens A, Perret C, Roux M, Shotar E, Thibord F, Puybasset L, Garnier S, Degos V, Tregouet DA. Whole-Blood miRNA Sequencing Profiling for Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage. Stroke. 2018 Sep;49(9):2220-2223. doi: 10.1161/STROKEAHA.118.021101.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03235258\",\n",
      "          \"briefTitle\": \"Cohort of HIV-infected Children\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2004-07\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2020-06\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2017-08-01\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"26762993\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Frange P, Faye A, Avettand-Fenoel V, Bellaton E, Descamps D, Angin M, David A, Caillat-Zucman S, Peytavin G, Dollfus C, Le Chenadec J, Warszawski J, Rouzioux C, Saez-Cirion A; ANRS EPF-CO10 Pediatric Cohort and the ANRS EP47 VISCONTI study group. HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report. Lancet HIV. 2016 Jan;3(1):e49-54. doi: 10.1016/S2352-3018(15)00232-5. Epub 2015 Dec 9.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24945880\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Aupiais C, Faye A, Le Chenadec J, Rouzioux C, Bouallag N, Laurent C, Blanche S, Dollfus C, Warszawski J; ANRS EPF-CO10 French Pediatric Cohort. Interruption of cART in clinical practice is associated with an increase in the long-term risk of subsequent immunosuppression in HIV-1-infected children. Pediatr Infect Dis J. 2014 Dec;33(12):1237-45. doi: 10.1097/INF.0000000000000450.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24705410\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Sofeu CL, Warszawski J, Ateba Ndongo F, Penda IC, Tetang Ndiang S, Guemkam G, Makwet N, Owona F, Kfutwah A, Tchendjou P, Texier G, Tchuente M, Faye A, Tejiokem MC; ANRS-PEDIACAM Study Group. Low birth weight in perinatally HIV-exposed uninfected infants: observations in urban settings in Cameroon. PLoS One. 2014 Apr 3;9(4):e93554. doi: 10.1371/journal.pone.0093554. eCollection 2014.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24253249\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Blanche S, Scott-Algara D, Le Chenadec J, Didier C, Montange T, Avettand-Fenoel V, Rouzioux C, Melard A, Viard JP, Dollfus C, Bouallag N, Warszawski J, Buseyne F. Naive T lymphocytes and recent thymic emigrants are associated with HIV-1 disease history in french adolescents and young adults infected in the perinatal period: the ANRS-EP38-IMMIP study. Clin Infect Dis. 2014 Feb;58(4):573-87. doi: 10.1093/cid/cit729. Epub 2013 Nov 18.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22427678\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Avettand-Fenoel V, Blanche S, Le Chenadec J, Scott-Algara D, Dollfus C, Viard JP, Bouallag N, Benmebarek Y, Riviere Y, Warszawski J, Rouzioux C, Buseyne F. Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study. J Infect Dis. 2012 May 15;205(10):1520-8. doi: 10.1093/infdis/jis233. Epub 2012 Mar 15.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22198788\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Goetghebuer T, Le Chenadec J, Haelterman E, Galli L, Dollfus C, Thorne C, Judd A, Keiser O, Ramos JT, Levy J, Warszawski J; European Infant Collaboration Group. Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation. Clin Infect Dis. 2012 Mar;54(6):878-81. doi: 10.1093/cid/cir950. Epub 2011 Dec 23.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21971357\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Judd A; European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord. Early antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens. AIDS. 2011 Nov 28;25(18):2279-87. doi: 10.1097/QAD.0b013e32834d614c.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21511330\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Pursuing Later Treatment Options II (PLATO II) project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE); Castro H, Judd A, Gibb DM, Butler K, Lodwick RK, van Sighem A, Ramos JT, Warsawski J, Thorne C, Noguera-Julian A, Obel N, Costagliola D, Tookey PA, Colin C, Kjaer J, Grarup J, Chene G, Phillips A. Risk of triple-class virological failure in children with HIV: a retrospective cohort study. Lancet. 2011 May 7;377(9777):1580-7. doi: 10.1016/S0140-6736(11)60208-0. Epub 2011 Apr 20.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20536367\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Dollfus C, Le Chenadec J, Faye A, Blanche S, Briand N, Rouzioux C, Warszawski J. Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10). Clin Infect Dis. 2010 Jul 15;51(2):214-24. doi: 10.1086/653674.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"19194272\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Goetghebuer T, Haelterman E, Le Chenadec J, Dollfus C, Gibb D, Judd A, Green H, Galli L, Ramos JT, Giaquinto C, Warszawski J, Levy J; European Infant Collaboration group. Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. AIDS. 2009 Mar 13;23(5):597-604. doi: 10.1097/QAD.0b013e328326ca37.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"18614870\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group; Sabin CA, Smith CJ, d'Arminio Monforte A, Battegay M, Gabiano C, Galli L, Geelen S, Gibb D, Guiguet M, Judd A, Leport C, Dabis F, Pantazis N, Porter K, Raffi F, Thorne C, Torti C, Walker S, Warszawski J, Wintergerst U, Chene G, Lundgren J. Response to combination antiretroviral therapy: variation by age. AIDS. 2008 Jul 31;22(12):1463-73. doi: 10.1097/QAD.0b013e3282f88d02.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"17712765\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Warszawski J, Lechenadec J, Faye A, Dollfus C, Firtion G, Meyer L, Douard D, Monpoux F, Tricoire J, Benmebarek Y, Rouzioux C, Blanche S. Long-term nonprogression of HIV infection in children: evaluation of the ANRS prospective French Pediatric Cohort. Clin Infect Dis. 2007 Sep 15;45(6):785-94. doi: 10.1086/521165. Epub 2007 Aug 14.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03071458\",\n",
      "          \"briefTitle\": \"Mutational Landscape in Hepatocellular Carcinoma\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2008-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-05\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2017-03-07\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02886416\",\n",
      "          \"briefTitle\": \"Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immunity\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2016-08\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2016-09-01\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01899196\",\n",
      "          \"briefTitle\": \"Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2013-07\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-03\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2013-07-15\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00944541\",\n",
      "          \"briefTitle\": \"Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-09\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2011-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2009-07-23\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Pfizer\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02160119\",\n",
      "          \"briefTitle\": \"Emotional and Change-related Attention in Autism\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-05-27\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-05-27\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-06-10\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00158496\",\n",
      "          \"briefTitle\": \"Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2002-08\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2005-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-09-12\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Hoffmann-La Roche\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"16956918\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Marzouk D, Sass J, Bakr I, El Hosseiny M, Abdel-Hamid M, Rekacewicz C, Chaturvedi N, Mohamed MK, Fontanet A. Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Gut. 2007 Aug;56(8):1105-10. doi: 10.1136/gut.2006.091983. Epub 2006 Sep 6.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"16847958\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Mohamed MK, Bakr I, El-Hoseiny M, Arafa N, Hassan A, Ismail S, Anwar M, Attala M, Rekacewicz C, Zalata K, Abdel-Hamid M, Esmat G, Fontanet A. HCV-related morbidity in a rural community of Egypt. J Med Virol. 2006 Sep;78(9):1185-9. doi: 10.1002/jmv.20679.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"16434426\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Bakr I, Rekacewicz C, El Hosseiny M, Ismail S, El Daly M, El-Kafrawy S, Esmat G, Hamid MA, Mohamed MK, Fontanet A. Higher clearance of hepatitis C virus infection in females compared with males. Gut. 2006 Aug;55(8):1183-7. doi: 10.1136/gut.2005.078147. Epub 2006 Jan 24.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"16019104\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Arafa N, El Hoseiny M, Rekacewicz C, Bakr I, El-Kafrawy S, El Daly M, Aoun S, Marzouk D, Mohamed MK, Fontanet A. Changing pattern of hepatitis C virus spread in rural areas of Egypt. J Hepatol. 2005 Sep;43(3):418-24. doi: 10.1016/j.jhep.2005.03.021.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02192658\",\n",
      "          \"briefTitle\": \"Disability and HIV: Vulnerability of People With Disabilities to HIV Infection in Sub-Saharan Africa\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-11\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-07\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-07-17\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Handicap International\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Institut de Recherche pour le Developpement\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Institut de Formation et de Recherche D\\u00e9mographique\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Forum Camerounais de Psychologie\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Centre de Recherche Internationale pour la Sant\\u00e9 de l'Universit\\u00e9 de Ouagadougou\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"26846895\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"De Beaudrap P, Pasquier E, Tchoumkeu A, Touko A, Essomba F, Brus A, Desgrees du Lou A, Aderemi TJ, Hanass-Hancock J, Eide AH, Mont D, Mac-Seing M, Beninguisse G. HandiVIH--A population-based survey to understand the vulnerability of people with disabilities to HIV and other sexual and reproductive health problems in Cameroon: protocol and methodological considerations. BMJ Open. 2016 Feb 4;6(2):e008934. doi: 10.1136/bmjopen-2015-008934.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00383734\",\n",
      "          \"briefTitle\": \"Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2006-12\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2010-09\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2006-10-03\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Procitech\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Sanofi\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"23432777\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Lafaurie M, Dolivo M, Girard PM, May T, Bouchaud O, Carbonnel E, Madelaine I, Loze B, Porcher R, Molina JM; ANRS 132 SMILE study group. Polylactic acid vs. polyacrylamide hydrogel for treatment of facial lipoatrophy: a randomized controlled trial [Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS) 132 SMILE]. HIV Med. 2013 Aug;14(7):410-20. doi: 10.1111/hiv.12021. Epub 2013 Feb 24.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02051413\",\n",
      "          \"briefTitle\": \"Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-02-18\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-05\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-01-31\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03109067\",\n",
      "          \"briefTitle\": \"Genetic and Metabolism of Post-prandial HDL Particles\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2011-09-21\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-11-21\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2017-04-12\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02073604\",\n",
      "          \"briefTitle\": \"Role of the SMA During Unimanual and Bimanual Movements Preparation: the Mirror Movements Paradigm\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-03\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-02-27\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01490489\",\n",
      "          \"briefTitle\": \"EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2011-07-11\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-03-13\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2011-12-13\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"17531315\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Hoffmann P, Feige JJ, Alfaidy N. Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation. Placenta. 2007 Oct;28(10):1049-58. doi: 10.1016/j.placenta.2007.03.008. Epub 2007 May 25.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"16384869\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Hoffmann P, Feige JJ, Alfaidy N. Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy. Endocrinology. 2006 Apr;147(4):1675-84. doi: 10.1210/en.2005-0912. Epub 2005 Dec 29.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"19602057\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Hoffmann P, Saoudi Y, Benharouga M, Graham CH, Schaal JP, Mazouni C, Feige JJ, Alfaidy N. Role of EG-VEGF in human placentation: Physiological and pathological implications. J Cell Mol Med. 2009 Aug;13(8B):2224-2235. doi: 10.1111/j.1582-4934.2008.00554.x.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01335529\",\n",
      "          \"briefTitle\": \"Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2011-05\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2014-05\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2011-04-14\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Rennes University Hospital\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Merck Sharp & Dohme LLC\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"27077673\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Poizot-Martin I, Bellissant E, Garraffo R, Colson P, Piroth L, Solas C, Renault A, Bourliere M, Halfon P, Ghosn J, Alric L, Naqvi A, Carrieri P, Molina JM; ANRS HC27 BOCEPREVIH Study Group. Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study. HIV Clin Trials. 2016 Mar;17(2):63-71. doi: 10.1080/15284336.2015.1135553. Epub 2016 Feb 11.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00545194\",\n",
      "          \"briefTitle\": \"Cervical Ripening Before Induction of Labour at Term: a Randomised Comparison of Prostin vs Propess\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2002-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2004-10\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2007-10-17\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"11236117\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Lyrenas S, Clason I, Ulmsten U. In vivo controlled release of PGE2 from a vaginal insert (0.8 mm, 10 mg) during induction of labour. BJOG. 2001 Feb;108(2):169-78. doi: 10.1111/j.1471-0528.2001.00039.x.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"16553177\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Strobelt N, Meregalli V, Ratti M, Mariani S, Zani G, Morana S. Randomized study on removable PGE2 vaginal insert versus PGE2 cervical gel for cervical priming and labor induction in low-Bishop-score pregnancy. Acta Obstet Gynecol Scand. 2006;85(3):302-5. doi: 10.1080/00016340500523685.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"17071427\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"El-Shawarby SA, Connell RJ. Induction of labour at term with vaginal prostaglandins preparations: a randomised controlled trial of Prostin vs Propess. J Obstet Gynaecol. 2006 Oct;26(7):627-30. doi: 10.1080/01443610600903362.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03298360\",\n",
      "          \"briefTitle\": \"A Chronological Study of the Formation of HIV Cellular Reservoirs Through the Expression of Surface Markers on CD4 + T Lymphocytes, Including CD32a\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2018-06-28\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2020-06-25\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2017-10-02\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01508494\",\n",
      "          \"briefTitle\": \"Cognitive Rehabilitation and Galantamine for Post Stroke Cognitive Impairment\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2011-06-29\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-06-22\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-01-12\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00573001\",\n",
      "          \"briefTitle\": \"Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2008-07\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2011-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2007-12-13\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Institut de M\\u00e9decine et d'Epid\\u00e9miologie Appliqu\\u00e9e - Fondation Internationale L\\u00e9on M'Ba\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Gilead Sciences\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Merck Sharp & Dohme LLC\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00236340\",\n",
      "          \"briefTitle\": \"Syringe or Continuous Amnioreduction for Symptomatic Polyhydramnios. A Prospective Randomized Study.\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2002-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2005-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-10-12\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"14770396\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Leung WC, Jouannic JM, Hyett J, Rodeck C, Jauniaux E. Procedure-related complications of rapid amniodrainage in the treatment of polyhydramnios. Ultrasound Obstet Gynecol. 2004 Feb;23(2):154-8. doi: 10.1002/uog.972.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"11438952\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Jauniaux E, Holmes A, Hyett J, Yates R, Rodeck C. Rapid and radical amniodrainage in the treatment of severe twin-twin transfusion syndrome. Prenat Diagn. 2001 Jun;21(6):471-6. doi: 10.1002/pd.96.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"7970458\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Elliott JP, Sawyer AT, Radin TG, Strong RE. Large-volume therapeutic amniocentesis in the treatment of hydramnios. Obstet Gynecol. 1994 Dec;84(6):1025-7.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"9464739\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Dolinger MB, Donnenfeld AE. Therapeutic amniocentesis using a vacuum bottle aspiration system. Obstet Gynecol. 1998 Jan;91(1):143-4. doi: 10.1016/s0029-7844(97)00584-x.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02542891\",\n",
      "          \"briefTitle\": \"European Comparative Effectiveness Research on Internet-based Depression Treatment\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2015-09\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-09-15\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2015-09-07\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"European Commission\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Fondation FondaMental\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Assistance Publique - H\\u00f4pitaux de Paris\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"34874888\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"van Genugten CR, Schuurmans J, Hoogendoorn AW, Araya R, Andersson G, Banos R, Botella C, Cerga Pashoja A, Cieslak R, Ebert DD, Garcia-Palacios A, Hazo JB, Herrero R, Holtzmann J, Kemmeren L, Kleiboer A, Krieger T, Smoktunowicz E, Titzler I, Topooco N, Urech A, Smit JH, Riper H. Examining the Theoretical Framework of Behavioral Activation for Major Depressive Disorder: Smartphone-Based Ecological Momentary Assessment Study. JMIR Ment Health. 2021 Dec 6;8(12):e32007. doi: 10.2196/32007.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27488181\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Kleiboer A, Smit J, Bosmans J, Ruwaard J, Andersson G, Topooco N, Berger T, Krieger T, Botella C, Banos R, Chevreul K, Araya R, Cerga-Pashoja A, Cieslak R, Rogala A, Vis C, Draisma S, van Schaik A, Kemmeren L, Ebert D, Berking M, Funk B, Cuijpers P, Riper H. European COMPARative Effectiveness research on blended Depression treatment versus treatment-as-usual (E-COMPARED): study protocol for a randomized controlled, non-inferiority trial in eight European countries. Trials. 2016 Aug 3;17(1):387. doi: 10.1186/s13063-016-1511-1.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03671291\",\n",
      "          \"briefTitle\": \"Missed Opportunities to Pre-exposure Prophylaxis for HIV Infection on Person Newly Diagnosed With HIV\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2019-04-03\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2021-10-03\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2018-09-14\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"University Hospital, Marseille\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University Hospital, Grenoble\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Centre Hospitalier Universitaire de Nice\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University Hospital, Montpellier\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Hospital Purpan\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University Hospital, Bordeaux\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"H\\u00f4pital de la Croix-Rousse\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Centre Hospitalier Universitaire Dijon\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University Hospital of Saint-Etienne\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University Hospital, Clermont-Ferrand\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Centre Hospitalier Universitaire de Besancon\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Tourcoing Hospital\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University Hospital, Strasbourg\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Nantes University Hospital\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Centre Hospitalier R\\u00e9gional d'Orl\\u00e9ans\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Rennes University Hospital\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Saint Antoine University Hospital\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Tenon Hospital, Paris\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Saint-Louis Hospital, Paris, France\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"H\\u00f4pital Necker-Enfants Malades\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Bicetre Hospital\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Piti\\u00e9-Salp\\u00eatri\\u00e8re Hospital\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Bichat Hospital\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University Hospital Center of Martinique\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01066962\",\n",
      "          \"briefTitle\": \"Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral na\\u00efve Subjects\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2010-08\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2013-10\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2010-02-10\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"NEAT - European AIDS Treatment Network\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"33794182\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Esteban-Cantos A, Rodriguez-Centeno J, Barruz P, Alejos B, Saiz-Medrano G, Nevado J, Martin A, Gaya F, De Miguel R, Bernardino JI, Montejano R, Mena-Garay B, Cadinanos J, Florence E, Mulcahy F, Banhegyi D, Antinori A, Pozniak A, Wallet C, Raffi F, Rodes B, Arribas JR; NEAT001/ANRS143 Study Group. Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial. Lancet HIV. 2021 Apr;8(4):e197-e205. doi: 10.1016/S2352-3018(21)00006-0. Erratum In: Lancet HIV. 2021 Dec;8(12):e734.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"30365452\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Ammassari A, Stohr W, Antinori A, Molina JM, Schwimmer C, Domingo P, Thalme A, Di Pietro M, Wallet C, Pozniak A, Richert L, Raffi F; NEAT001/ANRS143 Trial Study Group. Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial. J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):481-490. doi: 10.1097/QAI.0000000000001834.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26520926\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Bernardino JI, Mocroft A, Mallon PW, Wallet C, Gerstoft J, Russell C, Reiss P, Katlama C, De Wit S, Richert L, Babiker A, Buno A, Castagna A, Girard PM, Chene G, Raffi F, Arribas JR; NEAT001/ANRS143 Study Group. Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial. Lancet HIV. 2015 Nov;2(11):e464-73. doi: 10.1016/S2352-3018(15)00181-2. Epub 2015 Sep 30.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"25103176\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Raffi F, Babiker AG, Richert L, Molina JM, George EC, Antinori A, Arribas JR, Grarup J, Hudson F, Schwimmer C, Saillard J, Wallet C, Jansson PO, Allavena C, Van Leeuwen R, Delfraissy JF, Vella S, Chene G, Pozniak A; NEAT001/ANRS143 Study Group. Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial. Lancet. 2014 Nov 29;384(9958):1942-51. doi: 10.1016/S0140-6736(14)61170-3. Epub 2014 Aug 4.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01703962\",\n",
      "          \"briefTitle\": \"Non Invasive IDentification of Gliomas With IDH1 Mutation\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-03-14\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2014-03-20\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-10-11\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03642704\",\n",
      "          \"briefTitle\": \"HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2017-02-22\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2019-09-17\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2018-08-22\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01086904\",\n",
      "          \"briefTitle\": \"Safety and Efficacy of an Inactivated and Non Adjuvanted Vaccine Against Influenza A in Renal Transplant Recipients\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-11\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2010-05\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2010-03-15\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"MCM Vaccines B.V.\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01127204\",\n",
      "          \"briefTitle\": \"Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2011-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2010-05-20\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"European and Developing Countries Clinical Trials Partnership (EDCTP)\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Public Research Centre Health, Luxembourg\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Ministry of Foreign Affairs, Luxembourg\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University of Ouagadougou, Burkina Faso\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Programme PAC-CI, Site ANRS-MIE de C\\u00f4te d'Ivoire\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Ministry of Health, Rwanda\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University of Bordeaux\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Institut de Sante Publique, d'Epid\\u00e9miologie et de D\\u00e9veloppement\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Universit\\u00e9 Montpellier\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University of Paris 5 - Rene Descartes\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Queen Fabiola Children's University Hospital\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"34723858\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Pressiat C, Toni TD, Treluyer JM, Yonaba C, Dahourou DL, Malateste K, Seguin-Devaux C, Leroy V, Hirt D; MONOD ANRS Study Group. High nevirapine levels in breast milk and consequences in HIV-infected child when initiated on antiretroviral therapy. AIDS. 2021 Nov 15;35(14):2409-2410. doi: 10.1097/QAD.0000000000003043. No abstract available.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"31334298\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Desmonde S, Frank SC, Coovadia A, Dahourou DL, Hou T, Abrams EJ, Amorissani-Folquet M, Walensky RP, Strehlau R, Penazzato M, Freedberg KA, Kuhn L, Leroy V, Ciaranello AL. Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus. Open Forum Infect Dis. 2019 Jun 11;6(7):ofz276. doi: 10.1093/ofid/ofz276. eCollection 2019 Jul.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28800382\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Pressiat C, Mea-Assande V, Yonaba C, Treluyer JM, Dahourou DL, Amorissani-Folquet M, Blanche S, Eboua F, Ye D, Lui G, Malateste K, Zheng Y, Leroy V, Hirt D; MONOD Study Group. Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines. Br J Clin Pharmacol. 2017 Dec;83(12):2729-2740. doi: 10.1111/bcp.13397. Epub 2017 Sep 20.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28483965\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Pressiat C, Amorissani-Folquet M, Yonaba C, Treluyer JM, Dahourou DL, Eboua F, Blanche S, Mea-Assande V, Bouazza N, Foissac F, Malateste K, Ouedraogo S, Lui G, Leroy V, Hirt D. Pharmacokinetics of Efavirenz at a High Dose of 25 Milligrams per Kilogram per Day in Children 2 to 3 Years Old. Antimicrob Agents Chemother. 2017 Jun 27;61(7):e00297-17. doi: 10.1128/AAC.00297-17. Print 2017 Jul.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28453240\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Amani-Bosse C, Dahourou DL, Malateste K, Amorissani-Folquet M, Coulibaly M, Dattez S, Emieme A, Barry M, Rouzioux C, N'gbeche S, Yonaba C, Timite-Konan M, Mea V, Ouedraogo S, Blanche S, Meda N, Seguin-Devaux C, Leroy V. Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort. J Int AIDS Soc. 2017 Apr 25;20(1):21362. doi: 10.7448/IAS.20.01.21362.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28434406\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Dahourou DL, Amorissani-Folquet M, Malateste K, Amani-Bosse C, Coulibaly M, Seguin-Devaux C, Toni T, Ouedraogo R, Blanche S, Yonaba C, Eboua F, Lepage P, Avit D, Ouedraogo S, Van de Perre P, N'Gbeche S, Kalmogho A, Salamon R, Meda N, Timite-Konan M, Leroy V; MONOD Study Group. Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Cote d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial. BMC Med. 2017 Apr 24;15(1):85. doi: 10.1186/s12916-017-0842-4.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27015798\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Dahourou DL, Amorissani-Folquet M, Coulibaly M, Avit-Edi D, Meda N, Timite-Konan M, Arendt V, Ye D, Amani-Bosse C, Salamon R, Lepage P, Leroy V; Monod Anrs 12206 Study Group. Missed opportunities of inclusion in a cohort of HIV-infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013. J Int AIDS Soc. 2016 Mar 23;19(1):20601. doi: 10.7448/IAS.19.1.20601. eCollection 2016.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01771562\",\n",
      "          \"briefTitle\": \"Nutritional and Metabolic Disorders in HIV Infected Children and Adolescent\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2013-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2013-01-18\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"30081838\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Cames C, Pascal L, Ba A, Mbodj H, Ouattara B, Diallo NF, Msellati P, Mbaye N, Sy Signate H, Blanche S, Diack A; MAGGSEN Cohort Study Group. Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort Study. BMC Infect Dis. 2018 Aug 6;18(1):374. doi: 10.1186/s12879-018-3282-7.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27881690\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Cames C, Varloteaux M, Have NN, Diom AB, Msellati P, Mbaye N, Mbodj H, Sy Signate H, Diack A; ANRS 12279 MAGGSEN Cohort Study Group. Acceptability of Outpatient Ready-To-Use Food-Based Protocols in HIV-Infected Senegalese Children and Adolescents Within the MAGGSEN Cohort Study. Food Nutr Bull. 2017 Mar;38(1):27-36. doi: 10.1177/0379572116679053. Epub 2016 Nov 23.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00196612\",\n",
      "          \"briefTitle\": \"Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2001-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2004-09\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-09-20\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Triangle Pharmaceuticals\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Gilead Sciences\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Bristol-Myers Squibb\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Dupont Applied Biosciences\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"15717256\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Molina JM, Journot V, Morand-Joubert L, Yeni P, Rozenbaum W, Rancinan C, Fournier S, Morlat P, Palmer P, Dupont B, Goujard C, Dellamonica P, Collin F, Poizot-Martin I, Chene G; ALIZE (Agence Nationale de Recherches sur le SIDA 099) Study Team. Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HIV-1-infected adults with viral suppression receiving a protease inhibitor-based regimen: a randomized trial. J Infect Dis. 2005 Mar 15;191(6):830-9. doi: 10.1086/428091. Epub 2005 Feb 10.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01226446\",\n",
      "          \"briefTitle\": \"Efficacy of Vitamin D on Top of Pegylated Interferon and Ribavirin in Patients With Chronic Viral Hepatitis C Null-Responders\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2010-11\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2013-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2010-10-22\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"25987791\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Terrier B, Lapidus N, Pol S, Serfaty L, Ratziu V, Asselah T, Thibault V, Souberbielle JC, Carrat F, Cacoub P. Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study. World J Gastroenterol. 2015 May 14;21(18):5647-53. doi: 10.3748/wjg.v21.i18.5647.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02496312\",\n",
      "          \"briefTitle\": \"Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2015-07-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-10-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2015-07-14\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"12461757\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Robert PH, Clairet S, Benoit M, Koutaich J, Bertogliati C, Tible O, Caci H, Borg M, Brocker P, Bedoucha P. The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. Int J Geriatr Psychiatry. 2002 Dec;17(12):1099-105. doi: 10.1002/gps.755.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"10436334\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Pasquier F, Lebert F, Lavenu I, Guillaume B. The clinical picture of frontotemporal dementia: diagnosis and follow-up. Dement Geriatr Cogn Disord. 1999;10 Suppl 1:10-4. doi: 10.1159/000051206.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"19713543\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Mayo NE, Fellows LK, Scott SC, Cameron J, Wood-Dauphinee S. A longitudinal view of apathy and its impact after stroke. Stroke. 2009 Oct;40(10):3299-307. doi: 10.1161/STROKEAHA.109.554410. Epub 2009 Aug 27.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"17027767\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Winograd-Gurvich C, Fitzgerald PB, Georgiou-Karistianis N, Bradshaw JL, White OB. Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's disease. Brain Res Bull. 2006 Oct 16;70(4-6):312-21. doi: 10.1016/j.brainresbull.2006.06.007. Epub 2006 Jul 5.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"10678322\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Marin RS, Firinciogullari S, Biedrzycki RC. Group differences in the relationship between apathy and depression. J Nerv Ment Dis. 1994 Apr;182(4):235-9. doi: 10.1097/00005053-199404000-00008.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"18307266\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Dujardin K, Sockeel P, Delliaux M, Destee A, Defebvre L. The Lille Apathy Rating Scale: validation of a caregiver-based version. Mov Disord. 2008 Apr 30;23(6):845-9. doi: 10.1002/mds.21968.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"19533496\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Lane-Brown AT, Tate RL. Apathy after acquired brain impairment: a systematic review of non-pharmacological interventions. Neuropsychol Rehabil. 2009 Aug;19(4):481-516. doi: 10.1080/09602010902949207.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"15897497\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Czernecki V, Pillon B, Houeto JL, Welter ML, Mesnage V, Agid Y, Dubois B. Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease? J Neurol Neurosurg Psychiatry. 2005 Jun;76(6):775-9. doi: 10.1136/jnnp.2003.033258.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"19933975\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Le Jeune F, Drapier D, Bourguignon A, Peron J, Mesbah H, Drapier S, Sauleau P, Haegelen C, Travers D, Garin E, Malbert CH, Millet B, Verin M. Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Neurology. 2009 Nov 24;73(21):1746-51. doi: 10.1212/WNL.0b013e3181c34b34.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"1821241\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Marin RS. Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci. 1991 Summer;3(3):243-54. doi: 10.1176/jnp.3.3.243.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"16207933\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex. 2006 Jul;16(7):916-28. doi: 10.1093/cercor/bhj043. Epub 2005 Oct 5.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"17131230\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Levy R, Czernecki V. Apathy and the basal ganglia. J Neurol. 2006 Dec;253 Suppl 7:VII54-61. doi: 10.1007/s00415-006-7012-5.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"10941190\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Brown RG, Pluck G. Negative symptoms: the 'pathology' of motivation and goal-directed behaviour. Trends Neurosci. 2000 Sep;23(9):412-7. doi: 10.1016/s0166-2236(00)01626-x.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"16421064\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Muller U, Czymmek J, Thone-Otto A, Von Cramon DY. Reduced daytime activity in patients with acquired brain damage and apathy: a study with ambulatory actigraphy. Brain Inj. 2006 Feb;20(2):157-60. doi: 10.1080/02699050500443467.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21895376\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Funkiewiez A, Bertoux M, de Souza LC, Levy R, Dubois B. The SEA (Social cognition and Emotional Assessment): a clinical neuropsychological tool for early diagnosis of frontal variant of frontotemporal lobar degeneration. Neuropsychology. 2012 Jan;26(1):81-90. doi: 10.1037/a0025318. Epub 2011 Sep 5.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT04133012\",\n",
      "          \"briefTitle\": \"Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2020-02-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2023-06-09\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2019-10-21\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"ViiV Healthcare\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01100281\",\n",
      "          \"briefTitle\": \"Prefrontal Cortex and Abstract Thinking\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2010-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2011-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2010-04-08\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01647295\",\n",
      "          \"briefTitle\": \"Social Interactions: Ocular Explorations and Pupillometry in Autism\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2013-02-25\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2019-06-18\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-07-23\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00424814\",\n",
      "          \"briefTitle\": \"Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2007-03\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-11\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2007-01-22\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Abbott\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"25838291\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Sibiude J, Le Chenadec J, Bonnet D, Tubiana R, Faye A, Dollfus C, Mandelbrot L, Delmas S, Lelong N, Khoshnood B, Warszawski J, Blanche S; French National Agency for Research on AIDS and Viral Hepatitis French Perinatal Cohort/Protease Inhibitor Monotherapy Evaluation Trial. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial. Clin Infect Dis. 2015 Jul 15;61(2):270-80. doi: 10.1093/cid/civ260. Epub 2015 Apr 1.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23766338\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Tubiana R, Mandelbrot L, Le Chenadec J, Delmas S, Rouzioux C, Hirt D, Treluyer JM, Ekoukou D, Bui E, Chaix ML, Blanche S, Warszawski J; ANRS 135 PRIMEVA (Protease Inhibitor Monotherapy Evaluation) Study Group. Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial. Clin Infect Dis. 2013 Sep;57(6):891-902. doi: 10.1093/cid/cit390. Epub 2013 Jun 12.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02488395\",\n",
      "          \"briefTitle\": \"Superior Colliculus Activity in Parkinson Disease: a Potential Marker?\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2015-10-07\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-01-19\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2015-07-02\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"22639796\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Marino RA, Levy R, Boehnke S, White BJ, Itti L, Munoz DP. Linking visual response properties in the superior colliculus to saccade behavior. Eur J Neurosci. 2012 Jun;35(11):1738-52. doi: 10.1111/j.1460-9568.2012.08079.x. Epub 2012 May 28.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"6774653\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Wurtz RH, Albano JE. Visual-motor function of the primate superior colliculus. Annu Rev Neurosci. 1980;3:189-226. doi: 10.1146/annurev.ne.03.030180.001201. No abstract available.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23916713\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Rolland M, Carcenac C, Overton PG, Savasta M, Coizet V. Enhanced visual responses in the superior colliculus and subthalamic nucleus in an animal model of Parkinson's disease. Neuroscience. 2013 Nov 12;252:277-88. doi: 10.1016/j.neuroscience.2013.07.047. Epub 2013 Jul 31.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00658346\",\n",
      "          \"briefTitle\": \"Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2010-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-09\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2008-04-15\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"31063537\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Kouanfack C, Unal G, Schaeffer L, Kfutwah A, Aghokeng A, Mougnutou R, Tchemgui-Noumsi N, Alessandri-Gradt E, Delaporte E, Simon F, Vray M, Plantier JC; ANRS 12168 DynaMO Study. Comparative Immunovirological and Clinical Responses to Antiretroviral Therapy Between HIV-1 Group O and HIV-1 Group M Infected Patients. Clin Infect Dis. 2020 Mar 17;70(7):1471-1477. doi: 10.1093/cid/ciz371.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01188512\",\n",
      "          \"briefTitle\": \"First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2010-08\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2010-08-25\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"European Union\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Swedish Institute for Infectious Disease Control\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Innogenetics\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"16839199\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Mielcarek N, Debrie AS, Raze D, Bertout J, Rouanet C, Younes AB, Creusy C, Engle J, Goldman WE, Locht C. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog. 2006 Jul;2(7):e65. doi: 10.1371/journal.ppat.0020065.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"18762220\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Feunou PF, Ismaili J, Debrie AS, Huot L, Hot D, Raze D, Lemoine Y, Locht C. Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1. Vaccine. 2008 Oct 23;26(45):5722-7. doi: 10.1016/j.vaccine.2008.08.018. Epub 2008 Aug 30.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20107007\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Mielcarek N, Debrie AS, Mahieux S, Locht C. Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice. Clin Vaccine Immunol. 2010 Mar;17(3):317-24. doi: 10.1128/CVI.00322-09. Epub 2010 Jan 27.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20184606\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Kavanagh H, Noone C, Cahill E, English K, Locht C, Mahon BP. Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model. Clin Exp Allergy. 2010 Jun;40(6):933-41. doi: 10.1111/j.1365-2222.2010.03459.x. Epub 2010 Feb 22.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"19625486\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Skerry CM, Cassidy JP, English K, Feunou-Feunou P, Locht C, Mahon BP. A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice. Clin Vaccine Immunol. 2009 Sep;16(9):1344-51. doi: 10.1128/CVI.00082-09. Epub 2009 Jul 22.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24793938\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Jahnmatz M, Amu S, Ljungman M, Wehlin L, Chiodi F, Mielcarek N, Locht C, Thorstensson R. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial. Vaccine. 2014 Jun 5;32(27):3350-6. doi: 10.1016/j.vaccine.2014.04.048. Epub 2014 Apr 29.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24421886\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Thorstensson R, Trollfors B, Al-Tawil N, Jahnmatz M, Bergstrom J, Ljungman M, Torner A, Wehlin L, Van Broekhoven A, Bosman F, Debrie AS, Mielcarek N, Locht C. A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. PLoS One. 2014 Jan 8;9(1):e83449. doi: 10.1371/journal.pone.0083449. eCollection 2014.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24261996\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Schnoeller C, Roux X, Sawant D, Raze D, Olszewska W, Locht C, Openshaw PJ. Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism. Am J Respir Crit Care Med. 2014 Jan 15;189(2):194-202. doi: 10.1164/rccm.201307-1227OC.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT04945655\",\n",
      "          \"briefTitle\": \"Impact of a School- and Primary Care-based Multicomponent Intervention on HPV Vaccination Acceptability\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2021-11-15\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2023-04-30\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2021-06-30\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"35332045\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Bocquier A, Michel M, Giraudeau B, Bonnay S, Gagneux-Brunon A, Gauchet A, Gilberg S, Le Duc-Banaszuk AS, Mueller JE, Chevreul K, Thilly N; PrevHPV Study group. Impact of a school-based and primary care-based multicomponent intervention on HPV vaccination coverage among French adolescents: a cluster randomised controlled trial protocol (the PrevHPV study). BMJ Open. 2022 Mar 24;12(3):e057943. doi: 10.1136/bmjopen-2021-057943.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01942655\",\n",
      "          \"briefTitle\": \"IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-06-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-03-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2013-09-16\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01332955\",\n",
      "          \"briefTitle\": \"Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2011-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2013-09\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2011-04-11\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Janssen-Cilag Ltd.\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"25139963\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Cotte L, Braun J, Lascoux-Combe C, Vincent C, Valantin MA, Sogni P, Lacombe K, Neau D, Aumaitre H, Batisse D, de Truchis P, Gervais A, Michelet C, Morlat P, Vittecoq D, Rosa I, Bertucci I, Chevaliez S, Aboulker JP, Molina JM; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) HC26 Study Group. Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial. Clin Infect Dis. 2014 Dec 15;59(12):1768-76. doi: 10.1093/cid/ciu659. Epub 2014 Aug 18.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01552044\",\n",
      "          \"briefTitle\": \"Effect of Spironolactone in Treating Chronic Non-resolutive Central Serous Chorioretinitis\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2013-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-03-13\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02592174\",\n",
      "          \"briefTitle\": \"Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2016-01-26\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-10-27\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2015-10-30\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Merck Sharp & Dohme LLC\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"31755936\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Makinson A, Dubois J, Eymard-Duvernay S, Leclercq P, Zaegel-Faucher O, Bernard L, Vassallo M, Barbuat C, Geny C, Thouvenot E, Costagliola D, Ozguler A, Zins M, Simony M, Reynes J, Berr C. Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55-70 Study. Clin Infect Dis. 2020 Jun 10;70(12):2641-2648. doi: 10.1093/cid/ciz670.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02100774\",\n",
      "          \"briefTitle\": \"Effect of Genetic Variants on Fat-soluble Vitamin Bioavailability\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2013-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-04-01\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"21957063\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Borel P. Genetic variations involved in interindividual variability in carotenoid status. Mol Nutr Food Res. 2012 Feb;56(2):228-40. doi: 10.1002/mnfr.201100322. Epub 2011 Sep 29.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27798339\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Desmarchelier C, Borel P, Goncalves A, Kopec R, Nowicki M, Morange S, Lesavre N, Portugal H, Reboul E. A Combination of Single-Nucleotide Polymorphisms Is Associated with Interindividual Variability in Cholecalciferol Bioavailability in Healthy Men. J Nutr. 2016 Dec;146(12):2421-2428. doi: 10.3945/jn.116.237115. Epub 2016 Oct 26.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26063065\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Borel P, Desmarchelier C, Nowicki M, Bott R. A Combination of Single-Nucleotide Polymorphisms Is Associated with Interindividual Variability in Dietary beta-Carotene Bioavailability in Healthy Men. J Nutr. 2015 Aug;145(8):1740-7. doi: 10.3945/jn.115.212837. Epub 2015 Jun 10.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24808487\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Borel P, Desmarchelier C, Nowicki M, Bott R, Morange S, Lesavre N. Interindividual variability of lutein bioavailability in healthy men: characterization, genetic variants involved, and relation with fasting plasma lutein concentration. Am J Clin Nutr. 2014 Jul;100(1):168-75. doi: 10.3945/ajcn.114.085720. Epub 2014 May 7.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00490074\",\n",
      "          \"briefTitle\": \"Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2007-07\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2009-10\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2007-06-22\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"EuroVacc Foundation\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01882062\",\n",
      "          \"briefTitle\": \"Proof of Concept of an Anaplerotic Study Using Brain Phosphorus Magnetic Resonance Spectroscopy in Huntington Disease\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2013-05\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2013-07\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2013-06-20\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"25568297\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Adanyeguh IM, Rinaldi D, Henry PG, Caillet S, Valabregue R, Durr A, Mochel F. Triheptanoin improves brain energy metabolism in patients with Huntington disease. Neurology. 2015 Feb 3;84(5):490-5. doi: 10.1212/WNL.0000000000001214. Epub 2015 Jan 7.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": true\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01525472\",\n",
      "          \"briefTitle\": \"Accelerated Aging of the Cells of Visceral Adipose Tissue in Morbid Obese Subjects\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-02-13\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-10-20\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-02-03\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02650427\",\n",
      "          \"briefTitle\": \"A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver Resection\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2016-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-09\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2016-01-08\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01473472\",\n",
      "          \"briefTitle\": \"On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-12-15\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2011-11-17\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"31784343\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Antoni G, Tremblay C, Delaugerre C, Charreau I, Cua E, Rojas Castro D, Raffi F, Chas J, Huleux T, Spire B, Capitant C, Cotte L, Meyer L, Molina JM; ANRS IPERGAY study group. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial. Lancet HIV. 2020 Feb;7(2):e113-e120. doi: 10.1016/S2352-3018(19)30341-8. Epub 2019 Nov 26.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"29229440\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Molina JM, Charreau I, Chidiac C, Pialoux G, Cua E, Delaugerre C, Capitant C, Rojas-Castro D, Fonsart J, Bercot B, Bebear C, Cotte L, Robineau O, Raffi F, Charbonneau P, Aslan A, Chas J, Niedbalski L, Spire B, Sagaon-Teyssier L, Carette D, Mestre SL, Dore V, Meyer L; ANRS IPERGAY Study Group. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis. 2018 Mar;18(3):308-317. doi: 10.1016/S1473-3099(17)30725-9. Epub 2017 Dec 8.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28747274\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, Tremblay C, Rojas-Castro D, Cua E, Pasquet A, Bernaud C, Pintado C, Delaugerre C, Sagaon-Teyssier L, Mestre SL, Chidiac C, Pialoux G, Ponscarme D, Fonsart J, Thompson D, Wainberg MA, Dore V, Meyer L; ANRS IPERGAY Study Group. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Lancet HIV. 2017 Sep;4(9):e402-e410. doi: 10.1016/S2352-3018(17)30089-9. Epub 2017 Jul 23.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26624850\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, Tremblay C, Le Gall JM, Cua E, Pasquet A, Raffi F, Pintado C, Chidiac C, Chas J, Charbonneau P, Delaugerre C, Suzan-Monti M, Loze B, Fonsart J, Peytavin G, Cheret A, Timsit J, Girard G, Lorente N, Preau M, Rooney JF, Wainberg MA, Thompson D, Rozenbaum W, Dore V, Marchand L, Simon MC, Etien N, Aboulker JP, Meyer L, Delfraissy JF; ANRS IPERGAY Study Group. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N Engl J Med. 2015 Dec 3;373(23):2237-46. doi: 10.1056/NEJMoa1506273. Epub 2015 Dec 1.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02267304\",\n",
      "          \"briefTitle\": \"Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Morphine and Naloxone on Motivation (MBBAnalgesic)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2013-10-30\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-08-30\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-10-17\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT04780191\",\n",
      "          \"briefTitle\": \"Investigation of Treatment Using the MyoRegulator\\u00ae Device in Patients With Spasticity in the Lower Limb Due to Stroke\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2018-07-19\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2021-01-19\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2021-03-03\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"PathMaker Neurosystems Inc.\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"32232101\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Paget-Blanc A, Chang JL, Saul M, Lin R, Ahmed Z, Volpe BT. Non-invasive treatment of patients with upper extremity spasticity following stroke using paired trans-spinal and peripheral direct current stimulation. Bioelectron Med. 2019 Jul 23;5:11. doi: 10.1186/s42234-019-0028-9. eCollection 2019.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00495326\",\n",
      "          \"briefTitle\": \"Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2007-12\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2011-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2007-07-03\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Medecins Sans Frontieres, Netherlands\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"24663014\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Bhatt NB, Barau C, Amin A, Baudin E, Meggi B, Silva C, Furlan V, Grinsztejn B, Barrail-Tran A, Bonnet M, Taburet AM; ANRS 12146-CARINEMO Study Group. Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment. Antimicrob Agents Chemother. 2014 Jun;58(6):3182-90. doi: 10.1128/AAC.02379-13. Epub 2014 Mar 24.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23433590\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Bonnet M, Bhatt N, Baudin E, Silva C, Michon C, Taburet AM, Ciaffi L, Sobry A, Bastos R, Nunes E, Rouzioux C, Jani I, Calmy A; CARINEMO study group. Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial. Lancet Infect Dis. 2013 Apr;13(4):303-12. doi: 10.1016/S1473-3099(13)70007-0. Epub 2013 Feb 20.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03459157\",\n",
      "          \"briefTitle\": \"Access to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2017-11-20\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2021-06-30\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2018-03-08\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Expertise France\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Universit\\u00e9 Montpellier\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"SESSTIM (IRD, Inserm, Universit\\u00e9 Aix-Marseille)\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Coalition Internationale Sida\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Institut de M\\u00e9decine Tropicale, Anvers, Belgique\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"ARCAD-SIDA MALI\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Association African Solidarit\\u00e9\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Centre de Recherche Internationale pour la Sant\\u00e9, Universit\\u00e9 de Ouagadougou\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Espace Confiance, C\\u00f4te d'Ivoire\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Espoir Vie-Togo - ONG\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Laboratoire BIOLIM, Universit\\u00e9 de Lom\\u00e9\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"34048794\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Laurent C, Dembele Keita B, Yaya I, Le Guicher G, Sagaon-Teyssier L, Agboyibor MK, Coulibaly A, Traore I, Malan JB, De Baetselier I, Eubanks A, Riegel L, Rojas Castro D, Faye-Kette H, Kone A, Diande S, Dagnra CA, Serrano L, Diallo F, Mensah E, Dah TTE, Anoma C, Vuylsteke B, Spire B; CohMSM-PrEP Study Group. HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study. Lancet HIV. 2021 Jul;8(7):e420-e428. doi: 10.1016/S2352-3018(21)00005-9. Epub 2021 May 25.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01620957\",\n",
      "          \"briefTitle\": \"Longitudinal Study of the Default-mode Network Connectivity in Brain Injured Patients Recovering From Coma\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-07-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-07\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-06-15\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"University Hospital, Toulouse\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Association des Traumatis\\u00e9s du Crane et de la Face, Paris, France\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00339157\",\n",
      "          \"briefTitle\": \"Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2006-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2008-07\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2006-06-20\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"21173013\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Quartier P, Allantaz F, Cimaz R, Pillet P, Messiaen C, Bardin C, Bossuyt X, Boutten A, Bienvenu J, Duquesne A, Richer O, Chaussabel D, Mogenet A, Banchereau J, Treluyer JM, Landais P, Pascual V. A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Ann Rheum Dis. 2011 May;70(5):747-54. doi: 10.1136/ard.2010.134254. Epub 2010 Dec 20.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01555450\",\n",
      "          \"briefTitle\": \"Study of Patient Navigation to Reduce Social Inequalities\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2011-03\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2013-11\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-03-15\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"National Cancer Institute, France\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"21256688\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Dejardin O, Berchi C, Mignon A, Pornet C, Guillaume E, Guittet L, Bouvier V, Sailly M, Salinas A, Christophe V, Launoy G. [Social inequalities in health from observational studies to intervention: can the patient navigator reduce social inequalities in cancer patients?]. Rev Epidemiol Sante Publique. 2011 Feb;59(1):45-51. doi: 10.1016/j.respe.2010.10.008. Epub 2011 Jan 21. French.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"29909873\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"De Mil R, Guillaume E, Guittet L, Dejardin O, Bouvier V, Pornet C, Christophe V, Notari A, Delattre-Massy H, De Seze C, Peng J, Launoy G, Berchi C. Cost-Effectiveness Analysis of a Navigation Program for Colorectal Cancer Screening to Reduce Social Health Inequalities: A French Cluster Randomized Controlled Trial. Value Health. 2018 Jun;21(6):685-691. doi: 10.1016/j.jval.2017.09.020. Epub 2017 Nov 10.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28823681\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Guillaume E, Dejardin O, Bouvier V, De Mil R, Berchi C, Pornet C, Christophe V, Notari A, Delattre Massy H, De Seze C, Peng J, Guittet L, Launoy G. Patient navigation to reduce social inequalities in colorectal cancer screening participation: A cluster randomized controlled trial. Prev Med. 2017 Oct;103:76-83. doi: 10.1016/j.ypmed.2017.08.012. Epub 2017 Aug 16.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01348308\",\n",
      "          \"briefTitle\": \"Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2011-09\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-03\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2011-05-05\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Pfizer\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"32040959\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Levy Y, Lelievre JD, Assoumou L, Aznar E, Pulido F, Tambussi G, Crespo M, Meybeck A, Molina JM, Delaugerre C, Izopet J, Peytavin G, Cardon F, Diallo A, Lancar R, Beniguel L, Costagliola D. Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial. Ann Intern Med. 2020 Mar 3;172(5):297-305. doi: 10.7326/M19-2133. Epub 2020 Feb 11.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01696708\",\n",
      "          \"briefTitle\": \"Utilization of 31P-Nuclear Magnetic Resonance Spectroscopy to Monitor Brain Energy Deficit in Huntington Disease\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-12-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-11\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-10-01\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"25568297\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Adanyeguh IM, Rinaldi D, Henry PG, Caillet S, Valabregue R, Durr A, Mochel F. Triheptanoin improves brain energy metabolism in patients with Huntington disease. Neurology. 2015 Feb 3;84(5):490-5. doi: 10.1212/WNL.0000000000001214. Epub 2015 Jan 7.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01509508\",\n",
      "          \"briefTitle\": \"Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-03\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-06\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-01-13\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Africa Centre For Health and Population Studies\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University of KwaZulu\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"32970730\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Iwuji C, Chimukuche RS, Zuma T, Plazy M, Larmarange J, Orne-Gliemann J, Siedner M, Shahmanesh M, Seeley J. Test but not treat: Community members' experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa. PLoS One. 2020 Sep 24;15(9):e0239513. doi: 10.1371/journal.pone.0239513. eCollection 2020.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"31637821\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Larmarange J, Diallo MH, McGrath N, Iwuji C, Plazy M, Thiebaut R, Tanser F, Barnighausen T, Orne-Gliemann J, Pillay D, Dabis F; ANRS 12249 TasP Study Group. Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa. J Int AIDS Soc. 2019 Oct;22(10):e25402. doi: 10.1002/jia2.25402.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"30412926\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Perriat D, Plazy M, Gumede D, Boyer S, Pillay D, Dabis F, Seeley J, Orne-Gliemann J; ANRS 12249 TasP Study Group. \\\"If you are here at the clinic, you do not know how many people need help in the community\\\": Perspectives of home-based HIV services from health care workers in rural KwaZulu-Natal, South Africa in the era of universal test-and-treat. PLoS One. 2018 Nov 9;13(11):e0202473. doi: 10.1371/journal.pone.0202473. eCollection 2018.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"30321314\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Derache A, Iwuji CC, Baisley K, Danaviah S, Marcelin AG, Calvez V, de Oliveira T, Dabis F, Porter K, Pillay D. Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial. Clin Infect Dis. 2019 Jul 2;69(2):207-214. doi: 10.1093/cid/ciy881.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"30027600\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Larmarange J, Diallo MH, McGrath N, Iwuji C, Plazy M, Thiebaut R, Tanser F, Barnighausen T, Pillay D, Dabis F, Orne-Gliemann J; ANRS 12249 TasP Study Group. The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa). J Int AIDS Soc. 2018 Jul;21 Suppl 4(Suppl Suppl 4):e25128. doi: 10.1002/jia2.25128.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"29890048\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Iwuji C, McGrath N, Calmy A, Dabis F, Pillay D, Newell ML, Baisley K, Porter K. Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial. J Int AIDS Soc. 2018 Jun;21(6):e25112. doi: 10.1002/jia2.25112.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"29199100\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Iwuji CC, Orne-Gliemann J, Larmarange J, Balestre E, Thiebaut R, Tanser F, Okesola N, Makowa T, Dreyer J, Herbst K, McGrath N, Barnighausen T, Boyer S, De Oliveira T, Rekacewicz C, Bazin B, Newell ML, Pillay D, Dabis F; ANRS 12249 TasP Study Group. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. Lancet HIV. 2018 Mar;5(3):e116-e125. doi: 10.1016/S2352-3018(17)30205-9. Epub 2017 Nov 30.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28329393\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Collier D, Iwuji C, Derache A, de Oliveira T, Okesola N, Calmy A, Dabis F, Pillay D, Gupta RK; French National Agency for AIDS and Viral Hepatitis Research (ANRS) 12249 Treatment as Prevention (TasP) Study Group. Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis. Clin Infect Dis. 2017 Apr 15;64(8):1006-1016. doi: 10.1093/cid/cix015.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27504637\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Iwuji CC, Orne-Gliemann J, Larmarange J, Okesola N, Tanser F, Thiebaut R, Rekacewicz C, Newell ML, Dabis F; ANRS 12249 TasP trial group. Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial. PLoS Med. 2016 Aug 9;13(8):e1002107. doi: 10.1371/journal.pmed.1002107. eCollection 2016 Aug.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"25880823\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Orne-Gliemann J, Larmarange J, Boyer S, Iwuji C, McGrath N, Barnighausen T, Zuma T, Dray-Spira R, Spire B, Rochat T, Lert F, Imrie J; ANRS 12249 TasP Group. Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal. BMC Public Health. 2015 Mar 1;15:209. doi: 10.1186/s12889-015-1344-y.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23880306\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Iwuji CC, Orne-Gliemann J, Tanser F, Boyer S, Lessells RJ, Lert F, Imrie J, Barnighausen T, Rekacewicz C, Bazin B, Newell ML, Dabis F; ANRS 12249 TasP Study Group. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial. Trials. 2013 Jul 23;14:230. doi: 10.1186/1745-6215-14-230.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01874808\",\n",
      "          \"briefTitle\": \"From Movement Preparation to Gait Execution in ALS\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2013-06-21\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-12-21\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2013-06-11\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Universit\\u00e9 Paris Ouest-EA 2931-CEntre de Recherches sur le Sport et le Mouvement\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02126384\",\n",
      "          \"briefTitle\": \"Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-11-18\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-04-05\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-04-30\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03150290\",\n",
      "          \"briefTitle\": \"Brown Adipose Tissue in ALS\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2017-10-26\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2019-04-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2017-05-12\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03519503\",\n",
      "          \"briefTitle\": \"Infant Peri-Exposure Prophylaxis to Prevent HIV-1 Transmission by Breastfeeding: Mechanisms & Safety\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2017-02-27\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-02-15\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2018-05-09\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"21602695\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Heidari S, Mofenson L, Cotton MF, Marlink R, Cahn P, Katabira E. Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children. J Acquir Immune Defic Syndr. 2011 Aug 1;57(4):290-6. doi: 10.1097/QAI.0b013e318221c56a.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22814853\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Van de Perre P, Rubbo PA, Viljoen J, Nagot N, Tylleskar T, Lepage P, Vendrell JP, Tuaillon E. HIV-1 reservoirs in breast milk and challenges to elimination of breast-feeding transmission of HIV-1. Sci Transl Med. 2012 Jul 18;4(143):143sr3. doi: 10.1126/scitranslmed.3003327.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26603917\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Nagot N, Kankasa C, Tumwine JK, Meda N, Hofmeyr GJ, Vallo R, Mwiya M, Kwagala M, Traore H, Sunday A, Singata M, Siuluta C, Some E, Rutagwera D, Neboua D, Ndeezi G, Jackson D, Marechal V, Neveu D, Engebretsen IMS, Lombard C, Blanche S, Sommerfelt H, Rekacewicz C, Tylleskar T, Van de Perre P; ANRS 12174 Trial Group. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. Lancet. 2016 Feb 6;387(10018):566-573. doi: 10.1016/S0140-6736(15)00984-8. Epub 2015 Nov 19. Erratum In: Lancet. 2019 Jun 22;393(10190):2492.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00465790\",\n",
      "          \"briefTitle\": \"Research of Biomarkers in Parkinson Disease\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2007-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-06\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2007-04-25\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"European Union\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00122603\",\n",
      "          \"briefTitle\": \"Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2005-12\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2007-08\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-07-22\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Bristol-Myers Squibb\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"GlaxoSmithKline\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Hoffmann-La Roche\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"19420019\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Landman R, Capitant C, Descamps D, Chazallon C, Peytavin G, Katlama C, Pialoux G, Bentata M, Brun-Vezinet F, Aboulker JP, Yeni P; ANRS 127 Study Group. Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study. J Antimicrob Chemother. 2009 Jul;64(1):118-25. doi: 10.1093/jac/dkp146. Epub 2009 May 6.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02314208\",\n",
      "          \"briefTitle\": \"Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2015-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-01-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-12-11\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00121121\",\n",
      "          \"briefTitle\": \"Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2004-07\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2005-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-07-21\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"17712402\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Launay O, Durier C, Desaint C, Silbermann B, Jackson A, Pialoux G, Bonnet B, Poizot-Martin I, Gonzalez-Canali G, Cuzin L, Figuereido S, Surenaud M, Ben Hamouda N, Gahery H, Choppin J, Salmon D, Guerin C, Bourgault Villada I, Guillet JG; ANRS VAC16 Study Group. Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial. PLoS One. 2007 Aug 22;2(8):e725. doi: 10.1371/journal.pone.0000725.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01432821\",\n",
      "          \"briefTitle\": \"Blinking and Yawning in Epilepsy: The Role of Dopamine\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2011-09\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2014-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2011-09-13\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"15037514\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Ahmad S, Fowler LJ, Whitton PS. Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5-hydroxytryptamine and dopamine in the hippocampus of the freely moving rat. Br J Pharmacol. 2004 May;142(1):136-42. doi: 10.1038/sj.bjp.0705737. Epub 2004 Mar 22.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"15777732\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Ahmad S, Fowler LJ, Whitton PS. Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids. Epilepsy Res. 2005 Feb;63(2-3):141-9. doi: 10.1016/j.eplepsyres.2005.02.002.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"12914551\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Aymard G, Berlin I, de Brettes B, Diquet B. Pharmacokinetic-pharmacodynamic study of apomorphine's effect on growth hormone secretion in healthy subjects. Fundam Clin Pharmacol. 2003 Aug;17(4):473-81. doi: 10.1046/j.1472-8206.2003.00152.x.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"15249613\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Biraben A, Semah F, Ribeiro MJ, Douaud G, Remy P, Depaulis A. PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy. Neurology. 2004 Jul 13;63(1):73-7. doi: 10.1212/01.wnl.0000132840.40838.13.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"2271377\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Blin O, Masson G, Azulay JP, Fondarai J, Serratrice G. Apomorphine-induced blinking and yawning in healthy volunteers. Br J Clin Pharmacol. 1990 Nov;30(5):769-73. doi: 10.1111/j.1365-2125.1990.tb03848.x.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02071784\",\n",
      "          \"briefTitle\": \"Imaging Study of Neurovascular Coupling in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-07-08\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-10-24\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-02-26\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02738502\",\n",
      "          \"briefTitle\": \"Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2016-07-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2020-07-16\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2016-04-14\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"26709605\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Arribas JR, Girard PM, Paton N, Winston A, Marcelin AG, Elbirt D, Hill A, Hadacek MB. Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials. HIV Med. 2016 May;17(5):358-67. doi: 10.1111/hiv.12348. Epub 2015 Dec 28.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23766338\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Tubiana R, Mandelbrot L, Le Chenadec J, Delmas S, Rouzioux C, Hirt D, Treluyer JM, Ekoukou D, Bui E, Chaix ML, Blanche S, Warszawski J; ANRS 135 PRIMEVA (Protease Inhibitor Monotherapy Evaluation) Study Group. Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial. Clin Infect Dis. 2013 Sep;57(6):891-902. doi: 10.1093/cid/cit390. Epub 2013 Jun 12.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23559464\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Andre-Schmutz I, Dal-Cortivo L, Six E, Kaltenbach S, Cocchiarella F, Le Chenadec J, Cagnard N, Cordier AG, Benachi A, Mandelbrot L, Azria E, Bouallag N, Luce S, Ternaux B, Reimann C, Revy P, Radford-Weiss I, Leschi C, Recchia A, Mavilio F, Cavazzana M, Blanche S. Genotoxic signature in cord blood cells of newborns exposed in utero to a Zidovudine-based antiretroviral combination. J Infect Dis. 2013 Jul 15;208(2):235-43. doi: 10.1093/infdis/jit149. Epub 2013 Apr 4.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26854809\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Hleyhel M, Goujon S, Delteil C, Vasiljevic A, Luzi S, Stephan JL, Reliquet V, Jannier S, Tubiana R, Dollfus C, Faye A, Mandelbrot L, Clavel J, Warszawski J, Blanche S; ANRS French Perinatal Cohort Study Group. Risk of cancer in children exposed to didanosine in utero. AIDS. 2016 May 15;30(8):1245-56. doi: 10.1097/QAD.0000000000001051.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26197844\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Mandelbrot L, Tubiana R, Le Chenadec J, Dollfus C, Faye A, Pannier E, Matheron S, Khuong MA, Garrait V, Reliquet V, Devidas A, Berrebi A, Allisy C, Elleau C, Arvieux C, Rouzioux C, Warszawski J, Blanche S; ANRS-EPF Study Group. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception. Clin Infect Dis. 2015 Dec 1;61(11):1715-25. doi: 10.1093/cid/civ578. Epub 2015 Jul 21.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22160145\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Valantin MA, Lambert-Niclot S, Flandre P, Morand-Joubert L, Cabie A, Meynard JL, Ponscarme D, Ajana F, Slama L, Curjol A, Cuzin L, Schneider L, Taburet AM, Marcelin AG, Katlama C; MONOI ANRS 136 Study Group. Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study. J Antimicrob Chemother. 2012 Mar;67(3):691-5. doi: 10.1093/jac/dkr504. Epub 2011 Dec 7.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22848481\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Lambert-Niclot S, Flandre P, Valantin MA, Soulie C, Fourati S, Wirden M, Sayon S, Pakianather S, Bocket L, Masquelier B, Dos Santos G, Katlama C, Calvez V, Marcelin AG. Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks. PLoS One. 2012;7(7):e41390. doi: 10.1371/journal.pone.0041390. Epub 2012 Jul 25.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02992184\",\n",
      "          \"briefTitle\": \"PoC-HCV Genedrive Viral Detection Assay Validation Study\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2016-09\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2016-12-14\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"EPISTEM\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"29615488\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Llibre A, Shimakawa Y, Mottez E, Ainsworth S, Buivan TP, Firth R, Harrison E, Rosenberg AR, Meritet JF, Fontanet A, Castan P, Madejon A, Laverick M, Glass A, Viana R, Pol S, McClure CP, Irving WL, Miele G, Albert ML, Duffy D. Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus. Gut. 2018 Nov;67(11):2017-2024. doi: 10.1136/gutjnl-2017-315783. Epub 2018 Apr 3.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01514890\",\n",
      "          \"briefTitle\": \"French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and Ribavirin\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2011-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2014-03\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-01-23\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"25556540\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Sultanik P, Mallet V, Lagaye S, Casrouge A, Dorival C, Barthe Y, Fontaine H, Hezode C, Mottez E, Bronowicki JP, Carrat F, Theodorou I, Abel L, Gayat E, Fontanet A, Pol S, Albert ML; ANRS CO20-CUPIC. Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy. Liver Int. 2015 Jul;35(7):1833-44. doi: 10.1111/liv.12759. Epub 2015 Jan 23.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24704719\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Hezode C, Fontaine H, Dorival C, Zoulim F, Larrey D, Canva V, De Ledinghen V, Poynard T, Samuel D, Bourliere M, Alric L, Raabe JJ, Zarski JP, Marcellin P, Riachi G, Bernard PH, Loustaud-Ratti V, Chazouilleres O, Abergel A, Guyader D, Metivier S, Tran A, Di Martino V, Causse X, Dao T, Lucidarme D, Portal I, Cacoub P, Gournay J, Grando-Lemaire V, Hillon P, Attali P, Fontanges T, Rosa I, Petrov-Sanchez V, Barthe Y, Pawlotsky JM, Pol S, Carrat F, Bronowicki JP; CUPIC Study Group. Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis. Gastroenterology. 2014 Jul;147(1):132-142.e4. doi: 10.1053/j.gastro.2014.03.051. Epub 2014 Apr 3.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23669289\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Hezode C, Fontaine H, Dorival C, Larrey D, Zoulim F, Canva V, de Ledinghen V, Poynard T, Samuel D, Bourliere M, Zarski JP, Raabe JJ, Alric L, Marcellin P, Riachi G, Bernard PH, Loustaud-Ratti V, Metivier S, Tran A, Serfaty L, Abergel A, Causse X, Di Martino V, Guyader D, Lucidarme D, Grando-Lemaire V, Hillon P, Feray C, Dao T, Cacoub P, Rosa I, Attali P, Petrov-Sanchez V, Barthe Y, Pawlotsky JM, Pol S, Carrat F, Bronowicki JP; CUPIC Study Group. Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890. J Hepatol. 2013 Sep;59(3):434-41. doi: 10.1016/j.jhep.2013.04.035. Epub 2013 May 10.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02212379\",\n",
      "          \"briefTitle\": \"Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRAL\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2015-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-08-08\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Merck Sharp & Dohme LLC\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Janssen-Cilag Ltd.\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": true\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03652090\",\n",
      "          \"briefTitle\": \"Primary Nasal Cell Culture as a Tool for Personalized Therapy in Cystic Fibrosis\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2010-09-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-03-03\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2018-08-29\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"ABCF2\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00196664\",\n",
      "          \"briefTitle\": \"Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus Ribavirin\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2005-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2009-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-09-20\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03335995\",\n",
      "          \"briefTitle\": \"Stroke Prognosis in Intensive CarE\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2017-10-18\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2020-11-18\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2017-11-08\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"32026446\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Sonneville R, Mazighi M, Bresson D, Crassard I, Crozier S, de Montmollin E, Degos V, Faugeras F, Gayat E, Josse L, Lamy C, Magalhaes E, Maldjian A, Ruckly S, Servan J, Vassel P, Vigue B, Timsit JF, Woimant F; SPICE investigators. Outcomes of Acute Stroke Patients Requiring Mechanical Ventilation: Study Protocol for the SPICE Multicenter Prospective Observational Study. Neurocrit Care. 2020 Apr;32(2):624-629. doi: 10.1007/s12028-019-00907-0.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00946595\",\n",
      "          \"briefTitle\": \"Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-11\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2014-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2009-07-27\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Abbott\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Gilead Sciences\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"30968368\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Garay OU, Nishimwe ML, Bousmah MA, Janah A, Girard PM, Chene G, Moinot L, Sagaon-Teyssier L, Meynard JL, Spire B, Boyer S. Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM). Pharmacoecon Open. 2019 Dec;3(4):505-515. doi: 10.1007/s41669-019-0130-7.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"29767684\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Lambert-Niclot S, Grude M, Meynard JL, Marcelin AG, Valantin MA, Flandre P, Izopet J, Moinot L, Bouteloup V, Calvez V, Katlama C, Girard PM, Morand-Joubert L. Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies. Clin Infect Dis. 2018 Nov 28;67(12):1883-1889. doi: 10.1093/cid/ciy382.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02469350\",\n",
      "          \"briefTitle\": \"Serious Game for Parkinson's Disease Patients\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2015-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-10-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2015-06-11\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"29636105\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Nuic D, Vinti M, Karachi C, Foulon P, Van Hamme A, Welter ML. The feasibility and positive effects of a customised videogame rehabilitation programme for freezing of gait and falls in Parkinson's disease patients: a pilot study. J Neuroeng Rehabil. 2018 Apr 10;15(1):31. doi: 10.1186/s12984-018-0375-x.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01546181\",\n",
      "          \"briefTitle\": \"Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2010-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-06-15\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-03-07\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"25077537\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Paques M, Miloudi C, Kulcsar C, Leseigneur A, Chaumette C, Koch E. High-resolution imaging of gunn's dots. Retina. 2015 Jan;35(1):120-4. doi: 10.1097/IAE.0000000000000269.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26344727\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Audo I, Gocho K, Rossant F, Mohand-Said S, Loquin K, Bloch I, Sahel JA, Paques M. Functional and high-resolution retinal imaging monitoring photoreceptor damage in acute macular neuroretinopathy. Graefes Arch Clin Exp Ophthalmol. 2016 May;254(5):855-64. doi: 10.1007/s00417-015-3136-6. Epub 2015 Sep 7.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"25997175\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Paques M, Brolly A, Benesty J, Lerme N, Koch E, Rossant F, Bloch I, Girmens JF. Venous Nicking Without Arteriovenous Contact: The Role of the Arteriolar Microenvironment in Arteriovenous Nickings. JAMA Ophthalmol. 2015 Aug;133(8):947-50. doi: 10.1001/jamaophthalmol.2015.1132.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26523388\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Miloudi C, Rossant F, Bloch I, Chaumette C, Leseigneur A, Sahel JA, Meimon S, Mrejen S, Paques M. The Negative Cone Mosaic: A New Manifestation of the Optical Stiles-Crawford Effect in Normal Eyes. Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7043-50. doi: 10.1167/iovs.15-17022.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23620431\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Gocho K, Sarda V, Falah S, Sahel JA, Sennlaub F, Benchaboune M, Ullern M, Paques M. Adaptive optics imaging of geographic atrophy. Invest Ophthalmol Vis Sci. 2013 May 1;54(5):3673-80. doi: 10.1167/iovs.12-10672.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24406779\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Koch E, Rosenbaum D, Brolly A, Sahel JA, Chaumet-Riffaud P, Girerd X, Rossant F, Paques M. Morphometric analysis of small arteries in the human retina using adaptive optics imaging: relationship with blood pressure and focal vascular changes. J Hypertens. 2014 Apr;32(4):890-8. doi: 10.1097/HJH.0000000000000095.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24576889\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Errera MH, Coisy S, Fardeau C, Sahel JA, Kallel S, Westcott M, Bodaghi B, Paques M. Retinal vasculitis imaging by adaptive optics. Ophthalmology. 2014 Jun;121(6):1311-2.e2. doi: 10.1016/j.ophtha.2013.12.036. Epub 2014 Feb 25. No abstract available.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24337723\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Faure C, Gocho K, Le Mer Y, Sahel JA, Paques M, Audo I. Functional and high resolution retinal imaging assessment in a case of ocular siderosis. Doc Ophthalmol. 2014 Feb;128(1):69-75. doi: 10.1007/s10633-013-9421-y. Epub 2013 Dec 13.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"29369084\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Bottin C, Grieve K, Rossant F, Pedinielli A, Mrejen S, Paques M. DIRECTIONAL VARIABILITY OF FUNDUS REFLECTANCE IN ACUTE MACULAR NEURORETINOPATHY: EVIDENCE FOR A CONTRIBUTION OF THE STILES-CRAWFORD EFFECT. Retin Cases Brief Rep. 2018 Fall;12 Suppl 1:S19-S24. doi: 10.1097/ICB.0000000000000701.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"25284764\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Jacob J, Paques M, Krivosic V, Dupas B, Couturier A, Kulcsar C, Tadayoni R, Massin P, Gaudric A. Meaning of visualizing retinal cone mosaic on adaptive optics images. Am J Ophthalmol. 2015 Jan;159(1):118-23.e1. doi: 10.1016/j.ajo.2014.09.043. Epub 2014 Oct 2.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27065002\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Rosenbaum D, Mattina A, Koch E, Rossant F, Gallo A, Kachenoura N, Paques M, Redheuil A, Girerd X. Effects of age, blood pressure and antihypertensive treatments on retinal arterioles remodeling assessed by adaptive optics. J Hypertens. 2016 Jun;34(6):1115-22. doi: 10.1097/HJH.0000000000000894.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27009576\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Rosenbaum D, Kachenoura N, Koch E, Paques M, Cluzel P, Redheuil A, Girerd X. Relationships between retinal arteriole anatomy and aortic geometry and function and peripheral resistance in hypertensives. Hypertens Res. 2016 Jul;39(7):536-42. doi: 10.1038/hr.2016.26. Epub 2016 Mar 24.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28900746\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Faure C, Paques M, Audo I. Electrophysiological features and multimodal imaging in ritonavir-related maculopathy. Doc Ophthalmol. 2017 Dec;135(3):241-248. doi: 10.1007/s10633-017-9612-z. Epub 2017 Sep 12.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"30947025\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Boileve A, Jozwiak M, Malka D, Boige V, Le Roy F, Paques M, Ducreux M. Vision loss after chemotherapy: an irinotecan-induced retinopathy. Eur J Cancer. 2019 May;112:80-82. doi: 10.1016/j.ejca.2019.02.015. Epub 2019 Apr 1. No abstract available.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"30010022\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Paques M, Meimon S, Rossant F, Rosenbaum D, Mrejen S, Sennlaub F, Grieve K. Adaptive optics ophthalmoscopy: Application to age-related macular degeneration and vascular diseases. Prog Retin Eye Res. 2018 Sep;66:1-16. doi: 10.1016/j.preteyeres.2018.07.001. Epub 2018 Jul 17.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"31568064\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Sodi A, Germain DP, Bacherini D, Finocchio L, Pacini B, Marziali E, Lenzetti C, Tanini I, Koraichi F, Coriat C, Nencini P, Olivotto I, Virgili G, Rizzo S, Paques M. IN VIVO OBSERVATION OF RETINAL VASCULAR DEPOSITS USING ADAPTIVE OPTICS IMAGING IN FABRY DISEASE. Retina. 2020 Aug;40(8):1623-1629. doi: 10.1097/IAE.0000000000002648.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"31573376\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Errera MH, Laguarrigue M, Rossant F, Koch E, Chaumette C, Fardeau C, Westcott M, Sahel JA, Bodaghi B, Benesty J, Paques M. High-Resolution Imaging of Retinal Vasculitis by Flood Illumination Adaptive Optics Ophthalmoscopy: A Follow-up Study. Ocul Immunol Inflamm. 2020 Nov 16;28(8):1171-1180. doi: 10.1080/09273948.2019.1646773. Epub 2019 Oct 1.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"31922497\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Paques M, Rossant F, Finocchio L, Grieve K, Sahel JA, Pedinielli A, Mrejen S. ATTENUATION OUTER RETINAL BANDS ON OPTICAL COHERENCE TOMOGRAPHY FOLLOWING MACULAR EDEMA: A Possible Manifestation of Photoreceptor Misalignment. Retina. 2020 Nov;40(11):2232-2239. doi: 10.1097/IAE.0000000000002738.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"31972545\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Gallo A, Chaigneau E, Jublanc C, Rosenbaum D, Mattina A, Paques M, Rossant F, Girerd X, Leban M, Bruckert E. IGF-1 is an independent predictor of retinal arterioles remodeling in subjects with uncontrolled acromegaly. Eur J Endocrinol. 2020 Mar;182(3):375-383. doi: 10.1530/EJE-19-0390.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26418443\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Jacob J, Krivosic V, Paques M, Tadayoni R, Gaudric A. CONE DENSITY LOSS ON ADAPTIVE OPTICS IN EARLY MACULAR TELANGIECTASIA TYPE 2. Retina. 2016 Mar;36(3):545-51. doi: 10.1097/IAE.0000000000000737.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00122538\",\n",
      "          \"briefTitle\": \"Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2006-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2009-05\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-07-22\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"23719348\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Bouazza N, Treluyer JM, Msellati P, Van de Perre P, Diagbouga S, Nacro B, Hien H, Zoure E, Rouet F, Ouiminga A, Blanche S, Hirt D, Urien S. A novel pharmacokinetic approach to predict virologic failure in HIV-1-infected paediatric patients. AIDS. 2013 Mar 13;27(5):761-8. doi: 10.1097/QAD.0b013e32835caad1.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21857286\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Barro M, Some J, Foulongne V, Diasso Y, Zoure E, Hien H, Francois R, Michel S, Drabo A, Tamboura H, Ouiminga A, Diagbouga S, Hien A, Yameogo S, Van De Perre P, Nacro B, Msellati P. Short-term virological efficacy, immune reconstitution, tolerance, and adherence of once-daily dosing of didanosine, lamivudine, and efavirenz in HIV-1-infected African children: ANRS 12103 Burkiname. J Acquir Immune Defic Syndr. 2011 Jul 1;57 Suppl 1:S44-9. doi: 10.1097/QAI.0b013e31821fd64f.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20516271\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Bouazza N, Hirt D, Bardin C, Diagbouga S, Nacro B, Hien H, Zoure E, Rouet F, Ouiminga A, Blanche S, Van De Perre P, Treluyer JM, Msellati P, Urien S. Is the recommended once-daily dose of lamivudine optimal in West African HIV-infected children? Antimicrob Agents Chemother. 2010 Aug;54(8):3280-6. doi: 10.1128/AAC.00306-10. Epub 2010 Jun 1.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01426243\",\n",
      "          \"briefTitle\": \"The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient.\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2011-07\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2011-08-31\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"30096071\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Colin de Verdiere N, Durier C, Samri A, Meiffredy V, Launay O, Matheron S, Mercier-Delarue S, Even S, Aboulker JP, Molina JM, Autran B, Simon F; ANRS EP46 NOVAA Group. Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients. AIDS. 2018 Oct 23;32(16):2291-2299. doi: 10.1097/QAD.0000000000001963.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT04824638\",\n",
      "          \"briefTitle\": \"BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive Volunteers\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2021-03-08\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2023-12-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2021-04-01\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02113943\",\n",
      "          \"briefTitle\": \"Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Citalopram on Motivation\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2014-06\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-04-15\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00299143\",\n",
      "          \"briefTitle\": \"Pilot Study on Shear-induced Platelet Aggregation in Acute Coronary Syndromes\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2005-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2010-06\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2006-03-06\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03870438\",\n",
      "          \"briefTitle\": \"Prevention of Mother-to-child Transmission of HIV-1 Using a Responsive Intervention\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2019-12-14\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2022-10-31\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2019-03-12\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"University Teaching Hospital, Lusaka, Zambia\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Centre Muraz\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University of Bergen\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"26603917\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Nagot N, Kankasa C, Tumwine JK, Meda N, Hofmeyr GJ, Vallo R, Mwiya M, Kwagala M, Traore H, Sunday A, Singata M, Siuluta C, Some E, Rutagwera D, Neboua D, Ndeezi G, Jackson D, Marechal V, Neveu D, Engebretsen IMS, Lombard C, Blanche S, Sommerfelt H, Rekacewicz C, Tylleskar T, Van de Perre P; ANRS 12174 Trial Group. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. Lancet. 2016 Feb 6;387(10018):566-573. doi: 10.1016/S0140-6736(15)00984-8. Epub 2015 Nov 19. Erratum In: Lancet. 2019 Jun 22;393(10190):2492.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"33872801\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Mennecier A, Kankasa C, Fao P, Moles JP, Eymard-Duvernay S, Mwiya M, Kania D, Chunda-Liyoka C, Sakana L, Rutagwera D, Tassembedo S, Wilfred-Tonga MM, Mosqueira B, Tylleskar T, Nagot N, Van de Perre P; ANRS 12397 Study group. Design and challenges of a large HIV prevention clinical study on mother-to-child transmission: ANRS 12397 PROMISE-EPI study in Zambia and Burkina Faso. Contemp Clin Trials. 2021 Jun;105:106402. doi: 10.1016/j.cct.2021.106402. Epub 2021 Apr 17.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01605890\",\n",
      "          \"briefTitle\": \"Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-07\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-05-25\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Gilead Sciences\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Merck Sharp & Dohme LLC\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"29590335\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Matheron S, Descamps D, Gallien S, Besseghir A, Sellier P, Blum L, Mortier E, Charpentier C, Tubiana R, Damond F, Peytavin G, Ponscarme D, Collin F, Brun-Vezinet F, Chene G; France REcherche Nord&Sud Sida-Hiv Hepatites (ANRS) 159 HIV-2 Trial Study Group. First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2). Clin Infect Dis. 2018 Sep 28;67(8):1161-1167. doi: 10.1093/cid/ciy245.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": true\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00391638\",\n",
      "          \"briefTitle\": \"Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2007-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-10\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2006-10-24\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Gilead Sciences\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Roche Pharma AG\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02323308\",\n",
      "          \"briefTitle\": \"Isolated Anti-HBc Serological Profile in HIV Infected Patients: Immunological, Virological Characteristics and Response to Hepatitis B Vaccination\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2010-12\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2014-06\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-12-23\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02384967\",\n",
      "          \"briefTitle\": \"Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 Patients\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2015-03\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-10\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2015-03-10\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"29905808\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Le MP, Chaix ML, Chevret S, Bertrand J, Raffi F, Gallien S, El Abbassi EMB, Katlama C, Delobel P, Yazdanpanah Y, Saillard J, Molina JM, Peytavin G; ANRS 165 DARULIGHT Study Group. Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study. J Antimicrob Chemother. 2018 Aug 1;73(8):2120-2128. doi: 10.1093/jac/dky193.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00988767\",\n",
      "          \"briefTitle\": \"Safety and Immunogenicity of a Naked DNA-based Vaccine Therapy in Patients With Chronic Hepatitis B\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2001-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2004-10\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2009-10-02\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"15382173\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Mancini-Bourgine M, Fontaine H, Scott-Algara D, Pol S, Brechot C, Michel ML. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers. Hepatology. 2004 Oct;40(4):874-82. doi: 10.1002/hep.20408.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"16310901\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Mancini-Bourgine M, Fontaine H, Brechot C, Pol S, Michel ML. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. Vaccine. 2006 May 22;24(21):4482-9. doi: 10.1016/j.vaccine.2005.08.013. Epub 2005 Aug 18.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20090916\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Scott-Algara D, Mancini-Bourgine M, Fontaine H, Pol S, Michel ML. Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination. PLoS One. 2010 Jan 18;5(1):e8761. doi: 10.1371/journal.pone.0008761.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00323804\",\n",
      "          \"briefTitle\": \"Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2006-05\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2013-03\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2006-05-10\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Merck Sharp & Dohme LLC\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Rennes University Hospital\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT04849767\",\n",
      "          \"briefTitle\": \"National Survey About Trajectory and Life Conditions of HIV Trans People in France\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2020-10-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2023-12-31\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2021-04-19\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"34916316\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Mora M, Rincon G, Bourrelly M, Maradan G, Freire Maresca A, Michard F, Rouveix E, Pannetier J, Leriche D, Alain T, Yazdanpanah Y, Michels D, Spire B. Living conditions, HIV and gender affirmation care pathways of transgender people living with HIV in France: a nationwide, comprehensive, cross-sectional, community-based research protocol (ANRS Trans&HIV). BMJ Open. 2021 Dec 16;11(12):e052691. doi: 10.1136/bmjopen-2021-052691.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03047967\",\n",
      "          \"briefTitle\": \"Effects of Prenatal Tobacco Smoke Exposure on Lung Function and Respiratory Epithelium Functionality in Newborns\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2017-11-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2019-02-09\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2017-02-09\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00120367\",\n",
      "          \"briefTitle\": \"Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2005-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2007-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-07-18\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Hoffmann-La Roche\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Gilead Sciences\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"21738597\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Gasnault J, Costagliola D, Hendel-Chavez H, Dulioust A, Pakianather S, Mazet AA, de Goer de Herve MG, Lancar R, Lascaux AS, Porte L, Delfraissy JF, Taoufik Y; ANRS 125 Trial Team. Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy. PLoS One. 2011;6(6):e20967. doi: 10.1371/journal.pone.0020967. Epub 2011 Jun 30.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01038401\",\n",
      "          \"briefTitle\": \"Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2008-09\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2010-05\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2009-12-24\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT04484740\",\n",
      "          \"briefTitle\": \"Penetration of the Innovative Antibiotic Gepotidacin Into Prostate and Tonsillar Tissue\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2021-01-29\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2023-05-27\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2020-07-24\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Medical University of Vienna\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03078439\",\n",
      "          \"briefTitle\": \"EPIPAGE2 Cohort Study Follow up at Five and a Half Years\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2016-09-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-01-08\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2017-03-13\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00148863\",\n",
      "          \"briefTitle\": \"Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2004-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2007-08\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-09-08\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"InterMune\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Hoffmann-La Roche\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"23190183\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Couzigou P, Perusat S, Bourliere M, Trimoulet P, Poynard T, Leroy V, Marcellin P, Foucher J, Bronowicki JP, Chene G; ANRS HC16 GAMMATRI Trial Group. Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI). J Gastroenterol Hepatol. 2013 Feb;28(2):329-34. doi: 10.1111/jgh.12060.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01548586\",\n",
      "          \"briefTitle\": \"Effect of Transcranial Direct Current Stimulation (tDCS) on the Excitability of the Diaphragmatic Primary Motor Cortex\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-05\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-03-08\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Assistance Publique - H\\u00f4pitaux de Paris\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"15634731\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Hummel F, Celnik P, Giraux P, Floel A, Wu WH, Gerloff C, Cohen LG. Effects of non-invasive cortical stimulation on skilled motor function in chronic stroke. Brain. 2005 Mar;128(Pt 3):490-9. doi: 10.1093/brain/awh369. Epub 2005 Jan 5.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20161639\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Madhavan S, Stinear JW. Focal and bi-directional modulation of lower limb motor cortex using anodal transcranial direct current stimulation. Brain Stimul. 2010 Jan;3(1):42. doi: 10.1016/j.brs.2009.06.005.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22085959\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Nitsche MA, Paulus W. Transcranial direct current stimulation--update 2011. Restor Neurol Neurosci. 2011;29(6):463-92. doi: 10.3233/RNN-2011-0618.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"16002441\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Nitsche MA, Seeber A, Frommann K, Klein CC, Rochford C, Nitsche MS, Fricke K, Liebetanz D, Lang N, Antal A, Paulus W, Tergau F. Modulating parameters of excitability during and after transcranial direct current stimulation of the human motor cortex. J Physiol. 2005 Oct 1;568(Pt 1):291-303. doi: 10.1113/jphysiol.2005.092429. Epub 2005 Jul 7.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"11723286\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Nitsche MA, Paulus W. Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. Neurology. 2001 Nov 27;57(10):1899-901. doi: 10.1212/wnl.57.10.1899.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"10990547\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Nitsche MA, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol. 2000 Sep 15;527 Pt 3(Pt 3):633-9. doi: 10.1111/j.1469-7793.2000.t01-1-00633.x.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"19805746\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Roche N, Lackmy A, Achache V, Bussel B, Katz R. Impact of transcranial direct current stimulation on spinal network excitability in humans. J Physiol. 2009 Dec 1;587(Pt 23):5653-64. doi: 10.1113/jphysiol.2009.177550. Epub 2009 Oct 5.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"15272049\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Sharshar T, Hopkinson NS, Jonville S, Prigent H, Carlier R, Dayer MJ, Swallow EB, Lofaso F, Moxham J, Polkey MI. Demonstration of a second rapidly conducting cortico-diaphragmatic pathway in humans. J Physiol. 2004 Nov 1;560(Pt 3):897-908. doi: 10.1113/jphysiol.2004.061150. Epub 2004 Jul 22.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"8756819\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Similowski T, Catala M, Rancurel G, Derenne JP. Impairment of central motor conduction to the diaphragm in stroke. Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 1):436-41. doi: 10.1164/ajrccm.154.2.8756819.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00302822\",\n",
      "          \"briefTitle\": \"Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2006-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2009-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2006-03-15\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Hoffmann-La Roche\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Gilead Sciences\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00196625\",\n",
      "          \"briefTitle\": \"Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-Infected Patients in Virological Failure.\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2000-11\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2002-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-09-20\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"15456093\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Raguin G, Chene G, Morand-Joubert L, Taburet AM, Droz C, Le Tiec C, Clavel F, Girard PM; Puzzle 1 Study Group. Salvage therapy with amprenavir, lopinavir and ritonavir 200 mg/d or 400 mg/d in HIV-infected patients in virological failure. Antivir Ther. 2004 Aug;9(4):615-25.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"15060509\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Taburet AM, Raguin G, Le Tiec C, Droz C, Barrail A, Vincent I, Morand-Joubert L, Chene G, Clavel F, Girard PM. Interactions between amprenavir and the lopinavir-ritonavir combination in heavily pretreated patients infected with human immunodeficiency virus. Clin Pharmacol Ther. 2004 Apr;75(4):310-23. doi: 10.1016/j.clpt.2003.12.013.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01188525\",\n",
      "          \"briefTitle\": \"Pharmacokinetic Study to Characterize Individual Metabolic Profile\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2010-08\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2011-07\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2010-08-25\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Nuclear Energy Commission (CEA)\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00670839\",\n",
      "          \"briefTitle\": \"Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2008-05\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2013-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2008-05-02\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"MCM Vaccines B.V.\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"26257021\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Rey D, Piroth L, Wendling MJ, Miailhes P, Michel ML, Dufour C, Haour G, Sogni P, Rohel A, Ajana F, Billaud E, Molina JM, Launay O, Carrat F; ANRS HB04 B-BOOST study group. Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial. Lancet Infect Dis. 2015 Nov;15(11):1283-91. doi: 10.1016/S1473-3099(15)00220-0. Epub 2015 Aug 6.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00158522\",\n",
      "          \"briefTitle\": \"Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2003-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2007-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-09-12\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Hoffmann-La Roche\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"16434426\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Bakr I, Rekacewicz C, El Hosseiny M, Ismail S, El Daly M, El-Kafrawy S, Esmat G, Hamid MA, Mohamed MK, Fontanet A. Higher clearance of hepatitis C virus infection in females compared with males. Gut. 2006 Aug;55(8):1183-7. doi: 10.1136/gut.2005.078147. Epub 2006 Jan 24.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"15977225\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"El Gaafary MM, Rekacewicz C, Abdel-Rahman AG, Allam MF, El Hosseiny M, Hamid MA, Colombani F, Sultan Y, El-Aidy S, Fontanet A, Mohamed MK. Surveillance of acute hepatitis C in Cairo, Egypt. J Med Virol. 2005 Aug;76(4):520-5. doi: 10.1002/jmv.20392.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00196586\",\n",
      "          \"briefTitle\": \"Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2003-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2006-11\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-09-20\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Hoffmann-La Roche\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT04808986\",\n",
      "          \"briefTitle\": \"Seroprevalence of IgG Antibodies to SARS-CoV-2 (COVID-19) in Primary Health Care Workers and Their Household Contacts\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2021-05-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2021-10-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2021-03-22\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02626286\",\n",
      "          \"briefTitle\": \"Feasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan Africa\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2015-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2021-01-05\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2015-12-10\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Expertise France\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Universit\\u00e9 Montpellier\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"IRD Unit\\u00e9 SESSTIM (IRD, Inserm, Universit\\u00e9 Aix-Marseille)\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Coalition Internationale Sida\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"ARCAD-SIDA MALI\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Espace Confiance, C\\u00f4te d'Ivoire\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Programme PAC-CI, Abidjan, C\\u00f4te d'Ivoire\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Association African Solidarit\\u00e9\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Centre de Recherche Internationale pour la Sant\\u00e9, Ouagadougou, Burkina Faso\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Espoir Vie-Togo - ONG\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"34352834\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Dah TTE, Yaya I, Mensah E, Coulibaly A, Kouame JM, Traore I, Mora M, Palvadeau P, Anoma C, Keita BD, Spire B, Laurent C; CohMSM Study Group. Rapid antiretroviral therapy initiation and its effect on treatment response in MSM in West Africa. AIDS. 2021 Nov 1;35(13):2201-2210. doi: 10.1097/QAD.0000000000003046.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"34022820\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Dah TTE, Yaya I, Sagaon-Teyssier L, Coulibaly A, Kouame MJ, Agboyibor MK, Maiga K, Traore I, Mora M, Palvadeau P, Rojas-Castro D, Diallo F, Mensah E, Anoma C, Keita BD, Spire B, Laurent C; CohMSM Study Group. Adherence to quarterly HIV prevention services and its impact on HIV incidence in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France). BMC Public Health. 2021 May 22;21(1):972. doi: 10.1186/s12889-021-10994-4.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"33753460\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Yaya I, Diallo F, Kouame MJ, Agboyibor MK, Traore I, Coulibaly A, Maiga K, Mora M, Palvadeau P, Dah ETT, Mensah E, Anoma C, Dembele Keita B, Spire B, Laurent C; CohMSM Study Group. Decrease in incidence of sexually transmitted infections symptoms in men who have sex with men enrolled in a quarterly HIV prevention and care programme in West Africa (CohMSM ANRS 12324-Expertise France). Sex Transm Infect. 2022 Mar;98(2):85-94. doi: 10.1136/sextrans-2020-054755. Epub 2021 Mar 22.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01207986\",\n",
      "          \"briefTitle\": \"Early Lung Cancer Diagnosis in HIV Infected Population With an Important Smoking History With Low Dose CT: a Pilot Study\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2011-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2014-08\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2010-09-23\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03537196\",\n",
      "          \"briefTitle\": \"DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2018-11-13\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2022-12-30\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2018-05-25\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"25086286\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014 Nov;61(1 Suppl):S45-57. doi: 10.1016/j.jhep.2014.07.027. Epub 2014 Jul 30.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23172780\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013 Apr;57(4):1333-42. doi: 10.1002/hep.26141. Epub 2013 Feb 4.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22828983\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Sereno L, Mesquita F, Kato M, Jacka D, Nguyen TT, Nguyen TN. Epidemiology, responses, and way forward: the silent epidemic of viral hepatitis and HIV coinfection in Vietnam. J Int Assoc Physicians AIDS Care (Chic). 2012 Sep-Oct;11(5):311-20. doi: 10.1177/1545109712453939. Epub 2012 Jul 24.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20041309\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Clatts MC, Colon-Lopez V, Giang LM, Goldsamt LA. Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection. J Urban Health. 2010 Mar;87(2):278-291. doi: 10.1007/s11524-009-9417-9.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22098550\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Gish RG, Bui TD, Nguyen CT, Nguyen DT, Tran HV, Tran DM, Trinh HN; International Group for Liver Health in Viet Nam. Liver disease in Viet Nam: screening, surveillance, management and education: a 5-year plan and call to action. J Gastroenterol Hepatol. 2012 Feb;27(2):238-47. doi: 10.1111/j.1440-1746.2011.06974.x.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20196807\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Kallman JB, Tran S, Arsalla A, Haddad D, Stepanova M, Fang Y, Wrobel VJ, Srishord M, Younossi ZM. Vietnamese community screening for hepatitis B virus and hepatitis C virus. J Viral Hepat. 2011 Jan;18(1):70-6. doi: 10.1111/j.1365-2893.2010.01278.x.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"19839502\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Pham DA, Leuangwutiwong P, Jittmittraphap A, Luplertlop N, Bach HK, Akkarathamrongsin S, Theamboonlers A, Poovorawan Y. High prevalence of Hepatitis C virus genotype 6 in Vietnam. Asian Pac J Allergy Immunol. 2009 Jun-Sep;27(2-3):153-60.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20572071\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Tanimoto T, Nguyen HC, Ishizaki A, Chung PT, Hoang TT, Nguyen VT, Kageyama S, Oka S, Pham VT, Ichimura H. Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam. J Med Virol. 2010 Aug;82(8):1355-63. doi: 10.1002/jmv.21787.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23675659\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Liang TJ, Ghany MG. Current and future therapies for hepatitis C virus infection. N Engl J Med. 2013 May 16;368(20):1907-17. doi: 10.1056/NEJMra1213651.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"25920094\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Pawlotsky JM, Feld JJ, Zeuzem S, Hoofnagle JH. From non-A, non-B hepatitis to hepatitis C virus cure. J Hepatol. 2015 Apr;62(1 Suppl):S87-99. doi: 10.1016/j.jhep.2015.02.006.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23553643\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Martin NK, Vickerman P, Grebely J, Hellard M, Hutchinson SJ, Lima VD, Foster GR, Dillon JF, Goldberg DJ, Dore GJ, Hickman M. Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. Hepatology. 2013 Nov;58(5):1598-609. doi: 10.1002/hep.26431. Epub 2013 Aug 26.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23728143\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Grebely J, Matthews GV, Lloyd AR, Dore GJ. Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements. Clin Infect Dis. 2013 Oct;57(7):1014-20. doi: 10.1093/cid/cit377. Epub 2013 May 31.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27667367\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL Recommendations on Treatment of Hepatitis C 2016. J Hepatol. 2017 Jan;66(1):153-194. doi: 10.1016/j.jhep.2016.09.001. Epub 2016 Sep 22. No abstract available.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"25245939\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Bruggmann P, Grebely J. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs. Int J Drug Policy. 2015 Feb;26 Suppl 1:S22-6. doi: 10.1016/j.drugpo.2014.08.014. Epub 2014 Aug 30.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27178119\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Des Jarlais D, Duong HT, Pham Minh K, Khuat OH, Nham TT, Arasteh K, Feelemyer J, Heckathorn DD, Peries M, Moles JP, Laureillard D, Nagot N; (The Drive Study Team). Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. AIDS Care. 2016 Oct;28(10):1312-5. doi: 10.1080/09540121.2016.1178698. Epub 2016 May 13.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27227200\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection: Updated Version. Geneva: World Health Organization; 2016 Apr. Available from http://www.ncbi.nlm.nih.gov/books/NBK362924/\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27148964\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Nguyen Truong T, Laureillard D, Lacombe K, Duong Thi H, Pham Thi Hanh P, Truong Thi Xuan L, Chu Thi N, Luong Que A, Vu Hai V, Nagot N, Tuaillon E, Dominguez S, Lemoine M. High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262). PLoS One. 2016 May 5;11(5):e0153744. doi: 10.1371/journal.pone.0153744. eCollection 2016.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23884064\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Martin NK, Hickman M, Hutchinson SJ, Goldberg DJ, Vickerman P. Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. Clin Infect Dis. 2013 Aug;57 Suppl 2(Suppl 2):S39-45. doi: 10.1093/cid/cit296. Erratum In: Clin Infect Dis. 2014 Apr;58(8):1203.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27427455\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Altice FL, Azbel L, Stone J, Brooks-Pollock E, Smyrnov P, Dvoriak S, Taxman FS, El-Bassel N, Martin NK, Booth R, Stover H, Dolan K, Vickerman P. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. Lancet. 2016 Sep 17;388(10050):1228-48. doi: 10.1016/S0140-6736(16)30856-X. Epub 2016 Jul 14.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22564041\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Vickerman P, Martin N, Turner K, Hickman M. Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings. Addiction. 2012 Nov;107(11):1984-95. doi: 10.1111/j.1360-0443.2012.03932.x. Epub 2012 Jul 12.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26298331\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Smith DJ, Combellick J, Jordan AE, Hagan H. Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis. Int J Drug Policy. 2015 Oct;26(10):911-21. doi: 10.1016/j.drugpo.2015.07.004. Epub 2015 Jul 26.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27349488\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Conti F, Buonfiglioli F, Scuteri A, Crespi C, Bolondi L, Caraceni P, Foschi FG, Lenzi M, Mazzella G, Verucchi G, Andreone P, Brillanti S. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. J Hepatol. 2016 Oct;65(4):727-733. doi: 10.1016/j.jhep.2016.06.015. Epub 2016 Jun 24.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"33208326\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Rapoud D, Quillet C, Pham Minh K, Vu Hai V, Nguyen Thanh B, Nham Thi Tuyet T, Tran Thi H, Moles JP, Vallo R, Michel L, Feelemyer J, Weiss L, Lemoine M, Vickerman P, Fraser H, Duong Thi H, Khuat Thi Hai O, Des Jarlais D, Nagot N, Laureillard D; DRIVE-C Study Group. Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C). BMJ Open. 2020 Nov 18;10(11):e039234. doi: 10.1136/bmjopen-2020-039234.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT04684758\",\n",
      "          \"briefTitle\": \"HIV Acquisition and Life Course of Born-abroad Men Who Have Sex With Men Living in Ile-de-France: the GANYMEDE Study\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2021-04-14\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2022-06-30\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2020-12-28\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00121758\",\n",
      "          \"briefTitle\": \"AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptides Versus Placebo in Non Infected HIV Volunteers\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2004-09\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2007-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-07-21\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Aventis Pharmaceuticals\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"23759749\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Richert L, Hue S, Hocini H, Raimbault M, Lacabaratz C, Surenaud M, Wiedemann A, Tisserand P, Durier C, Salmon D, Lelievre JD, Chene G, Thiebaut R, Levy Y; ANRS Vaccine Network/Vaccine Research Institute. Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers. AIDS. 2013 Jun 1;27(9):1421-31. doi: 10.1097/QAD.0b013e32835f5b60.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20625264\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Salmon-Ceron D, Durier C, Desaint C, Cuzin L, Surenaud M, Hamouda NB, Lelievre JD, Bonnet B, Pialoux G, Poizot-Martin I, Aboulker JP, Levy Y, Launay O; ANRS VAC18 trial group. Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial. AIDS. 2010 Sep 10;24(14):2211-23. doi: 10.1097/QAD.0b013e32833ce566.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02527096\",\n",
      "          \"briefTitle\": \"A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir\\u00ae) and Dolutegravir (Tivicay\\u00ae) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 Lamidol)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2015-09-17\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-03\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2015-08-18\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"ViiV Healthcare\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00158457\",\n",
      "          \"briefTitle\": \"Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2004-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2006-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-09-12\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Gilead Sciences\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Institut de M\\u00e9decine et d'Epid\\u00e9miologie Appliqu\\u00e9e - Fondation Internationale L\\u00e9on M'Ba\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00136630\",\n",
      "          \"briefTitle\": \"Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2005-05\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2020-05\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-08-29\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Assistance Publique - H\\u00f4pitaux de Paris\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"16193476\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Klebe S, Durr A, Rentschler A, Hahn-Barma V, Abele M, Bouslam N, Schols L, Jedynak P, Forlani S, Denis E, Dussert C, Agid Y, Bauer P, Globas C, Wullner U, Brice A, Riess O, Stevanin G. New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14. Ann Neurol. 2005 Nov;58(5):720-9. doi: 10.1002/ana.20628.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"15313841\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Stevanin G, Hahn V, Lohmann E, Bouslam N, Gouttard M, Soumphonphakdy C, Welter ML, Ollagnon-Roman E, Lemainque A, Ruberg M, Brice A, Durr A. Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14. Arch Neurol. 2004 Aug;61(8):1242-8. doi: 10.1001/archneur.61.8.1242.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"15365159\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Stevanin G, Durr A, Dussert C, Penet C, Brice A. Mutations in the FGF14 gene are not a major cause of spinocerebellar ataxia in Caucasians. Neurology. 2004 Sep 14;63(5):936. doi: 10.1212/01.wnl.0000137020.30604.1e. No abstract available.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"16501573\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Waters MF, Minassian NA, Stevanin G, Figueroa KP, Bannister JP, Nolte D, Mock AF, Evidente VG, Fee DB, Muller U, Durr A, Brice A, Papazian DM, Pulst SM. Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes. Nat Genet. 2006 Apr;38(4):447-51. doi: 10.1038/ng1758. Epub 2006 Feb 26.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"16055926\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Labauge P, Brice A, Durr A. Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases. J Med Genet. 2006 Mar;43(3):259-65. doi: 10.1136/jmg.2005.035311. Epub 2005 Jul 31.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"17098887\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Depienne C, Fedirko E, Forlani S, Cazeneuve C, Ribai P, Feki I, Tallaksen C, Nguyen K, Stankoff B, Ruberg M, Stevanin G, Durr A, Brice A. Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia. J Med Genet. 2007 Apr;44(4):281-4. doi: 10.1136/jmg.2006.046425. Epub 2006 Nov 10.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"17597328\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Depienne C, Fedirko E, Faucheux JM, Forlani S, Bricka B, Goizet C, Lesourd S, Stevanin G, Ruberg M, Durr A, Brice A. A de novo SPAST mutation leading to somatic mosaicism is associated with a later age at onset in HSP. Neurogenetics. 2007 Aug;8(3):231-3. doi: 10.1007/s10048-007-0090-4. Epub 2007 Jun 28.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"17605047\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Hanein S, Durr A, Ribai P, Forlani S, Leutenegger AL, Nelson I, Babron MC, Elleuch N, Depienne C, Charon C, Brice A, Stevanin G. A novel locus for autosomal dominant \\\"uncomplicated\\\" hereditary spastic paraplegia maps to chromosome 8p21.1-q13.3. Hum Genet. 2007 Nov;122(3-4):261-73. doi: 10.1007/s00439-007-0396-1. Epub 2007 Jun 28.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"17957230\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Ribai P, Depienne C, Fedirko E, Jothy AC, Viveweger C, Hahn-Barma V, Brice A, Durr A. Mental deficiency in three families with SPG4 spastic paraplegia. Eur J Hum Genet. 2008 Jan;16(1):97-104. doi: 10.1038/sj.ejhg.5201922. Epub 2007 Oct 24.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"18378516\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"du Montcel ST, Charles P, Ribai P, Goizet C, Le Bayon A, Labauge P, Guyant-Marechal L, Forlani S, Jauffret C, Vandenberghe N, N'guyen K, Le Ber I, Devos D, Vincitorio CM, Manto MU, Tison F, Hannequin D, Ruberg M, Brice A, Durr A. Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment. Brain. 2008 May;131(Pt 5):1352-61. doi: 10.1093/brain/awn059. Epub 2008 Mar 31.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"18853458\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Goizet C, Boukhris A, Mundwiller E, Tallaksen C, Forlani S, Toutain A, Carriere N, Paquis V, Depienne C, Durr A, Stevanin G, Brice A. Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. Hum Mutat. 2009 Feb;30(2):E376-85. doi: 10.1002/humu.20920.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24780882\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Tezenas du Montcel S, Durr A, Rakowicz M, Nanetti L, Charles P, Sulek A, Mariotti C, Rola R, Schols L, Bauer P, Dufaure-Gare I, Jacobi H, Forlani S, Schmitz-Hubsch T, Filla A, Timmann D, van de Warrenburg BP, Marelli C, Kang JS, Giunti P, Cook A, Baliko L, Melegh B, Boesch S, Szymanski S, Berciano J, Infante J, Buerk K, Masciullo M, Di Fabio R, Depondt C, Ratka S, Stevanin G, Klockgether T, Brice A, Golmard JL. Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6. J Med Genet. 2014 Jul;51(7):479-86. doi: 10.1136/jmedgenet-2013-102200. Epub 2014 Apr 29. Erratum In: J Med Genet. 2014 Sep;51(9):613. Bela, Melegh [corrected to Melegh, Bela].\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22491195\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Tezenas du Montcel S, Charles P, Goizet C, Marelli C, Ribai P, Vincitorio C, Anheim M, Guyant-Marechal L, Le Bayon A, Vandenberghe N, Tchikviladze M, Devos D, Le Ber I, N'Guyen K, Cazeneuve C, Tallaksen C, Brice A, Durr A. Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegia. Arch Neurol. 2012 Apr;69(4):500-8. doi: 10.1001/archneurol.2011.2713.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01579435\",\n",
      "          \"briefTitle\": \"Experimental Therapeutics in Essential Tremor Using Transcranial Direct Current Stimulation\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2013-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-04-18\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02057796\",\n",
      "          \"briefTitle\": \"Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-09\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-02-07\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"32558469\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Blanc FX, Badje AD, Bonnet M, Gabillard D, Messou E, Muzoora C, Samreth S, Nguyen BD, Borand L, Domergue A, Rapoud D, Natukunda N, Thai S, Juchet S, Eholie SP, Lawn SD, Domoua SK, Anglaret X, Laureillard D; STATIS ANRS 12290 Trial Team. Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults. N Engl J Med. 2020 Jun 18;382(25):2397-2410. doi: 10.1056/NEJMoa1910708.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01713335\",\n",
      "          \"briefTitle\": \"Proteasis Evaluation in COPD\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-10-18\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-10-24\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02073630\",\n",
      "          \"briefTitle\": \"Contribution of the Cerebellum In Sensory-motor Adaptation Via Gamma Oscillations: the Case of Dystonia\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-08\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-02-27\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT05040048\",\n",
      "          \"briefTitle\": \"Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2015-09-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2021-09-10\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Innovative Medicines Initiative\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Institut d'Investigacions Biom\\u00e8diques August Pi i Sunyer\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"ICM Co. Ltd.\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University Hospital, Bonn\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Karolinska Institutet\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03446430\",\n",
      "          \"briefTitle\": \"Validation of Laser Doppler Vibrometer (LDV) for Measurement of Arterial Stiffness in Hypertensive Patients\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2018-06-21\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-12-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2018-02-26\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01094899\",\n",
      "          \"briefTitle\": \"Abnormal Structure and Bone Density in Diabetes\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2010-03-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2014-07-10\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2010-03-29\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03193099\",\n",
      "          \"briefTitle\": \"Decoding Presymptomatic White Matter Changes in Huntington Disease\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2017-07-11\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2019-12-30\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2017-06-20\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"University College, London\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03831906\",\n",
      "          \"briefTitle\": \"Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2019-03-20\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2021-06-30\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2019-02-06\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"UNITAID\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"33743621\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Vessiere A, Font H, Gabillard D, Adonis-Koffi L, Borand L, Chabala C, Khosa C, Mavale S, Moh R, Mulenga V, Mwanga-Amumpere J, Taguebue JV, Eang MT, Delacourt C, Seddon JA, Lounnas M, Godreuil S, Wobudeya E, Bonnet M, Marcy O. Impact of systematic early tuberculosis detection using Xpert MTB/RIF Ultra in children with severe pneumonia in high tuberculosis burden countries (TB-Speed pneumonia): a stepped wedge cluster randomized trial. BMC Pediatr. 2021 Mar 20;21(1):136. doi: 10.1186/s12887-021-02576-5.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"36395782\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Marcy O, Wobudeya E, Font H, Vessiere A, Chabala C, Khosa C, Taguebue JV, Moh R, Mwanga-Amumpaire J, Lounnas M, Mulenga V, Mavale S, Chilundo J, Rego D, Nduna B, Shankalala P, Chirwa U, De Lauzanne A, Dim B, Tiogouo Ngouana E, Folquet Amorrissani M, Cisse L, Amon Tanoh Dick F, Komena EA, Kwedi Nolna S, Businge G, Natukunda N, Cumbe S, Mbekeka P, Kim A, Kheang C, Pol S, Maleche-Obimbo E, Seddon JA, Mao TE, Graham SM, Delacourt C, Borand L, Bonnet M; TB-Speed Pneumonia Study Group. Effect of systematic tuberculosis detection on mortality in young children with severe pneumonia in countries with high incidence of tuberculosis: a stepped-wedge cluster-randomised trial. Lancet Infect Dis. 2023 Mar;23(3):341-351. doi: 10.1016/S1473-3099(22)00668-5. Epub 2022 Nov 14.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"32853411\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Kay AW, Gonzalez Fernandez L, Takwoingi Y, Eisenhut M, Detjen AK, Steingart KR, Mandalakas AM. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children. Cochrane Database Syst Rev. 2020 Aug 27;8(8):CD013359. doi: 10.1002/14651858.CD013359.pub2.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00148824\",\n",
      "          \"briefTitle\": \"Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults.\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2003-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2006-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-09-08\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Wyeth is now a wholly owned subsidiary of Pfizer\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"20210645\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Rabian C, Tschope I, Lesprit P, Katlama C, Molina JM, Meynard JL, Delfraissy JF, Chene G, Levy Y; ANRS 114 Pneumovac Study Group. Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults. Clin Infect Dis. 2010 Apr 15;50(8):1174-83. doi: 10.1086/651418.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00901524\",\n",
      "          \"briefTitle\": \"ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIV\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-06\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2009-05-13\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Roche Pharma AG\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"24905490\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Laird ME, Mohsen A, Duffy D, Mamdouh R, LeFouler L, Casrouge A, El-Daly M, Rafik M, Abdel-Hamid M, Soulier A, Pawlotsky JM, Hezode C, Rosa I, Renard P, Mohamed MK, Bonnard P, Izopet J, Mallet V, Pol S, Albert ML, Fontanet A. Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection. J Hepatol. 2014 Oct;61(4):770-6. doi: 10.1016/j.jhep.2014.05.040. Epub 2014 Jun 4.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00870649\",\n",
      "          \"briefTitle\": \"Efficacy of Bilhvax in Association With Praziquantel for Prevention of Clinical Recurrences of Schistosoma Haematobium\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2009-03-27\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"30532268\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Riveau G, Schacht AM, Dompnier JP, Deplanque D, Seck M, Waucquier N, Senghor S, Delcroix-Genete D, Hermann E, Idris-Khodja N, Levy-Marchal C, Capron M, Capron A. Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: A phase 3 randomized, controlled trial in Senegalese children. PLoS Negl Trop Dis. 2018 Dec 7;12(12):e0006968. doi: 10.1371/journal.pntd.0006968. eCollection 2018 Dec.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01207349\",\n",
      "          \"briefTitle\": \"Type 2 Diabetes Secondary Prevention\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2002-08\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2004-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2010-09-22\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Groupe Hospitalier Sud R\\u00e9union\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"22030240\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Debussche X, Rollot O, Le Pommelet C, Fianu A, Le Moullec N, Regnier C, Boyer MC, Cogne M, Bakiri F, Schwager JC, Favier F. Quarterly individual outpatients lifestyle counseling after initial inpatients education on type 2 diabetes: the REDIA Prev-2 randomized controlled trial in Reunion Island. Diabetes Metab. 2012 Feb;38(1):46-53. doi: 10.1016/j.diabet.2011.07.002. Epub 2011 Oct 24.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01531036\",\n",
      "          \"briefTitle\": \"3D Breast Ultrasound Elastography in Patients Under Neoadjuvant Chemotherapy\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2010-12\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-11\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-02-10\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"20505064\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Athanasiou A, Tardivon A, Tanter M, Sigal-Zafrani B, Bercoff J, Deffieux T, Gennisson JL, Fink M, Neuenschwander S. Breast lesions: quantitative elastography with supersonic shear imaging--preliminary results. Radiology. 2010 Jul;256(1):297-303. doi: 10.1148/radiol.10090385. Epub 2010 May 26.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00651066\",\n",
      "          \"briefTitle\": \"Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2010-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-09\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2008-04-02\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"24465443\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Lan NT, Thu NT, Barrail-Tran A, Duc NH, Lan NN, Laureillard D, Lien TT, Borand L, Quillet C, Connolly C, Lagarde D, Pym A, Lienhardt C, Dung NH, Taburet AM, Harries AD. Randomised pharmacokinetic trial of rifabutin with lopinavir/ritonavir-antiretroviral therapy in patients with HIV-associated tuberculosis in Vietnam. PLoS One. 2014 Jan 22;9(1):e84866. doi: 10.1371/journal.pone.0084866. eCollection 2014.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02081066\",\n",
      "          \"briefTitle\": \"Identification of CETP as a Marker of Atherosclerosis\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-09-25\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2020-09\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-03-07\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01164436\",\n",
      "          \"briefTitle\": \"Cohort of HIV Associated Lymphomas\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2008-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-06\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2010-07-16\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Dr Yassine Taoufik Dr Houria Chavez H\\u00f4pital Bic\\u00eatre CIB Paris Sud France\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Dr Guislaine Garcelain H\\u00f4pital Piti\\u00e9 Slap\\u00e9tri\\u00e8re Paris France\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University Hospital, Grenoble\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Dr Ir\\u00e8ne Joab H\\u00f4pital Paul Brousse Villejuif France\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Dr Alex Duval Fondation Jean Dausset CEPH\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Hopital Antoine Beclere\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01038999\",\n",
      "          \"briefTitle\": \"Accelerated Aging, HIV Infection, Antiretroviral Therapies\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-03\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2009-12-24\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"23285253\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Perrin S, Cremer J, Faucher O, Reynes J, Dellamonica P, Micallef J, Solas C, Lacarelle B, Stretti C, Kaspi E, Robaglia-Schlupp A, Nicolino-Brunet C, Tamalet C, Levy N, Poizot-Martin I, Cau P, Roll P. HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 \\\"aging\\\" study. PLoS One. 2012;7(12):e53035. doi: 10.1371/journal.pone.0053035. Epub 2012 Dec 28. Erratum In: PLoS One. 2013;8(8). doi:10.1371/annotation/f02cdfd3-b271-46fd-a78f-5a030f0b416d. Tamalet, Corine Nicolino-Brunet Catherine [corrected to Nicolino-Brunet, Corinne]; [ corrected to Tamalet, Catherine].\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22829920\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Perrin S, Cremer J, Roll P, Faucher O, Menard A, Reynes J, Dellamonica P, Naqvi A, Micallef J, Jouve E, Tamalet C, Solas C, Pissier C, Arnoux I, Nicolino-Brunet C, Espinosa L, Levy N, Kaspi E, Robaglia-Schlupp A, Poizot-Martin I, Cau P. HIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: the ANRS EP45 \\\"Aging\\\" study. PLoS One. 2012;7(7):e41129. doi: 10.1371/journal.pone.0041129. Epub 2012 Jul 19.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00604149\",\n",
      "          \"briefTitle\": \"Cardiac AResT And GENEtic\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2008-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2014-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2008-01-30\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01569399\",\n",
      "          \"briefTitle\": \"Efficacity of rTMS in Alcohol Dependance\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2011-02-11\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-08\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-04-03\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01917175\",\n",
      "          \"briefTitle\": \"Early Identification and Treatment of Early HIV Infection in C\\u00f4te d'Ivoire\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"1997-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-09\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2013-08-06\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01592175\",\n",
      "          \"briefTitle\": \"Magnetoencephalography (MEG), Attention and Conscience\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-03-08\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2013-07-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-05-07\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01271842\",\n",
      "          \"briefTitle\": \"Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU Study\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2010-10\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2011-01-07\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"22948576\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Luyt CE, Combes A, Becquemin MH, Beigelman-Aubry C, Hatem S, Brun AL, Zraik N, Carrat F, Grenier PA, Richard JM, Mercat A, Brochard L, Brun-Buisson C, Chastre J; REVA Study Group. Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS. Chest. 2012 Sep;142(3):583-592. doi: 10.1378/chest.11-2196.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00265642\",\n",
      "          \"briefTitle\": \"Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2006-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2013-11\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-12-15\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Sanofi\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01008813\",\n",
      "          \"briefTitle\": \"Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2010-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2009-11-06\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"GlaxoSmithKline\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00158470\",\n",
      "          \"briefTitle\": \"Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2003-09\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2007-05\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-09-12\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT04265742\",\n",
      "          \"briefTitle\": \"Microbiota and Bone Fragility:Study of the Relation Between Gut Microbiota and Bone Microarchitecture\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2019-02-08\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2022-02-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2020-02-12\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Merck Sharp & Dohme LLC\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT04631224\",\n",
      "          \"briefTitle\": \"Longitudinal Analysis of Oral Communication in Friedreich's Ataxia\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2015-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2020-11-17\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01493934\",\n",
      "          \"briefTitle\": \"Development of a Fast Measurement Technique of Insulin Resistance in Human\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2010-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2013-03\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2011-12-16\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02978924\",\n",
      "          \"briefTitle\": \"Trans-spinal Direct Current Stimulation in Primary Orthostatic Tremor\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2017-01-17\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-11-28\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2016-12-01\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00226434\",\n",
      "          \"briefTitle\": \"Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2006-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2010-05\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-09-27\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"National Institutes of Health (NIH)\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"17624825\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Blanc FX, Havlir DV, Onyebujoh PC, Thim S, Goldfeld AE, Delfraissy JF. Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials. J Infect Dis. 2007 Aug 15;196 Suppl 1:S46-51. doi: 10.1086/518658.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24759827\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Marcy O, Laureillard D, Madec Y, Chan S, Mayaud C, Borand L, Prak N, Kim C, Lak KK, Hak C, Dim B, Sok T, Delfraissy JF, Goldfeld AE, Blanc FX; CAMELIA (ANRS 1295-CIPRA KH001) Study Team. Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial. Clin Infect Dis. 2014 Aug 1;59(3):435-45. doi: 10.1093/cid/ciu283. Epub 2014 Apr 23.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24096631\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Laureillard D, Marcy O, Madec Y, Chea S, Chan S, Borand L, Fernandez M, Prak N, Kim C, Dim B, Nerrienet E, Sok T, Delfraissy JF, Goldfeld AE, Blanc FX; CAMELIA (ANRS 1295 - CIPRA KH001) Study Team. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial. AIDS. 2013 Oct 23;27(16):2577-86. doi: 10.1097/01.aids.0000432456.14099.c7.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24608960\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Borand L, Madec Y, Laureillard D, Chou M, Marcy O, Pheng P, Prak N, Kim C, Lak KK, Hak C, Dim B, Nerrienet E, Fontanet A, Sok T, Goldfeld AE, Blanc FX, Taburet AM. Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial). PLoS One. 2014 Mar 7;9(3):e90350. doi: 10.1371/journal.pone.0090350. eCollection 2014.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23237982\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Borand L, Laureillard D, Madec Y, Chou M, Pheng P, Marcy O, Sok T, Goldfeld AE, Taburet AM, Blanc FX; CAMELIA ANRS 1295-CIPRA KH001 Study Team. Plasma concentrations of efavirenz with a 600 mg standard dose in Cambodian HIV-infected adults treated for tuberculosis with a body weight above 50 kg. Antivir Ther. 2013;18(3):419-23. doi: 10.3851/IMP2483. Epub 2012 Dec 12.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22010913\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, Madec Y, Marcy O, Chan S, Prak N, Kim C, Lak KK, Hak C, Dim B, Sin CI, Sun S, Guillard B, Sar B, Vong S, Fernandez M, Fox L, Delfraissy JF, Goldfeld AE; CAMELIA (ANRS 1295-CIPRA KH001) Study Team. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med. 2011 Oct 20;365(16):1471-81. doi: 10.1056/NEJMoa1013911.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT04392388\",\n",
      "          \"briefTitle\": \"Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2020-05-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2023-04-11\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2020-05-18\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00928187\",\n",
      "          \"briefTitle\": \"Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaound\\u00e9)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-11\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2009-06-25\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Gilead Sciences\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Janssen Pharmaceutica\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"31273686\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Boyer S, Nishimwe ML, Sagaon-Teyssier L, March L, Koulla-Shiro S, Bousmah MQ, Toby R, Mpoudi-Etame MP, Ngom Gueye NF, Sawadogo A, Kouanfack C, Ciaffi L, Spire B, Delaporte E; 2-Lady Group. Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa. Pharmacoecon Open. 2020 Mar;4(1):45-60. doi: 10.1007/s41669-019-0157-9.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": true\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00640887\",\n",
      "          \"briefTitle\": \"Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2010-10\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2008-03-21\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"26482301\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Hennig S, Naiker S, Reddy T, Egan D, Kellerman T, Wiesner L, Owen A, McIlleron H, Pym A. Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis. Antimicrob Agents Chemother. 2015 Oct 19;60(1):617-20. doi: 10.1128/AAC.01195-15. Print 2016 Jan.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"25406657\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Naiker S, Connolly C, Wiesner L, Kellerman T, Reddy T, Harries A, McIlleron H, Lienhardt C, Pym A. Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy. BMC Pharmacol Toxicol. 2014 Nov 19;15:61. doi: 10.1186/2050-6511-15-61.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01952587\",\n",
      "          \"briefTitle\": \"X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2013-11\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-06\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2013-09-30\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01089387\",\n",
      "          \"briefTitle\": \"Intracavernous Bone Marrow Stem-cell Injection for Post Prostatectomy Erectile Dysfunction\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2010-05\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-03\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2010-03-18\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"28753830\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Yiou R, Hamidou L, Birebent B, Bitari D, Le Corvoisier P, Contremoulins I, Rodriguez AM, Augustin D, Roudot-Thoraval F, de la Taille A, Rouard H. Intracavernous Injections of Bone Marrow Mononucleated Cells for Postradical Prostatectomy Erectile Dysfunction: Final Results of the INSTIN Clinical Trial. Eur Urol Focus. 2017 Dec;3(6):643-645. doi: 10.1016/j.euf.2017.06.009. Epub 2017 Jun 24.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"25974235\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Khera M, Albersen M, Mulhall JP. Mesenchymal stem cell therapy for the treatment of erectile dysfunction. J Sex Med. 2015 May;12(5):1105-6. doi: 10.1111/jsm.12871. No abstract available.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02833961\",\n",
      "          \"briefTitle\": \"Diffusion Spectroscopy in Stroke\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2016-07-28\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2019-10-25\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2016-07-14\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02453061\",\n",
      "          \"briefTitle\": \"A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's Disease\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2015-06-29\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2019-12-03\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2015-05-25\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Ultragenyx Pharmaceutical Inc\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"31381524\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Rodrigues FB, Ferreira JJ, Wild EJ. Huntington's Disease Clinical Trials Corner: June 2019. J Huntingtons Dis. 2019;8(3):363-371. doi: 10.3233/JHD-199003.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01494961\",\n",
      "          \"briefTitle\": \"Couple-oriented Prenatal HIV Counseling in Low and Medium HIV Prevalence Countries\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2011-10\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2011-12-19\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Elizabeth Glaser Pediatric AIDS Foundation\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"20403152\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Orne-Gliemann J, Tchendjou PT, Miric M, Gadgil M, Butsashvili M, Eboko F, Perez-Then E, Darak S, Kulkarni S, Kamkamidze G, Balestre E, du Lou AD, Dabis F. Couple-oriented prenatal HIV counseling for HIV primary prevention: an acceptability study. BMC Public Health. 2010 Apr 19;10:197. doi: 10.1186/1471-2458-10-197.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21857289\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Tchendjou PT, Koki PN, Eboko F, Malateste K, Essounga AN, Amassana D, Mossus T, Tejiokem M, Boisier P, Orne-Gliemann J. Factors associated with history of HIV testing among pregnant women and their partners in Cameroon: baseline data from a Behavioral Intervention Trial (ANRS 12127 Prenahtest). J Acquir Immune Defic Syndr. 2011 Jul 1;57 Suppl 1:S9-15. doi: 10.1097/QAI.0b013e31821ec6e2.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"34329355\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Kengne-Nde C, Tejiokem MC, Orne-Gliemann J, Melingui B, Koki Ndombo P, Essounga NA, Bissek AC, Cauchemez S, Tchendjou PT. Couple oriented counselling improves male partner involvement in sexual and reproductive health of a couple: Evidence from the ANRS PRENAHTEST randomized trial. PLoS One. 2021 Jul 30;16(7):e0255330. doi: 10.1371/journal.pone.0255330. eCollection 2021.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"29178852\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Tiendrebeogo T, Plazy M, Darak S, Miric M, Perez-Then E, Butsashvili M, Tchendjou P, Dabis F, Orne-Gliemann J. Couples HIV counselling and couple relationships in India, Georgia and the Dominican Republic. BMC Public Health. 2017 Nov 25;17(1):901. doi: 10.1186/s12889-017-4901-8.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23343912\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Orne-Gliemann J, Balestre E, Tchendjou P, Miric M, Darak S, Butsashvili M, Perez-Then E, Eboko F, Plazy M, Kulkarni S, Desgrees du Lou A, Dabis F; Prenahtest ANRS 12127 Study Group. Increasing HIV testing among male partners. AIDS. 2013 Apr 24;27(7):1167-77. doi: 10.1097/QAD.0b013e32835f1d8c.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00301561\",\n",
      "          \"briefTitle\": \"Antiretroviral Treatment Simplified Follow-up Management Assessment (ANRS 12110 STRATALL)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2006-05\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2010-10\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2006-03-13\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"35248123\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Sandie AB, Molinari N, Wanjoya A, Kouanfack C, Laurent C, Tchatchueng-Mbougua JB. Non-inferiority test for a continuous variable with a flexible margin in an active controlled trial: an application to the \\\"Stratall ANRS 12110 / ESTHER\\\" trial. Trials. 2022 Mar 5;23(1):202. doi: 10.1186/s13063-022-06118-x.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21831714\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Laurent C, Kouanfack C, Laborde-Balen G, Aghokeng AF, Mbougua JB, Boyer S, Carrieri MP, Mben JM, Dontsop M, Kaze S, Molinari N, Bourgeois A, Mpoudi-Ngole E, Spire B, Koulla-Shiro S, Delaporte E; Stratall ANRS 12110/ESTHER study group. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial. Lancet Infect Dis. 2011 Nov;11(11):825-33. doi: 10.1016/S1473-3099(11)70168-2. Epub 2011 Aug 8.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01167283\",\n",
      "          \"briefTitle\": \"Effect of Electrostimulation in Chronic Obstructive Pulmonary Disease (COPD)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2006-07\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2010-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2010-07-22\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Centre Hospitalier R\\u00e9gional Universitaire Montpellier\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02150993\",\n",
      "          \"briefTitle\": \"First-Line Treatment for HIV-2\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2016-01-26\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2019-05-15\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-05-30\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01075061\",\n",
      "          \"briefTitle\": \"Study of a Large Family With Congenital Mirror Movements : From Underlying Pathophysiology to Culprit Gene Identification PROJET \\\" MOMIC \\\"\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2010-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2011-07\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2010-02-24\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02014883\",\n",
      "          \"briefTitle\": \"Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2013-12-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2019-07-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2013-12-18\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Ultragenyx Pharmaceutical Inc\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"26536893\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Mochel F, Hainque E, Gras D, Adanyeguh IM, Caillet S, Heron B, Roubertie A, Kaphan E, Valabregue R, Rinaldi D, Vuillaumier S, Schiffmann R, Ottolenghi C, Hogrel JY, Servais L, Roze E. Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency. J Neurol Neurosurg Psychiatry. 2016 May;87(5):550-3. doi: 10.1136/jnnp-2015-311475. Epub 2015 Nov 3.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00158483\",\n",
      "          \"briefTitle\": \"Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2003-05\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2005-10\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-09-12\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"16455895\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Legoff J, Bouhlal H, Gresenguet G, Weiss H, Khonde N, Hocini H, Desire N, Si-Mohamed A, de Dieu Longo J, Chemin C, Frost E, Pepin J, Malkin JE, Mayaud P, Belec L. Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV. J Clin Microbiol. 2006 Feb;44(2):423-32. doi: 10.1128/JCM.44.2.423-432.2006.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"18385443\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"LeGoff J, Mayaud P, Gresenguet G, Weiss HA, Nzambi K, Frost E, Pepin J, Belec L; ANRS 12-12 Study Group. Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2. J Clin Microbiol. 2008 Jun;46(6):1914-8. doi: 10.1128/JCM.02332-07. Epub 2008 Apr 2.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"19530940\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Mayaud P, Legoff J, Weiss HA, Gresenguet G, Nzambi K, Bouhlal H, Frost E, Pepin J, Malkin JE, Hayes RJ, Mabey DC, Belec L; ANRS 1212 Study Group. Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial. J Infect Dis. 2009 Jul 15;200(2):216-26. doi: 10.1086/599991.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02481453\",\n",
      "          \"briefTitle\": \"Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2015-07-15\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-01-22\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2015-06-25\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"20413309\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Benveniste O, Hilton-Jones D. International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009. Neuromuscul Disord. 2010 Jun;20(6):414-21. doi: 10.1016/j.nmd.2010.03.014. Epub 2010 Apr 21. No abstract available.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24975859\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Lloyd TE, Mammen AL, Amato AA, Weiss MD, Needham M, Greenberg SA. Evaluation and construction of diagnostic criteria for inclusion body myositis. Neurology. 2014 Jul 29;83(5):426-33. doi: 10.1212/WNL.0000000000000642. Epub 2014 Jun 27.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02329054\",\n",
      "          \"briefTitle\": \"Efficacy of Favipiravir Against Ebola (JIKI)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-12\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-09\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-12-31\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"25435054\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Mentre F, Taburet AM, Guedj J, Anglaret X, Keita S, de Lamballerie X, Malvy D. Dose regimen of favipiravir for Ebola virus disease. Lancet Infect Dis. 2015 Feb;15(2):150-1. doi: 10.1016/S1473-3099(14)71047-3. Epub 2014 Nov 28. No abstract available.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27046271\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Munoz VC, Doumbouya L, Harouna S, Kighoma PM, Koundouno FR, Lolamou R, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wolfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Uwamahoro MG, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D'Ortenzio E, Pizarro L, Etienne A, Guedj J, Fizet A, de Sainte Fare EB, Murgue B, Tran-Minh T, Rapp C, Piguet P, Poncin M, Draguez B, Duverger TA, Barbe S, Baret G, Defourny I, Carroll M, Raoul H, Augier A, Eholie SP, Yazdanpanah Y, Levy-Marchal C, Antierrens A, Van Herp M, Gunther S, de Lamballerie X, Keita S, Mentre F, Anglaret X, Malvy D; JIKI Study Group. Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLoS Med. 2016 Apr 5;13(4):e1002009. doi: 10.1371/journal.pmed.1002009. eCollection 2016 Apr.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28231247\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Nguyen TH, Guedj J, Anglaret X, Laouenan C, Madelain V, Taburet AM, Baize S, Sissoko D, Pastorino B, Rodallec A, Piorkowski G, Carazo S, Conde MN, Gala JL, Bore JA, Carbonnelle C, Jacquot F, Raoul H, Malvy D, de Lamballerie X, Mentre F; JIKI study group. Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted. PLoS Negl Trop Dis. 2017 Feb 23;11(2):e0005389. doi: 10.1371/journal.pntd.0005389. eCollection 2017 Feb.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26930627\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Chanfreau Munoz V, Doumbouya L, Souley Harouna, Kighoma PM, Koundouno FR, Rene Lolamou, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wolfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Gasasira Uwamahoro M, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D'Ortenzio E, Pizarro L, Etienne A, Guedj J, Fizet A, Barte de Sainte Fare E, Murgue B, Tran-Minh T, Rapp C, Piguet P, Poncin M, Draguez B, Allaford Duverger T, Barbe S, Baret G, Defourny I, Carroll M, Raoul H, Augier A, Eholie SP, Yazdanpanah Y, Levy-Marchal C, Antierrens A, Van Herp M, Gunther S, de Lamballerie X, Keita S, Mentre F, Anglaret X, Malvy D; JIKI Study Group. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLoS Med. 2016 Mar 1;13(3):e1001967. doi: 10.1371/journal.pmed.1001967. eCollection 2016 Mar. Erratum In: PLoS Med. 2016 Apr;13(4):e1002009. Dortenzio, Eric [corrected to D'Ortenzio, Eric]. PLoS Med. 2016 Jun;13(6):e1002066.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02027233\",\n",
      "          \"briefTitle\": \"Clinical Trial to Assess the Influenza Vaccination of the Hospitalized Adults\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2022-12-31\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-01-06\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02093754\",\n",
      "          \"briefTitle\": \"Assessing the Severity of Metabolic-related Liver Injuries in Aging HIV-monoinfected Patients\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-05\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-03\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-03-21\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03324633\",\n",
      "          \"briefTitle\": \"Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2005-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2022-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2017-10-30\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Bristol-Myers Squibb\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"GlaxoSmithKline\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Merck Serono International SA\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Roche Pharma AG\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Schering-Plough\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"27317796\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Sogni P, Gilbert C, Lacombe K, Piroth L, Rosenthal E, Miailhes P, Gervais A, Esterle L, Chas J, Poizot-Martin I, Dominguez S, Simon A, Morlat P, Neau D, Zucman D, Bouchaud O, Lascoux-Combe C, Bani-Sadr F, Alric L, Goujard C, Vittecoq D, Billaud E, Aumaitre H, Boue F, Valantin MA, Dabis F, Salmon D, Wittkop L. All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort. Clin Infect Dis. 2016 Sep 15;63(6):763-770. doi: 10.1093/cid/ciw379. Epub 2016 Jun 17.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27177169\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Marcellin F, Protopopescu C, Poizot-Martin I, Miailhes P, Esterle L, Wittkop L, Spire B, Bocquier A, Salmon-Ceron D, Dabis F, Carrieri MP; HEPAVIH ANRS CO13 Study Group. Short article: Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort). Eur J Gastroenterol Hepatol. 2016 Sep;28(9):1003-7. doi: 10.1097/MEG.0000000000000664.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27073179\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Marcellin F, Lions C, Rosenthal E, Roux P, Sogni P, Wittkop L, Protopopescu C, Spire B, Salmon-Ceron D, Dabis F, Carrieri MP; HEPAVIH ANRS CO13 Study Group*. No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort). Drug Alcohol Rev. 2017 Mar;36(2):227-238. doi: 10.1111/dar.12398. Epub 2016 Apr 13.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"25778750\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Carrieri MP, Serfaty L, Vilotitch A, Winnock M, Poizot-Martin I, Loko MA, Lions C, Lascoux-Combe C, Roux P, Salmon-Ceron D, Spire B, Dabis F; ANRS CO13 HEPAVIH Study Group. Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH). Clin Infect Dis. 2015 Jul 1;61(1):40-8. doi: 10.1093/cid/civ217. Epub 2015 Mar 16.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"25015913\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Marcellin F, Roux P, Loko MA, Lions C, Caumont-Prim A, Dabis F, Salmon-Ceron D, Spire B, Carrieri MP; HEPAVIH (ANRS CO13) Study Group. High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort. Clin Infect Dis. 2014 Oct 15;59(8):1190-2. doi: 10.1093/cid/ciu525. Epub 2014 Jul 11. No abstract available.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26528903\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Salmon D, Bani-Sadr F, Gilbert C, Rosenthal E, Valantin MA, Simon A, Neau D, Morlat P, Loko MA, Wittkop L, Dabis F; ANRS CO13HEPAVIH study group. HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patients. J Clin Virol. 2015 Dec;73:32-35. doi: 10.1016/j.jcv.2015.10.010. Epub 2015 Oct 19.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26372388\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"ANRS CO13 HEPAVIH Cohort. Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients. AIDS. 2015 Sep 10;29(14):1821-30. doi: 10.1097/QAD.0000000000000787.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24166726\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Roux P, Lions C, Cohen J, Winnock M, Salmon-Ceron D, Bani-Sadr F, Sogni P, Spire B, Dabis F, Carrieri MP; ANRS-CO13-HEPAVIH Study Group. Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort. Antivir Ther. 2014;19(2):171-8. doi: 10.3851/IMP2699. Epub 2013 Oct 28.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24580042\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Marcellin F, Roux P, Winnock M, Lions C, Dabis F, Salmon-Ceron D, Loko MA, Spire B, Carrieri MP. Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort. Expert Rev Gastroenterol Hepatol. 2014 May;8(4):351-8. doi: 10.1586/17474124.2014.888949. Epub 2014 Mar 3.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23978720\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Carrieri MP, Lions C, Sogni P, Winnock M, Roux P, Mora M, Bonnard P, Salmon D, Dabis F, Spire B; ANRS CO13 HEPAVIH Study Group. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study. J Hepatol. 2014 Jan;60(1):46-53. doi: 10.1016/j.jhep.2013.08.014. Epub 2013 Aug 24.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24499953\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Bani-Sadr F, Loko MA, Pambrun E, Winnock M, Carrieri P, Gilbert C, Duvivier C, Bouchaud O, Gervais A, Dabis F, Salmon D; ANRS CO 13 HEPAVIH Study Group. Correlates of HIV sustained viral suppression in HIV/hepatitis C virus coinfected patients: possible role of the hepatitis C virus sustained viral response. AIDS. 2014 May 15;28(8):1155-60. doi: 10.1097/QAD.0000000000000218.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23461846\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Winnock M, Bani-Sadr F, Pambrun E, Loko MA, Carrieri P, Neau D, Morlat P, Marchou B, Dabis F, Salmon D; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) CO13 HEPAVIH Study Group. Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions. HIV Med. 2013 Aug;14(7):430-6. doi: 10.1111/hiv.12023. Epub 2013 Mar 5.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23421419\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Marcellin F, Lions C, Winnock M, Salmon D, Durant J, Spire B, Mora M, Loko MA, Dabis F, Dominguez S, Roux P, Carrieri MP; ANRS CO13 HEPAVIH Study Group. Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort). Addiction. 2013 Jul;108(7):1250-8. doi: 10.1111/add.12149. Epub 2013 Mar 21.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22285372\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Trimoulet P, Merchadou L, Winnock M, Loko MA, Fleury H, Salmon D, Dabis F, Neau D; ANRS CO 13 HEPAVIH Study Group. Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: should the same test be applied to all samples? J Virol Methods. 2012 Apr;181(1):131-3. doi: 10.1016/j.jviromet.2012.01.006. Epub 2012 Jan 20.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22781224\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Solas C, Pambrun E, Winnock M, Salmon D, Poizot-Martin I, Dominguez S, Bani-Sadr F, Izopet J, Garraffo R, Peytavin G; ANRS CO-13 HEPAVIH Study Group. Ribavirin and abacavir drug interaction in HIV-HCV coinfected patients: fact or fiction? AIDS. 2012 Nov 13;26(17):2193-9. doi: 10.1097/QAD.0b013e32835763a4.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22409788\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Salmon-Ceron D, Cohen J, Winnock M, Roux P, Sadr FB, Rosenthal E, Martin IP, Loko MA, Mora M, Sogni P, Spire B, Dabis F, Carrieri MP; HEPAVIH group. Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France). BMC Health Serv Res. 2012 Mar 12;12:59. doi: 10.1186/1472-6963-12-59.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22173166\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Salmon D, Bani-Sadr F, Loko MA, Stitou H, Gervais A, Durant J, Rosenthal E, Quertainmont Y, Barange K, Vittecoq D, Shoai-Tehrani M, Alvarez M, Winnock M, Trinchet JC, Dabis F, Sogni P. Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH. J Hepatol. 2012 Apr;56(4):862-8. doi: 10.1016/j.jhep.2011.11.009. Epub 2011 Dec 13.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21819472\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Roux P, Fugon L, Winnock M, Salmon-Ceron D, Lacombe K, Sogni P, Spire B, Dabis F, Carrieri MP; ANRS-CO-13-HEPAVIH Study Group. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users. Addiction. 2012 Jan;107(1):152-9. doi: 10.1111/j.1360-0443.2011.03608.x. Epub 2011 Oct 12.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23052829\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Loko MA, Bani-Sadr F, Valantin MA, Lascoux-Combe C, Fontaine H, Bonnard P, Gervais A, Bouchaud O, Garipuy D, Quertainmont Y, Vittecoq D, Tehrani MS, Winnock M, Dabis F, Salmon D; ANRS CO 13 HEPAVIH Study Group. Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort. Antivir Ther. 2012;17(7):1335-43. doi: 10.3851/IMP2419. Epub 2012 Oct 10.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22535683\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Carrieri MP, Sogni P, Cohen J, Loko MA, Winnock M, Spire B; HEPAVIH Study Group. Elevated coffee consumption and reduced risk of insulin resistance in HIV-HCV coinfected patients (HEPAVIH ANRS CO-13). Hepatology. 2012 Nov;56(5):2010. doi: 10.1002/hep.25813. No abstract available.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21888878\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Carrieri MP, Cohen J, Salmon-Ceron D, Winnock M. Coffee consumption and reduced self-reported side effects in HIV-HCV co-infected patients during PEG-IFN and ribavirin treatment: results from ANRS CO13 HEPAVIH. J Hepatol. 2012 Mar;56(3):745-7. doi: 10.1016/j.jhep.2011.08.005. Epub 2011 Aug 31. No abstract available.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23226258\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Abravanel F, Raymond S, Pambrun E, Winnock M, Bonnard P, Sogni P, Trimoulet P, Dabis F, Salmon-Ceron D, Izopet J; ANRS CO13 HEPAVIH Study Group. HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients. PLoS One. 2012;7(11):e50289. doi: 10.1371/journal.pone.0050289. Epub 2012 Nov 30.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21920402\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Winnock M, Bani-Sadr F, Pambrun E, Loko MA, Lascoux-Combe C, Garipuy D, Rosenthal E, Carrieri P, Dabis F, Salmon D. Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination. Vaccine. 2011 Nov 3;29(47):8656-60. doi: 10.1016/j.vaccine.2011.08.125. Epub 2011 Sep 13.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21239121\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Roux P, Cohen J, Lascoux-Combe C, Sogni P, Winnock M, Salmon-Ceron D, Spire B, Dabis F, Carrieri MP; ANRS-CO13-HEPAVIH study group. Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician. Drug Alcohol Depend. 2011 Jul 1;116(1-3):228-32. doi: 10.1016/j.drugalcdep.2010.09.025. Epub 2011 Jan 15.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21692942\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Loko MA, Bani-Sadr F, Winnock M, Lacombe K, Carrieri P, Neau D, Morlat P, Serfaty L, Dabis F, Salmon D; ANRS CO 13 HEPAVIH Study Group. Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients. J Viral Hepat. 2011 Jul;18(7):e307-14. doi: 10.1111/j.1365-2893.2010.01417.x. Epub 2011 Jan 11.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20969743\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Loko MA, Salmon D, Carrieri P, Winnock M, Mora M, Merchadou L, Gillet S, Pambrun E, Delaune J, Valantin MA, Poizot-Martin I, Neau D, Bonnard P, Rosenthal E, Barange K, Morlat P, Lacombe K, Gervais A, Rouges F, See AB, Lascoux-Combe C, Vittecoq D, Goujard C, Duvivier C, Spire B, Izopet J, Sogni P, Serfaty L, Benhamou Y, Bani-Sadr F, Dabis F; ANRS CO 13 HEPAVIH Study Group. The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010. BMC Infect Dis. 2010 Oct 22;10:303. doi: 10.1186/1471-2334-10-303.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20876416\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Carrieri MP, Cohen J, Winnock M, Salmon D. Chocolate intake, depression, and clinical progression in HIV-HCV coinfected patients: still more questions than answers. Arch Intern Med. 2010 Sep 27;170(17):1607; author reply 1608-9. doi: 10.1001/archinternmed.2010.330. No abstract available.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20493576\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Cales P, Halfon P, Batisse D, Carrat F, Perre P, Penaranda G, Guyader D, d'Alteroche L, Fouchard-Hubert I, Michelet C, Veillon P, Lambert J, Weiss L, Salmon D, Cacoub P. Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection. J Hepatol. 2010 Aug;53(2):238-44. doi: 10.1016/j.jhep.2010.03.007. Epub 2010 Apr 18.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28942916\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Carrieri MP, Protopopescu C, Marcellin F, Rosellini S, Wittkop L, Esterle L, Zucman D, Raffi F, Rosenthal E, Poizot-Martin I, Salmon-Ceron D, Dabis F, Spire B; ANRS CO13 HEPAVIH Study Group. Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients. J Hepatol. 2017 Dec;67(6):1157-1167. doi: 10.1016/j.jhep.2017.08.005. Epub 2017 Sep 21.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28780609\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Yaya I, Roux P, Marcellin F, Salmon-Ceron D, Carrieri MP. Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort). Dig Dis Sci. 2017 Oct;62(10):2943-2944. doi: 10.1007/s10620-017-4703-y. Epub 2017 Aug 5. No abstract available.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28430385\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Knight R, Roux P, Vilotitch A, Marcellin F, Rosenthal E, Esterle L, Boue F, Rey D, Piroth L, Dominguez S, Sogni P, Salmon-Ceron D, Spire B, Carrieri MP; ANRS CO13-HEPAVIH Study Group. Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort. Addiction. 2017 Sep;112(9):1669-1679. doi: 10.1111/add.13851. Epub 2017 Jun 6.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28418984\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Marcellin F, Protopopescu C, Esterle L, Wittkop L, Piroth L, Aumaitre H, Bouchaud O, Goujard C, Vittecoq D, Dabis F, Salmon-Ceron D, Spire B, Roux P, Carrieri MP; ANRS CO13-HEPAVIH Study Group. Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH). Eur J Gastroenterol Hepatol. 2017 Jul;29(7):786-791. doi: 10.1097/MEG.0000000000000883.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28235612\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Piroth L, Wittkop L, Lacombe K, Rosenthal E, Gilbert C, Miailhes P, Carrieri P, Chas J, Poizot-Martin I, Gervais A, Dominguez S, Neau D, Zucman D, Billaud E, Morlat P, Aumaitre H, Lascoux-Combe C, Simon A, Bouchaud O, Teicher E, Bani-Sadr F, Alric L, Vittecoq D, Boue F, Duvivier C, Valantin MA, Esterle L, Dabis F, Sogni P, Salmon D; ANRS CO13 HEPAVIH study group. Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort. J Hepatol. 2017 Jul;67(1):23-31. doi: 10.1016/j.jhep.2017.02.012. Epub 2017 Feb 22.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27339598\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Ulveling D, Le Clerc S, Cobat A, Labib T, Noirel J, Laville V, Coulonges C, Carpentier W, Nalpas B, Heim MH, Poynard T, Cerny A, Pol S, Bochud PY, Dabis F, Theodorou I, Levy Y, Salmon D, Abel L, Dominguez S, Zagury JF; HEPAVIH ANRS CO13 Cohort Study Group; Swiss Hepatitis C Cohort Study Group; French ANRS HC EP 26 Genoscan Study Group. A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients. Hepatology. 2016 Nov;64(5):1462-1472. doi: 10.1002/hep.28695. Epub 2016 Jul 29.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"34212476\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Chalouni M, Wittkop L, Bani-Sadr F, Lacombe K, Esterle L, Gilbert C, Miailhes P, Zucman D, Valantin MA, Bregigeon-Ronot S, Morlat P, Billaud E, Piroth L, Naqvi A, Sogni P, Salmon D; ANRS CO13 HEPAVIH Cohort Study Group. Risk of severe clinical events after sustained virological response following direct-acting antiviral therapy in HIV and hepatitis C virus coinfected participants. HIV Med. 2021 Oct;22(9):791-804. doi: 10.1111/hiv.13127. Epub 2021 Jul 1.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"32798585\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Chalouni M, Pol S, Sogni P, Fontaine H, Lacombe K, Marc-Lacombe J, Esterle L, Dorival C, Bourliere M, Bani-Sadr F, de Ledinghen V, Zucman D, Larrey D, Salmon D, Carrat F, Wittkop L; ANRS CO13 HEPAVIH and ANRS CO22 HEPATHER cohort study groups. Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death. J Hepatol. 2021 Jan;74(1):37-47. doi: 10.1016/j.jhep.2020.08.008. Epub 2020 Aug 14.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"30570526\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Poizot-Martin I, Rosenthal E, Gilbert C, Cano CE, Simon A, Lascoux-Combe C, Alric L, Gervais A, Neau D, Esterle L, Salmon D, Sogni P, Wittkop L; ANRS CO13 HEPAVIH Study Group. Nadir CD4 Is Negatively Associated With Antinuclear Antibody Detection in HCV/HIV-Coinfected Patients. J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):461-466. doi: 10.1097/QAI.0000000000001940.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT04842851\",\n",
      "          \"briefTitle\": \"Cardiac Resynchronization Therapy in Congenital Heart Diseases With Systemic Right Ventricle\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2004-01-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2020-12-31\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2021-04-13\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Paris Cardiovascular Research Center (Inserm U970)\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Marie Lannelongue Hospital, Le Plessis Robinson, France\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Clinique Pasteur Toulouse\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Groupe Hospitalier Pitie-Salpetriere\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Hopital Louis Pradel\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University Hospital, Montpellier\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"European Georges Pompidou Hospital\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT04409405\",\n",
      "          \"briefTitle\": \"Evaluation and Support to EVD Cured Patients and Their Contacts (Les Vainqueurs d'Ebola)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2020-04-16\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2021-10-18\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2020-06-01\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Institut National de Recherche Biom\\u00e9dicale. Kinshasa, R\\u00e9publique D\\u00e9mocratique du Congo\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Institut de Recherche pour le Developpement\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00158405\",\n",
      "          \"briefTitle\": \"Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2002-12\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2006-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-09-12\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Bristol-Myers Squibb\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"16152755\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Moh R, Danel C, Sorho S, Sauvageot D, Anzian A, Minga A, Gomis OB, Konga C, Inwoley A, Gabillard D, Bissagnene E, Salamon R, Anglaret X. Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Cote d'Ivoire. Antivir Ther. 2005;10(5):615-24. doi: 10.1177/135965350501000510.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"16782488\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Danel C, Moh R, Minga A, Anzian A, Ba-Gomis O, Kanga C, Nzunetu G, Gabillard D, Rouet F, Sorho S, Chaix ML, Eholie S, Menan H, Sauvageot D, Bissagnene E, Salamon R, Anglaret X; Trivacan ANRS 1269 trial group. CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial. Lancet. 2006 Jun 17;367(9527):1981-9. doi: 10.1016/S0140-6736(06)68887-9.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"18986246\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Danel C, Moh R, Chaix ML, Gabillard D, Gnokoro J, Diby CJ, Toni T, Dohoun L, Rouzioux C, Bissagnene E, Salamon R, Anglaret X; Trivacan ANRS 1269 Trial Group. Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults. J Infect Dis. 2009 Jan 1;199(1):66-76. doi: 10.1086/595298.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02960698\",\n",
      "          \"briefTitle\": \"Impulsivity in Tourette Syndrome : Behavioral and Neuroimaging Study\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2016-10-14\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-04-24\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2016-11-10\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02931097\",\n",
      "          \"briefTitle\": \"DBS of the MLR for Gait and Balance Disorders in PD Patients\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2016-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2020-10\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2016-10-12\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00657397\",\n",
      "          \"briefTitle\": \"Initialization of Methadone in Primary Care, Randomized Intervention Research for Preventing HCV Transmission Practices\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2011-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2008-04-14\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"27770695\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Carrieri P, Vilotitch A, Nordmann S, Lions C, Michel L, Mora M, Morel A, Maradan G, Spire B, Roux P; Methaville Study Group. Decrease in self-reported offences and incarceration rates during methadone treatment: A comparison between patients switching from buprenorphine to methadone and maintenance treatment incident users (ANRS-Methaville trial). Int J Drug Policy. 2017 Jan;39:86-91. doi: 10.1016/j.drugpo.2016.08.005. Epub 2016 Oct 19.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27048152\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Roux P, Lions C, Vilotitch A, Michel L, Mora M, Maradan G, Marcellin F, Spire B, Morel A, Carrieri PM; ANRS Methaville study group. Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study). Harm Reduct J. 2016 Apr 5;13:12. doi: 10.1186/s12954-016-0100-7.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"25393311\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Carrieri PM, Michel L, Lions C, Cohen J, Vray M, Mora M, Marcellin F, Spire B, Morel A, Roux P; Methaville Study Group. Methadone induction in primary care for opioid dependence: a pragmatic randomized trial (ANRS Methaville). PLoS One. 2014 Nov 13;9(11):e112328. doi: 10.1371/journal.pone.0112328. eCollection 2014.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"25209306\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Roux P, Lions C, Michel L, Mora M, Daulouede JP, Marcellin F, Spire B, Morel A, Carrieri PM; ANRS Methaville study group. Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions. Subst Abuse Treat Prev Policy. 2014 Sep 10;9:37. doi: 10.1186/1747-597X-9-37.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24268548\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Lions C, Carrieri MP, Michel L, Mora M, Marcellin F, Morel A, Spire B, Roux P; Methaville Study Group. Predictors of non-prescribed opioid use after one year of methadone treatment: an attributable-risk approach (ANRS-Methaville trial). Drug Alcohol Depend. 2014 Feb 1;135:1-8. doi: 10.1016/j.drugalcdep.2013.10.018. Epub 2013 Oct 31.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22741944\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Roux P, Michel L, Cohen J, Mora M, Morel A, Aubertin JF, Desenclos JC, Spire B, Carrieri PM; ANRS Methaville Study Group. Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial. BMC Public Health. 2012 Jun 28;12:488. doi: 10.1186/1471-2458-12-488.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00421551\",\n",
      "          \"briefTitle\": \"Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2007-03\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2011-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2007-01-12\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Tibotec Pharmaceutical Limited\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"29767684\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Lambert-Niclot S, Grude M, Meynard JL, Marcelin AG, Valantin MA, Flandre P, Izopet J, Moinot L, Bouteloup V, Calvez V, Katlama C, Girard PM, Morand-Joubert L. Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies. Clin Infect Dis. 2018 Nov 28;67(12):1883-1889. doi: 10.1093/cid/ciy382.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22848481\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Lambert-Niclot S, Flandre P, Valantin MA, Soulie C, Fourati S, Wirden M, Sayon S, Pakianather S, Bocket L, Masquelier B, Dos Santos G, Katlama C, Calvez V, Marcelin AG. Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks. PLoS One. 2012;7(7):e41390. doi: 10.1371/journal.pone.0041390. Epub 2012 Jul 25.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20802297\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Katlama C, Valantin MA, Algarte-Genin M, Duvivier C, Lambert-Niclot S, Girard PM, Molina JM, Hoen B, Pakianather S, Peytavin G, Marcelin AG, Flandre P. Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136. AIDS. 2010 Sep 24;24(15):2365-74. doi: 10.1097/QAD.0b013e32833dec20.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00623051\",\n",
      "          \"briefTitle\": \"Evaluation of the Extension at Community Level of Safe Male Circumcision (ANRS 12126 ORANGE FARM 2)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2008-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2008-02-25\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00116454\",\n",
      "          \"briefTitle\": \"Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2005-07\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2013-08\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-06-30\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03954054\",\n",
      "          \"briefTitle\": \"Therapeutic Education for Harm Reduction in People With Alcohol Use Disorder\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2019-10-28\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2021-07-31\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2019-05-17\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Regional Agency for Health PACA\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"SESSTIM UMR1252 (Aix-Marseille Univ, INSERM, IRD)\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"35012570\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Antwerpes S, Costa M, Coste M, Bureau M, Maradan G, Cutarella C, Leloutre J, Riccobono-Soulier O, Hedoire S, Frot E, Vernier F, Vassas-Goyard S, Barre T, Casanova D, Carrieri P. Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER). Harm Reduct J. 2022 Jan 10;19(1):2. doi: 10.1186/s12954-021-00587-0.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02976298\",\n",
      "          \"briefTitle\": \"Effects of Cerebellum or Supplementary Motor Area Functional Inactivation on Gait and Balance Control\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2013-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2016-11-29\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02101398\",\n",
      "          \"briefTitle\": \"Study of the Effect of Transcranial Stimulations in Aphasic Subject Within a Year of Their Stroke\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-10-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-07\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-04-02\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT05472051\",\n",
      "          \"briefTitle\": \"Health and Migration Trajectories of Housekeepers in Bamako\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2022-02-28\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2023-06-22\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2022-07-25\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00495651\",\n",
      "          \"briefTitle\": \"Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2008-03\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2007-07-03\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Gilead Sciences\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Merck Sharp & Dohme LLC\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"35093007\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Moh DR, Ntakpe JB, Gabillard D, Yayo-Emieme AA, Badje A, Kouame GM, d'Aquin TT, Danel C, Anglaret X, Eholie SP. Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adults. BMC Infect Dis. 2022 Jan 29;22(1):100. doi: 10.1186/s12879-022-07082-2.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"29297443\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Moh R, Badje A, N'takpe JB, Kouame GM, Gabillard D, Ouassa T, Ouattara E, Le Carrou J, Bohoussou F, Messou E, Eholie S, Anglaret X, Danel C. Screening for active tuberculosis before isoniazid preventive therapy among HIV-infected West African adults. Int J Tuberc Lung Dis. 2017 Dec 1;21(12):1237-1244. doi: 10.5588/ijtld.17.0016.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"29020361\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Kouame GM, Boyd A, Moh R, Badje A, Gabillard D, Ouattara E, Ntakpe JB, Emieme A, Maylin S, Chekaraou MA, Eholie SP, Zoulim F, Lacombe K, Anglaret X, Danel C; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) 12136 Temprano and ANRS 12240 VarBVA Study Groups. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication. Clin Infect Dis. 2018 Jan 6;66(1):112-120. doi: 10.1093/cid/cix747.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26193126\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"TEMPRANO ANRS 12136 Study Group; Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpe JB, Minga A, Kouame GM, Bouhoussou F, Emieme A, Kouame A, Inwoley A, Toni TD, Ahiboh H, Kabran M, Rabe C, Sidibe B, Nzunetu G, Konan R, Gnokoro J, Gouesse P, Messou E, Dohoun L, Kamagate S, Yao A, Amon S, Kouame AB, Koua A, Kouame E, Ndri Y, Ba-Gomis O, Daligou M, Ackoundze S, Hawerlander D, Ani A, Dembele F, Kone F, Guehi C, Kanga C, Koule S, Seri J, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatounde N, Bleoue G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Assi R, Bakayoko A, Mahassadi A, Attia A, Oussou A, Mobio M, Bamba D, Koman M, Horo A, Deschamps N, Chenal H, Sassan-Morokro M, Konate S, Aka K, Aoussi E, Journot V, Nchot C, Karcher S, Chaix ML, Rouzioux C, Sow PS, Perronne C, Girard PM, Menan H, Bissagnene E, Kadio A, Ettiegne-Traore V, Moh-Semde C, Kouame A, Massumbuko JM, Chene G, Dosso M, Domoua SK, N'Dri-Yoman T, Salamon R, Eholie SP, Anglaret X. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. N Engl J Med. 2015 Aug 27;373(9):808-22. doi: 10.1056/NEJMoa1507198. Epub 2015 Jul 20.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"25330161\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Danel C, Kabran M, Inwoley A, Badje A, Herrmann JL, Moh R, Lecarrou J, Gabillard D, Ntakpe JB, Deschamps N, Ouattara E, Perronne C, Eholie S, Anglaret X. Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in Cote d'Ivoire, West Africa. PLoS One. 2014 Oct 16;9(10):e107245. doi: 10.1371/journal.pone.0107245. eCollection 2014.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24985779\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Jean K, Gabillard D, Moh R, Danel C, Desgrees-du-Lou A, N'takpe JB, Le Carrou J, Badje A, Eholie S, Lert F, Anglaret X, Dray-Spira R. Decrease in sexual risk behaviours after early initiation of antiretroviral therapy: a 24-month prospective study in Cote d'Ivoire. J Int AIDS Soc. 2014 Jun 30;17(1):18977. doi: 10.7448/IAS.17.1.18977. eCollection 2014.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23639243\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Ouattara E, Danel C, Moh R, Gabillard D, Peytavin G, Konan R, Carrou JL, Bohoussou F, Eholie SP, Anglaret X. Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts. J Int AIDS Soc. 2013 Apr 30;16(1):18059. doi: 10.7448/IAS.16.1.18059.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01693861\",\n",
      "          \"briefTitle\": \"\\\"Cancersensor\\\" Chemotherapy\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-09-26\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00272428\",\n",
      "          \"briefTitle\": \"Primary Prevention Trial of the Health Effects of Antioxidant Vitamins and Minerals.\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"1994-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2005-09\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2006-01-06\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"French private agencies\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"15557412\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A, Briancon S. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med. 2004 Nov 22;164(21):2335-42. doi: 10.1001/archinte.164.21.2335. Erratum In: Arch Intern Med. 2005 Feb 14;165(3):286.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"33738534\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Andreeva VA, Peneau S, Julia C, Shivappa N, Hebert JR, Wirth MD, Touvier M, Hercberg S, Galan P, Kesse-Guyot E. The inflammatory potential of the diet is prospectively associated with subjective hearing loss. Eur J Nutr. 2021 Oct;60(7):3669-3678. doi: 10.1007/s00394-021-02531-1. Epub 2021 Mar 18.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"31927670\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Lecuyer L, Dalle C, Micheau P, Petera M, Centeno D, Lyan B, Lagree M, Galan P, Hercberg S, Rossary A, Demidem A, Vasson MP, Partula V, Deschasaux M, Srour B, Latino-Martel P, Druesne-Pecollo N, Kesse-Guyot E, Durand S, Pujos-Guillot E, Manach C, Touvier M. Untargeted plasma metabolomic profiles associated with overall diet in women from the SU.VI.MAX cohort. Eur J Nutr. 2020 Dec;59(8):3425-3439. doi: 10.1007/s00394-020-02177-5. Epub 2020 Jan 11.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"31164347\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Lecuyer L, Dalle C, Lyan B, Demidem A, Rossary A, Vasson MP, Petera M, Lagree M, Ferreira T, Centeno D, Galan P, Hercberg S, Deschasaux M, Partula V, Srour B, Latino-Martel P, Kesse-Guyot E, Druesne-Pecollo N, Durand S, Pujos-Guillot E, Touvier M. Plasma Metabolomic Signatures Associated with Long-term Breast Cancer Risk in the SU.VI.MAX Prospective Cohort. Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1300-1307. doi: 10.1158/1055-9965.EPI-19-0154. Epub 2019 Jun 4.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"30517725\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Assmann KE, Adjibade M, Hercberg S, Galan P, Kesse-Guyot E. Unsaturated Fatty Acid Intakes During Midlife Are Positively Associated with Later Cognitive Function in Older Adults with Modulating Effects of Antioxidant Supplementation. J Nutr. 2018 Dec 1;148(12):1938-1945. doi: 10.1093/jn/nxy206.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"29649036\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Wiernik E, Lemogne C, Fezeu L, Arnault N, Hercberg S, Kesse-Guyot E, Galan P. Association Between Alexithymia and Risk of Incident Cardiovascular Diseases in the SUpplementation en VItamines et Mineraux AntioXydants (SU.VI.MAX) Cohort. Psychosom Med. 2018 Jun;80(5):460-467. doi: 10.1097/PSY.0000000000000592.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"29546305\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Assmann KE, Adjibade M, Shivappa N, Hebert JR, Wirth MD, Touvier M, Akbaraly T, Hercberg S, Galan P, Julia C, Kesse-Guyot E. The Inflammatory Potential of the Diet at Midlife Is Associated with Later Healthy Aging in French Adults. J Nutr. 2018 Mar 1;148(3):437-444. doi: 10.1093/jn/nxx061.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28494135\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Ruhunuhewa I, Adjibade M, Andreeva VA, Galan P, Hercberg S, Assmann KE, Kesse-Guyot E. Prospective association between body mass index at midlife and healthy aging among French adults. Obesity (Silver Spring). 2017 Jul;25(7):1254-1262. doi: 10.1002/oby.21853. Epub 2017 May 11.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28356432\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Adjibade M, Andreeva VA, Lemogne C, Touvier M, Shivappa N, Hebert JR, Wirth MD, Hercberg S, Galan P, Julia C, Assmann KE, Kesse-Guyot E. The Inflammatory Potential of the Diet Is Associated with Depressive Symptoms in Different Subgroups of the General Population. J Nutr. 2017 May;147(5):879-887. doi: 10.3945/jn.116.245167. Epub 2017 Mar 29.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28033414\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Walker V, Perret-Guillaume C, Kesse-Guyot E, Agrinier N, Hercberg S, Galan P, Assmann KE, Briancon S, Rotonda C. Effect of Multimorbidity on Health-Related Quality of Life in Adults Aged 55 Years or Older: Results from the SU.VI.MAX 2 Cohort. PLoS One. 2016 Dec 29;11(12):e0169282. doi: 10.1371/journal.pone.0169282. eCollection 2016.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27055851\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Kesse-Guyot E, Assmann KE, Andreeva VA, Touvier M, Neufcourt L, Shivappa N, Hebert JR, Wirth MD, Hercberg S, Galan P, Julia C. Long-term association between the dietary inflammatory index and cognitive functioning: findings from the SU.VI.MAX study. Eur J Nutr. 2017 Jun;56(4):1647-1655. doi: 10.1007/s00394-016-1211-3. Epub 2016 Apr 7.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27000099\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Adriouch S, Julia C, Kesse-Guyot E, Mejean C, Ducrot P, Peneau S, Donnenfeld M, Deschasaux M, Menai M, Hercberg S, Touvier M, Fezeu LK. Prospective association between a dietary quality index based on a nutrient profiling system and cardiovascular disease risk. Eur J Prev Cardiol. 2016 Oct;23(15):1669-76. doi: 10.1177/2047487316640659. Epub 2016 Mar 21.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26962176\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Graffouillere L, Deschasaux M, Mariotti F, Neufcourt L, Shivappa N, Hebert JR, Wirth MD, Latino-Martel P, Hercberg S, Galan P, Julia C, Kesse-Guyot E, Touvier M. The Dietary Inflammatory Index Is Associated with Prostate Cancer Risk in French Middle-Aged Adults in a Prospective Study. J Nutr. 2016 Apr 1;146(4):785-791. doi: 10.3945/jn.115.225623. Epub 2016 Mar 9.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26864363\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Graffouillere L, Deschasaux M, Mariotti F, Neufcourt L, Shivappa N, Hebert JR, Wirth MD, Latino-Martel P, Hercberg S, Galan P, Julia C, Kesse-Guyot E, Touvier M. Prospective association between the Dietary Inflammatory Index and mortality: modulation by antioxidant supplementation in the SU.VI.MAX randomized controlled trial. Am J Clin Nutr. 2016 Mar;103(3):878-85. doi: 10.3945/ajcn.115.126243. Epub 2016 Feb 10.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26817718\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Deschasaux M, Souberbielle JC, Latino-Martel P, Sutton A, Charnaux N, Druesne-Pecollo N, Galan P, Hercberg S, Le Clerc S, Kesse-Guyot E, Ezzedine K, Touvier M. Weight Status and Alcohol Intake Modify the Association between Vitamin D and Breast Cancer Risk. J Nutr. 2016 Mar;146(3):576-85. doi: 10.3945/jn.115.221481. Epub 2016 Jan 27.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26812508\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Kesse-Guyot E, Assmann KE, Andreeva VA, Ferry M, Hercberg S, Galan P; SU.VI.MAX 2 Research Group. Consumption of Dairy Products and Cognitive Functioning: Findings from the SU.VI.MAX 2 Study. J Nutr Health Aging. 2016 Feb;20(2):128-37. doi: 10.1007/s12603-015-0593-x.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26447153\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Deschasaux M, Souberbielle JC, Latino-Martel P, Sutton A, Charnaux N, Druesne-Pecollo N, Galan P, Hercberg S, Le Clerc S, Kesse-Guyot E, Ezzedine K, Touvier M. Prospective associations between vitamin D status, vitamin D-related gene polymorphisms, and risk of tobacco-related cancers. Am J Clin Nutr. 2015 Nov;102(5):1207-15. doi: 10.3945/ajcn.115.110510. Epub 2015 Oct 7.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26409628\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Kesse-Guyot E, Lassale C, Assmann KE, Andreeva VA, Julia C, Blacher J, Fezeu L, Hercberg S, Galan P. Are different vascular risk scores calculated at midlife uniformly associated with subsequent poor cognitive performance? Atherosclerosis. 2015 Nov;243(1):286-92. doi: 10.1016/j.atherosclerosis.2015.09.023. Epub 2015 Sep 21.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26156743\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Donnenfeld M, Deschasaux M, Latino-Martel P, Diallo A, Galan P, Hercberg S, Ezzedine K, Touvier M. Prospective association between dietary folate intake and skin cancer risk: results from the Supplementation en Vitamines et Mineraux Antioxydants cohort. Am J Clin Nutr. 2015 Aug;102(2):471-8. doi: 10.3945/ajcn.115.109041. Epub 2015 Jul 8.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"25994566\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Chhim AS, Fassier P, Latino-Martel P, Druesne-Pecollo N, Zelek L, Duverger L, Hercberg S, Galan P, Deschasaux M, Touvier M. Prospective association between alcohol intake and hormone-dependent cancer risk: modulation by dietary fiber intake. Am J Clin Nutr. 2015 Jul;102(1):182-9. doi: 10.3945/ajcn.114.098418. Epub 2015 May 20.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"25651444\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Kesse-Guyot E, Andreeva VA, Touvier M, Jeandel C, Ferry M, Hercberg S, Galan P; SU.VI.MAX 2 Research Group. Overall and abdominal adiposity in midlife and subsequent cognitive function. J Nutr Health Aging. 2015 Feb;19(2):183-9. doi: 10.1007/s12603-014-0508-2.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24553693\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Deschasaux M, Pouchieu C, His M, Hercberg S, Latino-Martel P, Touvier M. Dietary total and insoluble fiber intakes are inversely associated with prostate cancer risk. J Nutr. 2014 Apr;144(4):504-10. doi: 10.3945/jn.113.189670. Epub 2014 Feb 19.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24527713\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Touvier M, Deschasaux M, Montourcy M, Sutton A, Charnaux N, Kesse-Guyot E, Fezeu LK, Latino-Martel P, Druesne-Pecollo N, Malvy D, Galan P, Hercberg S, Ezzedine K, Souberbielle JC. Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values. J Clin Endocrinol Metab. 2014 Apr;99(4):1196-203. doi: 10.1210/jc.2013-3349. Epub 2014 Feb 14.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24089418\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Andreeva VA, Galan P, Arnaud J, Julia C, Hercberg S, Kesse-Guyot E. Midlife iron status is inversely associated with subsequent cognitive performance, particularly in perimenopausal women. J Nutr. 2013 Dec;143(12):1974-81. doi: 10.3945/jn.113.177089. Epub 2013 Oct 2.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24027184\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Julia C, Touvier M, Meunier N, Papet I, Galan P, Hercberg S, Kesse-Guyot E. Intakes of PUFAs were inversely associated with plasma C-reactive protein 12 years later in a middle-aged population with vitamin E intake as an effect modifier. J Nutr. 2013 Nov;143(11):1760-6. doi: 10.3945/jn.113.180943. Epub 2013 Sep 11.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23284983\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Kesse-Guyot E, Andreeva VA, Jeandel C, Ferry M, Touvier M, Hercberg S, Galan P. Alcohol consumption in midlife and cognitive performance assessed 13 years later in the SU.VI.MAX 2 cohort. PLoS One. 2012;7(12):e52311. doi: 10.1371/journal.pone.0052311. Epub 2012 Dec 19.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23283500\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Kesse-Guyot E, Andreeva VA, Lassale C, Ferry M, Jeandel C, Hercberg S, Galan P; SU.VI.MAX 2 Research Group. Mediterranean diet and cognitive function: a French study. Am J Clin Nutr. 2013 Feb;97(2):369-76. doi: 10.3945/ajcn.112.047993. Epub 2013 Jan 2.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23082222\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Kesse-Guyot E, Charreire H, Andreeva VA, Touvier M, Hercberg S, Galan P, Oppert JM. Cross-sectional and longitudinal associations of different sedentary behaviors with cognitive performance in older adults. PLoS One. 2012;7(10):e47831. doi: 10.1371/journal.pone.0047831. Epub 2012 Oct 17.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22633793\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Kesse-Guyot E, Ahluwalia N, Lassale C, Hercberg S, Fezeu L, Lairon D. Adherence to Mediterranean diet reduces the risk of metabolic syndrome: a 6-year prospective study. Nutr Metab Cardiovasc Dis. 2013 Jul;23(7):677-83. doi: 10.1016/j.numecd.2012.02.005. Epub 2012 May 25.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22378736\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Touvier M, Kesse-Guyot E, Andreeva VA, Fezeu L, Charnaux N, Sutton A, Druesne-Pecollo N, Hercberg S, Galan P, Zelek L, Latino-Martel P, Czernichow S. Modulation of the association between plasma intercellular adhesion molecule-1 and cancer risk by n-3 PUFA intake: a nested case-control study. Am J Clin Nutr. 2012 Apr;95(4):944-50. doi: 10.3945/ajcn.111.027805. Epub 2012 Feb 29.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22158670\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Briancon S, Boini S, Bertrais S, Guillemin F, Galan P, Hercberg S. Long-term antioxidant supplementation has no effect on health-related quality of life: the randomized, double-blind, placebo-controlled, primary prevention SU.VI.MAX trial. Int J Epidemiol. 2011 Dec;40(6):1605-16. doi: 10.1093/ije/dyr161.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21955649\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Peneau S, Galan P, Jeandel C, Ferry M, Andreeva V, Hercberg S, Kesse-Guyot E; SU.VI.MAX 2 Research Group. Fruit and vegetable intake and cognitive function in the SU.VI.MAX 2 prospective study. Am J Clin Nutr. 2011 Nov;94(5):1295-303. doi: 10.3945/ajcn.111.014712. Epub 2011 Sep 28.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21775560\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Kesse-Guyot E, Fezeu L, Jeandel C, Ferry M, Andreeva V, Amieva H, Hercberg S, Galan P. French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial. Am J Clin Nutr. 2011 Sep;94(3):892-9. doi: 10.3945/ajcn.110.007815. Epub 2011 Jul 20.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21490142\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Perez-Jimenez J, Fezeu L, Touvier M, Arnault N, Manach C, Hercberg S, Galan P, Scalbert A. Dietary intake of 337 polyphenols in French adults. Am J Clin Nutr. 2011 Jun;93(6):1220-8. doi: 10.3945/ajcn.110.007096. Epub 2011 Apr 13.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21106918\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Kesse-Guyot E, Amieva H, Castetbon K, Henegar A, Ferry M, Jeandel C, Hercberg S, Galan P; SU.VI.MAX 2 Research Group. Adherence to nutritional recommendations and subsequent cognitive performance: findings from the prospective Supplementation with Antioxidant Vitamins and Minerals 2 (SU.VI.MAX 2) study. Am J Clin Nutr. 2011 Jan;93(1):200-10. doi: 10.3945/ajcn.2010.29761. Epub 2010 Nov 24.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20605091\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Ezzedine K, Latreille J, Kesse-Guyot E, Galan P, Hercberg S, Guinot C, Malvy D. Incidence of skin cancers during 5-year follow-up after stopping antioxidant vitamins and mineral supplementation. Eur J Cancer. 2010 Dec;46(18):3316-22. doi: 10.1016/j.ejca.2010.06.008. Epub 2010 Jul 6.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20431391\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Kesse-Guyot E, Vergnaud AC, Fezeu L, Zureik M, Blacher J, Peneau S, Hercberg S, Galan P, Czernichow S. Associations between dietary patterns and arterial stiffness, carotid artery intima-media thickness and atherosclerosis. Eur J Cardiovasc Prev Rehabil. 2010 Dec;17(6):718-24. doi: 10.1097/HJR.0b013e32833a197f.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20176858\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Phillips CM, Goumidi L, Bertrais S, Field MR, Cupples LA, Ordovas JM, Defoort C, Lovegrove JA, Drevon CA, Gibney MJ, Blaak EE, Kiec-Wilk B, Karlstrom B, Lopez-Miranda J, McManus R, Hercberg S, Lairon D, Planells R, Roche HM. Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndrome. J Lipid Res. 2010 Jul;51(7):1793-800. doi: 10.1194/jlr.M003046. Epub 2010 Feb 22.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"19828715\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Phillips CM, Goumidi L, Bertrais S, Ferguson JF, Field MR, Kelly ED, Peloso GM, Cupples LA, Shen J, Ordovas JM, McManus R, Hercberg S, Portugal H, Lairon D, Planells R, Roche HM. Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome. Am J Clin Nutr. 2009 Dec;90(6):1665-73. doi: 10.3945/ajcn.2009.28101. Epub 2009 Oct 14.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"19491388\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Czernichow S, Vergnaud AC, Galan P, Arnaud J, Favier A, Faure H, Huxley R, Hercberg S, Ahluwalia N. Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults. Am J Clin Nutr. 2009 Aug;90(2):329-35. doi: 10.3945/ajcn.2009.27635. Epub 2009 Jun 2.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02052271\",\n",
      "          \"briefTitle\": \"Experimental Therapeutics in Essential Tremor Using Cerebellar Transcranial Direct Current Stimulation\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-06-03\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-03-27\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-02-03\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01534728\",\n",
      "          \"briefTitle\": \"Identification of Hepatitis C Virus (HCV) Specific T Cells\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2014-03\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-02-17\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01492985\",\n",
      "          \"briefTitle\": \"Lipopeptide Immunisation With GTU-multiHIV Trial\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2013-07\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-04-08\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2011-12-15\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"33568510\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Levy Y, Lacabaratz C, Lhomme E, Wiedemann A, Bauduin C, Fenwick C, Foucat E, Surenaud M, Guillaumat L, Boilet V, Rieux V, Bouchaud O, Girard PM, Molina JM, Morlat P, Hocqueloux L, Richert L, Pantaleo G, Lelievre JD, Thiebaut R. A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial. J Virol. 2021 Apr 12;95(9):e02165-20. doi: 10.1128/JVI.02165-20. Print 2021 Apr 12.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00120185\",\n",
      "          \"briefTitle\": \"Efficacy of Using Interleukin-2 in Antiretroviral Na\\u00efve HIV Patients (ANRS119)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2003-12\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2006-11\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-07-15\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Chiron Corporation\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"19508157\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Molina JM, Levy Y, Fournier I, Hamonic S, Bentata M, Beck-Wirth G, Gougeon ML, Venet A, Madelaine I, Sereni D, Jeanblanc F, Boulet T, Simon F, Aboulker JP; Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS) 119 Interstart Study Team. Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119). J Infect Dis. 2009 Jul 15;200(2):206-15. doi: 10.1086/599989.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01463956\",\n",
      "          \"briefTitle\": \"Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-01-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-01-22\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2011-11-02\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Merck Sharp & Dohme LLC\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00334256\",\n",
      "          \"briefTitle\": \"Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2006-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2009-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2006-06-07\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"European and Developing Countries Clinical Trials Partnership (EDCTP)\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Gilead Sciences\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"19307941\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"TEmAA ANRS 12109 Study group; Arrive E, Chaix ML, Nerrienet E, Blanche S, Rouzioux C, Coffie PA, Kruy Leang S, McIntyre J, Avit D, Srey VH, Gray G, N'Dri-Yoman T, Diallo A, Ekouevi DK, Dabis F. Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1. AIDS. 2009 Apr 27;23(7):825-33. doi: 10.1097/QAD.0b013e32832949d5.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"19104016\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Hirt D, Urien S, Rey E, Arrive E, Ekouevi DK, Coffie P, Leang SK, Lalsab S, Avit D, Nerrienet E, McIntyre J, Blanche S, Dabis F, Treluyer JM. Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Antimicrob Agents Chemother. 2009 Mar;53(3):1067-73. doi: 10.1128/AAC.00860-08. Epub 2008 Dec 22.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"18987623\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Hirt D, Urien S, Ekouevi DK, Rey E, Arrive E, Blanche S, Amani-Bosse C, Nerrienet E, Gray G, Kone M, Leang SK, McIntyre J, Dabis F, Treluyer JM; ANRS 12109. Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109). Clin Pharmacol Ther. 2009 Feb;85(2):182-9. doi: 10.1038/clpt.2008.201. Epub 2008 Nov 5.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00822315\",\n",
      "          \"briefTitle\": \"Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-07\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-05\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2009-01-14\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Gilead Sciences\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Merck Sharp & Dohme LLC\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"24726095\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Grinsztejn B, De Castro N, Arnold V, Veloso VG, Morgado M, Pilotto JH, Brites C, Madruga JV, Barcellos NT, Santos BR, Vorsatz C, Fagard C, Santini-Oliveira M, Patey O, Delaugerre C, Chene G, Molina JM; ANRS 12 180 Reflate TB study group. Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial. Lancet Infect Dis. 2014 Jun;14(6):459-67. doi: 10.1016/S1473-3099(14)70711-X. Epub 2014 Apr 9. Erratum In: Lancet Infect Dis. 2014 Jun;14(6):448.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT04120415\",\n",
      "          \"briefTitle\": \"A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2022-06-21\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2023-07-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2019-10-09\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"EuroVacc Foundation\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"European AIDS Treatment Group (EATG)\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Medical Research Council\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University College London Hospitals\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University of Liverpool\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Erasmus Medical Center\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Henri Mondor University Hospital\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"European Georges Pompidou Hospital\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Saint-Louis Hospital, Paris, France\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Centre Hospitalier Universitaire Vaudois\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Chelsea and Westminster Hospital, UK\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Universit\\u00e4tsklinikum Hamburg-Eppendorf\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Hospital Clinic of Barcelona\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Istituto Nazionale Malattie Infettive Lazaro Spallanzani\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Imperial College London\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Institut d'Investigacions Biom\\u00e8diques August Pi i Sunyer\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"European Commission\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Swiss Government\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02567071\",\n",
      "          \"briefTitle\": \"Natural Microbiota Restoration After C-section Birth\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2016-04-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2019-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2015-10-02\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01331811\",\n",
      "          \"briefTitle\": \"Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2011-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2014-05\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2011-04-08\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Institut Pasteur, Cambodia\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"National Pediatric Hospital, Cambodia\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Angkor Hospital for Children\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Pediatric Hospital Nhi Dong 1, Ho Chi Minh City, Vietnam\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Number 2 Children's Hospital, Ho Chi Minh City\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"H\\u00f4pital Necker-Enfants Malades, Paris, France\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Groupe Hospitalier Pitie-Salpetriere\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"CHRU Arnaud de Villeveuve, Montpellier, France\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"IRD, Yaounde, Cameroon\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Fondation Chantal Biya,Yaounde, Cameroon\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"CHU Sour\\u00f4 Sanou, Bobo Dioulasso, Burkina Faso\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Centre Muraz\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Centre Pasteur du Cameroun\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Centre Hospitalier D'essos\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"31455612\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Marcy O, Borand L, Ung V, Msellati P, Tejiokem M, Huu KT, Do Chau V, Ngoc Tran D, Ateba-Ndongo F, Tetang-Ndiang S, Nacro B, Sanogo B, Neou L, Goyet S, Dim B, Pean P, Quillet C, Fournier I, Berteloot L, Carcelain G, Godreuil S, Blanche S, Delacourt C; ANRS 12229 PAANTHER 01 STUDY GROUP. A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis. Pediatrics. 2019 Sep;144(3):e20182065. doi: 10.1542/peds.2018-2065.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"30689814\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Borand L, de Lauzanne A, Nguyen NL, Cheng S, Pham TH, Eyangoh S, Ouedraogo AS, Ung V, Msellati P, Tejiokem M, Nacro B, Inghammar M, Dim B, Delacourt C, Godreuil S, Blanche S, Marcy O; Pediatric Asian African Network for Tuberculosis and HIV Research (PAANTHER) Study Group. Isolation of Nontuberculous Mycobacteria in Southeast Asian and African Human Immunodeficiency Virus-infected Children With Suspected Tuberculosis. Clin Infect Dis. 2019 May 2;68(10):1750-1753. doi: 10.1093/cid/ciy897.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"29174612\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Marcy O, Tejiokem M, Msellati P, Truong Huu K, Do Chau V, Tran Ngoc D, Nacro B, Ateba-Ndongo F, Tetang-Ndiang S, Ung V, Dim B, Neou L, Berteloot L, Borand L, Delacourt C, Blanche S; ANRS 12229 PAANTHER 01 Study Group. Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study. Lancet HIV. 2018 Feb;5(2):e87-e95. doi: 10.1016/S2352-3018(17)30206-0. Epub 2017 Nov 23.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26908804\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Marcy O, Ung V, Goyet S, Borand L, Msellati P, Tejiokem M, Nguyen Thi NL, Nacro B, Cheng S, Eyangoh S, Pham TH, Ouedraogo AS, Tarantola A, Godreuil S, Blanche S, Delacourt C. Performance of Xpert MTB/RIF and Alternative Specimen Collection Methods for the Diagnosis of Tuberculosis in HIV-Infected Children. Clin Infect Dis. 2016 May 1;62(9):1161-1168. doi: 10.1093/cid/ciw036. Epub 2016 Feb 7.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02214511\",\n",
      "          \"briefTitle\": \"Biomarkers of Social Sensitivity in Major Depression\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-10-23\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-03-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-08-12\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01698411\",\n",
      "          \"briefTitle\": \"Study of the Influence of Sleep on Hemodynamic Parameters in Patients With Sleep Disorders\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-10-03\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT04288128\",\n",
      "          \"briefTitle\": \"Integrated Functional Evaluation of the Cerebellum\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2020-05-28\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2022-06-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2020-02-28\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Biogen\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Ionis Pharmaceuticals, Inc.\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02157311\",\n",
      "          \"briefTitle\": \"4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV Patients\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-07\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-06-06\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"29186458\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"de Truchis P, Assoumou L, Landman R, Mathez D, Le Du D, Bellet J, Amat K, Katlama C, Gras G, Bouchaud O, Duracinsky M, Abe E, Alvarez JC, Izopet J, Saillard J, Melchior JC, Leibowitch J, Costagliola D, Girard PM, Perronne C; ANRS 162-4D Study Group. Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial. J Antimicrob Chemother. 2018 Mar 1;73(3):738-747. doi: 10.1093/jac/dkx434.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02082171\",\n",
      "          \"briefTitle\": \"Multidomain Intervention to Prevent Disability in Elders\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2013-10-16\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-01-27\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-03-10\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"National Research Agency, France\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00918307\",\n",
      "          \"briefTitle\": \"Efficacy and Safety of Varenicline Among HIV-infected Patients\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2014-07\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2009-06-11\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Pfizer\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"34611902\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Hartmann-Boyce J, Theodoulou A, Farley A, Hajek P, Lycett D, Jones LL, Kudlek L, Heath L, Hajizadeh A, Schenkels M, Aveyard P. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev. 2021 Oct 6;10(10):CD006219. doi: 10.1002/14651858.CD006219.pub4.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"29329763\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Mercie P, Arsandaux J, Katlama C, Ferret S, Beuscart A, Spadone C, Duvivier C, Reynes J, Wirth N, Moinot L, Benard A, Zucman D, Duval X, Molina JM, Spire B, Fagard C, Chene G; ANRS 144 Inter-ACTIV study group. Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial. Lancet HIV. 2018 Mar;5(3):e126-e135. doi: 10.1016/S2352-3018(18)30002-X. Epub 2018 Jan 9.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT05090956\",\n",
      "          \"briefTitle\": \"Developpement of 3T MRI Protocol\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-06-08\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2020-01-29\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2021-10-25\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02346409\",\n",
      "          \"briefTitle\": \"Cerebello-thalamo-cortical Coupling in Essential Tremor\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2015-02-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-02-16\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2015-01-27\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00196599\",\n",
      "          \"briefTitle\": \"Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"1999-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2004-09\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-09-20\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Triangle Pharmaceuticals\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Gilead Sciences\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Bristol-Myers Squibb\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Dupont Applied Biosciences\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"10915095\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Molina JM, Ferchal F, Rancinan C, Raffi F, Rozenbaum W, Sereni D, Morlat P, Journot V, Decazes JM, Chene G. Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients. J Infect Dis. 2000 Aug;182(2):599-602. doi: 10.1086/315711. Epub 2000 Jul 13.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"15012649\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Molina JM, Peytavin G, Perusat S, Lascoux-Combes C, Sereni D, Rozenbaum W, Chene G. Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial). HIV Med. 2004 Mar;5(2):99-104. doi: 10.1111/j.1468-1293.2004.00194.x.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02102737\",\n",
      "          \"briefTitle\": \"Comparison of A New Technique of Measure of the Insulin Resistance By Scintigraphy With the Reference Technique\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-05-13\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-03\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-04-03\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00454337\",\n",
      "          \"briefTitle\": \"Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2007-05\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2008-09\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2007-03-30\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Merck Sharp & Dohme LLC\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"21576452\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Goldwirt L, Braun J, de Castro N, Charreau I, Barrail-Tran A, Delaugerre C, Raffi F, Lascoux-Combe C, Aboulker JP, Taburet AM, Molina JM. Switch from enfuvirtide to raltegravir lowers plasma concentrations of darunavir and tipranavir: a pharmacokinetic substudy of the EASIER-ANRS 138 trial. Antimicrob Agents Chemother. 2011 Jul;55(7):3613-5. doi: 10.1128/AAC.01827-10. Epub 2011 May 16.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"19995925\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Barau C, Delaugerre C, Braun J, de Castro N, Furlan V, Charreau I, Gerard L, Lascoux-Combe C, Molina JM, Taburet AM. High concentration of raltegravir in semen of HIV-infected men: results from a substudy of the EASIER-ANRS 138 trial. Antimicrob Agents Chemother. 2010 Feb;54(2):937-9. doi: 10.1128/AAC.01261-09. Epub 2009 Dec 7.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20683319\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Delaugerre C, Charreau I, Braun J, Nere ML, de Castro N, Yeni P, Ghosn J, Aboulker JP, Molina JM, Simon F; ANRS 138 study group. Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimen. AIDS. 2010 Sep 24;24(15):2391-5. doi: 10.1097/QAD.0b013e32833d214c.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21126958\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Boulet T, Pavie J, Charreau I, Braun J, Reynes J, Morlat P, Piroth L, Spire B, Molina JM, Aboulker JP; Easier-Anrs 138 Study Group. Impact on health-related quality of life of a switch from enfuvirtide to raltegravir among multidrug-resistant HIV-1-infected patients: a randomized open-label trial (EASIER-ANRS 138). HIV Clin Trials. 2010 Sep-Oct;11(5):283-93. doi: 10.1310/hct1105-283.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21326075\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Gallien S, Delaugerre C, Charreau I, Braun J, Boulet T, Barrail-Tran A, de Castro N, Molina JM, Kuritzkes DR. Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia. AIDS. 2011 Mar 13;25(5):665-9. doi: 10.1097/QAD.0b013e3283445834.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21712241\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Gallien S, Braun J, Delaugerre C, Charreau I, Reynes J, Jeanblanc F, Verdon R, de Truchis P, May T, Madelaine-Chambrin I, Aboulker JP, Molina JM; EASIER ANRS 138 Study Group. Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial. J Antimicrob Chemother. 2011 Sep;66(9):2099-106. doi: 10.1093/jac/dkr269. Epub 2011 Jun 28.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22416781\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Delaugerre C, Braun J, Charreau I, Delarue S, Nere ML, de Castro N, May T, Marchou B, Simon F, Molina JM, Aboulker JP; ANRS 138-EASIER study group. Comparison of resistance mutation patterns in historical plasma HIV RNA genotypes with those in current proviral HIV DNA genotypes among extensively treated patients with suppressed replication. HIV Med. 2012 Oct;13(9):517-25. doi: 10.1111/j.1468-1293.2012.01002.x. Epub 2012 Mar 14.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27042193\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"de Castro N, Braun J, Charreau I, Lafeuillade A, Viard JP, Allavena C, Aboulker JP, Molina JM; EASIER ANRS 138 study group. Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial. AIDS Res Ther. 2016 Apr 2;13:17. doi: 10.1186/s12981-016-0101-3. eCollection 2016.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"19757993\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"De Castro N, Braun J, Charreau I, Pialoux G, Cotte L, Katlama C, Raffi F, Weiss L, Meynard JL, Yazdanpanah Y, Delaugerre C, Madelaine-Chambrin I, Aboulker JP, Molina JM; EASIER ANRS 138 study group. Switch from enfuvirtide to raltegravir in virologically suppressed multidrug-resistant HIV-1-infected patients: a randomized open-label trial. Clin Infect Dis. 2009 Oct 15;49(8):1259-67. doi: 10.1086/605674.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02656407\",\n",
      "          \"briefTitle\": \"Intraoperative Functional Ultrasound\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2016-02-11\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2016-01-15\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"25955583\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Demene C, Deffieux T, Pernot M, Osmanski BF, Biran V, Gennisson JL, Sieu LA, Bergel A, Franqui S, Correas JM, Cohen I, Baud O, Tanter M. Spatiotemporal Clutter Filtering of Ultrafast Ultrasound Data Highly Increases Doppler and fUltrasound Sensitivity. IEEE Trans Med Imaging. 2015 Nov;34(11):2271-85. doi: 10.1109/TMI.2015.2428634. Epub 2015 Apr 30.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00158509\",\n",
      "          \"briefTitle\": \"Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2004-08\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2005-07\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-09-12\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"16044019\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Nagot N, Foulongne V, Becquart P, Mayaud P, Konate I, Ouedraogo A, Defer MC, Weiss H, Van de Perre P, Segondy M. Longitudinal assessment of HIV-1 and HSV-2 shedding in the genital tract of West African women. J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):632-4.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"18596069\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Mayaud P, Nagot N, Konate I, Ouedraogo A, Weiss HA, Foulongne V, Defer MC, Sawadogo A, Segondy M, Van de Perre P; ANRS 1285 Study Group. Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women. Sex Transm Infect. 2008 Oct;84(5):332-7. doi: 10.1136/sti.2008.030692. Epub 2008 Jul 2.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"18593294\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Nagot N, Ouedraogo A, Konate I, Weiss HA, Foulongne V, Defer MC, Sanon A, Becquart P, Segondy M, Sawadogo A, Van de Perre P, Mayaud P; ANRS 1285 Study Group. Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels. J Infect Dis. 2008 Jul 15;198(2):241-9. doi: 10.1086/589621.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"17314338\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Nagot N, Ouedraogo A, Foulongne V, Konate I, Weiss HA, Vergne L, Defer MC, Djagbare D, Sanon A, Andonaba JB, Becquart P, Segondy M, Vallo R, Sawadogo A, Van de Perre P, Mayaud P; ANRS 1285 Study Group. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med. 2007 Feb 22;356(8):790-9. doi: 10.1056/NEJMoa062607.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02038842\",\n",
      "          \"briefTitle\": \"Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-03\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-03\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-01-17\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01725542\",\n",
      "          \"briefTitle\": \"Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-12\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2014-06\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-11-14\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Bristol-Myers Squibb\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"25977266\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Piroth L, Paniez H, Taburet AM, Vincent C, Rosenthal E, Lacombe K, Billaud E, Rey D, Zucman D, Bailly F, Bronowicki JP, Simony M, Diallo A, Izopet J, Aboulker JP, Meyer L, Molina JM; ANRS HC30 QUADRIH Study Group. High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH Study. Clin Infect Dis. 2015 Sep 1;61(5):817-25. doi: 10.1093/cid/civ381. Epub 2015 May 14.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT06260319\",\n",
      "          \"briefTitle\": \"Decoding Developmental Disorders in Humams\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2019-01-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2024-01-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2024-02-15\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Imagine Institute\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Commissariat A L'energie Atomique\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01842919\",\n",
      "          \"briefTitle\": \"Dance and Huntington Disease\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2013-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-07-08\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2013-04-30\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02906137\",\n",
      "          \"briefTitle\": \"Gut-Associated Lymphocyte Trafficking\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2017-02-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2020-02-25\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2016-09-19\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01192737\",\n",
      "          \"briefTitle\": \"\\\"COhort Study on A/H1N1 FLU During PREGnancy\\\"\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2010-11\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2010-09-01\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02647632\",\n",
      "          \"briefTitle\": \"Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With Sofosbuvir\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2016-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2016-01-06\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"29077864\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"de Ledinghen V, Laforest C, Hezode C, Pol S, Renault A, Alric L, Larrey D, Metivier S, Tran A, Jezequel C, Samuel D, Zoulim F, Tual C, Pailhe A, Gibowski S, Bourliere M, Bellissant E, Pawlotsky JM. Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study. Clin Infect Dis. 2018 Mar 19;66(7):1013-1018. doi: 10.1093/cid/cix916.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01065207\",\n",
      "          \"briefTitle\": \"Patients Infected With HIV Since More Than 10 Years With a Plasma Viral RNA <400 Copies / mL in the Absence of Any Treatment: Study Mechanisms Involved in Controlling the Infection\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-03\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-03\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2010-02-09\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02542800\",\n",
      "          \"briefTitle\": \"The Influence of Collective Schemas on Individual Memory\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2015-09\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-06-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2015-09-07\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"La R\\u00e9gion Basse-Normandie\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Universit\\u00e9 de Caen Normandie\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University Hospital, Caen\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Ecole Pratique des Hautes Etudes\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Equipement d'Excellence Matrice\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01089400\",\n",
      "          \"briefTitle\": \"Immuno-virological Characterization of Severe H1N1v Influenza Infection in Bronchoalveolar Lavage\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2011-04\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2010-03-18\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Assistance Publique - H\\u00f4pitaux de Paris\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Institut Pasteur\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"24646009\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Guihot A, Luyt CE, Parrot A, Rousset D, Cavaillon JM, Boutolleau D, Fitting C, Pajanirassa P, Mallet A, Fartoukh M, Agut H, Musset L, Zoorob R, Kirilovksy A, Combadiere B, van der Werf S, Autran B, Carcelain G; FluBAL Study Group. Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection. Am J Respir Crit Care Med. 2014 May 15;189(10):1240-9. doi: 10.1164/rccm.201311-2071OC.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00574652\",\n",
      "          \"briefTitle\": \"Evaluation of Clinical Efficacy and Immunologic Response After IL-2 Therapy in HCV-related Vasculitis Patients\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2008-03\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2010-09\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2007-12-17\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"22129253\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Saadoun D, Rosenzwajg M, Joly F, Six A, Carrat F, Thibault V, Sene D, Cacoub P, Klatzmann D. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med. 2011 Dec 1;365(22):2067-77. doi: 10.1056/NEJMoa1105143. Erratum In: N Engl J Med. 2014 Feb 20;370(8):786.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01905059\",\n",
      "          \"briefTitle\": \"Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2013-07-23\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Janssen Pharmaceuticals\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"16249701\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Arribas JR, Pulido F, Delgado R, Lorenzo A, Miralles P, Arranz A, Gonzalez-Garcia JJ, Cepeda C, Hervas R, Pano JR, Gaya F, Carcas A, Montes ML, Costa JR, Pena JM. Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study). J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):280-7. doi: 10.1097/01.qai.0000180077.59159.f4.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"18097218\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Pulido F, Arribas JR, Delgado R, Cabrero E, Gonzalez-Garcia J, Perez-Elias MJ, Arranz A, Portilla J, Pasquau J, Iribarren JA, Rubio R, Norton M; OK04 Study Group. Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV. AIDS. 2008 Jan 11;22(2):F1-9. doi: 10.1097/QAD.0b013e3282f4243b.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"18540803\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Cameron DW, da Silva BA, Arribas JR, Myers RA, Bellos NC, Gilmore N, King MS, Bernstein BM, Brun SC, Hanna GJ. A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy. J Infect Dis. 2008 Jul 15;198(2):234-40. doi: 10.1086/589622.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21886816\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Cahn P, Montaner J, Junod P, Patterson P, Krolewiecki A, Andrade-Villanueva J, Cassetti I, Sierra-Madero J, Casiro AD, Bortolozzi R, Lupo SH, Longo N, Rampakakis E, Ackad N, Sampalis JS. Pilot, randomized study assessing safety, tolerability and efficacy of simplified LPV/r maintenance therapy in HIV patients on the 1 PI-based regimen. PLoS One. 2011;6(8):e23726. doi: 10.1371/journal.pone.0023726. Epub 2011 Aug 19.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"17545707\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Vernazza P, Daneel S, Schiffer V, Decosterd L, Fierz W, Klimkait T, Hoffmann M, Hirschel B. The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial. AIDS. 2007 Jun 19;21(10):1309-15. doi: 10.1097/QAD.0b013e32814e6b1c.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20802298\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Gutmann C, Cusini A, Gunthard HF, Fux C, Hirschel B, Decosterd LA, Cavassini M, Yerly S, Vernazza PL; Swiss HIV Cohort Study (SHCS). Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir. AIDS. 2010 Sep 24;24(15):2347-54. doi: 10.1097/QAD.0b013e32833db9a1.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20802297\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Katlama C, Valantin MA, Algarte-Genin M, Duvivier C, Lambert-Niclot S, Girard PM, Molina JM, Hoen B, Pakianather S, Peytavin G, Marcelin AG, Flandre P. Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136. AIDS. 2010 Sep 24;24(15):2365-74. doi: 10.1097/QAD.0b013e32833dec20.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"20010070\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Arribas JR, Horban A, Gerstoft J, Fatkenheuer G, Nelson M, Clumeck N, Pulido F, Hill A, van Delft Y, Stark T, Moecklinghoff C. The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml. AIDS. 2010 Jan 16;24(2):223-30. doi: 10.1097/QAD.0b013e3283348944.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"21811554\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Mathis S, Khanlari B, Pulido F, Schechter M, Negredo E, Nelson M, Vernazza P, Cahn P, Meynard JL, Arribas J, Bucher HC. Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis. PLoS One. 2011;6(7):e22003. doi: 10.1371/journal.pone.0022003. Epub 2011 Jul 19.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22814125\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Gilks CF, Walker AS, Dunn DT, Gibb DM, Kikaire B, Reid A, Musana H, Mambule I, Kasirye R, Robertson V, Ssali F, Spyer M, Pillay D, Yirrell D, Kaleebu P; DART Virology Group and Trial Team. Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA). Antivir Ther. 2012;17(7):1363-73. doi: 10.3851/IMP2253. Epub 2012 Jul 19.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22441252\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Bartlett JA, Ribaudo HJ, Wallis CL, Aga E, Katzenstein DA, Stevens WS, Norton MR, Klingman KL, Hosseinipour MC, Crump JA, Supparatpinyo K, Badal-Faesen S, Kallungal BA, Kumarasamy N. Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings. AIDS. 2012 Jul 17;26(11):1345-54. doi: 10.1097/QAD.0b013e328353b066.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"16549962\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Castagna A, Danise A, Menzo S, Galli L, Gianotti N, Carini E, Boeri E, Galli A, Cernuschi M, Hasson H, Clementi M, Lazzarin A. Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study). AIDS. 2006 Apr 4;20(6):795-803. doi: 10.1097/01.aids.0000218542.08845.b2.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23075703\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Bunupuradah T, Chetchotisakd P, Ananworanich J, Munsakul W, Jirajariyavej S, Kantipong P, Prasithsirikul W, Sungkanuparph S, Bowonwatanuwong C, Klinbuayaem V, Kerr SJ, Sophonphan J, Bhakeecheep S, Hirschel B, Ruxrungtham K; HIV STAR Study Group. A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: the HIV STAR study. Antivir Ther. 2012;17(7):1351-61. doi: 10.3851/IMP2443. Epub 2012 Jul 2. Erratum In: Antivir Ther. 2012;17(7):1389-90.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"28566227\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Ciaffi L, Koulla-Shiro S, Sawadogo AB, Ndour CT, Eymard-Duvernay S, Mbouyap PR, Ayangma L, Zoungrana J, Gueye NFN, Diallo M, Izard S, Bado G, Kane CT, Aghokeng AF, Peeters M, Girard PM, Le Moing V, Reynes J, Delaporte E; MOBIDIP study group. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial. Lancet HIV. 2017 Sep;4(9):e384-e392. doi: 10.1016/S2352-3018(17)30069-3. Epub 2017 May 28.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02125500\",\n",
      "          \"briefTitle\": \"Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-08\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-04-29\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01413152\",\n",
      "          \"briefTitle\": \"Residual Risk Assessment Of HIV Transmission\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2011-07\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-03\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2011-08-10\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02236832\",\n",
      "          \"briefTitle\": \"Study of the Neural Basis of Analogical Reasoning\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2015-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2021-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-09-11\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Fondation pour la Recherche M\\u00e9dicale\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00115609\",\n",
      "          \"briefTitle\": \"Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2006-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2009-11\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-06-24\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT04396288\",\n",
      "          \"briefTitle\": \"Ultrasound Imaging-based Measurement of Intra-osseous Vascular Response\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2021-09-14\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2024-01-30\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2020-05-20\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00445575\",\n",
      "          \"briefTitle\": \"Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2007-07-22\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-12-07\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2007-03-09\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"ZonMw: The Netherlands Organisation for Health Research and Development\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Cliniques universitaires Saint-Luc- Universit\\u00e9 Catholique de Louvain\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Charite University, Berlin, Germany\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01024400\",\n",
      "          \"briefTitle\": \"Immunogenicity and Safety of an Inactivated Non-adjuvanted A(H1N1)v Influenza Vaccine in Pregnant Women\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-11\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2010-07\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2009-12-02\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"MCM Vaccines B.V.\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"22147712\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Tsatsaris V, Capitant C, Schmitz T, Chazallon C, Bulifon S, Riethmuller D, Picone O, Poulain P, Lewin F, Laine F, Jacqz-Aigrain E, Aboulker JP, Launay O; Inserm C09-33 PREFLUVAC (Immunogenicity and Safety of an Inactivated Nonadjuvanted A[H1N1v] Influenza Vaccine in Pregnant Women) Study Group. Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial. Ann Intern Med. 2011 Dec 6;155(11):733-41. doi: 10.7326/0003-4819-155-11-201112060-00005.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01779752\",\n",
      "          \"briefTitle\": \"Vestibular Cortex and TMS\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2013-01-20\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2013-01-30\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03215732\",\n",
      "          \"briefTitle\": \"Cross Sectional Survey on the Burden and Impacts of Chronic Hepatitis B in the Rural Area of Niakhar, Senegal\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2017-10-19\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2019-07-31\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2017-07-12\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Institute of Research for Development, France\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"31320358\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Coste M, De Seze M, Diallo A, Carrieri MP, Marcellin F, Boyer S; ANRS 12356 AmBASS Study Group. Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356). BMJ Open. 2019 Jul 17;9(7):e030211. doi: 10.1136/bmjopen-2019-030211.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03005652\",\n",
      "          \"briefTitle\": \"Effects Of An 8-Weeks Mindfulness-based Intervention In Individuals With Subjective Cognitive Decline\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2017-04-21\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-09-18\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2016-12-29\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"36068621\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Whitfield T, Demnitz-King H, Schlosser M, Barnhofer T, Frison E, Coll-Padros N, Dautricourt S, Requier F, Delarue M, Gonneaud J, Klimecki OM, Lutz A, Paly L, Salmon E, Schild AK, Walker Z, Jessen F, Chetelat G, Collette F, Wirth M, Marchant NL; Medit-Ageing Research Group. Effects of a mindfulness-based versus a health self-management intervention on objective cognitive performance in older adults with subjective cognitive decline (SCD): a secondary analysis of the SCD-Well randomized controlled trial. Alzheimers Res Ther. 2022 Sep 6;14(1):125. doi: 10.1186/s13195-022-01057-w.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"35853750\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Demnitz-King H, Gonneaud J, Klimecki OM, Chocat A, Collette F, Dautricourt S, Jessen F, Krolak-Salmon P, Lutz A, Morse RM, Molinuevo JL, Poisnel G, Touron E, Wirth M, Walker Z, Chetelat G, Marchant NL; Medit-Ageing Research Group. Association of Self-reflection With Cognition and Brain Health in Cognitively Unimpaired Older Adults. Neurology. 2022 Sep 27;99(13):e1422-e1431. doi: 10.1212/WNL.0000000000200951. Epub 2022 Jul 19.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"33873195\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Marchant NL, Barnhofer T, Coueron R, Wirth M, Lutz A, Arenaza-Urquijo EM, Collette F, Poisnel G, Demnitz-King H, Schild AK, Coll-Padros N, Delphin-Combe F, Whitfield T, Schlosser M, Gonneaud J, Asselineau J, Walker Z, Krolak-Salmon P, Molinuevo JL, Frison E, Chetelat G, Jessen F, Klimecki OM; The Medit-Ageing Research Group. Effects of a Mindfulness-Based Intervention versus Health Self-Management on Subclinical Anxiety in Older Adults with Subjective Cognitive Decline: The SCD-Well Randomized Superiority Trial. Psychother Psychosom. 2021;90(5):341-350. doi: 10.1159/000515669. Epub 2021 Apr 19.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02916732\",\n",
      "          \"briefTitle\": \"Zika Virus Infection's Pregnancy Consequences in French Department of America\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2016-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2019-02\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2016-09-27\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"33657112\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Funk AL, Hoen B, Vingdassalom I, Ryan C, Kadhel P, Schepers K, Gaete S, Tressieres B, Fontanet A. Reassessment of the risk of birth defects due to Zika virus in Guadeloupe, 2016. PLoS Negl Trop Dis. 2021 Mar 3;15(3):e0009048. doi: 10.1371/journal.pntd.0009048. eCollection 2021 Mar.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"29539287\",\n",
      "              \"type\": \"RESULT\",\n",
      "              \"citation\": \"Hoen B, Schaub B, Funk AL, Ardillon V, Boullard M, Cabie A, Callier C, Carles G, Cassadou S, Cesaire R, Douine M, Herrmann-Storck C, Kadhel P, Laouenan C, Madec Y, Monthieux A, Nacher M, Najioullah F, Rousset D, Ryan C, Schepers K, Stegmann-Planchard S, Tressieres B, Volumenie JL, Yassinguezo S, Janky E, Fontanet A. Pregnancy Outcomes after ZIKV Infection in French Territories in the Americas. N Engl J Med. 2018 Mar 15;378(11):985-994. doi: 10.1056/NEJMoa1709481.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01311752\",\n",
      "          \"briefTitle\": \"Study of Human Papillomavirus Related Genital Pathology Among HIV Positive Women\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2007-11\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2011-03-09\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"Virology study Heather A Cubie Catherine Moore Edinburg United Kingdom\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Anatomopathology study Christine Bergeron Laboratoire Pasteur Cerba Cergy Pontoise France\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Paris, Isabelle Cartier, M.D.\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Immunology study Guislaine Carcelain Groupe Hospitalier Piti\\u00e9 Salp\\u00e9tri\\u00e8re Paris\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Surgery study Herv\\u00e9 Foulot Cochin Paris\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01269632\",\n",
      "          \"briefTitle\": \"Cohort of Young Adults Infected With HIV Since Birth or During Childhood\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2010-06\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2018-12-27\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2011-01-04\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01495897\",\n",
      "          \"briefTitle\": \"Abnormal Movements, Cerebellum and Sensorimotor : Oculomotor Study\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2011-03\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2014-03\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2011-12-20\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00463983\",\n",
      "          \"briefTitle\": \"Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2006-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2012-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2007-04-20\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"16883006\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Lebtahi R, Moreau S, Marchand-Adam S, Debray MP, Brauner M, Soler P, Marchal J, Raguin O, Gruaz-Guyon A, Reubi JC, Le Guludec D, Crestani B. Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis. J Nucl Med. 2006 Aug;47(8):1281-7.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22379151\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Crestani B, Chapron J, Wallaert B, Bergot E, Delaval P, Israel-Biet D, Lacronique J, Monnet I, Reynaud-Gaubert M, Tazi A, Lebtahi R, Debray MP, Brauner M, Dehoux M, Dornic Q, Aubier M, Mentre F, Duval X. Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study. Eur Respir J. 2012 Mar;39(3):772-5. doi: 10.1183/09031936.00113011. No abstract available.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT03137797\",\n",
      "          \"briefTitle\": \"Cohort of Patients Naive of Antiretroviral Treatment at Enrollment\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2004-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-06\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2017-05-03\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"ANRS, Emerging Infectious Diseases\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"22267473\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Boufassa F, Goujard C, Viard JP, Carlier R, Lefebvre B, Yeni P, Bouchaud O, Capeau J, Meyer L, Vigouroux C; ANRS COPANA Cohort Study Group. Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort. Antivir Ther. 2012;17(1):91-100. doi: 10.3851/IMP1916.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"22008658\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Dray-Spira R, Legeai C, Le Den M, Boue F, Lascoux-Combe C, Simon A, May T, Goujard C, Meyer L; ANRS-COPANA Cohort Study Group. Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use. AIDS. 2012 Jan 14;26(2):207-15. doi: 10.1097/QAD.0b013e32834dcf61.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23079802\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Rachas A, Warszawski J, Le Chenadec J, Legeai C, Teglas JP, Goujard C, Rouzioux C, Mandelbrot L, Tubiana R, Meyer L. Does pregnancy affect the early response to cART? AIDS. 2013 Jan 28;27(3):357-67. doi: 10.1097/QAD.0b013e32835ac8bc.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23936509\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Krastinova E, Seng R, Yeni P, Viard JP, Vittecoq D, Lascoux-Combe C, Fourn E, Pahlavan G, Delfraissy JF, Goujard C, Meyer L; ANRS PRIMO and COPANA Cohorts. Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts. PLoS One. 2013 Aug 1;8(8):e71473. doi: 10.1371/journal.pone.0071473. Print 2013. Erratum In: PLoS One. 2013;8(11). doi:10.1371/annotation/aed12a66-9c76-4e49-806b-881a2fe23bba. Goujard, Cecile [added].\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24058636\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Legeai C, Vigouroux C, Souberbielle JC, Bouchaud O, Boufassa F, Bastard JP, Carlier R, Capeau J, Goujard C, Meyer L, Viard JP; ANRS-COPANA Cohort Study Group. Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 <<COPANA>> cohort study. PLoS One. 2013 Sep 18;8(9):e74868. doi: 10.1371/journal.pone.0074868. eCollection 2013.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24465584\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Boufassa F, Lechenadec J, Meyer L, Costagliola D, Hunt PW, Pereyra F, Deeks S, Pancino G, Taulera O, Lichterfeld M, Delobel P, Saez-Cirion A, Lambotte O; ANRS CO18 HIV Controllers Cohort; Cascade Collaboration in Eurocoord; SCOPE Cohort; International HIV Controllers Study. Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaboration. PLoS One. 2014 Jan 17;9(1):e85516. doi: 10.1371/journal.pone.0085516. eCollection 2014.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"25573889\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"El Khoury P, Ghislain M, Villard EF, Le Goff W, Lascoux-Combe C, Yeni P, Meyer L, Vigouroux C, Goujard C, Guerin M. Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART. J Lipid Res. 2015 Mar;56(3):692-702. doi: 10.1194/jlr.M054510. Epub 2015 Jan 8.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"26636578\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Ghislain M, Bastard JP, Meyer L, Capeau J, Fellahi S, Gerard L, May T, Simon A, Vigouroux C, Goujard C; ANRS-COPANA Cohort Study Group. Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities. PLoS One. 2015 Dec 4;10(12):e0144317. doi: 10.1371/journal.pone.0144317. eCollection 2015.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"27509048\",\n",
      "              \"type\": \"BACKGROUND\",\n",
      "              \"citation\": \"Ploquin MJ, Madec Y, Casrouge A, Huot N, Passaes C, Lecuroux C, Essat A, Boufassa F, Jacquelin B, Jochems SP, Petitjean G, Angin M, Gartner K, Garcia-Tellez T, Noel N, Booiman T, Boeser-Nunnink BD, Roques P, Saez-Cirion A, Vaslin B, Dereudre-Bosquet N, Barre-Sinoussi F, Ghislain M, Rouzioux C, Lambotte O, Albert ML, Goujard C, Kootstra N, Meyer L, Muller-Trutwin MC. Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset. PLoS Pathog. 2016 Aug 10;12(8):e1005774. doi: 10.1371/journal.ppat.1005774. eCollection 2016 Aug.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01037777\",\n",
      "          \"briefTitle\": \"RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2009-05-07\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-12-14\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2009-12-23\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"35264424\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Wilke C, Mengel D, Schols L, Hengel H, Rakowicz M, Klockgether T, Durr A, Filla A, Melegh B, Schule R, Reetz K, Jacobi H, Synofzik M. Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1. Neurology. 2022 May 17;98(20):e1985-e1996. doi: 10.1212/WNL.0000000000200257. Epub 2022 Mar 9.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"32822634\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Jacobi H, du Montcel ST, Romanzetti S, Harmuth F, Mariotti C, Nanetti L, Rakowicz M, Makowicz G, Durr A, Monin ML, Filla A, Roca A, Schols L, Hengel H, Infante J, Kang JS, Timmann D, Casali C, Masciullo M, Baliko L, Melegh B, Nachbauer W, Burk-Gergs K, Schulz JB, Riess O, Reetz K, Klockgether T. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study. Lancet Neurol. 2020 Sep;19(9):738-747. doi: 10.1016/S1474-4422(20)30235-0.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"24780882\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Tezenas du Montcel S, Durr A, Rakowicz M, Nanetti L, Charles P, Sulek A, Mariotti C, Rola R, Schols L, Bauer P, Dufaure-Gare I, Jacobi H, Forlani S, Schmitz-Hubsch T, Filla A, Timmann D, van de Warrenburg BP, Marelli C, Kang JS, Giunti P, Cook A, Baliko L, Melegh B, Boesch S, Szymanski S, Berciano J, Infante J, Buerk K, Masciullo M, Di Fabio R, Depondt C, Ratka S, Stevanin G, Klockgether T, Brice A, Golmard JL. Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6. J Med Genet. 2014 Jul;51(7):479-86. doi: 10.1136/jmedgenet-2013-102200. Epub 2014 Apr 29. Erratum In: J Med Genet. 2014 Sep;51(9):613. Bela, Melegh [corrected to Melegh, Bela].\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"23707147\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Jacobi H, Reetz K, du Montcel ST, Bauer P, Mariotti C, Nanetti L, Rakowicz M, Sulek A, Durr A, Charles P, Filla A, Antenora A, Schols L, Schicks J, Infante J, Kang JS, Timmann D, Di Fabio R, Masciullo M, Baliko L, Melegh B, Boesch S, Burk K, Peltz A, Schulz JB, Dufaure-Gare I, Klockgether T. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data. Lancet Neurol. 2013 Jul;12(7):650-8. doi: 10.1016/S1474-4422(13)70104-2. Epub 2013 May 22. Erratum In: Lancet Neurol. 2013 Jul;12(7):630.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01842477\",\n",
      "          \"briefTitle\": \"Evaluation of Efficacy and Safety of Autologous MSCs Combined to Biomaterials to Enhance Bone Healing\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2013-05\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-02-05\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2013-04-29\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {}\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02721745\",\n",
      "          \"briefTitle\": \"Cause and Consequence of Neural Fatigue\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2016-05-23\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2020-12\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2016-03-29\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02408354\",\n",
      "          \"briefTitle\": \"Pilot Study, Comparative, Single-center, Randomized, Crossover, Double-blind, Against Placebo, Testing the Effectiveness of Triheptanoin Oil in Alternating Hemiplegia of Childhood\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2015-04-15\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-04-05\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2015-04-03\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"28969699\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Hainque E, Caillet S, Leroy S, Flamand-Roze C, Adanyeguh I, Charbonnier-Beaupel F, Retail M, Le Toullec B, Atencio M, Rivaud-Pechoux S, Brochard V, Habarou F, Ottolenghi C, Cormier F, Meneret A, Ruiz M, Doulazmi M, Roubergue A, Corvol JC, Vidailhet M, Mochel F, Roze E. A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood. Orphanet J Rare Dis. 2017 Oct 2;12(1):160. doi: 10.1186/s13023-017-0713-2.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01688453\",\n",
      "          \"briefTitle\": \"Overweight Management and Social Inequalities\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2012-04\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2015-11\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2012-09-19\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"34087324\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Manneville F, Omorou AY, Legrand K, Lecomte E, Rydberg JA, Briancon S, Guillemin F; PRALIMAP Trial Group. Sociodemographic and psychological characteristics associated with discrepancy between body satisfaction and weight change among adolescents. Prev Med. 2021 Sep;150:106668. doi: 10.1016/j.ypmed.2021.106668. Epub 2021 Jun 1.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"32097754\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Omorou AY, Manneville F, Langlois J, Legrand K, Bohme P, Muller L, Guillemin F, Briancon S, Lecomte E; PRALIMAP-INES Trial Group. Physical activity rather than sedentary behaviour is socially determined in French adolescents with overweight and obesity. Prev Med. 2020 May;134:106043. doi: 10.1016/j.ypmed.2020.106043. Epub 2020 Feb 22.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"29934380\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Saez L, Legrand K, Alleyrat C, Ramisasoa S, Langlois J, Muller L, Omorou AY, De Lavenne R, Kivits J, Lecomte E, Briancon S; PRALIMAP-INES Trial Group. Using facilitator-receiver peer dyads matched according to socioeconomic status to promote behaviour change in overweight adolescents: a feasibility study. BMJ Open. 2018 Jun 22;8(6):e019731. doi: 10.1136/bmjopen-2017-019731.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"29776897\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Saez L, Langlois J, Legrand K, Quinet MH, Lecomte E, Omorou AY, Briancon S; PRALIMAP-INES Trial Group. Reach and Acceptability of a Mobile Reminder Strategy and Facebook Group Intervention for Weight Management in Less Advantaged Adolescents: Insights From the PRALIMAP-INES Trial. JMIR Mhealth Uhealth. 2018 May 18;6(5):e110. doi: 10.2196/mhealth.7657.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"29696179\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Legrand K, Lecomte E, Langlois J, Muller L, Saez L, Quinet MH, Bohme P, Spitz E, Omorou AY, Briancon S; PRALIMAP-INES trial group. Reducing social inequalities in access to overweight and obesity care management for adolescents: The PRALIMAP-INES trial protocol and inclusion data analysis. Contemp Clin Trials Commun. 2017 Jun 16;7:141-157. doi: 10.1016/j.conctc.2017.05.010. eCollection 2017 Sep.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02172677\",\n",
      "          \"briefTitle\": \"The Influence of Collective Schemas on Individual Memory\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-10\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2016-10-14\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-06-24\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"La R\\u00e9gion Basse-Normandie\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Universit\\u00e9 de Caen Normandie\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"University Hospital, Caen\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Ecole Pratique des Hautes Etudes\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Equipement d'Excellence Matrice\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT01880151\",\n",
      "          \"briefTitle\": \"Neuroelectrical Biomarkers for Alzheimer's Disease Stages\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2013-07-12\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2019-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2013-06-18\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02658253\",\n",
      "          \"briefTitle\": \"Trial to Evaluate the Safety and Immunogenicity of a Placental Malaria Vaccine Candidate (PRIMVAC ) in Healthy Adults\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2016-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2019-02-21\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2016-01-18\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          },\n",
      "          \"collaborators\": [\n",
      "            {\n",
      "              \"name\": \"EVI Industries, Inc.\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Recherche Clinique Paris Descartes Necker Cochin Sainte Anne\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"Centre national de recherche et de formation sur le paludisme\"\n",
      "            },\n",
      "            {\n",
      "              \"name\": \"EUCLID Clinical Trial Platform\"\n",
      "            }\n",
      "          ]\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"33717176\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Gamain B, Chene A, Viebig NK, Tuikue Ndam N, Nielsen MA. Progress and Insights Toward an Effective Placental Malaria Vaccine. Front Immunol. 2021 Feb 25;12:634508. doi: 10.3389/fimmu.2021.634508. eCollection 2021.\"\n",
      "            },\n",
      "            {\n",
      "              \"pmid\": \"32032566\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Sirima SB, Richert L, Chene A, Konate AT, Campion C, Dechavanne S, Semblat JP, Benhamouda N, Bahuaud M, Loulergue P, Ouedraogo A, Nebie I, Kabore M, Kargougou D, Barry A, Ouattara SM, Boilet V, Allais F, Roguet G, Havelange N, Lopez-Perez E, Kuppers A, Konate E, Roussillon C, Kante M, Belarbi L, Diarra A, Henry N, Soulama I, Ouedraogo A, Esperou H, Leroy O, Batteux F, Tartour E, Viebig NK, Thiebaut R, Launay O, Gamain B. PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study. Lancet Infect Dis. 2020 May;20(5):585-597. doi: 10.1016/S1473-3099(19)30739-X. Epub 2020 Feb 4.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT02027051\",\n",
      "          \"briefTitle\": \"Etude g\\u00e9n\\u00e9tique Des Arm\\u00e9niens\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2014-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2017-01\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2014-01-03\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"OBSERVATIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00118677\",\n",
      "          \"briefTitle\": \"Long-Term Supervised Treatment Interruption in HIV-Infected Patients\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2003-02\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2007-05\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2005-07-12\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        },\n",
      "        \"referencesModule\": {\n",
      "          \"references\": [\n",
      "            {\n",
      "              \"pmid\": \"20657770\",\n",
      "              \"type\": \"DERIVED\",\n",
      "              \"citation\": \"Weiss L, Piketty C, Assoumou L, Didier C, Caccavelli L, Donkova-Petrini V, Levy Y, Girard PM, Burgard M, Viard JP, Rouzioux C, Costagliola D; ANRS 116 SALTO study group. Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy. PLoS One. 2010 Jul 21;5(7):e11659. doi: 10.1371/journal.pone.0011659.\"\n",
      "            }\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    },\n",
      "    {\n",
      "      \"protocolSection\": {\n",
      "        \"identificationModule\": {\n",
      "          \"nctId\": \"NCT00647205\",\n",
      "          \"briefTitle\": \"Evaluation of 2 Interferon \\u03b3 Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT\"\n",
      "        },\n",
      "        \"statusModule\": {\n",
      "          \"overallStatus\": \"COMPLETED\",\n",
      "          \"startDateStruct\": {\n",
      "            \"date\": \"2008-01\"\n",
      "          },\n",
      "          \"completionDateStruct\": {\n",
      "            \"date\": \"2010-11\"\n",
      "          },\n",
      "          \"studyFirstPostDateStruct\": {\n",
      "            \"date\": \"2008-03-31\"\n",
      "          }\n",
      "        },\n",
      "        \"sponsorCollaboratorsModule\": {\n",
      "          \"leadSponsor\": {\n",
      "            \"name\": \"French National Agency for Research on AIDS and Viral Hepatitis\"\n",
      "          }\n",
      "        },\n",
      "        \"designModule\": {\n",
      "          \"studyType\": \"INTERVENTIONAL\"\n",
      "        }\n",
      "      },\n",
      "      \"hasResults\": false\n",
      "    }\n",
      "  ]\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "print(json.dumps(response.json(), indent=2))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f8239b23-3a6b-4541-a657-98ee97e80ea5",
   "metadata": {},
   "source": [
    "***La structure du JSON est bien trop imbriquée pour le normaliser avec Pandas, du coup on l'applatit à la main:***"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1de1fc10-a370-4b0d-8dfc-eaa17dfab0f2",
   "metadata": {},
   "source": [
    "A partir du JSON on construit un dictionnaire équivalent mais beaucoup plus \"plat\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "0abd0476-5bc8-44d7-bcf2-a83fd3917852",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Si la liste des collaborateurs est vide on renvoie None, sinon on concatène les valeurs de la liste\n",
    "# sous la forme \"collaborateur_0 | collaborateur_1 | ...\"\n",
    "def concatenate_collaborator_list(collaborator_list):\n",
    "    if collaborator_list == []:\n",
    "        return None\n",
    "    else:\n",
    "        return ' | '.join(collaborator_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "c0192b08-9e25-4254-a542-b5b8d55d1388",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[\n",
      "  {\n",
      "    \"NCTId\": \"NCT02014727\",\n",
      "    \"BriefTitle\": \"Safety and Immunogenicity of Recombinant Pichia Pastoris AMA1-DiCo Candidate Malaria Vaccine With GLA-SE and Alhydrogel \\u00ae as Adjuvant in Healthy Malaria Non-Exposed European and Malaria Exposed African Adults\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"EVI Industries, Inc. | BPRC | Recherche Clinique Paris Descartes Necker Cochin Sainte Anne | Centre national de recherche et de formation sur le paludisme\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2013-12-18\",\n",
      "    \"StartDate\": \"2014-01\",\n",
      "    \"CompletionDate\": \"2015-07\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"28947345\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Sirima SB, Durier C, Kara L, Houard S, Gansane A, Loulergue P, Bahuaud M, Benhamouda N, Nebie I, Faber B, Remarque E, Launay O; AMA1-DiCo Study Group. Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel(R) in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial. Vaccine. 2017 Oct 27;35(45):6218-6227. doi: 10.1016/j.vaccine.2017.09.027. Epub 2017 Sep 22.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00117494\",\n",
      "    \"BriefTitle\": \"Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-07-07\",\n",
      "    \"StartDate\": \"2005-10\",\n",
      "    \"CompletionDate\": \"2007-06\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"22739396\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Bittar R, Giral P, Aslangul E, Assoumou L, Valantin MA, Kalmykova O, Federspiel MC, Cherfils C, Costagliola D, Bonnefont-Rousselot D; French National Agency for AIDS and Viral Hepatitis Research (ANRS) 126 study group. Effects of rosuvastatin versus pravastatin on low-density lipoprotein diameter in HIV-1-infected patients receiving ritonavir-boosted protease inhibitor. AIDS. 2012 Sep 10;26(14):1801-5. doi: 10.1097/QAD.0b013e328357063c.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22318219\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Bittar R, Giral P, Aslangul E, Assoumou L, Valantin MA, Kalmykova O, Fesel-Fouquier V, Costagliola D, Bonnefont-Rousselot D; ANRS 126 study group. Determinants of low-density lipoprotein particle diameter during antiretroviral therapy including protease inhibitors in HIV-1-infected patients. Antivir Ther. 2012;17(5):855-60. doi: 10.3851/IMP2065. Epub 2012 Feb 9.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00536627\",\n",
      "    \"BriefTitle\": \"Efficacy and Tolerance of Naked DNA Vaccine in Patients With Chronic B Hepatitis\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2007-09-28\",\n",
      "    \"StartDate\": \"2008-01\",\n",
      "    \"CompletionDate\": \"2010-11\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"16310901\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Mancini-Bourgine M, Fontaine H, Brechot C, Pol S, Michel ML. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. Vaccine. 2006 May 22;24(21):4482-9. doi: 10.1016/j.vaccine.2005.08.013. Epub 2005 Aug 18.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15382173\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Mancini-Bourgine M, Fontaine H, Scott-Algara D, Pol S, Brechot C, Michel ML. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers. Hepatology. 2004 Oct;40(4):874-82. doi: 10.1002/hep.20408.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24555998\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Fontaine H, Kahi S, Chazallon C, Bourgine M, Varaut A, Buffet C, Godon O, Meritet JF, Saidi Y, Michel ML, Scott-Algara D, Aboulker JP, Pol S; ANRS HB02 study group. Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN. Gut. 2015 Jan;64(1):139-47. doi: 10.1136/gutjnl-2013-305707. Epub 2014 Feb 20.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24394187\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Godon O, Fontaine H, Kahi S, Meritet JF, Scott-Algara D, Pol S, Michel ML, Bourgine M; ANRS HB02 study group. Immunological and antiviral responses after therapeutic DNA immunization in chronic hepatitis B patients efficiently treated by analogues. Mol Ther. 2014 Mar;22(3):675-684. doi: 10.1038/mt.2013.274. Epub 2013 Dec 5.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01033760\",\n",
      "    \"BriefTitle\": \"Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Gilead Sciences | Merck Sharp & Dohme LLC | Pfizer | Janssen-Cilag Ltd.\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2009-12-16\",\n",
      "    \"StartDate\": \"2010-04\",\n",
      "    \"CompletionDate\": \"2013-12\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"28708873\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Cheret A, Durier C, Melard A, Ploquin M, Heitzmann J, Lecuroux C, Avettand-Fenoel V, David L, Pialoux G, Chennebault JM, Muller-Trutwin M, Goujard C, Rouzioux C, Meyer L; ANRS OPTIPRIM study group. Impact of early cART on HIV blood and semen compartments at the time of primary infection. PLoS One. 2017 Jul 14;12(7):e0180191. doi: 10.1371/journal.pone.0180191. eCollection 2017.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25701561\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Cheret A, Nembot G, Melard A, Lascoux C, Slama L, Miailhes P, Yeni P, Abel S, Avettand-Fenoel V, Venet A, Chaix ML, Molina JM, Katlama C, Goujard C, Tamalet C, Raffi F, Lafeuillade A, Reynes J, Ravaux I, Hoen B, Delfraissy JF, Meyer L, Rouzioux C; OPTIPRIM ANRS Study Group. Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial. Lancet Infect Dis. 2015 Apr;15(4):387-96. doi: 10.1016/S1473-3099(15)70021-6. Epub 2015 Feb 18.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT05349162\",\n",
      "    \"BriefTitle\": \"Epicardial vs. Transvenous ICDs in Children\",\n",
      "    \"LeadSponsorName\": \"Paris Cardiovascular Research Center (Inserm U970)\",\n",
      "    \"CollaboratorName\": \"H\\u00f4pital Necker-Enfants Malades\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2022-04-27\",\n",
      "    \"StartDate\": \"2003-01-01\",\n",
      "    \"CompletionDate\": \"2022-04-01\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01164462\",\n",
      "    \"BriefTitle\": \"Feasibility and Limitations of Offering Community Based Rapid HIV Testing to Men Who Have Sex With Men (MSM)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2010-07-16\",\n",
      "    \"StartDate\": \"2010-03\",\n",
      "    \"CompletionDate\": \"2011-04\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02777229\",\n",
      "    \"BriefTitle\": \"Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited Settings\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Institut de Recherche pour le Developpement | UNITAID\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2016-05-19\",\n",
      "    \"StartDate\": \"2016-07\",\n",
      "    \"CompletionDate\": \"2021-07\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"33355914\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Bousmah MA, Nishimwe ML, Tovar-Sanchez T, Lantche Wandji M, Mpoudi-Etame M, Maradan G, Omgba Bassega P, Varloteaux M, Montoyo A, Kouanfack C, Delaporte E, Boyer S; New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries (NAMSAL) ANRS 12313 Study Group. Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial). Pharmacoeconomics. 2021 Mar;39(3):331-343. doi: 10.1007/s40273-020-00987-3. Epub 2020 Dec 23.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33010241\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Calmy A, Tovar Sanchez T, Kouanfack C, Mpoudi-Etame M, Leroy S, Perrineau S, Lantche Wandji M, Tetsa Tata D, Omgba Bassega P, Abong Bwenda T, Varloteaux M, Tongo M, Mpoudi-Ngole E, Montoyo A, Mercier N, LeMoing V, Peeters M, Reynes J, Delaporte E; New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries (NAMSAL) ANRS 12313 Study Group. Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon. Lancet HIV. 2020 Oct;7(10):e677-e687. doi: 10.1016/S2352-3018(20)30238-1.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31339676\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"NAMSAL ANRS 12313 Study Group; Kouanfack C, Mpoudi-Etame M, Omgba Bassega P, Eymard-Duvernay S, Leroy S, Boyer S, Peeters M, Calmy A, Delaporte E. Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1. N Engl J Med. 2019 Aug 29;381(9):816-826. doi: 10.1056/NEJMoa1904340. Epub 2019 Jul 24.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00480792\",\n",
      "    \"BriefTitle\": \"Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"MCM Vaccines B.V.\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2007-05-31\",\n",
      "    \"StartDate\": \"2007-06\",\n",
      "    \"CompletionDate\": \"2012-09\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"27064975\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Launay O, Rosenberg AR, Rey D, Pouget N, Michel ML, Reynes J, Neau D, Raffi F, Piroth L, Carrat F; ANRS HB03 VIHVAC-B (Trial Comparing 3 Strategies of Vaccination Against the Virus of Hepatitis B in HIV-Infected Patients) Group. Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial. JAMA Intern Med. 2016 May 1;176(5):603-10. doi: 10.1001/jamainternmed.2016.0741.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21486976\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Launay O, van der Vliet D, Rosenberg AR, Michel ML, Piroth L, Rey D, Colin de Verdiere N, Slama L, Martin K, Lortholary O, Carrat F; ANRS HB03 VIHVAC-B Trial. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial. JAMA. 2011 Apr 13;305(14):1432-40. doi: 10.1001/jama.2011.351.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01095744\",\n",
      "    \"BriefTitle\": \"Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2010-03-30\",\n",
      "    \"StartDate\": \"2009-03\",\n",
      "    \"CompletionDate\": \"2012-05\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01489592\",\n",
      "    \"BriefTitle\": \"Effect of Curcumin on Iron Metabolism in Healthy Volunteer\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2011-12-09\",\n",
      "    \"StartDate\": \"2011-10\",\n",
      "    \"CompletionDate\": \"2012-03\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"20169331\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Fatih N, Camberlein E, Island ML, Corlu A, Abgueguen E, Detivaud L, Leroyer P, Brissot P, Loreal O. Natural and synthetic STAT3 inhibitors reduce hepcidin expression in differentiated mouse hepatocytes expressing the active phosphorylated STAT3 form. J Mol Med (Berl). 2010 May;88(5):477-86. doi: 10.1007/s00109-009-0588-3. Epub 2010 Feb 19.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15974953\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Loreal O, Haziza-Pigeon C, Troadec MB, Detivaud L, Turlin B, Courselaud B, Ilyin G, Brissot P. Hepcidin in iron metabolism. Curr Protein Pept Sci. 2005 Jun;6(3):279-91. doi: 10.2174/1389203054065392.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16946298\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stolte J, Hentze MW, Muckenthaler MU. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood. 2007 Jan 1;109(1):353-8. doi: 10.1182/blood-2006-07-033969. Epub 2006 Aug 31.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15501961\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, Marczylo TH, Morgan B, Hemingway D, Plummer SM, Pirmohamed M, Gescher AJ, Steward WP. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res. 2004 Oct 15;10(20):6847-54. doi: 10.1158/1078-0432.CCR-04-0744.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18559556\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Vareed SK, Kakarala M, Ruffin MT, Crowell JA, Normolle DP, Djuric Z, Brenner DE. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1411-7. doi: 10.1158/1055-9965.EPI-07-2693.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01453192\",\n",
      "    \"BriefTitle\": \"Renal Transplantation and Raltegravir in HIV-Infected Patients\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Merck Sharp & Dohme LLC\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2011-10-17\",\n",
      "    \"StartDate\": \"2011-12\",\n",
      "    \"CompletionDate\": \"2015-11\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00460382\",\n",
      "    \"BriefTitle\": \"Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Merck Sharp & Dohme LLC | Janssen-Cilag Tibotec\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2007-04-13\",\n",
      "    \"StartDate\": \"2007-05\",\n",
      "    \"CompletionDate\": \"2009-09\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02486731\",\n",
      "    \"BriefTitle\": \"Hormonal Sensitivity in Patients With Noonan and LEOPARD Syndromes\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2015-07-01\",\n",
      "    \"StartDate\": \"2015-12-16\",\n",
      "    \"CompletionDate\": \"2018-12\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02116374\",\n",
      "    \"BriefTitle\": \"Physiopathology Study of the Microbiota Biodiversity of HIV Seropositive Patients\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-04-16\",\n",
      "    \"StartDate\": \"2014-12\",\n",
      "    \"CompletionDate\": \"2016-06\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02497274\",\n",
      "    \"BriefTitle\": \"Obesity and Lipids: a Matter of Taste?\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2015-07-14\",\n",
      "    \"StartDate\": \"2016-01-11\",\n",
      "    \"CompletionDate\": \"2019-01\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01022476\",\n",
      "    \"BriefTitle\": \"Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Merck Sharp & Dohme LLC\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2009-12-01\",\n",
      "    \"StartDate\": \"2010-05\",\n",
      "    \"CompletionDate\": \"2013-05\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00528060\",\n",
      "    \"BriefTitle\": \"Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Bristol-Myers Squibb | Gilead Sciences\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2007-09-11\",\n",
      "    \"StartDate\": \"2008-01\",\n",
      "    \"CompletionDate\": \"2008-11\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"23459496\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Parienti JJ, Barrail-Tran A, Duval X, Nembot G, Descamps D, Vigan M, Vrijens B, Panhard X, Taburet AM, Mentre F, Goujard C. Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial. Antimicrob Agents Chemother. 2013 May;57(5):2265-71. doi: 10.1128/AAC.02605-12. Epub 2013 Mar 4.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02078076\",\n",
      "    \"BriefTitle\": \"IRM Cardiaque en Respiration Libre Pour Des Patients Atteints de Dystrophinopathie s\\u00e9v\\u00e8re\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-03-05\",\n",
      "    \"StartDate\": \"2013-06\",\n",
      "    \"CompletionDate\": \"2015-11\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04008927\",\n",
      "    \"BriefTitle\": \"A Community-based Intervention Among Active Drug Users in Montpellier\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2019-07-05\",\n",
      "    \"StartDate\": \"2020-09-18\",\n",
      "    \"CompletionDate\": \"2021-09-10\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"27168667\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Blackburn NA, Patel RC, Zibbell JE. Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014. Public Health Rep. 2016 May-Jun;131 Suppl 2(Suppl 2):91-7. doi: 10.1177/00333549161310S214.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26806260\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Chevaliez S, Poiteau L, Rosa I, Soulier A, Roudot-Thoraval F, Laperche S, Hezode C, Pawlotsky JM. Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care. Clin Microbiol Infect. 2016 May;22(5):459.e1-6. doi: 10.1016/j.cmi.2016.01.009. Epub 2016 Jan 22.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22310560\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012 Mar;50(3):217-26. doi: 10.1097/MLR.0b013e3182408812.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29432973\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Des Jarlais D, Khue PM, Feelemyer J, Arasteh K, Thi Huong D, Thi Hai Oanh K, Thi Giang H, Thi Tuyet Thanh N, Vinh VH, Heckathorn DD, Moles JP, Vallo R, Quillet C, Rapoud D, Michel L, Laureillard D, Hammett T, Nagot N. Using dual capture/recapture studies to estimate the population size of persons who inject drugs (PWID) in the city of Hai Phong, Vietnam. Drug Alcohol Depend. 2018 Apr 1;185:106-111. doi: 10.1016/j.drugalcdep.2017.11.033. Epub 2018 Feb 2.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27178119\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Des Jarlais D, Duong HT, Pham Minh K, Khuat OH, Nham TT, Arasteh K, Feelemyer J, Heckathorn DD, Peries M, Moles JP, Laureillard D, Nagot N; (The Drive Study Team). Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. AIDS Care. 2016 Oct;28(10):1312-5. doi: 10.1080/09540121.2016.1178698. Epub 2016 May 13.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27537841\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Dore GJ, Altice F, Litwin AH, Dalgard O, Gane EJ, Shibolet O, Luetkemeyer A, Nahass R, Peng CY, Conway B, Grebely J, Howe AY, Gendrano IN, Chen E, Huang HC, Dutko FJ, Nickle DC, Nguyen BY, Wahl J, Barr E, Robertson MN, Platt HL; C-EDGE CO-STAR Study Group. Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial. Ann Intern Med. 2016 Nov 1;165(9):625-634. doi: 10.7326/M16-0816. Epub 2016 Aug 9.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28004616\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Leon L, Kasereka S, Barin F, Larsen C, Weill-Barillet L, Pascal X, Chevaliez S, Pillonel J, Jauffret-Roustide M, LE Strat Y. Age- and time-dependent prevalence and incidence of hepatitis C virus infection in drug users in France, 2004-2011: model-based estimation from two national cross-sectional serosurveys. Epidemiol Infect. 2017 Apr;145(5):895-907. doi: 10.1017/S0950268816002934. Epub 2016 Dec 22.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35774932\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Nagot N, D'Ottavi M, Quillet C, Debellefontaine A, Castellani J, Langendorfer N, Hanslik B, Guichard S, Baglioni R, Faucherre V, Tuaillon E, Pageaux GP, Laureillard D, Donnadieu-Rigole H. Reaching Hard-to-Reach People Who Use Drugs: A Community-Based Strategy for the Elimination of Hepatitis C. Open Forum Infect Dis. 2022 Apr 14;9(6):ofac181. doi: 10.1093/ofid/ofac181. eCollection 2022 Jun.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01331876\",\n",
      "    \"BriefTitle\": \"Modification of Cerebral Activity of Obsessive Compulsive Disorder (OCD) Patients During Cognitive and Behavioral Therapy\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2011-04-08\",\n",
      "    \"StartDate\": \"2009-10\",\n",
      "    \"CompletionDate\": \"2012-07\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00820820\",\n",
      "    \"BriefTitle\": \"IDA (Immunoth\\u00e9rapie de la Dermatite Atopique) Adult - Immunotherapy in Atopic Dermatitis\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"Ministry of Health, France\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2009-01-12\",\n",
      "    \"StartDate\": \"2009-01-09\",\n",
      "    \"CompletionDate\": \"2012-03-26\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02273765\",\n",
      "    \"BriefTitle\": \"Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Merck Sharp & Dohme LLC | Ministry of Health, Brazil\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-10-24\",\n",
      "    \"StartDate\": \"2015-09-11\",\n",
      "    \"CompletionDate\": \"2018-11-28\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"33667406\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"De Castro N, Marcy O, Chazallon C, Messou E, Eholie S, N'takpe JB, Bhatt N, Khosa C, Timana Massango I, Laureillard D, Chau GD, Domergue A, Veloso V, Escada R, Wagner Cardoso S, Delaugerre C, Anglaret X, Molina JM, Grinsztejn B; ANRS 12300 Reflate TB2 study group. Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial. Lancet Infect Dis. 2021 Jun;21(6):813-822. doi: 10.1016/S1473-3099(20)30869-0. Epub 2021 Mar 2.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02107365\",\n",
      "    \"BriefTitle\": \"Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO)\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Bristol-Myers Squibb\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-04-08\",\n",
      "    \"StartDate\": \"2013-11\",\n",
      "    \"CompletionDate\": \"2015-04\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00113282\",\n",
      "    \"BriefTitle\": \"Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Chiron Corporation\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-06-08\",\n",
      "    \"StartDate\": \"2004-06\",\n",
      "    \"CompletionDate\": \"2008-02\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01055873\",\n",
      "    \"BriefTitle\": \"Immunology of the Infection Perinatal\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Institut Pasteur | University of Paris 5 - Rene Descartes | H\\u00f4pital Necker-Enfants Malades\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2010-01-26\",\n",
      "    \"StartDate\": \"2007-02\",\n",
      "    \"CompletionDate\": \"2009-02\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"22427678\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Avettand-Fenoel V, Blanche S, Le Chenadec J, Scott-Algara D, Dollfus C, Viard JP, Bouallag N, Benmebarek Y, Riviere Y, Warszawski J, Rouzioux C, Buseyne F. Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study. J Infect Dis. 2012 May 15;205(10):1520-8. doi: 10.1093/infdis/jis233. Epub 2012 Mar 15.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT05199831\",\n",
      "    \"BriefTitle\": \"Situational Analysis of HIV-related Disability in the Context of Ivory Coast\",\n",
      "    \"LeadSponsorName\": \"Programme PAC-CI, Site ANRS-MIE de C\\u00f4te d'Ivoire\",\n",
      "    \"CollaboratorName\": \"Institute of Research for Development, France | Institut de Sante Publique, d'Epidemiologie et de Developpement | University of Toronto | Universit\\u00e9 de Lille\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2022-01-20\",\n",
      "    \"StartDate\": \"2021-02-05\",\n",
      "    \"CompletionDate\": \"2022-08-10\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01359774\",\n",
      "    \"BriefTitle\": \"31P-MRS and Huntington Disease\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2011-05-25\",\n",
      "    \"StartDate\": \"2011-04\",\n",
      "    \"CompletionDate\": \"2012-04\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"21285522\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Mochel F, Haller RG. Energy deficit in Huntington disease: why it matters. J Clin Invest. 2011 Feb;121(2):493-9. doi: 10.1172/JCI45691. Epub 2011 Feb 1.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17653274\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Mochel F, Charles P, Seguin F, Barritault J, Coussieu C, Perin L, Le Bouc Y, Gervais C, Carcelain G, Vassault A, Feingold J, Rabier D, Durr A. Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. PLoS One. 2007 Jul 25;2(7):e647. doi: 10.1371/journal.pone.0000647.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21320997\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Mochel F, Benaich S, Rabier D, Durr A. Validation of plasma branched chain amino acids as biomarkers in Huntington disease. Arch Neurol. 2011 Feb;68(2):265-7. doi: 10.1001/archneurol.2010.358. No abstract available.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02099474\",\n",
      "    \"BriefTitle\": \"Evaluation of Raltegravir During the Third Trimester of Pregnancy\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-03-31\",\n",
      "    \"StartDate\": \"2014-06-30\",\n",
      "    \"CompletionDate\": \"2017-04\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"32661003\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Zheng Y, Hirt D, Delmas S, Lui G, Benaboud S, Lechedanec J, Treluyer JM, Chenevier-Gobeaux C, Arezes E, Gelley A, Amri I, Urien S, Bouazza N, Foissac F, Warszawski J, Ghosn J. Effect of Pregnancy on Unbound Raltegravir Concentrations in the ANRS 160 RalFe Trial. Antimicrob Agents Chemother. 2020 Sep 21;64(10):e00759-20. doi: 10.1128/AAC.00759-20. Print 2020 Sep 21.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03546127\",\n",
      "    \"BriefTitle\": \"Molecular Profiling to Improve Outcome of Patients in Cancer. A Pilot Study\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"Institut Bergoni\\u00e9 | Plateforme labellis\\u00e9e Inca - Institut Bergoni\\u00e9, Bordeaux | Plateforme labellis\\u00e9e Inca - H\\u00f4pital Europ\\u00e9en Georges Pompidou, Paris | CNRGH, Evry | EUCLID Clinical Trial Platform\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2018-06-06\",\n",
      "    \"StartDate\": \"2017-05-23\",\n",
      "    \"CompletionDate\": \"2017-09-21\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04315948\",\n",
      "    \"BriefTitle\": \"Trial of Treatments for COVID-19 in Hospitalized Adults\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2020-03-20\",\n",
      "    \"StartDate\": \"2020-03-22\",\n",
      "    \"CompletionDate\": \"2023-09-25\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"32958495\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Ader F; Discovery French Trial Management Team. Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults. BMJ Open. 2020 Sep 21;10(9):e041437. doi: 10.1136/bmjopen-2020-041437.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34763056\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"EU-Response investigators group; Diallo A, Troseid M, Simensen VC, Boston A, Demotes J, Olsen IC, Chung F, Paiva JA, Hites M, Ader F, Arribas JR, Baratt-Due A, Melien O, Tacconelli E, Staub T, Greil R, Tsiodras S, Briel M, Esperou H, Mentre F, Eustace J, Saillard J, Delmas C, LeMestre S, Dumousseaux M, Costagliola D, Rottingen JA, Yazdanpanah Y. Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group. Clin Microbiol Infect. 2022 Jan;28(1):1-5. doi: 10.1016/j.cmi.2021.10.011. Epub 2021 Nov 8. No abstract available.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35623577\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Troseid M, Hentzien M, Ader F, Cardoso SW, Arribas JR, Molina JM, Mueller N, Hites M, Bonnet F, Manuel O, Costagliola D, Grinsztejn B, Olsen IC, Yazdapanah Y, Calmy A; EU RESPONSE; COMBINE. Immunocompromised patients have been neglected in COVID-19 trials: a call for action. Clin Microbiol Infect. 2022 Sep;28(9):1182-1183. doi: 10.1016/j.cmi.2022.05.005. Epub 2022 May 25. No abstract available.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"36680782\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Terzic V, Levoyer L, Figarella M, Bigagli E, Mercier N, De Gastines L, Gibowski S, Troseid M, Demotes J, Olsen IC, Hites M, Ader F, Lopez JRA, Mentre F, Esperou H, Costagliola D, Rottingen JA, Poissy J, Roze JC, Warris A, O'Leary J, Fernandes RM, Assoumou L, Hankard R, Turner MA, Yazdanpanah Y, Diallo A; EU-Response safety group; c4c safety group. Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia. Br J Clin Pharmacol. 2023 Apr;89(4):1318-1328. doi: 10.1111/bcp.15669. Epub 2023 Feb 8.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"36828006\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Amstutz A, Speich B, Mentre F, Rueegg CS, Belhadi D, Assoumou L, Burdet C, Murthy S, Dodd LE, Wang Y, Tikkinen KAO, Ader F, Hites M, Bouscambert M, Trabaud MA, Fralick M, Lee TC, Pinto R, Barratt-Due A, Lund-Johansen F, Muller F, Nevalainen OPO, Cao B, Bonnett T, Griessbach A, Taji Heravi A, Schonenberger C, Janiaud P, Werlen L, Aghlmandi S, Schandelmaier S, Yazdanpanah Y, Costagliola D, Olsen IC, Briel M. Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials. Lancet Respir Med. 2023 May;11(5):453-464. doi: 10.1016/S2213-2600(22)00528-8. Epub 2023 Feb 21. Erratum In: Lancet Respir Med. 2023 Aug;11(8):e77.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32473020\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Le MP, Peiffer-Smadja N, Guedj J, Neant N, Mentre F, Ader F, Yazdanpanah Y, Peytavin G. Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial. J Antimicrob Chemother. 2020 Sep 1;75(9):2376-2380. doi: 10.1093/jac/dkaa191.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33089306\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Le MP, Peiffer-Smadja N, Guedj J, Neant N, Mentre F, Ader F, Yazdanpanah Y, Peytavin G; C-20-15 DisCoVeRy French Steering Committee. Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response. J Antimicrob Chemother. 2021 Jan 1;76(1):277-279. doi: 10.1093/jac/dkaa415. No abstract available.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"37269068\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Mercier N, Belhadi D, DeChanet A, Delmas C, Saillard J, Dumousseaux M, Le Mestre S, Fougerou-Leurent C, Ferrane A, Burdet C, Esperou H, Ader F, Hites M, Peiffer-Smadja N, Poissy J, Andrejak C, Paiva JA, Tacconelli E, Staub T, Greil R, Costagliola D, Mentre F, Yazdanpanah Y, Diallo A; DisCoVeRy Safety Working group. Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial. Pharmacol Res Perspect. 2023 Jun;11(3):e01072. doi: 10.1002/prp2.1072.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"37302469\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Fougerou-Leurent C, Delmas C, Saillard J, Dumousseaux M, Ferrane A, Mercier N, Terzic V, Le Mestre S, Dechanet A, Belhadi D, Metois A, Burdet C, Mentre F, Noret M, Diallo A, Petrov-Sanchez V, Couffin-Cadiergues S, Hites M, Ader F, Esperou H. Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20-15 DisCoVeRy study. Contemp Clin Trials. 2023 Aug;131:107267. doi: 10.1016/j.cct.2023.107267. Epub 2023 Jun 9.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33264556\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"WHO Solidarity Trial Consortium; Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, Alejandria MM, Hernandez Garcia C, Kieny MP, Malekzadeh R, Murthy S, Reddy KS, Roses Periago M, Abi Hanna P, Ader F, Al-Bader AM, Alhasawi A, Allum E, Alotaibi A, Alvarez-Moreno CA, Appadoo S, Asiri A, Aukrust P, Barratt-Due A, Bellani S, Branca M, Cappel-Porter HBC, Cerrato N, Chow TS, Como N, Eustace J, Garcia PJ, Godbole S, Gotuzzo E, Griskevicius L, Hamra R, Hassan M, Hassany M, Hutton D, Irmansyah I, Jancoriene L, Kirwan J, Kumar S, Lennon P, Lopardo G, Lydon P, Magrini N, Maguire T, Manevska S, Manuel O, McGinty S, Medina MT, Mesa Rubio ML, Miranda-Montoya MC, Nel J, Nunes EP, Perola M, Portoles A, Rasmin MR, Raza A, Rees H, Reges PPS, Rogers CA, Salami K, Salvadori MI, Sinani N, Sterne JAC, Stevanovikj M, Tacconelli E, Tikkinen KAO, Trelle S, Zaid H, Rottingen JA, Swaminathan S. Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34048876\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Ader F, Peiffer-Smadja N, Poissy J, Bouscambert-Duchamp M, Belhadi D, Diallo A, Delmas C, Saillard J, Dechanet A, Mercier N, Dupont A, Alfaiate T, Lescure FX, Raffi F, Goehringer F, Kimmoun A, Jaureguiberry S, Reignier J, Nseir S, Danion F, Clere-Jehl R, Bouiller K, Navellou JC, Tolsma V, Cabie A, Dubost C, Courjon J, Leroy S, Mootien J, Gaci R, Mourvillier B, Faure E, Pourcher V, Gallien S, Launay O, Lacombe K, Lanoix JP, Makinson A, Martin-Blondel G, Bouadma L, Botelho-Nevers E, Gagneux-Brunon A, Epaulard O, Piroth L, Wallet F, Richard JC, Reuter J, Staub T, Lina B, Noret M, Andrejak C, Le MP, Peytavin G, Hites M, Costagliola D, Yazdanpanah Y, Burdet C, Mentre F; DisCoVeRy study group. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-beta-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec;27(12):1826-1837. doi: 10.1016/j.cmi.2021.05.020. Epub 2021 May 26.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34534511\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Poissy J, Belhadi D, Diallo A, Le MP, Peytavin G, Staub T, Greil R, Guedj J, Paiva JA, Costagliola D, Yazdanpanah Y, Burdet C, Mentre F; DisCoVeRy Study Group. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial. Lancet Infect Dis. 2022 Feb;22(2):209-221. doi: 10.1016/S1473-3099(21)00485-0. Epub 2021 Sep 14.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35233617\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Lingas G, Neant N, Gaymard A, Belhadi D, Peytavin G, Hites M, Staub T, Greil R, Paiva JA, Poissy J, Peiffer-Smadja N, Costagliola D, Yazdanpanah Y, Wallet F, Gagneux-Brunon A, Mentre F, Ader F, Burdet C, Guedj J, Bouscambert-Duchamp M. Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial. J Antimicrob Chemother. 2022 Apr 27;77(5):1404-1412. doi: 10.1093/jac/dkac048.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35643099\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Mentre F, Burdet C; DisCoVeRy Study Group. Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19. Lancet Infect Dis. 2022 Jun;22(6):764-765. doi: 10.1016/S1473-3099(22)00295-X. No abstract available.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35533972\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Ader F; DisCoVeRy Study Group. An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-beta-1a, and hydroxychloroquine in hospitalized patients with COVID-19: final results. Clin Microbiol Infect. 2022 Sep;28(9):1293-1296. doi: 10.1016/j.cmi.2022.04.016. Epub 2022 May 7. No abstract available.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"37728045\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Neant N, Lingas G, Gaymard A, Belhadi D, Hites M, Staub T, Greil R, Paiva JA, Poissy J, Peiffer-Smadja N, Costagliola D, Yazdanpanah Y, Bouscambert-Duchamp M, Gagneux-Brunon A, Ader F, Mentre F, Wallet F, Burdet C, Guedj J; DisCoVeRy study group. Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients. CPT Pharmacometrics Syst Pharmacol. 2023 Dec;12(12):2027-2037. doi: 10.1002/psp4.13051. Epub 2023 Oct 11.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35512728\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"WHO Solidarity Trial Consortium. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses. Lancet. 2022 May 21;399(10339):1941-1953. doi: 10.1016/S0140-6736(22)00519-0. Epub 2022 May 2. Erratum In: Lancet. 2022 Oct 29;400(10362):1512. Lancet. 2024 Jan 13;403(10422):146.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34473343\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34350582\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Ansems K, Grundeis F, Dahms K, Mikolajewska A, Thieme V, Piechotta V, Metzendorf MI, Stegemann M, Benstoem C, Fichtner F. Remdesivir for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Aug 5;8(8):CD014962. doi: 10.1002/14651858.CD014962.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32304640\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Taccone FS, Gorham J, Vincent JL. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base. Lancet Respir Med. 2020 Jun;8(6):539-541. doi: 10.1016/S2213-2600(20)30172-7. Epub 2020 Apr 15. No abstract available.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02987530\",\n",
      "    \"BriefTitle\": \"National Multicenter Trial Evaluating Two Treatments in Patients With Primary Human Immunodeficiency Virus (HIV-1) Infection\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2016-12-09\",\n",
      "    \"StartDate\": \"2017-04-11\",\n",
      "    \"CompletionDate\": \"2020-01-31\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT05311865\",\n",
      "    \"BriefTitle\": \"Transmission of Covid-19 During Clubbing Events in Closed Places\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Cerballiance | Kappa Sant\\u00e9\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2022-04-05\",\n",
      "    \"StartDate\": \"2021-09-04\",\n",
      "    \"CompletionDate\": \"2022-02-26\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00122616\",\n",
      "    \"BriefTitle\": \"Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Hoffmann-La Roche\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-07-22\",\n",
      "    \"StartDate\": \"2003-11\",\n",
      "    \"CompletionDate\": \"2009-03\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"23800784\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Chapplain JM, Bellissant E, Guyader D, Molina JM, Poizot-Martin I, Perre P, Pialoux G, Turlin B, Mouchel C, Renault A, Michelet C; ANRS HC-12 Study Group. The effects of a maintenance therapy with peg-interferon alpha-2a on liver fibrosis in HIV/HCV co-infected patients: a randomized controlled trial. J Infect. 2013 Oct;67(4):313-21. doi: 10.1016/j.jinf.2013.05.007. Epub 2013 Jun 22.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02428816\",\n",
      "    \"BriefTitle\": \"Evaluation of a Multimodal Neuroimaging Method for Diagnosis in Parkinsonian Syndromes\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2015-04-29\",\n",
      "    \"StartDate\": \"2013-01-24\",\n",
      "    \"CompletionDate\": \"2016-07-28\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02453048\",\n",
      "    \"BriefTitle\": \"Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": true,\n",
      "    \"StudyFirstPostDate\": \"2015-05-25\",\n",
      "    \"StartDate\": \"2015-09\",\n",
      "    \"CompletionDate\": \"2017-12\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"24421886\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Thorstensson R, Trollfors B, Al-Tawil N, Jahnmatz M, Bergstrom J, Ljungman M, Torner A, Wehlin L, Van Broekhoven A, Bosman F, Debrie AS, Mielcarek N, Locht C. A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. PLoS One. 2014 Jan 8;9(1):e83449. doi: 10.1371/journal.pone.0083449. eCollection 2014.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24793938\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Jahnmatz M, Amu S, Ljungman M, Wehlin L, Chiodi F, Mielcarek N, Locht C, Thorstensson R. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial. Vaccine. 2014 Jun 5;32(27):3350-6. doi: 10.1016/j.vaccine.2014.04.048. Epub 2014 Apr 29.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24950361\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Feunou PF, Kammoun H, Debrie AS, Locht C. Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice. Vaccine. 2014 Jul 23;32(34):4281-8. doi: 10.1016/j.vaccine.2014.06.019. Epub 2014 Jun 17.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22814407\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Kammoun H, Feunou PF, Foligne B, Debrie AS, Raze D, Mielcarek N, Locht C. Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice. Vaccine. 2012 Aug 31;30(40):5864-70. doi: 10.1016/j.vaccine.2012.07.005. Epub 2012 Jul 17.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21430219\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Fedele G, Bianco M, Debrie AS, Locht C, Ausiello CM. Attenuated Bordetella pertussis vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1/Th17 response. J Immunol. 2011 May 1;186(9):5388-96. doi: 10.4049/jimmunol.1003765. Epub 2011 Mar 23.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21147936\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Skerry CM, Mahon BP. A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model. Clin Vaccine Immunol. 2011 Feb;18(2):187-93. doi: 10.1128/CVI.00371-10. Epub 2010 Dec 8.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20708998\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Feunou PF, Kammoun H, Debrie AS, Mielcarek N, Locht C. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1. Vaccine. 2010 Oct 8;28(43):7047-53. doi: 10.1016/j.vaccine.2010.08.017. Epub 2010 Aug 13.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20419113\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Feunou PF, Bertout J, Locht C. T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis. PLoS One. 2010 Apr 15;5(4):e10178. doi: 10.1371/journal.pone.0010178.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20107007\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Mielcarek N, Debrie AS, Mahieux S, Locht C. Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice. Clin Vaccine Immunol. 2010 Mar;17(3):317-24. doi: 10.1128/CVI.00322-09. Epub 2010 Jan 27.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19625486\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Skerry CM, Cassidy JP, English K, Feunou-Feunou P, Locht C, Mahon BP. A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice. Clin Vaccine Immunol. 2009 Sep;16(9):1344-51. doi: 10.1128/CVI.00082-09. Epub 2009 Jul 22.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18762220\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Feunou PF, Ismaili J, Debrie AS, Huot L, Hot D, Raze D, Lemoine Y, Locht C. Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1. Vaccine. 2008 Oct 23;26(45):5722-7. doi: 10.1016/j.vaccine.2008.08.018. Epub 2008 Aug 30.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32687804\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Jahnmatz M, Richert L, Al-Tawil N, Storsaeter J, Colin C, Bauduin C, Thalen M, Solovay K, Rubin K, Mielcarek N, Thorstensson R, Locht C; BPZE1 study team. Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study. Lancet Infect Dis. 2020 Nov;20(11):1290-1301. doi: 10.1016/S1473-3099(20)30274-7. Epub 2020 Jul 17. Erratum In: Lancet Infect Dis. 2020 Sep;20(9):e215.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31945015\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Lin A, Apostolovic D, Jahnmatz M, Liang F, Ols S, Tecleab T, Wu C, van Hage M, Solovay K, Rubin K, Locht C, Thorstensson R, Thalen M, Lore K. Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans. J Clin Invest. 2020 May 1;130(5):2332-2346. doi: 10.1172/JCI135020.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00120757\",\n",
      "    \"BriefTitle\": \"Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-07-19\",\n",
      "    \"StartDate\": \"2004-10\",\n",
      "    \"CompletionDate\": \"2008-11\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"22353022\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Rozenberg S, Lanoy E, Bentata M, Viard JP, Valantin MA, Missy P, Darasteanu I, Roux C, Kolta S, Costagliola D; ANRS 120 Fosivir Study Group. Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120). AIDS Res Hum Retroviruses. 2012 Sep;28(9):972-80. doi: 10.1089/AID.2011.0224. Epub 2012 Mar 23.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02566148\",\n",
      "    \"BriefTitle\": \"Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Ministry of Health, France | Institut de Recherche pour le Developpement | Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France | Institut national de prevention et d'education pour la sante\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2015-10-02\",\n",
      "    \"StartDate\": \"2012-02\",\n",
      "    \"CompletionDate\": \"2013-05\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"29982518\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Vignier N, Dray Spira R, Pannetier J, Ravalihasy A, Gosselin A, Lert F, Lydie N, Bouchaud O, Desgrees Du Lou A, Chauvin P; PARCOURS Study Group. Refusal to provide healthcare to sub-Saharan migrants in France: a comparison according to their HIV and HBV status. Eur J Public Health. 2018 Oct 1;28(5):904-910. doi: 10.1093/eurpub/cky118.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29437866\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Gosselin A, Desgrees du Lou A, Lelievre E; PARCOURS Study Group. How to use sequence analysis for life course epidemiology? An example on HIV-positive Sub-Saharan migrants in France. J Epidemiol Community Health. 2018 Jun;72(6):507-512. doi: 10.1136/jech-2017-209739. Epub 2018 Feb 2.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29307383\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Pannetier J, Ravalihasy A, Lydie N, Lert F, Desgrees du Lou A; Parcours study group. Prevalence and circumstances of forced sex and post-migration HIV acquisition in sub-Saharan African migrant women in France: an analysis of the ANRS-PARCOURS retrospective population-based study. Lancet Public Health. 2018 Jan;3(1):e16-e23. doi: 10.1016/S2468-2667(17)30211-6. Epub 2017 Nov 23.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00640263\",\n",
      "    \"BriefTitle\": \"Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"European and Developing Countries Clinical Trials Partnership (EDCTP) | The Research Council of Norway | Swedish International Development Cooperation Agency (SIDA) | Universit\\u00e9 Montpellier | University of Bergen\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2008-03-21\",\n",
      "    \"StartDate\": \"2009-12\",\n",
      "    \"CompletionDate\": \"2014-02\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"17825642\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Kourtis AP, Jamieson DJ, de Vincenzi I, Taylor A, Thigpen MC, Dao H, Farley T, Fowler MG. Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments. Am J Obstet Gynecol. 2007 Sep;197(3 Suppl):S113-22. doi: 10.1016/j.ajog.2007.03.003.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32991450\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Birungi N, Fadnes LT, Engebretsen IMS, Tumwine JK, Astrom AN; for ANRS 12174 AND 12341 study groups. Antiretroviral treatment and its impact on oral health outcomes in 5 to 7 year old Ugandan children: A 6 year follow-up visit from the ANRS 12174 randomized trial. Medicine (Baltimore). 2020 Sep 25;99(39):e22352. doi: 10.1097/MD.0000000000022352.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32228542\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Birungi N, Fadnes LT, Engebretsen IMS, Lie SA, Tumwine JK, Astrom AN; ANRS 12174 and 12341 study groups. Caries experience and oral health related quality of life in a cohort of Ugandan HIV-1 exposed uninfected children compared with a matched cohort of HIV unexposed uninfected children. BMC Public Health. 2020 Mar 30;20(1):423. doi: 10.1186/s12889-020-08564-1.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32067040\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Montoya-Ferrer A, Sanosyan A, Fayd'herbe de Maudave A, Pisoni A, Bollore K, Moles JP, Peries M, Tylleskar T, Tumwine JK, Ndeezi G, Gorgolas M, Nagot N, van de Perre P, Tuaillon E. Clinical and Biological Factors Associated With Early Epstein-Barr Virus Infection in Human Immunodeficiency Virus-Exposed Uninfected Infants in Eastern Uganda. Clin Infect Dis. 2021 Mar 15;72(6):1026-1032. doi: 10.1093/cid/ciaa161.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31994250\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Birungi N, Fadnes LT, Engebretsen IMS, Lie SA, Tumwine JK, Astrom AN; ANRS 12174 and 12341 study groups. Association of maternal HIV-1 severity with dental caries: an observational study of uninfected 5- to 7-yr-old children of HIV-1-infected mothers without severe immune suppression. Eur J Oral Sci. 2020 Feb;128(1):46-54. doi: 10.1111/eos.12669. Epub 2020 Jan 29.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31633158\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Kariyawasam D, Peries M, Foissac F, Eymard-Duvernay S, Tylleskar T, Singata-Madliki M, Kankasa C, Meda N, Tumwine J, Mwiya M, Engebretsen I, Fluck CE, Hartmann MF, Wudy SA, Hirt D, Treluyer JM, Moles JP, Blanche S, Van De Perre P, Polak M, Nagot N; ANRS 12174 Trial Group. Lopinavir-Ritonavir Impairs Adrenal Function in Infants. Clin Infect Dis. 2020 Aug 14;71(4):1030-1039. doi: 10.1093/cid/ciz888.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30814028\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Blanche S, Tylleskar T, Peries M, Kankasa C, Engebretsen I, Meda N, Tumwine JK, Singata-Madliki M, Mwiya M, Van de Perre P, Nagot N; ANRS 12174 Trial Group. Growth in HIV-1-exposed but uninfected infants treated with lopinavir-ritonavir versus lamivudine: a secondary analysis of the ANRS 12174 trial. Lancet HIV. 2019 May;6(5):e307-e314. doi: 10.1016/S2352-3018(18)30361-8. Epub 2019 Feb 24.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28469697\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Some EN, Engebretsen IMS, Nagot N, Meda N, Lombard C, Vallo R, Peries M, Kankasa C, Tumwine JK, Hofmeyr GJ, Singata M, Harper K, Van De Perre P, Tylleskar T; ANRS 12174 Trial Group. Breastfeeding patterns and its determinants among mothers living with Human Immuno-deficiency Virus -1 in four African countries participating in the ANRS 12174 trial. Int Breastfeed J. 2017 May 2;12:22. doi: 10.1186/s13006-017-0112-2. eCollection 2016.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27895016\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Foissac F, Blume J, Treluyer JM, Tylleskar T, Kankasa C, Meda N, Tumwine JK, Singata-Madliki M, Harper K, Illamola SM, Bouazza N, Nagot N, Van de Perre P, Blanche S, Hirt D. Are Prophylactic and Therapeutic Target Concentrations Different?: the Case of Lopinavir-Ritonavir or Lamivudine Administered to Infants for Prevention of Mother-to-Child HIV-1 Transmission during Breastfeeding. Antimicrob Agents Chemother. 2017 Jan 24;61(2):e01869-16. doi: 10.1128/AAC.01869-16. Print 2017 Feb.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26603917\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Nagot N, Kankasa C, Tumwine JK, Meda N, Hofmeyr GJ, Vallo R, Mwiya M, Kwagala M, Traore H, Sunday A, Singata M, Siuluta C, Some E, Rutagwera D, Neboua D, Ndeezi G, Jackson D, Marechal V, Neveu D, Engebretsen IMS, Lombard C, Blanche S, Sommerfelt H, Rekacewicz C, Tylleskar T, Van de Perre P; ANRS 12174 Trial Group. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. Lancet. 2016 Feb 6;387(10018):566-573. doi: 10.1016/S0140-6736(15)00984-8. Epub 2015 Nov 19. Erratum In: Lancet. 2019 Jun 22;393(10190):2492.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23039034\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Nagot N, Kankasa C, Meda N, Hofmeyr J, Nikodem C, Tumwine JK, Karamagi C, Sommerfelt H, Neveu D, Tylleskar T, Van de Perre P; PROMISE-PEP group. Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding: the PROMISE-PEP trial Protocol ANRS 12174. BMC Infect Dis. 2012 Oct 6;12:246. doi: 10.1186/1471-2334-12-246.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01693835\",\n",
      "    \"BriefTitle\": \"\\\"Cancersensor\\\": Circadian Rhythms\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-09-26\",\n",
      "    \"StartDate\": \"2012-08\",\n",
      "    \"CompletionDate\": \"2014-06\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04470648\",\n",
      "    \"BriefTitle\": \"COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"Samusocial de Paris | Assistance Publique - H\\u00f4pitaux de Paris\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2020-07-14\",\n",
      "    \"StartDate\": \"2020-07-22\",\n",
      "    \"CompletionDate\": \"2021-08-22\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"32070465\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Bernard Stoecklin S, Rolland P, Silue Y, Mailles A, Campese C, Simondon A, Mechain M, Meurice L, Nguyen M, Bassi C, Yamani E, Behillil S, Ismael S, Nguyen D, Malvy D, Lescure FX, Georges S, Lazarus C, Tabai A, Stempfelet M, Enouf V, Coignard B, Levy-Bruhl D; Investigation team. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro Surveill. 2020 Feb;25(6):2000094. doi: 10.2807/1560-7917.ES.2020.25.6.2000094.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32224310\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Lescure FX, Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S, Gaymard A, Bouscambert-Duchamp M, Donati F, Le Hingrat Q, Enouf V, Houhou-Fidouh N, Valette M, Mailles A, Lucet JC, Mentre F, Duval X, Descamps D, Malvy D, Timsit JF, Lina B, van-der-Werf S, Yazdanpanah Y. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020 Jun;20(6):697-706. doi: 10.1016/S1473-3099(20)30200-0. Epub 2020 Mar 27. Erratum In: Lancet Infect Dis. 2020 May 19;: Lancet Infect Dis. 2020 Jun;20(6):e116.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32371096\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Deslandes A, Berti V, Tandjaoui-Lambotte Y, Alloui C, Carbonnelle E, Zahar JR, Brichler S, Cohen Y. SARS-CoV-2 was already spreading in France in late December 2019. Int J Antimicrob Agents. 2020 Jun;55(6):106006. doi: 10.1016/j.ijantimicag.2020.106006. Epub 2020 May 3.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31978945\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W; China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32046819\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveill. 2020 Feb;25(5):2000062. doi: 10.2807/1560-7917.ES.2020.25.5.2000062.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31995857\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32109013\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32338732\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Baggett TP, Keyes H, Sporn N, Gaeta JM. Prevalence of SARS-CoV-2 Infection in Residents of a Large Homeless Shelter in Boston. JAMA. 2020 Jun 2;323(21):2191-2192. doi: 10.1001/jama.2020.6887.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02573948\",\n",
      "    \"BriefTitle\": \"Feasibility of Interventions on People Who Inject Drugs in Vietnam\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"National Institute on Drug Abuse (NIDA)\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": true,\n",
      "    \"StudyFirstPostDate\": \"2015-10-12\",\n",
      "    \"StartDate\": \"2014-09\",\n",
      "    \"CompletionDate\": \"2016-06\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"26080690\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Elliott JC, Hasin DS, Stohl M, Des Jarlais DC. HIV, Hepatitis C, and Abstinence from Alcohol Among Injection and Non-injection Drug Users. AIDS Behav. 2016 Mar;20(3):548-54. doi: 10.1007/s10461-015-1113-z.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26075647\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Perlman DC, Des Jarlais DC, Feelemyer J. Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs? J Addict Dis. 2015;34(2-3):198-205. doi: 10.1080/10550887.2015.1059111.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26050614\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Perlman DC, Jordan AE, Uuskula A, Huong DT, Masson CL, Schackman BR, Des Jarlais DC. An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential. Int J Drug Policy. 2015 Nov;26(11):1056-63. doi: 10.1016/j.drugpo.2015.04.015. Epub 2015 Apr 27.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26032121\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Hatzakis A, Sypsa V, Paraskevis D, Nikolopoulos G, Tsiara C, Micha K, Panopoulos A, Malliori M, Psichogiou M, Pharris A, Wiessing L, van de Laar M, Donoghoe M, Heckathorn DD, Friedman SR, Des Jarlais DC. Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme. Addiction. 2015 Sep;110(9):1453-67. doi: 10.1111/add.12999. Epub 2015 Jul 14.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25540950\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Des Jarlais DC. AIDS, people who use drugs, and altruism: reflection on a personal image. Subst Use Misuse. 2015 Mar;50(4):532-3. doi: 10.3109/10826084.2015.978185. Epub 2014 Dec 26. No abstract available.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28800503\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Michel L, Des Jarlais DC, Duong Thi H, Khuat Thi Hai O, Pham Minh K, Peries M, Vallo R, Nham Thi Tuyet T, Hoang Thi G, Le Sao M, Feelemyer J, Vu Hai V, Moles JP, Laureillard D, Nagot N; DRIVE Study Team. Intravenous heroin use in Haiphong, Vietnam: Need for comprehensive care including methamphetamine use-related interventions. Drug Alcohol Depend. 2017 Oct 1;179:198-204. doi: 10.1016/j.drugalcdep.2017.07.004. Epub 2017 Aug 2.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27178119\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Des Jarlais D, Duong HT, Pham Minh K, Khuat OH, Nham TT, Arasteh K, Feelemyer J, Heckathorn DD, Peries M, Moles JP, Laureillard D, Nagot N; (The Drive Study Team). Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. AIDS Care. 2016 Oct;28(10):1312-5. doi: 10.1080/09540121.2016.1178698. Epub 2016 May 13.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27006257\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Des Jarlais DC, Thi Huong D, Thi Hai Oanh K, Khue Pham M, Thi Giang H, Thi Tuyet Thanh N, Arasteh K, Feelemyer J, Hammett T, Peries M, Michel L, Vu Hai V, Roustide MJ, Moles JP, Laureillard D, Nagot N; DRIVE Study Team. Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam. Int J Drug Policy. 2016 Jun;32:50-6. doi: 10.1016/j.drugpo.2016.02.021. Epub 2016 Feb 27.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28612212\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Duong HT, Jarlais DD, Khuat OHT, Arasteh K, Feelemyer J, Khue PM, Giang HT, Laureillard D, Hai VV, Vallo R, Michel L, Moles JP, Nagot N; Drive Study Group. Risk Behaviors for HIV and HCV Infection Among People Who Inject Drugs in Hai Phong, Viet Nam, 2014. AIDS Behav. 2018 Jul;22(7):2161-2171. doi: 10.1007/s10461-017-1814-6.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01693848\",\n",
      "    \"BriefTitle\": \"\\\"Cancersensor\\\" Metastasis Resection\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-09-26\",\n",
      "    \"StartDate\": \"2012-09\",\n",
      "    \"CompletionDate\": \"2014-11\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01895920\",\n",
      "    \"BriefTitle\": \"Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread?\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2013-07-11\",\n",
      "    \"StartDate\": \"2013-01\",\n",
      "    \"CompletionDate\": \"2018-02\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01039220\",\n",
      "    \"BriefTitle\": \"Incidence of H1N1v Influenza-like Illness and Risk Factors for Serious Influenza Forms in HIV Infected Patients\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2009-12-24\",\n",
      "    \"StartDate\": \"2009-12\",\n",
      "    \"CompletionDate\": \"2010-11\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00820118\",\n",
      "    \"BriefTitle\": \"Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2009-01-09\",\n",
      "    \"StartDate\": \"2009-05\",\n",
      "    \"CompletionDate\": \"2012-05\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"26568566\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Piroth L, Moinot L, Yeni P, Avettand-Fenoel V, Reynes J, Girard PM, Marchou B, Georget A, Rouzioux C, Autran B, Duvillard L, Chene G, Fagard C; ANRS 141 TIPI Trial Study Group. Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial). J Antimicrob Chemother. 2016 Feb;71(2):490-6. doi: 10.1093/jac/dkv369. Epub 2015 Nov 14.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01801618\",\n",
      "    \"BriefTitle\": \"National Evaluation of PI-based 2nd Line Efficacy in Cambodia\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2013-03-01\",\n",
      "    \"StartDate\": \"2013-02\",\n",
      "    \"CompletionDate\": \"2014-12\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02405013\",\n",
      "    \"BriefTitle\": \"Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2015-04-01\",\n",
      "    \"StartDate\": \"2015-10\",\n",
      "    \"CompletionDate\": \"2017-11\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01779713\",\n",
      "    \"BriefTitle\": \"Transcriptomic Signature of Vasospasm Consecutive to Sub-arachnoid Aneurismal Hemorrhage\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2013-01-30\",\n",
      "    \"StartDate\": \"2013-02-04\",\n",
      "    \"CompletionDate\": \"2016-07-04\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"30354977\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Pulcrano-Nicolas AS, Proust C, Clarencon F, Jacquens A, Perret C, Roux M, Shotar E, Thibord F, Puybasset L, Garnier S, Degos V, Tregouet DA. Whole-Blood miRNA Sequencing Profiling for Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage. Stroke. 2018 Sep;49(9):2220-2223. doi: 10.1161/STROKEAHA.118.021101.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03235258\",\n",
      "    \"BriefTitle\": \"Cohort of HIV-infected Children\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2017-08-01\",\n",
      "    \"StartDate\": \"2004-07\",\n",
      "    \"CompletionDate\": \"2020-06\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"26762993\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Frange P, Faye A, Avettand-Fenoel V, Bellaton E, Descamps D, Angin M, David A, Caillat-Zucman S, Peytavin G, Dollfus C, Le Chenadec J, Warszawski J, Rouzioux C, Saez-Cirion A; ANRS EPF-CO10 Pediatric Cohort and the ANRS EP47 VISCONTI study group. HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report. Lancet HIV. 2016 Jan;3(1):e49-54. doi: 10.1016/S2352-3018(15)00232-5. Epub 2015 Dec 9.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24945880\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Aupiais C, Faye A, Le Chenadec J, Rouzioux C, Bouallag N, Laurent C, Blanche S, Dollfus C, Warszawski J; ANRS EPF-CO10 French Pediatric Cohort. Interruption of cART in clinical practice is associated with an increase in the long-term risk of subsequent immunosuppression in HIV-1-infected children. Pediatr Infect Dis J. 2014 Dec;33(12):1237-45. doi: 10.1097/INF.0000000000000450.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24705410\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Sofeu CL, Warszawski J, Ateba Ndongo F, Penda IC, Tetang Ndiang S, Guemkam G, Makwet N, Owona F, Kfutwah A, Tchendjou P, Texier G, Tchuente M, Faye A, Tejiokem MC; ANRS-PEDIACAM Study Group. Low birth weight in perinatally HIV-exposed uninfected infants: observations in urban settings in Cameroon. PLoS One. 2014 Apr 3;9(4):e93554. doi: 10.1371/journal.pone.0093554. eCollection 2014.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24253249\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Blanche S, Scott-Algara D, Le Chenadec J, Didier C, Montange T, Avettand-Fenoel V, Rouzioux C, Melard A, Viard JP, Dollfus C, Bouallag N, Warszawski J, Buseyne F. Naive T lymphocytes and recent thymic emigrants are associated with HIV-1 disease history in french adolescents and young adults infected in the perinatal period: the ANRS-EP38-IMMIP study. Clin Infect Dis. 2014 Feb;58(4):573-87. doi: 10.1093/cid/cit729. Epub 2013 Nov 18.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22427678\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Avettand-Fenoel V, Blanche S, Le Chenadec J, Scott-Algara D, Dollfus C, Viard JP, Bouallag N, Benmebarek Y, Riviere Y, Warszawski J, Rouzioux C, Buseyne F. Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study. J Infect Dis. 2012 May 15;205(10):1520-8. doi: 10.1093/infdis/jis233. Epub 2012 Mar 15.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22198788\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Goetghebuer T, Le Chenadec J, Haelterman E, Galli L, Dollfus C, Thorne C, Judd A, Keiser O, Ramos JT, Levy J, Warszawski J; European Infant Collaboration Group. Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation. Clin Infect Dis. 2012 Mar;54(6):878-81. doi: 10.1093/cid/cir950. Epub 2011 Dec 23.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21971357\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Judd A; European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord. Early antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens. AIDS. 2011 Nov 28;25(18):2279-87. doi: 10.1097/QAD.0b013e32834d614c.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21511330\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Pursuing Later Treatment Options II (PLATO II) project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE); Castro H, Judd A, Gibb DM, Butler K, Lodwick RK, van Sighem A, Ramos JT, Warsawski J, Thorne C, Noguera-Julian A, Obel N, Costagliola D, Tookey PA, Colin C, Kjaer J, Grarup J, Chene G, Phillips A. Risk of triple-class virological failure in children with HIV: a retrospective cohort study. Lancet. 2011 May 7;377(9777):1580-7. doi: 10.1016/S0140-6736(11)60208-0. Epub 2011 Apr 20.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20536367\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Dollfus C, Le Chenadec J, Faye A, Blanche S, Briand N, Rouzioux C, Warszawski J. Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10). Clin Infect Dis. 2010 Jul 15;51(2):214-24. doi: 10.1086/653674.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19194272\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Goetghebuer T, Haelterman E, Le Chenadec J, Dollfus C, Gibb D, Judd A, Green H, Galli L, Ramos JT, Giaquinto C, Warszawski J, Levy J; European Infant Collaboration group. Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. AIDS. 2009 Mar 13;23(5):597-604. doi: 10.1097/QAD.0b013e328326ca37.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18614870\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group; Sabin CA, Smith CJ, d'Arminio Monforte A, Battegay M, Gabiano C, Galli L, Geelen S, Gibb D, Guiguet M, Judd A, Leport C, Dabis F, Pantazis N, Porter K, Raffi F, Thorne C, Torti C, Walker S, Warszawski J, Wintergerst U, Chene G, Lundgren J. Response to combination antiretroviral therapy: variation by age. AIDS. 2008 Jul 31;22(12):1463-73. doi: 10.1097/QAD.0b013e3282f88d02.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17712765\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Warszawski J, Lechenadec J, Faye A, Dollfus C, Firtion G, Meyer L, Douard D, Monpoux F, Tricoire J, Benmebarek Y, Rouzioux C, Blanche S. Long-term nonprogression of HIV infection in children: evaluation of the ANRS prospective French Pediatric Cohort. Clin Infect Dis. 2007 Sep 15;45(6):785-94. doi: 10.1086/521165. Epub 2007 Aug 14.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03071458\",\n",
      "    \"BriefTitle\": \"Mutational Landscape in Hepatocellular Carcinoma\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2017-03-07\",\n",
      "    \"StartDate\": \"2008-01\",\n",
      "    \"CompletionDate\": \"2015-05\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02886416\",\n",
      "    \"BriefTitle\": \"Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immunity\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2016-09-01\",\n",
      "    \"StartDate\": \"2016-08\",\n",
      "    \"CompletionDate\": \"2017-04\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01899196\",\n",
      "    \"BriefTitle\": \"Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2013-07-15\",\n",
      "    \"StartDate\": \"2013-07\",\n",
      "    \"CompletionDate\": \"2016-03\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00944541\",\n",
      "    \"BriefTitle\": \"Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Pfizer\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2009-07-23\",\n",
      "    \"StartDate\": \"2009-09\",\n",
      "    \"CompletionDate\": \"2011-01\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02160119\",\n",
      "    \"BriefTitle\": \"Emotional and Change-related Attention in Autism\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-06-10\",\n",
      "    \"StartDate\": \"2014-05-27\",\n",
      "    \"CompletionDate\": \"2018-05-27\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00158496\",\n",
      "    \"BriefTitle\": \"Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Hoffmann-La Roche\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-09-12\",\n",
      "    \"StartDate\": \"2002-08\",\n",
      "    \"CompletionDate\": \"2005-01\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"16956918\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Marzouk D, Sass J, Bakr I, El Hosseiny M, Abdel-Hamid M, Rekacewicz C, Chaturvedi N, Mohamed MK, Fontanet A. Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Gut. 2007 Aug;56(8):1105-10. doi: 10.1136/gut.2006.091983. Epub 2006 Sep 6.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16847958\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Mohamed MK, Bakr I, El-Hoseiny M, Arafa N, Hassan A, Ismail S, Anwar M, Attala M, Rekacewicz C, Zalata K, Abdel-Hamid M, Esmat G, Fontanet A. HCV-related morbidity in a rural community of Egypt. J Med Virol. 2006 Sep;78(9):1185-9. doi: 10.1002/jmv.20679.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16434426\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Bakr I, Rekacewicz C, El Hosseiny M, Ismail S, El Daly M, El-Kafrawy S, Esmat G, Hamid MA, Mohamed MK, Fontanet A. Higher clearance of hepatitis C virus infection in females compared with males. Gut. 2006 Aug;55(8):1183-7. doi: 10.1136/gut.2005.078147. Epub 2006 Jan 24.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16019104\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Arafa N, El Hoseiny M, Rekacewicz C, Bakr I, El-Kafrawy S, El Daly M, Aoun S, Marzouk D, Mohamed MK, Fontanet A. Changing pattern of hepatitis C virus spread in rural areas of Egypt. J Hepatol. 2005 Sep;43(3):418-24. doi: 10.1016/j.jhep.2005.03.021.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02192658\",\n",
      "    \"BriefTitle\": \"Disability and HIV: Vulnerability of People With Disabilities to HIV Infection in Sub-Saharan Africa\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Handicap International | Institut de Recherche pour le Developpement | Institut de Formation et de Recherche D\\u00e9mographique | Forum Camerounais de Psychologie | Centre de Recherche Internationale pour la Sant\\u00e9 de l'Universit\\u00e9 de Ouagadougou\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-07-17\",\n",
      "    \"StartDate\": \"2014-11\",\n",
      "    \"CompletionDate\": \"2016-07\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"26846895\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"De Beaudrap P, Pasquier E, Tchoumkeu A, Touko A, Essomba F, Brus A, Desgrees du Lou A, Aderemi TJ, Hanass-Hancock J, Eide AH, Mont D, Mac-Seing M, Beninguisse G. HandiVIH--A population-based survey to understand the vulnerability of people with disabilities to HIV and other sexual and reproductive health problems in Cameroon: protocol and methodological considerations. BMJ Open. 2016 Feb 4;6(2):e008934. doi: 10.1136/bmjopen-2015-008934.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00383734\",\n",
      "    \"BriefTitle\": \"Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Procitech | Sanofi\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2006-10-03\",\n",
      "    \"StartDate\": \"2006-12\",\n",
      "    \"CompletionDate\": \"2010-09\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"23432777\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Lafaurie M, Dolivo M, Girard PM, May T, Bouchaud O, Carbonnel E, Madelaine I, Loze B, Porcher R, Molina JM; ANRS 132 SMILE study group. Polylactic acid vs. polyacrylamide hydrogel for treatment of facial lipoatrophy: a randomized controlled trial [Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS) 132 SMILE]. HIV Med. 2013 Aug;14(7):410-20. doi: 10.1111/hiv.12021. Epub 2013 Feb 24.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02051413\",\n",
      "    \"BriefTitle\": \"Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN)\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-01-31\",\n",
      "    \"StartDate\": \"2014-02-18\",\n",
      "    \"CompletionDate\": \"2018-05\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03109067\",\n",
      "    \"BriefTitle\": \"Genetic and Metabolism of Post-prandial HDL Particles\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2017-04-12\",\n",
      "    \"StartDate\": \"2011-09-21\",\n",
      "    \"CompletionDate\": \"2015-11-21\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02073604\",\n",
      "    \"BriefTitle\": \"Role of the SMA During Unimanual and Bimanual Movements Preparation: the Mirror Movements Paradigm\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-02-27\",\n",
      "    \"StartDate\": \"2014-03\",\n",
      "    \"CompletionDate\": \"2016-02\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01490489\",\n",
      "    \"BriefTitle\": \"EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2011-12-13\",\n",
      "    \"StartDate\": \"2011-07-11\",\n",
      "    \"CompletionDate\": \"2015-03-13\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"17531315\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Hoffmann P, Feige JJ, Alfaidy N. Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation. Placenta. 2007 Oct;28(10):1049-58. doi: 10.1016/j.placenta.2007.03.008. Epub 2007 May 25.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16384869\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Hoffmann P, Feige JJ, Alfaidy N. Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy. Endocrinology. 2006 Apr;147(4):1675-84. doi: 10.1210/en.2005-0912. Epub 2005 Dec 29.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19602057\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Hoffmann P, Saoudi Y, Benharouga M, Graham CH, Schaal JP, Mazouni C, Feige JJ, Alfaidy N. Role of EG-VEGF in human placentation: Physiological and pathological implications. J Cell Mol Med. 2009 Aug;13(8B):2224-2235. doi: 10.1111/j.1582-4934.2008.00554.x.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01335529\",\n",
      "    \"BriefTitle\": \"Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Rennes University Hospital | Merck Sharp & Dohme LLC\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2011-04-14\",\n",
      "    \"StartDate\": \"2011-05\",\n",
      "    \"CompletionDate\": \"2014-05\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"27077673\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Poizot-Martin I, Bellissant E, Garraffo R, Colson P, Piroth L, Solas C, Renault A, Bourliere M, Halfon P, Ghosn J, Alric L, Naqvi A, Carrieri P, Molina JM; ANRS HC27 BOCEPREVIH Study Group. Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study. HIV Clin Trials. 2016 Mar;17(2):63-71. doi: 10.1080/15284336.2015.1135553. Epub 2016 Feb 11.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00545194\",\n",
      "    \"BriefTitle\": \"Cervical Ripening Before Induction of Labour at Term: a Randomised Comparison of Prostin vs Propess\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2007-10-17\",\n",
      "    \"StartDate\": \"2002-01\",\n",
      "    \"CompletionDate\": \"2004-10\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"11236117\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Lyrenas S, Clason I, Ulmsten U. In vivo controlled release of PGE2 from a vaginal insert (0.8 mm, 10 mg) during induction of labour. BJOG. 2001 Feb;108(2):169-78. doi: 10.1111/j.1471-0528.2001.00039.x.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16553177\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Strobelt N, Meregalli V, Ratti M, Mariani S, Zani G, Morana S. Randomized study on removable PGE2 vaginal insert versus PGE2 cervical gel for cervical priming and labor induction in low-Bishop-score pregnancy. Acta Obstet Gynecol Scand. 2006;85(3):302-5. doi: 10.1080/00016340500523685.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17071427\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"El-Shawarby SA, Connell RJ. Induction of labour at term with vaginal prostaglandins preparations: a randomised controlled trial of Prostin vs Propess. J Obstet Gynaecol. 2006 Oct;26(7):627-30. doi: 10.1080/01443610600903362.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03298360\",\n",
      "    \"BriefTitle\": \"A Chronological Study of the Formation of HIV Cellular Reservoirs Through the Expression of Surface Markers on CD4 + T Lymphocytes, Including CD32a\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2017-10-02\",\n",
      "    \"StartDate\": \"2018-06-28\",\n",
      "    \"CompletionDate\": \"2020-06-25\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01508494\",\n",
      "    \"BriefTitle\": \"Cognitive Rehabilitation and Galantamine for Post Stroke Cognitive Impairment\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-01-12\",\n",
      "    \"StartDate\": \"2011-06-29\",\n",
      "    \"CompletionDate\": \"2016-06-22\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00573001\",\n",
      "    \"BriefTitle\": \"Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Institut de M\\u00e9decine et d'Epid\\u00e9miologie Appliqu\\u00e9e - Fondation Internationale L\\u00e9on M'Ba | Gilead Sciences | Merck Sharp & Dohme LLC\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2007-12-13\",\n",
      "    \"StartDate\": \"2008-07\",\n",
      "    \"CompletionDate\": \"2011-12\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00236340\",\n",
      "    \"BriefTitle\": \"Syringe or Continuous Amnioreduction for Symptomatic Polyhydramnios. A Prospective Randomized Study.\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-10-12\",\n",
      "    \"StartDate\": \"2002-01\",\n",
      "    \"CompletionDate\": \"2005-02\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"14770396\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Leung WC, Jouannic JM, Hyett J, Rodeck C, Jauniaux E. Procedure-related complications of rapid amniodrainage in the treatment of polyhydramnios. Ultrasound Obstet Gynecol. 2004 Feb;23(2):154-8. doi: 10.1002/uog.972.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"11438952\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Jauniaux E, Holmes A, Hyett J, Yates R, Rodeck C. Rapid and radical amniodrainage in the treatment of severe twin-twin transfusion syndrome. Prenat Diagn. 2001 Jun;21(6):471-6. doi: 10.1002/pd.96.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"7970458\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Elliott JP, Sawyer AT, Radin TG, Strong RE. Large-volume therapeutic amniocentesis in the treatment of hydramnios. Obstet Gynecol. 1994 Dec;84(6):1025-7.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"9464739\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Dolinger MB, Donnenfeld AE. Therapeutic amniocentesis using a vacuum bottle aspiration system. Obstet Gynecol. 1998 Jan;91(1):143-4. doi: 10.1016/s0029-7844(97)00584-x.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02542891\",\n",
      "    \"BriefTitle\": \"European Comparative Effectiveness Research on Internet-based Depression Treatment\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"European Commission | Fondation FondaMental | Assistance Publique - H\\u00f4pitaux de Paris\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2015-09-07\",\n",
      "    \"StartDate\": \"2015-09\",\n",
      "    \"CompletionDate\": \"2018-09-15\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"34874888\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"van Genugten CR, Schuurmans J, Hoogendoorn AW, Araya R, Andersson G, Banos R, Botella C, Cerga Pashoja A, Cieslak R, Ebert DD, Garcia-Palacios A, Hazo JB, Herrero R, Holtzmann J, Kemmeren L, Kleiboer A, Krieger T, Smoktunowicz E, Titzler I, Topooco N, Urech A, Smit JH, Riper H. Examining the Theoretical Framework of Behavioral Activation for Major Depressive Disorder: Smartphone-Based Ecological Momentary Assessment Study. JMIR Ment Health. 2021 Dec 6;8(12):e32007. doi: 10.2196/32007.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27488181\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Kleiboer A, Smit J, Bosmans J, Ruwaard J, Andersson G, Topooco N, Berger T, Krieger T, Botella C, Banos R, Chevreul K, Araya R, Cerga-Pashoja A, Cieslak R, Rogala A, Vis C, Draisma S, van Schaik A, Kemmeren L, Ebert D, Berking M, Funk B, Cuijpers P, Riper H. European COMPARative Effectiveness research on blended Depression treatment versus treatment-as-usual (E-COMPARED): study protocol for a randomized controlled, non-inferiority trial in eight European countries. Trials. 2016 Aug 3;17(1):387. doi: 10.1186/s13063-016-1511-1.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03671291\",\n",
      "    \"BriefTitle\": \"Missed Opportunities to Pre-exposure Prophylaxis for HIV Infection on Person Newly Diagnosed With HIV\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"University Hospital, Marseille | University Hospital, Grenoble | Centre Hospitalier Universitaire de Nice | University Hospital, Montpellier | Hospital Purpan | University Hospital, Bordeaux | H\\u00f4pital de la Croix-Rousse | Centre Hospitalier Universitaire Dijon | University Hospital of Saint-Etienne | University Hospital, Clermont-Ferrand | Centre Hospitalier Universitaire de Besancon | Tourcoing Hospital | University Hospital, Strasbourg | Nantes University Hospital | Centre Hospitalier R\\u00e9gional d'Orl\\u00e9ans | Rennes University Hospital | Saint Antoine University Hospital | Tenon Hospital, Paris | Saint-Louis Hospital, Paris, France | H\\u00f4pital Necker-Enfants Malades | Bicetre Hospital | Piti\\u00e9-Salp\\u00eatri\\u00e8re Hospital | Bichat Hospital | University Hospital Center of Martinique\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2018-09-14\",\n",
      "    \"StartDate\": \"2019-04-03\",\n",
      "    \"CompletionDate\": \"2021-10-03\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01066962\",\n",
      "    \"BriefTitle\": \"Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral na\\u00efve Subjects\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"NEAT - European AIDS Treatment Network\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2010-02-10\",\n",
      "    \"StartDate\": \"2010-08\",\n",
      "    \"CompletionDate\": \"2013-10\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"33794182\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Esteban-Cantos A, Rodriguez-Centeno J, Barruz P, Alejos B, Saiz-Medrano G, Nevado J, Martin A, Gaya F, De Miguel R, Bernardino JI, Montejano R, Mena-Garay B, Cadinanos J, Florence E, Mulcahy F, Banhegyi D, Antinori A, Pozniak A, Wallet C, Raffi F, Rodes B, Arribas JR; NEAT001/ANRS143 Study Group. Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial. Lancet HIV. 2021 Apr;8(4):e197-e205. doi: 10.1016/S2352-3018(21)00006-0. Erratum In: Lancet HIV. 2021 Dec;8(12):e734.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30365452\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Ammassari A, Stohr W, Antinori A, Molina JM, Schwimmer C, Domingo P, Thalme A, Di Pietro M, Wallet C, Pozniak A, Richert L, Raffi F; NEAT001/ANRS143 Trial Study Group. Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial. J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):481-490. doi: 10.1097/QAI.0000000000001834.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26520926\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Bernardino JI, Mocroft A, Mallon PW, Wallet C, Gerstoft J, Russell C, Reiss P, Katlama C, De Wit S, Richert L, Babiker A, Buno A, Castagna A, Girard PM, Chene G, Raffi F, Arribas JR; NEAT001/ANRS143 Study Group. Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial. Lancet HIV. 2015 Nov;2(11):e464-73. doi: 10.1016/S2352-3018(15)00181-2. Epub 2015 Sep 30.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25103176\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Raffi F, Babiker AG, Richert L, Molina JM, George EC, Antinori A, Arribas JR, Grarup J, Hudson F, Schwimmer C, Saillard J, Wallet C, Jansson PO, Allavena C, Van Leeuwen R, Delfraissy JF, Vella S, Chene G, Pozniak A; NEAT001/ANRS143 Study Group. Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial. Lancet. 2014 Nov 29;384(9958):1942-51. doi: 10.1016/S0140-6736(14)61170-3. Epub 2014 Aug 4.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01703962\",\n",
      "    \"BriefTitle\": \"Non Invasive IDentification of Gliomas With IDH1 Mutation\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-10-11\",\n",
      "    \"StartDate\": \"2012-03-14\",\n",
      "    \"CompletionDate\": \"2014-03-20\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03642704\",\n",
      "    \"BriefTitle\": \"HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2018-08-22\",\n",
      "    \"StartDate\": \"2017-02-22\",\n",
      "    \"CompletionDate\": \"2019-09-17\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01086904\",\n",
      "    \"BriefTitle\": \"Safety and Efficacy of an Inactivated and Non Adjuvanted Vaccine Against Influenza A in Renal Transplant Recipients\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"MCM Vaccines B.V.\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2010-03-15\",\n",
      "    \"StartDate\": \"2009-11\",\n",
      "    \"CompletionDate\": \"2010-05\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01127204\",\n",
      "    \"BriefTitle\": \"Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"European and Developing Countries Clinical Trials Partnership (EDCTP) | Public Research Centre Health, Luxembourg | Ministry of Foreign Affairs, Luxembourg | University of Ouagadougou, Burkina Faso | Programme PAC-CI, Site ANRS-MIE de C\\u00f4te d'Ivoire | Ministry of Health, Rwanda | Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France | University of Bordeaux | Institut de Sante Publique, d'Epid\\u00e9miologie et de D\\u00e9veloppement | Universit\\u00e9 Montpellier | University of Paris 5 - Rene Descartes | Queen Fabiola Children's University Hospital\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2010-05-20\",\n",
      "    \"StartDate\": \"2011-06\",\n",
      "    \"CompletionDate\": \"2015-04\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"34723858\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Pressiat C, Toni TD, Treluyer JM, Yonaba C, Dahourou DL, Malateste K, Seguin-Devaux C, Leroy V, Hirt D; MONOD ANRS Study Group. High nevirapine levels in breast milk and consequences in HIV-infected child when initiated on antiretroviral therapy. AIDS. 2021 Nov 15;35(14):2409-2410. doi: 10.1097/QAD.0000000000003043. No abstract available.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31334298\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Desmonde S, Frank SC, Coovadia A, Dahourou DL, Hou T, Abrams EJ, Amorissani-Folquet M, Walensky RP, Strehlau R, Penazzato M, Freedberg KA, Kuhn L, Leroy V, Ciaranello AL. Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus. Open Forum Infect Dis. 2019 Jun 11;6(7):ofz276. doi: 10.1093/ofid/ofz276. eCollection 2019 Jul.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28800382\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Pressiat C, Mea-Assande V, Yonaba C, Treluyer JM, Dahourou DL, Amorissani-Folquet M, Blanche S, Eboua F, Ye D, Lui G, Malateste K, Zheng Y, Leroy V, Hirt D; MONOD Study Group. Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines. Br J Clin Pharmacol. 2017 Dec;83(12):2729-2740. doi: 10.1111/bcp.13397. Epub 2017 Sep 20.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28483965\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Pressiat C, Amorissani-Folquet M, Yonaba C, Treluyer JM, Dahourou DL, Eboua F, Blanche S, Mea-Assande V, Bouazza N, Foissac F, Malateste K, Ouedraogo S, Lui G, Leroy V, Hirt D. Pharmacokinetics of Efavirenz at a High Dose of 25 Milligrams per Kilogram per Day in Children 2 to 3 Years Old. Antimicrob Agents Chemother. 2017 Jun 27;61(7):e00297-17. doi: 10.1128/AAC.00297-17. Print 2017 Jul.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28453240\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Amani-Bosse C, Dahourou DL, Malateste K, Amorissani-Folquet M, Coulibaly M, Dattez S, Emieme A, Barry M, Rouzioux C, N'gbeche S, Yonaba C, Timite-Konan M, Mea V, Ouedraogo S, Blanche S, Meda N, Seguin-Devaux C, Leroy V. Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort. J Int AIDS Soc. 2017 Apr 25;20(1):21362. doi: 10.7448/IAS.20.01.21362.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28434406\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Dahourou DL, Amorissani-Folquet M, Malateste K, Amani-Bosse C, Coulibaly M, Seguin-Devaux C, Toni T, Ouedraogo R, Blanche S, Yonaba C, Eboua F, Lepage P, Avit D, Ouedraogo S, Van de Perre P, N'Gbeche S, Kalmogho A, Salamon R, Meda N, Timite-Konan M, Leroy V; MONOD Study Group. Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Cote d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial. BMC Med. 2017 Apr 24;15(1):85. doi: 10.1186/s12916-017-0842-4.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27015798\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Dahourou DL, Amorissani-Folquet M, Coulibaly M, Avit-Edi D, Meda N, Timite-Konan M, Arendt V, Ye D, Amani-Bosse C, Salamon R, Lepage P, Leroy V; Monod Anrs 12206 Study Group. Missed opportunities of inclusion in a cohort of HIV-infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013. J Int AIDS Soc. 2016 Mar 23;19(1):20601. doi: 10.7448/IAS.19.1.20601. eCollection 2016.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01771562\",\n",
      "    \"BriefTitle\": \"Nutritional and Metabolic Disorders in HIV Infected Children and Adolescent\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2013-01-18\",\n",
      "    \"StartDate\": \"2013-04\",\n",
      "    \"CompletionDate\": \"2016-04\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"30081838\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Cames C, Pascal L, Ba A, Mbodj H, Ouattara B, Diallo NF, Msellati P, Mbaye N, Sy Signate H, Blanche S, Diack A; MAGGSEN Cohort Study Group. Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort Study. BMC Infect Dis. 2018 Aug 6;18(1):374. doi: 10.1186/s12879-018-3282-7.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27881690\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Cames C, Varloteaux M, Have NN, Diom AB, Msellati P, Mbaye N, Mbodj H, Sy Signate H, Diack A; ANRS 12279 MAGGSEN Cohort Study Group. Acceptability of Outpatient Ready-To-Use Food-Based Protocols in HIV-Infected Senegalese Children and Adolescents Within the MAGGSEN Cohort Study. Food Nutr Bull. 2017 Mar;38(1):27-36. doi: 10.1177/0379572116679053. Epub 2016 Nov 23.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00196612\",\n",
      "    \"BriefTitle\": \"Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Triangle Pharmaceuticals | Gilead Sciences | Bristol-Myers Squibb | Dupont Applied Biosciences\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-09-20\",\n",
      "    \"StartDate\": \"2001-04\",\n",
      "    \"CompletionDate\": \"2004-09\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"15717256\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Molina JM, Journot V, Morand-Joubert L, Yeni P, Rozenbaum W, Rancinan C, Fournier S, Morlat P, Palmer P, Dupont B, Goujard C, Dellamonica P, Collin F, Poizot-Martin I, Chene G; ALIZE (Agence Nationale de Recherches sur le SIDA 099) Study Team. Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HIV-1-infected adults with viral suppression receiving a protease inhibitor-based regimen: a randomized trial. J Infect Dis. 2005 Mar 15;191(6):830-9. doi: 10.1086/428091. Epub 2005 Feb 10.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01226446\",\n",
      "    \"BriefTitle\": \"Efficacy of Vitamin D on Top of Pegylated Interferon and Ribavirin in Patients With Chronic Viral Hepatitis C Null-Responders\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2010-10-22\",\n",
      "    \"StartDate\": \"2010-11\",\n",
      "    \"CompletionDate\": \"2013-01\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"25987791\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Terrier B, Lapidus N, Pol S, Serfaty L, Ratziu V, Asselah T, Thibault V, Souberbielle JC, Carrat F, Cacoub P. Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study. World J Gastroenterol. 2015 May 14;21(18):5647-53. doi: 10.3748/wjg.v21.i18.5647.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02496312\",\n",
      "    \"BriefTitle\": \"Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2015-07-14\",\n",
      "    \"StartDate\": \"2015-07-10\",\n",
      "    \"CompletionDate\": \"2015-10-02\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"12461757\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Robert PH, Clairet S, Benoit M, Koutaich J, Bertogliati C, Tible O, Caci H, Borg M, Brocker P, Bedoucha P. The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. Int J Geriatr Psychiatry. 2002 Dec;17(12):1099-105. doi: 10.1002/gps.755.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"10436334\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Pasquier F, Lebert F, Lavenu I, Guillaume B. The clinical picture of frontotemporal dementia: diagnosis and follow-up. Dement Geriatr Cogn Disord. 1999;10 Suppl 1:10-4. doi: 10.1159/000051206.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19713543\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Mayo NE, Fellows LK, Scott SC, Cameron J, Wood-Dauphinee S. A longitudinal view of apathy and its impact after stroke. Stroke. 2009 Oct;40(10):3299-307. doi: 10.1161/STROKEAHA.109.554410. Epub 2009 Aug 27.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17027767\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Winograd-Gurvich C, Fitzgerald PB, Georgiou-Karistianis N, Bradshaw JL, White OB. Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's disease. Brain Res Bull. 2006 Oct 16;70(4-6):312-21. doi: 10.1016/j.brainresbull.2006.06.007. Epub 2006 Jul 5.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"10678322\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Marin RS, Firinciogullari S, Biedrzycki RC. Group differences in the relationship between apathy and depression. J Nerv Ment Dis. 1994 Apr;182(4):235-9. doi: 10.1097/00005053-199404000-00008.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18307266\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Dujardin K, Sockeel P, Delliaux M, Destee A, Defebvre L. The Lille Apathy Rating Scale: validation of a caregiver-based version. Mov Disord. 2008 Apr 30;23(6):845-9. doi: 10.1002/mds.21968.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19533496\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Lane-Brown AT, Tate RL. Apathy after acquired brain impairment: a systematic review of non-pharmacological interventions. Neuropsychol Rehabil. 2009 Aug;19(4):481-516. doi: 10.1080/09602010902949207.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15897497\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Czernecki V, Pillon B, Houeto JL, Welter ML, Mesnage V, Agid Y, Dubois B. Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease? J Neurol Neurosurg Psychiatry. 2005 Jun;76(6):775-9. doi: 10.1136/jnnp.2003.033258.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19933975\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Le Jeune F, Drapier D, Bourguignon A, Peron J, Mesbah H, Drapier S, Sauleau P, Haegelen C, Travers D, Garin E, Malbert CH, Millet B, Verin M. Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Neurology. 2009 Nov 24;73(21):1746-51. doi: 10.1212/WNL.0b013e3181c34b34.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"1821241\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Marin RS. Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci. 1991 Summer;3(3):243-54. doi: 10.1176/jnp.3.3.243.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16207933\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex. 2006 Jul;16(7):916-28. doi: 10.1093/cercor/bhj043. Epub 2005 Oct 5.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17131230\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Levy R, Czernecki V. Apathy and the basal ganglia. J Neurol. 2006 Dec;253 Suppl 7:VII54-61. doi: 10.1007/s00415-006-7012-5.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"10941190\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Brown RG, Pluck G. Negative symptoms: the 'pathology' of motivation and goal-directed behaviour. Trends Neurosci. 2000 Sep;23(9):412-7. doi: 10.1016/s0166-2236(00)01626-x.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16421064\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Muller U, Czymmek J, Thone-Otto A, Von Cramon DY. Reduced daytime activity in patients with acquired brain damage and apathy: a study with ambulatory actigraphy. Brain Inj. 2006 Feb;20(2):157-60. doi: 10.1080/02699050500443467.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21895376\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Funkiewiez A, Bertoux M, de Souza LC, Levy R, Dubois B. The SEA (Social cognition and Emotional Assessment): a clinical neuropsychological tool for early diagnosis of frontal variant of frontotemporal lobar degeneration. Neuropsychology. 2012 Jan;26(1):81-90. doi: 10.1037/a0025318. Epub 2011 Sep 5.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04133012\",\n",
      "    \"BriefTitle\": \"Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"ViiV Healthcare\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2019-10-21\",\n",
      "    \"StartDate\": \"2020-02-10\",\n",
      "    \"CompletionDate\": \"2023-06-09\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01100281\",\n",
      "    \"BriefTitle\": \"Prefrontal Cortex and Abstract Thinking\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2010-04-08\",\n",
      "    \"StartDate\": \"2010-04\",\n",
      "    \"CompletionDate\": \"2011-04\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01647295\",\n",
      "    \"BriefTitle\": \"Social Interactions: Ocular Explorations and Pupillometry in Autism\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-07-23\",\n",
      "    \"StartDate\": \"2013-02-25\",\n",
      "    \"CompletionDate\": \"2019-06-18\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00424814\",\n",
      "    \"BriefTitle\": \"Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Abbott\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2007-01-22\",\n",
      "    \"StartDate\": \"2007-03\",\n",
      "    \"CompletionDate\": \"2012-11\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"25838291\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Sibiude J, Le Chenadec J, Bonnet D, Tubiana R, Faye A, Dollfus C, Mandelbrot L, Delmas S, Lelong N, Khoshnood B, Warszawski J, Blanche S; French National Agency for Research on AIDS and Viral Hepatitis French Perinatal Cohort/Protease Inhibitor Monotherapy Evaluation Trial. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial. Clin Infect Dis. 2015 Jul 15;61(2):270-80. doi: 10.1093/cid/civ260. Epub 2015 Apr 1.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23766338\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Tubiana R, Mandelbrot L, Le Chenadec J, Delmas S, Rouzioux C, Hirt D, Treluyer JM, Ekoukou D, Bui E, Chaix ML, Blanche S, Warszawski J; ANRS 135 PRIMEVA (Protease Inhibitor Monotherapy Evaluation) Study Group. Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial. Clin Infect Dis. 2013 Sep;57(6):891-902. doi: 10.1093/cid/cit390. Epub 2013 Jun 12.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02488395\",\n",
      "    \"BriefTitle\": \"Superior Colliculus Activity in Parkinson Disease: a Potential Marker?\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2015-07-02\",\n",
      "    \"StartDate\": \"2015-10-07\",\n",
      "    \"CompletionDate\": \"2018-01-19\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"22639796\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Marino RA, Levy R, Boehnke S, White BJ, Itti L, Munoz DP. Linking visual response properties in the superior colliculus to saccade behavior. Eur J Neurosci. 2012 Jun;35(11):1738-52. doi: 10.1111/j.1460-9568.2012.08079.x. Epub 2012 May 28.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"6774653\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Wurtz RH, Albano JE. Visual-motor function of the primate superior colliculus. Annu Rev Neurosci. 1980;3:189-226. doi: 10.1146/annurev.ne.03.030180.001201. No abstract available.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23916713\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Rolland M, Carcenac C, Overton PG, Savasta M, Coizet V. Enhanced visual responses in the superior colliculus and subthalamic nucleus in an animal model of Parkinson's disease. Neuroscience. 2013 Nov 12;252:277-88. doi: 10.1016/j.neuroscience.2013.07.047. Epub 2013 Jul 31.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00658346\",\n",
      "    \"BriefTitle\": \"Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2008-04-15\",\n",
      "    \"StartDate\": \"2010-06\",\n",
      "    \"CompletionDate\": \"2016-09\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"31063537\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Kouanfack C, Unal G, Schaeffer L, Kfutwah A, Aghokeng A, Mougnutou R, Tchemgui-Noumsi N, Alessandri-Gradt E, Delaporte E, Simon F, Vray M, Plantier JC; ANRS 12168 DynaMO Study. Comparative Immunovirological and Clinical Responses to Antiretroviral Therapy Between HIV-1 Group O and HIV-1 Group M Infected Patients. Clin Infect Dis. 2020 Mar 17;70(7):1471-1477. doi: 10.1093/cid/ciz371.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01188512\",\n",
      "    \"BriefTitle\": \"First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"European Union | Swedish Institute for Infectious Disease Control | Innogenetics\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2010-08-25\",\n",
      "    \"StartDate\": \"2010-08\",\n",
      "    \"CompletionDate\": \"2012-01\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"16839199\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Mielcarek N, Debrie AS, Raze D, Bertout J, Rouanet C, Younes AB, Creusy C, Engle J, Goldman WE, Locht C. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog. 2006 Jul;2(7):e65. doi: 10.1371/journal.ppat.0020065.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18762220\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Feunou PF, Ismaili J, Debrie AS, Huot L, Hot D, Raze D, Lemoine Y, Locht C. Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1. Vaccine. 2008 Oct 23;26(45):5722-7. doi: 10.1016/j.vaccine.2008.08.018. Epub 2008 Aug 30.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20107007\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Mielcarek N, Debrie AS, Mahieux S, Locht C. Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice. Clin Vaccine Immunol. 2010 Mar;17(3):317-24. doi: 10.1128/CVI.00322-09. Epub 2010 Jan 27.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20184606\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Kavanagh H, Noone C, Cahill E, English K, Locht C, Mahon BP. Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model. Clin Exp Allergy. 2010 Jun;40(6):933-41. doi: 10.1111/j.1365-2222.2010.03459.x. Epub 2010 Feb 22.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19625486\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Skerry CM, Cassidy JP, English K, Feunou-Feunou P, Locht C, Mahon BP. A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice. Clin Vaccine Immunol. 2009 Sep;16(9):1344-51. doi: 10.1128/CVI.00082-09. Epub 2009 Jul 22.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24793938\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Jahnmatz M, Amu S, Ljungman M, Wehlin L, Chiodi F, Mielcarek N, Locht C, Thorstensson R. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial. Vaccine. 2014 Jun 5;32(27):3350-6. doi: 10.1016/j.vaccine.2014.04.048. Epub 2014 Apr 29.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24421886\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Thorstensson R, Trollfors B, Al-Tawil N, Jahnmatz M, Bergstrom J, Ljungman M, Torner A, Wehlin L, Van Broekhoven A, Bosman F, Debrie AS, Mielcarek N, Locht C. A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. PLoS One. 2014 Jan 8;9(1):e83449. doi: 10.1371/journal.pone.0083449. eCollection 2014.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24261996\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Schnoeller C, Roux X, Sawant D, Raze D, Olszewska W, Locht C, Openshaw PJ. Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism. Am J Respir Crit Care Med. 2014 Jan 15;189(2):194-202. doi: 10.1164/rccm.201307-1227OC.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04945655\",\n",
      "    \"BriefTitle\": \"Impact of a School- and Primary Care-based Multicomponent Intervention on HPV Vaccination Acceptability\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2021-06-30\",\n",
      "    \"StartDate\": \"2021-11-15\",\n",
      "    \"CompletionDate\": \"2023-04-30\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"35332045\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Bocquier A, Michel M, Giraudeau B, Bonnay S, Gagneux-Brunon A, Gauchet A, Gilberg S, Le Duc-Banaszuk AS, Mueller JE, Chevreul K, Thilly N; PrevHPV Study group. Impact of a school-based and primary care-based multicomponent intervention on HPV vaccination coverage among French adolescents: a cluster randomised controlled trial protocol (the PrevHPV study). BMJ Open. 2022 Mar 24;12(3):e057943. doi: 10.1136/bmjopen-2021-057943.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01942655\",\n",
      "    \"BriefTitle\": \"IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2013-09-16\",\n",
      "    \"StartDate\": \"2014-06-01\",\n",
      "    \"CompletionDate\": \"2018-03-01\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01332955\",\n",
      "    \"BriefTitle\": \"Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Janssen-Cilag Ltd.\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2011-04-11\",\n",
      "    \"StartDate\": \"2011-04\",\n",
      "    \"CompletionDate\": \"2013-09\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"25139963\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Cotte L, Braun J, Lascoux-Combe C, Vincent C, Valantin MA, Sogni P, Lacombe K, Neau D, Aumaitre H, Batisse D, de Truchis P, Gervais A, Michelet C, Morlat P, Vittecoq D, Rosa I, Bertucci I, Chevaliez S, Aboulker JP, Molina JM; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) HC26 Study Group. Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial. Clin Infect Dis. 2014 Dec 15;59(12):1768-76. doi: 10.1093/cid/ciu659. Epub 2014 Aug 18.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01552044\",\n",
      "    \"BriefTitle\": \"Effect of Spironolactone in Treating Chronic Non-resolutive Central Serous Chorioretinitis\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-03-13\",\n",
      "    \"StartDate\": \"2012-01\",\n",
      "    \"CompletionDate\": \"2013-02\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02592174\",\n",
      "    \"BriefTitle\": \"Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Merck Sharp & Dohme LLC\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2015-10-30\",\n",
      "    \"StartDate\": \"2016-01-26\",\n",
      "    \"CompletionDate\": \"2017-10-27\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"31755936\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Makinson A, Dubois J, Eymard-Duvernay S, Leclercq P, Zaegel-Faucher O, Bernard L, Vassallo M, Barbuat C, Geny C, Thouvenot E, Costagliola D, Ozguler A, Zins M, Simony M, Reynes J, Berr C. Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55-70 Study. Clin Infect Dis. 2020 Jun 10;70(12):2641-2648. doi: 10.1093/cid/ciz670.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02100774\",\n",
      "    \"BriefTitle\": \"Effect of Genetic Variants on Fat-soluble Vitamin Bioavailability\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-04-01\",\n",
      "    \"StartDate\": \"2009-01\",\n",
      "    \"CompletionDate\": \"2013-12\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"21957063\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Borel P. Genetic variations involved in interindividual variability in carotenoid status. Mol Nutr Food Res. 2012 Feb;56(2):228-40. doi: 10.1002/mnfr.201100322. Epub 2011 Sep 29.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27798339\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Desmarchelier C, Borel P, Goncalves A, Kopec R, Nowicki M, Morange S, Lesavre N, Portugal H, Reboul E. A Combination of Single-Nucleotide Polymorphisms Is Associated with Interindividual Variability in Cholecalciferol Bioavailability in Healthy Men. J Nutr. 2016 Dec;146(12):2421-2428. doi: 10.3945/jn.116.237115. Epub 2016 Oct 26.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26063065\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Borel P, Desmarchelier C, Nowicki M, Bott R. A Combination of Single-Nucleotide Polymorphisms Is Associated with Interindividual Variability in Dietary beta-Carotene Bioavailability in Healthy Men. J Nutr. 2015 Aug;145(8):1740-7. doi: 10.3945/jn.115.212837. Epub 2015 Jun 10.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24808487\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Borel P, Desmarchelier C, Nowicki M, Bott R, Morange S, Lesavre N. Interindividual variability of lutein bioavailability in healthy men: characterization, genetic variants involved, and relation with fasting plasma lutein concentration. Am J Clin Nutr. 2014 Jul;100(1):168-75. doi: 10.3945/ajcn.114.085720. Epub 2014 May 7.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00490074\",\n",
      "    \"BriefTitle\": \"Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"EuroVacc Foundation\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2007-06-22\",\n",
      "    \"StartDate\": \"2007-07\",\n",
      "    \"CompletionDate\": \"2009-10\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01882062\",\n",
      "    \"BriefTitle\": \"Proof of Concept of an Anaplerotic Study Using Brain Phosphorus Magnetic Resonance Spectroscopy in Huntington Disease\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": true,\n",
      "    \"StudyFirstPostDate\": \"2013-06-20\",\n",
      "    \"StartDate\": \"2013-05\",\n",
      "    \"CompletionDate\": \"2013-07\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"25568297\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Adanyeguh IM, Rinaldi D, Henry PG, Caillet S, Valabregue R, Durr A, Mochel F. Triheptanoin improves brain energy metabolism in patients with Huntington disease. Neurology. 2015 Feb 3;84(5):490-5. doi: 10.1212/WNL.0000000000001214. Epub 2015 Jan 7.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01525472\",\n",
      "    \"BriefTitle\": \"Accelerated Aging of the Cells of Visceral Adipose Tissue in Morbid Obese Subjects\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-02-03\",\n",
      "    \"StartDate\": \"2012-02-13\",\n",
      "    \"CompletionDate\": \"2015-10-20\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02650427\",\n",
      "    \"BriefTitle\": \"A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver Resection\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2016-01-08\",\n",
      "    \"StartDate\": \"2016-02\",\n",
      "    \"CompletionDate\": \"2018-09\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01473472\",\n",
      "    \"BriefTitle\": \"On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2011-11-17\",\n",
      "    \"StartDate\": \"2012-01\",\n",
      "    \"CompletionDate\": \"2016-12-15\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"31784343\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Antoni G, Tremblay C, Delaugerre C, Charreau I, Cua E, Rojas Castro D, Raffi F, Chas J, Huleux T, Spire B, Capitant C, Cotte L, Meyer L, Molina JM; ANRS IPERGAY study group. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial. Lancet HIV. 2020 Feb;7(2):e113-e120. doi: 10.1016/S2352-3018(19)30341-8. Epub 2019 Nov 26.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29229440\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Molina JM, Charreau I, Chidiac C, Pialoux G, Cua E, Delaugerre C, Capitant C, Rojas-Castro D, Fonsart J, Bercot B, Bebear C, Cotte L, Robineau O, Raffi F, Charbonneau P, Aslan A, Chas J, Niedbalski L, Spire B, Sagaon-Teyssier L, Carette D, Mestre SL, Dore V, Meyer L; ANRS IPERGAY Study Group. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis. 2018 Mar;18(3):308-317. doi: 10.1016/S1473-3099(17)30725-9. Epub 2017 Dec 8.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28747274\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, Tremblay C, Rojas-Castro D, Cua E, Pasquet A, Bernaud C, Pintado C, Delaugerre C, Sagaon-Teyssier L, Mestre SL, Chidiac C, Pialoux G, Ponscarme D, Fonsart J, Thompson D, Wainberg MA, Dore V, Meyer L; ANRS IPERGAY Study Group. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Lancet HIV. 2017 Sep;4(9):e402-e410. doi: 10.1016/S2352-3018(17)30089-9. Epub 2017 Jul 23.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26624850\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, Tremblay C, Le Gall JM, Cua E, Pasquet A, Raffi F, Pintado C, Chidiac C, Chas J, Charbonneau P, Delaugerre C, Suzan-Monti M, Loze B, Fonsart J, Peytavin G, Cheret A, Timsit J, Girard G, Lorente N, Preau M, Rooney JF, Wainberg MA, Thompson D, Rozenbaum W, Dore V, Marchand L, Simon MC, Etien N, Aboulker JP, Meyer L, Delfraissy JF; ANRS IPERGAY Study Group. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N Engl J Med. 2015 Dec 3;373(23):2237-46. doi: 10.1056/NEJMoa1506273. Epub 2015 Dec 1.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02267304\",\n",
      "    \"BriefTitle\": \"Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Morphine and Naloxone on Motivation (MBBAnalgesic)\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-10-17\",\n",
      "    \"StartDate\": \"2013-10-30\",\n",
      "    \"CompletionDate\": \"2016-08-30\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04780191\",\n",
      "    \"BriefTitle\": \"Investigation of Treatment Using the MyoRegulator\\u00ae Device in Patients With Spasticity in the Lower Limb Due to Stroke\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"PathMaker Neurosystems Inc.\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2021-03-03\",\n",
      "    \"StartDate\": \"2018-07-19\",\n",
      "    \"CompletionDate\": \"2021-01-19\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"32232101\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Paget-Blanc A, Chang JL, Saul M, Lin R, Ahmed Z, Volpe BT. Non-invasive treatment of patients with upper extremity spasticity following stroke using paired trans-spinal and peripheral direct current stimulation. Bioelectron Med. 2019 Jul 23;5:11. doi: 10.1186/s42234-019-0028-9. eCollection 2019.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00495326\",\n",
      "    \"BriefTitle\": \"Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Medecins Sans Frontieres, Netherlands\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2007-07-03\",\n",
      "    \"StartDate\": \"2007-12\",\n",
      "    \"CompletionDate\": \"2011-04\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"24663014\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Bhatt NB, Barau C, Amin A, Baudin E, Meggi B, Silva C, Furlan V, Grinsztejn B, Barrail-Tran A, Bonnet M, Taburet AM; ANRS 12146-CARINEMO Study Group. Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment. Antimicrob Agents Chemother. 2014 Jun;58(6):3182-90. doi: 10.1128/AAC.02379-13. Epub 2014 Mar 24.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23433590\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Bonnet M, Bhatt N, Baudin E, Silva C, Michon C, Taburet AM, Ciaffi L, Sobry A, Bastos R, Nunes E, Rouzioux C, Jani I, Calmy A; CARINEMO study group. Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial. Lancet Infect Dis. 2013 Apr;13(4):303-12. doi: 10.1016/S1473-3099(13)70007-0. Epub 2013 Feb 20.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03459157\",\n",
      "    \"BriefTitle\": \"Access to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP)\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Expertise France | Universit\\u00e9 Montpellier | SESSTIM (IRD, Inserm, Universit\\u00e9 Aix-Marseille) | Coalition Internationale Sida | Institut de M\\u00e9decine Tropicale, Anvers, Belgique | ARCAD-SIDA MALI | Association African Solidarit\\u00e9 | Centre de Recherche Internationale pour la Sant\\u00e9, Universit\\u00e9 de Ouagadougou | Espace Confiance, C\\u00f4te d'Ivoire | Espoir Vie-Togo - ONG | Laboratoire BIOLIM, Universit\\u00e9 de Lom\\u00e9\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2018-03-08\",\n",
      "    \"StartDate\": \"2017-11-20\",\n",
      "    \"CompletionDate\": \"2021-06-30\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"34048794\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Laurent C, Dembele Keita B, Yaya I, Le Guicher G, Sagaon-Teyssier L, Agboyibor MK, Coulibaly A, Traore I, Malan JB, De Baetselier I, Eubanks A, Riegel L, Rojas Castro D, Faye-Kette H, Kone A, Diande S, Dagnra CA, Serrano L, Diallo F, Mensah E, Dah TTE, Anoma C, Vuylsteke B, Spire B; CohMSM-PrEP Study Group. HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study. Lancet HIV. 2021 Jul;8(7):e420-e428. doi: 10.1016/S2352-3018(21)00005-9. Epub 2021 May 25.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01620957\",\n",
      "    \"BriefTitle\": \"Longitudinal Study of the Default-mode Network Connectivity in Brain Injured Patients Recovering From Coma\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"University Hospital, Toulouse | Association des Traumatis\\u00e9s du Crane et de la Face, Paris, France\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-06-15\",\n",
      "    \"StartDate\": \"2012-07-10\",\n",
      "    \"CompletionDate\": \"2017-07\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00339157\",\n",
      "    \"BriefTitle\": \"Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2006-06-20\",\n",
      "    \"StartDate\": \"2006-06\",\n",
      "    \"CompletionDate\": \"2008-07\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"21173013\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Quartier P, Allantaz F, Cimaz R, Pillet P, Messiaen C, Bardin C, Bossuyt X, Boutten A, Bienvenu J, Duquesne A, Richer O, Chaussabel D, Mogenet A, Banchereau J, Treluyer JM, Landais P, Pascual V. A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Ann Rheum Dis. 2011 May;70(5):747-54. doi: 10.1136/ard.2010.134254. Epub 2010 Dec 20.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01555450\",\n",
      "    \"BriefTitle\": \"Study of Patient Navigation to Reduce Social Inequalities\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"National Cancer Institute, France\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-03-15\",\n",
      "    \"StartDate\": \"2011-03\",\n",
      "    \"CompletionDate\": \"2013-11\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"21256688\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Dejardin O, Berchi C, Mignon A, Pornet C, Guillaume E, Guittet L, Bouvier V, Sailly M, Salinas A, Christophe V, Launoy G. [Social inequalities in health from observational studies to intervention: can the patient navigator reduce social inequalities in cancer patients?]. Rev Epidemiol Sante Publique. 2011 Feb;59(1):45-51. doi: 10.1016/j.respe.2010.10.008. Epub 2011 Jan 21. French.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29909873\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"De Mil R, Guillaume E, Guittet L, Dejardin O, Bouvier V, Pornet C, Christophe V, Notari A, Delattre-Massy H, De Seze C, Peng J, Launoy G, Berchi C. Cost-Effectiveness Analysis of a Navigation Program for Colorectal Cancer Screening to Reduce Social Health Inequalities: A French Cluster Randomized Controlled Trial. Value Health. 2018 Jun;21(6):685-691. doi: 10.1016/j.jval.2017.09.020. Epub 2017 Nov 10.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28823681\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Guillaume E, Dejardin O, Bouvier V, De Mil R, Berchi C, Pornet C, Christophe V, Notari A, Delattre Massy H, De Seze C, Peng J, Guittet L, Launoy G. Patient navigation to reduce social inequalities in colorectal cancer screening participation: A cluster randomized controlled trial. Prev Med. 2017 Oct;103:76-83. doi: 10.1016/j.ypmed.2017.08.012. Epub 2017 Aug 16.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01348308\",\n",
      "    \"BriefTitle\": \"Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Pfizer\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2011-05-05\",\n",
      "    \"StartDate\": \"2011-09\",\n",
      "    \"CompletionDate\": \"2016-03\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"32040959\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Levy Y, Lelievre JD, Assoumou L, Aznar E, Pulido F, Tambussi G, Crespo M, Meybeck A, Molina JM, Delaugerre C, Izopet J, Peytavin G, Cardon F, Diallo A, Lancar R, Beniguel L, Costagliola D. Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial. Ann Intern Med. 2020 Mar 3;172(5):297-305. doi: 10.7326/M19-2133. Epub 2020 Feb 11.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01696708\",\n",
      "    \"BriefTitle\": \"Utilization of 31P-Nuclear Magnetic Resonance Spectroscopy to Monitor Brain Energy Deficit in Huntington Disease\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-10-01\",\n",
      "    \"StartDate\": \"2012-12-06\",\n",
      "    \"CompletionDate\": \"2015-11\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"25568297\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Adanyeguh IM, Rinaldi D, Henry PG, Caillet S, Valabregue R, Durr A, Mochel F. Triheptanoin improves brain energy metabolism in patients with Huntington disease. Neurology. 2015 Feb 3;84(5):490-5. doi: 10.1212/WNL.0000000000001214. Epub 2015 Jan 7.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01509508\",\n",
      "    \"BriefTitle\": \"Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Africa Centre For Health and Population Studies | University of KwaZulu\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-01-13\",\n",
      "    \"StartDate\": \"2012-03\",\n",
      "    \"CompletionDate\": \"2016-06\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"32970730\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Iwuji C, Chimukuche RS, Zuma T, Plazy M, Larmarange J, Orne-Gliemann J, Siedner M, Shahmanesh M, Seeley J. Test but not treat: Community members' experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa. PLoS One. 2020 Sep 24;15(9):e0239513. doi: 10.1371/journal.pone.0239513. eCollection 2020.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31637821\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Larmarange J, Diallo MH, McGrath N, Iwuji C, Plazy M, Thiebaut R, Tanser F, Barnighausen T, Orne-Gliemann J, Pillay D, Dabis F; ANRS 12249 TasP Study Group. Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa. J Int AIDS Soc. 2019 Oct;22(10):e25402. doi: 10.1002/jia2.25402.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30412926\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Perriat D, Plazy M, Gumede D, Boyer S, Pillay D, Dabis F, Seeley J, Orne-Gliemann J; ANRS 12249 TasP Study Group. \\\"If you are here at the clinic, you do not know how many people need help in the community\\\": Perspectives of home-based HIV services from health care workers in rural KwaZulu-Natal, South Africa in the era of universal test-and-treat. PLoS One. 2018 Nov 9;13(11):e0202473. doi: 10.1371/journal.pone.0202473. eCollection 2018.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30321314\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Derache A, Iwuji CC, Baisley K, Danaviah S, Marcelin AG, Calvez V, de Oliveira T, Dabis F, Porter K, Pillay D. Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial. Clin Infect Dis. 2019 Jul 2;69(2):207-214. doi: 10.1093/cid/ciy881.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30027600\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Larmarange J, Diallo MH, McGrath N, Iwuji C, Plazy M, Thiebaut R, Tanser F, Barnighausen T, Pillay D, Dabis F, Orne-Gliemann J; ANRS 12249 TasP Study Group. The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa). J Int AIDS Soc. 2018 Jul;21 Suppl 4(Suppl Suppl 4):e25128. doi: 10.1002/jia2.25128.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29890048\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Iwuji C, McGrath N, Calmy A, Dabis F, Pillay D, Newell ML, Baisley K, Porter K. Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial. J Int AIDS Soc. 2018 Jun;21(6):e25112. doi: 10.1002/jia2.25112.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29199100\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Iwuji CC, Orne-Gliemann J, Larmarange J, Balestre E, Thiebaut R, Tanser F, Okesola N, Makowa T, Dreyer J, Herbst K, McGrath N, Barnighausen T, Boyer S, De Oliveira T, Rekacewicz C, Bazin B, Newell ML, Pillay D, Dabis F; ANRS 12249 TasP Study Group. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. Lancet HIV. 2018 Mar;5(3):e116-e125. doi: 10.1016/S2352-3018(17)30205-9. Epub 2017 Nov 30.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28329393\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Collier D, Iwuji C, Derache A, de Oliveira T, Okesola N, Calmy A, Dabis F, Pillay D, Gupta RK; French National Agency for AIDS and Viral Hepatitis Research (ANRS) 12249 Treatment as Prevention (TasP) Study Group. Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis. Clin Infect Dis. 2017 Apr 15;64(8):1006-1016. doi: 10.1093/cid/cix015.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27504637\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Iwuji CC, Orne-Gliemann J, Larmarange J, Okesola N, Tanser F, Thiebaut R, Rekacewicz C, Newell ML, Dabis F; ANRS 12249 TasP trial group. Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial. PLoS Med. 2016 Aug 9;13(8):e1002107. doi: 10.1371/journal.pmed.1002107. eCollection 2016 Aug.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25880823\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Orne-Gliemann J, Larmarange J, Boyer S, Iwuji C, McGrath N, Barnighausen T, Zuma T, Dray-Spira R, Spire B, Rochat T, Lert F, Imrie J; ANRS 12249 TasP Group. Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal. BMC Public Health. 2015 Mar 1;15:209. doi: 10.1186/s12889-015-1344-y.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23880306\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Iwuji CC, Orne-Gliemann J, Tanser F, Boyer S, Lessells RJ, Lert F, Imrie J, Barnighausen T, Rekacewicz C, Bazin B, Newell ML, Dabis F; ANRS 12249 TasP Study Group. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial. Trials. 2013 Jul 23;14:230. doi: 10.1186/1745-6215-14-230.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01874808\",\n",
      "    \"BriefTitle\": \"From Movement Preparation to Gait Execution in ALS\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"Universit\\u00e9 Paris Ouest-EA 2931-CEntre de Recherches sur le Sport et le Mouvement\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2013-06-11\",\n",
      "    \"StartDate\": \"2013-06-21\",\n",
      "    \"CompletionDate\": \"2015-12-21\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02126384\",\n",
      "    \"BriefTitle\": \"Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-04-30\",\n",
      "    \"StartDate\": \"2014-11-18\",\n",
      "    \"CompletionDate\": \"2016-04-05\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03150290\",\n",
      "    \"BriefTitle\": \"Brown Adipose Tissue in ALS\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2017-05-12\",\n",
      "    \"StartDate\": \"2017-10-26\",\n",
      "    \"CompletionDate\": \"2019-04-01\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03519503\",\n",
      "    \"BriefTitle\": \"Infant Peri-Exposure Prophylaxis to Prevent HIV-1 Transmission by Breastfeeding: Mechanisms & Safety\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2018-05-09\",\n",
      "    \"StartDate\": \"2017-02-27\",\n",
      "    \"CompletionDate\": \"2018-02-15\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"21602695\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Heidari S, Mofenson L, Cotton MF, Marlink R, Cahn P, Katabira E. Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children. J Acquir Immune Defic Syndr. 2011 Aug 1;57(4):290-6. doi: 10.1097/QAI.0b013e318221c56a.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22814853\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Van de Perre P, Rubbo PA, Viljoen J, Nagot N, Tylleskar T, Lepage P, Vendrell JP, Tuaillon E. HIV-1 reservoirs in breast milk and challenges to elimination of breast-feeding transmission of HIV-1. Sci Transl Med. 2012 Jul 18;4(143):143sr3. doi: 10.1126/scitranslmed.3003327.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26603917\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Nagot N, Kankasa C, Tumwine JK, Meda N, Hofmeyr GJ, Vallo R, Mwiya M, Kwagala M, Traore H, Sunday A, Singata M, Siuluta C, Some E, Rutagwera D, Neboua D, Ndeezi G, Jackson D, Marechal V, Neveu D, Engebretsen IMS, Lombard C, Blanche S, Sommerfelt H, Rekacewicz C, Tylleskar T, Van de Perre P; ANRS 12174 Trial Group. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. Lancet. 2016 Feb 6;387(10018):566-573. doi: 10.1016/S0140-6736(15)00984-8. Epub 2015 Nov 19. Erratum In: Lancet. 2019 Jun 22;393(10190):2492.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00465790\",\n",
      "    \"BriefTitle\": \"Research of Biomarkers in Parkinson Disease\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"European Union\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2007-04-25\",\n",
      "    \"StartDate\": \"2007-10\",\n",
      "    \"CompletionDate\": \"2012-06\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00122603\",\n",
      "    \"BriefTitle\": \"Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Bristol-Myers Squibb | GlaxoSmithKline | Hoffmann-La Roche\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-07-22\",\n",
      "    \"StartDate\": \"2005-12\",\n",
      "    \"CompletionDate\": \"2007-08\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"19420019\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Landman R, Capitant C, Descamps D, Chazallon C, Peytavin G, Katlama C, Pialoux G, Bentata M, Brun-Vezinet F, Aboulker JP, Yeni P; ANRS 127 Study Group. Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study. J Antimicrob Chemother. 2009 Jul;64(1):118-25. doi: 10.1093/jac/dkp146. Epub 2009 May 6.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02314208\",\n",
      "    \"BriefTitle\": \"Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-12-11\",\n",
      "    \"StartDate\": \"2015-01\",\n",
      "    \"CompletionDate\": \"2018-01-01\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00121121\",\n",
      "    \"BriefTitle\": \"Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-07-21\",\n",
      "    \"StartDate\": \"2004-07\",\n",
      "    \"CompletionDate\": \"2005-12\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"17712402\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Launay O, Durier C, Desaint C, Silbermann B, Jackson A, Pialoux G, Bonnet B, Poizot-Martin I, Gonzalez-Canali G, Cuzin L, Figuereido S, Surenaud M, Ben Hamouda N, Gahery H, Choppin J, Salmon D, Guerin C, Bourgault Villada I, Guillet JG; ANRS VAC16 Study Group. Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial. PLoS One. 2007 Aug 22;2(8):e725. doi: 10.1371/journal.pone.0000725.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01432821\",\n",
      "    \"BriefTitle\": \"Blinking and Yawning in Epilepsy: The Role of Dopamine\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2011-09-13\",\n",
      "    \"StartDate\": \"2011-09\",\n",
      "    \"CompletionDate\": \"2014-12\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"15037514\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Ahmad S, Fowler LJ, Whitton PS. Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5-hydroxytryptamine and dopamine in the hippocampus of the freely moving rat. Br J Pharmacol. 2004 May;142(1):136-42. doi: 10.1038/sj.bjp.0705737. Epub 2004 Mar 22.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15777732\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Ahmad S, Fowler LJ, Whitton PS. Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids. Epilepsy Res. 2005 Feb;63(2-3):141-9. doi: 10.1016/j.eplepsyres.2005.02.002.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"12914551\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Aymard G, Berlin I, de Brettes B, Diquet B. Pharmacokinetic-pharmacodynamic study of apomorphine's effect on growth hormone secretion in healthy subjects. Fundam Clin Pharmacol. 2003 Aug;17(4):473-81. doi: 10.1046/j.1472-8206.2003.00152.x.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15249613\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Biraben A, Semah F, Ribeiro MJ, Douaud G, Remy P, Depaulis A. PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy. Neurology. 2004 Jul 13;63(1):73-7. doi: 10.1212/01.wnl.0000132840.40838.13.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"2271377\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Blin O, Masson G, Azulay JP, Fondarai J, Serratrice G. Apomorphine-induced blinking and yawning in healthy volunteers. Br J Clin Pharmacol. 1990 Nov;30(5):769-73. doi: 10.1111/j.1365-2125.1990.tb03848.x.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02071784\",\n",
      "    \"BriefTitle\": \"Imaging Study of Neurovascular Coupling in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-02-26\",\n",
      "    \"StartDate\": \"2014-07-08\",\n",
      "    \"CompletionDate\": \"2016-10-24\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02738502\",\n",
      "    \"BriefTitle\": \"Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2016-04-14\",\n",
      "    \"StartDate\": \"2016-07-06\",\n",
      "    \"CompletionDate\": \"2020-07-16\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"26709605\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Arribas JR, Girard PM, Paton N, Winston A, Marcelin AG, Elbirt D, Hill A, Hadacek MB. Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials. HIV Med. 2016 May;17(5):358-67. doi: 10.1111/hiv.12348. Epub 2015 Dec 28.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23766338\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Tubiana R, Mandelbrot L, Le Chenadec J, Delmas S, Rouzioux C, Hirt D, Treluyer JM, Ekoukou D, Bui E, Chaix ML, Blanche S, Warszawski J; ANRS 135 PRIMEVA (Protease Inhibitor Monotherapy Evaluation) Study Group. Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial. Clin Infect Dis. 2013 Sep;57(6):891-902. doi: 10.1093/cid/cit390. Epub 2013 Jun 12.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23559464\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Andre-Schmutz I, Dal-Cortivo L, Six E, Kaltenbach S, Cocchiarella F, Le Chenadec J, Cagnard N, Cordier AG, Benachi A, Mandelbrot L, Azria E, Bouallag N, Luce S, Ternaux B, Reimann C, Revy P, Radford-Weiss I, Leschi C, Recchia A, Mavilio F, Cavazzana M, Blanche S. Genotoxic signature in cord blood cells of newborns exposed in utero to a Zidovudine-based antiretroviral combination. J Infect Dis. 2013 Jul 15;208(2):235-43. doi: 10.1093/infdis/jit149. Epub 2013 Apr 4.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26854809\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Hleyhel M, Goujon S, Delteil C, Vasiljevic A, Luzi S, Stephan JL, Reliquet V, Jannier S, Tubiana R, Dollfus C, Faye A, Mandelbrot L, Clavel J, Warszawski J, Blanche S; ANRS French Perinatal Cohort Study Group. Risk of cancer in children exposed to didanosine in utero. AIDS. 2016 May 15;30(8):1245-56. doi: 10.1097/QAD.0000000000001051.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26197844\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Mandelbrot L, Tubiana R, Le Chenadec J, Dollfus C, Faye A, Pannier E, Matheron S, Khuong MA, Garrait V, Reliquet V, Devidas A, Berrebi A, Allisy C, Elleau C, Arvieux C, Rouzioux C, Warszawski J, Blanche S; ANRS-EPF Study Group. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception. Clin Infect Dis. 2015 Dec 1;61(11):1715-25. doi: 10.1093/cid/civ578. Epub 2015 Jul 21.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22160145\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Valantin MA, Lambert-Niclot S, Flandre P, Morand-Joubert L, Cabie A, Meynard JL, Ponscarme D, Ajana F, Slama L, Curjol A, Cuzin L, Schneider L, Taburet AM, Marcelin AG, Katlama C; MONOI ANRS 136 Study Group. Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study. J Antimicrob Chemother. 2012 Mar;67(3):691-5. doi: 10.1093/jac/dkr504. Epub 2011 Dec 7.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22848481\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Lambert-Niclot S, Flandre P, Valantin MA, Soulie C, Fourati S, Wirden M, Sayon S, Pakianather S, Bocket L, Masquelier B, Dos Santos G, Katlama C, Calvez V, Marcelin AG. Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks. PLoS One. 2012;7(7):e41390. doi: 10.1371/journal.pone.0041390. Epub 2012 Jul 25.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02992184\",\n",
      "    \"BriefTitle\": \"PoC-HCV Genedrive Viral Detection Assay Validation Study\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"EPISTEM\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2016-12-14\",\n",
      "    \"StartDate\": \"2016-09\",\n",
      "    \"CompletionDate\": \"2016-12\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"29615488\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Llibre A, Shimakawa Y, Mottez E, Ainsworth S, Buivan TP, Firth R, Harrison E, Rosenberg AR, Meritet JF, Fontanet A, Castan P, Madejon A, Laverick M, Glass A, Viana R, Pol S, McClure CP, Irving WL, Miele G, Albert ML, Duffy D. Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus. Gut. 2018 Nov;67(11):2017-2024. doi: 10.1136/gutjnl-2017-315783. Epub 2018 Apr 3.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01514890\",\n",
      "    \"BriefTitle\": \"French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and Ribavirin\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-01-23\",\n",
      "    \"StartDate\": \"2011-02\",\n",
      "    \"CompletionDate\": \"2014-03\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"25556540\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Sultanik P, Mallet V, Lagaye S, Casrouge A, Dorival C, Barthe Y, Fontaine H, Hezode C, Mottez E, Bronowicki JP, Carrat F, Theodorou I, Abel L, Gayat E, Fontanet A, Pol S, Albert ML; ANRS CO20-CUPIC. Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy. Liver Int. 2015 Jul;35(7):1833-44. doi: 10.1111/liv.12759. Epub 2015 Jan 23.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24704719\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Hezode C, Fontaine H, Dorival C, Zoulim F, Larrey D, Canva V, De Ledinghen V, Poynard T, Samuel D, Bourliere M, Alric L, Raabe JJ, Zarski JP, Marcellin P, Riachi G, Bernard PH, Loustaud-Ratti V, Chazouilleres O, Abergel A, Guyader D, Metivier S, Tran A, Di Martino V, Causse X, Dao T, Lucidarme D, Portal I, Cacoub P, Gournay J, Grando-Lemaire V, Hillon P, Attali P, Fontanges T, Rosa I, Petrov-Sanchez V, Barthe Y, Pawlotsky JM, Pol S, Carrat F, Bronowicki JP; CUPIC Study Group. Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis. Gastroenterology. 2014 Jul;147(1):132-142.e4. doi: 10.1053/j.gastro.2014.03.051. Epub 2014 Apr 3.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23669289\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Hezode C, Fontaine H, Dorival C, Larrey D, Zoulim F, Canva V, de Ledinghen V, Poynard T, Samuel D, Bourliere M, Zarski JP, Raabe JJ, Alric L, Marcellin P, Riachi G, Bernard PH, Loustaud-Ratti V, Metivier S, Tran A, Serfaty L, Abergel A, Causse X, Di Martino V, Guyader D, Lucidarme D, Grando-Lemaire V, Hillon P, Feray C, Dao T, Cacoub P, Rosa I, Attali P, Petrov-Sanchez V, Barthe Y, Pawlotsky JM, Pol S, Carrat F, Bronowicki JP; CUPIC Study Group. Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890. J Hepatol. 2013 Sep;59(3):434-41. doi: 10.1016/j.jhep.2013.04.035. Epub 2013 May 10.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02212379\",\n",
      "    \"BriefTitle\": \"Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRAL\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Merck Sharp & Dohme LLC | Janssen-Cilag Ltd.\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": true,\n",
      "    \"StudyFirstPostDate\": \"2014-08-08\",\n",
      "    \"StartDate\": \"2015-01\",\n",
      "    \"CompletionDate\": \"2018-04\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03652090\",\n",
      "    \"BriefTitle\": \"Primary Nasal Cell Culture as a Tool for Personalized Therapy in Cystic Fibrosis\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"ABCF2\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2018-08-29\",\n",
      "    \"StartDate\": \"2010-09-01\",\n",
      "    \"CompletionDate\": \"2016-03-03\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00196664\",\n",
      "    \"BriefTitle\": \"Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus Ribavirin\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-09-20\",\n",
      "    \"StartDate\": \"2005-10\",\n",
      "    \"CompletionDate\": \"2009-02\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03335995\",\n",
      "    \"BriefTitle\": \"Stroke Prognosis in Intensive CarE\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2017-11-08\",\n",
      "    \"StartDate\": \"2017-10-18\",\n",
      "    \"CompletionDate\": \"2020-11-18\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"32026446\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Sonneville R, Mazighi M, Bresson D, Crassard I, Crozier S, de Montmollin E, Degos V, Faugeras F, Gayat E, Josse L, Lamy C, Magalhaes E, Maldjian A, Ruckly S, Servan J, Vassel P, Vigue B, Timsit JF, Woimant F; SPICE investigators. Outcomes of Acute Stroke Patients Requiring Mechanical Ventilation: Study Protocol for the SPICE Multicenter Prospective Observational Study. Neurocrit Care. 2020 Apr;32(2):624-629. doi: 10.1007/s12028-019-00907-0.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00946595\",\n",
      "    \"BriefTitle\": \"Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Abbott | Gilead Sciences\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2009-07-27\",\n",
      "    \"StartDate\": \"2009-11\",\n",
      "    \"CompletionDate\": \"2014-01\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"30968368\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Garay OU, Nishimwe ML, Bousmah MA, Janah A, Girard PM, Chene G, Moinot L, Sagaon-Teyssier L, Meynard JL, Spire B, Boyer S. Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM). Pharmacoecon Open. 2019 Dec;3(4):505-515. doi: 10.1007/s41669-019-0130-7.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29767684\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Lambert-Niclot S, Grude M, Meynard JL, Marcelin AG, Valantin MA, Flandre P, Izopet J, Moinot L, Bouteloup V, Calvez V, Katlama C, Girard PM, Morand-Joubert L. Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies. Clin Infect Dis. 2018 Nov 28;67(12):1883-1889. doi: 10.1093/cid/ciy382.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02469350\",\n",
      "    \"BriefTitle\": \"Serious Game for Parkinson's Disease Patients\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2015-06-11\",\n",
      "    \"StartDate\": \"2015-06\",\n",
      "    \"CompletionDate\": \"2017-10-04\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"29636105\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Nuic D, Vinti M, Karachi C, Foulon P, Van Hamme A, Welter ML. The feasibility and positive effects of a customised videogame rehabilitation programme for freezing of gait and falls in Parkinson's disease patients: a pilot study. J Neuroeng Rehabil. 2018 Apr 10;15(1):31. doi: 10.1186/s12984-018-0375-x.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01546181\",\n",
      "    \"BriefTitle\": \"Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-03-07\",\n",
      "    \"StartDate\": \"2010-10\",\n",
      "    \"CompletionDate\": \"2017-06-15\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"25077537\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Paques M, Miloudi C, Kulcsar C, Leseigneur A, Chaumette C, Koch E. High-resolution imaging of gunn's dots. Retina. 2015 Jan;35(1):120-4. doi: 10.1097/IAE.0000000000000269.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26344727\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Audo I, Gocho K, Rossant F, Mohand-Said S, Loquin K, Bloch I, Sahel JA, Paques M. Functional and high-resolution retinal imaging monitoring photoreceptor damage in acute macular neuroretinopathy. Graefes Arch Clin Exp Ophthalmol. 2016 May;254(5):855-64. doi: 10.1007/s00417-015-3136-6. Epub 2015 Sep 7.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25997175\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Paques M, Brolly A, Benesty J, Lerme N, Koch E, Rossant F, Bloch I, Girmens JF. Venous Nicking Without Arteriovenous Contact: The Role of the Arteriolar Microenvironment in Arteriovenous Nickings. JAMA Ophthalmol. 2015 Aug;133(8):947-50. doi: 10.1001/jamaophthalmol.2015.1132.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26523388\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Miloudi C, Rossant F, Bloch I, Chaumette C, Leseigneur A, Sahel JA, Meimon S, Mrejen S, Paques M. The Negative Cone Mosaic: A New Manifestation of the Optical Stiles-Crawford Effect in Normal Eyes. Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7043-50. doi: 10.1167/iovs.15-17022.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23620431\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Gocho K, Sarda V, Falah S, Sahel JA, Sennlaub F, Benchaboune M, Ullern M, Paques M. Adaptive optics imaging of geographic atrophy. Invest Ophthalmol Vis Sci. 2013 May 1;54(5):3673-80. doi: 10.1167/iovs.12-10672.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24406779\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Koch E, Rosenbaum D, Brolly A, Sahel JA, Chaumet-Riffaud P, Girerd X, Rossant F, Paques M. Morphometric analysis of small arteries in the human retina using adaptive optics imaging: relationship with blood pressure and focal vascular changes. J Hypertens. 2014 Apr;32(4):890-8. doi: 10.1097/HJH.0000000000000095.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24576889\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Errera MH, Coisy S, Fardeau C, Sahel JA, Kallel S, Westcott M, Bodaghi B, Paques M. Retinal vasculitis imaging by adaptive optics. Ophthalmology. 2014 Jun;121(6):1311-2.e2. doi: 10.1016/j.ophtha.2013.12.036. Epub 2014 Feb 25. No abstract available.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24337723\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Faure C, Gocho K, Le Mer Y, Sahel JA, Paques M, Audo I. Functional and high resolution retinal imaging assessment in a case of ocular siderosis. Doc Ophthalmol. 2014 Feb;128(1):69-75. doi: 10.1007/s10633-013-9421-y. Epub 2013 Dec 13.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29369084\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Bottin C, Grieve K, Rossant F, Pedinielli A, Mrejen S, Paques M. DIRECTIONAL VARIABILITY OF FUNDUS REFLECTANCE IN ACUTE MACULAR NEURORETINOPATHY: EVIDENCE FOR A CONTRIBUTION OF THE STILES-CRAWFORD EFFECT. Retin Cases Brief Rep. 2018 Fall;12 Suppl 1:S19-S24. doi: 10.1097/ICB.0000000000000701.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25284764\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Jacob J, Paques M, Krivosic V, Dupas B, Couturier A, Kulcsar C, Tadayoni R, Massin P, Gaudric A. Meaning of visualizing retinal cone mosaic on adaptive optics images. Am J Ophthalmol. 2015 Jan;159(1):118-23.e1. doi: 10.1016/j.ajo.2014.09.043. Epub 2014 Oct 2.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27065002\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Rosenbaum D, Mattina A, Koch E, Rossant F, Gallo A, Kachenoura N, Paques M, Redheuil A, Girerd X. Effects of age, blood pressure and antihypertensive treatments on retinal arterioles remodeling assessed by adaptive optics. J Hypertens. 2016 Jun;34(6):1115-22. doi: 10.1097/HJH.0000000000000894.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27009576\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Rosenbaum D, Kachenoura N, Koch E, Paques M, Cluzel P, Redheuil A, Girerd X. Relationships between retinal arteriole anatomy and aortic geometry and function and peripheral resistance in hypertensives. Hypertens Res. 2016 Jul;39(7):536-42. doi: 10.1038/hr.2016.26. Epub 2016 Mar 24.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28900746\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Faure C, Paques M, Audo I. Electrophysiological features and multimodal imaging in ritonavir-related maculopathy. Doc Ophthalmol. 2017 Dec;135(3):241-248. doi: 10.1007/s10633-017-9612-z. Epub 2017 Sep 12.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30947025\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Boileve A, Jozwiak M, Malka D, Boige V, Le Roy F, Paques M, Ducreux M. Vision loss after chemotherapy: an irinotecan-induced retinopathy. Eur J Cancer. 2019 May;112:80-82. doi: 10.1016/j.ejca.2019.02.015. Epub 2019 Apr 1. No abstract available.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30010022\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Paques M, Meimon S, Rossant F, Rosenbaum D, Mrejen S, Sennlaub F, Grieve K. Adaptive optics ophthalmoscopy: Application to age-related macular degeneration and vascular diseases. Prog Retin Eye Res. 2018 Sep;66:1-16. doi: 10.1016/j.preteyeres.2018.07.001. Epub 2018 Jul 17.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31568064\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Sodi A, Germain DP, Bacherini D, Finocchio L, Pacini B, Marziali E, Lenzetti C, Tanini I, Koraichi F, Coriat C, Nencini P, Olivotto I, Virgili G, Rizzo S, Paques M. IN VIVO OBSERVATION OF RETINAL VASCULAR DEPOSITS USING ADAPTIVE OPTICS IMAGING IN FABRY DISEASE. Retina. 2020 Aug;40(8):1623-1629. doi: 10.1097/IAE.0000000000002648.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31573376\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Errera MH, Laguarrigue M, Rossant F, Koch E, Chaumette C, Fardeau C, Westcott M, Sahel JA, Bodaghi B, Benesty J, Paques M. High-Resolution Imaging of Retinal Vasculitis by Flood Illumination Adaptive Optics Ophthalmoscopy: A Follow-up Study. Ocul Immunol Inflamm. 2020 Nov 16;28(8):1171-1180. doi: 10.1080/09273948.2019.1646773. Epub 2019 Oct 1.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31922497\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Paques M, Rossant F, Finocchio L, Grieve K, Sahel JA, Pedinielli A, Mrejen S. ATTENUATION OUTER RETINAL BANDS ON OPTICAL COHERENCE TOMOGRAPHY FOLLOWING MACULAR EDEMA: A Possible Manifestation of Photoreceptor Misalignment. Retina. 2020 Nov;40(11):2232-2239. doi: 10.1097/IAE.0000000000002738.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31972545\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Gallo A, Chaigneau E, Jublanc C, Rosenbaum D, Mattina A, Paques M, Rossant F, Girerd X, Leban M, Bruckert E. IGF-1 is an independent predictor of retinal arterioles remodeling in subjects with uncontrolled acromegaly. Eur J Endocrinol. 2020 Mar;182(3):375-383. doi: 10.1530/EJE-19-0390.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26418443\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Jacob J, Krivosic V, Paques M, Tadayoni R, Gaudric A. CONE DENSITY LOSS ON ADAPTIVE OPTICS IN EARLY MACULAR TELANGIECTASIA TYPE 2. Retina. 2016 Mar;36(3):545-51. doi: 10.1097/IAE.0000000000000737.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00122538\",\n",
      "    \"BriefTitle\": \"Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-07-22\",\n",
      "    \"StartDate\": \"2006-02\",\n",
      "    \"CompletionDate\": \"2009-05\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"23719348\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Bouazza N, Treluyer JM, Msellati P, Van de Perre P, Diagbouga S, Nacro B, Hien H, Zoure E, Rouet F, Ouiminga A, Blanche S, Hirt D, Urien S. A novel pharmacokinetic approach to predict virologic failure in HIV-1-infected paediatric patients. AIDS. 2013 Mar 13;27(5):761-8. doi: 10.1097/QAD.0b013e32835caad1.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21857286\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Barro M, Some J, Foulongne V, Diasso Y, Zoure E, Hien H, Francois R, Michel S, Drabo A, Tamboura H, Ouiminga A, Diagbouga S, Hien A, Yameogo S, Van De Perre P, Nacro B, Msellati P. Short-term virological efficacy, immune reconstitution, tolerance, and adherence of once-daily dosing of didanosine, lamivudine, and efavirenz in HIV-1-infected African children: ANRS 12103 Burkiname. J Acquir Immune Defic Syndr. 2011 Jul 1;57 Suppl 1:S44-9. doi: 10.1097/QAI.0b013e31821fd64f.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20516271\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Bouazza N, Hirt D, Bardin C, Diagbouga S, Nacro B, Hien H, Zoure E, Rouet F, Ouiminga A, Blanche S, Van De Perre P, Treluyer JM, Msellati P, Urien S. Is the recommended once-daily dose of lamivudine optimal in West African HIV-infected children? Antimicrob Agents Chemother. 2010 Aug;54(8):3280-6. doi: 10.1128/AAC.00306-10. Epub 2010 Jun 1.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01426243\",\n",
      "    \"BriefTitle\": \"The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient.\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2011-08-31\",\n",
      "    \"StartDate\": \"2011-07\",\n",
      "    \"CompletionDate\": \"2017-12\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"30096071\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Colin de Verdiere N, Durier C, Samri A, Meiffredy V, Launay O, Matheron S, Mercier-Delarue S, Even S, Aboulker JP, Molina JM, Autran B, Simon F; ANRS EP46 NOVAA Group. Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients. AIDS. 2018 Oct 23;32(16):2291-2299. doi: 10.1097/QAD.0000000000001963.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04824638\",\n",
      "    \"BriefTitle\": \"BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive Volunteers\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2021-04-01\",\n",
      "    \"StartDate\": \"2021-03-08\",\n",
      "    \"CompletionDate\": \"2023-12-02\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02113943\",\n",
      "    \"BriefTitle\": \"Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Citalopram on Motivation\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-04-15\",\n",
      "    \"StartDate\": \"2014-04\",\n",
      "    \"CompletionDate\": \"2014-06\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00299143\",\n",
      "    \"BriefTitle\": \"Pilot Study on Shear-induced Platelet Aggregation in Acute Coronary Syndromes\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2006-03-06\",\n",
      "    \"StartDate\": \"2005-06\",\n",
      "    \"CompletionDate\": \"2010-06\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03870438\",\n",
      "    \"BriefTitle\": \"Prevention of Mother-to-child Transmission of HIV-1 Using a Responsive Intervention\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"University Teaching Hospital, Lusaka, Zambia | Centre Muraz | Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France | University of Bergen\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2019-03-12\",\n",
      "    \"StartDate\": \"2019-12-14\",\n",
      "    \"CompletionDate\": \"2022-10-31\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"26603917\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Nagot N, Kankasa C, Tumwine JK, Meda N, Hofmeyr GJ, Vallo R, Mwiya M, Kwagala M, Traore H, Sunday A, Singata M, Siuluta C, Some E, Rutagwera D, Neboua D, Ndeezi G, Jackson D, Marechal V, Neveu D, Engebretsen IMS, Lombard C, Blanche S, Sommerfelt H, Rekacewicz C, Tylleskar T, Van de Perre P; ANRS 12174 Trial Group. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. Lancet. 2016 Feb 6;387(10018):566-573. doi: 10.1016/S0140-6736(15)00984-8. Epub 2015 Nov 19. Erratum In: Lancet. 2019 Jun 22;393(10190):2492.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33872801\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Mennecier A, Kankasa C, Fao P, Moles JP, Eymard-Duvernay S, Mwiya M, Kania D, Chunda-Liyoka C, Sakana L, Rutagwera D, Tassembedo S, Wilfred-Tonga MM, Mosqueira B, Tylleskar T, Nagot N, Van de Perre P; ANRS 12397 Study group. Design and challenges of a large HIV prevention clinical study on mother-to-child transmission: ANRS 12397 PROMISE-EPI study in Zambia and Burkina Faso. Contemp Clin Trials. 2021 Jun;105:106402. doi: 10.1016/j.cct.2021.106402. Epub 2021 Apr 17.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01605890\",\n",
      "    \"BriefTitle\": \"Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Gilead Sciences | Merck Sharp & Dohme LLC\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": true,\n",
      "    \"StudyFirstPostDate\": \"2012-05-25\",\n",
      "    \"StartDate\": \"2012-07\",\n",
      "    \"CompletionDate\": \"2015-12\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"29590335\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Matheron S, Descamps D, Gallien S, Besseghir A, Sellier P, Blum L, Mortier E, Charpentier C, Tubiana R, Damond F, Peytavin G, Ponscarme D, Collin F, Brun-Vezinet F, Chene G; France REcherche Nord&Sud Sida-Hiv Hepatites (ANRS) 159 HIV-2 Trial Study Group. First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2). Clin Infect Dis. 2018 Sep 28;67(8):1161-1167. doi: 10.1093/cid/ciy245.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00391638\",\n",
      "    \"BriefTitle\": \"Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Gilead Sciences | Roche Pharma AG\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2006-10-24\",\n",
      "    \"StartDate\": \"2007-01\",\n",
      "    \"CompletionDate\": \"2012-10\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02323308\",\n",
      "    \"BriefTitle\": \"Isolated Anti-HBc Serological Profile in HIV Infected Patients: Immunological, Virological Characteristics and Response to Hepatitis B Vaccination\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-12-23\",\n",
      "    \"StartDate\": \"2010-12\",\n",
      "    \"CompletionDate\": \"2014-06\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02384967\",\n",
      "    \"BriefTitle\": \"Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 Patients\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2015-03-10\",\n",
      "    \"StartDate\": \"2015-03\",\n",
      "    \"CompletionDate\": \"2016-10\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"29905808\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Le MP, Chaix ML, Chevret S, Bertrand J, Raffi F, Gallien S, El Abbassi EMB, Katlama C, Delobel P, Yazdanpanah Y, Saillard J, Molina JM, Peytavin G; ANRS 165 DARULIGHT Study Group. Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study. J Antimicrob Chemother. 2018 Aug 1;73(8):2120-2128. doi: 10.1093/jac/dky193.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00988767\",\n",
      "    \"BriefTitle\": \"Safety and Immunogenicity of a Naked DNA-based Vaccine Therapy in Patients With Chronic Hepatitis B\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2009-10-02\",\n",
      "    \"StartDate\": \"2001-02\",\n",
      "    \"CompletionDate\": \"2004-10\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"15382173\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Mancini-Bourgine M, Fontaine H, Scott-Algara D, Pol S, Brechot C, Michel ML. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers. Hepatology. 2004 Oct;40(4):874-82. doi: 10.1002/hep.20408.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16310901\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Mancini-Bourgine M, Fontaine H, Brechot C, Pol S, Michel ML. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. Vaccine. 2006 May 22;24(21):4482-9. doi: 10.1016/j.vaccine.2005.08.013. Epub 2005 Aug 18.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20090916\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Scott-Algara D, Mancini-Bourgine M, Fontaine H, Pol S, Michel ML. Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination. PLoS One. 2010 Jan 18;5(1):e8761. doi: 10.1371/journal.pone.0008761.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00323804\",\n",
      "    \"BriefTitle\": \"Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Merck Sharp & Dohme LLC | Rennes University Hospital\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2006-05-10\",\n",
      "    \"StartDate\": \"2006-05\",\n",
      "    \"CompletionDate\": \"2013-03\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04849767\",\n",
      "    \"BriefTitle\": \"National Survey About Trajectory and Life Conditions of HIV Trans People in France\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2021-04-19\",\n",
      "    \"StartDate\": \"2020-10-01\",\n",
      "    \"CompletionDate\": \"2023-12-31\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"34916316\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Mora M, Rincon G, Bourrelly M, Maradan G, Freire Maresca A, Michard F, Rouveix E, Pannetier J, Leriche D, Alain T, Yazdanpanah Y, Michels D, Spire B. Living conditions, HIV and gender affirmation care pathways of transgender people living with HIV in France: a nationwide, comprehensive, cross-sectional, community-based research protocol (ANRS Trans&HIV). BMJ Open. 2021 Dec 16;11(12):e052691. doi: 10.1136/bmjopen-2021-052691.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03047967\",\n",
      "    \"BriefTitle\": \"Effects of Prenatal Tobacco Smoke Exposure on Lung Function and Respiratory Epithelium Functionality in Newborns\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2017-02-09\",\n",
      "    \"StartDate\": \"2017-11-10\",\n",
      "    \"CompletionDate\": \"2019-02-09\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00120367\",\n",
      "    \"BriefTitle\": \"Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Hoffmann-La Roche | Gilead Sciences\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-07-18\",\n",
      "    \"StartDate\": \"2005-04\",\n",
      "    \"CompletionDate\": \"2007-12\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"21738597\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Gasnault J, Costagliola D, Hendel-Chavez H, Dulioust A, Pakianather S, Mazet AA, de Goer de Herve MG, Lancar R, Lascaux AS, Porte L, Delfraissy JF, Taoufik Y; ANRS 125 Trial Team. Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy. PLoS One. 2011;6(6):e20967. doi: 10.1371/journal.pone.0020967. Epub 2011 Jun 30.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01038401\",\n",
      "    \"BriefTitle\": \"Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2009-12-24\",\n",
      "    \"StartDate\": \"2008-09\",\n",
      "    \"CompletionDate\": \"2010-05\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04484740\",\n",
      "    \"BriefTitle\": \"Penetration of the Innovative Antibiotic Gepotidacin Into Prostate and Tonsillar Tissue\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"Medical University of Vienna\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2020-07-24\",\n",
      "    \"StartDate\": \"2021-01-29\",\n",
      "    \"CompletionDate\": \"2023-05-27\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03078439\",\n",
      "    \"BriefTitle\": \"EPIPAGE2 Cohort Study Follow up at Five and a Half Years\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2017-03-13\",\n",
      "    \"StartDate\": \"2016-09-02\",\n",
      "    \"CompletionDate\": \"2018-01-08\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00148863\",\n",
      "    \"BriefTitle\": \"Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"InterMune | Hoffmann-La Roche\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-09-08\",\n",
      "    \"StartDate\": \"2004-06\",\n",
      "    \"CompletionDate\": \"2007-08\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"23190183\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Couzigou P, Perusat S, Bourliere M, Trimoulet P, Poynard T, Leroy V, Marcellin P, Foucher J, Bronowicki JP, Chene G; ANRS HC16 GAMMATRI Trial Group. Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI). J Gastroenterol Hepatol. 2013 Feb;28(2):329-34. doi: 10.1111/jgh.12060.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01548586\",\n",
      "    \"BriefTitle\": \"Effect of Transcranial Direct Current Stimulation (tDCS) on the Excitability of the Diaphragmatic Primary Motor Cortex\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"Assistance Publique - H\\u00f4pitaux de Paris\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-03-08\",\n",
      "    \"StartDate\": \"2012-01\",\n",
      "    \"CompletionDate\": \"2012-05\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"15634731\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Hummel F, Celnik P, Giraux P, Floel A, Wu WH, Gerloff C, Cohen LG. Effects of non-invasive cortical stimulation on skilled motor function in chronic stroke. Brain. 2005 Mar;128(Pt 3):490-9. doi: 10.1093/brain/awh369. Epub 2005 Jan 5.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20161639\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Madhavan S, Stinear JW. Focal and bi-directional modulation of lower limb motor cortex using anodal transcranial direct current stimulation. Brain Stimul. 2010 Jan;3(1):42. doi: 10.1016/j.brs.2009.06.005.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22085959\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Nitsche MA, Paulus W. Transcranial direct current stimulation--update 2011. Restor Neurol Neurosci. 2011;29(6):463-92. doi: 10.3233/RNN-2011-0618.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16002441\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Nitsche MA, Seeber A, Frommann K, Klein CC, Rochford C, Nitsche MS, Fricke K, Liebetanz D, Lang N, Antal A, Paulus W, Tergau F. Modulating parameters of excitability during and after transcranial direct current stimulation of the human motor cortex. J Physiol. 2005 Oct 1;568(Pt 1):291-303. doi: 10.1113/jphysiol.2005.092429. Epub 2005 Jul 7.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"11723286\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Nitsche MA, Paulus W. Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. Neurology. 2001 Nov 27;57(10):1899-901. doi: 10.1212/wnl.57.10.1899.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"10990547\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Nitsche MA, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol. 2000 Sep 15;527 Pt 3(Pt 3):633-9. doi: 10.1111/j.1469-7793.2000.t01-1-00633.x.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19805746\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Roche N, Lackmy A, Achache V, Bussel B, Katz R. Impact of transcranial direct current stimulation on spinal network excitability in humans. J Physiol. 2009 Dec 1;587(Pt 23):5653-64. doi: 10.1113/jphysiol.2009.177550. Epub 2009 Oct 5.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15272049\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Sharshar T, Hopkinson NS, Jonville S, Prigent H, Carlier R, Dayer MJ, Swallow EB, Lofaso F, Moxham J, Polkey MI. Demonstration of a second rapidly conducting cortico-diaphragmatic pathway in humans. J Physiol. 2004 Nov 1;560(Pt 3):897-908. doi: 10.1113/jphysiol.2004.061150. Epub 2004 Jul 22.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"8756819\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Similowski T, Catala M, Rancurel G, Derenne JP. Impairment of central motor conduction to the diaphragm in stroke. Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 1):436-41. doi: 10.1164/ajrccm.154.2.8756819.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00302822\",\n",
      "    \"BriefTitle\": \"Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Hoffmann-La Roche | Gilead Sciences\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2006-03-15\",\n",
      "    \"StartDate\": \"2006-04\",\n",
      "    \"CompletionDate\": \"2009-12\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00196625\",\n",
      "    \"BriefTitle\": \"Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-Infected Patients in Virological Failure.\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-09-20\",\n",
      "    \"StartDate\": \"2000-11\",\n",
      "    \"CompletionDate\": \"2002-02\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"15456093\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Raguin G, Chene G, Morand-Joubert L, Taburet AM, Droz C, Le Tiec C, Clavel F, Girard PM; Puzzle 1 Study Group. Salvage therapy with amprenavir, lopinavir and ritonavir 200 mg/d or 400 mg/d in HIV-infected patients in virological failure. Antivir Ther. 2004 Aug;9(4):615-25.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15060509\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Taburet AM, Raguin G, Le Tiec C, Droz C, Barrail A, Vincent I, Morand-Joubert L, Chene G, Clavel F, Girard PM. Interactions between amprenavir and the lopinavir-ritonavir combination in heavily pretreated patients infected with human immunodeficiency virus. Clin Pharmacol Ther. 2004 Apr;75(4):310-23. doi: 10.1016/j.clpt.2003.12.013.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01188525\",\n",
      "    \"BriefTitle\": \"Pharmacokinetic Study to Characterize Individual Metabolic Profile\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"Nuclear Energy Commission (CEA)\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2010-08-25\",\n",
      "    \"StartDate\": \"2010-08\",\n",
      "    \"CompletionDate\": \"2011-07\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00670839\",\n",
      "    \"BriefTitle\": \"Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"MCM Vaccines B.V.\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2008-05-02\",\n",
      "    \"StartDate\": \"2008-05\",\n",
      "    \"CompletionDate\": \"2013-02\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"26257021\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Rey D, Piroth L, Wendling MJ, Miailhes P, Michel ML, Dufour C, Haour G, Sogni P, Rohel A, Ajana F, Billaud E, Molina JM, Launay O, Carrat F; ANRS HB04 B-BOOST study group. Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial. Lancet Infect Dis. 2015 Nov;15(11):1283-91. doi: 10.1016/S1473-3099(15)00220-0. Epub 2015 Aug 6.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00158522\",\n",
      "    \"BriefTitle\": \"Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Hoffmann-La Roche\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-09-12\",\n",
      "    \"StartDate\": \"2003-02\",\n",
      "    \"CompletionDate\": \"2007-12\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"16434426\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Bakr I, Rekacewicz C, El Hosseiny M, Ismail S, El Daly M, El-Kafrawy S, Esmat G, Hamid MA, Mohamed MK, Fontanet A. Higher clearance of hepatitis C virus infection in females compared with males. Gut. 2006 Aug;55(8):1183-7. doi: 10.1136/gut.2005.078147. Epub 2006 Jan 24.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15977225\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"El Gaafary MM, Rekacewicz C, Abdel-Rahman AG, Allam MF, El Hosseiny M, Hamid MA, Colombani F, Sultan Y, El-Aidy S, Fontanet A, Mohamed MK. Surveillance of acute hepatitis C in Cairo, Egypt. J Med Virol. 2005 Aug;76(4):520-5. doi: 10.1002/jmv.20392.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00196586\",\n",
      "    \"BriefTitle\": \"Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Hoffmann-La Roche\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-09-20\",\n",
      "    \"StartDate\": \"2003-04\",\n",
      "    \"CompletionDate\": \"2006-11\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04808986\",\n",
      "    \"BriefTitle\": \"Seroprevalence of IgG Antibodies to SARS-CoV-2 (COVID-19) in Primary Health Care Workers and Their Household Contacts\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2021-03-22\",\n",
      "    \"StartDate\": \"2021-05-10\",\n",
      "    \"CompletionDate\": \"2021-10-12\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02626286\",\n",
      "    \"BriefTitle\": \"Feasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan Africa\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Expertise France | Universit\\u00e9 Montpellier | IRD Unit\\u00e9 SESSTIM (IRD, Inserm, Universit\\u00e9 Aix-Marseille) | Coalition Internationale Sida | ARCAD-SIDA MALI | Espace Confiance, C\\u00f4te d'Ivoire | Programme PAC-CI, Abidjan, C\\u00f4te d'Ivoire | Association African Solidarit\\u00e9 | Centre de Recherche Internationale pour la Sant\\u00e9, Ouagadougou, Burkina Faso | Espoir Vie-Togo - ONG\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2015-12-10\",\n",
      "    \"StartDate\": \"2015-06\",\n",
      "    \"CompletionDate\": \"2021-01-05\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"34352834\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Dah TTE, Yaya I, Mensah E, Coulibaly A, Kouame JM, Traore I, Mora M, Palvadeau P, Anoma C, Keita BD, Spire B, Laurent C; CohMSM Study Group. Rapid antiretroviral therapy initiation and its effect on treatment response in MSM in West Africa. AIDS. 2021 Nov 1;35(13):2201-2210. doi: 10.1097/QAD.0000000000003046.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34022820\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Dah TTE, Yaya I, Sagaon-Teyssier L, Coulibaly A, Kouame MJ, Agboyibor MK, Maiga K, Traore I, Mora M, Palvadeau P, Rojas-Castro D, Diallo F, Mensah E, Anoma C, Keita BD, Spire B, Laurent C; CohMSM Study Group. Adherence to quarterly HIV prevention services and its impact on HIV incidence in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France). BMC Public Health. 2021 May 22;21(1):972. doi: 10.1186/s12889-021-10994-4.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33753460\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Yaya I, Diallo F, Kouame MJ, Agboyibor MK, Traore I, Coulibaly A, Maiga K, Mora M, Palvadeau P, Dah ETT, Mensah E, Anoma C, Dembele Keita B, Spire B, Laurent C; CohMSM Study Group. Decrease in incidence of sexually transmitted infections symptoms in men who have sex with men enrolled in a quarterly HIV prevention and care programme in West Africa (CohMSM ANRS 12324-Expertise France). Sex Transm Infect. 2022 Mar;98(2):85-94. doi: 10.1136/sextrans-2020-054755. Epub 2021 Mar 22.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01207986\",\n",
      "    \"BriefTitle\": \"Early Lung Cancer Diagnosis in HIV Infected Population With an Important Smoking History With Low Dose CT: a Pilot Study\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2010-09-23\",\n",
      "    \"StartDate\": \"2011-02\",\n",
      "    \"CompletionDate\": \"2014-08\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03537196\",\n",
      "    \"BriefTitle\": \"DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C)\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2018-05-25\",\n",
      "    \"StartDate\": \"2018-11-13\",\n",
      "    \"CompletionDate\": \"2022-12-30\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"25086286\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014 Nov;61(1 Suppl):S45-57. doi: 10.1016/j.jhep.2014.07.027. Epub 2014 Jul 30.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23172780\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013 Apr;57(4):1333-42. doi: 10.1002/hep.26141. Epub 2013 Feb 4.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22828983\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Sereno L, Mesquita F, Kato M, Jacka D, Nguyen TT, Nguyen TN. Epidemiology, responses, and way forward: the silent epidemic of viral hepatitis and HIV coinfection in Vietnam. J Int Assoc Physicians AIDS Care (Chic). 2012 Sep-Oct;11(5):311-20. doi: 10.1177/1545109712453939. Epub 2012 Jul 24.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20041309\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Clatts MC, Colon-Lopez V, Giang LM, Goldsamt LA. Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection. J Urban Health. 2010 Mar;87(2):278-291. doi: 10.1007/s11524-009-9417-9.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22098550\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Gish RG, Bui TD, Nguyen CT, Nguyen DT, Tran HV, Tran DM, Trinh HN; International Group for Liver Health in Viet Nam. Liver disease in Viet Nam: screening, surveillance, management and education: a 5-year plan and call to action. J Gastroenterol Hepatol. 2012 Feb;27(2):238-47. doi: 10.1111/j.1440-1746.2011.06974.x.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20196807\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Kallman JB, Tran S, Arsalla A, Haddad D, Stepanova M, Fang Y, Wrobel VJ, Srishord M, Younossi ZM. Vietnamese community screening for hepatitis B virus and hepatitis C virus. J Viral Hepat. 2011 Jan;18(1):70-6. doi: 10.1111/j.1365-2893.2010.01278.x.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19839502\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Pham DA, Leuangwutiwong P, Jittmittraphap A, Luplertlop N, Bach HK, Akkarathamrongsin S, Theamboonlers A, Poovorawan Y. High prevalence of Hepatitis C virus genotype 6 in Vietnam. Asian Pac J Allergy Immunol. 2009 Jun-Sep;27(2-3):153-60.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20572071\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Tanimoto T, Nguyen HC, Ishizaki A, Chung PT, Hoang TT, Nguyen VT, Kageyama S, Oka S, Pham VT, Ichimura H. Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam. J Med Virol. 2010 Aug;82(8):1355-63. doi: 10.1002/jmv.21787.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23675659\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Liang TJ, Ghany MG. Current and future therapies for hepatitis C virus infection. N Engl J Med. 2013 May 16;368(20):1907-17. doi: 10.1056/NEJMra1213651.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25920094\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Pawlotsky JM, Feld JJ, Zeuzem S, Hoofnagle JH. From non-A, non-B hepatitis to hepatitis C virus cure. J Hepatol. 2015 Apr;62(1 Suppl):S87-99. doi: 10.1016/j.jhep.2015.02.006.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23553643\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Martin NK, Vickerman P, Grebely J, Hellard M, Hutchinson SJ, Lima VD, Foster GR, Dillon JF, Goldberg DJ, Dore GJ, Hickman M. Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. Hepatology. 2013 Nov;58(5):1598-609. doi: 10.1002/hep.26431. Epub 2013 Aug 26.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23728143\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Grebely J, Matthews GV, Lloyd AR, Dore GJ. Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements. Clin Infect Dis. 2013 Oct;57(7):1014-20. doi: 10.1093/cid/cit377. Epub 2013 May 31.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27667367\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL Recommendations on Treatment of Hepatitis C 2016. J Hepatol. 2017 Jan;66(1):153-194. doi: 10.1016/j.jhep.2016.09.001. Epub 2016 Sep 22. No abstract available.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25245939\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Bruggmann P, Grebely J. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs. Int J Drug Policy. 2015 Feb;26 Suppl 1:S22-6. doi: 10.1016/j.drugpo.2014.08.014. Epub 2014 Aug 30.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27178119\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Des Jarlais D, Duong HT, Pham Minh K, Khuat OH, Nham TT, Arasteh K, Feelemyer J, Heckathorn DD, Peries M, Moles JP, Laureillard D, Nagot N; (The Drive Study Team). Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. AIDS Care. 2016 Oct;28(10):1312-5. doi: 10.1080/09540121.2016.1178698. Epub 2016 May 13.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27227200\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection: Updated Version. Geneva: World Health Organization; 2016 Apr. Available from http://www.ncbi.nlm.nih.gov/books/NBK362924/\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27148964\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Nguyen Truong T, Laureillard D, Lacombe K, Duong Thi H, Pham Thi Hanh P, Truong Thi Xuan L, Chu Thi N, Luong Que A, Vu Hai V, Nagot N, Tuaillon E, Dominguez S, Lemoine M. High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262). PLoS One. 2016 May 5;11(5):e0153744. doi: 10.1371/journal.pone.0153744. eCollection 2016.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23884064\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Martin NK, Hickman M, Hutchinson SJ, Goldberg DJ, Vickerman P. Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. Clin Infect Dis. 2013 Aug;57 Suppl 2(Suppl 2):S39-45. doi: 10.1093/cid/cit296. Erratum In: Clin Infect Dis. 2014 Apr;58(8):1203.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27427455\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Altice FL, Azbel L, Stone J, Brooks-Pollock E, Smyrnov P, Dvoriak S, Taxman FS, El-Bassel N, Martin NK, Booth R, Stover H, Dolan K, Vickerman P. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. Lancet. 2016 Sep 17;388(10050):1228-48. doi: 10.1016/S0140-6736(16)30856-X. Epub 2016 Jul 14.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22564041\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Vickerman P, Martin N, Turner K, Hickman M. Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings. Addiction. 2012 Nov;107(11):1984-95. doi: 10.1111/j.1360-0443.2012.03932.x. Epub 2012 Jul 12.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26298331\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Smith DJ, Combellick J, Jordan AE, Hagan H. Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis. Int J Drug Policy. 2015 Oct;26(10):911-21. doi: 10.1016/j.drugpo.2015.07.004. Epub 2015 Jul 26.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27349488\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Conti F, Buonfiglioli F, Scuteri A, Crespi C, Bolondi L, Caraceni P, Foschi FG, Lenzi M, Mazzella G, Verucchi G, Andreone P, Brillanti S. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. J Hepatol. 2016 Oct;65(4):727-733. doi: 10.1016/j.jhep.2016.06.015. Epub 2016 Jun 24.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33208326\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Rapoud D, Quillet C, Pham Minh K, Vu Hai V, Nguyen Thanh B, Nham Thi Tuyet T, Tran Thi H, Moles JP, Vallo R, Michel L, Feelemyer J, Weiss L, Lemoine M, Vickerman P, Fraser H, Duong Thi H, Khuat Thi Hai O, Des Jarlais D, Nagot N, Laureillard D; DRIVE-C Study Group. Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C). BMJ Open. 2020 Nov 18;10(11):e039234. doi: 10.1136/bmjopen-2020-039234.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04684758\",\n",
      "    \"BriefTitle\": \"HIV Acquisition and Life Course of Born-abroad Men Who Have Sex With Men Living in Ile-de-France: the GANYMEDE Study\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2020-12-28\",\n",
      "    \"StartDate\": \"2021-04-14\",\n",
      "    \"CompletionDate\": \"2022-06-30\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00121758\",\n",
      "    \"BriefTitle\": \"AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptides Versus Placebo in Non Infected HIV Volunteers\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Aventis Pharmaceuticals\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-07-21\",\n",
      "    \"StartDate\": \"2004-09\",\n",
      "    \"CompletionDate\": \"2007-12\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"23759749\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Richert L, Hue S, Hocini H, Raimbault M, Lacabaratz C, Surenaud M, Wiedemann A, Tisserand P, Durier C, Salmon D, Lelievre JD, Chene G, Thiebaut R, Levy Y; ANRS Vaccine Network/Vaccine Research Institute. Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers. AIDS. 2013 Jun 1;27(9):1421-31. doi: 10.1097/QAD.0b013e32835f5b60.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20625264\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Salmon-Ceron D, Durier C, Desaint C, Cuzin L, Surenaud M, Hamouda NB, Lelievre JD, Bonnet B, Pialoux G, Poizot-Martin I, Aboulker JP, Levy Y, Launay O; ANRS VAC18 trial group. Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial. AIDS. 2010 Sep 10;24(14):2211-23. doi: 10.1097/QAD.0b013e32833ce566.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02527096\",\n",
      "    \"BriefTitle\": \"A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir\\u00ae) and Dolutegravir (Tivicay\\u00ae) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 Lamidol)\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"ViiV Healthcare\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2015-08-18\",\n",
      "    \"StartDate\": \"2015-09-17\",\n",
      "    \"CompletionDate\": \"2017-03\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00158457\",\n",
      "    \"BriefTitle\": \"Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Gilead Sciences | Institut de M\\u00e9decine et d'Epid\\u00e9miologie Appliqu\\u00e9e - Fondation Internationale L\\u00e9on M'Ba\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-09-12\",\n",
      "    \"StartDate\": \"2004-06\",\n",
      "    \"CompletionDate\": \"2006-12\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00136630\",\n",
      "    \"BriefTitle\": \"Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"Assistance Publique - H\\u00f4pitaux de Paris\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-08-29\",\n",
      "    \"StartDate\": \"2005-05\",\n",
      "    \"CompletionDate\": \"2020-05\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"16193476\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Klebe S, Durr A, Rentschler A, Hahn-Barma V, Abele M, Bouslam N, Schols L, Jedynak P, Forlani S, Denis E, Dussert C, Agid Y, Bauer P, Globas C, Wullner U, Brice A, Riess O, Stevanin G. New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14. Ann Neurol. 2005 Nov;58(5):720-9. doi: 10.1002/ana.20628.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15313841\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Stevanin G, Hahn V, Lohmann E, Bouslam N, Gouttard M, Soumphonphakdy C, Welter ML, Ollagnon-Roman E, Lemainque A, Ruberg M, Brice A, Durr A. Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14. Arch Neurol. 2004 Aug;61(8):1242-8. doi: 10.1001/archneur.61.8.1242.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15365159\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Stevanin G, Durr A, Dussert C, Penet C, Brice A. Mutations in the FGF14 gene are not a major cause of spinocerebellar ataxia in Caucasians. Neurology. 2004 Sep 14;63(5):936. doi: 10.1212/01.wnl.0000137020.30604.1e. No abstract available.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16501573\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Waters MF, Minassian NA, Stevanin G, Figueroa KP, Bannister JP, Nolte D, Mock AF, Evidente VG, Fee DB, Muller U, Durr A, Brice A, Papazian DM, Pulst SM. Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes. Nat Genet. 2006 Apr;38(4):447-51. doi: 10.1038/ng1758. Epub 2006 Feb 26.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16055926\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Labauge P, Brice A, Durr A. Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases. J Med Genet. 2006 Mar;43(3):259-65. doi: 10.1136/jmg.2005.035311. Epub 2005 Jul 31.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17098887\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Depienne C, Fedirko E, Forlani S, Cazeneuve C, Ribai P, Feki I, Tallaksen C, Nguyen K, Stankoff B, Ruberg M, Stevanin G, Durr A, Brice A. Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia. J Med Genet. 2007 Apr;44(4):281-4. doi: 10.1136/jmg.2006.046425. Epub 2006 Nov 10.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17597328\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Depienne C, Fedirko E, Faucheux JM, Forlani S, Bricka B, Goizet C, Lesourd S, Stevanin G, Ruberg M, Durr A, Brice A. A de novo SPAST mutation leading to somatic mosaicism is associated with a later age at onset in HSP. Neurogenetics. 2007 Aug;8(3):231-3. doi: 10.1007/s10048-007-0090-4. Epub 2007 Jun 28.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17605047\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Hanein S, Durr A, Ribai P, Forlani S, Leutenegger AL, Nelson I, Babron MC, Elleuch N, Depienne C, Charon C, Brice A, Stevanin G. A novel locus for autosomal dominant \\\"uncomplicated\\\" hereditary spastic paraplegia maps to chromosome 8p21.1-q13.3. Hum Genet. 2007 Nov;122(3-4):261-73. doi: 10.1007/s00439-007-0396-1. Epub 2007 Jun 28.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17957230\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Ribai P, Depienne C, Fedirko E, Jothy AC, Viveweger C, Hahn-Barma V, Brice A, Durr A. Mental deficiency in three families with SPG4 spastic paraplegia. Eur J Hum Genet. 2008 Jan;16(1):97-104. doi: 10.1038/sj.ejhg.5201922. Epub 2007 Oct 24.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18378516\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"du Montcel ST, Charles P, Ribai P, Goizet C, Le Bayon A, Labauge P, Guyant-Marechal L, Forlani S, Jauffret C, Vandenberghe N, N'guyen K, Le Ber I, Devos D, Vincitorio CM, Manto MU, Tison F, Hannequin D, Ruberg M, Brice A, Durr A. Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment. Brain. 2008 May;131(Pt 5):1352-61. doi: 10.1093/brain/awn059. Epub 2008 Mar 31.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18853458\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Goizet C, Boukhris A, Mundwiller E, Tallaksen C, Forlani S, Toutain A, Carriere N, Paquis V, Depienne C, Durr A, Stevanin G, Brice A. Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. Hum Mutat. 2009 Feb;30(2):E376-85. doi: 10.1002/humu.20920.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24780882\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Tezenas du Montcel S, Durr A, Rakowicz M, Nanetti L, Charles P, Sulek A, Mariotti C, Rola R, Schols L, Bauer P, Dufaure-Gare I, Jacobi H, Forlani S, Schmitz-Hubsch T, Filla A, Timmann D, van de Warrenburg BP, Marelli C, Kang JS, Giunti P, Cook A, Baliko L, Melegh B, Boesch S, Szymanski S, Berciano J, Infante J, Buerk K, Masciullo M, Di Fabio R, Depondt C, Ratka S, Stevanin G, Klockgether T, Brice A, Golmard JL. Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6. J Med Genet. 2014 Jul;51(7):479-86. doi: 10.1136/jmedgenet-2013-102200. Epub 2014 Apr 29. Erratum In: J Med Genet. 2014 Sep;51(9):613. Bela, Melegh [corrected to Melegh, Bela].\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22491195\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Tezenas du Montcel S, Charles P, Goizet C, Marelli C, Ribai P, Vincitorio C, Anheim M, Guyant-Marechal L, Le Bayon A, Vandenberghe N, Tchikviladze M, Devos D, Le Ber I, N'Guyen K, Cazeneuve C, Tallaksen C, Brice A, Durr A. Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegia. Arch Neurol. 2012 Apr;69(4):500-8. doi: 10.1001/archneurol.2011.2713.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01579435\",\n",
      "    \"BriefTitle\": \"Experimental Therapeutics in Essential Tremor Using Transcranial Direct Current Stimulation\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-04-18\",\n",
      "    \"StartDate\": \"2012-04\",\n",
      "    \"CompletionDate\": \"2013-04\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02057796\",\n",
      "    \"BriefTitle\": \"Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-02-07\",\n",
      "    \"StartDate\": \"2014-09\",\n",
      "    \"CompletionDate\": \"2018-04\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"32558469\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Blanc FX, Badje AD, Bonnet M, Gabillard D, Messou E, Muzoora C, Samreth S, Nguyen BD, Borand L, Domergue A, Rapoud D, Natukunda N, Thai S, Juchet S, Eholie SP, Lawn SD, Domoua SK, Anglaret X, Laureillard D; STATIS ANRS 12290 Trial Team. Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults. N Engl J Med. 2020 Jun 18;382(25):2397-2410. doi: 10.1056/NEJMoa1910708.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01713335\",\n",
      "    \"BriefTitle\": \"Proteasis Evaluation in COPD\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-10-24\",\n",
      "    \"StartDate\": \"2012-10-18\",\n",
      "    \"CompletionDate\": \"2017-04\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02073630\",\n",
      "    \"BriefTitle\": \"Contribution of the Cerebellum In Sensory-motor Adaptation Via Gamma Oscillations: the Case of Dystonia\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-02-27\",\n",
      "    \"StartDate\": \"2014-02\",\n",
      "    \"CompletionDate\": \"2016-08\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT05040048\",\n",
      "    \"BriefTitle\": \"Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"Innovative Medicines Initiative | Institut d'Investigacions Biom\\u00e8diques August Pi i Sunyer | ICM Co. Ltd. | University Hospital, Bonn | Karolinska Institutet\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2021-09-10\",\n",
      "    \"StartDate\": \"2015-09-04\",\n",
      "    \"CompletionDate\": \"2018-02\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03446430\",\n",
      "    \"BriefTitle\": \"Validation of Laser Doppler Vibrometer (LDV) for Measurement of Arterial Stiffness in Hypertensive Patients\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2018-02-26\",\n",
      "    \"StartDate\": \"2018-06-21\",\n",
      "    \"CompletionDate\": \"2018-12-04\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01094899\",\n",
      "    \"BriefTitle\": \"Abnormal Structure and Bone Density in Diabetes\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2010-03-29\",\n",
      "    \"StartDate\": \"2010-03-10\",\n",
      "    \"CompletionDate\": \"2014-07-10\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03193099\",\n",
      "    \"BriefTitle\": \"Decoding Presymptomatic White Matter Changes in Huntington Disease\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"University College, London\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2017-06-20\",\n",
      "    \"StartDate\": \"2017-07-11\",\n",
      "    \"CompletionDate\": \"2019-12-30\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03831906\",\n",
      "    \"BriefTitle\": \"Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia)\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"UNITAID\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2019-02-06\",\n",
      "    \"StartDate\": \"2019-03-20\",\n",
      "    \"CompletionDate\": \"2021-06-30\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"33743621\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Vessiere A, Font H, Gabillard D, Adonis-Koffi L, Borand L, Chabala C, Khosa C, Mavale S, Moh R, Mulenga V, Mwanga-Amumpere J, Taguebue JV, Eang MT, Delacourt C, Seddon JA, Lounnas M, Godreuil S, Wobudeya E, Bonnet M, Marcy O. Impact of systematic early tuberculosis detection using Xpert MTB/RIF Ultra in children with severe pneumonia in high tuberculosis burden countries (TB-Speed pneumonia): a stepped wedge cluster randomized trial. BMC Pediatr. 2021 Mar 20;21(1):136. doi: 10.1186/s12887-021-02576-5.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"36395782\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Marcy O, Wobudeya E, Font H, Vessiere A, Chabala C, Khosa C, Taguebue JV, Moh R, Mwanga-Amumpaire J, Lounnas M, Mulenga V, Mavale S, Chilundo J, Rego D, Nduna B, Shankalala P, Chirwa U, De Lauzanne A, Dim B, Tiogouo Ngouana E, Folquet Amorrissani M, Cisse L, Amon Tanoh Dick F, Komena EA, Kwedi Nolna S, Businge G, Natukunda N, Cumbe S, Mbekeka P, Kim A, Kheang C, Pol S, Maleche-Obimbo E, Seddon JA, Mao TE, Graham SM, Delacourt C, Borand L, Bonnet M; TB-Speed Pneumonia Study Group. Effect of systematic tuberculosis detection on mortality in young children with severe pneumonia in countries with high incidence of tuberculosis: a stepped-wedge cluster-randomised trial. Lancet Infect Dis. 2023 Mar;23(3):341-351. doi: 10.1016/S1473-3099(22)00668-5. Epub 2022 Nov 14.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32853411\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Kay AW, Gonzalez Fernandez L, Takwoingi Y, Eisenhut M, Detjen AK, Steingart KR, Mandalakas AM. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children. Cochrane Database Syst Rev. 2020 Aug 27;8(8):CD013359. doi: 10.1002/14651858.CD013359.pub2.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00148824\",\n",
      "    \"BriefTitle\": \"Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults.\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Wyeth is now a wholly owned subsidiary of Pfizer\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-09-08\",\n",
      "    \"StartDate\": \"2003-02\",\n",
      "    \"CompletionDate\": \"2006-01\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"20210645\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Rabian C, Tschope I, Lesprit P, Katlama C, Molina JM, Meynard JL, Delfraissy JF, Chene G, Levy Y; ANRS 114 Pneumovac Study Group. Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults. Clin Infect Dis. 2010 Apr 15;50(8):1174-83. doi: 10.1086/651418.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00901524\",\n",
      "    \"BriefTitle\": \"ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIV\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Roche Pharma AG\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2009-05-13\",\n",
      "    \"StartDate\": \"2009-06\",\n",
      "    \"CompletionDate\": \"2012-06\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"24905490\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Laird ME, Mohsen A, Duffy D, Mamdouh R, LeFouler L, Casrouge A, El-Daly M, Rafik M, Abdel-Hamid M, Soulier A, Pawlotsky JM, Hezode C, Rosa I, Renard P, Mohamed MK, Bonnard P, Izopet J, Mallet V, Pol S, Albert ML, Fontanet A. Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection. J Hepatol. 2014 Oct;61(4):770-6. doi: 10.1016/j.jhep.2014.05.040. Epub 2014 Jun 4.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00870649\",\n",
      "    \"BriefTitle\": \"Efficacy of Bilhvax in Association With Praziquantel for Prevention of Clinical Recurrences of Schistosoma Haematobium\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2009-03-27\",\n",
      "    \"StartDate\": \"2009-02\",\n",
      "    \"CompletionDate\": \"2012-12\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"30532268\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Riveau G, Schacht AM, Dompnier JP, Deplanque D, Seck M, Waucquier N, Senghor S, Delcroix-Genete D, Hermann E, Idris-Khodja N, Levy-Marchal C, Capron M, Capron A. Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: A phase 3 randomized, controlled trial in Senegalese children. PLoS Negl Trop Dis. 2018 Dec 7;12(12):e0006968. doi: 10.1371/journal.pntd.0006968. eCollection 2018 Dec.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01207349\",\n",
      "    \"BriefTitle\": \"Type 2 Diabetes Secondary Prevention\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"Groupe Hospitalier Sud R\\u00e9union\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2010-09-22\",\n",
      "    \"StartDate\": \"2002-08\",\n",
      "    \"CompletionDate\": \"2004-12\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"22030240\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Debussche X, Rollot O, Le Pommelet C, Fianu A, Le Moullec N, Regnier C, Boyer MC, Cogne M, Bakiri F, Schwager JC, Favier F. Quarterly individual outpatients lifestyle counseling after initial inpatients education on type 2 diabetes: the REDIA Prev-2 randomized controlled trial in Reunion Island. Diabetes Metab. 2012 Feb;38(1):46-53. doi: 10.1016/j.diabet.2011.07.002. Epub 2011 Oct 24.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01531036\",\n",
      "    \"BriefTitle\": \"3D Breast Ultrasound Elastography in Patients Under Neoadjuvant Chemotherapy\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-02-10\",\n",
      "    \"StartDate\": \"2010-12\",\n",
      "    \"CompletionDate\": \"2012-11\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"20505064\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Athanasiou A, Tardivon A, Tanter M, Sigal-Zafrani B, Bercoff J, Deffieux T, Gennisson JL, Fink M, Neuenschwander S. Breast lesions: quantitative elastography with supersonic shear imaging--preliminary results. Radiology. 2010 Jul;256(1):297-303. doi: 10.1148/radiol.10090385. Epub 2010 May 26.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00651066\",\n",
      "    \"BriefTitle\": \"Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2008-04-02\",\n",
      "    \"StartDate\": \"2010-06\",\n",
      "    \"CompletionDate\": \"2012-09\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"24465443\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Lan NT, Thu NT, Barrail-Tran A, Duc NH, Lan NN, Laureillard D, Lien TT, Borand L, Quillet C, Connolly C, Lagarde D, Pym A, Lienhardt C, Dung NH, Taburet AM, Harries AD. Randomised pharmacokinetic trial of rifabutin with lopinavir/ritonavir-antiretroviral therapy in patients with HIV-associated tuberculosis in Vietnam. PLoS One. 2014 Jan 22;9(1):e84866. doi: 10.1371/journal.pone.0084866. eCollection 2014.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02081066\",\n",
      "    \"BriefTitle\": \"Identification of CETP as a Marker of Atherosclerosis\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-03-07\",\n",
      "    \"StartDate\": \"2014-09-25\",\n",
      "    \"CompletionDate\": \"2020-09\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01164436\",\n",
      "    \"BriefTitle\": \"Cohort of HIV Associated Lymphomas\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Dr Yassine Taoufik Dr Houria Chavez H\\u00f4pital Bic\\u00eatre CIB Paris Sud France | Dr Guislaine Garcelain H\\u00f4pital Piti\\u00e9 Slap\\u00e9tri\\u00e8re Paris France | University Hospital, Grenoble | Dr Ir\\u00e8ne Joab H\\u00f4pital Paul Brousse Villejuif France | Dr Alex Duval Fondation Jean Dausset CEPH | Hopital Antoine Beclere\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2010-07-16\",\n",
      "    \"StartDate\": \"2008-06\",\n",
      "    \"CompletionDate\": \"2017-06\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01038999\",\n",
      "    \"BriefTitle\": \"Accelerated Aging, HIV Infection, Antiretroviral Therapies\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2009-12-24\",\n",
      "    \"StartDate\": \"2009-04\",\n",
      "    \"CompletionDate\": \"2012-03\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"23285253\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Perrin S, Cremer J, Faucher O, Reynes J, Dellamonica P, Micallef J, Solas C, Lacarelle B, Stretti C, Kaspi E, Robaglia-Schlupp A, Nicolino-Brunet C, Tamalet C, Levy N, Poizot-Martin I, Cau P, Roll P. HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 \\\"aging\\\" study. PLoS One. 2012;7(12):e53035. doi: 10.1371/journal.pone.0053035. Epub 2012 Dec 28. Erratum In: PLoS One. 2013;8(8). doi:10.1371/annotation/f02cdfd3-b271-46fd-a78f-5a030f0b416d. Tamalet, Corine Nicolino-Brunet Catherine [corrected to Nicolino-Brunet, Corinne]; [ corrected to Tamalet, Catherine].\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22829920\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Perrin S, Cremer J, Roll P, Faucher O, Menard A, Reynes J, Dellamonica P, Naqvi A, Micallef J, Jouve E, Tamalet C, Solas C, Pissier C, Arnoux I, Nicolino-Brunet C, Espinosa L, Levy N, Kaspi E, Robaglia-Schlupp A, Poizot-Martin I, Cau P. HIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: the ANRS EP45 \\\"Aging\\\" study. PLoS One. 2012;7(7):e41129. doi: 10.1371/journal.pone.0041129. Epub 2012 Jul 19.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00604149\",\n",
      "    \"BriefTitle\": \"Cardiac AResT And GENEtic\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2008-01-30\",\n",
      "    \"StartDate\": \"2008-01\",\n",
      "    \"CompletionDate\": \"2014-01\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01569399\",\n",
      "    \"BriefTitle\": \"Efficacity of rTMS in Alcohol Dependance\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-04-03\",\n",
      "    \"StartDate\": \"2011-02-11\",\n",
      "    \"CompletionDate\": \"2016-08\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01917175\",\n",
      "    \"BriefTitle\": \"Early Identification and Treatment of Early HIV Infection in C\\u00f4te d'Ivoire\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2013-08-06\",\n",
      "    \"StartDate\": \"1997-06\",\n",
      "    \"CompletionDate\": \"2018-09\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01592175\",\n",
      "    \"BriefTitle\": \"Magnetoencephalography (MEG), Attention and Conscience\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-05-07\",\n",
      "    \"StartDate\": \"2012-03-08\",\n",
      "    \"CompletionDate\": \"2013-07-02\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01271842\",\n",
      "    \"BriefTitle\": \"Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU Study\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2011-01-07\",\n",
      "    \"StartDate\": \"2010-10\",\n",
      "    \"CompletionDate\": null,\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"22948576\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Luyt CE, Combes A, Becquemin MH, Beigelman-Aubry C, Hatem S, Brun AL, Zraik N, Carrat F, Grenier PA, Richard JM, Mercat A, Brochard L, Brun-Buisson C, Chastre J; REVA Study Group. Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS. Chest. 2012 Sep;142(3):583-592. doi: 10.1378/chest.11-2196.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00265642\",\n",
      "    \"BriefTitle\": \"Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Sanofi\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-12-15\",\n",
      "    \"StartDate\": \"2006-10\",\n",
      "    \"CompletionDate\": \"2013-11\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01008813\",\n",
      "    \"BriefTitle\": \"Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"GlaxoSmithKline\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2009-11-06\",\n",
      "    \"StartDate\": \"2009-10\",\n",
      "    \"CompletionDate\": \"2010-12\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00158470\",\n",
      "    \"BriefTitle\": \"Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-09-12\",\n",
      "    \"StartDate\": \"2003-09\",\n",
      "    \"CompletionDate\": \"2007-05\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04265742\",\n",
      "    \"BriefTitle\": \"Microbiota and Bone Fragility:Study of the Relation Between Gut Microbiota and Bone Microarchitecture\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"Merck Sharp & Dohme LLC\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2020-02-12\",\n",
      "    \"StartDate\": \"2019-02-08\",\n",
      "    \"CompletionDate\": \"2022-02-04\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04631224\",\n",
      "    \"BriefTitle\": \"Longitudinal Analysis of Oral Communication in Friedreich's Ataxia\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2020-11-17\",\n",
      "    \"StartDate\": \"2015-02\",\n",
      "    \"CompletionDate\": \"2017-02\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01493934\",\n",
      "    \"BriefTitle\": \"Development of a Fast Measurement Technique of Insulin Resistance in Human\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2011-12-16\",\n",
      "    \"StartDate\": \"2010-04\",\n",
      "    \"CompletionDate\": \"2013-03\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02978924\",\n",
      "    \"BriefTitle\": \"Trans-spinal Direct Current Stimulation in Primary Orthostatic Tremor\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2016-12-01\",\n",
      "    \"StartDate\": \"2017-01-17\",\n",
      "    \"CompletionDate\": \"2017-11-28\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00226434\",\n",
      "    \"BriefTitle\": \"Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"National Institutes of Health (NIH)\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-09-27\",\n",
      "    \"StartDate\": \"2006-01\",\n",
      "    \"CompletionDate\": \"2010-05\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"17624825\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Blanc FX, Havlir DV, Onyebujoh PC, Thim S, Goldfeld AE, Delfraissy JF. Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials. J Infect Dis. 2007 Aug 15;196 Suppl 1:S46-51. doi: 10.1086/518658.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24759827\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Marcy O, Laureillard D, Madec Y, Chan S, Mayaud C, Borand L, Prak N, Kim C, Lak KK, Hak C, Dim B, Sok T, Delfraissy JF, Goldfeld AE, Blanc FX; CAMELIA (ANRS 1295-CIPRA KH001) Study Team. Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial. Clin Infect Dis. 2014 Aug 1;59(3):435-45. doi: 10.1093/cid/ciu283. Epub 2014 Apr 23.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24096631\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Laureillard D, Marcy O, Madec Y, Chea S, Chan S, Borand L, Fernandez M, Prak N, Kim C, Dim B, Nerrienet E, Sok T, Delfraissy JF, Goldfeld AE, Blanc FX; CAMELIA (ANRS 1295 - CIPRA KH001) Study Team. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial. AIDS. 2013 Oct 23;27(16):2577-86. doi: 10.1097/01.aids.0000432456.14099.c7.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24608960\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Borand L, Madec Y, Laureillard D, Chou M, Marcy O, Pheng P, Prak N, Kim C, Lak KK, Hak C, Dim B, Nerrienet E, Fontanet A, Sok T, Goldfeld AE, Blanc FX, Taburet AM. Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial). PLoS One. 2014 Mar 7;9(3):e90350. doi: 10.1371/journal.pone.0090350. eCollection 2014.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23237982\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Borand L, Laureillard D, Madec Y, Chou M, Pheng P, Marcy O, Sok T, Goldfeld AE, Taburet AM, Blanc FX; CAMELIA ANRS 1295-CIPRA KH001 Study Team. Plasma concentrations of efavirenz with a 600 mg standard dose in Cambodian HIV-infected adults treated for tuberculosis with a body weight above 50 kg. Antivir Ther. 2013;18(3):419-23. doi: 10.3851/IMP2483. Epub 2012 Dec 12.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22010913\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, Madec Y, Marcy O, Chan S, Prak N, Kim C, Lak KK, Hak C, Dim B, Sin CI, Sun S, Guillard B, Sar B, Vong S, Fernandez M, Fox L, Delfraissy JF, Goldfeld AE; CAMELIA (ANRS 1295-CIPRA KH001) Study Team. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med. 2011 Oct 20;365(16):1471-81. doi: 10.1056/NEJMoa1013911.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04392388\",\n",
      "    \"BriefTitle\": \"Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2020-05-18\",\n",
      "    \"StartDate\": \"2020-05-01\",\n",
      "    \"CompletionDate\": \"2023-04-11\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00928187\",\n",
      "    \"BriefTitle\": \"Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaound\\u00e9)\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Gilead Sciences | Janssen Pharmaceutica\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": true,\n",
      "    \"StudyFirstPostDate\": \"2009-06-25\",\n",
      "    \"StartDate\": \"2009-11\",\n",
      "    \"CompletionDate\": \"2015-12\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"31273686\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Boyer S, Nishimwe ML, Sagaon-Teyssier L, March L, Koulla-Shiro S, Bousmah MQ, Toby R, Mpoudi-Etame MP, Ngom Gueye NF, Sawadogo A, Kouanfack C, Ciaffi L, Spire B, Delaporte E; 2-Lady Group. Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa. Pharmacoecon Open. 2020 Mar;4(1):45-60. doi: 10.1007/s41669-019-0157-9.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00640887\",\n",
      "    \"BriefTitle\": \"Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2008-03-21\",\n",
      "    \"StartDate\": \"2009-02\",\n",
      "    \"CompletionDate\": \"2010-10\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"26482301\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Hennig S, Naiker S, Reddy T, Egan D, Kellerman T, Wiesner L, Owen A, McIlleron H, Pym A. Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis. Antimicrob Agents Chemother. 2015 Oct 19;60(1):617-20. doi: 10.1128/AAC.01195-15. Print 2016 Jan.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25406657\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Naiker S, Connolly C, Wiesner L, Kellerman T, Reddy T, Harries A, McIlleron H, Lienhardt C, Pym A. Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy. BMC Pharmacol Toxicol. 2014 Nov 19;15:61. doi: 10.1186/2050-6511-15-61.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01952587\",\n",
      "    \"BriefTitle\": \"X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2013-09-30\",\n",
      "    \"StartDate\": \"2013-11\",\n",
      "    \"CompletionDate\": \"2015-06\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01089387\",\n",
      "    \"BriefTitle\": \"Intracavernous Bone Marrow Stem-cell Injection for Post Prostatectomy Erectile Dysfunction\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2010-03-18\",\n",
      "    \"StartDate\": \"2010-05\",\n",
      "    \"CompletionDate\": \"2015-03\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"28753830\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Yiou R, Hamidou L, Birebent B, Bitari D, Le Corvoisier P, Contremoulins I, Rodriguez AM, Augustin D, Roudot-Thoraval F, de la Taille A, Rouard H. Intracavernous Injections of Bone Marrow Mononucleated Cells for Postradical Prostatectomy Erectile Dysfunction: Final Results of the INSTIN Clinical Trial. Eur Urol Focus. 2017 Dec;3(6):643-645. doi: 10.1016/j.euf.2017.06.009. Epub 2017 Jun 24.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25974235\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Khera M, Albersen M, Mulhall JP. Mesenchymal stem cell therapy for the treatment of erectile dysfunction. J Sex Med. 2015 May;12(5):1105-6. doi: 10.1111/jsm.12871. No abstract available.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02833961\",\n",
      "    \"BriefTitle\": \"Diffusion Spectroscopy in Stroke\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2016-07-14\",\n",
      "    \"StartDate\": \"2016-07-28\",\n",
      "    \"CompletionDate\": \"2019-10-25\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02453061\",\n",
      "    \"BriefTitle\": \"A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's Disease\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"Ultragenyx Pharmaceutical Inc\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2015-05-25\",\n",
      "    \"StartDate\": \"2015-06-29\",\n",
      "    \"CompletionDate\": \"2019-12-03\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"31381524\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Rodrigues FB, Ferreira JJ, Wild EJ. Huntington's Disease Clinical Trials Corner: June 2019. J Huntingtons Dis. 2019;8(3):363-371. doi: 10.3233/JHD-199003.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01494961\",\n",
      "    \"BriefTitle\": \"Couple-oriented Prenatal HIV Counseling in Low and Medium HIV Prevalence Countries\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Elizabeth Glaser Pediatric AIDS Foundation\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2011-12-19\",\n",
      "    \"StartDate\": \"2009-02\",\n",
      "    \"CompletionDate\": \"2011-10\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"20403152\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Orne-Gliemann J, Tchendjou PT, Miric M, Gadgil M, Butsashvili M, Eboko F, Perez-Then E, Darak S, Kulkarni S, Kamkamidze G, Balestre E, du Lou AD, Dabis F. Couple-oriented prenatal HIV counseling for HIV primary prevention: an acceptability study. BMC Public Health. 2010 Apr 19;10:197. doi: 10.1186/1471-2458-10-197.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21857289\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Tchendjou PT, Koki PN, Eboko F, Malateste K, Essounga AN, Amassana D, Mossus T, Tejiokem M, Boisier P, Orne-Gliemann J. Factors associated with history of HIV testing among pregnant women and their partners in Cameroon: baseline data from a Behavioral Intervention Trial (ANRS 12127 Prenahtest). J Acquir Immune Defic Syndr. 2011 Jul 1;57 Suppl 1:S9-15. doi: 10.1097/QAI.0b013e31821ec6e2.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34329355\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Kengne-Nde C, Tejiokem MC, Orne-Gliemann J, Melingui B, Koki Ndombo P, Essounga NA, Bissek AC, Cauchemez S, Tchendjou PT. Couple oriented counselling improves male partner involvement in sexual and reproductive health of a couple: Evidence from the ANRS PRENAHTEST randomized trial. PLoS One. 2021 Jul 30;16(7):e0255330. doi: 10.1371/journal.pone.0255330. eCollection 2021.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29178852\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Tiendrebeogo T, Plazy M, Darak S, Miric M, Perez-Then E, Butsashvili M, Tchendjou P, Dabis F, Orne-Gliemann J. Couples HIV counselling and couple relationships in India, Georgia and the Dominican Republic. BMC Public Health. 2017 Nov 25;17(1):901. doi: 10.1186/s12889-017-4901-8.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23343912\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Orne-Gliemann J, Balestre E, Tchendjou P, Miric M, Darak S, Butsashvili M, Perez-Then E, Eboko F, Plazy M, Kulkarni S, Desgrees du Lou A, Dabis F; Prenahtest ANRS 12127 Study Group. Increasing HIV testing among male partners. AIDS. 2013 Apr 24;27(7):1167-77. doi: 10.1097/QAD.0b013e32835f1d8c.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00301561\",\n",
      "    \"BriefTitle\": \"Antiretroviral Treatment Simplified Follow-up Management Assessment (ANRS 12110 STRATALL)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2006-03-13\",\n",
      "    \"StartDate\": \"2006-05\",\n",
      "    \"CompletionDate\": \"2010-10\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"35248123\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Sandie AB, Molinari N, Wanjoya A, Kouanfack C, Laurent C, Tchatchueng-Mbougua JB. Non-inferiority test for a continuous variable with a flexible margin in an active controlled trial: an application to the \\\"Stratall ANRS 12110 / ESTHER\\\" trial. Trials. 2022 Mar 5;23(1):202. doi: 10.1186/s13063-022-06118-x.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21831714\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Laurent C, Kouanfack C, Laborde-Balen G, Aghokeng AF, Mbougua JB, Boyer S, Carrieri MP, Mben JM, Dontsop M, Kaze S, Molinari N, Bourgeois A, Mpoudi-Ngole E, Spire B, Koulla-Shiro S, Delaporte E; Stratall ANRS 12110/ESTHER study group. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial. Lancet Infect Dis. 2011 Nov;11(11):825-33. doi: 10.1016/S1473-3099(11)70168-2. Epub 2011 Aug 8.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01167283\",\n",
      "    \"BriefTitle\": \"Effect of Electrostimulation in Chronic Obstructive Pulmonary Disease (COPD)\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"Centre Hospitalier R\\u00e9gional Universitaire Montpellier\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2010-07-22\",\n",
      "    \"StartDate\": \"2006-07\",\n",
      "    \"CompletionDate\": \"2010-04\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02150993\",\n",
      "    \"BriefTitle\": \"First-Line Treatment for HIV-2\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-05-30\",\n",
      "    \"StartDate\": \"2016-01-26\",\n",
      "    \"CompletionDate\": \"2019-05-15\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01075061\",\n",
      "    \"BriefTitle\": \"Study of a Large Family With Congenital Mirror Movements : From Underlying Pathophysiology to Culprit Gene Identification PROJET \\\" MOMIC \\\"\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2010-02-24\",\n",
      "    \"StartDate\": \"2010-02\",\n",
      "    \"CompletionDate\": \"2011-07\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02014883\",\n",
      "    \"BriefTitle\": \"Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"Ultragenyx Pharmaceutical Inc\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2013-12-18\",\n",
      "    \"StartDate\": \"2013-12-04\",\n",
      "    \"CompletionDate\": \"2019-07-04\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"26536893\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Mochel F, Hainque E, Gras D, Adanyeguh IM, Caillet S, Heron B, Roubertie A, Kaphan E, Valabregue R, Rinaldi D, Vuillaumier S, Schiffmann R, Ottolenghi C, Hogrel JY, Servais L, Roze E. Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency. J Neurol Neurosurg Psychiatry. 2016 May;87(5):550-3. doi: 10.1136/jnnp-2015-311475. Epub 2015 Nov 3.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00158483\",\n",
      "    \"BriefTitle\": \"Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-09-12\",\n",
      "    \"StartDate\": \"2003-05\",\n",
      "    \"CompletionDate\": \"2005-10\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"16455895\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Legoff J, Bouhlal H, Gresenguet G, Weiss H, Khonde N, Hocini H, Desire N, Si-Mohamed A, de Dieu Longo J, Chemin C, Frost E, Pepin J, Malkin JE, Mayaud P, Belec L. Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV. J Clin Microbiol. 2006 Feb;44(2):423-32. doi: 10.1128/JCM.44.2.423-432.2006.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18385443\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"LeGoff J, Mayaud P, Gresenguet G, Weiss HA, Nzambi K, Frost E, Pepin J, Belec L; ANRS 12-12 Study Group. Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2. J Clin Microbiol. 2008 Jun;46(6):1914-8. doi: 10.1128/JCM.02332-07. Epub 2008 Apr 2.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19530940\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Mayaud P, Legoff J, Weiss HA, Gresenguet G, Nzambi K, Bouhlal H, Frost E, Pepin J, Malkin JE, Hayes RJ, Mabey DC, Belec L; ANRS 1212 Study Group. Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial. J Infect Dis. 2009 Jul 15;200(2):216-26. doi: 10.1086/599991.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02481453\",\n",
      "    \"BriefTitle\": \"Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2015-06-25\",\n",
      "    \"StartDate\": \"2015-07-15\",\n",
      "    \"CompletionDate\": \"2018-01-22\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"20413309\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Benveniste O, Hilton-Jones D. International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009. Neuromuscul Disord. 2010 Jun;20(6):414-21. doi: 10.1016/j.nmd.2010.03.014. Epub 2010 Apr 21. No abstract available.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24975859\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Lloyd TE, Mammen AL, Amato AA, Weiss MD, Needham M, Greenberg SA. Evaluation and construction of diagnostic criteria for inclusion body myositis. Neurology. 2014 Jul 29;83(5):426-33. doi: 10.1212/WNL.0000000000000642. Epub 2014 Jun 27.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02329054\",\n",
      "    \"BriefTitle\": \"Efficacy of Favipiravir Against Ebola (JIKI)\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-12-31\",\n",
      "    \"StartDate\": \"2014-12\",\n",
      "    \"CompletionDate\": \"2015-09\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"25435054\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Mentre F, Taburet AM, Guedj J, Anglaret X, Keita S, de Lamballerie X, Malvy D. Dose regimen of favipiravir for Ebola virus disease. Lancet Infect Dis. 2015 Feb;15(2):150-1. doi: 10.1016/S1473-3099(14)71047-3. Epub 2014 Nov 28. No abstract available.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27046271\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Munoz VC, Doumbouya L, Harouna S, Kighoma PM, Koundouno FR, Lolamou R, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wolfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Uwamahoro MG, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D'Ortenzio E, Pizarro L, Etienne A, Guedj J, Fizet A, de Sainte Fare EB, Murgue B, Tran-Minh T, Rapp C, Piguet P, Poncin M, Draguez B, Duverger TA, Barbe S, Baret G, Defourny I, Carroll M, Raoul H, Augier A, Eholie SP, Yazdanpanah Y, Levy-Marchal C, Antierrens A, Van Herp M, Gunther S, de Lamballerie X, Keita S, Mentre F, Anglaret X, Malvy D; JIKI Study Group. Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLoS Med. 2016 Apr 5;13(4):e1002009. doi: 10.1371/journal.pmed.1002009. eCollection 2016 Apr.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28231247\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Nguyen TH, Guedj J, Anglaret X, Laouenan C, Madelain V, Taburet AM, Baize S, Sissoko D, Pastorino B, Rodallec A, Piorkowski G, Carazo S, Conde MN, Gala JL, Bore JA, Carbonnelle C, Jacquot F, Raoul H, Malvy D, de Lamballerie X, Mentre F; JIKI study group. Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted. PLoS Negl Trop Dis. 2017 Feb 23;11(2):e0005389. doi: 10.1371/journal.pntd.0005389. eCollection 2017 Feb.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26930627\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Chanfreau Munoz V, Doumbouya L, Souley Harouna, Kighoma PM, Koundouno FR, Rene Lolamou, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wolfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Gasasira Uwamahoro M, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D'Ortenzio E, Pizarro L, Etienne A, Guedj J, Fizet A, Barte de Sainte Fare E, Murgue B, Tran-Minh T, Rapp C, Piguet P, Poncin M, Draguez B, Allaford Duverger T, Barbe S, Baret G, Defourny I, Carroll M, Raoul H, Augier A, Eholie SP, Yazdanpanah Y, Levy-Marchal C, Antierrens A, Van Herp M, Gunther S, de Lamballerie X, Keita S, Mentre F, Anglaret X, Malvy D; JIKI Study Group. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLoS Med. 2016 Mar 1;13(3):e1001967. doi: 10.1371/journal.pmed.1001967. eCollection 2016 Mar. Erratum In: PLoS Med. 2016 Apr;13(4):e1002009. Dortenzio, Eric [corrected to D'Ortenzio, Eric]. PLoS Med. 2016 Jun;13(6):e1002066.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02027233\",\n",
      "    \"BriefTitle\": \"Clinical Trial to Assess the Influenza Vaccination of the Hospitalized Adults\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-01-06\",\n",
      "    \"StartDate\": \"2014-01\",\n",
      "    \"CompletionDate\": \"2022-12-31\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02093754\",\n",
      "    \"BriefTitle\": \"Assessing the Severity of Metabolic-related Liver Injuries in Aging HIV-monoinfected Patients\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-03-21\",\n",
      "    \"StartDate\": \"2014-05\",\n",
      "    \"CompletionDate\": \"2016-03\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03324633\",\n",
      "    \"BriefTitle\": \"Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Bristol-Myers Squibb | GlaxoSmithKline | Merck Serono International SA | Roche Pharma AG | Schering-Plough\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2017-10-30\",\n",
      "    \"StartDate\": \"2005-06\",\n",
      "    \"CompletionDate\": \"2022-12\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"27317796\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Sogni P, Gilbert C, Lacombe K, Piroth L, Rosenthal E, Miailhes P, Gervais A, Esterle L, Chas J, Poizot-Martin I, Dominguez S, Simon A, Morlat P, Neau D, Zucman D, Bouchaud O, Lascoux-Combe C, Bani-Sadr F, Alric L, Goujard C, Vittecoq D, Billaud E, Aumaitre H, Boue F, Valantin MA, Dabis F, Salmon D, Wittkop L. All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort. Clin Infect Dis. 2016 Sep 15;63(6):763-770. doi: 10.1093/cid/ciw379. Epub 2016 Jun 17.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27177169\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Marcellin F, Protopopescu C, Poizot-Martin I, Miailhes P, Esterle L, Wittkop L, Spire B, Bocquier A, Salmon-Ceron D, Dabis F, Carrieri MP; HEPAVIH ANRS CO13 Study Group. Short article: Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort). Eur J Gastroenterol Hepatol. 2016 Sep;28(9):1003-7. doi: 10.1097/MEG.0000000000000664.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27073179\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Marcellin F, Lions C, Rosenthal E, Roux P, Sogni P, Wittkop L, Protopopescu C, Spire B, Salmon-Ceron D, Dabis F, Carrieri MP; HEPAVIH ANRS CO13 Study Group*. No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort). Drug Alcohol Rev. 2017 Mar;36(2):227-238. doi: 10.1111/dar.12398. Epub 2016 Apr 13.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25778750\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Carrieri MP, Serfaty L, Vilotitch A, Winnock M, Poizot-Martin I, Loko MA, Lions C, Lascoux-Combe C, Roux P, Salmon-Ceron D, Spire B, Dabis F; ANRS CO13 HEPAVIH Study Group. Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH). Clin Infect Dis. 2015 Jul 1;61(1):40-8. doi: 10.1093/cid/civ217. Epub 2015 Mar 16.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25015913\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Marcellin F, Roux P, Loko MA, Lions C, Caumont-Prim A, Dabis F, Salmon-Ceron D, Spire B, Carrieri MP; HEPAVIH (ANRS CO13) Study Group. High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort. Clin Infect Dis. 2014 Oct 15;59(8):1190-2. doi: 10.1093/cid/ciu525. Epub 2014 Jul 11. No abstract available.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26528903\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Salmon D, Bani-Sadr F, Gilbert C, Rosenthal E, Valantin MA, Simon A, Neau D, Morlat P, Loko MA, Wittkop L, Dabis F; ANRS CO13HEPAVIH study group. HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patients. J Clin Virol. 2015 Dec;73:32-35. doi: 10.1016/j.jcv.2015.10.010. Epub 2015 Oct 19.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26372388\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"ANRS CO13 HEPAVIH Cohort. Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients. AIDS. 2015 Sep 10;29(14):1821-30. doi: 10.1097/QAD.0000000000000787.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24166726\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Roux P, Lions C, Cohen J, Winnock M, Salmon-Ceron D, Bani-Sadr F, Sogni P, Spire B, Dabis F, Carrieri MP; ANRS-CO13-HEPAVIH Study Group. Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort. Antivir Ther. 2014;19(2):171-8. doi: 10.3851/IMP2699. Epub 2013 Oct 28.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24580042\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Marcellin F, Roux P, Winnock M, Lions C, Dabis F, Salmon-Ceron D, Loko MA, Spire B, Carrieri MP. Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort. Expert Rev Gastroenterol Hepatol. 2014 May;8(4):351-8. doi: 10.1586/17474124.2014.888949. Epub 2014 Mar 3.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23978720\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Carrieri MP, Lions C, Sogni P, Winnock M, Roux P, Mora M, Bonnard P, Salmon D, Dabis F, Spire B; ANRS CO13 HEPAVIH Study Group. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study. J Hepatol. 2014 Jan;60(1):46-53. doi: 10.1016/j.jhep.2013.08.014. Epub 2013 Aug 24.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24499953\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Bani-Sadr F, Loko MA, Pambrun E, Winnock M, Carrieri P, Gilbert C, Duvivier C, Bouchaud O, Gervais A, Dabis F, Salmon D; ANRS CO 13 HEPAVIH Study Group. Correlates of HIV sustained viral suppression in HIV/hepatitis C virus coinfected patients: possible role of the hepatitis C virus sustained viral response. AIDS. 2014 May 15;28(8):1155-60. doi: 10.1097/QAD.0000000000000218.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23461846\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Winnock M, Bani-Sadr F, Pambrun E, Loko MA, Carrieri P, Neau D, Morlat P, Marchou B, Dabis F, Salmon D; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) CO13 HEPAVIH Study Group. Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions. HIV Med. 2013 Aug;14(7):430-6. doi: 10.1111/hiv.12023. Epub 2013 Mar 5.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23421419\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Marcellin F, Lions C, Winnock M, Salmon D, Durant J, Spire B, Mora M, Loko MA, Dabis F, Dominguez S, Roux P, Carrieri MP; ANRS CO13 HEPAVIH Study Group. Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort). Addiction. 2013 Jul;108(7):1250-8. doi: 10.1111/add.12149. Epub 2013 Mar 21.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22285372\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Trimoulet P, Merchadou L, Winnock M, Loko MA, Fleury H, Salmon D, Dabis F, Neau D; ANRS CO 13 HEPAVIH Study Group. Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: should the same test be applied to all samples? J Virol Methods. 2012 Apr;181(1):131-3. doi: 10.1016/j.jviromet.2012.01.006. Epub 2012 Jan 20.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22781224\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Solas C, Pambrun E, Winnock M, Salmon D, Poizot-Martin I, Dominguez S, Bani-Sadr F, Izopet J, Garraffo R, Peytavin G; ANRS CO-13 HEPAVIH Study Group. Ribavirin and abacavir drug interaction in HIV-HCV coinfected patients: fact or fiction? AIDS. 2012 Nov 13;26(17):2193-9. doi: 10.1097/QAD.0b013e32835763a4.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22409788\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Salmon-Ceron D, Cohen J, Winnock M, Roux P, Sadr FB, Rosenthal E, Martin IP, Loko MA, Mora M, Sogni P, Spire B, Dabis F, Carrieri MP; HEPAVIH group. Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France). BMC Health Serv Res. 2012 Mar 12;12:59. doi: 10.1186/1472-6963-12-59.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22173166\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Salmon D, Bani-Sadr F, Loko MA, Stitou H, Gervais A, Durant J, Rosenthal E, Quertainmont Y, Barange K, Vittecoq D, Shoai-Tehrani M, Alvarez M, Winnock M, Trinchet JC, Dabis F, Sogni P. Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH. J Hepatol. 2012 Apr;56(4):862-8. doi: 10.1016/j.jhep.2011.11.009. Epub 2011 Dec 13.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21819472\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Roux P, Fugon L, Winnock M, Salmon-Ceron D, Lacombe K, Sogni P, Spire B, Dabis F, Carrieri MP; ANRS-CO-13-HEPAVIH Study Group. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users. Addiction. 2012 Jan;107(1):152-9. doi: 10.1111/j.1360-0443.2011.03608.x. Epub 2011 Oct 12.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23052829\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Loko MA, Bani-Sadr F, Valantin MA, Lascoux-Combe C, Fontaine H, Bonnard P, Gervais A, Bouchaud O, Garipuy D, Quertainmont Y, Vittecoq D, Tehrani MS, Winnock M, Dabis F, Salmon D; ANRS CO 13 HEPAVIH Study Group. Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort. Antivir Ther. 2012;17(7):1335-43. doi: 10.3851/IMP2419. Epub 2012 Oct 10.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22535683\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Carrieri MP, Sogni P, Cohen J, Loko MA, Winnock M, Spire B; HEPAVIH Study Group. Elevated coffee consumption and reduced risk of insulin resistance in HIV-HCV coinfected patients (HEPAVIH ANRS CO-13). Hepatology. 2012 Nov;56(5):2010. doi: 10.1002/hep.25813. No abstract available.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21888878\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Carrieri MP, Cohen J, Salmon-Ceron D, Winnock M. Coffee consumption and reduced self-reported side effects in HIV-HCV co-infected patients during PEG-IFN and ribavirin treatment: results from ANRS CO13 HEPAVIH. J Hepatol. 2012 Mar;56(3):745-7. doi: 10.1016/j.jhep.2011.08.005. Epub 2011 Aug 31. No abstract available.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23226258\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Abravanel F, Raymond S, Pambrun E, Winnock M, Bonnard P, Sogni P, Trimoulet P, Dabis F, Salmon-Ceron D, Izopet J; ANRS CO13 HEPAVIH Study Group. HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients. PLoS One. 2012;7(11):e50289. doi: 10.1371/journal.pone.0050289. Epub 2012 Nov 30.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21920402\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Winnock M, Bani-Sadr F, Pambrun E, Loko MA, Lascoux-Combe C, Garipuy D, Rosenthal E, Carrieri P, Dabis F, Salmon D. Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination. Vaccine. 2011 Nov 3;29(47):8656-60. doi: 10.1016/j.vaccine.2011.08.125. Epub 2011 Sep 13.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21239121\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Roux P, Cohen J, Lascoux-Combe C, Sogni P, Winnock M, Salmon-Ceron D, Spire B, Dabis F, Carrieri MP; ANRS-CO13-HEPAVIH study group. Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician. Drug Alcohol Depend. 2011 Jul 1;116(1-3):228-32. doi: 10.1016/j.drugalcdep.2010.09.025. Epub 2011 Jan 15.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21692942\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Loko MA, Bani-Sadr F, Winnock M, Lacombe K, Carrieri P, Neau D, Morlat P, Serfaty L, Dabis F, Salmon D; ANRS CO 13 HEPAVIH Study Group. Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients. J Viral Hepat. 2011 Jul;18(7):e307-14. doi: 10.1111/j.1365-2893.2010.01417.x. Epub 2011 Jan 11.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20969743\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Loko MA, Salmon D, Carrieri P, Winnock M, Mora M, Merchadou L, Gillet S, Pambrun E, Delaune J, Valantin MA, Poizot-Martin I, Neau D, Bonnard P, Rosenthal E, Barange K, Morlat P, Lacombe K, Gervais A, Rouges F, See AB, Lascoux-Combe C, Vittecoq D, Goujard C, Duvivier C, Spire B, Izopet J, Sogni P, Serfaty L, Benhamou Y, Bani-Sadr F, Dabis F; ANRS CO 13 HEPAVIH Study Group. The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010. BMC Infect Dis. 2010 Oct 22;10:303. doi: 10.1186/1471-2334-10-303.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20876416\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Carrieri MP, Cohen J, Winnock M, Salmon D. Chocolate intake, depression, and clinical progression in HIV-HCV coinfected patients: still more questions than answers. Arch Intern Med. 2010 Sep 27;170(17):1607; author reply 1608-9. doi: 10.1001/archinternmed.2010.330. No abstract available.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20493576\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Cales P, Halfon P, Batisse D, Carrat F, Perre P, Penaranda G, Guyader D, d'Alteroche L, Fouchard-Hubert I, Michelet C, Veillon P, Lambert J, Weiss L, Salmon D, Cacoub P. Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection. J Hepatol. 2010 Aug;53(2):238-44. doi: 10.1016/j.jhep.2010.03.007. Epub 2010 Apr 18.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28942916\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Carrieri MP, Protopopescu C, Marcellin F, Rosellini S, Wittkop L, Esterle L, Zucman D, Raffi F, Rosenthal E, Poizot-Martin I, Salmon-Ceron D, Dabis F, Spire B; ANRS CO13 HEPAVIH Study Group. Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients. J Hepatol. 2017 Dec;67(6):1157-1167. doi: 10.1016/j.jhep.2017.08.005. Epub 2017 Sep 21.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28780609\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Yaya I, Roux P, Marcellin F, Salmon-Ceron D, Carrieri MP. Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort). Dig Dis Sci. 2017 Oct;62(10):2943-2944. doi: 10.1007/s10620-017-4703-y. Epub 2017 Aug 5. No abstract available.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28430385\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Knight R, Roux P, Vilotitch A, Marcellin F, Rosenthal E, Esterle L, Boue F, Rey D, Piroth L, Dominguez S, Sogni P, Salmon-Ceron D, Spire B, Carrieri MP; ANRS CO13-HEPAVIH Study Group. Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort. Addiction. 2017 Sep;112(9):1669-1679. doi: 10.1111/add.13851. Epub 2017 Jun 6.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28418984\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Marcellin F, Protopopescu C, Esterle L, Wittkop L, Piroth L, Aumaitre H, Bouchaud O, Goujard C, Vittecoq D, Dabis F, Salmon-Ceron D, Spire B, Roux P, Carrieri MP; ANRS CO13-HEPAVIH Study Group. Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH). Eur J Gastroenterol Hepatol. 2017 Jul;29(7):786-791. doi: 10.1097/MEG.0000000000000883.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28235612\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Piroth L, Wittkop L, Lacombe K, Rosenthal E, Gilbert C, Miailhes P, Carrieri P, Chas J, Poizot-Martin I, Gervais A, Dominguez S, Neau D, Zucman D, Billaud E, Morlat P, Aumaitre H, Lascoux-Combe C, Simon A, Bouchaud O, Teicher E, Bani-Sadr F, Alric L, Vittecoq D, Boue F, Duvivier C, Valantin MA, Esterle L, Dabis F, Sogni P, Salmon D; ANRS CO13 HEPAVIH study group. Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort. J Hepatol. 2017 Jul;67(1):23-31. doi: 10.1016/j.jhep.2017.02.012. Epub 2017 Feb 22.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27339598\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Ulveling D, Le Clerc S, Cobat A, Labib T, Noirel J, Laville V, Coulonges C, Carpentier W, Nalpas B, Heim MH, Poynard T, Cerny A, Pol S, Bochud PY, Dabis F, Theodorou I, Levy Y, Salmon D, Abel L, Dominguez S, Zagury JF; HEPAVIH ANRS CO13 Cohort Study Group; Swiss Hepatitis C Cohort Study Group; French ANRS HC EP 26 Genoscan Study Group. A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients. Hepatology. 2016 Nov;64(5):1462-1472. doi: 10.1002/hep.28695. Epub 2016 Jul 29.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34212476\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Chalouni M, Wittkop L, Bani-Sadr F, Lacombe K, Esterle L, Gilbert C, Miailhes P, Zucman D, Valantin MA, Bregigeon-Ronot S, Morlat P, Billaud E, Piroth L, Naqvi A, Sogni P, Salmon D; ANRS CO13 HEPAVIH Cohort Study Group. Risk of severe clinical events after sustained virological response following direct-acting antiviral therapy in HIV and hepatitis C virus coinfected participants. HIV Med. 2021 Oct;22(9):791-804. doi: 10.1111/hiv.13127. Epub 2021 Jul 1.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32798585\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Chalouni M, Pol S, Sogni P, Fontaine H, Lacombe K, Marc-Lacombe J, Esterle L, Dorival C, Bourliere M, Bani-Sadr F, de Ledinghen V, Zucman D, Larrey D, Salmon D, Carrat F, Wittkop L; ANRS CO13 HEPAVIH and ANRS CO22 HEPATHER cohort study groups. Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death. J Hepatol. 2021 Jan;74(1):37-47. doi: 10.1016/j.jhep.2020.08.008. Epub 2020 Aug 14.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30570526\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Poizot-Martin I, Rosenthal E, Gilbert C, Cano CE, Simon A, Lascoux-Combe C, Alric L, Gervais A, Neau D, Esterle L, Salmon D, Sogni P, Wittkop L; ANRS CO13 HEPAVIH Study Group. Nadir CD4 Is Negatively Associated With Antinuclear Antibody Detection in HCV/HIV-Coinfected Patients. J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):461-466. doi: 10.1097/QAI.0000000000001940.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04842851\",\n",
      "    \"BriefTitle\": \"Cardiac Resynchronization Therapy in Congenital Heart Diseases With Systemic Right Ventricle\",\n",
      "    \"LeadSponsorName\": \"Paris Cardiovascular Research Center (Inserm U970)\",\n",
      "    \"CollaboratorName\": \"Marie Lannelongue Hospital, Le Plessis Robinson, France | Clinique Pasteur Toulouse | Groupe Hospitalier Pitie-Salpetriere | Hopital Louis Pradel | University Hospital, Montpellier | European Georges Pompidou Hospital\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2021-04-13\",\n",
      "    \"StartDate\": \"2004-01-01\",\n",
      "    \"CompletionDate\": \"2020-12-31\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04409405\",\n",
      "    \"BriefTitle\": \"Evaluation and Support to EVD Cured Patients and Their Contacts (Les Vainqueurs d'Ebola)\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"Institut National de Recherche Biom\\u00e9dicale. Kinshasa, R\\u00e9publique D\\u00e9mocratique du Congo | Institut de Recherche pour le Developpement\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2020-06-01\",\n",
      "    \"StartDate\": \"2020-04-16\",\n",
      "    \"CompletionDate\": \"2021-10-18\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00158405\",\n",
      "    \"BriefTitle\": \"Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Bristol-Myers Squibb\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-09-12\",\n",
      "    \"StartDate\": \"2002-12\",\n",
      "    \"CompletionDate\": \"2006-12\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"16152755\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Moh R, Danel C, Sorho S, Sauvageot D, Anzian A, Minga A, Gomis OB, Konga C, Inwoley A, Gabillard D, Bissagnene E, Salamon R, Anglaret X. Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Cote d'Ivoire. Antivir Ther. 2005;10(5):615-24. doi: 10.1177/135965350501000510.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16782488\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Danel C, Moh R, Minga A, Anzian A, Ba-Gomis O, Kanga C, Nzunetu G, Gabillard D, Rouet F, Sorho S, Chaix ML, Eholie S, Menan H, Sauvageot D, Bissagnene E, Salamon R, Anglaret X; Trivacan ANRS 1269 trial group. CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial. Lancet. 2006 Jun 17;367(9527):1981-9. doi: 10.1016/S0140-6736(06)68887-9.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18986246\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Danel C, Moh R, Chaix ML, Gabillard D, Gnokoro J, Diby CJ, Toni T, Dohoun L, Rouzioux C, Bissagnene E, Salamon R, Anglaret X; Trivacan ANRS 1269 Trial Group. Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults. J Infect Dis. 2009 Jan 1;199(1):66-76. doi: 10.1086/595298.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02960698\",\n",
      "    \"BriefTitle\": \"Impulsivity in Tourette Syndrome : Behavioral and Neuroimaging Study\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2016-11-10\",\n",
      "    \"StartDate\": \"2016-10-14\",\n",
      "    \"CompletionDate\": \"2018-04-24\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02931097\",\n",
      "    \"BriefTitle\": \"DBS of the MLR for Gait and Balance Disorders in PD Patients\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2016-10-12\",\n",
      "    \"StartDate\": \"2016-10\",\n",
      "    \"CompletionDate\": \"2020-10\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00657397\",\n",
      "    \"BriefTitle\": \"Initialization of Methadone in Primary Care, Randomized Intervention Research for Preventing HCV Transmission Practices\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2008-04-14\",\n",
      "    \"StartDate\": \"2009-01\",\n",
      "    \"CompletionDate\": \"2011-12\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"27770695\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Carrieri P, Vilotitch A, Nordmann S, Lions C, Michel L, Mora M, Morel A, Maradan G, Spire B, Roux P; Methaville Study Group. Decrease in self-reported offences and incarceration rates during methadone treatment: A comparison between patients switching from buprenorphine to methadone and maintenance treatment incident users (ANRS-Methaville trial). Int J Drug Policy. 2017 Jan;39:86-91. doi: 10.1016/j.drugpo.2016.08.005. Epub 2016 Oct 19.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27048152\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Roux P, Lions C, Vilotitch A, Michel L, Mora M, Maradan G, Marcellin F, Spire B, Morel A, Carrieri PM; ANRS Methaville study group. Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study). Harm Reduct J. 2016 Apr 5;13:12. doi: 10.1186/s12954-016-0100-7.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25393311\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Carrieri PM, Michel L, Lions C, Cohen J, Vray M, Mora M, Marcellin F, Spire B, Morel A, Roux P; Methaville Study Group. Methadone induction in primary care for opioid dependence: a pragmatic randomized trial (ANRS Methaville). PLoS One. 2014 Nov 13;9(11):e112328. doi: 10.1371/journal.pone.0112328. eCollection 2014.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25209306\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Roux P, Lions C, Michel L, Mora M, Daulouede JP, Marcellin F, Spire B, Morel A, Carrieri PM; ANRS Methaville study group. Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions. Subst Abuse Treat Prev Policy. 2014 Sep 10;9:37. doi: 10.1186/1747-597X-9-37.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24268548\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Lions C, Carrieri MP, Michel L, Mora M, Marcellin F, Morel A, Spire B, Roux P; Methaville Study Group. Predictors of non-prescribed opioid use after one year of methadone treatment: an attributable-risk approach (ANRS-Methaville trial). Drug Alcohol Depend. 2014 Feb 1;135:1-8. doi: 10.1016/j.drugalcdep.2013.10.018. Epub 2013 Oct 31.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22741944\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Roux P, Michel L, Cohen J, Mora M, Morel A, Aubertin JF, Desenclos JC, Spire B, Carrieri PM; ANRS Methaville Study Group. Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial. BMC Public Health. 2012 Jun 28;12:488. doi: 10.1186/1471-2458-12-488.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00421551\",\n",
      "    \"BriefTitle\": \"Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Tibotec Pharmaceutical Limited\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2007-01-12\",\n",
      "    \"StartDate\": \"2007-03\",\n",
      "    \"CompletionDate\": \"2011-02\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"29767684\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Lambert-Niclot S, Grude M, Meynard JL, Marcelin AG, Valantin MA, Flandre P, Izopet J, Moinot L, Bouteloup V, Calvez V, Katlama C, Girard PM, Morand-Joubert L. Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies. Clin Infect Dis. 2018 Nov 28;67(12):1883-1889. doi: 10.1093/cid/ciy382.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22848481\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Lambert-Niclot S, Flandre P, Valantin MA, Soulie C, Fourati S, Wirden M, Sayon S, Pakianather S, Bocket L, Masquelier B, Dos Santos G, Katlama C, Calvez V, Marcelin AG. Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks. PLoS One. 2012;7(7):e41390. doi: 10.1371/journal.pone.0041390. Epub 2012 Jul 25.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20802297\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Katlama C, Valantin MA, Algarte-Genin M, Duvivier C, Lambert-Niclot S, Girard PM, Molina JM, Hoen B, Pakianather S, Peytavin G, Marcelin AG, Flandre P. Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136. AIDS. 2010 Sep 24;24(15):2365-74. doi: 10.1097/QAD.0b013e32833dec20.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00623051\",\n",
      "    \"BriefTitle\": \"Evaluation of the Extension at Community Level of Safe Male Circumcision (ANRS 12126 ORANGE FARM 2)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2008-02-25\",\n",
      "    \"StartDate\": \"2008-01\",\n",
      "    \"CompletionDate\": \"2012-12\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00116454\",\n",
      "    \"BriefTitle\": \"Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-06-30\",\n",
      "    \"StartDate\": \"2005-07\",\n",
      "    \"CompletionDate\": \"2013-08\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03954054\",\n",
      "    \"BriefTitle\": \"Therapeutic Education for Harm Reduction in People With Alcohol Use Disorder\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"Regional Agency for Health PACA | SESSTIM UMR1252 (Aix-Marseille Univ, INSERM, IRD)\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2019-05-17\",\n",
      "    \"StartDate\": \"2019-10-28\",\n",
      "    \"CompletionDate\": \"2021-07-31\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"35012570\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Antwerpes S, Costa M, Coste M, Bureau M, Maradan G, Cutarella C, Leloutre J, Riccobono-Soulier O, Hedoire S, Frot E, Vernier F, Vassas-Goyard S, Barre T, Casanova D, Carrieri P. Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER). Harm Reduct J. 2022 Jan 10;19(1):2. doi: 10.1186/s12954-021-00587-0.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02976298\",\n",
      "    \"BriefTitle\": \"Effects of Cerebellum or Supplementary Motor Area Functional Inactivation on Gait and Balance Control\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2016-11-29\",\n",
      "    \"StartDate\": \"2013-02\",\n",
      "    \"CompletionDate\": \"2015-01\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02101398\",\n",
      "    \"BriefTitle\": \"Study of the Effect of Transcranial Stimulations in Aphasic Subject Within a Year of Their Stroke\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-04-02\",\n",
      "    \"StartDate\": \"2014-10-02\",\n",
      "    \"CompletionDate\": \"2016-07\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT05472051\",\n",
      "    \"BriefTitle\": \"Health and Migration Trajectories of Housekeepers in Bamako\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2022-07-25\",\n",
      "    \"StartDate\": \"2022-02-28\",\n",
      "    \"CompletionDate\": \"2023-06-22\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00495651\",\n",
      "    \"BriefTitle\": \"Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Gilead Sciences | Merck Sharp & Dohme LLC\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2007-07-03\",\n",
      "    \"StartDate\": \"2008-03\",\n",
      "    \"CompletionDate\": \"2015-01\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"35093007\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Moh DR, Ntakpe JB, Gabillard D, Yayo-Emieme AA, Badje A, Kouame GM, d'Aquin TT, Danel C, Anglaret X, Eholie SP. Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adults. BMC Infect Dis. 2022 Jan 29;22(1):100. doi: 10.1186/s12879-022-07082-2.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29297443\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Moh R, Badje A, N'takpe JB, Kouame GM, Gabillard D, Ouassa T, Ouattara E, Le Carrou J, Bohoussou F, Messou E, Eholie S, Anglaret X, Danel C. Screening for active tuberculosis before isoniazid preventive therapy among HIV-infected West African adults. Int J Tuberc Lung Dis. 2017 Dec 1;21(12):1237-1244. doi: 10.5588/ijtld.17.0016.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29020361\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Kouame GM, Boyd A, Moh R, Badje A, Gabillard D, Ouattara E, Ntakpe JB, Emieme A, Maylin S, Chekaraou MA, Eholie SP, Zoulim F, Lacombe K, Anglaret X, Danel C; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) 12136 Temprano and ANRS 12240 VarBVA Study Groups. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication. Clin Infect Dis. 2018 Jan 6;66(1):112-120. doi: 10.1093/cid/cix747.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26193126\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"TEMPRANO ANRS 12136 Study Group; Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpe JB, Minga A, Kouame GM, Bouhoussou F, Emieme A, Kouame A, Inwoley A, Toni TD, Ahiboh H, Kabran M, Rabe C, Sidibe B, Nzunetu G, Konan R, Gnokoro J, Gouesse P, Messou E, Dohoun L, Kamagate S, Yao A, Amon S, Kouame AB, Koua A, Kouame E, Ndri Y, Ba-Gomis O, Daligou M, Ackoundze S, Hawerlander D, Ani A, Dembele F, Kone F, Guehi C, Kanga C, Koule S, Seri J, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatounde N, Bleoue G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Assi R, Bakayoko A, Mahassadi A, Attia A, Oussou A, Mobio M, Bamba D, Koman M, Horo A, Deschamps N, Chenal H, Sassan-Morokro M, Konate S, Aka K, Aoussi E, Journot V, Nchot C, Karcher S, Chaix ML, Rouzioux C, Sow PS, Perronne C, Girard PM, Menan H, Bissagnene E, Kadio A, Ettiegne-Traore V, Moh-Semde C, Kouame A, Massumbuko JM, Chene G, Dosso M, Domoua SK, N'Dri-Yoman T, Salamon R, Eholie SP, Anglaret X. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. N Engl J Med. 2015 Aug 27;373(9):808-22. doi: 10.1056/NEJMoa1507198. Epub 2015 Jul 20.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25330161\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Danel C, Kabran M, Inwoley A, Badje A, Herrmann JL, Moh R, Lecarrou J, Gabillard D, Ntakpe JB, Deschamps N, Ouattara E, Perronne C, Eholie S, Anglaret X. Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in Cote d'Ivoire, West Africa. PLoS One. 2014 Oct 16;9(10):e107245. doi: 10.1371/journal.pone.0107245. eCollection 2014.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24985779\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Jean K, Gabillard D, Moh R, Danel C, Desgrees-du-Lou A, N'takpe JB, Le Carrou J, Badje A, Eholie S, Lert F, Anglaret X, Dray-Spira R. Decrease in sexual risk behaviours after early initiation of antiretroviral therapy: a 24-month prospective study in Cote d'Ivoire. J Int AIDS Soc. 2014 Jun 30;17(1):18977. doi: 10.7448/IAS.17.1.18977. eCollection 2014.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23639243\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Ouattara E, Danel C, Moh R, Gabillard D, Peytavin G, Konan R, Carrou JL, Bohoussou F, Eholie SP, Anglaret X. Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts. J Int AIDS Soc. 2013 Apr 30;16(1):18059. doi: 10.7448/IAS.16.1.18059.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01693861\",\n",
      "    \"BriefTitle\": \"\\\"Cancersensor\\\" Chemotherapy\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-09-26\",\n",
      "    \"StartDate\": \"2012-10\",\n",
      "    \"CompletionDate\": \"2015-02\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00272428\",\n",
      "    \"BriefTitle\": \"Primary Prevention Trial of the Health Effects of Antioxidant Vitamins and Minerals.\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"French private agencies\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2006-01-06\",\n",
      "    \"StartDate\": \"1994-10\",\n",
      "    \"CompletionDate\": \"2005-09\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"15557412\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A, Briancon S. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med. 2004 Nov 22;164(21):2335-42. doi: 10.1001/archinte.164.21.2335. Erratum In: Arch Intern Med. 2005 Feb 14;165(3):286.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33738534\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Andreeva VA, Peneau S, Julia C, Shivappa N, Hebert JR, Wirth MD, Touvier M, Hercberg S, Galan P, Kesse-Guyot E. The inflammatory potential of the diet is prospectively associated with subjective hearing loss. Eur J Nutr. 2021 Oct;60(7):3669-3678. doi: 10.1007/s00394-021-02531-1. Epub 2021 Mar 18.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31927670\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Lecuyer L, Dalle C, Micheau P, Petera M, Centeno D, Lyan B, Lagree M, Galan P, Hercberg S, Rossary A, Demidem A, Vasson MP, Partula V, Deschasaux M, Srour B, Latino-Martel P, Druesne-Pecollo N, Kesse-Guyot E, Durand S, Pujos-Guillot E, Manach C, Touvier M. Untargeted plasma metabolomic profiles associated with overall diet in women from the SU.VI.MAX cohort. Eur J Nutr. 2020 Dec;59(8):3425-3439. doi: 10.1007/s00394-020-02177-5. Epub 2020 Jan 11.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31164347\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Lecuyer L, Dalle C, Lyan B, Demidem A, Rossary A, Vasson MP, Petera M, Lagree M, Ferreira T, Centeno D, Galan P, Hercberg S, Deschasaux M, Partula V, Srour B, Latino-Martel P, Kesse-Guyot E, Druesne-Pecollo N, Durand S, Pujos-Guillot E, Touvier M. Plasma Metabolomic Signatures Associated with Long-term Breast Cancer Risk in the SU.VI.MAX Prospective Cohort. Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1300-1307. doi: 10.1158/1055-9965.EPI-19-0154. Epub 2019 Jun 4.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30517725\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Assmann KE, Adjibade M, Hercberg S, Galan P, Kesse-Guyot E. Unsaturated Fatty Acid Intakes During Midlife Are Positively Associated with Later Cognitive Function in Older Adults with Modulating Effects of Antioxidant Supplementation. J Nutr. 2018 Dec 1;148(12):1938-1945. doi: 10.1093/jn/nxy206.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29649036\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Wiernik E, Lemogne C, Fezeu L, Arnault N, Hercberg S, Kesse-Guyot E, Galan P. Association Between Alexithymia and Risk of Incident Cardiovascular Diseases in the SUpplementation en VItamines et Mineraux AntioXydants (SU.VI.MAX) Cohort. Psychosom Med. 2018 Jun;80(5):460-467. doi: 10.1097/PSY.0000000000000592.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29546305\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Assmann KE, Adjibade M, Shivappa N, Hebert JR, Wirth MD, Touvier M, Akbaraly T, Hercberg S, Galan P, Julia C, Kesse-Guyot E. The Inflammatory Potential of the Diet at Midlife Is Associated with Later Healthy Aging in French Adults. J Nutr. 2018 Mar 1;148(3):437-444. doi: 10.1093/jn/nxx061.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28494135\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Ruhunuhewa I, Adjibade M, Andreeva VA, Galan P, Hercberg S, Assmann KE, Kesse-Guyot E. Prospective association between body mass index at midlife and healthy aging among French adults. Obesity (Silver Spring). 2017 Jul;25(7):1254-1262. doi: 10.1002/oby.21853. Epub 2017 May 11.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28356432\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Adjibade M, Andreeva VA, Lemogne C, Touvier M, Shivappa N, Hebert JR, Wirth MD, Hercberg S, Galan P, Julia C, Assmann KE, Kesse-Guyot E. The Inflammatory Potential of the Diet Is Associated with Depressive Symptoms in Different Subgroups of the General Population. J Nutr. 2017 May;147(5):879-887. doi: 10.3945/jn.116.245167. Epub 2017 Mar 29.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28033414\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Walker V, Perret-Guillaume C, Kesse-Guyot E, Agrinier N, Hercberg S, Galan P, Assmann KE, Briancon S, Rotonda C. Effect of Multimorbidity on Health-Related Quality of Life in Adults Aged 55 Years or Older: Results from the SU.VI.MAX 2 Cohort. PLoS One. 2016 Dec 29;11(12):e0169282. doi: 10.1371/journal.pone.0169282. eCollection 2016.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27055851\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Kesse-Guyot E, Assmann KE, Andreeva VA, Touvier M, Neufcourt L, Shivappa N, Hebert JR, Wirth MD, Hercberg S, Galan P, Julia C. Long-term association between the dietary inflammatory index and cognitive functioning: findings from the SU.VI.MAX study. Eur J Nutr. 2017 Jun;56(4):1647-1655. doi: 10.1007/s00394-016-1211-3. Epub 2016 Apr 7.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27000099\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Adriouch S, Julia C, Kesse-Guyot E, Mejean C, Ducrot P, Peneau S, Donnenfeld M, Deschasaux M, Menai M, Hercberg S, Touvier M, Fezeu LK. Prospective association between a dietary quality index based on a nutrient profiling system and cardiovascular disease risk. Eur J Prev Cardiol. 2016 Oct;23(15):1669-76. doi: 10.1177/2047487316640659. Epub 2016 Mar 21.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26962176\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Graffouillere L, Deschasaux M, Mariotti F, Neufcourt L, Shivappa N, Hebert JR, Wirth MD, Latino-Martel P, Hercberg S, Galan P, Julia C, Kesse-Guyot E, Touvier M. The Dietary Inflammatory Index Is Associated with Prostate Cancer Risk in French Middle-Aged Adults in a Prospective Study. J Nutr. 2016 Apr 1;146(4):785-791. doi: 10.3945/jn.115.225623. Epub 2016 Mar 9.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26864363\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Graffouillere L, Deschasaux M, Mariotti F, Neufcourt L, Shivappa N, Hebert JR, Wirth MD, Latino-Martel P, Hercberg S, Galan P, Julia C, Kesse-Guyot E, Touvier M. Prospective association between the Dietary Inflammatory Index and mortality: modulation by antioxidant supplementation in the SU.VI.MAX randomized controlled trial. Am J Clin Nutr. 2016 Mar;103(3):878-85. doi: 10.3945/ajcn.115.126243. Epub 2016 Feb 10.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26817718\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Deschasaux M, Souberbielle JC, Latino-Martel P, Sutton A, Charnaux N, Druesne-Pecollo N, Galan P, Hercberg S, Le Clerc S, Kesse-Guyot E, Ezzedine K, Touvier M. Weight Status and Alcohol Intake Modify the Association between Vitamin D and Breast Cancer Risk. J Nutr. 2016 Mar;146(3):576-85. doi: 10.3945/jn.115.221481. Epub 2016 Jan 27.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26812508\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Kesse-Guyot E, Assmann KE, Andreeva VA, Ferry M, Hercberg S, Galan P; SU.VI.MAX 2 Research Group. Consumption of Dairy Products and Cognitive Functioning: Findings from the SU.VI.MAX 2 Study. J Nutr Health Aging. 2016 Feb;20(2):128-37. doi: 10.1007/s12603-015-0593-x.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26447153\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Deschasaux M, Souberbielle JC, Latino-Martel P, Sutton A, Charnaux N, Druesne-Pecollo N, Galan P, Hercberg S, Le Clerc S, Kesse-Guyot E, Ezzedine K, Touvier M. Prospective associations between vitamin D status, vitamin D-related gene polymorphisms, and risk of tobacco-related cancers. Am J Clin Nutr. 2015 Nov;102(5):1207-15. doi: 10.3945/ajcn.115.110510. Epub 2015 Oct 7.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26409628\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Kesse-Guyot E, Lassale C, Assmann KE, Andreeva VA, Julia C, Blacher J, Fezeu L, Hercberg S, Galan P. Are different vascular risk scores calculated at midlife uniformly associated with subsequent poor cognitive performance? Atherosclerosis. 2015 Nov;243(1):286-92. doi: 10.1016/j.atherosclerosis.2015.09.023. Epub 2015 Sep 21.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26156743\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Donnenfeld M, Deschasaux M, Latino-Martel P, Diallo A, Galan P, Hercberg S, Ezzedine K, Touvier M. Prospective association between dietary folate intake and skin cancer risk: results from the Supplementation en Vitamines et Mineraux Antioxydants cohort. Am J Clin Nutr. 2015 Aug;102(2):471-8. doi: 10.3945/ajcn.115.109041. Epub 2015 Jul 8.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25994566\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Chhim AS, Fassier P, Latino-Martel P, Druesne-Pecollo N, Zelek L, Duverger L, Hercberg S, Galan P, Deschasaux M, Touvier M. Prospective association between alcohol intake and hormone-dependent cancer risk: modulation by dietary fiber intake. Am J Clin Nutr. 2015 Jul;102(1):182-9. doi: 10.3945/ajcn.114.098418. Epub 2015 May 20.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25651444\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Kesse-Guyot E, Andreeva VA, Touvier M, Jeandel C, Ferry M, Hercberg S, Galan P; SU.VI.MAX 2 Research Group. Overall and abdominal adiposity in midlife and subsequent cognitive function. J Nutr Health Aging. 2015 Feb;19(2):183-9. doi: 10.1007/s12603-014-0508-2.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24553693\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Deschasaux M, Pouchieu C, His M, Hercberg S, Latino-Martel P, Touvier M. Dietary total and insoluble fiber intakes are inversely associated with prostate cancer risk. J Nutr. 2014 Apr;144(4):504-10. doi: 10.3945/jn.113.189670. Epub 2014 Feb 19.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24527713\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Touvier M, Deschasaux M, Montourcy M, Sutton A, Charnaux N, Kesse-Guyot E, Fezeu LK, Latino-Martel P, Druesne-Pecollo N, Malvy D, Galan P, Hercberg S, Ezzedine K, Souberbielle JC. Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values. J Clin Endocrinol Metab. 2014 Apr;99(4):1196-203. doi: 10.1210/jc.2013-3349. Epub 2014 Feb 14.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24089418\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Andreeva VA, Galan P, Arnaud J, Julia C, Hercberg S, Kesse-Guyot E. Midlife iron status is inversely associated with subsequent cognitive performance, particularly in perimenopausal women. J Nutr. 2013 Dec;143(12):1974-81. doi: 10.3945/jn.113.177089. Epub 2013 Oct 2.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24027184\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Julia C, Touvier M, Meunier N, Papet I, Galan P, Hercberg S, Kesse-Guyot E. Intakes of PUFAs were inversely associated with plasma C-reactive protein 12 years later in a middle-aged population with vitamin E intake as an effect modifier. J Nutr. 2013 Nov;143(11):1760-6. doi: 10.3945/jn.113.180943. Epub 2013 Sep 11.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23284983\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Kesse-Guyot E, Andreeva VA, Jeandel C, Ferry M, Touvier M, Hercberg S, Galan P. Alcohol consumption in midlife and cognitive performance assessed 13 years later in the SU.VI.MAX 2 cohort. PLoS One. 2012;7(12):e52311. doi: 10.1371/journal.pone.0052311. Epub 2012 Dec 19.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23283500\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Kesse-Guyot E, Andreeva VA, Lassale C, Ferry M, Jeandel C, Hercberg S, Galan P; SU.VI.MAX 2 Research Group. Mediterranean diet and cognitive function: a French study. Am J Clin Nutr. 2013 Feb;97(2):369-76. doi: 10.3945/ajcn.112.047993. Epub 2013 Jan 2.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23082222\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Kesse-Guyot E, Charreire H, Andreeva VA, Touvier M, Hercberg S, Galan P, Oppert JM. Cross-sectional and longitudinal associations of different sedentary behaviors with cognitive performance in older adults. PLoS One. 2012;7(10):e47831. doi: 10.1371/journal.pone.0047831. Epub 2012 Oct 17.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22633793\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Kesse-Guyot E, Ahluwalia N, Lassale C, Hercberg S, Fezeu L, Lairon D. Adherence to Mediterranean diet reduces the risk of metabolic syndrome: a 6-year prospective study. Nutr Metab Cardiovasc Dis. 2013 Jul;23(7):677-83. doi: 10.1016/j.numecd.2012.02.005. Epub 2012 May 25.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22378736\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Touvier M, Kesse-Guyot E, Andreeva VA, Fezeu L, Charnaux N, Sutton A, Druesne-Pecollo N, Hercberg S, Galan P, Zelek L, Latino-Martel P, Czernichow S. Modulation of the association between plasma intercellular adhesion molecule-1 and cancer risk by n-3 PUFA intake: a nested case-control study. Am J Clin Nutr. 2012 Apr;95(4):944-50. doi: 10.3945/ajcn.111.027805. Epub 2012 Feb 29.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22158670\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Briancon S, Boini S, Bertrais S, Guillemin F, Galan P, Hercberg S. Long-term antioxidant supplementation has no effect on health-related quality of life: the randomized, double-blind, placebo-controlled, primary prevention SU.VI.MAX trial. Int J Epidemiol. 2011 Dec;40(6):1605-16. doi: 10.1093/ije/dyr161.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21955649\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Peneau S, Galan P, Jeandel C, Ferry M, Andreeva V, Hercberg S, Kesse-Guyot E; SU.VI.MAX 2 Research Group. Fruit and vegetable intake and cognitive function in the SU.VI.MAX 2 prospective study. Am J Clin Nutr. 2011 Nov;94(5):1295-303. doi: 10.3945/ajcn.111.014712. Epub 2011 Sep 28.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21775560\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Kesse-Guyot E, Fezeu L, Jeandel C, Ferry M, Andreeva V, Amieva H, Hercberg S, Galan P. French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial. Am J Clin Nutr. 2011 Sep;94(3):892-9. doi: 10.3945/ajcn.110.007815. Epub 2011 Jul 20.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21490142\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Perez-Jimenez J, Fezeu L, Touvier M, Arnault N, Manach C, Hercberg S, Galan P, Scalbert A. Dietary intake of 337 polyphenols in French adults. Am J Clin Nutr. 2011 Jun;93(6):1220-8. doi: 10.3945/ajcn.110.007096. Epub 2011 Apr 13.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21106918\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Kesse-Guyot E, Amieva H, Castetbon K, Henegar A, Ferry M, Jeandel C, Hercberg S, Galan P; SU.VI.MAX 2 Research Group. Adherence to nutritional recommendations and subsequent cognitive performance: findings from the prospective Supplementation with Antioxidant Vitamins and Minerals 2 (SU.VI.MAX 2) study. Am J Clin Nutr. 2011 Jan;93(1):200-10. doi: 10.3945/ajcn.2010.29761. Epub 2010 Nov 24.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20605091\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Ezzedine K, Latreille J, Kesse-Guyot E, Galan P, Hercberg S, Guinot C, Malvy D. Incidence of skin cancers during 5-year follow-up after stopping antioxidant vitamins and mineral supplementation. Eur J Cancer. 2010 Dec;46(18):3316-22. doi: 10.1016/j.ejca.2010.06.008. Epub 2010 Jul 6.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20431391\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Kesse-Guyot E, Vergnaud AC, Fezeu L, Zureik M, Blacher J, Peneau S, Hercberg S, Galan P, Czernichow S. Associations between dietary patterns and arterial stiffness, carotid artery intima-media thickness and atherosclerosis. Eur J Cardiovasc Prev Rehabil. 2010 Dec;17(6):718-24. doi: 10.1097/HJR.0b013e32833a197f.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20176858\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Phillips CM, Goumidi L, Bertrais S, Field MR, Cupples LA, Ordovas JM, Defoort C, Lovegrove JA, Drevon CA, Gibney MJ, Blaak EE, Kiec-Wilk B, Karlstrom B, Lopez-Miranda J, McManus R, Hercberg S, Lairon D, Planells R, Roche HM. Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndrome. J Lipid Res. 2010 Jul;51(7):1793-800. doi: 10.1194/jlr.M003046. Epub 2010 Feb 22.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19828715\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Phillips CM, Goumidi L, Bertrais S, Ferguson JF, Field MR, Kelly ED, Peloso GM, Cupples LA, Shen J, Ordovas JM, McManus R, Hercberg S, Portugal H, Lairon D, Planells R, Roche HM. Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome. Am J Clin Nutr. 2009 Dec;90(6):1665-73. doi: 10.3945/ajcn.2009.28101. Epub 2009 Oct 14.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19491388\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Czernichow S, Vergnaud AC, Galan P, Arnaud J, Favier A, Faure H, Huxley R, Hercberg S, Ahluwalia N. Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults. Am J Clin Nutr. 2009 Aug;90(2):329-35. doi: 10.3945/ajcn.2009.27635. Epub 2009 Jun 2.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02052271\",\n",
      "    \"BriefTitle\": \"Experimental Therapeutics in Essential Tremor Using Cerebellar Transcranial Direct Current Stimulation\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-02-03\",\n",
      "    \"StartDate\": \"2014-06-03\",\n",
      "    \"CompletionDate\": \"2018-03-27\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01534728\",\n",
      "    \"BriefTitle\": \"Identification of Hepatitis C Virus (HCV) Specific T Cells\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-02-17\",\n",
      "    \"StartDate\": \"2012-02\",\n",
      "    \"CompletionDate\": \"2014-03\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01492985\",\n",
      "    \"BriefTitle\": \"Lipopeptide Immunisation With GTU-multiHIV Trial\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2011-12-15\",\n",
      "    \"StartDate\": \"2013-07\",\n",
      "    \"CompletionDate\": \"2017-04-08\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"33568510\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Levy Y, Lacabaratz C, Lhomme E, Wiedemann A, Bauduin C, Fenwick C, Foucat E, Surenaud M, Guillaumat L, Boilet V, Rieux V, Bouchaud O, Girard PM, Molina JM, Morlat P, Hocqueloux L, Richert L, Pantaleo G, Lelievre JD, Thiebaut R. A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial. J Virol. 2021 Apr 12;95(9):e02165-20. doi: 10.1128/JVI.02165-20. Print 2021 Apr 12.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00120185\",\n",
      "    \"BriefTitle\": \"Efficacy of Using Interleukin-2 in Antiretroviral Na\\u00efve HIV Patients (ANRS119)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Chiron Corporation\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-07-15\",\n",
      "    \"StartDate\": \"2003-12\",\n",
      "    \"CompletionDate\": \"2006-11\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"19508157\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Molina JM, Levy Y, Fournier I, Hamonic S, Bentata M, Beck-Wirth G, Gougeon ML, Venet A, Madelaine I, Sereni D, Jeanblanc F, Boulet T, Simon F, Aboulker JP; Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS) 119 Interstart Study Team. Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119). J Infect Dis. 2009 Jul 15;200(2):206-15. doi: 10.1086/599989.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01463956\",\n",
      "    \"BriefTitle\": \"Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Merck Sharp & Dohme LLC\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2011-11-02\",\n",
      "    \"StartDate\": \"2012-01-06\",\n",
      "    \"CompletionDate\": \"2015-01-22\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00334256\",\n",
      "    \"BriefTitle\": \"Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"European and Developing Countries Clinical Trials Partnership (EDCTP) | Gilead Sciences\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2006-06-07\",\n",
      "    \"StartDate\": \"2006-10\",\n",
      "    \"CompletionDate\": \"2009-12\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"19307941\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"TEmAA ANRS 12109 Study group; Arrive E, Chaix ML, Nerrienet E, Blanche S, Rouzioux C, Coffie PA, Kruy Leang S, McIntyre J, Avit D, Srey VH, Gray G, N'Dri-Yoman T, Diallo A, Ekouevi DK, Dabis F. Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1. AIDS. 2009 Apr 27;23(7):825-33. doi: 10.1097/QAD.0b013e32832949d5.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19104016\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Hirt D, Urien S, Rey E, Arrive E, Ekouevi DK, Coffie P, Leang SK, Lalsab S, Avit D, Nerrienet E, McIntyre J, Blanche S, Dabis F, Treluyer JM. Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Antimicrob Agents Chemother. 2009 Mar;53(3):1067-73. doi: 10.1128/AAC.00860-08. Epub 2008 Dec 22.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18987623\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Hirt D, Urien S, Ekouevi DK, Rey E, Arrive E, Blanche S, Amani-Bosse C, Nerrienet E, Gray G, Kone M, Leang SK, McIntyre J, Dabis F, Treluyer JM; ANRS 12109. Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109). Clin Pharmacol Ther. 2009 Feb;85(2):182-9. doi: 10.1038/clpt.2008.201. Epub 2008 Nov 5.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00822315\",\n",
      "    \"BriefTitle\": \"Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Gilead Sciences | Merck Sharp & Dohme LLC\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2009-01-14\",\n",
      "    \"StartDate\": \"2009-07\",\n",
      "    \"CompletionDate\": \"2012-05\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"24726095\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Grinsztejn B, De Castro N, Arnold V, Veloso VG, Morgado M, Pilotto JH, Brites C, Madruga JV, Barcellos NT, Santos BR, Vorsatz C, Fagard C, Santini-Oliveira M, Patey O, Delaugerre C, Chene G, Molina JM; ANRS 12 180 Reflate TB study group. Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial. Lancet Infect Dis. 2014 Jun;14(6):459-67. doi: 10.1016/S1473-3099(14)70711-X. Epub 2014 Apr 9. Erratum In: Lancet Infect Dis. 2014 Jun;14(6):448.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04120415\",\n",
      "    \"BriefTitle\": \"A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"EuroVacc Foundation | European AIDS Treatment Group (EATG) | Medical Research Council | University College London Hospitals | University of Liverpool | Erasmus Medical Center | Henri Mondor University Hospital | European Georges Pompidou Hospital | Saint-Louis Hospital, Paris, France | Centre Hospitalier Universitaire Vaudois | Chelsea and Westminster Hospital, UK | Universit\\u00e4tsklinikum Hamburg-Eppendorf | Hospital Clinic of Barcelona | Istituto Nazionale Malattie Infettive Lazaro Spallanzani | Imperial College London | Institut d'Investigacions Biom\\u00e8diques August Pi i Sunyer | European Commission | Swiss Government\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2019-10-09\",\n",
      "    \"StartDate\": \"2022-06-21\",\n",
      "    \"CompletionDate\": \"2023-07-12\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02567071\",\n",
      "    \"BriefTitle\": \"Natural Microbiota Restoration After C-section Birth\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2015-10-02\",\n",
      "    \"StartDate\": \"2016-04-06\",\n",
      "    \"CompletionDate\": \"2019-04\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01331811\",\n",
      "    \"BriefTitle\": \"Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon)\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Institut Pasteur, Cambodia | National Pediatric Hospital, Cambodia | Angkor Hospital for Children | Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam | Pediatric Hospital Nhi Dong 1, Ho Chi Minh City, Vietnam | Number 2 Children's Hospital, Ho Chi Minh City | H\\u00f4pital Necker-Enfants Malades, Paris, France | Groupe Hospitalier Pitie-Salpetriere | CHRU Arnaud de Villeveuve, Montpellier, France | IRD, Yaounde, Cameroon | Fondation Chantal Biya,Yaounde, Cameroon | CHU Sour\\u00f4 Sanou, Bobo Dioulasso, Burkina Faso | Centre Muraz | Centre Pasteur du Cameroun | Centre Hospitalier D'essos\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2011-04-08\",\n",
      "    \"StartDate\": \"2011-04\",\n",
      "    \"CompletionDate\": \"2014-05\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"31455612\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Marcy O, Borand L, Ung V, Msellati P, Tejiokem M, Huu KT, Do Chau V, Ngoc Tran D, Ateba-Ndongo F, Tetang-Ndiang S, Nacro B, Sanogo B, Neou L, Goyet S, Dim B, Pean P, Quillet C, Fournier I, Berteloot L, Carcelain G, Godreuil S, Blanche S, Delacourt C; ANRS 12229 PAANTHER 01 STUDY GROUP. A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis. Pediatrics. 2019 Sep;144(3):e20182065. doi: 10.1542/peds.2018-2065.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30689814\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Borand L, de Lauzanne A, Nguyen NL, Cheng S, Pham TH, Eyangoh S, Ouedraogo AS, Ung V, Msellati P, Tejiokem M, Nacro B, Inghammar M, Dim B, Delacourt C, Godreuil S, Blanche S, Marcy O; Pediatric Asian African Network for Tuberculosis and HIV Research (PAANTHER) Study Group. Isolation of Nontuberculous Mycobacteria in Southeast Asian and African Human Immunodeficiency Virus-infected Children With Suspected Tuberculosis. Clin Infect Dis. 2019 May 2;68(10):1750-1753. doi: 10.1093/cid/ciy897.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29174612\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Marcy O, Tejiokem M, Msellati P, Truong Huu K, Do Chau V, Tran Ngoc D, Nacro B, Ateba-Ndongo F, Tetang-Ndiang S, Ung V, Dim B, Neou L, Berteloot L, Borand L, Delacourt C, Blanche S; ANRS 12229 PAANTHER 01 Study Group. Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study. Lancet HIV. 2018 Feb;5(2):e87-e95. doi: 10.1016/S2352-3018(17)30206-0. Epub 2017 Nov 23.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26908804\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Marcy O, Ung V, Goyet S, Borand L, Msellati P, Tejiokem M, Nguyen Thi NL, Nacro B, Cheng S, Eyangoh S, Pham TH, Ouedraogo AS, Tarantola A, Godreuil S, Blanche S, Delacourt C. Performance of Xpert MTB/RIF and Alternative Specimen Collection Methods for the Diagnosis of Tuberculosis in HIV-Infected Children. Clin Infect Dis. 2016 May 1;62(9):1161-1168. doi: 10.1093/cid/ciw036. Epub 2016 Feb 7.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02214511\",\n",
      "    \"BriefTitle\": \"Biomarkers of Social Sensitivity in Major Depression\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-08-12\",\n",
      "    \"StartDate\": \"2014-10-23\",\n",
      "    \"CompletionDate\": \"2017-03-01\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01698411\",\n",
      "    \"BriefTitle\": \"Study of the Influence of Sleep on Hemodynamic Parameters in Patients With Sleep Disorders\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-10-03\",\n",
      "    \"StartDate\": \"2012-10\",\n",
      "    \"CompletionDate\": \"2015-02\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04288128\",\n",
      "    \"BriefTitle\": \"Integrated Functional Evaluation of the Cerebellum\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"Biogen | Ionis Pharmaceuticals, Inc.\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2020-02-28\",\n",
      "    \"StartDate\": \"2020-05-28\",\n",
      "    \"CompletionDate\": \"2022-06-01\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02157311\",\n",
      "    \"BriefTitle\": \"4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV Patients\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-06-06\",\n",
      "    \"StartDate\": \"2014-07\",\n",
      "    \"CompletionDate\": \"2016-01\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"29186458\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"de Truchis P, Assoumou L, Landman R, Mathez D, Le Du D, Bellet J, Amat K, Katlama C, Gras G, Bouchaud O, Duracinsky M, Abe E, Alvarez JC, Izopet J, Saillard J, Melchior JC, Leibowitch J, Costagliola D, Girard PM, Perronne C; ANRS 162-4D Study Group. Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial. J Antimicrob Chemother. 2018 Mar 1;73(3):738-747. doi: 10.1093/jac/dkx434.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02082171\",\n",
      "    \"BriefTitle\": \"Multidomain Intervention to Prevent Disability in Elders\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"National Research Agency, France\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-03-10\",\n",
      "    \"StartDate\": \"2013-10-16\",\n",
      "    \"CompletionDate\": \"2016-01-27\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00918307\",\n",
      "    \"BriefTitle\": \"Efficacy and Safety of Varenicline Among HIV-infected Patients\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Pfizer\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2009-06-11\",\n",
      "    \"StartDate\": \"2009-10\",\n",
      "    \"CompletionDate\": \"2014-07\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"34611902\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Hartmann-Boyce J, Theodoulou A, Farley A, Hajek P, Lycett D, Jones LL, Kudlek L, Heath L, Hajizadeh A, Schenkels M, Aveyard P. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev. 2021 Oct 6;10(10):CD006219. doi: 10.1002/14651858.CD006219.pub4.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29329763\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Mercie P, Arsandaux J, Katlama C, Ferret S, Beuscart A, Spadone C, Duvivier C, Reynes J, Wirth N, Moinot L, Benard A, Zucman D, Duval X, Molina JM, Spire B, Fagard C, Chene G; ANRS 144 Inter-ACTIV study group. Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial. Lancet HIV. 2018 Mar;5(3):e126-e135. doi: 10.1016/S2352-3018(18)30002-X. Epub 2018 Jan 9.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT05090956\",\n",
      "    \"BriefTitle\": \"Developpement of 3T MRI Protocol\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2021-10-25\",\n",
      "    \"StartDate\": \"2012-06-08\",\n",
      "    \"CompletionDate\": \"2020-01-29\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02346409\",\n",
      "    \"BriefTitle\": \"Cerebello-thalamo-cortical Coupling in Essential Tremor\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2015-01-27\",\n",
      "    \"StartDate\": \"2015-02-04\",\n",
      "    \"CompletionDate\": \"2018-02-16\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00196599\",\n",
      "    \"BriefTitle\": \"Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Triangle Pharmaceuticals | Gilead Sciences | Bristol-Myers Squibb | Dupont Applied Biosciences\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-09-20\",\n",
      "    \"StartDate\": \"1999-02\",\n",
      "    \"CompletionDate\": \"2004-09\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"10915095\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Molina JM, Ferchal F, Rancinan C, Raffi F, Rozenbaum W, Sereni D, Morlat P, Journot V, Decazes JM, Chene G. Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients. J Infect Dis. 2000 Aug;182(2):599-602. doi: 10.1086/315711. Epub 2000 Jul 13.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15012649\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Molina JM, Peytavin G, Perusat S, Lascoux-Combes C, Sereni D, Rozenbaum W, Chene G. Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial). HIV Med. 2004 Mar;5(2):99-104. doi: 10.1111/j.1468-1293.2004.00194.x.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02102737\",\n",
      "    \"BriefTitle\": \"Comparison of A New Technique of Measure of the Insulin Resistance By Scintigraphy With the Reference Technique\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-04-03\",\n",
      "    \"StartDate\": \"2014-05-13\",\n",
      "    \"CompletionDate\": \"2018-03\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00454337\",\n",
      "    \"BriefTitle\": \"Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Merck Sharp & Dohme LLC\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2007-03-30\",\n",
      "    \"StartDate\": \"2007-05\",\n",
      "    \"CompletionDate\": \"2008-09\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"21576452\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Goldwirt L, Braun J, de Castro N, Charreau I, Barrail-Tran A, Delaugerre C, Raffi F, Lascoux-Combe C, Aboulker JP, Taburet AM, Molina JM. Switch from enfuvirtide to raltegravir lowers plasma concentrations of darunavir and tipranavir: a pharmacokinetic substudy of the EASIER-ANRS 138 trial. Antimicrob Agents Chemother. 2011 Jul;55(7):3613-5. doi: 10.1128/AAC.01827-10. Epub 2011 May 16.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19995925\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Barau C, Delaugerre C, Braun J, de Castro N, Furlan V, Charreau I, Gerard L, Lascoux-Combe C, Molina JM, Taburet AM. High concentration of raltegravir in semen of HIV-infected men: results from a substudy of the EASIER-ANRS 138 trial. Antimicrob Agents Chemother. 2010 Feb;54(2):937-9. doi: 10.1128/AAC.01261-09. Epub 2009 Dec 7.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20683319\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Delaugerre C, Charreau I, Braun J, Nere ML, de Castro N, Yeni P, Ghosn J, Aboulker JP, Molina JM, Simon F; ANRS 138 study group. Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimen. AIDS. 2010 Sep 24;24(15):2391-5. doi: 10.1097/QAD.0b013e32833d214c.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21126958\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Boulet T, Pavie J, Charreau I, Braun J, Reynes J, Morlat P, Piroth L, Spire B, Molina JM, Aboulker JP; Easier-Anrs 138 Study Group. Impact on health-related quality of life of a switch from enfuvirtide to raltegravir among multidrug-resistant HIV-1-infected patients: a randomized open-label trial (EASIER-ANRS 138). HIV Clin Trials. 2010 Sep-Oct;11(5):283-93. doi: 10.1310/hct1105-283.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21326075\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Gallien S, Delaugerre C, Charreau I, Braun J, Boulet T, Barrail-Tran A, de Castro N, Molina JM, Kuritzkes DR. Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia. AIDS. 2011 Mar 13;25(5):665-9. doi: 10.1097/QAD.0b013e3283445834.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21712241\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Gallien S, Braun J, Delaugerre C, Charreau I, Reynes J, Jeanblanc F, Verdon R, de Truchis P, May T, Madelaine-Chambrin I, Aboulker JP, Molina JM; EASIER ANRS 138 Study Group. Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial. J Antimicrob Chemother. 2011 Sep;66(9):2099-106. doi: 10.1093/jac/dkr269. Epub 2011 Jun 28.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22416781\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Delaugerre C, Braun J, Charreau I, Delarue S, Nere ML, de Castro N, May T, Marchou B, Simon F, Molina JM, Aboulker JP; ANRS 138-EASIER study group. Comparison of resistance mutation patterns in historical plasma HIV RNA genotypes with those in current proviral HIV DNA genotypes among extensively treated patients with suppressed replication. HIV Med. 2012 Oct;13(9):517-25. doi: 10.1111/j.1468-1293.2012.01002.x. Epub 2012 Mar 14.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27042193\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"de Castro N, Braun J, Charreau I, Lafeuillade A, Viard JP, Allavena C, Aboulker JP, Molina JM; EASIER ANRS 138 study group. Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial. AIDS Res Ther. 2016 Apr 2;13:17. doi: 10.1186/s12981-016-0101-3. eCollection 2016.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19757993\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"De Castro N, Braun J, Charreau I, Pialoux G, Cotte L, Katlama C, Raffi F, Weiss L, Meynard JL, Yazdanpanah Y, Delaugerre C, Madelaine-Chambrin I, Aboulker JP, Molina JM; EASIER ANRS 138 study group. Switch from enfuvirtide to raltegravir in virologically suppressed multidrug-resistant HIV-1-infected patients: a randomized open-label trial. Clin Infect Dis. 2009 Oct 15;49(8):1259-67. doi: 10.1086/605674.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02656407\",\n",
      "    \"BriefTitle\": \"Intraoperative Functional Ultrasound\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2016-01-15\",\n",
      "    \"StartDate\": \"2016-02-11\",\n",
      "    \"CompletionDate\": \"2018-02\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"25955583\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Demene C, Deffieux T, Pernot M, Osmanski BF, Biran V, Gennisson JL, Sieu LA, Bergel A, Franqui S, Correas JM, Cohen I, Baud O, Tanter M. Spatiotemporal Clutter Filtering of Ultrafast Ultrasound Data Highly Increases Doppler and fUltrasound Sensitivity. IEEE Trans Med Imaging. 2015 Nov;34(11):2271-85. doi: 10.1109/TMI.2015.2428634. Epub 2015 Apr 30.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00158509\",\n",
      "    \"BriefTitle\": \"Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-09-12\",\n",
      "    \"StartDate\": \"2004-08\",\n",
      "    \"CompletionDate\": \"2005-07\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"16044019\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Nagot N, Foulongne V, Becquart P, Mayaud P, Konate I, Ouedraogo A, Defer MC, Weiss H, Van de Perre P, Segondy M. Longitudinal assessment of HIV-1 and HSV-2 shedding in the genital tract of West African women. J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):632-4.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18596069\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Mayaud P, Nagot N, Konate I, Ouedraogo A, Weiss HA, Foulongne V, Defer MC, Sawadogo A, Segondy M, Van de Perre P; ANRS 1285 Study Group. Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women. Sex Transm Infect. 2008 Oct;84(5):332-7. doi: 10.1136/sti.2008.030692. Epub 2008 Jul 2.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18593294\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Nagot N, Ouedraogo A, Konate I, Weiss HA, Foulongne V, Defer MC, Sanon A, Becquart P, Segondy M, Sawadogo A, Van de Perre P, Mayaud P; ANRS 1285 Study Group. Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels. J Infect Dis. 2008 Jul 15;198(2):241-9. doi: 10.1086/589621.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17314338\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Nagot N, Ouedraogo A, Foulongne V, Konate I, Weiss HA, Vergne L, Defer MC, Djagbare D, Sanon A, Andonaba JB, Becquart P, Segondy M, Vallo R, Sawadogo A, Van de Perre P, Mayaud P; ANRS 1285 Study Group. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med. 2007 Feb 22;356(8):790-9. doi: 10.1056/NEJMoa062607.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02038842\",\n",
      "    \"BriefTitle\": \"Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-01-17\",\n",
      "    \"StartDate\": \"2014-03\",\n",
      "    \"CompletionDate\": \"2016-03\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01725542\",\n",
      "    \"BriefTitle\": \"Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Bristol-Myers Squibb\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-11-14\",\n",
      "    \"StartDate\": \"2012-12\",\n",
      "    \"CompletionDate\": \"2014-06\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"25977266\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Piroth L, Paniez H, Taburet AM, Vincent C, Rosenthal E, Lacombe K, Billaud E, Rey D, Zucman D, Bailly F, Bronowicki JP, Simony M, Diallo A, Izopet J, Aboulker JP, Meyer L, Molina JM; ANRS HC30 QUADRIH Study Group. High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH Study. Clin Infect Dis. 2015 Sep 1;61(5):817-25. doi: 10.1093/cid/civ381. Epub 2015 May 14.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT06260319\",\n",
      "    \"BriefTitle\": \"Decoding Developmental Disorders in Humams\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"Imagine Institute | Commissariat A L'energie Atomique\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2024-02-15\",\n",
      "    \"StartDate\": \"2019-01-01\",\n",
      "    \"CompletionDate\": \"2024-01-01\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01842919\",\n",
      "    \"BriefTitle\": \"Dance and Huntington Disease\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2013-04-30\",\n",
      "    \"StartDate\": \"2013-04\",\n",
      "    \"CompletionDate\": \"2016-07-08\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02906137\",\n",
      "    \"BriefTitle\": \"Gut-Associated Lymphocyte Trafficking\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2016-09-19\",\n",
      "    \"StartDate\": \"2017-02-06\",\n",
      "    \"CompletionDate\": \"2020-02-25\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01192737\",\n",
      "    \"BriefTitle\": \"\\\"COhort Study on A/H1N1 FLU During PREGnancy\\\"\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2010-09-01\",\n",
      "    \"StartDate\": \"2009-10\",\n",
      "    \"CompletionDate\": \"2010-11\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02647632\",\n",
      "    \"BriefTitle\": \"Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With Sofosbuvir\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2016-01-06\",\n",
      "    \"StartDate\": \"2016-01\",\n",
      "    \"CompletionDate\": \"2017-04\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"29077864\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"de Ledinghen V, Laforest C, Hezode C, Pol S, Renault A, Alric L, Larrey D, Metivier S, Tran A, Jezequel C, Samuel D, Zoulim F, Tual C, Pailhe A, Gibowski S, Bourliere M, Bellissant E, Pawlotsky JM. Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study. Clin Infect Dis. 2018 Mar 19;66(7):1013-1018. doi: 10.1093/cid/cix916.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01065207\",\n",
      "    \"BriefTitle\": \"Patients Infected With HIV Since More Than 10 Years With a Plasma Viral RNA <400 Copies / mL in the Absence of Any Treatment: Study Mechanisms Involved in Controlling the Infection\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2010-02-09\",\n",
      "    \"StartDate\": \"2009-03\",\n",
      "    \"CompletionDate\": \"2012-03\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02542800\",\n",
      "    \"BriefTitle\": \"The Influence of Collective Schemas on Individual Memory\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"La R\\u00e9gion Basse-Normandie | Universit\\u00e9 de Caen Normandie | University Hospital, Caen | Ecole Pratique des Hautes Etudes | Equipement d'Excellence Matrice\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2015-09-07\",\n",
      "    \"StartDate\": \"2015-09\",\n",
      "    \"CompletionDate\": \"2017-06-02\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01089400\",\n",
      "    \"BriefTitle\": \"Immuno-virological Characterization of Severe H1N1v Influenza Infection in Bronchoalveolar Lavage\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"Assistance Publique - H\\u00f4pitaux de Paris | Institut Pasteur\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2010-03-18\",\n",
      "    \"StartDate\": \"2009-10\",\n",
      "    \"CompletionDate\": \"2011-04\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"24646009\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Guihot A, Luyt CE, Parrot A, Rousset D, Cavaillon JM, Boutolleau D, Fitting C, Pajanirassa P, Mallet A, Fartoukh M, Agut H, Musset L, Zoorob R, Kirilovksy A, Combadiere B, van der Werf S, Autran B, Carcelain G; FluBAL Study Group. Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection. Am J Respir Crit Care Med. 2014 May 15;189(10):1240-9. doi: 10.1164/rccm.201311-2071OC.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00574652\",\n",
      "    \"BriefTitle\": \"Evaluation of Clinical Efficacy and Immunologic Response After IL-2 Therapy in HCV-related Vasculitis Patients\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2007-12-17\",\n",
      "    \"StartDate\": \"2008-03\",\n",
      "    \"CompletionDate\": \"2010-09\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"22129253\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Saadoun D, Rosenzwajg M, Joly F, Six A, Carrat F, Thibault V, Sene D, Cacoub P, Klatzmann D. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med. 2011 Dec 1;365(22):2067-77. doi: 10.1056/NEJMoa1105143. Erratum In: N Engl J Med. 2014 Feb 20;370(8):786.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01905059\",\n",
      "    \"BriefTitle\": \"Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Janssen Pharmaceuticals\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2013-07-23\",\n",
      "    \"StartDate\": \"2014-02\",\n",
      "    \"CompletionDate\": \"2017-02\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"16249701\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Arribas JR, Pulido F, Delgado R, Lorenzo A, Miralles P, Arranz A, Gonzalez-Garcia JJ, Cepeda C, Hervas R, Pano JR, Gaya F, Carcas A, Montes ML, Costa JR, Pena JM. Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study). J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):280-7. doi: 10.1097/01.qai.0000180077.59159.f4.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18097218\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Pulido F, Arribas JR, Delgado R, Cabrero E, Gonzalez-Garcia J, Perez-Elias MJ, Arranz A, Portilla J, Pasquau J, Iribarren JA, Rubio R, Norton M; OK04 Study Group. Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV. AIDS. 2008 Jan 11;22(2):F1-9. doi: 10.1097/QAD.0b013e3282f4243b.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18540803\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Cameron DW, da Silva BA, Arribas JR, Myers RA, Bellos NC, Gilmore N, King MS, Bernstein BM, Brun SC, Hanna GJ. A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy. J Infect Dis. 2008 Jul 15;198(2):234-40. doi: 10.1086/589622.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21886816\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Cahn P, Montaner J, Junod P, Patterson P, Krolewiecki A, Andrade-Villanueva J, Cassetti I, Sierra-Madero J, Casiro AD, Bortolozzi R, Lupo SH, Longo N, Rampakakis E, Ackad N, Sampalis JS. Pilot, randomized study assessing safety, tolerability and efficacy of simplified LPV/r maintenance therapy in HIV patients on the 1 PI-based regimen. PLoS One. 2011;6(8):e23726. doi: 10.1371/journal.pone.0023726. Epub 2011 Aug 19.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17545707\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Vernazza P, Daneel S, Schiffer V, Decosterd L, Fierz W, Klimkait T, Hoffmann M, Hirschel B. The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial. AIDS. 2007 Jun 19;21(10):1309-15. doi: 10.1097/QAD.0b013e32814e6b1c.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20802298\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Gutmann C, Cusini A, Gunthard HF, Fux C, Hirschel B, Decosterd LA, Cavassini M, Yerly S, Vernazza PL; Swiss HIV Cohort Study (SHCS). Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir. AIDS. 2010 Sep 24;24(15):2347-54. doi: 10.1097/QAD.0b013e32833db9a1.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20802297\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Katlama C, Valantin MA, Algarte-Genin M, Duvivier C, Lambert-Niclot S, Girard PM, Molina JM, Hoen B, Pakianather S, Peytavin G, Marcelin AG, Flandre P. Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136. AIDS. 2010 Sep 24;24(15):2365-74. doi: 10.1097/QAD.0b013e32833dec20.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20010070\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Arribas JR, Horban A, Gerstoft J, Fatkenheuer G, Nelson M, Clumeck N, Pulido F, Hill A, van Delft Y, Stark T, Moecklinghoff C. The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml. AIDS. 2010 Jan 16;24(2):223-30. doi: 10.1097/QAD.0b013e3283348944.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21811554\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Mathis S, Khanlari B, Pulido F, Schechter M, Negredo E, Nelson M, Vernazza P, Cahn P, Meynard JL, Arribas J, Bucher HC. Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis. PLoS One. 2011;6(7):e22003. doi: 10.1371/journal.pone.0022003. Epub 2011 Jul 19.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22814125\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Gilks CF, Walker AS, Dunn DT, Gibb DM, Kikaire B, Reid A, Musana H, Mambule I, Kasirye R, Robertson V, Ssali F, Spyer M, Pillay D, Yirrell D, Kaleebu P; DART Virology Group and Trial Team. Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA). Antivir Ther. 2012;17(7):1363-73. doi: 10.3851/IMP2253. Epub 2012 Jul 19.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22441252\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Bartlett JA, Ribaudo HJ, Wallis CL, Aga E, Katzenstein DA, Stevens WS, Norton MR, Klingman KL, Hosseinipour MC, Crump JA, Supparatpinyo K, Badal-Faesen S, Kallungal BA, Kumarasamy N. Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings. AIDS. 2012 Jul 17;26(11):1345-54. doi: 10.1097/QAD.0b013e328353b066.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16549962\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Castagna A, Danise A, Menzo S, Galli L, Gianotti N, Carini E, Boeri E, Galli A, Cernuschi M, Hasson H, Clementi M, Lazzarin A. Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study). AIDS. 2006 Apr 4;20(6):795-803. doi: 10.1097/01.aids.0000218542.08845.b2.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23075703\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Bunupuradah T, Chetchotisakd P, Ananworanich J, Munsakul W, Jirajariyavej S, Kantipong P, Prasithsirikul W, Sungkanuparph S, Bowonwatanuwong C, Klinbuayaem V, Kerr SJ, Sophonphan J, Bhakeecheep S, Hirschel B, Ruxrungtham K; HIV STAR Study Group. A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: the HIV STAR study. Antivir Ther. 2012;17(7):1351-61. doi: 10.3851/IMP2443. Epub 2012 Jul 2. Erratum In: Antivir Ther. 2012;17(7):1389-90.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28566227\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Ciaffi L, Koulla-Shiro S, Sawadogo AB, Ndour CT, Eymard-Duvernay S, Mbouyap PR, Ayangma L, Zoungrana J, Gueye NFN, Diallo M, Izard S, Bado G, Kane CT, Aghokeng AF, Peeters M, Girard PM, Le Moing V, Reynes J, Delaporte E; MOBIDIP study group. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial. Lancet HIV. 2017 Sep;4(9):e384-e392. doi: 10.1016/S2352-3018(17)30069-3. Epub 2017 May 28.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02125500\",\n",
      "    \"BriefTitle\": \"Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-04-29\",\n",
      "    \"StartDate\": \"2014-08\",\n",
      "    \"CompletionDate\": \"2015-12\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01413152\",\n",
      "    \"BriefTitle\": \"Residual Risk Assessment Of HIV Transmission\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2011-08-10\",\n",
      "    \"StartDate\": \"2011-07\",\n",
      "    \"CompletionDate\": \"2012-03\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02236832\",\n",
      "    \"BriefTitle\": \"Study of the Neural Basis of Analogical Reasoning\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"Fondation pour la Recherche M\\u00e9dicale\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-09-11\",\n",
      "    \"StartDate\": \"2015-02\",\n",
      "    \"CompletionDate\": \"2021-02\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00115609\",\n",
      "    \"BriefTitle\": \"Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-06-24\",\n",
      "    \"StartDate\": \"2006-01\",\n",
      "    \"CompletionDate\": \"2009-11\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04396288\",\n",
      "    \"BriefTitle\": \"Ultrasound Imaging-based Measurement of Intra-osseous Vascular Response\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2020-05-20\",\n",
      "    \"StartDate\": \"2021-09-14\",\n",
      "    \"CompletionDate\": \"2024-01-30\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00445575\",\n",
      "    \"BriefTitle\": \"Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"ZonMw: The Netherlands Organisation for Health Research and Development | Cliniques universitaires Saint-Luc- Universit\\u00e9 Catholique de Louvain | Charite University, Berlin, Germany\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2007-03-09\",\n",
      "    \"StartDate\": \"2007-07-22\",\n",
      "    \"CompletionDate\": \"2017-12-07\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01024400\",\n",
      "    \"BriefTitle\": \"Immunogenicity and Safety of an Inactivated Non-adjuvanted A(H1N1)v Influenza Vaccine in Pregnant Women\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"MCM Vaccines B.V.\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2009-12-02\",\n",
      "    \"StartDate\": \"2009-11\",\n",
      "    \"CompletionDate\": \"2010-07\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"22147712\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Tsatsaris V, Capitant C, Schmitz T, Chazallon C, Bulifon S, Riethmuller D, Picone O, Poulain P, Lewin F, Laine F, Jacqz-Aigrain E, Aboulker JP, Launay O; Inserm C09-33 PREFLUVAC (Immunogenicity and Safety of an Inactivated Nonadjuvanted A[H1N1v] Influenza Vaccine in Pregnant Women) Study Group. Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial. Ann Intern Med. 2011 Dec 6;155(11):733-41. doi: 10.7326/0003-4819-155-11-201112060-00005.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01779752\",\n",
      "    \"BriefTitle\": \"Vestibular Cortex and TMS\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2013-01-30\",\n",
      "    \"StartDate\": \"2013-01-20\",\n",
      "    \"CompletionDate\": \"2016-01\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03215732\",\n",
      "    \"BriefTitle\": \"Cross Sectional Survey on the Burden and Impacts of Chronic Hepatitis B in the Rural Area of Niakhar, Senegal\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": \"Institute of Research for Development, France\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2017-07-12\",\n",
      "    \"StartDate\": \"2017-10-19\",\n",
      "    \"CompletionDate\": \"2019-07-31\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"31320358\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Coste M, De Seze M, Diallo A, Carrieri MP, Marcellin F, Boyer S; ANRS 12356 AmBASS Study Group. Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356). BMJ Open. 2019 Jul 17;9(7):e030211. doi: 10.1136/bmjopen-2019-030211.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03005652\",\n",
      "    \"BriefTitle\": \"Effects Of An 8-Weeks Mindfulness-based Intervention In Individuals With Subjective Cognitive Decline\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2016-12-29\",\n",
      "    \"StartDate\": \"2017-04-21\",\n",
      "    \"CompletionDate\": \"2018-09-18\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"36068621\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Whitfield T, Demnitz-King H, Schlosser M, Barnhofer T, Frison E, Coll-Padros N, Dautricourt S, Requier F, Delarue M, Gonneaud J, Klimecki OM, Lutz A, Paly L, Salmon E, Schild AK, Walker Z, Jessen F, Chetelat G, Collette F, Wirth M, Marchant NL; Medit-Ageing Research Group. Effects of a mindfulness-based versus a health self-management intervention on objective cognitive performance in older adults with subjective cognitive decline (SCD): a secondary analysis of the SCD-Well randomized controlled trial. Alzheimers Res Ther. 2022 Sep 6;14(1):125. doi: 10.1186/s13195-022-01057-w.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35853750\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Demnitz-King H, Gonneaud J, Klimecki OM, Chocat A, Collette F, Dautricourt S, Jessen F, Krolak-Salmon P, Lutz A, Morse RM, Molinuevo JL, Poisnel G, Touron E, Wirth M, Walker Z, Chetelat G, Marchant NL; Medit-Ageing Research Group. Association of Self-reflection With Cognition and Brain Health in Cognitively Unimpaired Older Adults. Neurology. 2022 Sep 27;99(13):e1422-e1431. doi: 10.1212/WNL.0000000000200951. Epub 2022 Jul 19.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33873195\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Marchant NL, Barnhofer T, Coueron R, Wirth M, Lutz A, Arenaza-Urquijo EM, Collette F, Poisnel G, Demnitz-King H, Schild AK, Coll-Padros N, Delphin-Combe F, Whitfield T, Schlosser M, Gonneaud J, Asselineau J, Walker Z, Krolak-Salmon P, Molinuevo JL, Frison E, Chetelat G, Jessen F, Klimecki OM; The Medit-Ageing Research Group. Effects of a Mindfulness-Based Intervention versus Health Self-Management on Subclinical Anxiety in Older Adults with Subjective Cognitive Decline: The SCD-Well Randomized Superiority Trial. Psychother Psychosom. 2021;90(5):341-350. doi: 10.1159/000515669. Epub 2021 Apr 19.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02916732\",\n",
      "    \"BriefTitle\": \"Zika Virus Infection's Pregnancy Consequences in French Department of America\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2016-09-27\",\n",
      "    \"StartDate\": \"2016-04\",\n",
      "    \"CompletionDate\": \"2019-02\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"33657112\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Funk AL, Hoen B, Vingdassalom I, Ryan C, Kadhel P, Schepers K, Gaete S, Tressieres B, Fontanet A. Reassessment of the risk of birth defects due to Zika virus in Guadeloupe, 2016. PLoS Negl Trop Dis. 2021 Mar 3;15(3):e0009048. doi: 10.1371/journal.pntd.0009048. eCollection 2021 Mar.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29539287\",\n",
      "        \"type\": \"RESULT\",\n",
      "        \"citation\": \"Hoen B, Schaub B, Funk AL, Ardillon V, Boullard M, Cabie A, Callier C, Carles G, Cassadou S, Cesaire R, Douine M, Herrmann-Storck C, Kadhel P, Laouenan C, Madec Y, Monthieux A, Nacher M, Najioullah F, Rousset D, Ryan C, Schepers K, Stegmann-Planchard S, Tressieres B, Volumenie JL, Yassinguezo S, Janky E, Fontanet A. Pregnancy Outcomes after ZIKV Infection in French Territories in the Americas. N Engl J Med. 2018 Mar 15;378(11):985-994. doi: 10.1056/NEJMoa1709481.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01311752\",\n",
      "    \"BriefTitle\": \"Study of Human Papillomavirus Related Genital Pathology Among HIV Positive Women\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": \"Virology study Heather A Cubie Catherine Moore Edinburg United Kingdom | Anatomopathology study Christine Bergeron Laboratoire Pasteur Cerba Cergy Pontoise France | Paris, Isabelle Cartier, M.D. | Immunology study Guislaine Carcelain Groupe Hospitalier Piti\\u00e9 Salp\\u00e9tri\\u00e8re Paris | Surgery study Herv\\u00e9 Foulot Cochin Paris\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2011-03-09\",\n",
      "    \"StartDate\": \"2007-11\",\n",
      "    \"CompletionDate\": \"2012-12\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01269632\",\n",
      "    \"BriefTitle\": \"Cohort of Young Adults Infected With HIV Since Birth or During Childhood\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2011-01-04\",\n",
      "    \"StartDate\": \"2010-06\",\n",
      "    \"CompletionDate\": \"2018-12-27\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01495897\",\n",
      "    \"BriefTitle\": \"Abnormal Movements, Cerebellum and Sensorimotor : Oculomotor Study\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2011-12-20\",\n",
      "    \"StartDate\": \"2011-03\",\n",
      "    \"CompletionDate\": \"2014-03\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00463983\",\n",
      "    \"BriefTitle\": \"Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2007-04-20\",\n",
      "    \"StartDate\": \"2006-10\",\n",
      "    \"CompletionDate\": \"2012-01\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"16883006\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Lebtahi R, Moreau S, Marchand-Adam S, Debray MP, Brauner M, Soler P, Marchal J, Raguin O, Gruaz-Guyon A, Reubi JC, Le Guludec D, Crestani B. Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis. J Nucl Med. 2006 Aug;47(8):1281-7.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22379151\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Crestani B, Chapron J, Wallaert B, Bergot E, Delaval P, Israel-Biet D, Lacronique J, Monnet I, Reynaud-Gaubert M, Tazi A, Lebtahi R, Debray MP, Brauner M, Dehoux M, Dornic Q, Aubier M, Mentre F, Duval X. Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study. Eur Respir J. 2012 Mar;39(3):772-5. doi: 10.1183/09031936.00113011. No abstract available.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03137797\",\n",
      "    \"BriefTitle\": \"Cohort of Patients Naive of Antiretroviral Treatment at Enrollment\",\n",
      "    \"LeadSponsorName\": \"ANRS, Emerging Infectious Diseases\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2017-05-03\",\n",
      "    \"StartDate\": \"2004-02\",\n",
      "    \"CompletionDate\": \"2016-06\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"22267473\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Boufassa F, Goujard C, Viard JP, Carlier R, Lefebvre B, Yeni P, Bouchaud O, Capeau J, Meyer L, Vigouroux C; ANRS COPANA Cohort Study Group. Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort. Antivir Ther. 2012;17(1):91-100. doi: 10.3851/IMP1916.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22008658\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Dray-Spira R, Legeai C, Le Den M, Boue F, Lascoux-Combe C, Simon A, May T, Goujard C, Meyer L; ANRS-COPANA Cohort Study Group. Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use. AIDS. 2012 Jan 14;26(2):207-15. doi: 10.1097/QAD.0b013e32834dcf61.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23079802\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Rachas A, Warszawski J, Le Chenadec J, Legeai C, Teglas JP, Goujard C, Rouzioux C, Mandelbrot L, Tubiana R, Meyer L. Does pregnancy affect the early response to cART? AIDS. 2013 Jan 28;27(3):357-67. doi: 10.1097/QAD.0b013e32835ac8bc.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23936509\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Krastinova E, Seng R, Yeni P, Viard JP, Vittecoq D, Lascoux-Combe C, Fourn E, Pahlavan G, Delfraissy JF, Goujard C, Meyer L; ANRS PRIMO and COPANA Cohorts. Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts. PLoS One. 2013 Aug 1;8(8):e71473. doi: 10.1371/journal.pone.0071473. Print 2013. Erratum In: PLoS One. 2013;8(11). doi:10.1371/annotation/aed12a66-9c76-4e49-806b-881a2fe23bba. Goujard, Cecile [added].\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24058636\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Legeai C, Vigouroux C, Souberbielle JC, Bouchaud O, Boufassa F, Bastard JP, Carlier R, Capeau J, Goujard C, Meyer L, Viard JP; ANRS-COPANA Cohort Study Group. Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 <<COPANA>> cohort study. PLoS One. 2013 Sep 18;8(9):e74868. doi: 10.1371/journal.pone.0074868. eCollection 2013.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24465584\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Boufassa F, Lechenadec J, Meyer L, Costagliola D, Hunt PW, Pereyra F, Deeks S, Pancino G, Taulera O, Lichterfeld M, Delobel P, Saez-Cirion A, Lambotte O; ANRS CO18 HIV Controllers Cohort; Cascade Collaboration in Eurocoord; SCOPE Cohort; International HIV Controllers Study. Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaboration. PLoS One. 2014 Jan 17;9(1):e85516. doi: 10.1371/journal.pone.0085516. eCollection 2014.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25573889\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"El Khoury P, Ghislain M, Villard EF, Le Goff W, Lascoux-Combe C, Yeni P, Meyer L, Vigouroux C, Goujard C, Guerin M. Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART. J Lipid Res. 2015 Mar;56(3):692-702. doi: 10.1194/jlr.M054510. Epub 2015 Jan 8.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26636578\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Ghislain M, Bastard JP, Meyer L, Capeau J, Fellahi S, Gerard L, May T, Simon A, Vigouroux C, Goujard C; ANRS-COPANA Cohort Study Group. Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities. PLoS One. 2015 Dec 4;10(12):e0144317. doi: 10.1371/journal.pone.0144317. eCollection 2015.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27509048\",\n",
      "        \"type\": \"BACKGROUND\",\n",
      "        \"citation\": \"Ploquin MJ, Madec Y, Casrouge A, Huot N, Passaes C, Lecuroux C, Essat A, Boufassa F, Jacquelin B, Jochems SP, Petitjean G, Angin M, Gartner K, Garcia-Tellez T, Noel N, Booiman T, Boeser-Nunnink BD, Roques P, Saez-Cirion A, Vaslin B, Dereudre-Bosquet N, Barre-Sinoussi F, Ghislain M, Rouzioux C, Lambotte O, Albert ML, Goujard C, Kootstra N, Meyer L, Muller-Trutwin MC. Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset. PLoS Pathog. 2016 Aug 10;12(8):e1005774. doi: 10.1371/journal.ppat.1005774. eCollection 2016 Aug.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01037777\",\n",
      "    \"BriefTitle\": \"RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2009-12-23\",\n",
      "    \"StartDate\": \"2009-05-07\",\n",
      "    \"CompletionDate\": \"2017-12-14\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"35264424\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Wilke C, Mengel D, Schols L, Hengel H, Rakowicz M, Klockgether T, Durr A, Filla A, Melegh B, Schule R, Reetz K, Jacobi H, Synofzik M. Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1. Neurology. 2022 May 17;98(20):e1985-e1996. doi: 10.1212/WNL.0000000000200257. Epub 2022 Mar 9.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32822634\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Jacobi H, du Montcel ST, Romanzetti S, Harmuth F, Mariotti C, Nanetti L, Rakowicz M, Makowicz G, Durr A, Monin ML, Filla A, Roca A, Schols L, Hengel H, Infante J, Kang JS, Timmann D, Casali C, Masciullo M, Baliko L, Melegh B, Nachbauer W, Burk-Gergs K, Schulz JB, Riess O, Reetz K, Klockgether T. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study. Lancet Neurol. 2020 Sep;19(9):738-747. doi: 10.1016/S1474-4422(20)30235-0.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24780882\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Tezenas du Montcel S, Durr A, Rakowicz M, Nanetti L, Charles P, Sulek A, Mariotti C, Rola R, Schols L, Bauer P, Dufaure-Gare I, Jacobi H, Forlani S, Schmitz-Hubsch T, Filla A, Timmann D, van de Warrenburg BP, Marelli C, Kang JS, Giunti P, Cook A, Baliko L, Melegh B, Boesch S, Szymanski S, Berciano J, Infante J, Buerk K, Masciullo M, Di Fabio R, Depondt C, Ratka S, Stevanin G, Klockgether T, Brice A, Golmard JL. Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6. J Med Genet. 2014 Jul;51(7):479-86. doi: 10.1136/jmedgenet-2013-102200. Epub 2014 Apr 29. Erratum In: J Med Genet. 2014 Sep;51(9):613. Bela, Melegh [corrected to Melegh, Bela].\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23707147\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Jacobi H, Reetz K, du Montcel ST, Bauer P, Mariotti C, Nanetti L, Rakowicz M, Sulek A, Durr A, Charles P, Filla A, Antenora A, Schols L, Schicks J, Infante J, Kang JS, Timmann D, Di Fabio R, Masciullo M, Baliko L, Melegh B, Boesch S, Burk K, Peltz A, Schulz JB, Dufaure-Gare I, Klockgether T. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data. Lancet Neurol. 2013 Jul;12(7):650-8. doi: 10.1016/S1474-4422(13)70104-2. Epub 2013 May 22. Erratum In: Lancet Neurol. 2013 Jul;12(7):630.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01842477\",\n",
      "    \"BriefTitle\": \"Evaluation of Efficacy and Safety of Autologous MSCs Combined to Biomaterials to Enhance Bone Healing\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2013-04-29\",\n",
      "    \"StartDate\": \"2013-05\",\n",
      "    \"CompletionDate\": \"2016-02-05\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02721745\",\n",
      "    \"BriefTitle\": \"Cause and Consequence of Neural Fatigue\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2016-03-29\",\n",
      "    \"StartDate\": \"2016-05-23\",\n",
      "    \"CompletionDate\": \"2020-12\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02408354\",\n",
      "    \"BriefTitle\": \"Pilot Study, Comparative, Single-center, Randomized, Crossover, Double-blind, Against Placebo, Testing the Effectiveness of Triheptanoin Oil in Alternating Hemiplegia of Childhood\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2015-04-03\",\n",
      "    \"StartDate\": \"2015-04-15\",\n",
      "    \"CompletionDate\": \"2017-04-05\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"28969699\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Hainque E, Caillet S, Leroy S, Flamand-Roze C, Adanyeguh I, Charbonnier-Beaupel F, Retail M, Le Toullec B, Atencio M, Rivaud-Pechoux S, Brochard V, Habarou F, Ottolenghi C, Cormier F, Meneret A, Ruiz M, Doulazmi M, Roubergue A, Corvol JC, Vidailhet M, Mochel F, Roze E. A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood. Orphanet J Rare Dis. 2017 Oct 2;12(1):160. doi: 10.1186/s13023-017-0713-2.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01688453\",\n",
      "    \"BriefTitle\": \"Overweight Management and Social Inequalities\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2012-09-19\",\n",
      "    \"StartDate\": \"2012-04\",\n",
      "    \"CompletionDate\": \"2015-11\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"34087324\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Manneville F, Omorou AY, Legrand K, Lecomte E, Rydberg JA, Briancon S, Guillemin F; PRALIMAP Trial Group. Sociodemographic and psychological characteristics associated with discrepancy between body satisfaction and weight change among adolescents. Prev Med. 2021 Sep;150:106668. doi: 10.1016/j.ypmed.2021.106668. Epub 2021 Jun 1.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32097754\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Omorou AY, Manneville F, Langlois J, Legrand K, Bohme P, Muller L, Guillemin F, Briancon S, Lecomte E; PRALIMAP-INES Trial Group. Physical activity rather than sedentary behaviour is socially determined in French adolescents with overweight and obesity. Prev Med. 2020 May;134:106043. doi: 10.1016/j.ypmed.2020.106043. Epub 2020 Feb 22.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29934380\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Saez L, Legrand K, Alleyrat C, Ramisasoa S, Langlois J, Muller L, Omorou AY, De Lavenne R, Kivits J, Lecomte E, Briancon S; PRALIMAP-INES Trial Group. Using facilitator-receiver peer dyads matched according to socioeconomic status to promote behaviour change in overweight adolescents: a feasibility study. BMJ Open. 2018 Jun 22;8(6):e019731. doi: 10.1136/bmjopen-2017-019731.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29776897\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Saez L, Langlois J, Legrand K, Quinet MH, Lecomte E, Omorou AY, Briancon S; PRALIMAP-INES Trial Group. Reach and Acceptability of a Mobile Reminder Strategy and Facebook Group Intervention for Weight Management in Less Advantaged Adolescents: Insights From the PRALIMAP-INES Trial. JMIR Mhealth Uhealth. 2018 May 18;6(5):e110. doi: 10.2196/mhealth.7657.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29696179\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Legrand K, Lecomte E, Langlois J, Muller L, Saez L, Quinet MH, Bohme P, Spitz E, Omorou AY, Briancon S; PRALIMAP-INES trial group. Reducing social inequalities in access to overweight and obesity care management for adolescents: The PRALIMAP-INES trial protocol and inclusion data analysis. Contemp Clin Trials Commun. 2017 Jun 16;7:141-157. doi: 10.1016/j.conctc.2017.05.010. eCollection 2017 Sep.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02172677\",\n",
      "    \"BriefTitle\": \"The Influence of Collective Schemas on Individual Memory\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"La R\\u00e9gion Basse-Normandie | Universit\\u00e9 de Caen Normandie | University Hospital, Caen | Ecole Pratique des Hautes Etudes | Equipement d'Excellence Matrice\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-06-24\",\n",
      "    \"StartDate\": \"2014-10\",\n",
      "    \"CompletionDate\": \"2016-10-14\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01880151\",\n",
      "    \"BriefTitle\": \"Neuroelectrical Biomarkers for Alzheimer's Disease Stages\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2013-06-18\",\n",
      "    \"StartDate\": \"2013-07-12\",\n",
      "    \"CompletionDate\": \"2019-01\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02658253\",\n",
      "    \"BriefTitle\": \"Trial to Evaluate the Safety and Immunogenicity of a Placental Malaria Vaccine Candidate (PRIMVAC ) in Healthy Adults\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": \"EVI Industries, Inc. | Recherche Clinique Paris Descartes Necker Cochin Sainte Anne | Centre national de recherche et de formation sur le paludisme | EUCLID Clinical Trial Platform\",\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2016-01-18\",\n",
      "    \"StartDate\": \"2016-01\",\n",
      "    \"CompletionDate\": \"2019-02-21\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"33717176\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Gamain B, Chene A, Viebig NK, Tuikue Ndam N, Nielsen MA. Progress and Insights Toward an Effective Placental Malaria Vaccine. Front Immunol. 2021 Feb 25;12:634508. doi: 10.3389/fimmu.2021.634508. eCollection 2021.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32032566\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Sirima SB, Richert L, Chene A, Konate AT, Campion C, Dechavanne S, Semblat JP, Benhamouda N, Bahuaud M, Loulergue P, Ouedraogo A, Nebie I, Kabore M, Kargougou D, Barry A, Ouattara SM, Boilet V, Allais F, Roguet G, Havelange N, Lopez-Perez E, Kuppers A, Konate E, Roussillon C, Kante M, Belarbi L, Diarra A, Henry N, Soulama I, Ouedraogo A, Esperou H, Leroy O, Batteux F, Tartour E, Viebig NK, Thiebaut R, Launay O, Gamain B. PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study. Lancet Infect Dis. 2020 May;20(5):585-597. doi: 10.1016/S1473-3099(19)30739-X. Epub 2020 Feb 4.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02027051\",\n",
      "    \"BriefTitle\": \"Etude g\\u00e9n\\u00e9tique Des Arm\\u00e9niens\",\n",
      "    \"LeadSponsorName\": \"Institut National de la Sant\\u00e9 Et de la Recherche M\\u00e9dicale, France\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"OBSERVATIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2014-01-03\",\n",
      "    \"StartDate\": \"2014-01\",\n",
      "    \"CompletionDate\": \"2017-01\",\n",
      "    \"Reference\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00118677\",\n",
      "    \"BriefTitle\": \"Long-Term Supervised Treatment Interruption in HIV-Infected Patients\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2005-07-12\",\n",
      "    \"StartDate\": \"2003-02\",\n",
      "    \"CompletionDate\": \"2007-05\",\n",
      "    \"Reference\": [\n",
      "      {\n",
      "        \"pmid\": \"20657770\",\n",
      "        \"type\": \"DERIVED\",\n",
      "        \"citation\": \"Weiss L, Piketty C, Assoumou L, Didier C, Caccavelli L, Donkova-Petrini V, Levy Y, Girard PM, Burgard M, Viard JP, Rouzioux C, Costagliola D; ANRS 116 SALTO study group. Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy. PLoS One. 2010 Jul 21;5(7):e11659. doi: 10.1371/journal.pone.0011659.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00647205\",\n",
      "    \"BriefTitle\": \"Evaluation of 2 Interferon \\u03b3 Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT\",\n",
      "    \"LeadSponsorName\": \"French National Agency for Research on AIDS and Viral Hepatitis\",\n",
      "    \"CollaboratorName\": null,\n",
      "    \"OverallStatus\": \"COMPLETED\",\n",
      "    \"StudyType\": \"INTERVENTIONAL\",\n",
      "    \"HasResults\": false,\n",
      "    \"StudyFirstPostDate\": \"2008-03-31\",\n",
      "    \"StartDate\": \"2008-01\",\n",
      "    \"CompletionDate\": \"2010-11\",\n",
      "    \"Reference\": []\n",
      "  }\n",
      "]\n"
     ]
    }
   ],
   "source": [
    "studies_list = []\n",
    "for study in response.json()['studies']:\n",
    "    study_dict = {\n",
    "        'NCTId': study['protocolSection']['identificationModule']['nctId'],\n",
    "        'BriefTitle': study['protocolSection']['identificationModule']['briefTitle'],\n",
    "        'LeadSponsorName': study['protocolSection']['sponsorCollaboratorsModule']['leadSponsor']['name'],\n",
    "        'CollaboratorName': concatenate_collaborator_list(\n",
    "            [\n",
    "                c['name']\n",
    "                for c in (\n",
    "                    study['protocolSection']['sponsorCollaboratorsModule'].get('collaborators', [])  # can be missing\n",
    "                )\n",
    "            ]\n",
    "        ),\n",
    "        'OverallStatus': study['protocolSection']['statusModule']['overallStatus'],\n",
    "        'StudyType': study['protocolSection']['designModule']['studyType'],\n",
    "        'HasResults': study['hasResults'],\n",
    "        'StudyFirstPostDate': study['protocolSection']['statusModule']['studyFirstPostDateStruct']['date'],\n",
    "        'StartDate': study['protocolSection']['statusModule'].get('startDateStruct', {}).get('date', None),  # can be missing\n",
    "        # 'PrimaryCompletionDate' : study[\"protocolSection\"][\"statusModule\"].get('primaryCompletionDateStruct', {}).get('date', None), # can be missing\n",
    "        'CompletionDate': study['protocolSection']['statusModule'].get('completionDateStruct', {}).get('date', None),  # can be missing\n",
    "        'Reference': study['protocolSection'].get('referencesModule', {}).get('references', []),  # can be missing\n",
    "    }\n",
    "    studies_list.append(study_dict)\n",
    "\n",
    "print(json.dumps(studies_list, indent=2))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "79beae31-da09-4108-8900-26d423062495",
   "metadata": {},
   "source": [
    "On vérifie que l'on n'a pas perdu de NCTId en route:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "591c6902-e73c-4db6-b27c-89d68e06e2c0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nombre de NCTId: 289\n"
     ]
    }
   ],
   "source": [
    "print(f'Nombre de NCTId: {len(studies_list)}')\n",
    "assert response.json()['totalCount'] == len(studies_list)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2536328d-746c-4fab-8245-d498eaa2fc55",
   "metadata": {},
   "source": [
    "### Import dans Pandas"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "a6866a1d-8c4a-4992-815c-66faf4a42a46",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>StartDate</th>\n",
       "      <th>CompletionDate</th>\n",
       "      <th>Reference</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02014727</td>\n",
       "      <td>Safety and Immunogenicity of Recombinant Pichi...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>EVI Industries, Inc. | BPRC | Recherche Cliniq...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2013-12-18</td>\n",
       "      <td>2014-01</td>\n",
       "      <td>2015-07</td>\n",
       "      <td>[{'pmid': '28947345', 'type': 'DERIVED', 'cita...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT00117494</td>\n",
       "      <td>Rosuvastatin Versus Pravastatin in HIV Patient...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-07-07</td>\n",
       "      <td>2005-10</td>\n",
       "      <td>2007-06</td>\n",
       "      <td>[{'pmid': '22739396', 'type': 'DERIVED', 'cita...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT00536627</td>\n",
       "      <td>Efficacy and Tolerance of Naked DNA Vaccine in...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2007-09-28</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>2010-11</td>\n",
       "      <td>[{'pmid': '16310901', 'type': 'BACKGROUND', 'c...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT01033760</td>\n",
       "      <td>Optimisation of Primary HIV1 Infection Treatme...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Gilead Sciences | Merck Sharp &amp; Dohme LLC | Pf...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2009-12-16</td>\n",
       "      <td>2010-04</td>\n",
       "      <td>2013-12</td>\n",
       "      <td>[{'pmid': '28708873', 'type': 'DERIVED', 'cita...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT05349162</td>\n",
       "      <td>Epicardial vs. Transvenous ICDs in Children</td>\n",
       "      <td>Paris Cardiovascular Research Center (Inserm U...</td>\n",
       "      <td>Hôpital Necker-Enfants Malades</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2022-04-27</td>\n",
       "      <td>2003-01-01</td>\n",
       "      <td>2022-04-01</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>284</th>\n",
       "      <td>NCT01880151</td>\n",
       "      <td>Neuroelectrical Biomarkers for Alzheimer's Dis...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2013-06-18</td>\n",
       "      <td>2013-07-12</td>\n",
       "      <td>2019-01</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>285</th>\n",
       "      <td>NCT02658253</td>\n",
       "      <td>Trial to Evaluate the Safety and Immunogenicit...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>EVI Industries, Inc. | Recherche Clinique Pari...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-01-18</td>\n",
       "      <td>2016-01</td>\n",
       "      <td>2019-02-21</td>\n",
       "      <td>[{'pmid': '33717176', 'type': 'DERIVED', 'cita...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>286</th>\n",
       "      <td>NCT02027051</td>\n",
       "      <td>Etude génétique Des Arméniens</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2014-01-03</td>\n",
       "      <td>2014-01</td>\n",
       "      <td>2017-01</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>287</th>\n",
       "      <td>NCT00118677</td>\n",
       "      <td>Long-Term Supervised Treatment Interruption in...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-07-12</td>\n",
       "      <td>2003-02</td>\n",
       "      <td>2007-05</td>\n",
       "      <td>[{'pmid': '20657770', 'type': 'DERIVED', 'cita...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>288</th>\n",
       "      <td>NCT00647205</td>\n",
       "      <td>Evaluation of 2 Interferon γ Assays in the Dia...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2008-03-31</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>2010-11</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>289 rows × 11 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                         BriefTitle  \\\n",
       "0    NCT02014727  Safety and Immunogenicity of Recombinant Pichi...   \n",
       "1    NCT00117494  Rosuvastatin Versus Pravastatin in HIV Patient...   \n",
       "2    NCT00536627  Efficacy and Tolerance of Naked DNA Vaccine in...   \n",
       "3    NCT01033760  Optimisation of Primary HIV1 Infection Treatme...   \n",
       "4    NCT05349162        Epicardial vs. Transvenous ICDs in Children   \n",
       "..           ...                                                ...   \n",
       "284  NCT01880151  Neuroelectrical Biomarkers for Alzheimer's Dis...   \n",
       "285  NCT02658253  Trial to Evaluate the Safety and Immunogenicit...   \n",
       "286  NCT02027051                      Etude génétique Des Arméniens   \n",
       "287  NCT00118677  Long-Term Supervised Treatment Interruption in...   \n",
       "288  NCT00647205  Evaluation of 2 Interferon γ Assays in the Dia...   \n",
       "\n",
       "                                       LeadSponsorName  \\\n",
       "0    Institut National de la Santé Et de la Recherc...   \n",
       "1    French National Agency for Research on AIDS an...   \n",
       "2    French National Agency for Research on AIDS an...   \n",
       "3                   ANRS, Emerging Infectious Diseases   \n",
       "4    Paris Cardiovascular Research Center (Inserm U...   \n",
       "..                                                 ...   \n",
       "284  Institut National de la Santé Et de la Recherc...   \n",
       "285  Institut National de la Santé Et de la Recherc...   \n",
       "286  Institut National de la Santé Et de la Recherc...   \n",
       "287  French National Agency for Research on AIDS an...   \n",
       "288  French National Agency for Research on AIDS an...   \n",
       "\n",
       "                                      CollaboratorName OverallStatus  \\\n",
       "0    EVI Industries, Inc. | BPRC | Recherche Cliniq...     COMPLETED   \n",
       "1                                                 None     COMPLETED   \n",
       "2                                                 None     COMPLETED   \n",
       "3    Gilead Sciences | Merck Sharp & Dohme LLC | Pf...     COMPLETED   \n",
       "4                       Hôpital Necker-Enfants Malades     COMPLETED   \n",
       "..                                                 ...           ...   \n",
       "284                                               None     COMPLETED   \n",
       "285  EVI Industries, Inc. | Recherche Clinique Pari...     COMPLETED   \n",
       "286                                               None     COMPLETED   \n",
       "287                                               None     COMPLETED   \n",
       "288                                               None     COMPLETED   \n",
       "\n",
       "          StudyType  HasResults StudyFirstPostDate   StartDate CompletionDate  \\\n",
       "0    INTERVENTIONAL       False         2013-12-18     2014-01        2015-07   \n",
       "1    INTERVENTIONAL       False         2005-07-07     2005-10        2007-06   \n",
       "2    INTERVENTIONAL       False         2007-09-28     2008-01        2010-11   \n",
       "3    INTERVENTIONAL       False         2009-12-16     2010-04        2013-12   \n",
       "4     OBSERVATIONAL       False         2022-04-27  2003-01-01     2022-04-01   \n",
       "..              ...         ...                ...         ...            ...   \n",
       "284  INTERVENTIONAL       False         2013-06-18  2013-07-12        2019-01   \n",
       "285  INTERVENTIONAL       False         2016-01-18     2016-01     2019-02-21   \n",
       "286   OBSERVATIONAL       False         2014-01-03     2014-01        2017-01   \n",
       "287  INTERVENTIONAL       False         2005-07-12     2003-02        2007-05   \n",
       "288  INTERVENTIONAL       False         2008-03-31     2008-01        2010-11   \n",
       "\n",
       "                                             Reference  \n",
       "0    [{'pmid': '28947345', 'type': 'DERIVED', 'cita...  \n",
       "1    [{'pmid': '22739396', 'type': 'DERIVED', 'cita...  \n",
       "2    [{'pmid': '16310901', 'type': 'BACKGROUND', 'c...  \n",
       "3    [{'pmid': '28708873', 'type': 'DERIVED', 'cita...  \n",
       "4                                                   []  \n",
       "..                                                 ...  \n",
       "284                                                 []  \n",
       "285  [{'pmid': '33717176', 'type': 'DERIVED', 'cita...  \n",
       "286                                                 []  \n",
       "287  [{'pmid': '20657770', 'type': 'DERIVED', 'cita...  \n",
       "288                                                 []  \n",
       "\n",
       "[289 rows x 11 columns]"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_ct = pd.json_normalize(data=studies_list)\n",
    "df_ct"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bcf7da5f-f67d-4cf6-ab62-136eae59d865",
   "metadata": {},
   "source": [
    "#### On \"explose\" la colonne \"References\":\n",
    "\n",
    "Pour chaque NCTId, la colonne réferences contient potentiellement une liste de plusieurs références.  \n",
    "Si par exemple, on a 3 références, on veut se retrouver avec 3 lignes, chacune indexée par le même NCTId et contenant une unique réference.  \n",
    "\n",
    "*Avant*:  \n",
    "**`NCTId    References`**  \n",
    "`NCT0001, [Ref1, Ref2, Ref3]`   \n",
    "\n",
    "*Après*:  \n",
    "**`NCTId    References`**  \n",
    "`NCT0001,   Ref1`  \n",
    "`NCT0001,   Ref2`  \n",
    "`NCT0001,   Ref3`   "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "3af5b2f7-9a14-4d85-823f-5335ec9d66e7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>StartDate</th>\n",
       "      <th>CompletionDate</th>\n",
       "      <th>Reference</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02014727</td>\n",
       "      <td>Safety and Immunogenicity of Recombinant Pichi...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>EVI Industries, Inc. | BPRC | Recherche Cliniq...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2013-12-18</td>\n",
       "      <td>2014-01</td>\n",
       "      <td>2015-07</td>\n",
       "      <td>{'pmid': '28947345', 'type': 'DERIVED', 'citat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT00117494</td>\n",
       "      <td>Rosuvastatin Versus Pravastatin in HIV Patient...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-07-07</td>\n",
       "      <td>2005-10</td>\n",
       "      <td>2007-06</td>\n",
       "      <td>{'pmid': '22739396', 'type': 'DERIVED', 'citat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT00117494</td>\n",
       "      <td>Rosuvastatin Versus Pravastatin in HIV Patient...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-07-07</td>\n",
       "      <td>2005-10</td>\n",
       "      <td>2007-06</td>\n",
       "      <td>{'pmid': '22318219', 'type': 'DERIVED', 'citat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00536627</td>\n",
       "      <td>Efficacy and Tolerance of Naked DNA Vaccine in...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2007-09-28</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>2010-11</td>\n",
       "      <td>{'pmid': '16310901', 'type': 'BACKGROUND', 'ci...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT00536627</td>\n",
       "      <td>Efficacy and Tolerance of Naked DNA Vaccine in...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2007-09-28</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>2010-11</td>\n",
       "      <td>{'pmid': '15382173', 'type': 'BACKGROUND', 'ci...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>686</th>\n",
       "      <td>NCT02658253</td>\n",
       "      <td>Trial to Evaluate the Safety and Immunogenicit...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>EVI Industries, Inc. | Recherche Clinique Pari...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-01-18</td>\n",
       "      <td>2016-01</td>\n",
       "      <td>2019-02-21</td>\n",
       "      <td>{'pmid': '33717176', 'type': 'DERIVED', 'citat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>687</th>\n",
       "      <td>NCT02658253</td>\n",
       "      <td>Trial to Evaluate the Safety and Immunogenicit...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>EVI Industries, Inc. | Recherche Clinique Pari...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-01-18</td>\n",
       "      <td>2016-01</td>\n",
       "      <td>2019-02-21</td>\n",
       "      <td>{'pmid': '32032566', 'type': 'DERIVED', 'citat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>688</th>\n",
       "      <td>NCT02027051</td>\n",
       "      <td>Etude génétique Des Arméniens</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2014-01-03</td>\n",
       "      <td>2014-01</td>\n",
       "      <td>2017-01</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>689</th>\n",
       "      <td>NCT00118677</td>\n",
       "      <td>Long-Term Supervised Treatment Interruption in...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-07-12</td>\n",
       "      <td>2003-02</td>\n",
       "      <td>2007-05</td>\n",
       "      <td>{'pmid': '20657770', 'type': 'DERIVED', 'citat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>690</th>\n",
       "      <td>NCT00647205</td>\n",
       "      <td>Evaluation of 2 Interferon γ Assays in the Dia...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2008-03-31</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>2010-11</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>691 rows × 11 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                         BriefTitle  \\\n",
       "0    NCT02014727  Safety and Immunogenicity of Recombinant Pichi...   \n",
       "1    NCT00117494  Rosuvastatin Versus Pravastatin in HIV Patient...   \n",
       "2    NCT00117494  Rosuvastatin Versus Pravastatin in HIV Patient...   \n",
       "3    NCT00536627  Efficacy and Tolerance of Naked DNA Vaccine in...   \n",
       "4    NCT00536627  Efficacy and Tolerance of Naked DNA Vaccine in...   \n",
       "..           ...                                                ...   \n",
       "686  NCT02658253  Trial to Evaluate the Safety and Immunogenicit...   \n",
       "687  NCT02658253  Trial to Evaluate the Safety and Immunogenicit...   \n",
       "688  NCT02027051                      Etude génétique Des Arméniens   \n",
       "689  NCT00118677  Long-Term Supervised Treatment Interruption in...   \n",
       "690  NCT00647205  Evaluation of 2 Interferon γ Assays in the Dia...   \n",
       "\n",
       "                                       LeadSponsorName  \\\n",
       "0    Institut National de la Santé Et de la Recherc...   \n",
       "1    French National Agency for Research on AIDS an...   \n",
       "2    French National Agency for Research on AIDS an...   \n",
       "3    French National Agency for Research on AIDS an...   \n",
       "4    French National Agency for Research on AIDS an...   \n",
       "..                                                 ...   \n",
       "686  Institut National de la Santé Et de la Recherc...   \n",
       "687  Institut National de la Santé Et de la Recherc...   \n",
       "688  Institut National de la Santé Et de la Recherc...   \n",
       "689  French National Agency for Research on AIDS an...   \n",
       "690  French National Agency for Research on AIDS an...   \n",
       "\n",
       "                                      CollaboratorName OverallStatus  \\\n",
       "0    EVI Industries, Inc. | BPRC | Recherche Cliniq...     COMPLETED   \n",
       "1                                                 None     COMPLETED   \n",
       "2                                                 None     COMPLETED   \n",
       "3                                                 None     COMPLETED   \n",
       "4                                                 None     COMPLETED   \n",
       "..                                                 ...           ...   \n",
       "686  EVI Industries, Inc. | Recherche Clinique Pari...     COMPLETED   \n",
       "687  EVI Industries, Inc. | Recherche Clinique Pari...     COMPLETED   \n",
       "688                                               None     COMPLETED   \n",
       "689                                               None     COMPLETED   \n",
       "690                                               None     COMPLETED   \n",
       "\n",
       "          StudyType  HasResults StudyFirstPostDate StartDate CompletionDate  \\\n",
       "0    INTERVENTIONAL       False         2013-12-18   2014-01        2015-07   \n",
       "1    INTERVENTIONAL       False         2005-07-07   2005-10        2007-06   \n",
       "2    INTERVENTIONAL       False         2005-07-07   2005-10        2007-06   \n",
       "3    INTERVENTIONAL       False         2007-09-28   2008-01        2010-11   \n",
       "4    INTERVENTIONAL       False         2007-09-28   2008-01        2010-11   \n",
       "..              ...         ...                ...       ...            ...   \n",
       "686  INTERVENTIONAL       False         2016-01-18   2016-01     2019-02-21   \n",
       "687  INTERVENTIONAL       False         2016-01-18   2016-01     2019-02-21   \n",
       "688   OBSERVATIONAL       False         2014-01-03   2014-01        2017-01   \n",
       "689  INTERVENTIONAL       False         2005-07-12   2003-02        2007-05   \n",
       "690  INTERVENTIONAL       False         2008-03-31   2008-01        2010-11   \n",
       "\n",
       "                                             Reference  \n",
       "0    {'pmid': '28947345', 'type': 'DERIVED', 'citat...  \n",
       "1    {'pmid': '22739396', 'type': 'DERIVED', 'citat...  \n",
       "2    {'pmid': '22318219', 'type': 'DERIVED', 'citat...  \n",
       "3    {'pmid': '16310901', 'type': 'BACKGROUND', 'ci...  \n",
       "4    {'pmid': '15382173', 'type': 'BACKGROUND', 'ci...  \n",
       "..                                                 ...  \n",
       "686  {'pmid': '33717176', 'type': 'DERIVED', 'citat...  \n",
       "687  {'pmid': '32032566', 'type': 'DERIVED', 'citat...  \n",
       "688                                                NaN  \n",
       "689  {'pmid': '20657770', 'type': 'DERIVED', 'citat...  \n",
       "690                                                NaN  \n",
       "\n",
       "[691 rows x 11 columns]"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_ct = df_ct.explode('Reference', ignore_index=True)\n",
    "df_ct"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8a141674-4974-432d-8c4a-4b1c0b9f9970",
   "metadata": {},
   "source": [
    "Pour chaque NCTId, la colonne réference contient maintenant un dictionnaire de la forme:  \n",
    "`{  \n",
    "\"pmid\": \"17545707\",  \n",
    "\"type\": \"BACKGROUND\",  \n",
    "\"citation\": \"...\",  \n",
    "}`\n",
    "\n",
    "Dont on veut extraire de nouvelles colonnes en utilant les clés du dictionnaire:  \n",
    "**`pmid     type        citation`**  \n",
    "`17545707, BACKGROUND, \"...\"`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "0b7f8365-bbf5-4e6a-96b0-23946df93a8b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pmid</th>\n",
       "      <th>type</th>\n",
       "      <th>citation</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>28947345</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Sirima SB, Durier C, Kara L, Houard S, Gansane...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>22739396</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Bittar R, Giral P, Aslangul E, Assoumou L, Val...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>22318219</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Bittar R, Giral P, Aslangul E, Assoumou L, Val...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>16310901</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Mancini-Bourgine M, Fontaine H, Brechot C, Pol...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>15382173</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Mancini-Bourgine M, Fontaine H, Scott-Algara D...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>686</th>\n",
       "      <td>33717176</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Gamain B, Chene A, Viebig NK, Tuikue Ndam N, N...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>687</th>\n",
       "      <td>32032566</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Sirima SB, Richert L, Chene A, Konate AT, Camp...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>688</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>689</th>\n",
       "      <td>20657770</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Weiss L, Piketty C, Assoumou L, Didier C, Cacc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>690</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>691 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "         pmid        type                                           citation\n",
       "0    28947345     DERIVED  Sirima SB, Durier C, Kara L, Houard S, Gansane...\n",
       "1    22739396     DERIVED  Bittar R, Giral P, Aslangul E, Assoumou L, Val...\n",
       "2    22318219     DERIVED  Bittar R, Giral P, Aslangul E, Assoumou L, Val...\n",
       "3    16310901  BACKGROUND  Mancini-Bourgine M, Fontaine H, Brechot C, Pol...\n",
       "4    15382173  BACKGROUND  Mancini-Bourgine M, Fontaine H, Scott-Algara D...\n",
       "..        ...         ...                                                ...\n",
       "686  33717176     DERIVED  Gamain B, Chene A, Viebig NK, Tuikue Ndam N, N...\n",
       "687  32032566     DERIVED  Sirima SB, Richert L, Chene A, Konate AT, Camp...\n",
       "688       NaN         NaN                                                NaN\n",
       "689  20657770     DERIVED  Weiss L, Piketty C, Assoumou L, Didier C, Cacc...\n",
       "690       NaN         NaN                                                NaN\n",
       "\n",
       "[691 rows x 3 columns]"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_ct_references = pd.json_normalize(df_ct.pop('Reference'))\n",
    "df_ct_references"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cb7ea35e-3816-48f8-b91a-526e99768b8e",
   "metadata": {},
   "source": [
    "On réassemble la dataFrame complète:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "0f55da6b-f2f3-4554-88b0-dac5850614d4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>StartDate</th>\n",
       "      <th>CompletionDate</th>\n",
       "      <th>pmid</th>\n",
       "      <th>type</th>\n",
       "      <th>citation</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02014727</td>\n",
       "      <td>Safety and Immunogenicity of Recombinant Pichi...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>EVI Industries, Inc. | BPRC | Recherche Cliniq...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2013-12-18</td>\n",
       "      <td>2014-01</td>\n",
       "      <td>2015-07</td>\n",
       "      <td>28947345</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Sirima SB, Durier C, Kara L, Houard S, Gansane...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT00117494</td>\n",
       "      <td>Rosuvastatin Versus Pravastatin in HIV Patient...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-07-07</td>\n",
       "      <td>2005-10</td>\n",
       "      <td>2007-06</td>\n",
       "      <td>22739396</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Bittar R, Giral P, Aslangul E, Assoumou L, Val...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT00117494</td>\n",
       "      <td>Rosuvastatin Versus Pravastatin in HIV Patient...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-07-07</td>\n",
       "      <td>2005-10</td>\n",
       "      <td>2007-06</td>\n",
       "      <td>22318219</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Bittar R, Giral P, Aslangul E, Assoumou L, Val...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00536627</td>\n",
       "      <td>Efficacy and Tolerance of Naked DNA Vaccine in...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2007-09-28</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>2010-11</td>\n",
       "      <td>16310901</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Mancini-Bourgine M, Fontaine H, Brechot C, Pol...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT00536627</td>\n",
       "      <td>Efficacy and Tolerance of Naked DNA Vaccine in...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2007-09-28</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>2010-11</td>\n",
       "      <td>15382173</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Mancini-Bourgine M, Fontaine H, Scott-Algara D...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>686</th>\n",
       "      <td>NCT02658253</td>\n",
       "      <td>Trial to Evaluate the Safety and Immunogenicit...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>EVI Industries, Inc. | Recherche Clinique Pari...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-01-18</td>\n",
       "      <td>2016-01</td>\n",
       "      <td>2019-02-21</td>\n",
       "      <td>33717176</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Gamain B, Chene A, Viebig NK, Tuikue Ndam N, N...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>687</th>\n",
       "      <td>NCT02658253</td>\n",
       "      <td>Trial to Evaluate the Safety and Immunogenicit...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>EVI Industries, Inc. | Recherche Clinique Pari...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-01-18</td>\n",
       "      <td>2016-01</td>\n",
       "      <td>2019-02-21</td>\n",
       "      <td>32032566</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Sirima SB, Richert L, Chene A, Konate AT, Camp...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>688</th>\n",
       "      <td>NCT02027051</td>\n",
       "      <td>Etude génétique Des Arméniens</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2014-01-03</td>\n",
       "      <td>2014-01</td>\n",
       "      <td>2017-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>689</th>\n",
       "      <td>NCT00118677</td>\n",
       "      <td>Long-Term Supervised Treatment Interruption in...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-07-12</td>\n",
       "      <td>2003-02</td>\n",
       "      <td>2007-05</td>\n",
       "      <td>20657770</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Weiss L, Piketty C, Assoumou L, Didier C, Cacc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>690</th>\n",
       "      <td>NCT00647205</td>\n",
       "      <td>Evaluation of 2 Interferon γ Assays in the Dia...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>None</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2008-03-31</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>2010-11</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>691 rows × 13 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                         BriefTitle  \\\n",
       "0    NCT02014727  Safety and Immunogenicity of Recombinant Pichi...   \n",
       "1    NCT00117494  Rosuvastatin Versus Pravastatin in HIV Patient...   \n",
       "2    NCT00117494  Rosuvastatin Versus Pravastatin in HIV Patient...   \n",
       "3    NCT00536627  Efficacy and Tolerance of Naked DNA Vaccine in...   \n",
       "4    NCT00536627  Efficacy and Tolerance of Naked DNA Vaccine in...   \n",
       "..           ...                                                ...   \n",
       "686  NCT02658253  Trial to Evaluate the Safety and Immunogenicit...   \n",
       "687  NCT02658253  Trial to Evaluate the Safety and Immunogenicit...   \n",
       "688  NCT02027051                      Etude génétique Des Arméniens   \n",
       "689  NCT00118677  Long-Term Supervised Treatment Interruption in...   \n",
       "690  NCT00647205  Evaluation of 2 Interferon γ Assays in the Dia...   \n",
       "\n",
       "                                       LeadSponsorName  \\\n",
       "0    Institut National de la Santé Et de la Recherc...   \n",
       "1    French National Agency for Research on AIDS an...   \n",
       "2    French National Agency for Research on AIDS an...   \n",
       "3    French National Agency for Research on AIDS an...   \n",
       "4    French National Agency for Research on AIDS an...   \n",
       "..                                                 ...   \n",
       "686  Institut National de la Santé Et de la Recherc...   \n",
       "687  Institut National de la Santé Et de la Recherc...   \n",
       "688  Institut National de la Santé Et de la Recherc...   \n",
       "689  French National Agency for Research on AIDS an...   \n",
       "690  French National Agency for Research on AIDS an...   \n",
       "\n",
       "                                      CollaboratorName OverallStatus  \\\n",
       "0    EVI Industries, Inc. | BPRC | Recherche Cliniq...     COMPLETED   \n",
       "1                                                 None     COMPLETED   \n",
       "2                                                 None     COMPLETED   \n",
       "3                                                 None     COMPLETED   \n",
       "4                                                 None     COMPLETED   \n",
       "..                                                 ...           ...   \n",
       "686  EVI Industries, Inc. | Recherche Clinique Pari...     COMPLETED   \n",
       "687  EVI Industries, Inc. | Recherche Clinique Pari...     COMPLETED   \n",
       "688                                               None     COMPLETED   \n",
       "689                                               None     COMPLETED   \n",
       "690                                               None     COMPLETED   \n",
       "\n",
       "          StudyType  HasResults StudyFirstPostDate StartDate CompletionDate  \\\n",
       "0    INTERVENTIONAL       False         2013-12-18   2014-01        2015-07   \n",
       "1    INTERVENTIONAL       False         2005-07-07   2005-10        2007-06   \n",
       "2    INTERVENTIONAL       False         2005-07-07   2005-10        2007-06   \n",
       "3    INTERVENTIONAL       False         2007-09-28   2008-01        2010-11   \n",
       "4    INTERVENTIONAL       False         2007-09-28   2008-01        2010-11   \n",
       "..              ...         ...                ...       ...            ...   \n",
       "686  INTERVENTIONAL       False         2016-01-18   2016-01     2019-02-21   \n",
       "687  INTERVENTIONAL       False         2016-01-18   2016-01     2019-02-21   \n",
       "688   OBSERVATIONAL       False         2014-01-03   2014-01        2017-01   \n",
       "689  INTERVENTIONAL       False         2005-07-12   2003-02        2007-05   \n",
       "690  INTERVENTIONAL       False         2008-03-31   2008-01        2010-11   \n",
       "\n",
       "         pmid        type                                           citation  \n",
       "0    28947345     DERIVED  Sirima SB, Durier C, Kara L, Houard S, Gansane...  \n",
       "1    22739396     DERIVED  Bittar R, Giral P, Aslangul E, Assoumou L, Val...  \n",
       "2    22318219     DERIVED  Bittar R, Giral P, Aslangul E, Assoumou L, Val...  \n",
       "3    16310901  BACKGROUND  Mancini-Bourgine M, Fontaine H, Brechot C, Pol...  \n",
       "4    15382173  BACKGROUND  Mancini-Bourgine M, Fontaine H, Scott-Algara D...  \n",
       "..        ...         ...                                                ...  \n",
       "686  33717176     DERIVED  Gamain B, Chene A, Viebig NK, Tuikue Ndam N, N...  \n",
       "687  32032566     DERIVED  Sirima SB, Richert L, Chene A, Konate AT, Camp...  \n",
       "688       NaN         NaN                                                NaN  \n",
       "689  20657770     DERIVED  Weiss L, Piketty C, Assoumou L, Didier C, Cacc...  \n",
       "690       NaN         NaN                                                NaN  \n",
       "\n",
       "[691 rows x 13 columns]"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_ct = df_ct.join(df_ct_references)\n",
    "df_ct"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0e42f325-90f5-415a-a500-e4caea12146a",
   "metadata": {},
   "source": [
    "***On reconstruit l'index :***"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "a76d82bd-7c03-4a42-bca1-1d56efa90532",
   "metadata": {},
   "outputs": [],
   "source": [
    "# df_studies_v2.set_index('NCTId', inplace = True)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cd0416a3-4af4-45d2-b4a0-167004409a31",
   "metadata": {},
   "source": [
    "***On précise les types :***"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "b191aeb2-c4cb-431d-a7d1-074f30454ad7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 691 entries, 0 to 690\n",
      "Data columns (total 13 columns):\n",
      " #   Column              Non-Null Count  Dtype   \n",
      "---  ------              --------------  -----   \n",
      " 0   NCTId               691 non-null    string  \n",
      " 1   BriefTitle          691 non-null    string  \n",
      " 2   LeadSponsorName     691 non-null    string  \n",
      " 3   CollaboratorName    350 non-null    string  \n",
      " 4   OverallStatus       691 non-null    category\n",
      " 5   StudyType           691 non-null    category\n",
      " 6   HasResults          691 non-null    boolean \n",
      " 7   StudyFirstPostDate  691 non-null    string  \n",
      " 8   StartDate           691 non-null    string  \n",
      " 9   CompletionDate      690 non-null    string  \n",
      " 10  pmid                541 non-null    string  \n",
      " 11  type                541 non-null    string  \n",
      " 12  citation            541 non-null    string  \n",
      "dtypes: boolean(1), category(2), string(10)\n",
      "memory usage: 57.0 KB\n"
     ]
    }
   ],
   "source": [
    "df_ct = df_ct.convert_dtypes()\n",
    "# df_ct = df_ct.astype({\"OverallStatus\" : 'category', \"StudyType\" : 'category', \"type\": 'category',})\n",
    "df_ct = df_ct.astype({'OverallStatus': 'category', 'StudyType': 'category'})\n",
    "df_ct.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "c5c3a664-539b-40d0-af12-fdc0d7f7f3ff",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>StartDate</th>\n",
       "      <th>CompletionDate</th>\n",
       "      <th>pmid</th>\n",
       "      <th>type</th>\n",
       "      <th>citation</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02014727</td>\n",
       "      <td>Safety and Immunogenicity of Recombinant Pichi...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>EVI Industries, Inc. | BPRC | Recherche Cliniq...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2013-12-18</td>\n",
       "      <td>2014-01</td>\n",
       "      <td>2015-07</td>\n",
       "      <td>28947345</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Sirima SB, Durier C, Kara L, Houard S, Gansane...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT00117494</td>\n",
       "      <td>Rosuvastatin Versus Pravastatin in HIV Patient...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-07-07</td>\n",
       "      <td>2005-10</td>\n",
       "      <td>2007-06</td>\n",
       "      <td>22739396</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Bittar R, Giral P, Aslangul E, Assoumou L, Val...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT00117494</td>\n",
       "      <td>Rosuvastatin Versus Pravastatin in HIV Patient...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-07-07</td>\n",
       "      <td>2005-10</td>\n",
       "      <td>2007-06</td>\n",
       "      <td>22318219</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Bittar R, Giral P, Aslangul E, Assoumou L, Val...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00536627</td>\n",
       "      <td>Efficacy and Tolerance of Naked DNA Vaccine in...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2007-09-28</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>2010-11</td>\n",
       "      <td>16310901</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Mancini-Bourgine M, Fontaine H, Brechot C, Pol...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT00536627</td>\n",
       "      <td>Efficacy and Tolerance of Naked DNA Vaccine in...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2007-09-28</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>2010-11</td>\n",
       "      <td>15382173</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Mancini-Bourgine M, Fontaine H, Scott-Algara D...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>686</th>\n",
       "      <td>NCT02658253</td>\n",
       "      <td>Trial to Evaluate the Safety and Immunogenicit...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>EVI Industries, Inc. | Recherche Clinique Pari...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-01-18</td>\n",
       "      <td>2016-01</td>\n",
       "      <td>2019-02-21</td>\n",
       "      <td>33717176</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Gamain B, Chene A, Viebig NK, Tuikue Ndam N, N...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>687</th>\n",
       "      <td>NCT02658253</td>\n",
       "      <td>Trial to Evaluate the Safety and Immunogenicit...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>EVI Industries, Inc. | Recherche Clinique Pari...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-01-18</td>\n",
       "      <td>2016-01</td>\n",
       "      <td>2019-02-21</td>\n",
       "      <td>32032566</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Sirima SB, Richert L, Chene A, Konate AT, Camp...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>688</th>\n",
       "      <td>NCT02027051</td>\n",
       "      <td>Etude génétique Des Arméniens</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2014-01-03</td>\n",
       "      <td>2014-01</td>\n",
       "      <td>2017-01</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>689</th>\n",
       "      <td>NCT00118677</td>\n",
       "      <td>Long-Term Supervised Treatment Interruption in...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-07-12</td>\n",
       "      <td>2003-02</td>\n",
       "      <td>2007-05</td>\n",
       "      <td>20657770</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Weiss L, Piketty C, Assoumou L, Didier C, Cacc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>690</th>\n",
       "      <td>NCT00647205</td>\n",
       "      <td>Evaluation of 2 Interferon γ Assays in the Dia...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2008-03-31</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>2010-11</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>691 rows × 13 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                         BriefTitle  \\\n",
       "0    NCT02014727  Safety and Immunogenicity of Recombinant Pichi...   \n",
       "1    NCT00117494  Rosuvastatin Versus Pravastatin in HIV Patient...   \n",
       "2    NCT00117494  Rosuvastatin Versus Pravastatin in HIV Patient...   \n",
       "3    NCT00536627  Efficacy and Tolerance of Naked DNA Vaccine in...   \n",
       "4    NCT00536627  Efficacy and Tolerance of Naked DNA Vaccine in...   \n",
       "..           ...                                                ...   \n",
       "686  NCT02658253  Trial to Evaluate the Safety and Immunogenicit...   \n",
       "687  NCT02658253  Trial to Evaluate the Safety and Immunogenicit...   \n",
       "688  NCT02027051                      Etude génétique Des Arméniens   \n",
       "689  NCT00118677  Long-Term Supervised Treatment Interruption in...   \n",
       "690  NCT00647205  Evaluation of 2 Interferon γ Assays in the Dia...   \n",
       "\n",
       "                                       LeadSponsorName  \\\n",
       "0    Institut National de la Santé Et de la Recherc...   \n",
       "1    French National Agency for Research on AIDS an...   \n",
       "2    French National Agency for Research on AIDS an...   \n",
       "3    French National Agency for Research on AIDS an...   \n",
       "4    French National Agency for Research on AIDS an...   \n",
       "..                                                 ...   \n",
       "686  Institut National de la Santé Et de la Recherc...   \n",
       "687  Institut National de la Santé Et de la Recherc...   \n",
       "688  Institut National de la Santé Et de la Recherc...   \n",
       "689  French National Agency for Research on AIDS an...   \n",
       "690  French National Agency for Research on AIDS an...   \n",
       "\n",
       "                                      CollaboratorName OverallStatus  \\\n",
       "0    EVI Industries, Inc. | BPRC | Recherche Cliniq...     COMPLETED   \n",
       "1                                                 <NA>     COMPLETED   \n",
       "2                                                 <NA>     COMPLETED   \n",
       "3                                                 <NA>     COMPLETED   \n",
       "4                                                 <NA>     COMPLETED   \n",
       "..                                                 ...           ...   \n",
       "686  EVI Industries, Inc. | Recherche Clinique Pari...     COMPLETED   \n",
       "687  EVI Industries, Inc. | Recherche Clinique Pari...     COMPLETED   \n",
       "688                                               <NA>     COMPLETED   \n",
       "689                                               <NA>     COMPLETED   \n",
       "690                                               <NA>     COMPLETED   \n",
       "\n",
       "          StudyType  HasResults StudyFirstPostDate StartDate CompletionDate  \\\n",
       "0    INTERVENTIONAL       False         2013-12-18   2014-01        2015-07   \n",
       "1    INTERVENTIONAL       False         2005-07-07   2005-10        2007-06   \n",
       "2    INTERVENTIONAL       False         2005-07-07   2005-10        2007-06   \n",
       "3    INTERVENTIONAL       False         2007-09-28   2008-01        2010-11   \n",
       "4    INTERVENTIONAL       False         2007-09-28   2008-01        2010-11   \n",
       "..              ...         ...                ...       ...            ...   \n",
       "686  INTERVENTIONAL       False         2016-01-18   2016-01     2019-02-21   \n",
       "687  INTERVENTIONAL       False         2016-01-18   2016-01     2019-02-21   \n",
       "688   OBSERVATIONAL       False         2014-01-03   2014-01        2017-01   \n",
       "689  INTERVENTIONAL       False         2005-07-12   2003-02        2007-05   \n",
       "690  INTERVENTIONAL       False         2008-03-31   2008-01        2010-11   \n",
       "\n",
       "         pmid        type                                           citation  \n",
       "0    28947345     DERIVED  Sirima SB, Durier C, Kara L, Houard S, Gansane...  \n",
       "1    22739396     DERIVED  Bittar R, Giral P, Aslangul E, Assoumou L, Val...  \n",
       "2    22318219     DERIVED  Bittar R, Giral P, Aslangul E, Assoumou L, Val...  \n",
       "3    16310901  BACKGROUND  Mancini-Bourgine M, Fontaine H, Brechot C, Pol...  \n",
       "4    15382173  BACKGROUND  Mancini-Bourgine M, Fontaine H, Scott-Algara D...  \n",
       "..        ...         ...                                                ...  \n",
       "686  33717176     DERIVED  Gamain B, Chene A, Viebig NK, Tuikue Ndam N, N...  \n",
       "687  32032566     DERIVED  Sirima SB, Richert L, Chene A, Konate AT, Camp...  \n",
       "688      <NA>        <NA>                                               <NA>  \n",
       "689  20657770     DERIVED  Weiss L, Piketty C, Assoumou L, Didier C, Cacc...  \n",
       "690      <NA>        <NA>                                               <NA>  \n",
       "\n",
       "[691 rows x 13 columns]"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_ct"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a7b5fc9d-ac46-475b-b842-6fb462dd4860",
   "metadata": {},
   "source": [
    "#### Export en CSV :"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "48250189-42cc-4bc8-ab9d-f143850c541d",
   "metadata": {},
   "outputs": [],
   "source": [
    "# df_ct.to_csv('Data/outputs/extract_CT_api_v2.csv', sep=\";\", encoding='utf-8-sig')\n",
    "df_ct.to_csv(\n",
    "    'Data/outputs/extract_CT_api_v2.csv',\n",
    "    sep=';',\n",
    "    index=False,\n",
    "    encoding='utf-8-sig',\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f4754b32-ee8e-4b1c-b634-7177c4e273ab",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "5dc82c20-529d-463f-a5ae-7a8ba6a07684",
   "metadata": {},
   "source": [
    "# PubMed"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cde7add4-bea7-4155-a522-a4bc75979ebd",
   "metadata": {},
   "source": [
    "### Utilisation d'une clé pour l'API Pubmed : "
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "id": "9679e4c2-6f3c-4754-bd37-44646d6f7633",
   "metadata": {},
   "source": [
    "Il est recommandé d'utiliser une clé pour accéder à l'API Pubmed, ce qui permet de lancer jusqu'à 10 requêtes par seconde.  \n",
    "Sans clé, la limite est de 3 requêtes par seconde.  \n",
    "\n",
    "> E-utils users are allowed 3 requests/second without an API key. Create an API key to increase your e-utils limit to 10 requests/second.\n",
    "\n",
    "**En pratique, l'API Pubmed étant beaucoup plus lente (~1 requête par seconde), cela ne semble pas changer grand chose.**\n",
    "\n",
    "Pour récupérer sa clé, se rendre sur la page en étant loggué:\n",
    "https://account.ncbi.nlm.nih.gov/settings/\n",
    "\n",
    "Une fois la clé récupérée, l'ajouter aux variables d'environnement avec la commande suivante:\n",
    "\n",
    "**Windows :** \n",
    "\n",
    "`setx NCBI_API_KEY “123456\"`\n",
    "\n",
    "**Linux/MacOS :**\n",
    "\n",
    "`export NCBI_API_KEY = 123456`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "ccc06834-ea85-48c2-b66b-f9ef01329ec7",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "\n",
    "assert os.getenv('NCBI_API_KEY', None) is not None"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "494cb7ad-b0c7-4cc5-86fe-c0e40f9a1ff5",
   "metadata": {},
   "source": [
    "### Installer metapub :\n",
    "- Dans Conda Navigator, se placer dans le meme environnement que celui qui execute Jupyter  \n",
    "- Lancer Powershell Prompt dans cet environnement  \n",
    "- Taper la commande suivante :  `pip install metapub`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "1f910a19-7c98-4f30-ba71-2e9b5364a267",
   "metadata": {},
   "outputs": [],
   "source": [
    "from metapub import PubMedFetcher\n",
    "from metapub.exceptions import InvalidPMID\n",
    "\n",
    "fetch = PubMedFetcher(cachedir='./.cache/')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7103b475-2af0-4a49-9581-4f8196e29d87",
   "metadata": {},
   "source": [
    "### Récupération des PMIDs via PubMed:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9bc92598-3bee-4975-8fd2-efe55de4050d",
   "metadata": {},
   "source": [
    "Pour chaque NCTId de CT, on récupère les PMIDs des publications associées via PubMed:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "36a9a2dc-fa3b-4959-96e1-2ca4146c4427",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "289/289..."
     ]
    }
   ],
   "source": [
    "# Liste unique des NCTId extraits de ClinicalTrial\n",
    "nctid_array = df_ct.loc[:, 'NCTId'].unique()\n",
    "\n",
    "pmids_pubmed_dict = {}\n",
    "for i, nctid in enumerate(nctid_array):\n",
    "    # Display the progress on a single line\n",
    "    print(f'\\r{i+1}/{len(nctid_array)}...', end='', flush=True)\n",
    "\n",
    "    pmids = [pmid for pmid in fetch.pmids_for_query(nctid)]\n",
    "    pmids_pubmed_dict[nctid] = set(pmids)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "6724fc4b-eff7-4c44-b5c8-63a4045f9507",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'NCT02014727': {'28947345'},\n",
       " 'NCT00117494': {'22318219', '22739396'},\n",
       " 'NCT00536627': {'24394187', '24555998'},\n",
       " 'NCT01033760': {'25701561', '28708873'},\n",
       " 'NCT05349162': {'36735263'},\n",
       " 'NCT01164462': set(),\n",
       " 'NCT02777229': {'31339676', '33010241', '33355914', '37851566', '38156046'},\n",
       " 'NCT00480792': {'21486976', '27064975'},\n",
       " 'NCT01095744': set(),\n",
       " 'NCT01489592': set(),\n",
       " 'NCT01453192': {'30688008'},\n",
       " 'NCT00460382': set(),\n",
       " 'NCT02486731': set(),\n",
       " 'NCT02116374': set(),\n",
       " 'NCT02497274': set(),\n",
       " 'NCT01022476': set(),\n",
       " 'NCT00528060': {'23459496'},\n",
       " 'NCT02078076': set(),\n",
       " 'NCT04008927': {'35774932'},\n",
       " 'NCT01331876': set(),\n",
       " 'NCT00820820': set(),\n",
       " 'NCT02273765': {'33667406'},\n",
       " 'NCT02107365': set(),\n",
       " 'NCT00113282': set(),\n",
       " 'NCT01055873': {'22427678'},\n",
       " 'NCT05199831': set(),\n",
       " 'NCT01359774': set(),\n",
       " 'NCT02099474': {'32661003'},\n",
       " 'NCT03546127': set(),\n",
       " 'NCT04315948': {'32304640',\n",
       "  '32958495',\n",
       "  '33264556',\n",
       "  '34048876',\n",
       "  '34350582',\n",
       "  '34473343',\n",
       "  '34534511',\n",
       "  '35233617',\n",
       "  '35512728',\n",
       "  '36695483',\n",
       "  '37728045'},\n",
       " 'NCT02987530': set(),\n",
       " 'NCT05311865': {'36438274', '37795682'},\n",
       " 'NCT00122616': {'23800784'},\n",
       " 'NCT02428816': set(),\n",
       " 'NCT02453048': {'31945015', '32687804'},\n",
       " 'NCT00120757': {'22353022'},\n",
       " 'NCT02566148': {'29307383', '29437866', '29982518'},\n",
       " 'NCT00640263': {'23039034',\n",
       "  '26603917',\n",
       "  '27895016',\n",
       "  '28469697',\n",
       "  '30814028',\n",
       "  '31633158',\n",
       "  '31994250',\n",
       "  '32067040',\n",
       "  '32228542',\n",
       "  '32991450',\n",
       "  '34425825'},\n",
       " 'NCT01693835': set(),\n",
       " 'NCT04470648': set(),\n",
       " 'NCT02573948': set(),\n",
       " 'NCT01693848': set(),\n",
       " 'NCT01895920': set(),\n",
       " 'NCT01039220': set(),\n",
       " 'NCT00820118': {'26568566'},\n",
       " 'NCT01801618': {'29662875'},\n",
       " 'NCT02405013': {'36686592'},\n",
       " 'NCT01779713': {'30354977'},\n",
       " 'NCT03235258': set(),\n",
       " 'NCT03071458': set(),\n",
       " 'NCT02886416': set(),\n",
       " 'NCT01899196': set(),\n",
       " 'NCT00944541': set(),\n",
       " 'NCT02160119': set(),\n",
       " 'NCT00158496': set(),\n",
       " 'NCT02192658': {'26846895'},\n",
       " 'NCT00383734': {'23432777'},\n",
       " 'NCT02051413': set(),\n",
       " 'NCT03109067': set(),\n",
       " 'NCT02073604': set(),\n",
       " 'NCT01490489': set(),\n",
       " 'NCT01335529': {'27077673'},\n",
       " 'NCT00545194': set(),\n",
       " 'NCT03298360': set(),\n",
       " 'NCT01508494': set(),\n",
       " 'NCT00573001': set(),\n",
       " 'NCT00236340': set(),\n",
       " 'NCT02542891': {'27488181', '34874888'},\n",
       " 'NCT03671291': set(),\n",
       " 'NCT01066962': {'25103176', '26520926', '30365452', '33794182'},\n",
       " 'NCT01703962': {'37668523'},\n",
       " 'NCT03642704': set(),\n",
       " 'NCT01086904': set(),\n",
       " 'NCT01127204': {'27015798',\n",
       "  '28434406',\n",
       "  '28453240',\n",
       "  '28483965',\n",
       "  '28800382',\n",
       "  '31334298',\n",
       "  '34723858'},\n",
       " 'NCT01771562': {'27881690', '30081838'},\n",
       " 'NCT00196612': set(),\n",
       " 'NCT01226446': {'25987791'},\n",
       " 'NCT02496312': set(),\n",
       " 'NCT04133012': set(),\n",
       " 'NCT01100281': set(),\n",
       " 'NCT01647295': set(),\n",
       " 'NCT00424814': {'23766338', '25838291'},\n",
       " 'NCT02488395': set(),\n",
       " 'NCT00658346': {'31063537'},\n",
       " 'NCT01188512': {'24261996', '24421886', '24793938'},\n",
       " 'NCT04945655': {'35332045'},\n",
       " 'NCT01942655': set(),\n",
       " 'NCT01332955': {'25139963'},\n",
       " 'NCT01552044': set(),\n",
       " 'NCT02592174': {'31755936'},\n",
       " 'NCT02100774': {'24808487', '26063065', '27798339'},\n",
       " 'NCT00490074': set(),\n",
       " 'NCT01882062': {'25568297'},\n",
       " 'NCT01525472': set(),\n",
       " 'NCT02650427': set(),\n",
       " 'NCT01473472': {'26624850', '28747274', '29229440', '31784343', '36601747'},\n",
       " 'NCT02267304': set(),\n",
       " 'NCT04780191': set(),\n",
       " 'NCT00495326': {'23433590', '24663014'},\n",
       " 'NCT03459157': {'34048794'},\n",
       " 'NCT01620957': set(),\n",
       " 'NCT00339157': {'21173013'},\n",
       " 'NCT01555450': {'28823681', '29909873'},\n",
       " 'NCT01348308': {'32040959'},\n",
       " 'NCT01696708': {'25568297'},\n",
       " 'NCT01509508': {'23880306',\n",
       "  '25880823',\n",
       "  '27504637',\n",
       "  '28329393',\n",
       "  '29199100',\n",
       "  '29890048',\n",
       "  '30027600',\n",
       "  '30321314',\n",
       "  '30412926',\n",
       "  '31637821',\n",
       "  '32970730'},\n",
       " 'NCT01874808': set(),\n",
       " 'NCT02126384': set(),\n",
       " 'NCT03150290': set(),\n",
       " 'NCT03519503': set(),\n",
       " 'NCT00465790': set(),\n",
       " 'NCT00122603': {'19420019'},\n",
       " 'NCT02314208': set(),\n",
       " 'NCT00121121': {'17712402'},\n",
       " 'NCT01432821': set(),\n",
       " 'NCT02071784': set(),\n",
       " 'NCT02738502': set(),\n",
       " 'NCT02992184': {'29615488'},\n",
       " 'NCT01514890': {'23669289', '24704719', '25556540'},\n",
       " 'NCT02212379': {'31269208'},\n",
       " 'NCT03652090': set(),\n",
       " 'NCT00196664': set(),\n",
       " 'NCT03335995': {'32026446', '37497675'},\n",
       " 'NCT00946595': {'29767684', '30968368'},\n",
       " 'NCT02469350': {'29636105'},\n",
       " 'NCT01546181': {'23620431',\n",
       "  '24406779',\n",
       "  '24576889',\n",
       "  '25077537',\n",
       "  '26418443',\n",
       "  '26523388',\n",
       "  '30010022'},\n",
       " 'NCT00122538': {'20516271', '21857286', '23719348'},\n",
       " 'NCT01426243': {'26314624', '30096071'},\n",
       " 'NCT04824638': set(),\n",
       " 'NCT02113943': set(),\n",
       " 'NCT00299143': set(),\n",
       " 'NCT03870438': {'38484756'},\n",
       " 'NCT01605890': {'29590335'},\n",
       " 'NCT00391638': set(),\n",
       " 'NCT02323308': set(),\n",
       " 'NCT02384967': {'29905808'},\n",
       " 'NCT00988767': {'20090916'},\n",
       " 'NCT00323804': set(),\n",
       " 'NCT04849767': {'34916316'},\n",
       " 'NCT03047967': set(),\n",
       " 'NCT00120367': {'21738597'},\n",
       " 'NCT01038401': set(),\n",
       " 'NCT04484740': set(),\n",
       " 'NCT03078439': {'38408861'},\n",
       " 'NCT00148863': {'23190183'},\n",
       " 'NCT01548586': set(),\n",
       " 'NCT00302822': set(),\n",
       " 'NCT00196625': set(),\n",
       " 'NCT01188525': set(),\n",
       " 'NCT00670839': {'26257021'},\n",
       " 'NCT00158522': set(),\n",
       " 'NCT00196586': set(),\n",
       " 'NCT04808986': set(),\n",
       " 'NCT02626286': {'33753460', '34022820', '34352834'},\n",
       " 'NCT01207986': set(),\n",
       " 'NCT03537196': {'33208326'},\n",
       " 'NCT04684758': set(),\n",
       " 'NCT00121758': {'20625264', '23759749'},\n",
       " 'NCT02527096': set(),\n",
       " 'NCT00158457': set(),\n",
       " 'NCT00136630': {'22491195', '24780882'},\n",
       " 'NCT01579435': set(),\n",
       " 'NCT02057796': {'32558469', '36883573'},\n",
       " 'NCT01713335': set(),\n",
       " 'NCT02073630': set(),\n",
       " 'NCT05040048': set(),\n",
       " 'NCT03446430': set(),\n",
       " 'NCT01094899': set(),\n",
       " 'NCT03193099': set(),\n",
       " 'NCT03831906': {'32853411', '33743621', '36395782'},\n",
       " 'NCT00148824': {'20210645'},\n",
       " 'NCT00901524': {'24905490'},\n",
       " 'NCT00870649': {'30532268'},\n",
       " 'NCT01207349': {'22030240'},\n",
       " 'NCT01531036': set(),\n",
       " 'NCT00651066': {'24465443'},\n",
       " 'NCT02081066': set(),\n",
       " 'NCT01164436': set(),\n",
       " 'NCT01038999': {'22829920', '23285253'},\n",
       " 'NCT00604149': set(),\n",
       " 'NCT01569399': set(),\n",
       " 'NCT01917175': set(),\n",
       " 'NCT01592175': set(),\n",
       " 'NCT01271842': {'22948576'},\n",
       " 'NCT00265642': set(),\n",
       " 'NCT01008813': set(),\n",
       " 'NCT00158470': set(),\n",
       " 'NCT04265742': set(),\n",
       " 'NCT04631224': set(),\n",
       " 'NCT01493934': set(),\n",
       " 'NCT02978924': set(),\n",
       " 'NCT00226434': {'24096631', '24759827'},\n",
       " 'NCT04392388': {'34293141'},\n",
       " 'NCT00928187': {'31273686'},\n",
       " 'NCT00640887': {'25406657', '26482301'},\n",
       " 'NCT01952587': set(),\n",
       " 'NCT01089387': {'25974235', '26439886', '28753830'},\n",
       " 'NCT02833961': {'36318030'},\n",
       " 'NCT02453061': {'31381524'},\n",
       " 'NCT01494961': {'23343912', '29178852', '34329355'},\n",
       " 'NCT00301561': {'21831714', '35248123'},\n",
       " 'NCT01167283': set(),\n",
       " 'NCT02150993': set(),\n",
       " 'NCT01075061': set(),\n",
       " 'NCT02014883': {'26536893'},\n",
       " 'NCT00158483': {'19530940'},\n",
       " 'NCT02481453': {'38273639'},\n",
       " 'NCT02329054': {'26930627', '28231247'},\n",
       " 'NCT02027233': set(),\n",
       " 'NCT02093754': set(),\n",
       " 'NCT03324633': {'30570526', '32798585', '34212476'},\n",
       " 'NCT04842851': set(),\n",
       " 'NCT04409405': {'38043556'},\n",
       " 'NCT00158405': {'16782488', '18986246'},\n",
       " 'NCT02960698': set(),\n",
       " 'NCT02931097': set(),\n",
       " 'NCT00657397': {'22741944',\n",
       "  '24268548',\n",
       "  '25209306',\n",
       "  '25393311',\n",
       "  '27048152',\n",
       "  '27770695'},\n",
       " 'NCT00421551': {'20802297', '22848481', '29767684'},\n",
       " 'NCT00623051': set(),\n",
       " 'NCT00116454': set(),\n",
       " 'NCT03954054': {'35012570'},\n",
       " 'NCT02976298': set(),\n",
       " 'NCT02101398': set(),\n",
       " 'NCT05472051': set(),\n",
       " 'NCT00495651': {'23639243',\n",
       "  '24985779',\n",
       "  '25330161',\n",
       "  '26193126',\n",
       "  '29020361',\n",
       "  '29297443',\n",
       "  '35093007'},\n",
       " 'NCT01693861': set(),\n",
       " 'NCT00272428': {'19491388',\n",
       "  '19828715',\n",
       "  '20176858',\n",
       "  '20431391',\n",
       "  '20605091',\n",
       "  '21106918',\n",
       "  '21490142',\n",
       "  '21775560',\n",
       "  '21955649',\n",
       "  '22158670',\n",
       "  '22378736',\n",
       "  '22633793',\n",
       "  '23082222',\n",
       "  '23283500',\n",
       "  '23284983',\n",
       "  '24027184',\n",
       "  '24089418',\n",
       "  '24527713',\n",
       "  '24553693',\n",
       "  '25651444',\n",
       "  '25994566',\n",
       "  '26156743',\n",
       "  '26409628',\n",
       "  '26447153',\n",
       "  '26812508',\n",
       "  '26817718',\n",
       "  '26864363',\n",
       "  '26962176',\n",
       "  '27000099',\n",
       "  '27055851',\n",
       "  '28033414',\n",
       "  '28356432',\n",
       "  '28494135',\n",
       "  '29546305',\n",
       "  '29649036',\n",
       "  '30517725',\n",
       "  '31164347',\n",
       "  '31927670',\n",
       "  '33738534'},\n",
       " 'NCT02052271': set(),\n",
       " 'NCT01534728': set(),\n",
       " 'NCT01492985': {'33568510'},\n",
       " 'NCT00120185': {'19508157'},\n",
       " 'NCT01463956': set(),\n",
       " 'NCT00334256': set(),\n",
       " 'NCT00822315': {'24726095'},\n",
       " 'NCT04120415': set(),\n",
       " 'NCT02567071': set(),\n",
       " 'NCT01331811': {'26908804', '29174612', '30689814', '31455612'},\n",
       " 'NCT02214511': set(),\n",
       " 'NCT01698411': set(),\n",
       " 'NCT04288128': {'38419144', '38421662'},\n",
       " 'NCT02157311': {'29186458'},\n",
       " 'NCT02082171': set(),\n",
       " 'NCT00918307': {'29329763', '34611902'},\n",
       " 'NCT05090956': set(),\n",
       " 'NCT02346409': set(),\n",
       " 'NCT00196599': set(),\n",
       " 'NCT02102737': set(),\n",
       " 'NCT00454337': {'19757993', '21712241', '27042193'},\n",
       " 'NCT02656407': set(),\n",
       " 'NCT00158509': {'17314338', '18593294', '18596069'},\n",
       " 'NCT02038842': set(),\n",
       " 'NCT01725542': {'25977266'},\n",
       " 'NCT06260319': set(),\n",
       " 'NCT01842919': set(),\n",
       " 'NCT02906137': set(),\n",
       " 'NCT01192737': set(),\n",
       " 'NCT02647632': {'29077864'},\n",
       " 'NCT01065207': set(),\n",
       " 'NCT02542800': set(),\n",
       " 'NCT01089400': {'24646009'},\n",
       " 'NCT00574652': {'22129253'},\n",
       " 'NCT01905059': {'28566227'},\n",
       " 'NCT02125500': set(),\n",
       " 'NCT01413152': set(),\n",
       " 'NCT02236832': set(),\n",
       " 'NCT00115609': set(),\n",
       " 'NCT04396288': set(),\n",
       " 'NCT00445575': set(),\n",
       " 'NCT01024400': {'22147712'},\n",
       " 'NCT01779752': set(),\n",
       " 'NCT03215732': {'31320358', '37143029'},\n",
       " 'NCT03005652': {'33873195', '35853750', '36068621', '38100477'},\n",
       " 'NCT02916732': {'29539287', '33657112'},\n",
       " 'NCT01311752': set(),\n",
       " 'NCT01269632': set(),\n",
       " 'NCT01495897': set(),\n",
       " 'NCT00463983': {'22379151'},\n",
       " 'NCT03137797': set(),\n",
       " 'NCT01037777': {'23707147', '24780882', '32822634', '35264424'},\n",
       " 'NCT01842477': set(),\n",
       " 'NCT02721745': set(),\n",
       " 'NCT02408354': {'28969699'},\n",
       " 'NCT01688453': {'29696179',\n",
       "  '29776897',\n",
       "  '29934380',\n",
       "  '32097754',\n",
       "  '34087324',\n",
       "  '35272723'},\n",
       " 'NCT02172677': set(),\n",
       " 'NCT01880151': set(),\n",
       " 'NCT02658253': {'32032566', '33717176'},\n",
       " 'NCT02027051': set(),\n",
       " 'NCT00118677': {'20657770'},\n",
       " 'NCT00647205': set()}"
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pmids_pubmed_dict"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "351d2549-e3c2-4331-b90b-3ea14530008e",
   "metadata": {},
   "source": [
    "**On veut fusionner la liste PMIDs que l'on vient de récupérer sur PubMed, à la liste des PMIDs déjà récupérés via CT.**"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4c8b94f1-2851-40b8-9ed2-77348b74477e",
   "metadata": {},
   "source": [
    "On met les PMIDs de CT sous la même forme:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "6ddaabb3-f3ce-4a4d-9ef9-4d391c7205df",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'NCT02014727': {'28947345'},\n",
       " 'NCT00117494': {'22318219', '22739396'},\n",
       " 'NCT00536627': {'15382173', '16310901', '24394187', '24555998'},\n",
       " 'NCT01033760': {'25701561', '28708873'},\n",
       " 'NCT05349162': set(),\n",
       " 'NCT01164462': set(),\n",
       " 'NCT02777229': {'31339676', '33010241', '33355914'},\n",
       " 'NCT00480792': {'21486976', '27064975'},\n",
       " 'NCT01095744': set(),\n",
       " 'NCT01489592': {'15501961', '15974953', '16946298', '18559556', '20169331'},\n",
       " 'NCT01453192': set(),\n",
       " 'NCT00460382': set(),\n",
       " 'NCT02486731': set(),\n",
       " 'NCT02116374': set(),\n",
       " 'NCT02497274': set(),\n",
       " 'NCT01022476': set(),\n",
       " 'NCT00528060': {'23459496'},\n",
       " 'NCT02078076': set(),\n",
       " 'NCT04008927': {'22310560',\n",
       "  '26806260',\n",
       "  '27168667',\n",
       "  '27178119',\n",
       "  '27537841',\n",
       "  '28004616',\n",
       "  '29432973',\n",
       "  '35774932'},\n",
       " 'NCT01331876': set(),\n",
       " 'NCT00820820': set(),\n",
       " 'NCT02273765': {'33667406'},\n",
       " 'NCT02107365': set(),\n",
       " 'NCT00113282': set(),\n",
       " 'NCT01055873': {'22427678'},\n",
       " 'NCT05199831': set(),\n",
       " 'NCT01359774': {'17653274', '21285522', '21320997'},\n",
       " 'NCT02099474': {'32661003'},\n",
       " 'NCT03546127': set(),\n",
       " 'NCT04315948': {'32304640',\n",
       "  '32473020',\n",
       "  '32958495',\n",
       "  '33089306',\n",
       "  '33264556',\n",
       "  '34048876',\n",
       "  '34350582',\n",
       "  '34473343',\n",
       "  '34534511',\n",
       "  '34763056',\n",
       "  '35233617',\n",
       "  '35512728',\n",
       "  '35533972',\n",
       "  '35623577',\n",
       "  '35643099',\n",
       "  '36680782',\n",
       "  '36828006',\n",
       "  '37269068',\n",
       "  '37302469',\n",
       "  '37728045'},\n",
       " 'NCT02987530': set(),\n",
       " 'NCT05311865': set(),\n",
       " 'NCT00122616': {'23800784'},\n",
       " 'NCT02428816': set(),\n",
       " 'NCT02453048': {'18762220',\n",
       "  '19625486',\n",
       "  '20107007',\n",
       "  '20419113',\n",
       "  '20708998',\n",
       "  '21147936',\n",
       "  '21430219',\n",
       "  '22814407',\n",
       "  '24421886',\n",
       "  '24793938',\n",
       "  '24950361',\n",
       "  '31945015',\n",
       "  '32687804'},\n",
       " 'NCT00120757': {'22353022'},\n",
       " 'NCT02566148': {'29307383', '29437866', '29982518'},\n",
       " 'NCT00640263': {'17825642',\n",
       "  '23039034',\n",
       "  '26603917',\n",
       "  '27895016',\n",
       "  '28469697',\n",
       "  '30814028',\n",
       "  '31633158',\n",
       "  '31994250',\n",
       "  '32067040',\n",
       "  '32228542',\n",
       "  '32991450'},\n",
       " 'NCT01693835': set(),\n",
       " 'NCT04470648': {'31978945',\n",
       "  '31995857',\n",
       "  '32046819',\n",
       "  '32070465',\n",
       "  '32109013',\n",
       "  '32224310',\n",
       "  '32338732',\n",
       "  '32371096'},\n",
       " 'NCT02573948': {'25540950',\n",
       "  '26032121',\n",
       "  '26050614',\n",
       "  '26075647',\n",
       "  '26080690',\n",
       "  '27006257',\n",
       "  '27178119',\n",
       "  '28612212',\n",
       "  '28800503'},\n",
       " 'NCT01693848': set(),\n",
       " 'NCT01895920': set(),\n",
       " 'NCT01039220': set(),\n",
       " 'NCT00820118': {'26568566'},\n",
       " 'NCT01801618': set(),\n",
       " 'NCT02405013': set(),\n",
       " 'NCT01779713': {'30354977'},\n",
       " 'NCT03235258': {'17712765',\n",
       "  '18614870',\n",
       "  '19194272',\n",
       "  '20536367',\n",
       "  '21511330',\n",
       "  '21971357',\n",
       "  '22198788',\n",
       "  '22427678',\n",
       "  '24253249',\n",
       "  '24705410',\n",
       "  '24945880',\n",
       "  '26762993'},\n",
       " 'NCT03071458': set(),\n",
       " 'NCT02886416': set(),\n",
       " 'NCT01899196': set(),\n",
       " 'NCT00944541': set(),\n",
       " 'NCT02160119': set(),\n",
       " 'NCT00158496': {'16019104', '16434426', '16847958', '16956918'},\n",
       " 'NCT02192658': {'26846895'},\n",
       " 'NCT00383734': {'23432777'},\n",
       " 'NCT02051413': set(),\n",
       " 'NCT03109067': set(),\n",
       " 'NCT02073604': set(),\n",
       " 'NCT01490489': {'16384869', '17531315', '19602057'},\n",
       " 'NCT01335529': {'27077673'},\n",
       " 'NCT00545194': {'11236117', '16553177', '17071427'},\n",
       " 'NCT03298360': set(),\n",
       " 'NCT01508494': set(),\n",
       " 'NCT00573001': set(),\n",
       " 'NCT00236340': {'11438952', '14770396', '7970458', '9464739'},\n",
       " 'NCT02542891': {'27488181', '34874888'},\n",
       " 'NCT03671291': set(),\n",
       " 'NCT01066962': {'25103176', '26520926', '30365452', '33794182'},\n",
       " 'NCT01703962': set(),\n",
       " 'NCT03642704': set(),\n",
       " 'NCT01086904': set(),\n",
       " 'NCT01127204': {'27015798',\n",
       "  '28434406',\n",
       "  '28453240',\n",
       "  '28483965',\n",
       "  '28800382',\n",
       "  '31334298',\n",
       "  '34723858'},\n",
       " 'NCT01771562': {'27881690', '30081838'},\n",
       " 'NCT00196612': {'15717256'},\n",
       " 'NCT01226446': {'25987791'},\n",
       " 'NCT02496312': {'10436334',\n",
       "  '10678322',\n",
       "  '10941190',\n",
       "  '12461757',\n",
       "  '15897497',\n",
       "  '16207933',\n",
       "  '16421064',\n",
       "  '17027767',\n",
       "  '17131230',\n",
       "  '1821241',\n",
       "  '18307266',\n",
       "  '19533496',\n",
       "  '19713543',\n",
       "  '19933975',\n",
       "  '21895376'},\n",
       " 'NCT04133012': set(),\n",
       " 'NCT01100281': set(),\n",
       " 'NCT01647295': set(),\n",
       " 'NCT00424814': {'23766338', '25838291'},\n",
       " 'NCT02488395': {'22639796', '23916713', '6774653'},\n",
       " 'NCT00658346': {'31063537'},\n",
       " 'NCT01188512': {'16839199',\n",
       "  '18762220',\n",
       "  '19625486',\n",
       "  '20107007',\n",
       "  '20184606',\n",
       "  '24261996',\n",
       "  '24421886',\n",
       "  '24793938'},\n",
       " 'NCT04945655': {'35332045'},\n",
       " 'NCT01942655': set(),\n",
       " 'NCT01332955': {'25139963'},\n",
       " 'NCT01552044': set(),\n",
       " 'NCT02592174': {'31755936'},\n",
       " 'NCT02100774': {'21957063', '24808487', '26063065', '27798339'},\n",
       " 'NCT00490074': set(),\n",
       " 'NCT01882062': {'25568297'},\n",
       " 'NCT01525472': set(),\n",
       " 'NCT02650427': set(),\n",
       " 'NCT01473472': {'26624850', '28747274', '29229440', '31784343'},\n",
       " 'NCT02267304': set(),\n",
       " 'NCT04780191': {'32232101'},\n",
       " 'NCT00495326': {'23433590', '24663014'},\n",
       " 'NCT03459157': {'34048794'},\n",
       " 'NCT01620957': set(),\n",
       " 'NCT00339157': {'21173013'},\n",
       " 'NCT01555450': {'21256688', '28823681', '29909873'},\n",
       " 'NCT01348308': {'32040959'},\n",
       " 'NCT01696708': {'25568297'},\n",
       " 'NCT01509508': {'23880306',\n",
       "  '25880823',\n",
       "  '27504637',\n",
       "  '28329393',\n",
       "  '29199100',\n",
       "  '29890048',\n",
       "  '30027600',\n",
       "  '30321314',\n",
       "  '30412926',\n",
       "  '31637821',\n",
       "  '32970730'},\n",
       " 'NCT01874808': set(),\n",
       " 'NCT02126384': set(),\n",
       " 'NCT03150290': set(),\n",
       " 'NCT03519503': {'21602695', '22814853', '26603917'},\n",
       " 'NCT00465790': set(),\n",
       " 'NCT00122603': {'19420019'},\n",
       " 'NCT02314208': set(),\n",
       " 'NCT00121121': {'17712402'},\n",
       " 'NCT01432821': {'12914551', '15037514', '15249613', '15777732', '2271377'},\n",
       " 'NCT02071784': set(),\n",
       " 'NCT02738502': {'22160145',\n",
       "  '22848481',\n",
       "  '23559464',\n",
       "  '23766338',\n",
       "  '26197844',\n",
       "  '26709605',\n",
       "  '26854809'},\n",
       " 'NCT02992184': {'29615488'},\n",
       " 'NCT01514890': {'23669289', '24704719', '25556540'},\n",
       " 'NCT02212379': set(),\n",
       " 'NCT03652090': set(),\n",
       " 'NCT00196664': set(),\n",
       " 'NCT03335995': {'32026446'},\n",
       " 'NCT00946595': {'29767684', '30968368'},\n",
       " 'NCT02469350': {'29636105'},\n",
       " 'NCT01546181': {'23620431',\n",
       "  '24337723',\n",
       "  '24406779',\n",
       "  '24576889',\n",
       "  '25077537',\n",
       "  '25284764',\n",
       "  '25997175',\n",
       "  '26344727',\n",
       "  '26418443',\n",
       "  '26523388',\n",
       "  '27009576',\n",
       "  '27065002',\n",
       "  '28900746',\n",
       "  '29369084',\n",
       "  '30010022',\n",
       "  '30947025',\n",
       "  '31568064',\n",
       "  '31573376',\n",
       "  '31922497',\n",
       "  '31972545'},\n",
       " 'NCT00122538': {'20516271', '21857286', '23719348'},\n",
       " 'NCT01426243': {'30096071'},\n",
       " 'NCT04824638': set(),\n",
       " 'NCT02113943': set(),\n",
       " 'NCT00299143': set(),\n",
       " 'NCT03870438': {'26603917', '33872801'},\n",
       " 'NCT01605890': {'29590335'},\n",
       " 'NCT00391638': set(),\n",
       " 'NCT02323308': set(),\n",
       " 'NCT02384967': {'29905808'},\n",
       " 'NCT00988767': {'15382173', '16310901', '20090916'},\n",
       " 'NCT00323804': set(),\n",
       " 'NCT04849767': {'34916316'},\n",
       " 'NCT03047967': set(),\n",
       " 'NCT00120367': {'21738597'},\n",
       " 'NCT01038401': set(),\n",
       " 'NCT04484740': set(),\n",
       " 'NCT03078439': set(),\n",
       " 'NCT00148863': {'23190183'},\n",
       " 'NCT01548586': {'10990547',\n",
       "  '11723286',\n",
       "  '15272049',\n",
       "  '15634731',\n",
       "  '16002441',\n",
       "  '19805746',\n",
       "  '20161639',\n",
       "  '22085959',\n",
       "  '8756819'},\n",
       " 'NCT00302822': set(),\n",
       " 'NCT00196625': {'15060509', '15456093'},\n",
       " 'NCT01188525': set(),\n",
       " 'NCT00670839': {'26257021'},\n",
       " 'NCT00158522': {'15977225', '16434426'},\n",
       " 'NCT00196586': set(),\n",
       " 'NCT04808986': set(),\n",
       " 'NCT02626286': {'33753460', '34022820', '34352834'},\n",
       " 'NCT01207986': set(),\n",
       " 'NCT03537196': {'19839502',\n",
       "  '20041309',\n",
       "  '20196807',\n",
       "  '20572071',\n",
       "  '22098550',\n",
       "  '22564041',\n",
       "  '22828983',\n",
       "  '23172780',\n",
       "  '23553643',\n",
       "  '23675659',\n",
       "  '23728143',\n",
       "  '23884064',\n",
       "  '25086286',\n",
       "  '25245939',\n",
       "  '25920094',\n",
       "  '26298331',\n",
       "  '27148964',\n",
       "  '27178119',\n",
       "  '27227200',\n",
       "  '27349488',\n",
       "  '27427455',\n",
       "  '27667367',\n",
       "  '33208326'},\n",
       " 'NCT04684758': set(),\n",
       " 'NCT00121758': {'20625264', '23759749'},\n",
       " 'NCT02527096': set(),\n",
       " 'NCT00158457': set(),\n",
       " 'NCT00136630': {'15313841',\n",
       "  '15365159',\n",
       "  '16055926',\n",
       "  '16193476',\n",
       "  '16501573',\n",
       "  '17098887',\n",
       "  '17597328',\n",
       "  '17605047',\n",
       "  '17957230',\n",
       "  '18378516',\n",
       "  '18853458',\n",
       "  '22491195',\n",
       "  '24780882'},\n",
       " 'NCT01579435': set(),\n",
       " 'NCT02057796': {'32558469'},\n",
       " 'NCT01713335': set(),\n",
       " 'NCT02073630': set(),\n",
       " 'NCT05040048': set(),\n",
       " 'NCT03446430': set(),\n",
       " 'NCT01094899': set(),\n",
       " 'NCT03193099': set(),\n",
       " 'NCT03831906': {'32853411', '33743621', '36395782'},\n",
       " 'NCT00148824': {'20210645'},\n",
       " 'NCT00901524': {'24905490'},\n",
       " 'NCT00870649': {'30532268'},\n",
       " 'NCT01207349': {'22030240'},\n",
       " 'NCT01531036': {'20505064'},\n",
       " 'NCT00651066': {'24465443'},\n",
       " 'NCT02081066': set(),\n",
       " 'NCT01164436': set(),\n",
       " 'NCT01038999': {'22829920', '23285253'},\n",
       " 'NCT00604149': set(),\n",
       " 'NCT01569399': set(),\n",
       " 'NCT01917175': set(),\n",
       " 'NCT01592175': set(),\n",
       " 'NCT01271842': {'22948576'},\n",
       " 'NCT00265642': set(),\n",
       " 'NCT01008813': set(),\n",
       " 'NCT00158470': set(),\n",
       " 'NCT04265742': set(),\n",
       " 'NCT04631224': set(),\n",
       " 'NCT01493934': set(),\n",
       " 'NCT02978924': set(),\n",
       " 'NCT00226434': {'17624825',\n",
       "  '22010913',\n",
       "  '23237982',\n",
       "  '24096631',\n",
       "  '24608960',\n",
       "  '24759827'},\n",
       " 'NCT04392388': set(),\n",
       " 'NCT00928187': {'31273686'},\n",
       " 'NCT00640887': {'25406657', '26482301'},\n",
       " 'NCT01952587': set(),\n",
       " 'NCT01089387': {'25974235', '28753830'},\n",
       " 'NCT02833961': set(),\n",
       " 'NCT02453061': {'31381524'},\n",
       " 'NCT01494961': {'20403152', '21857289', '23343912', '29178852', '34329355'},\n",
       " 'NCT00301561': {'21831714', '35248123'},\n",
       " 'NCT01167283': set(),\n",
       " 'NCT02150993': set(),\n",
       " 'NCT01075061': set(),\n",
       " 'NCT02014883': {'26536893'},\n",
       " 'NCT00158483': {'16455895', '18385443', '19530940'},\n",
       " 'NCT02481453': {'20413309', '24975859'},\n",
       " 'NCT02329054': {'25435054', '26930627', '27046271', '28231247'},\n",
       " 'NCT02027233': set(),\n",
       " 'NCT02093754': set(),\n",
       " 'NCT03324633': {'20493576',\n",
       "  '20876416',\n",
       "  '20969743',\n",
       "  '21239121',\n",
       "  '21692942',\n",
       "  '21819472',\n",
       "  '21888878',\n",
       "  '21920402',\n",
       "  '22173166',\n",
       "  '22285372',\n",
       "  '22409788',\n",
       "  '22535683',\n",
       "  '22781224',\n",
       "  '23052829',\n",
       "  '23226258',\n",
       "  '23421419',\n",
       "  '23461846',\n",
       "  '23978720',\n",
       "  '24166726',\n",
       "  '24499953',\n",
       "  '24580042',\n",
       "  '25015913',\n",
       "  '25778750',\n",
       "  '26372388',\n",
       "  '26528903',\n",
       "  '27073179',\n",
       "  '27177169',\n",
       "  '27317796',\n",
       "  '27339598',\n",
       "  '28235612',\n",
       "  '28418984',\n",
       "  '28430385',\n",
       "  '28780609',\n",
       "  '28942916',\n",
       "  '30570526',\n",
       "  '32798585',\n",
       "  '34212476'},\n",
       " 'NCT04842851': set(),\n",
       " 'NCT04409405': set(),\n",
       " 'NCT00158405': {'16152755', '16782488', '18986246'},\n",
       " 'NCT02960698': set(),\n",
       " 'NCT02931097': set(),\n",
       " 'NCT00657397': {'22741944',\n",
       "  '24268548',\n",
       "  '25209306',\n",
       "  '25393311',\n",
       "  '27048152',\n",
       "  '27770695'},\n",
       " 'NCT00421551': {'20802297', '22848481', '29767684'},\n",
       " 'NCT00623051': set(),\n",
       " 'NCT00116454': set(),\n",
       " 'NCT03954054': {'35012570'},\n",
       " 'NCT02976298': set(),\n",
       " 'NCT02101398': set(),\n",
       " 'NCT05472051': set(),\n",
       " 'NCT00495651': {'23639243',\n",
       "  '24985779',\n",
       "  '25330161',\n",
       "  '26193126',\n",
       "  '29020361',\n",
       "  '29297443',\n",
       "  '35093007'},\n",
       " 'NCT01693861': set(),\n",
       " 'NCT00272428': {'15557412',\n",
       "  '19491388',\n",
       "  '19828715',\n",
       "  '20176858',\n",
       "  '20431391',\n",
       "  '20605091',\n",
       "  '21106918',\n",
       "  '21490142',\n",
       "  '21775560',\n",
       "  '21955649',\n",
       "  '22158670',\n",
       "  '22378736',\n",
       "  '22633793',\n",
       "  '23082222',\n",
       "  '23283500',\n",
       "  '23284983',\n",
       "  '24027184',\n",
       "  '24089418',\n",
       "  '24527713',\n",
       "  '24553693',\n",
       "  '25651444',\n",
       "  '25994566',\n",
       "  '26156743',\n",
       "  '26409628',\n",
       "  '26447153',\n",
       "  '26812508',\n",
       "  '26817718',\n",
       "  '26864363',\n",
       "  '26962176',\n",
       "  '27000099',\n",
       "  '27055851',\n",
       "  '28033414',\n",
       "  '28356432',\n",
       "  '28494135',\n",
       "  '29546305',\n",
       "  '29649036',\n",
       "  '30517725',\n",
       "  '31164347',\n",
       "  '31927670',\n",
       "  '33738534'},\n",
       " 'NCT02052271': set(),\n",
       " 'NCT01534728': set(),\n",
       " 'NCT01492985': {'33568510'},\n",
       " 'NCT00120185': {'19508157'},\n",
       " 'NCT01463956': set(),\n",
       " 'NCT00334256': {'18987623', '19104016', '19307941'},\n",
       " 'NCT00822315': {'24726095'},\n",
       " 'NCT04120415': set(),\n",
       " 'NCT02567071': set(),\n",
       " 'NCT01331811': {'26908804', '29174612', '30689814', '31455612'},\n",
       " 'NCT02214511': set(),\n",
       " 'NCT01698411': set(),\n",
       " 'NCT04288128': set(),\n",
       " 'NCT02157311': {'29186458'},\n",
       " 'NCT02082171': set(),\n",
       " 'NCT00918307': {'29329763', '34611902'},\n",
       " 'NCT05090956': set(),\n",
       " 'NCT02346409': set(),\n",
       " 'NCT00196599': {'10915095', '15012649'},\n",
       " 'NCT02102737': set(),\n",
       " 'NCT00454337': {'19757993',\n",
       "  '19995925',\n",
       "  '20683319',\n",
       "  '21126958',\n",
       "  '21326075',\n",
       "  '21576452',\n",
       "  '21712241',\n",
       "  '22416781',\n",
       "  '27042193'},\n",
       " 'NCT02656407': {'25955583'},\n",
       " 'NCT00158509': {'16044019', '17314338', '18593294', '18596069'},\n",
       " 'NCT02038842': set(),\n",
       " 'NCT01725542': {'25977266'},\n",
       " 'NCT06260319': set(),\n",
       " 'NCT01842919': set(),\n",
       " 'NCT02906137': set(),\n",
       " 'NCT01192737': set(),\n",
       " 'NCT02647632': {'29077864'},\n",
       " 'NCT01065207': set(),\n",
       " 'NCT02542800': set(),\n",
       " 'NCT01089400': {'24646009'},\n",
       " 'NCT00574652': {'22129253'},\n",
       " 'NCT01905059': {'16249701',\n",
       "  '16549962',\n",
       "  '17545707',\n",
       "  '18097218',\n",
       "  '18540803',\n",
       "  '20010070',\n",
       "  '20802297',\n",
       "  '20802298',\n",
       "  '21811554',\n",
       "  '21886816',\n",
       "  '22441252',\n",
       "  '22814125',\n",
       "  '23075703',\n",
       "  '28566227'},\n",
       " 'NCT02125500': set(),\n",
       " 'NCT01413152': set(),\n",
       " 'NCT02236832': set(),\n",
       " 'NCT00115609': set(),\n",
       " 'NCT04396288': set(),\n",
       " 'NCT00445575': set(),\n",
       " 'NCT01024400': {'22147712'},\n",
       " 'NCT01779752': set(),\n",
       " 'NCT03215732': {'31320358'},\n",
       " 'NCT03005652': {'33873195', '35853750', '36068621'},\n",
       " 'NCT02916732': {'29539287', '33657112'},\n",
       " 'NCT01311752': set(),\n",
       " 'NCT01269632': set(),\n",
       " 'NCT01495897': set(),\n",
       " 'NCT00463983': {'16883006', '22379151'},\n",
       " 'NCT03137797': {'22008658',\n",
       "  '22267473',\n",
       "  '23079802',\n",
       "  '23936509',\n",
       "  '24058636',\n",
       "  '24465584',\n",
       "  '25573889',\n",
       "  '26636578',\n",
       "  '27509048'},\n",
       " 'NCT01037777': {'23707147', '24780882', '32822634', '35264424'},\n",
       " 'NCT01842477': set(),\n",
       " 'NCT02721745': set(),\n",
       " 'NCT02408354': {'28969699'},\n",
       " 'NCT01688453': {'29696179', '29776897', '29934380', '32097754', '34087324'},\n",
       " 'NCT02172677': set(),\n",
       " 'NCT01880151': set(),\n",
       " 'NCT02658253': {'32032566', '33717176'},\n",
       " 'NCT02027051': set(),\n",
       " 'NCT00118677': {'20657770'},\n",
       " 'NCT00647205': set()}"
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pmids_ct_dict = {}\n",
    "for nctid in nctid_array:\n",
    "    pmids = df_ct[df_ct.loc[:, 'NCTId'] == nctid].loc[:, 'pmid'].dropna()\n",
    "    pmids_ct_dict[nctid] = set(pmids)\n",
    "pmids_ct_dict"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bead8f40-8dab-40f8-8650-87043c1c803a",
   "metadata": {},
   "source": [
    "Pour un NCTDId donné, on fait l'union des deux ensembles de PMIDs:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "1d60a430-c91c-4094-8a93-7d948dc0c29c",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'NCT02014727': {'28947345'},\n",
       " 'NCT00117494': {'22318219', '22739396'},\n",
       " 'NCT00536627': {'15382173', '16310901', '24394187', '24555998'},\n",
       " 'NCT01033760': {'25701561', '28708873'},\n",
       " 'NCT05349162': {'36735263'},\n",
       " 'NCT01164462': set(),\n",
       " 'NCT02777229': {'31339676', '33010241', '33355914', '37851566', '38156046'},\n",
       " 'NCT00480792': {'21486976', '27064975'},\n",
       " 'NCT01095744': set(),\n",
       " 'NCT01489592': {'15501961', '15974953', '16946298', '18559556', '20169331'},\n",
       " 'NCT01453192': {'30688008'},\n",
       " 'NCT00460382': set(),\n",
       " 'NCT02486731': set(),\n",
       " 'NCT02116374': set(),\n",
       " 'NCT02497274': set(),\n",
       " 'NCT01022476': set(),\n",
       " 'NCT00528060': {'23459496'},\n",
       " 'NCT02078076': set(),\n",
       " 'NCT04008927': {'22310560',\n",
       "  '26806260',\n",
       "  '27168667',\n",
       "  '27178119',\n",
       "  '27537841',\n",
       "  '28004616',\n",
       "  '29432973',\n",
       "  '35774932'},\n",
       " 'NCT01331876': set(),\n",
       " 'NCT00820820': set(),\n",
       " 'NCT02273765': {'33667406'},\n",
       " 'NCT02107365': set(),\n",
       " 'NCT00113282': set(),\n",
       " 'NCT01055873': {'22427678'},\n",
       " 'NCT05199831': set(),\n",
       " 'NCT01359774': {'17653274', '21285522', '21320997'},\n",
       " 'NCT02099474': {'32661003'},\n",
       " 'NCT03546127': set(),\n",
       " 'NCT04315948': {'32304640',\n",
       "  '32473020',\n",
       "  '32958495',\n",
       "  '33089306',\n",
       "  '33264556',\n",
       "  '34048876',\n",
       "  '34350582',\n",
       "  '34473343',\n",
       "  '34534511',\n",
       "  '34763056',\n",
       "  '35233617',\n",
       "  '35512728',\n",
       "  '35533972',\n",
       "  '35623577',\n",
       "  '35643099',\n",
       "  '36680782',\n",
       "  '36695483',\n",
       "  '36828006',\n",
       "  '37269068',\n",
       "  '37302469',\n",
       "  '37728045'},\n",
       " 'NCT02987530': set(),\n",
       " 'NCT05311865': {'36438274', '37795682'},\n",
       " 'NCT00122616': {'23800784'},\n",
       " 'NCT02428816': set(),\n",
       " 'NCT02453048': {'18762220',\n",
       "  '19625486',\n",
       "  '20107007',\n",
       "  '20419113',\n",
       "  '20708998',\n",
       "  '21147936',\n",
       "  '21430219',\n",
       "  '22814407',\n",
       "  '24421886',\n",
       "  '24793938',\n",
       "  '24950361',\n",
       "  '31945015',\n",
       "  '32687804'},\n",
       " 'NCT00120757': {'22353022'},\n",
       " 'NCT02566148': {'29307383', '29437866', '29982518'},\n",
       " 'NCT00640263': {'17825642',\n",
       "  '23039034',\n",
       "  '26603917',\n",
       "  '27895016',\n",
       "  '28469697',\n",
       "  '30814028',\n",
       "  '31633158',\n",
       "  '31994250',\n",
       "  '32067040',\n",
       "  '32228542',\n",
       "  '32991450',\n",
       "  '34425825'},\n",
       " 'NCT01693835': set(),\n",
       " 'NCT04470648': {'31978945',\n",
       "  '31995857',\n",
       "  '32046819',\n",
       "  '32070465',\n",
       "  '32109013',\n",
       "  '32224310',\n",
       "  '32338732',\n",
       "  '32371096'},\n",
       " 'NCT02573948': {'25540950',\n",
       "  '26032121',\n",
       "  '26050614',\n",
       "  '26075647',\n",
       "  '26080690',\n",
       "  '27006257',\n",
       "  '27178119',\n",
       "  '28612212',\n",
       "  '28800503'},\n",
       " 'NCT01693848': set(),\n",
       " 'NCT01895920': set(),\n",
       " 'NCT01039220': set(),\n",
       " 'NCT00820118': {'26568566'},\n",
       " 'NCT01801618': {'29662875'},\n",
       " 'NCT02405013': {'36686592'},\n",
       " 'NCT01779713': {'30354977'},\n",
       " 'NCT03235258': {'17712765',\n",
       "  '18614870',\n",
       "  '19194272',\n",
       "  '20536367',\n",
       "  '21511330',\n",
       "  '21971357',\n",
       "  '22198788',\n",
       "  '22427678',\n",
       "  '24253249',\n",
       "  '24705410',\n",
       "  '24945880',\n",
       "  '26762993'},\n",
       " 'NCT03071458': set(),\n",
       " 'NCT02886416': set(),\n",
       " 'NCT01899196': set(),\n",
       " 'NCT00944541': set(),\n",
       " 'NCT02160119': set(),\n",
       " 'NCT00158496': {'16019104', '16434426', '16847958', '16956918'},\n",
       " 'NCT02192658': {'26846895'},\n",
       " 'NCT00383734': {'23432777'},\n",
       " 'NCT02051413': set(),\n",
       " 'NCT03109067': set(),\n",
       " 'NCT02073604': set(),\n",
       " 'NCT01490489': {'16384869', '17531315', '19602057'},\n",
       " 'NCT01335529': {'27077673'},\n",
       " 'NCT00545194': {'11236117', '16553177', '17071427'},\n",
       " 'NCT03298360': set(),\n",
       " 'NCT01508494': set(),\n",
       " 'NCT00573001': set(),\n",
       " 'NCT00236340': {'11438952', '14770396', '7970458', '9464739'},\n",
       " 'NCT02542891': {'27488181', '34874888'},\n",
       " 'NCT03671291': set(),\n",
       " 'NCT01066962': {'25103176', '26520926', '30365452', '33794182'},\n",
       " 'NCT01703962': {'37668523'},\n",
       " 'NCT03642704': set(),\n",
       " 'NCT01086904': set(),\n",
       " 'NCT01127204': {'27015798',\n",
       "  '28434406',\n",
       "  '28453240',\n",
       "  '28483965',\n",
       "  '28800382',\n",
       "  '31334298',\n",
       "  '34723858'},\n",
       " 'NCT01771562': {'27881690', '30081838'},\n",
       " 'NCT00196612': {'15717256'},\n",
       " 'NCT01226446': {'25987791'},\n",
       " 'NCT02496312': {'10436334',\n",
       "  '10678322',\n",
       "  '10941190',\n",
       "  '12461757',\n",
       "  '15897497',\n",
       "  '16207933',\n",
       "  '16421064',\n",
       "  '17027767',\n",
       "  '17131230',\n",
       "  '1821241',\n",
       "  '18307266',\n",
       "  '19533496',\n",
       "  '19713543',\n",
       "  '19933975',\n",
       "  '21895376'},\n",
       " 'NCT04133012': set(),\n",
       " 'NCT01100281': set(),\n",
       " 'NCT01647295': set(),\n",
       " 'NCT00424814': {'23766338', '25838291'},\n",
       " 'NCT02488395': {'22639796', '23916713', '6774653'},\n",
       " 'NCT00658346': {'31063537'},\n",
       " 'NCT01188512': {'16839199',\n",
       "  '18762220',\n",
       "  '19625486',\n",
       "  '20107007',\n",
       "  '20184606',\n",
       "  '24261996',\n",
       "  '24421886',\n",
       "  '24793938'},\n",
       " 'NCT04945655': {'35332045'},\n",
       " 'NCT01942655': set(),\n",
       " 'NCT01332955': {'25139963'},\n",
       " 'NCT01552044': set(),\n",
       " 'NCT02592174': {'31755936'},\n",
       " 'NCT02100774': {'21957063', '24808487', '26063065', '27798339'},\n",
       " 'NCT00490074': set(),\n",
       " 'NCT01882062': {'25568297'},\n",
       " 'NCT01525472': set(),\n",
       " 'NCT02650427': set(),\n",
       " 'NCT01473472': {'26624850', '28747274', '29229440', '31784343', '36601747'},\n",
       " 'NCT02267304': set(),\n",
       " 'NCT04780191': {'32232101'},\n",
       " 'NCT00495326': {'23433590', '24663014'},\n",
       " 'NCT03459157': {'34048794'},\n",
       " 'NCT01620957': set(),\n",
       " 'NCT00339157': {'21173013'},\n",
       " 'NCT01555450': {'21256688', '28823681', '29909873'},\n",
       " 'NCT01348308': {'32040959'},\n",
       " 'NCT01696708': {'25568297'},\n",
       " 'NCT01509508': {'23880306',\n",
       "  '25880823',\n",
       "  '27504637',\n",
       "  '28329393',\n",
       "  '29199100',\n",
       "  '29890048',\n",
       "  '30027600',\n",
       "  '30321314',\n",
       "  '30412926',\n",
       "  '31637821',\n",
       "  '32970730'},\n",
       " 'NCT01874808': set(),\n",
       " 'NCT02126384': set(),\n",
       " 'NCT03150290': set(),\n",
       " 'NCT03519503': {'21602695', '22814853', '26603917'},\n",
       " 'NCT00465790': set(),\n",
       " 'NCT00122603': {'19420019'},\n",
       " 'NCT02314208': set(),\n",
       " 'NCT00121121': {'17712402'},\n",
       " 'NCT01432821': {'12914551', '15037514', '15249613', '15777732', '2271377'},\n",
       " 'NCT02071784': set(),\n",
       " 'NCT02738502': {'22160145',\n",
       "  '22848481',\n",
       "  '23559464',\n",
       "  '23766338',\n",
       "  '26197844',\n",
       "  '26709605',\n",
       "  '26854809'},\n",
       " 'NCT02992184': {'29615488'},\n",
       " 'NCT01514890': {'23669289', '24704719', '25556540'},\n",
       " 'NCT02212379': {'31269208'},\n",
       " 'NCT03652090': set(),\n",
       " 'NCT00196664': set(),\n",
       " 'NCT03335995': {'32026446', '37497675'},\n",
       " 'NCT00946595': {'29767684', '30968368'},\n",
       " 'NCT02469350': {'29636105'},\n",
       " 'NCT01546181': {'23620431',\n",
       "  '24337723',\n",
       "  '24406779',\n",
       "  '24576889',\n",
       "  '25077537',\n",
       "  '25284764',\n",
       "  '25997175',\n",
       "  '26344727',\n",
       "  '26418443',\n",
       "  '26523388',\n",
       "  '27009576',\n",
       "  '27065002',\n",
       "  '28900746',\n",
       "  '29369084',\n",
       "  '30010022',\n",
       "  '30947025',\n",
       "  '31568064',\n",
       "  '31573376',\n",
       "  '31922497',\n",
       "  '31972545'},\n",
       " 'NCT00122538': {'20516271', '21857286', '23719348'},\n",
       " 'NCT01426243': {'26314624', '30096071'},\n",
       " 'NCT04824638': set(),\n",
       " 'NCT02113943': set(),\n",
       " 'NCT00299143': set(),\n",
       " 'NCT03870438': {'26603917', '33872801', '38484756'},\n",
       " 'NCT01605890': {'29590335'},\n",
       " 'NCT00391638': set(),\n",
       " 'NCT02323308': set(),\n",
       " 'NCT02384967': {'29905808'},\n",
       " 'NCT00988767': {'15382173', '16310901', '20090916'},\n",
       " 'NCT00323804': set(),\n",
       " 'NCT04849767': {'34916316'},\n",
       " 'NCT03047967': set(),\n",
       " 'NCT00120367': {'21738597'},\n",
       " 'NCT01038401': set(),\n",
       " 'NCT04484740': set(),\n",
       " 'NCT03078439': {'38408861'},\n",
       " 'NCT00148863': {'23190183'},\n",
       " 'NCT01548586': {'10990547',\n",
       "  '11723286',\n",
       "  '15272049',\n",
       "  '15634731',\n",
       "  '16002441',\n",
       "  '19805746',\n",
       "  '20161639',\n",
       "  '22085959',\n",
       "  '8756819'},\n",
       " 'NCT00302822': set(),\n",
       " 'NCT00196625': {'15060509', '15456093'},\n",
       " 'NCT01188525': set(),\n",
       " 'NCT00670839': {'26257021'},\n",
       " 'NCT00158522': {'15977225', '16434426'},\n",
       " 'NCT00196586': set(),\n",
       " 'NCT04808986': set(),\n",
       " 'NCT02626286': {'33753460', '34022820', '34352834'},\n",
       " 'NCT01207986': set(),\n",
       " 'NCT03537196': {'19839502',\n",
       "  '20041309',\n",
       "  '20196807',\n",
       "  '20572071',\n",
       "  '22098550',\n",
       "  '22564041',\n",
       "  '22828983',\n",
       "  '23172780',\n",
       "  '23553643',\n",
       "  '23675659',\n",
       "  '23728143',\n",
       "  '23884064',\n",
       "  '25086286',\n",
       "  '25245939',\n",
       "  '25920094',\n",
       "  '26298331',\n",
       "  '27148964',\n",
       "  '27178119',\n",
       "  '27227200',\n",
       "  '27349488',\n",
       "  '27427455',\n",
       "  '27667367',\n",
       "  '33208326'},\n",
       " 'NCT04684758': set(),\n",
       " 'NCT00121758': {'20625264', '23759749'},\n",
       " 'NCT02527096': set(),\n",
       " 'NCT00158457': set(),\n",
       " 'NCT00136630': {'15313841',\n",
       "  '15365159',\n",
       "  '16055926',\n",
       "  '16193476',\n",
       "  '16501573',\n",
       "  '17098887',\n",
       "  '17597328',\n",
       "  '17605047',\n",
       "  '17957230',\n",
       "  '18378516',\n",
       "  '18853458',\n",
       "  '22491195',\n",
       "  '24780882'},\n",
       " 'NCT01579435': set(),\n",
       " 'NCT02057796': {'32558469', '36883573'},\n",
       " 'NCT01713335': set(),\n",
       " 'NCT02073630': set(),\n",
       " 'NCT05040048': set(),\n",
       " 'NCT03446430': set(),\n",
       " 'NCT01094899': set(),\n",
       " 'NCT03193099': set(),\n",
       " 'NCT03831906': {'32853411', '33743621', '36395782'},\n",
       " 'NCT00148824': {'20210645'},\n",
       " 'NCT00901524': {'24905490'},\n",
       " 'NCT00870649': {'30532268'},\n",
       " 'NCT01207349': {'22030240'},\n",
       " 'NCT01531036': {'20505064'},\n",
       " 'NCT00651066': {'24465443'},\n",
       " 'NCT02081066': set(),\n",
       " 'NCT01164436': set(),\n",
       " 'NCT01038999': {'22829920', '23285253'},\n",
       " 'NCT00604149': set(),\n",
       " 'NCT01569399': set(),\n",
       " 'NCT01917175': set(),\n",
       " 'NCT01592175': set(),\n",
       " 'NCT01271842': {'22948576'},\n",
       " 'NCT00265642': set(),\n",
       " 'NCT01008813': set(),\n",
       " 'NCT00158470': set(),\n",
       " 'NCT04265742': set(),\n",
       " 'NCT04631224': set(),\n",
       " 'NCT01493934': set(),\n",
       " 'NCT02978924': set(),\n",
       " 'NCT00226434': {'17624825',\n",
       "  '22010913',\n",
       "  '23237982',\n",
       "  '24096631',\n",
       "  '24608960',\n",
       "  '24759827'},\n",
       " 'NCT04392388': {'34293141'},\n",
       " 'NCT00928187': {'31273686'},\n",
       " 'NCT00640887': {'25406657', '26482301'},\n",
       " 'NCT01952587': set(),\n",
       " 'NCT01089387': {'25974235', '26439886', '28753830'},\n",
       " 'NCT02833961': {'36318030'},\n",
       " 'NCT02453061': {'31381524'},\n",
       " 'NCT01494961': {'20403152', '21857289', '23343912', '29178852', '34329355'},\n",
       " 'NCT00301561': {'21831714', '35248123'},\n",
       " 'NCT01167283': set(),\n",
       " 'NCT02150993': set(),\n",
       " 'NCT01075061': set(),\n",
       " 'NCT02014883': {'26536893'},\n",
       " 'NCT00158483': {'16455895', '18385443', '19530940'},\n",
       " 'NCT02481453': {'20413309', '24975859', '38273639'},\n",
       " 'NCT02329054': {'25435054', '26930627', '27046271', '28231247'},\n",
       " 'NCT02027233': set(),\n",
       " 'NCT02093754': set(),\n",
       " 'NCT03324633': {'20493576',\n",
       "  '20876416',\n",
       "  '20969743',\n",
       "  '21239121',\n",
       "  '21692942',\n",
       "  '21819472',\n",
       "  '21888878',\n",
       "  '21920402',\n",
       "  '22173166',\n",
       "  '22285372',\n",
       "  '22409788',\n",
       "  '22535683',\n",
       "  '22781224',\n",
       "  '23052829',\n",
       "  '23226258',\n",
       "  '23421419',\n",
       "  '23461846',\n",
       "  '23978720',\n",
       "  '24166726',\n",
       "  '24499953',\n",
       "  '24580042',\n",
       "  '25015913',\n",
       "  '25778750',\n",
       "  '26372388',\n",
       "  '26528903',\n",
       "  '27073179',\n",
       "  '27177169',\n",
       "  '27317796',\n",
       "  '27339598',\n",
       "  '28235612',\n",
       "  '28418984',\n",
       "  '28430385',\n",
       "  '28780609',\n",
       "  '28942916',\n",
       "  '30570526',\n",
       "  '32798585',\n",
       "  '34212476'},\n",
       " 'NCT04842851': set(),\n",
       " 'NCT04409405': {'38043556'},\n",
       " 'NCT00158405': {'16152755', '16782488', '18986246'},\n",
       " 'NCT02960698': set(),\n",
       " 'NCT02931097': set(),\n",
       " 'NCT00657397': {'22741944',\n",
       "  '24268548',\n",
       "  '25209306',\n",
       "  '25393311',\n",
       "  '27048152',\n",
       "  '27770695'},\n",
       " 'NCT00421551': {'20802297', '22848481', '29767684'},\n",
       " 'NCT00623051': set(),\n",
       " 'NCT00116454': set(),\n",
       " 'NCT03954054': {'35012570'},\n",
       " 'NCT02976298': set(),\n",
       " 'NCT02101398': set(),\n",
       " 'NCT05472051': set(),\n",
       " 'NCT00495651': {'23639243',\n",
       "  '24985779',\n",
       "  '25330161',\n",
       "  '26193126',\n",
       "  '29020361',\n",
       "  '29297443',\n",
       "  '35093007'},\n",
       " 'NCT01693861': set(),\n",
       " 'NCT00272428': {'15557412',\n",
       "  '19491388',\n",
       "  '19828715',\n",
       "  '20176858',\n",
       "  '20431391',\n",
       "  '20605091',\n",
       "  '21106918',\n",
       "  '21490142',\n",
       "  '21775560',\n",
       "  '21955649',\n",
       "  '22158670',\n",
       "  '22378736',\n",
       "  '22633793',\n",
       "  '23082222',\n",
       "  '23283500',\n",
       "  '23284983',\n",
       "  '24027184',\n",
       "  '24089418',\n",
       "  '24527713',\n",
       "  '24553693',\n",
       "  '25651444',\n",
       "  '25994566',\n",
       "  '26156743',\n",
       "  '26409628',\n",
       "  '26447153',\n",
       "  '26812508',\n",
       "  '26817718',\n",
       "  '26864363',\n",
       "  '26962176',\n",
       "  '27000099',\n",
       "  '27055851',\n",
       "  '28033414',\n",
       "  '28356432',\n",
       "  '28494135',\n",
       "  '29546305',\n",
       "  '29649036',\n",
       "  '30517725',\n",
       "  '31164347',\n",
       "  '31927670',\n",
       "  '33738534'},\n",
       " 'NCT02052271': set(),\n",
       " 'NCT01534728': set(),\n",
       " 'NCT01492985': {'33568510'},\n",
       " 'NCT00120185': {'19508157'},\n",
       " 'NCT01463956': set(),\n",
       " 'NCT00334256': {'18987623', '19104016', '19307941'},\n",
       " 'NCT00822315': {'24726095'},\n",
       " 'NCT04120415': set(),\n",
       " 'NCT02567071': set(),\n",
       " 'NCT01331811': {'26908804', '29174612', '30689814', '31455612'},\n",
       " 'NCT02214511': set(),\n",
       " 'NCT01698411': set(),\n",
       " 'NCT04288128': {'38419144', '38421662'},\n",
       " 'NCT02157311': {'29186458'},\n",
       " 'NCT02082171': set(),\n",
       " 'NCT00918307': {'29329763', '34611902'},\n",
       " 'NCT05090956': set(),\n",
       " 'NCT02346409': set(),\n",
       " 'NCT00196599': {'10915095', '15012649'},\n",
       " 'NCT02102737': set(),\n",
       " 'NCT00454337': {'19757993',\n",
       "  '19995925',\n",
       "  '20683319',\n",
       "  '21126958',\n",
       "  '21326075',\n",
       "  '21576452',\n",
       "  '21712241',\n",
       "  '22416781',\n",
       "  '27042193'},\n",
       " 'NCT02656407': {'25955583'},\n",
       " 'NCT00158509': {'16044019', '17314338', '18593294', '18596069'},\n",
       " 'NCT02038842': set(),\n",
       " 'NCT01725542': {'25977266'},\n",
       " 'NCT06260319': set(),\n",
       " 'NCT01842919': set(),\n",
       " 'NCT02906137': set(),\n",
       " 'NCT01192737': set(),\n",
       " 'NCT02647632': {'29077864'},\n",
       " 'NCT01065207': set(),\n",
       " 'NCT02542800': set(),\n",
       " 'NCT01089400': {'24646009'},\n",
       " 'NCT00574652': {'22129253'},\n",
       " 'NCT01905059': {'16249701',\n",
       "  '16549962',\n",
       "  '17545707',\n",
       "  '18097218',\n",
       "  '18540803',\n",
       "  '20010070',\n",
       "  '20802297',\n",
       "  '20802298',\n",
       "  '21811554',\n",
       "  '21886816',\n",
       "  '22441252',\n",
       "  '22814125',\n",
       "  '23075703',\n",
       "  '28566227'},\n",
       " 'NCT02125500': set(),\n",
       " 'NCT01413152': set(),\n",
       " 'NCT02236832': set(),\n",
       " 'NCT00115609': set(),\n",
       " 'NCT04396288': set(),\n",
       " 'NCT00445575': set(),\n",
       " 'NCT01024400': {'22147712'},\n",
       " 'NCT01779752': set(),\n",
       " 'NCT03215732': {'31320358', '37143029'},\n",
       " 'NCT03005652': {'33873195', '35853750', '36068621', '38100477'},\n",
       " 'NCT02916732': {'29539287', '33657112'},\n",
       " 'NCT01311752': set(),\n",
       " 'NCT01269632': set(),\n",
       " 'NCT01495897': set(),\n",
       " 'NCT00463983': {'16883006', '22379151'},\n",
       " 'NCT03137797': {'22008658',\n",
       "  '22267473',\n",
       "  '23079802',\n",
       "  '23936509',\n",
       "  '24058636',\n",
       "  '24465584',\n",
       "  '25573889',\n",
       "  '26636578',\n",
       "  '27509048'},\n",
       " 'NCT01037777': {'23707147', '24780882', '32822634', '35264424'},\n",
       " 'NCT01842477': set(),\n",
       " 'NCT02721745': set(),\n",
       " 'NCT02408354': {'28969699'},\n",
       " 'NCT01688453': {'29696179',\n",
       "  '29776897',\n",
       "  '29934380',\n",
       "  '32097754',\n",
       "  '34087324',\n",
       "  '35272723'},\n",
       " 'NCT02172677': set(),\n",
       " 'NCT01880151': set(),\n",
       " 'NCT02658253': {'32032566', '33717176'},\n",
       " 'NCT02027051': set(),\n",
       " 'NCT00118677': {'20657770'},\n",
       " 'NCT00647205': set()}"
      ]
     },
     "execution_count": 44,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pmids_complete_dict = {}\n",
    "for nctid in nctid_array:\n",
    "    # L'ensemble des PMIds présents dans PubMed et CT\n",
    "    pmids_complete_dict[nctid] = pmids_pubmed_dict[nctid] | pmids_ct_dict[nctid]\n",
    "pmids_complete_dict"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a808cce0-ad9a-4236-a7d7-5bf8a796eca9",
   "metadata": {},
   "source": [
    "#### Verifications:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "d181cb92-9626-406f-b36d-b15845b45b0d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nombre total de publications issus de CT: 541\n"
     ]
    }
   ],
   "source": [
    "num_pmids_ct = sum((len(v) for v in pmids_ct_dict.values()))\n",
    "print(f'Nombre total de publications issus de CT: {num_pmids_ct}')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "880fadf5-199b-49b8-b81b-99f7ba7b2343",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nombre total de publications après consultation PubMed: 569\n"
     ]
    }
   ],
   "source": [
    "num_pmids_complete = sum((len(v) for v in pmids_complete_dict.values()))\n",
    "print(f'Nombre total de publications après consultation PubMed: {num_pmids_complete}')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "ed3165a6-3f0a-4b95-b7c0-b2caf0167cc7",
   "metadata": {},
   "outputs": [],
   "source": [
    "pmids_pubmed_only_dict = {}\n",
    "for nctid in nctid_array:\n",
    "    # L'ensemble des PMIds présents dans PubMed uniquement\n",
    "    pmids_pubmed_only_dict[nctid] = pmids_pubmed_dict[nctid] - pmids_ct_dict[nctid]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "c9201565-039e-469b-979b-2a496d4a03ae",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nombre de nouveaux PMIDs trouvés via Pubmed: 28\n"
     ]
    }
   ],
   "source": [
    "num_pmids_pubmed_only = sum((len(v) for v in pmids_pubmed_only_dict.values()))\n",
    "print(f'Nombre de nouveaux PMIDs trouvés via Pubmed: {num_pmids_pubmed_only}')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "3dcf6bbb-ad35-4d3e-9224-f13dc3052571",
   "metadata": {},
   "outputs": [],
   "source": [
    "assert num_pmids_complete - num_pmids_ct == num_pmids_pubmed_only"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "eab933fe-2aa5-4ece-a4e6-9a07bec66d04",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "NCTId des nouveaux PMIDs trouvés via Pubmed:\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "{'NCT05349162': {'36735263'},\n",
       " 'NCT02777229': {'37851566', '38156046'},\n",
       " 'NCT01453192': {'30688008'},\n",
       " 'NCT04315948': {'36695483'},\n",
       " 'NCT05311865': {'36438274', '37795682'},\n",
       " 'NCT00640263': {'34425825'},\n",
       " 'NCT01801618': {'29662875'},\n",
       " 'NCT02405013': {'36686592'},\n",
       " 'NCT01703962': {'37668523'},\n",
       " 'NCT01473472': {'36601747'},\n",
       " 'NCT02212379': {'31269208'},\n",
       " 'NCT03335995': {'37497675'},\n",
       " 'NCT01426243': {'26314624'},\n",
       " 'NCT03870438': {'38484756'},\n",
       " 'NCT03078439': {'38408861'},\n",
       " 'NCT02057796': {'36883573'},\n",
       " 'NCT04392388': {'34293141'},\n",
       " 'NCT01089387': {'26439886'},\n",
       " 'NCT02833961': {'36318030'},\n",
       " 'NCT02481453': {'38273639'},\n",
       " 'NCT04409405': {'38043556'},\n",
       " 'NCT04288128': {'38419144', '38421662'},\n",
       " 'NCT03215732': {'37143029'},\n",
       " 'NCT03005652': {'38100477'},\n",
       " 'NCT01688453': {'35272723'}}"
      ]
     },
     "execution_count": 50,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "print('NCTId des nouveaux PMIDs trouvés via Pubmed:')\n",
    "{k: v for k, v in pmids_pubmed_only_dict.items() if v != set()}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "id": "b28d3dd2-8dd8-4231-b29b-aa55563d4336",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nombre d'études sans PMIDs issus de CT: 150\n"
     ]
    }
   ],
   "source": [
    "num_nctid_empty_ct = sum((1 for v in pmids_ct_dict.values() if v == set()))\n",
    "print(f\"Nombre d'études sans PMIDs issus de CT: {num_nctid_empty_ct}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "0e4ba4ae-ce84-4b25-82ea-98e4c8972a7b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nombre d'études sans PMIDs après consultation PubMed: 138\n"
     ]
    }
   ],
   "source": [
    "num_nctid_empty_pubmed = sum((1 for v in pmids_complete_dict.values() if v == set()))\n",
    "print(f\"Nombre d'études sans PMIDs après consultation PubMed: {num_nctid_empty_pubmed}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "0f2f7862-2d98-4e8a-a707-fa4be829e133",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "NCTIds qui n'avait aucun PMIDs sous CT, mais enrichis via Pubmed:\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "{'NCT02405013': {'36686592'},\n",
       " 'NCT05349162': {'36735263'},\n",
       " 'NCT04288128': {'38419144', '38421662'},\n",
       " 'NCT01453192': {'30688008'},\n",
       " 'NCT01801618': {'29662875'},\n",
       " 'NCT02212379': {'31269208'},\n",
       " 'NCT01703962': {'37668523'},\n",
       " 'NCT03078439': {'38408861'},\n",
       " 'NCT04409405': {'38043556'},\n",
       " 'NCT02833961': {'36318030'},\n",
       " 'NCT04392388': {'34293141'},\n",
       " 'NCT05311865': {'36438274', '37795682'}}"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "print(\"NCTIds qui n'avait aucun PMIDs sous CT, mais enrichis via Pubmed:\")\n",
    "nctids_previously_empty = {k for k, v in pmids_ct_dict.items() if v == set()} - {k for k, v in pmids_complete_dict.items() if v == set()}\n",
    "{k: pmids_complete_dict[k] for k in nctids_previously_empty}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "id": "a9f76a73-72da-4319-a441-365a7cd8f9db",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "12"
      ]
     },
     "execution_count": 54,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(nctids_previously_empty)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "id": "9b818f69-9f1e-4778-9c2e-603ca9fd378e",
   "metadata": {},
   "outputs": [],
   "source": [
    "assert num_nctid_empty_ct - num_nctid_empty_pubmed == len(nctids_previously_empty)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7ccd4072-b497-4a87-baf0-67b55c8a4845",
   "metadata": {},
   "source": [
    "### Enrichissement des PMIDs via l'API Pubmed"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6fffb32b-b3d8-4814-ae72-9d2656a6ecc0",
   "metadata": {},
   "source": [
    "Pour chaque PMID récupéré, on l'enrichit avec les données de PubMed tel que le titre, les auteurs, ...:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "7a8cd865-03da-49e2-88ac-13a3dbd3c5b9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "569 / 569..."
     ]
    }
   ],
   "source": [
    "counter = 0   # To keep track of progress\n",
    "book_counter = 0   # type different from 'article', get ignored\n",
    "total_publications_list = []\n",
    "\n",
    "# For each NTCID...\n",
    "for nctid, pmids in pmids_complete_dict.items():\n",
    "    pmids_list = []\n",
    "\n",
    "    # We process each PMID...\n",
    "    for pmid in pmids:\n",
    "\n",
    "        # Display the progress on a single line\n",
    "        print(f'\\r{counter+1} / {num_pmids_complete}...', end='', flush=True)\n",
    "\n",
    "        try:\n",
    "            # Fetch article details from Pubmed\n",
    "            article = fetch.article_by_pmid(pmid)\n",
    "\n",
    "            # We are not interested by articles with type 'book'\n",
    "            # TODO: book special case ?\n",
    "            if article.pubmed_type == 'article':\n",
    "                pmids_list.append(\n",
    "                    {\n",
    "                        'pmid': pmid,\n",
    "                        'title': article.title,\n",
    "                        'authors': article.authors_str.strip(),\n",
    "                        'doi': article.doi,\n",
    "                        'year': article.year,\n",
    "                        'publication_types': list(article.publication_types.values()),\n",
    "                        'citation': article.citation,\n",
    "                    }\n",
    "                )\n",
    "            else:\n",
    "                book_counter += 1\n",
    "                book = (nctid, pmid)\n",
    "\n",
    "            counter += 1\n",
    "        except InvalidPMID as e:\n",
    "            print(f'\\n{e}')\n",
    "\n",
    "    publication_dict = {'NCTId': nctid, 'publications': pmids_list}\n",
    "\n",
    "    total_publications_list.append(publication_dict)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "id": "66dc9fed-b144-47c8-9637-0685aed7d3da",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nb de publications avec un type différent d\"article\": 1\n",
      "('NCT03537196', '27227200')\n"
     ]
    }
   ],
   "source": [
    "print(f'Nb de publications avec un type différent d\"article\": {book_counter}')\n",
    "print(book)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "id": "3f26319c-fb30-4810-8f0e-2ee72592866e",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[\n",
      "  {\n",
      "    \"NCTId\": \"NCT02014727\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"28947345\",\n",
      "        \"title\": \"Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel\\u00ae in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial.\",\n",
      "        \"authors\": \"Sirima SB; Durier C; Kara L; Houard S; Gansane A; Loulergue P; Bahuaud M; Benhamouda N; Nebi\\u00e9 I; Faber B; Remarque E; Launay O; AMA1-DiCo Study Group\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2017.09.027\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Sirima SB, et al. Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel\\u00ae in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial. Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel\\u00ae in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial. 2017; 35:6218-6227. doi: 10.1016/j.vaccine.2017.09.027\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00117494\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"22739396\",\n",
      "        \"title\": \"Effects of rosuvastatin versus pravastatin on low-density lipoprotein diameter in HIV-1-infected patients receiving ritonavir-boosted protease inhibitor.\",\n",
      "        \"authors\": \"Bittar R; Giral P; Aslangul E; Assoumou L; Valantin MA; Kalmykova O; Federspiel MC; Cherfils C; Costagliola D; Bonnefont-Rousselot D; French National Agency for AIDS and Viral Hepatitis Research (ANRS) 126 study group\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e328357063c\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bittar R, et al. Effects of rosuvastatin versus pravastatin on low-density lipoprotein diameter in HIV-1-infected patients receiving ritonavir-boosted protease inhibitor. Effects of rosuvastatin versus pravastatin on low-density lipoprotein diameter in HIV-1-infected patients receiving ritonavir-boosted protease inhibitor. 2012; 26:1801-5. doi: 10.1097/QAD.0b013e328357063c\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22318219\",\n",
      "        \"title\": \"Determinants of low-density lipoprotein particle diameter during antiretroviral therapy including protease inhibitors in HIV-1-infected patients.\",\n",
      "        \"authors\": \"Bittar R; Giral P; Aslangul E; Assoumou L; Valantin MA; Kalmykova O; Fesel-Fouquier V; Costagliola D; Bonnefont-Rousselot D; ANRS 126 study group\",\n",
      "        \"doi\": \"10.3851/IMP2065\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bittar R, et al. Determinants of low-density lipoprotein particle diameter during antiretroviral therapy including protease inhibitors in HIV-1-infected patients. Determinants of low-density lipoprotein particle diameter during antiretroviral therapy including protease inhibitors in HIV-1-infected patients. 2012; 17:855-60. doi: 10.3851/IMP2065\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00536627\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"24394187\",\n",
      "        \"title\": \"Immunological and antiviral responses after therapeutic DNA immunization in chronic hepatitis B patients efficiently treated by analogues.\",\n",
      "        \"authors\": \"Godon O; Fontaine H; Kahi S; Meritet JF; Scott-Algara D; Pol S; Michel ML; Bourgine M; ANRS HB02 study group\",\n",
      "        \"doi\": \"10.1038/mt.2013.274\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Godon O, et al. Immunological and antiviral responses after therapeutic DNA immunization in chronic hepatitis B patients efficiently treated by analogues. Immunological and antiviral responses after therapeutic DNA immunization in chronic hepatitis B patients efficiently treated by analogues. 2014; 22:675-684. doi: 10.1038/mt.2013.274\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15382173\",\n",
      "        \"title\": \"Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers.\",\n",
      "        \"authors\": \"Mancini-Bourgine M; Fontaine H; Scott-Algara D; Pol S; Br\\u00e9chot C; Michel ML\",\n",
      "        \"doi\": \"10.1002/hep.20408\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mancini-Bourgine M, et al. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers. 2004; 40:874-82. doi: 10.1002/hep.20408\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24555998\",\n",
      "        \"title\": \"Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN.\",\n",
      "        \"authors\": \"Fontaine H; Kahi S; Chazallon C; Bourgine M; Varaut A; Buffet C; Godon O; Meritet JF; Sa\\u00efdi Y; Michel ML; Scott-Algara D; Aboulker JP; Pol S; ANRS HB02 study group\",\n",
      "        \"doi\": \"10.1136/gutjnl-2013-305707\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Fontaine H, et al. Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN. Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN. 2015; 64:139-47. doi: 10.1136/gutjnl-2013-305707\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16310901\",\n",
      "        \"title\": \"Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers.\",\n",
      "        \"authors\": \"Mancini-Bourgine M; Fontaine H; Br\\u00e9chot C; Pol S; Michel ML\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2005.08.013\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mancini-Bourgine M, et al. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. 2006; 24:4482-9. doi: 10.1016/j.vaccine.2005.08.013\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01033760\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"25701561\",\n",
      "        \"title\": \"Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.\",\n",
      "        \"authors\": \"Ch\\u00e9ret A; Nembot G; M\\u00e9lard A; Lascoux C; Slama L; Miailhes P; Yeni P; Abel S; Avettand-Fenoel V; Venet A; Chaix ML; Molina JM; Katlama C; Goujard C; Tamalet C; Raffi F; Lafeuillade A; Reynes J; Ravaux I; Ho\\u00ebn B; Delfraissy JF; Meyer L; Rouzioux C; OPTIPRIM ANRS Study Group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(15)70021-6\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Ch\\u00e9ret A, et al. Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial. Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial. 2015; 15:387-96. doi: 10.1016/S1473-3099(15)70021-6\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28708873\",\n",
      "        \"title\": \"Impact of early cART on HIV blood and semen compartments at the time of primary infection.\",\n",
      "        \"authors\": \"Ch\\u00e9ret A; Durier C; M\\u00e9lard A; Ploquin M; Heitzmann J; L\\u00e9curoux C; Avettand-Feno\\u00ebl V; David L; Pialoux G; Chennebault JM; M\\u00fcller-Trutwin M; Goujard C; Rouzioux C; Meyer L; ANRS OPTIPRIM study group\",\n",
      "        \"doi\": \"10.1371/journal.pone.0180191\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Ch\\u00e9ret A, et al. Impact of early cART on HIV blood and semen compartments at the time of primary infection. Impact of early cART on HIV blood and semen compartments at the time of primary infection. 2017; 12:e0180191. doi: 10.1371/journal.pone.0180191\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT05349162\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"36735263\",\n",
      "        \"title\": \"Epicardial vs. transvenous implantable cardioverter defibrillators in children.\",\n",
      "        \"authors\": \"Le Bos PA; Pontailler M; Maltret A; Kraiche D; Gaudin R; Barbanti C; Marijon E; Raisky O; Bonnet D; Waldmann V\",\n",
      "        \"doi\": \"10.1093/europace/euad015\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Le Bos PA, et al. Epicardial vs. transvenous implantable cardioverter defibrillators in children. Epicardial vs. transvenous implantable cardioverter defibrillators in children. 2023; 25:961-968. doi: 10.1093/europace/euad015\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01164462\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02777229\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"37851566\",\n",
      "        \"title\": \"Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial).\",\n",
      "        \"authors\": \"Bousmah MA; Protopopescu C; Mpoudi-Etame M; Omgba Bassega P; Maradan G; Olinga J; Varloteaux M; Tovar-Sanchez T; Delaporte \\u00c9; Kouanfack C; Boyer S; NAMSAL ANRS 12313 Study Group\",\n",
      "        \"doi\": \"10.1097/QAI.0000000000003273\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bousmah MA, et al. Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial). Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial). 2023; 94:262-272. doi: 10.1097/QAI.0000000000003273\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33010241\",\n",
      "        \"title\": \"Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon.\",\n",
      "        \"authors\": \"Calmy A; Tovar Sanchez T; Kouanfack C; Mpoudi-Etame M; Leroy S; Perrineau S; Lantche Wandji M; Tetsa Tata D; Omgba Bassega P; Abong Bwenda T; Varloteaux M; Tongo M; Mpoudi-Ngol\\u00e9 E; Montoyo A; Mercier N; LeMoing V; Peeters M; Reynes J; Delaporte E; New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries (NAMSAL) ANRS 12313 Study Group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(20)30238-1\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Calmy A, et al. Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon. Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon. 2020; 7:e677-e687. doi: 10.1016/S2352-3018(20)30238-1\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33355914\",\n",
      "        \"title\": \"Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial).\",\n",
      "        \"authors\": \"Bousmah MA; Nishimwe ML; Tovar-Sanchez T; Lantche Wandji M; Mpoudi-Etame M; Maradan G; Omgba Bassega P; Varloteaux M; Montoyo A; Kouanfack C; Delaporte E; Boyer S; New Antiretroviral\\u00a0and Monitoring Strategies in HIV-infected Adults in Low-Income Countries (NAMSAL) ANRS 12313 Study Group\",\n",
      "        \"doi\": \"10.1007/s40273-020-00987-3\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bousmah MA, et al. Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial). Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial). 2021; 39:331-343. doi: 10.1007/s40273-020-00987-3\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"38156046\",\n",
      "        \"title\": \"Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study.\",\n",
      "        \"authors\": \"Mpoudi-Etame M; Tovar Sanchez T; Bousmah MA; Omgba Bassega P; Olinga J; Mimbe E; Foalem M; Chiep C; Edimo S; Varloteaux M; Pelloquin R; Lamare N; Boyer S; Peeters M; Reynes J; Calmy A; Hill A; Delaporte E; Kouanfack C; New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-income countries (NAMSAL-ANRS-12313) study group\",\n",
      "        \"doi\": \"10.1093/ofid/ofad582\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Mpoudi-Etame M, et al. Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study. Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study. 2023; 10:ofad582. doi: 10.1093/ofid/ofad582\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31339676\",\n",
      "        \"title\": \"Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1.\",\n",
      "        \"authors\": \"NAMSAL ANRS 12313 Study Group; Kouanfack C; Mpoudi-Etame M; Omgba Bassega P; Eymard-Duvernay S; Leroy S; Boyer S; Peeters M; Calmy A; Delaporte E\",\n",
      "        \"doi\": \"10.1056/NEJMoa1904340\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Equivalence Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"NAMSAL ANRS 12313 Study Group, et al. Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1. Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1. 2019; 381:816-826. doi: 10.1056/NEJMoa1904340\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00480792\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"21486976\",\n",
      "        \"title\": \"Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.\",\n",
      "        \"authors\": \"Launay O; van der Vliet D; Rosenberg AR; Michel ML; Piroth L; Rey D; Colin de Verdi\\u00e8re N; Slama L; Martin K; Lortholary O; Carrat F; ANRS HB03 VIHVAC-B Trial\",\n",
      "        \"doi\": \"10.1001/jama.2011.351\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Launay O, et al. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial. 2011; 305:1432-40. doi: 10.1001/jama.2011.351\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27064975\",\n",
      "        \"title\": \"Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial.\",\n",
      "        \"authors\": \"Launay O; Rosenberg AR; Rey D; Pouget N; Michel ML; Reynes J; Neau D; Raffi F; Piroth L; Carrat F; ANRS HB03 VIHVAC-B (Trial Comparing 3 Strategies of Vaccination Against the Virus of Hepatitis B in HIV-Infected Patients) Group\",\n",
      "        \"doi\": \"10.1001/jamainternmed.2016.0741\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Launay O, et al. Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial. Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial. 2016; 176:603-10. doi: 10.1001/jamainternmed.2016.0741\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01095744\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01489592\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"15974953\",\n",
      "        \"title\": \"Hepcidin in iron metabolism.\",\n",
      "        \"authors\": \"Lor\\u00e9al O; Haziza-Pigeon C; Troadec MB; Detivaud L; Turlin B; Courselaud B; Ilyin G; Brissot P\",\n",
      "        \"doi\": \"10.2174/1389203054065392\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Lor\\u00e9al O, et al. Hepcidin in iron metabolism. Hepcidin in iron metabolism. 2005; 6:279-91. doi: 10.2174/1389203054065392\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18559556\",\n",
      "        \"title\": \"Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects.\",\n",
      "        \"authors\": \"Vareed SK; Kakarala M; Ruffin MT; Crowell JA; Normolle DP; Djuric Z; Brenner DE\",\n",
      "        \"doi\": \"10.1158/1055-9965.EPI-07-2693\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Vareed SK, et al. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. 2008; 17:1411-7. doi: 10.1158/1055-9965.EPI-07-2693\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20169331\",\n",
      "        \"title\": \"Natural and synthetic STAT3 inhibitors reduce hepcidin expression in differentiated mouse hepatocytes expressing the active phosphorylated STAT3 form.\",\n",
      "        \"authors\": \"Fatih N; Camberlein E; Island ML; Corlu A; Abgueguen E; D\\u00e9tivaud L; Leroyer P; Brissot P; Lor\\u00e9al O\",\n",
      "        \"doi\": \"10.1007/s00109-009-0588-3\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Fatih N, et al. Natural and synthetic STAT3 inhibitors reduce hepcidin expression in differentiated mouse hepatocytes expressing the active phosphorylated STAT3 form. Natural and synthetic STAT3 inhibitors reduce hepcidin expression in differentiated mouse hepatocytes expressing the active phosphorylated STAT3 form. 2010; 88:477-86. doi: 10.1007/s00109-009-0588-3\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15501961\",\n",
      "        \"title\": \"Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance.\",\n",
      "        \"authors\": \"Sharma RA; Euden SA; Platton SL; Cooke DN; Shafayat A; Hewitt HR; Marczylo TH; Morgan B; Hemingway D; Plummer SM; Pirmohamed M; Gescher AJ; Steward WP\",\n",
      "        \"doi\": \"10.1158/1078-0432.CCR-04-0744\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Sharma RA, et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. 2004; 10:6847-54. doi: 10.1158/1078-0432.CCR-04-0744\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16946298\",\n",
      "        \"title\": \"STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation.\",\n",
      "        \"authors\": \"Verga Falzacappa MV; Vujic Spasic M; Kessler R; Stolte J; Hentze MW; Muckenthaler MU\",\n",
      "        \"doi\": \"10.1182/blood-2006-07-033969\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Verga Falzacappa MV, et al. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. 2007; 109:353-8. doi: 10.1182/blood-2006-07-033969\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01453192\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"30688008\",\n",
      "        \"title\": \"Low incidence of acute rejection within 6 months of kidney transplantation in HIV-infected recipients treated with raltegravir: the Agence Nationale de Recherche sur le Sida et les H\\u00e9patites Virales (ANRS) 153 TREVE trial.\",\n",
      "        \"authors\": \"Matignon M; Leli\\u00e8vre JD; Lahiani A; Abbassi K; Desvaux D; Diallo A; Peraldi MN; Taburet AM; Saillard J; Delaugerre C; Costagliola D; Assoumou L; Grimbert P; ANRS 153 TREVE study group\",\n",
      "        \"doi\": \"10.1111/hiv.12700\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Matignon M, et al. Low incidence of acute rejection within 6 months of kidney transplantation in HIV-infected recipients treated with raltegravir: the Agence Nationale de Recherche sur le Sida et les H\\u00e9patites Virales (ANRS) 153 TREVE trial. Low incidence of acute rejection within 6 months of kidney transplantation in HIV-infected recipients treated with raltegravir: the Agence Nationale de Recherche sur le Sida et les H\\u00e9patites Virales (ANRS) 153 TREVE trial. 2019; 20:202-213. doi: 10.1111/hiv.12700\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00460382\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02486731\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02116374\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02497274\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01022476\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00528060\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"23459496\",\n",
      "        \"title\": \"Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial.\",\n",
      "        \"authors\": \"Parienti JJ; Barrail-Tran A; Duval X; Nembot G; Descamps D; Vigan M; Vrijens B; Panhard X; Taburet AM; Mentr\\u00e9 F; Goujard C\",\n",
      "        \"doi\": \"10.1128/AAC.02605-12\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Parienti JJ, et al. Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial. Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial. 2013; 57:2265-71. doi: 10.1128/AAC.02605-12\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02078076\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04008927\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"22310560\",\n",
      "        \"title\": \"Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact.\",\n",
      "        \"authors\": \"Curran GM; Bauer M; Mittman B; Pyne JM; Stetler C\",\n",
      "        \"doi\": \"10.1097/MLR.0b013e3182408812\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, U.S. Gov't, Non-P.H.S.\"\n",
      "        ],\n",
      "        \"citation\": \"Curran GM, et al. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. 2012; 50:217-26. doi: 10.1097/MLR.0b013e3182408812\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28004616\",\n",
      "        \"title\": \"Age- and time-dependent prevalence and incidence of hepatitis C virus infection in drug users in France, 2004-2011: model-based estimation from two national cross-sectional serosurveys.\",\n",
      "        \"authors\": \"Leon L; Kasereka S; Barin F; Larsen C; Weill-Barillet L; Pascal X; Chevaliez S; Pillonel J; Jauffret-Roustide M; LE Strat Y\",\n",
      "        \"doi\": \"10.1017/S0950268816002934\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Leon L, et al. Age- and time-dependent prevalence and incidence of hepatitis C virus infection in drug users in France, 2004-2011: model-based estimation from two national cross-sectional serosurveys. Age- and time-dependent prevalence and incidence of hepatitis C virus infection in drug users in France, 2004-2011: model-based estimation from two national cross-sectional serosurveys. 2017; 145:895-907. doi: 10.1017/S0950268816002934\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27537841\",\n",
      "        \"title\": \"Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial.\",\n",
      "        \"authors\": \"Dore GJ; Altice F; Litwin AH; Dalgard O; Gane EJ; Shibolet O; Luetkemeyer A; Nahass R; Peng CY; Conway B; Grebely J; Howe AY; Gendrano IN; Chen E; Huang HC; Dutko FJ; Nickle DC; Nguyen BY; Wahl J; Barr E; Robertson MN; Platt HL; C-EDGE CO-STAR Study Group\",\n",
      "        \"doi\": \"10.7326/M16-0816\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Dore GJ, et al. Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial. Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial. 2016; 165:625-634. doi: 10.7326/M16-0816\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26806260\",\n",
      "        \"title\": \"Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care.\",\n",
      "        \"authors\": \"Chevaliez S; Poiteau L; Rosa I; Soulier A; Roudot-Thoraval F; Laperche S; H\\u00e9zode C; Pawlotsky JM\",\n",
      "        \"doi\": \"10.1016/j.cmi.2016.01.009\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Evaluation Study\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Chevaliez S, et al. Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care. Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care. 2016; 22:459.e1-6. doi: 10.1016/j.cmi.2016.01.009\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27178119\",\n",
      "        \"title\": \"Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.\",\n",
      "        \"authors\": \"Des Jarlais D; Duong HT; Pham Minh K; Khuat OH; Nham TT; Arasteh K; Feelemyer J; Heckathorn DD; Peries M; Moles JP; Laureillard D; Nagot N; (The Drive Study Team)\",\n",
      "        \"doi\": \"10.1080/09540121.2016.1178698\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Des Jarlais D, et al. Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. 2016; 28:1312-5. doi: 10.1080/09540121.2016.1178698\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29432973\",\n",
      "        \"title\": \"Using dual capture/recapture studies to estimate the population size of persons who inject drugs (PWID) in the city of Hai Phong, Vietnam.\",\n",
      "        \"authors\": \"Des Jarlais D; Khue PM; Feelemyer J; Arasteh K; Thi Huong D; Thi Hai Oanh K; Thi Giang H; Thi Tuyet Thanh N; Vinh VH; Heckathorn DD; Moles JP; Vallo R; Quillet C; Rapoud D; Michel L; Laureillard D; Hammett T; Nagot N\",\n",
      "        \"doi\": \"10.1016/j.drugalcdep.2017.11.033\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Des Jarlais D, et al. Using dual capture/recapture studies to estimate the population size of persons who inject drugs (PWID) in the city of Hai Phong, Vietnam. Using dual capture/recapture studies to estimate the population size of persons who inject drugs (PWID) in the city of Hai Phong, Vietnam. 2018; 185:106-111. doi: 10.1016/j.drugalcdep.2017.11.033\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35774932\",\n",
      "        \"title\": \"Reaching Hard-to-Reach People Who Use Drugs: A Community-Based Strategy for the Elimination of Hepatitis C.\",\n",
      "        \"authors\": \"Nagot N; D'Ottavi M; Quillet C; Debellefontaine A; Castellani J; Langendorfer N; Hanslik B; Guichard S; Baglioni R; Faucherre V; Tuaillon E; Pageaux GP; Laureillard D; Donnadieu-Rigole H\",\n",
      "        \"doi\": \"10.1093/ofid/ofac181\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Nagot N, et al. Reaching Hard-to-Reach People Who Use Drugs: A Community-Based Strategy for the Elimination of Hepatitis C. Reaching Hard-to-Reach People Who Use Drugs: A Community-Based Strategy for the Elimination of Hepatitis C. 2022; 9:ofac181. doi: 10.1093/ofid/ofac181\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27168667\",\n",
      "        \"title\": \"Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014.\",\n",
      "        \"authors\": \"Blackburn NA; Patel RC; Zibbell JE\",\n",
      "        \"doi\": \"10.1177/00333549161310S214\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Blackburn NA, et al. Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014. Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014. 2016; 131 Suppl 2:91-7. doi: 10.1177/00333549161310S214\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01331876\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00820820\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02273765\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"33667406\",\n",
      "        \"title\": \"Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12\\u2008300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial.\",\n",
      "        \"authors\": \"De Castro N; Marcy O; Chazallon C; Messou E; Eholi\\u00e9 S; N'takpe JB; Bhatt N; Khosa C; Timana Massango I; Laureillard D; Chau GD; Domergue A; Veloso V; Escada R; Wagner Cardoso S; Delaugerre C; Anglaret X; Molina JM; Grinsztejn B; ANRS 12300 Reflate TB2 study group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(20)30869-0\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"De Castro N, et al. Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12\\u2008300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial. Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12\\u2008300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial. 2021; 21:813-822. doi: 10.1016/S1473-3099(20)30869-0\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02107365\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00113282\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01055873\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"22427678\",\n",
      "        \"title\": \"Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study.\",\n",
      "        \"authors\": \"Avettand-Fenoel V; Blanche S; Le Chenadec J; Scott-Algara D; Dollfus C; Viard JP; Bouallag N; Benmebarek Y; Rivi\\u00e8re Y; Warszawski J; Rouzioux C; Buseyne F\",\n",
      "        \"doi\": \"10.1093/infdis/jis233\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Avettand-Fenoel V, et al. Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study. Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study. 2012; 205:1520-8. doi: 10.1093/infdis/jis233\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT05199831\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01359774\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"17653274\",\n",
      "        \"title\": \"Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression.\",\n",
      "        \"authors\": \"Mochel F; Charles P; Seguin F; Barritault J; Coussieu C; Perin L; Le Bouc Y; Gervais C; Carcelain G; Vassault A; Feingold J; Rabier D; Durr A\",\n",
      "        \"doi\": \"10.1371/journal.pone.0000647\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mochel F, et al. Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. 2007; 2:e647. doi: 10.1371/journal.pone.0000647\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21320997\",\n",
      "        \"title\": \"Validation of plasma branched chain amino acids as biomarkers in Huntington disease.\",\n",
      "        \"authors\": \"Mochel F; Benaich S; Rabier D; Durr A\",\n",
      "        \"doi\": \"10.1001/archneurol.2010.358\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Letter\",\n",
      "          \"Validation Study\"\n",
      "        ],\n",
      "        \"citation\": \"Mochel F, et al. Validation of plasma branched chain amino acids as biomarkers in Huntington disease. Validation of plasma branched chain amino acids as biomarkers in Huntington disease. 2011; 68:265-7. doi: 10.1001/archneurol.2010.358\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21285522\",\n",
      "        \"title\": \"Energy deficit in Huntington disease: why it matters.\",\n",
      "        \"authors\": \"Mochel F; Haller RG\",\n",
      "        \"doi\": \"10.1172/JCI45691\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Mochel F and Haller RG. Energy deficit in Huntington disease: why it matters. Energy deficit in Huntington disease: why it matters. 2011; 121:493-9. doi: 10.1172/JCI45691\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02099474\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"32661003\",\n",
      "        \"title\": \"Effect of Pregnancy on Unbound Raltegravir Concentrations in the ANRS 160 RalFe Trial.\",\n",
      "        \"authors\": \"Zheng Y; Hirt D; Delmas S; Lui G; Benaboud S; Lechedanec J; Tr\\u00e9luyer JM; Chenevier-Gobeaux C; Arezes E; Gelley A; Amri I; Urien S; Bouazza N; Foissac F; Warszawski J; Ghosn J\",\n",
      "        \"doi\": \"10.1128/AAC.00759-20\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Zheng Y, et al. Effect of Pregnancy on Unbound Raltegravir Concentrations in the ANRS 160 RalFe Trial. Effect of Pregnancy on Unbound Raltegravir Concentrations in the ANRS 160 RalFe Trial. 2020; 64:(unknown pages). doi: 10.1128/AAC.00759-20\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03546127\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04315948\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"34350582\",\n",
      "        \"title\": \"Remdesivir for the treatment of COVID-19.\",\n",
      "        \"authors\": \"Ansems K; Grundeis F; Dahms K; Mikolajewska A; Thieme V; Piechotta V; Metzendorf MI; Stegemann M; Benstoem C; Fichtner F\",\n",
      "        \"doi\": \"10.1002/14651858.CD014962\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Systematic Review\"\n",
      "        ],\n",
      "        \"citation\": \"Ansems K, et al. Remdesivir for the treatment of COVID-19. Remdesivir for the treatment of COVID-19. 2021; 8:CD014962. doi: 10.1002/14651858.CD014962\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"37269068\",\n",
      "        \"title\": \"Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial.\",\n",
      "        \"authors\": \"Mercier N; Belhadi D; DeChanet A; Delmas C; Saillard J; Dumousseaux M; Le Mestre S; Fougerou-Leurent C; Ferrane A; Burdet C; Esp\\u00e9rou H; Ader F; Hites M; Peiffer-Smadja N; Poissy J; Andrejak C; Paiva JA; Tacconelli E; Staub T; Greil R; Costagliola D; Mentre F; Yazdanpanah Y; Diallo A; DisCoVeRy Safety Working group\",\n",
      "        \"doi\": \"10.1002/prp2.1072\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mercier N, et al. Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial. Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial. 2023; 11:e01072. doi: 10.1002/prp2.1072\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32473020\",\n",
      "        \"title\": \"Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.\",\n",
      "        \"authors\": \"L\\u00ea MP; Peiffer-Smadja N; Guedj J; N\\u00e9ant N; Mentr\\u00e9 F; Ader F; Yazdanpanah Y; Peytavin G\",\n",
      "        \"doi\": \"10.1093/jac/dkaa191\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"L\\u00ea MP, et al. Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial. Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial. 2020; 75:2376-2380. doi: 10.1093/jac/dkaa191\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"37302469\",\n",
      "        \"title\": \"Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20-15 DisCoVeRy study.\",\n",
      "        \"authors\": \"Fougerou-Leurent C; Delmas C; Saillard J; Dumousseaux M; Ferrane A; Mercier N; Terzic V; Le Mestre S; Dechanet A; Belhadi D; Metois A; Burdet C; Mentr\\u00e9 F; Noret M; Diallo A; Petrov-Sanchez V; Couffin-Cadiergues S; Hites M; Ader F; Esperou H\",\n",
      "        \"doi\": \"10.1016/j.cct.2023.107267\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Fougerou-Leurent C, et al. Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20-15 DisCoVeRy study. Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20-15 DisCoVeRy study. 2023; 131:107267. doi: 10.1016/j.cct.2023.107267\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35512728\",\n",
      "        \"title\": \"Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.\",\n",
      "        \"authors\": \"WHO Solidarity Trial Consortium\",\n",
      "        \"doi\": \"10.1016/S0140-6736(22)00519-0\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Meta-Analysis\"\n",
      "        ],\n",
      "        \"citation\": \"WHO Solidarity Trial Consortium. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses. 2022; 399:1941-1953. doi: 10.1016/S0140-6736(22)00519-0\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34048876\",\n",
      "        \"title\": \"An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-\\u03b2-1a and hydroxychloroquine in hospitalized patients with COVID-19.\",\n",
      "        \"authors\": \"Ader F; Peiffer-Smadja N; Poissy J; Bouscambert-Duchamp M; Belhadi D; Diallo A; Delmas C; Saillard J; Dechanet A; Mercier N; Dupont A; Alfaiate T; Lescure FX; Raffi F; Goehringer F; Kimmoun A; Jaureguiberry S; Reignier J; Nseir S; Danion F; Clere-Jehl R; Bouiller K; Navellou JC; Tolsma V; Cabi\\u00e9 A; Dubost C; Courjon J; Leroy S; Mootien J; Gaci R; Mourvillier B; Faure E; Pourcher V; Gallien S; Launay O; Lacombe K; Lanoix JP; Makinson A; Martin-Blondel G; Bouadma L; Botelho-Nevers E; Gagneux-Brunon A; Epaulard O; Piroth L; Wallet F; Richard JC; Reuter J; Staub T; Lina B; Noret M; Andrejak C; L\\u00ea MP; Peytavin G; Hites M; Costagliola D; Yazdanpanah Y; Burdet C; Mentr\\u00e9 F; DisCoVeRy study group\",\n",
      "        \"doi\": \"10.1016/j.cmi.2021.05.020\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Ader F, et al. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-\\u03b2-1a and hydroxychloroquine in hospitalized patients with COVID-19. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-\\u03b2-1a and hydroxychloroquine in hospitalized patients with COVID-19. 2021; 27:1826-1837. doi: 10.1016/j.cmi.2021.05.020\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"36680782\",\n",
      "        \"title\": \"Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia.\",\n",
      "        \"authors\": \"Terzi\\u0107 V; Levoyer L; Figarella M; Bigagli E; Mercier N; De Gastines L; Gibowski S; Tr\\u00f8seid M; Demotes J; Olsen IC; Hites M; Ader F; Lopez JRA; Mentr\\u00e9 F; Esp\\u00e9rou H; Costagliola D; R\\u00f8ttingen JA; Poissy J; Roz\\u00e9 JC; Warris A; O'Leary J; Fernandes RM; Assoumou L; Hankard R; Turner MA; Yazdanpanah Y; Diallo A; EU-Response safety group; c4c safety group\",\n",
      "        \"doi\": \"10.1111/bcp.15669\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Terzi\\u0107 V, et al. Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia. Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia. 2023; 89:1318-1328. doi: 10.1111/bcp.15669\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34763056\",\n",
      "        \"title\": \"Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group.\",\n",
      "        \"authors\": \"EU-Response investigators group; Diallo A; Tr\\u00f8seid M; Simensen VC; Boston A; Demotes J; Olsen IC; Chung F; Paiva JA; Hites M; Ader F; Arribas JR; Baratt-Due A; Melien \\u00d8; Tacconelli E; Staub T; Greil R; Tsiodras S; Briel M; Esperou H; Mentr\\u00e9 F; Eustace J; Saillard J; Delmas C; LeMestre S; Dumousseaux M; Costagliola D; R\\u00f8ttingen JA; Yazdanpanah Y\",\n",
      "        \"doi\": \"10.1016/j.cmi.2021.10.011\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"EU-Response investigators group, et al. Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group. Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group. 2022; 28:1-5. doi: 10.1016/j.cmi.2021.10.011\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"36695483\",\n",
      "        \"title\": \"Remdesivir for the treatment of COVID-19.\",\n",
      "        \"authors\": \"Grundeis F; Ansems K; Dahms K; Thieme V; Metzendorf MI; Skoetz N; Benstoem C; Mikolajewska A; Griesel M; Fichtner F; Stegemann M\",\n",
      "        \"doi\": \"10.1002/14651858.CD014962.pub2\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Systematic Review\"\n",
      "        ],\n",
      "        \"citation\": \"Grundeis F, et al. Remdesivir for the treatment of COVID-19. Remdesivir for the treatment of COVID-19. 2023; 1:CD014962. doi: 10.1002/14651858.CD014962.pub2\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32958495\",\n",
      "        \"title\": \"Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults.\",\n",
      "        \"authors\": \"Ader F; Discovery French Trial Management Team\",\n",
      "        \"doi\": \"10.1136/bmjopen-2020-041437\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial Protocol\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Ader F and Discovery French Trial Management Team. Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults. Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults. 2020; 10:e041437. doi: 10.1136/bmjopen-2020-041437\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33089306\",\n",
      "        \"title\": \"Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response.\",\n",
      "        \"authors\": \"L\\u00ea MP; Peiffer-Smadja N; Guedj J; Neant N; Mentr\\u00e9 F; Ader F; Yazdanpanah Y; Peytavin G; C-20-15 DisCoVeRy French Steering Committee\",\n",
      "        \"doi\": \"10.1093/jac/dkaa415\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Comment\"\n",
      "        ],\n",
      "        \"citation\": \"L\\u00ea MP, et al. Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response. Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response. 2021; 76:277-279. doi: 10.1093/jac/dkaa415\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"37728045\",\n",
      "        \"title\": \"Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients.\",\n",
      "        \"authors\": \"N\\u00e9ant N; Lingas G; Gaymard A; Belhadi D; Hites M; Staub T; Greil R; Paiva JA; Poissy J; Peiffer-Smadja N; Costagliola D; Yazdanpanah Y; Bouscambert-Duchamp M; Gagneux-Brunon A; Ader F; Mentr\\u00e9 F; Wallet F; Burdet C; Guedj J; DisCoVeRy study group\",\n",
      "        \"doi\": \"10.1002/psp4.13051\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"N\\u00e9ant N, et al. Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients. Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients. 2023; 12:2027-2037. doi: 10.1002/psp4.13051\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35233617\",\n",
      "        \"title\": \"Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial.\",\n",
      "        \"authors\": \"Lingas G; N\\u00e9ant N; Gaymard A; Belhadi D; Peytavin G; Hites M; Staub T; Greil R; Paiva JA; Poissy J; Peiffer-Smadja N; Costagliola D; Yazdanpanah Y; Wallet F; Gagneux-Brunon A; Mentr\\u00e9 F; Ader F; Burdet C; Guedj J; Bouscambert-Duchamp M\",\n",
      "        \"doi\": \"10.1093/jac/dkac048\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Lingas G, et al. Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial. Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial. 2022; 77:1404-1412. doi: 10.1093/jac/dkac048\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33264556\",\n",
      "        \"title\": \"Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.\",\n",
      "        \"authors\": \"WHO Solidarity Trial Consortium; Pan H; Peto R; Henao-Restrepo AM; Preziosi MP; Sathiyamoorthy V; Abdool Karim Q; Alejandria MM; Hern\\u00e1ndez Garc\\u00eda C; Kieny MP; Malekzadeh R; Murthy S; Reddy KS; Roses Periago M; Abi Hanna P; Ader F; Al-Bader AM; Alhasawi A; Allum E; Alotaibi A; Alvarez-Moreno CA; Appadoo S; Asiri A; Aukrust P; Barratt-Due A; Bellani S; Branca M; Cappel-Porter HBC; Cerrato N; Chow TS; Como N; Eustace J; Garc\\u00eda PJ; Godbole S; Gotuzzo E; Griskevicius L; Hamra R; Hassan M; Hassany M; Hutton D; Irmansyah I; Jancoriene L; Kirwan J; Kumar S; Lennon P; Lopardo G; Lydon P; Magrini N; Maguire T; Manevska S; Manuel O; McGinty S; Medina MT; Mesa Rubio ML; Miranda-Montoya MC; Nel J; Nunes EP; Perola M; Portol\\u00e9s A; Rasmin MR; Raza A; Rees H; Reges PPS; Rogers CA; Salami K; Salvadori MI; Sinani N; Sterne JAC; Stevanovikj M; Tacconelli E; Tikkinen KAO; Trelle S; Zaid H; R\\u00f8ttingen JA; Swaminathan S\",\n",
      "        \"doi\": \"10.1056/NEJMoa2023184\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"WHO Solidarity Trial Consortium, et al. Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. 2021; 384:497-511. doi: 10.1056/NEJMoa2023184\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"36828006\",\n",
      "        \"title\": \"Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials.\",\n",
      "        \"authors\": \"Amstutz A; Speich B; Mentr\\u00e9 F; Rueegg CS; Belhadi D; Assoumou L; Burdet C; Murthy S; Dodd LE; Wang Y; Tikkinen KAO; Ader F; Hites M; Bouscambert M; Trabaud MA; Fralick M; Lee TC; Pinto R; Barratt-Due A; Lund-Johansen F; M\\u00fcller F; Nevalainen OPO; Cao B; Bonnett T; Griessbach A; Taji Heravi A; Sch\\u00f6nenberger C; Janiaud P; Werlen L; Aghlmandi S; Schandelmaier S; Yazdanpanah Y; Costagliola D; Olsen IC; Briel M\",\n",
      "        \"doi\": \"10.1016/S2213-2600(22)00528-8\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Systematic Review\",\n",
      "          \"Meta-Analysis\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Amstutz A, et al. Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials. Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials. 2023; 11:453-464. doi: 10.1016/S2213-2600(22)00528-8\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35623577\",\n",
      "        \"title\": \"Immunocompromised patients have been neglected in COVID-19 trials: a call for action.\",\n",
      "        \"authors\": \"Tr\\u00f8seid M; Hentzien M; Ader F; Cardoso SW; Arribas JR; Molina JM; Mueller N; Hites M; Bonnet F; Manuel O; Costagliola D; Grinsztejn B; Olsen IC; Yazdapanah Y; Calmy A; EU RESPONSE; COMBINE\",\n",
      "        \"doi\": \"10.1016/j.cmi.2022.05.005\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Tr\\u00f8seid M, et al. Immunocompromised patients have been neglected in COVID-19 trials: a call for action. Immunocompromised patients have been neglected in COVID-19 trials: a call for action. 2022; 28:1182-1183. doi: 10.1016/j.cmi.2022.05.005\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35533972\",\n",
      "        \"title\": \"An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-\\u03b2-1a, and hydroxychloroquine in hospitalized patients with COVID-19: final results.\",\n",
      "        \"authors\": \"Ader F; DisCoVeRy Study Group\",\n",
      "        \"doi\": \"10.1016/j.cmi.2022.04.016\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Letter\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Ader F and DisCoVeRy Study Group. An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-\\u03b2-1a, and hydroxychloroquine in hospitalized patients with COVID-19: final results. An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-\\u03b2-1a, and hydroxychloroquine in hospitalized patients with COVID-19: final results. 2022; 28:1293-1296. doi: 10.1016/j.cmi.2022.04.016\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34534511\",\n",
      "        \"title\": \"Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.\",\n",
      "        \"authors\": \"Ader F; Bouscambert-Duchamp M; Hites M; Peiffer-Smadja N; Poissy J; Belhadi D; Diallo A; L\\u00ea MP; Peytavin G; Staub T; Greil R; Guedj J; Paiva JA; Costagliola D; Yazdanpanah Y; Burdet C; Mentr\\u00e9 F; DisCoVeRy Study Group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(21)00485-0\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Ader F, et al. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial. 2022; 22:209-221. doi: 10.1016/S1473-3099(21)00485-0\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32304640\",\n",
      "        \"title\": \"Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base.\",\n",
      "        \"authors\": \"Taccone FS; Gorham J; Vincent JL\",\n",
      "        \"doi\": \"10.1016/S2213-2600(20)30172-7\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Taccone FS, et al. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base. 2020; 8:539-541. doi: 10.1016/S2213-2600(20)30172-7\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34473343\",\n",
      "        \"title\": \"SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.\",\n",
      "        \"authors\": \"Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N\",\n",
      "        \"doi\": \"10.1002/14651858.CD013825.pub2\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\",\n",
      "          \"Systematic Review\"\n",
      "        ],\n",
      "        \"citation\": \"Kreuzberger N, et al. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. 2021; 9:CD013825. doi: 10.1002/14651858.CD013825.pub2\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35643099\",\n",
      "        \"title\": \"Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19.\",\n",
      "        \"authors\": \"Ader F; Bouscambert-Duchamp M; Hites M; Peiffer-Smadja N; Mentr\\u00e9 F; Burdet C; DisCoVeRy Study Group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(22)00295-X\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Letter\"\n",
      "        ],\n",
      "        \"citation\": \"Ader F, et al. Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19. Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19. 2022; 22:764-765. doi: 10.1016/S1473-3099(22)00295-X\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02987530\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT05311865\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"37795682\",\n",
      "        \"title\": \"A randomised controlled trial to study the transmission of SARS-CoV-2 and other respiratory viruses during indoor clubbing events (ANRS0066s ITOC study).\",\n",
      "        \"authors\": \"Luong Nguyen LB; Goupil de Bouill\\u00e9 J; Menant L; Noret M; Dumas A; Salmona M; Le Goff J; Delaugerre C; Cr\\u00e9pey P; Zeggagh J; ITOC Study Group\",\n",
      "        \"doi\": \"10.1093/cid/ciad603\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Luong Nguyen LB, et al. A randomised controlled trial to study the transmission of SARS-CoV-2 and other respiratory viruses during indoor clubbing events (ANRS0066s ITOC study). A randomised controlled trial to study the transmission of SARS-CoV-2 and other respiratory viruses during indoor clubbing events (ANRS0066s ITOC study). 2023; 77:1648-55. doi: 10.1093/cid/ciad603\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"36438274\",\n",
      "        \"title\": \"Transmission of SARS-CoV-2 during indoor clubbing events: A clustered randomized, controlled, multicentre trial protocol.\",\n",
      "        \"authors\": \"Goupil de Bouill\\u00e9 J; Luong Nguyen LB; Cr\\u00e9pey P; Garlantezec R; Dor\\u00e9 V; Dumas A; Ben Mechlia M; Tattevin P; Gaudart J; Spire B; Lert F; Yazdanpanah Y; Delaugerre C; Noret M; Zeggagh J\",\n",
      "        \"doi\": \"10.3389/fpubh.2022.981213\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial Protocol\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Goupil de Bouill\\u00e9 J, et al. Transmission of SARS-CoV-2 during indoor clubbing events: A clustered randomized, controlled, multicentre trial protocol. Transmission of SARS-CoV-2 during indoor clubbing events: A clustered randomized, controlled, multicentre trial protocol. 2022; 10:981213. doi: 10.3389/fpubh.2022.981213\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00122616\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"23800784\",\n",
      "        \"title\": \"The effects of a maintenance therapy with peg-interferon alpha-2a on liver fibrosis in HIV/HCV co-infected patients: a randomized controlled trial.\",\n",
      "        \"authors\": \"Chapplain JM; Bellissant E; Guyader D; Molina JM; Poizot-Martin I; Perr\\u00e9 P; Pialoux G; Turlin B; Mouchel C; Renault A; Michelet C; ANRS HC-12 Study Group\",\n",
      "        \"doi\": \"10.1016/j.jinf.2013.05.007\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Chapplain JM, et al. The effects of a maintenance therapy with peg-interferon alpha-2a on liver fibrosis in HIV/HCV co-infected patients: a randomized controlled trial. The effects of a maintenance therapy with peg-interferon alpha-2a on liver fibrosis in HIV/HCV co-infected patients: a randomized controlled trial. 2013; 67:313-21. doi: 10.1016/j.jinf.2013.05.007\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02428816\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02453048\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"24793938\",\n",
      "        \"title\": \"B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial.\",\n",
      "        \"authors\": \"Jahnmatz M; Amu S; Ljungman M; Wehlin L; Chiodi F; Mielcarek N; Locht C; Thorstensson R\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2014.04.048\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Jahnmatz M, et al. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial. 2014; 32:3350-6. doi: 10.1016/j.vaccine.2014.04.048\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24950361\",\n",
      "        \"title\": \"Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice.\",\n",
      "        \"authors\": \"Feunou PF; Kammoun H; Debrie AS; Locht C\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2014.06.019\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Feunou PF, et al. Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice. Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice. 2014; 32:4281-8. doi: 10.1016/j.vaccine.2014.06.019\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22814407\",\n",
      "        \"title\": \"Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice.\",\n",
      "        \"authors\": \"Kammoun H; Feunou PF; Foligne B; Debrie AS; Raze D; Mielcarek N; Locht C\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2012.07.005\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kammoun H, et al. Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice. Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice. 2012; 30:5864-70. doi: 10.1016/j.vaccine.2012.07.005\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24421886\",\n",
      "        \"title\": \"A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers.\",\n",
      "        \"authors\": \"Thorstensson R; Trollfors B; Al-Tawil N; Jahnmatz M; Bergstr\\u00f6m J; Ljungman M; T\\u00f6rner A; Wehlin L; Van Broekhoven A; Bosman F; Debrie AS; Mielcarek N; Locht C\",\n",
      "        \"doi\": \"10.1371/journal.pone.0083449\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Thorstensson R, et al. A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. 2014; 9:e83449. doi: 10.1371/journal.pone.0083449\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21430219\",\n",
      "        \"title\": \"Attenuated Bordetella pertussis vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1/Th17 response.\",\n",
      "        \"authors\": \"Fedele G; Bianco M; Debrie AS; Locht C; Ausiello CM\",\n",
      "        \"doi\": \"10.4049/jimmunol.1003765\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Fedele G, et al. Attenuated Bordetella pertussis vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1/Th17 response. Attenuated Bordetella pertussis vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1/Th17 response. 2011; 186:5388-96. doi: 10.4049/jimmunol.1003765\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21147936\",\n",
      "        \"title\": \"A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model.\",\n",
      "        \"authors\": \"Skerry CM; Mahon BP\",\n",
      "        \"doi\": \"10.1128/CVI.00371-10\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Skerry CM and Mahon BP. A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model. A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model. 2011; 18:187-93. doi: 10.1128/CVI.00371-10\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31945015\",\n",
      "        \"title\": \"Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans.\",\n",
      "        \"authors\": \"Lin A; Apostolovic D; Jahnmatz M; Liang F; Ols S; Tecleab T; Wu C; van Hage M; Solovay K; Rubin K; Locht C; Thorstensson R; Thalen M; Lor\\u00e9 K\",\n",
      "        \"doi\": \"10.1172/JCI135020\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Lin A, et al. Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans. Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans. 2020; 130:2332-2346. doi: 10.1172/JCI135020\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19625486\",\n",
      "        \"title\": \"A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice.\",\n",
      "        \"authors\": \"Skerry CM; Cassidy JP; English K; Feunou-Feunou P; Locht C; Mahon BP\",\n",
      "        \"doi\": \"10.1128/CVI.00082-09\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Skerry CM, et al. A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice. A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice. 2009; 16:1344-51. doi: 10.1128/CVI.00082-09\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32687804\",\n",
      "        \"title\": \"Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study.\",\n",
      "        \"authors\": \"Jahnmatz M; Richert L; Al-Tawil N; Storsaeter J; Colin C; Bauduin C; Thalen M; Solovay K; Rubin K; Mielcarek N; Thorstensson R; Locht C; BPZE1 study team\",\n",
      "        \"doi\": \"10.1016/S1473-3099(20)30274-7\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Jahnmatz M, et al. Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study. Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study. 2020; 20:1290-1301. doi: 10.1016/S1473-3099(20)30274-7\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20708998\",\n",
      "        \"title\": \"Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1.\",\n",
      "        \"authors\": \"Feunou PF; Kammoun H; Debrie AS; Mielcarek N; Locht C\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2010.08.017\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Feunou PF, et al. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1. 2010; 28:7047-53. doi: 10.1016/j.vaccine.2010.08.017\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20419113\",\n",
      "        \"title\": \"T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis.\",\n",
      "        \"authors\": \"Feunou PF; Bertout J; Locht C\",\n",
      "        \"doi\": \"10.1371/journal.pone.0010178\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Feunou PF, et al. T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis. T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis. 2010; 5:e10178. doi: 10.1371/journal.pone.0010178\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18762220\",\n",
      "        \"title\": \"Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1.\",\n",
      "        \"authors\": \"Feunou PF; Ismaili J; Debrie AS; Huot L; Hot D; Raze D; Lemoine Y; Locht C\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2008.08.018\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Feunou PF, et al. Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1. Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1. 2008; 26:5722-7. doi: 10.1016/j.vaccine.2008.08.018\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20107007\",\n",
      "        \"title\": \"Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice.\",\n",
      "        \"authors\": \"Mielcarek N; Debrie AS; Mahieux S; Locht C\",\n",
      "        \"doi\": \"10.1128/CVI.00322-09\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mielcarek N, et al. Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice. Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice. 2010; 17:317-24. doi: 10.1128/CVI.00322-09\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00120757\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"22353022\",\n",
      "        \"title\": \"Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120).\",\n",
      "        \"authors\": \"Rozenberg S; Lanoy E; Bentata M; Viard JP; Valantin MA; Missy P; Darasteanu I; Roux C; Kolta S; Costagliola D; ANRS 120 Fosivir Study Group\",\n",
      "        \"doi\": \"10.1089/AID.2011.0224\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Rozenberg S, et al. Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120). Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120). 2012; 28:972-80. doi: 10.1089/AID.2011.0224\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02566148\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29982518\",\n",
      "        \"title\": \"Refusal to provide healthcare to sub-Saharan migrants in France: a comparison according to their HIV and HBV status.\",\n",
      "        \"authors\": \"Vignier N; Dray Spira R; Pannetier J; Ravalihasy A; Gosselin A; Lert F; Lydie N; Bouchaud O; Desgrees Du Lou A; Chauvin P; PARCOURS Study Group\",\n",
      "        \"doi\": \"10.1093/eurpub/cky118\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Vignier N, et al. Refusal to provide healthcare to sub-Saharan migrants in France: a comparison according to their HIV and HBV status. Refusal to provide healthcare to sub-Saharan migrants in France: a comparison according to their HIV and HBV status. 2018; 28:904-910. doi: 10.1093/eurpub/cky118\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29307383\",\n",
      "        \"title\": \"Prevalence and circumstances of forced sex and post-migration HIV acquisition in sub-Saharan African migrant women in France: an analysis of the ANRS-PARCOURS retrospective population-based study.\",\n",
      "        \"authors\": \"Pannetier J; Ravalihasy A; Lydi\\u00e9 N; Lert F; Desgr\\u00e9es du Lo\\u00fb A; Parcours study group\",\n",
      "        \"doi\": \"10.1016/S2468-2667(17)30211-6\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Pannetier J, et al. Prevalence and circumstances of forced sex and post-migration HIV acquisition in sub-Saharan African migrant women in France: an analysis of the ANRS-PARCOURS retrospective population-based study. Prevalence and circumstances of forced sex and post-migration HIV acquisition in sub-Saharan African migrant women in France: an analysis of the ANRS-PARCOURS retrospective population-based study. 2018; 3:e16-e23. doi: 10.1016/S2468-2667(17)30211-6\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29437866\",\n",
      "        \"title\": \"How to use sequence analysis for life course epidemiology? An example on HIV-positive Sub-Saharan migrants in France.\",\n",
      "        \"authors\": \"Gosselin A; Desgr\\u00e9es du Lo\\u00fb A; Leli\\u00e8vre E; PARCOURS Study Group\",\n",
      "        \"doi\": \"10.1136/jech-2017-209739\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Gosselin A, et al. How to use sequence analysis for life course epidemiology? An example on HIV-positive Sub-Saharan migrants in France. How to use sequence analysis for life course epidemiology? An example on HIV-positive Sub-Saharan migrants in France. 2018; 72:507-512. doi: 10.1136/jech-2017-209739\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00640263\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"27895016\",\n",
      "        \"title\": \"Are Prophylactic and Therapeutic Target Concentrations Different?: the Case of Lopinavir-Ritonavir or Lamivudine Administered to Infants for Prevention of Mother-to-Child HIV-1 Transmission during Breastfeeding.\",\n",
      "        \"authors\": \"Foissac F; Blume J; Tr\\u00e9luyer JM; Tyllesk\\u00e4r T; Kankasa C; Meda N; Tumwine JK; Singata-Madliki M; Harper K; Illamola SM; Bouazza N; Nagot N; Van de Perre P; Blanche S; Hirt D\",\n",
      "        \"doi\": \"10.1128/AAC.01869-16\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Foissac F, et al. Are Prophylactic and Therapeutic Target Concentrations Different?: the Case of Lopinavir-Ritonavir or Lamivudine Administered to Infants for Prevention of Mother-to-Child HIV-1 Transmission during Breastfeeding. Are Prophylactic and Therapeutic Target Concentrations Different?: the Case of Lopinavir-Ritonavir or Lamivudine Administered to Infants for Prevention of Mother-to-Child HIV-1 Transmission during Breastfeeding. 2017; 61:(unknown pages). doi: 10.1128/AAC.01869-16\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32991450\",\n",
      "        \"title\": \"Antiretroviral treatment and its impact on oral health outcomes in 5 to 7 year old Ugandan children: A 6 year follow-up visit from the ANRS 12174 randomized trial.\",\n",
      "        \"authors\": \"Birungi N; Fadnes LT; Engebretsen IMS; Tumwine JK; \\u00c5str\\u00f8m AN; for ANRS 12174 AND 12341 study groups\",\n",
      "        \"doi\": \"10.1097/MD.0000000000022352\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Birungi N, et al. Antiretroviral treatment and its impact on oral health outcomes in 5 to 7 year old Ugandan children: A 6 year follow-up visit from the ANRS 12174 randomized trial. Antiretroviral treatment and its impact on oral health outcomes in 5 to 7 year old Ugandan children: A 6 year follow-up visit from the ANRS 12174 randomized trial. 2020; 99:e22352. doi: 10.1097/MD.0000000000022352\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31994250\",\n",
      "        \"title\": \"Association of maternal HIV-1 severity with dental caries: an observational study of uninfected 5- to 7-yr-old children of HIV-1-infected mothers without severe immune suppression.\",\n",
      "        \"authors\": \"Birungi N; Fadnes LT; Engebretsen IMS; Lie SA; Tumwine JK; \\u00c5str\\u00f8m AN; ANRS 12174 and 12341 study groups\",\n",
      "        \"doi\": \"10.1111/eos.12669\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Birungi N, et al. Association of maternal HIV-1 severity with dental caries: an observational study of uninfected 5- to 7-yr-old children of HIV-1-infected mothers without severe immune suppression. Association of maternal HIV-1 severity with dental caries: an observational study of uninfected 5- to 7-yr-old children of HIV-1-infected mothers without severe immune suppression. 2020; 128:46-54. doi: 10.1111/eos.12669\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17825642\",\n",
      "        \"title\": \"Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments.\",\n",
      "        \"authors\": \"Kourtis AP; Jamieson DJ; de Vincenzi I; Taylor A; Thigpen MC; Dao H; Farley T; Fowler MG\",\n",
      "        \"doi\": \"10.1016/j.ajog.2007.03.003\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Kourtis AP, et al. Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments. Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments. 2007; 197:S113-22. doi: 10.1016/j.ajog.2007.03.003\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32067040\",\n",
      "        \"title\": \"Clinical and Biological Factors Associated With Early Epstein-Barr Virus Infection in Human Immunodeficiency Virus-Exposed Uninfected Infants in Eastern Uganda.\",\n",
      "        \"authors\": \"Montoya-Ferrer A; Sanosyan A; Fayd'herbe de Maudave A; Pisoni A; Bollore K; Mol\\u00e8s JP; Peries M; Tylleskar T; Tumwine JK; Ndeezi G; Gorgolas M; Nagot N; van de Perre P; Tuaillon E\",\n",
      "        \"doi\": \"10.1093/cid/ciaa161\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Montoya-Ferrer A, et al. Clinical and Biological Factors Associated With Early Epstein-Barr Virus Infection in Human Immunodeficiency Virus-Exposed Uninfected Infants in Eastern Uganda. Clinical and Biological Factors Associated With Early Epstein-Barr Virus Infection in Human Immunodeficiency Virus-Exposed Uninfected Infants in Eastern Uganda. 2021; 72:1026-1032. doi: 10.1093/cid/ciaa161\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28469697\",\n",
      "        \"title\": \"Breastfeeding patterns and its determinants among mothers living with Human Immuno-deficiency Virus -1 in four African countries participating in the ANRS 12174 trial.\",\n",
      "        \"authors\": \"Som\\u00e9 EN; Engebretsen IMS; Nagot N; Meda N; Lombard C; Vallo R; Peries M; Kankasa C; Tumwine JK; Hofmeyr GJ; Singata M; Harper K; Van De Perre P; Tylleskar T; ANRS 12174 Trial Group\",\n",
      "        \"doi\": \"10.1186/s13006-017-0112-2\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Som\\u00e9 EN, et al. Breastfeeding patterns and its determinants among mothers living with Human Immuno-deficiency Virus -1 in four African countries participating in the ANRS 12174 trial. Breastfeeding patterns and its determinants among mothers living with Human Immuno-deficiency Virus -1 in four African countries participating in the ANRS 12174 trial. 2016; 12:22. doi: 10.1186/s13006-017-0112-2\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30814028\",\n",
      "        \"title\": \"Growth in HIV-1-exposed but uninfected infants treated with lopinavir-ritonavir versus lamivudine: a secondary analysis of the ANRS 12174 trial.\",\n",
      "        \"authors\": \"Blanche S; Tyllesk\\u00e4r T; Peries M; Kankasa C; Engebretsen I; Meda N; Tumwine JK; Singata-Madliki M; Mwiya M; Van de Perre P; Nagot N; ANRS 12174 Trial Group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(18)30361-8\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Blanche S, et al. Growth in HIV-1-exposed but uninfected infants treated with lopinavir-ritonavir versus lamivudine: a secondary analysis of the ANRS 12174 trial. Growth in HIV-1-exposed but uninfected infants treated with lopinavir-ritonavir versus lamivudine: a secondary analysis of the ANRS 12174 trial. 2019; 6:e307-e314. doi: 10.1016/S2352-3018(18)30361-8\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26603917\",\n",
      "        \"title\": \"Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial.\",\n",
      "        \"authors\": \"Nagot N; Kankasa C; Tumwine JK; Meda N; Hofmeyr GJ; Vallo R; Mwiya M; Kwagala M; Traore H; Sunday A; Singata M; Siuluta C; Some E; Rutagwera D; Neboua D; Ndeezi G; Jackson D; Mar\\u00e9chal V; Neveu D; Engebretsen IMS; Lombard C; Blanche S; Sommerfelt H; Rekacewicz C; Tyllesk\\u00e4r T; Van de Perre P; ANRS 12174 Trial Group\",\n",
      "        \"doi\": \"10.1016/S0140-6736(15)00984-8\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nagot N, et al. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. 2016; 387:566-573. doi: 10.1016/S0140-6736(15)00984-8\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34425825\",\n",
      "        \"title\": \"The prevalence and socio-behavioural and clinical covariates of oral health related quality of life in Ugandan mothers with and without HIV-1.\",\n",
      "        \"authors\": \"Birungi N; Fadnes LT; Engebretsen IMS; Tumwine JK; \\u00c5str\\u00f8m AN; ANRS 12174 and 12341 study groups\",\n",
      "        \"doi\": \"10.1186/s12955-021-01844-3\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Birungi N, et al. The prevalence and socio-behavioural and clinical covariates of oral health related quality of life in Ugandan mothers with and without HIV-1. The prevalence and socio-behavioural and clinical covariates of oral health related quality of life in Ugandan mothers with and without HIV-1. 2021; 19:201. doi: 10.1186/s12955-021-01844-3\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31633158\",\n",
      "        \"title\": \"Lopinavir-Ritonavir Impairs Adrenal Function in Infants.\",\n",
      "        \"authors\": \"Kariyawasam D; Peries M; Foissac F; Eymard-Duvernay S; Tyllesk\\u00e4r T; Singata-Madliki M; Kankasa C; Meda N; Tumwine J; Mwiya M; Engebretsen I; Fl\\u00fcck CE; Hartmann MF; Wudy SA; Hirt D; Treluyer JM; Mol\\u00e8s JP; Blanche S; Van De Perre P; Polak M; Nagot N; ANRS 12174 Trial Group\",\n",
      "        \"doi\": \"10.1093/cid/ciz888\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kariyawasam D, et al. Lopinavir-Ritonavir Impairs Adrenal Function in Infants. Lopinavir-Ritonavir Impairs Adrenal Function in Infants. 2020; 71:1030-1039. doi: 10.1093/cid/ciz888\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23039034\",\n",
      "        \"title\": \"Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding: the PROMISE-PEP trial Protocol ANRS 12174.\",\n",
      "        \"authors\": \"Nagot N; Kankasa C; Meda N; Hofmeyr J; Nikodem C; Tumwine JK; Karamagi C; Sommerfelt H; Neveu D; Tyllesk\\u00e4r T; Van de Perre P; PROMISE-PEP group\",\n",
      "        \"doi\": \"10.1186/1471-2334-12-246\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nagot N, et al. Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding: the PROMISE-PEP trial Protocol ANRS 12174. Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding: the PROMISE-PEP trial Protocol ANRS 12174. 2012; 12:246. doi: 10.1186/1471-2334-12-246\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32228542\",\n",
      "        \"title\": \"Caries experience and oral health related quality of life in a cohort of Ugandan HIV-1 exposed uninfected children compared with a matched cohort of HIV unexposed uninfected children.\",\n",
      "        \"authors\": \"Birungi N; Fadnes LT; Engebretsen IMS; Lie SA; Tumwine JK; \\u00c5str\\u00f8m AN; ANRS 12174 and 12341 study groups\",\n",
      "        \"doi\": \"10.1186/s12889-020-08564-1\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Birungi N, et al. Caries experience and oral health related quality of life in a cohort of Ugandan HIV-1 exposed uninfected children compared with a matched cohort of HIV unexposed uninfected children. Caries experience and oral health related quality of life in a cohort of Ugandan HIV-1 exposed uninfected children compared with a matched cohort of HIV unexposed uninfected children. 2020; 20:423. doi: 10.1186/s12889-020-08564-1\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01693835\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04470648\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"32371096\",\n",
      "        \"title\": \"SARS-CoV-2 was already spreading in France in late December 2019.\",\n",
      "        \"authors\": \"Deslandes A; Berti V; Tandjaoui-Lambotte Y; Alloui C; Carbonnelle E; Zahar JR; Brichler S; Cohen Y\",\n",
      "        \"doi\": \"10.1016/j.ijantimicag.2020.106006\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Deslandes A, et al. SARS-CoV-2 was already spreading in France in late December 2019. SARS-CoV-2 was already spreading in France in late December 2019. 2020; 55:106006. doi: 10.1016/j.ijantimicag.2020.106006\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32046819\",\n",
      "        \"title\": \"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020.\",\n",
      "        \"authors\": \"Backer JA; Klinkenberg D; Wallinga J\",\n",
      "        \"doi\": \"10.2807/1560-7917.ES.2020.25.5.2000062\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Backer JA, et al. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. 2020; 25:(unknown pages). doi: 10.2807/1560-7917.ES.2020.25.5.2000062\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32338732\",\n",
      "        \"title\": \"Prevalence of SARS-CoV-2 Infection in Residents of a Large Homeless Shelter in Boston.\",\n",
      "        \"authors\": \"Baggett TP; Keyes H; Sporn N; Gaeta JM\",\n",
      "        \"doi\": \"10.1001/jama.2020.6887\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Baggett TP, et al. Prevalence of SARS-CoV-2 Infection in Residents of a Large Homeless Shelter in Boston. Prevalence of SARS-CoV-2 Infection in Residents of a Large Homeless Shelter in Boston. 2020; 323:2191-2192. doi: 10.1001/jama.2020.6887\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32070465\",\n",
      "        \"title\": \"First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020.\",\n",
      "        \"authors\": \"Bernard Stoecklin S; Rolland P; Silue Y; Mailles A; Campese C; Simondon A; Mechain M; Meurice L; Nguyen M; Bassi C; Yamani E; Behillil S; Ismael S; Nguyen D; Malvy D; Lescure FX; Georges S; Lazarus C; Taba\\u00ef A; Stempfelet M; Enouf V; Coignard B; Levy-Bruhl D; Investigation team\",\n",
      "        \"doi\": \"10.2807/1560-7917.ES.2020.25.6.2000094\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Case Reports\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Bernard Stoecklin S, et al. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. 2020; 25:(unknown pages). doi: 10.2807/1560-7917.ES.2020.25.6.2000094\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31978945\",\n",
      "        \"title\": \"A Novel Coronavirus from Patients with Pneumonia in China, 2019.\",\n",
      "        \"authors\": \"Zhu N; Zhang D; Wang W; Li X; Yang B; Song J; Zhao X; Huang B; Shi W; Lu R; Niu P; Zhan F; Ma X; Wang D; Xu W; Wu G; Gao GF; Tan W; China Novel Coronavirus Investigating and Research Team\",\n",
      "        \"doi\": \"10.1056/NEJMoa2001017\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Zhu N, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. A Novel Coronavirus from Patients with Pneumonia in China, 2019. 2020; 382:727-733. doi: 10.1056/NEJMoa2001017\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32109013\",\n",
      "        \"title\": \"Clinical Characteristics of Coronavirus Disease 2019 in China.\",\n",
      "        \"authors\": \"Guan WJ; Ni ZY; Hu Y; Liang WH; Ou CQ; He JX; Liu L; Shan H; Lei CL; Hui DSC; Du B; Li LJ; Zeng G; Yuen KY; Chen RC; Tang CL; Wang T; Chen PY; Xiang J; Li SY; Wang JL; Liang ZJ; Peng YX; Wei L; Liu Y; Hu YH; Peng P; Wang JM; Liu JY; Chen Z; Li G; Zheng ZJ; Qiu SQ; Luo J; Ye CJ; Zhu SY; Zhong NS; China Medical Treatment Expert Group for Covid-19\",\n",
      "        \"doi\": \"10.1056/NEJMoa2002032\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Guan WJ, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. Clinical Characteristics of Coronavirus Disease 2019 in China. 2020; 382:1708-1720. doi: 10.1056/NEJMoa2002032\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31995857\",\n",
      "        \"title\": \"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.\",\n",
      "        \"authors\": \"Li Q; Guan X; Wu P; Wang X; Zhou L; Tong Y; Ren R; Leung KSM; Lau EHY; Wong JY; Xing X; Xiang N; Wu Y; Li C; Chen Q; Li D; Liu T; Zhao J; Liu M; Tu W; Chen C; Jin L; Yang R; Wang Q; Zhou S; Wang R; Liu H; Luo Y; Liu Y; Shao G; Li H; Tao Z; Yang Y; Deng Z; Liu B; Ma Z; Zhang Y; Shi G; Lam TTY; Wu JT; Gao GF; Cowling BJ; Yang B; Leung GM; Feng Z\",\n",
      "        \"doi\": \"10.1056/NEJMoa2001316\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Li Q, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. 2020; 382:1199-1207. doi: 10.1056/NEJMoa2001316\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32224310\",\n",
      "        \"title\": \"Clinical and virological data of the first cases of COVID-19 in Europe: a case series.\",\n",
      "        \"authors\": \"Lescure FX; Bouadma L; Nguyen D; Parisey M; Wicky PH; Behillil S; Gaymard A; Bouscambert-Duchamp M; Donati F; Le Hingrat Q; Enouf V; Houhou-Fidouh N; Valette M; Mailles A; Lucet JC; Mentre F; Duval X; Descamps D; Malvy D; Timsit JF; Lina B; van-der-Werf S; Yazdanpanah Y\",\n",
      "        \"doi\": \"10.1016/S1473-3099(20)30200-0\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Lescure FX, et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. 2020; 20:697-706. doi: 10.1016/S1473-3099(20)30200-0\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02573948\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26075647\",\n",
      "        \"title\": \"Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?\",\n",
      "        \"authors\": \"Perlman DC; Des Jarlais DC; Feelemyer J\",\n",
      "        \"doi\": \"10.1080/10550887.2015.1059111\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\"\n",
      "        ],\n",
      "        \"citation\": \"Perlman DC, et al. Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?. Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?. 2015; 34:198-205. doi: 10.1080/10550887.2015.1059111\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27006257\",\n",
      "        \"title\": \"Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam.\",\n",
      "        \"authors\": \"Des Jarlais DC; Thi Huong D; Thi Hai Oanh K; Khu\\u00ea Pham M; Thi Giang H; Thi Tuyet Thanh N; Arasteh K; Feelemyer J; Hammett T; Peries M; Michel L; Vu Hai V; Roustide MJ; Moles JP; Laureillard D; Nagot N; DRIVE Study Team\",\n",
      "        \"doi\": \"10.1016/j.drugpo.2016.02.021\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Research Support, N.I.H., Extramural\"\n",
      "        ],\n",
      "        \"citation\": \"Des Jarlais DC, et al. Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam. Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam. 2016; 32:50-6. doi: 10.1016/j.drugpo.2016.02.021\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27178119\",\n",
      "        \"title\": \"Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.\",\n",
      "        \"authors\": \"Des Jarlais D; Duong HT; Pham Minh K; Khuat OH; Nham TT; Arasteh K; Feelemyer J; Heckathorn DD; Peries M; Moles JP; Laureillard D; Nagot N; (The Drive Study Team)\",\n",
      "        \"doi\": \"10.1080/09540121.2016.1178698\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Des Jarlais D, et al. Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. 2016; 28:1312-5. doi: 10.1080/09540121.2016.1178698\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26080690\",\n",
      "        \"title\": \"HIV, Hepatitis C, and Abstinence from Alcohol Among Injection and Non-injection Drug Users.\",\n",
      "        \"authors\": \"Elliott JC; Hasin DS; Stohl M; Des Jarlais DC\",\n",
      "        \"doi\": \"10.1007/s10461-015-1113-z\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Elliott JC, et al. HIV, Hepatitis C, and Abstinence from Alcohol Among Injection and Non-injection Drug Users. HIV, Hepatitis C, and Abstinence from Alcohol Among Injection and Non-injection Drug Users. 2016; 20:548-54. doi: 10.1007/s10461-015-1113-z\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28612212\",\n",
      "        \"title\": \"Risk Behaviors for HIV and HCV Infection Among People Who Inject Drugs in Hai Phong, Viet Nam, 2014.\",\n",
      "        \"authors\": \"Duong HT; Jarlais DD; Khuat OHT; Arasteh K; Feelemyer J; Khue PM; Giang HT; Laureillard D; Hai VV; Vallo R; Michel L; Moles JP; Nagot N; Drive Study Group\",\n",
      "        \"doi\": \"10.1007/s10461-017-1814-6\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Duong HT, et al. Risk Behaviors for HIV and HCV Infection Among People Who Inject Drugs in Hai Phong, Viet Nam, 2014. Risk Behaviors for HIV and HCV Infection Among People Who Inject Drugs in Hai Phong, Viet Nam, 2014. 2018; 22:2161-2171. doi: 10.1007/s10461-017-1814-6\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26050614\",\n",
      "        \"title\": \"An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential.\",\n",
      "        \"authors\": \"Perlman DC; Jordan AE; Uuskula A; Huong DT; Masson CL; Schackman BR; Des Jarlais DC\",\n",
      "        \"doi\": \"10.1016/j.drugpo.2015.04.015\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\"\n",
      "        ],\n",
      "        \"citation\": \"Perlman DC, et al. An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential. An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential. 2015; 26:1056-63. doi: 10.1016/j.drugpo.2015.04.015\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28800503\",\n",
      "        \"title\": \"Intravenous heroin use in Haiphong, Vietnam: Need for comprehensive care including methamphetamine use-related interventions.\",\n",
      "        \"authors\": \"Michel L; Des Jarlais DC; Duong Thi H; Khuat Thi Hai O; Pham Minh K; Peries M; Vallo R; Nham Thi Tuyet T; Hoang Thi G; Le Sao M; Feelemyer J; Vu Hai V; Moles JP; Laureillard D; Nagot N; DRIVE Study Team\",\n",
      "        \"doi\": \"10.1016/j.drugalcdep.2017.07.004\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Michel L, et al. Intravenous heroin use in Haiphong, Vietnam: Need for comprehensive care including methamphetamine use-related interventions. Intravenous heroin use in Haiphong, Vietnam: Need for comprehensive care including methamphetamine use-related interventions. 2017; 179:198-204. doi: 10.1016/j.drugalcdep.2017.07.004\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26032121\",\n",
      "        \"title\": \"Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme.\",\n",
      "        \"authors\": \"Hatzakis A; Sypsa V; Paraskevis D; Nikolopoulos G; Tsiara C; Micha K; Panopoulos A; Malliori M; Psichogiou M; Pharris A; Wiessing L; van de Laar M; Donoghoe M; Heckathorn DD; Friedman SR; Des Jarlais DC\",\n",
      "        \"doi\": \"10.1111/add.12999\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hatzakis A, et al. Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme. Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme. 2015; 110:1453-67. doi: 10.1111/add.12999\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25540950\",\n",
      "        \"title\": \"AIDS, people who use drugs, and altruism: reflection on a personal image.\",\n",
      "        \"authors\": \"Des Jarlais DC\",\n",
      "        \"doi\": \"10.3109/10826084.2015.978185\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Des Jarlais DC. AIDS, people who use drugs, and altruism: reflection on a personal image. AIDS, people who use drugs, and altruism: reflection on a personal image. 2015; 50:532-3. doi: 10.3109/10826084.2015.978185\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01693848\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01895920\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01039220\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00820118\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26568566\",\n",
      "        \"title\": \"Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial).\",\n",
      "        \"authors\": \"Piroth L; Moinot L; Yeni P; Avettand-F\\u00e9noel V; Reynes J; Girard PM; Marchou B; Georget A; Rouzioux C; Autran B; Duvillard L; Ch\\u00eane G; Fagard C; ANRS 141 TIPI Trial Study Group\",\n",
      "        \"doi\": \"10.1093/jac/dkv369\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Piroth L, et al. Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial). Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial). 2016; 71:490-6. doi: 10.1093/jac/dkv369\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01801618\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29662875\",\n",
      "        \"title\": \"Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study.\",\n",
      "        \"authors\": \"S\\u00e9g\\u00e9ral O; Nerrienet E; Neth S; Spire B; Khol V; Ferradini L; Sarun S; Mom C; Ngin S; Charpentier C; Men P; Mora M; Mean Chhi V; Ly P; Saphonn V\",\n",
      "        \"doi\": \"10.3389/fpubh.2018.00063\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"S\\u00e9g\\u00e9ral O, et al. Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study. Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study. 2018; 6:63. doi: 10.3389/fpubh.2018.00063\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02405013\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"36686592\",\n",
      "        \"title\": \"Patient-reported outcomes with direct-acting antiviral treatment for hepatitis C in West and Central Africa (TAC ANRS 12311 trial).\",\n",
      "        \"authors\": \"Marcellin F; Mourad A; Lemoine M; Kouanfack C; Seydi M; Carrieri P; Attia A; Protopopescu C; Lacombe K; Boyer S\",\n",
      "        \"doi\": \"10.1016/j.jhepr.2022.100665\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Marcellin F, et al. Patient-reported outcomes with direct-acting antiviral treatment for hepatitis C in West and Central Africa (TAC ANRS 12311 trial). Patient-reported outcomes with direct-acting antiviral treatment for hepatitis C in West and Central Africa (TAC ANRS 12311 trial). 2023; 5:100665. doi: 10.1016/j.jhepr.2022.100665\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01779713\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"30354977\",\n",
      "        \"title\": \"Whole-Blood miRNA Sequencing Profiling for Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage.\",\n",
      "        \"authors\": \"Pulcrano-Nicolas AS; Proust C; Claren\\u00e7on F; Jacquens A; Perret C; Roux M; Shotar E; Thibord F; Puybasset L; Garnier S; Degos V; Tr\\u00e9gou\\u00ebt DA\",\n",
      "        \"doi\": \"10.1161/STROKEAHA.118.021101\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Pulcrano-Nicolas AS, et al. Whole-Blood miRNA Sequencing Profiling for Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage. Whole-Blood miRNA Sequencing Profiling for Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage. 2018; 49:2220-2223. doi: 10.1161/STROKEAHA.118.021101\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03235258\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"21971357\",\n",
      "        \"title\": \"Early antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens.\",\n",
      "        \"authors\": \"Judd A; European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32834d614c\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Judd A and European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord. Early antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens. Early antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens. 2011; 25:2279-87. doi: 10.1097/QAD.0b013e32834d614c\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22427678\",\n",
      "        \"title\": \"Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study.\",\n",
      "        \"authors\": \"Avettand-Fenoel V; Blanche S; Le Chenadec J; Scott-Algara D; Dollfus C; Viard JP; Bouallag N; Benmebarek Y; Rivi\\u00e8re Y; Warszawski J; Rouzioux C; Buseyne F\",\n",
      "        \"doi\": \"10.1093/infdis/jis233\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Avettand-Fenoel V, et al. Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study. Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study. 2012; 205:1520-8. doi: 10.1093/infdis/jis233\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17712765\",\n",
      "        \"title\": \"Long-term nonprogression of HIV infection in children: evaluation of the ANRS prospective French Pediatric Cohort.\",\n",
      "        \"authors\": \"Warszawski J; Lechenadec J; Faye A; Dollfus C; Firtion G; Meyer L; Douard D; Monpoux F; Tricoire J; Benmebarek Y; Rouzioux C; Blanche S\",\n",
      "        \"doi\": \"10.1086/521165\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Warszawski J, et al. Long-term nonprogression of HIV infection in children: evaluation of the ANRS prospective French Pediatric Cohort. Long-term nonprogression of HIV infection in children: evaluation of the ANRS prospective French Pediatric Cohort. 2007; 45:785-94. doi: 10.1086/521165\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24253249\",\n",
      "        \"title\": \"Naive T lymphocytes and recent thymic emigrants are associated with HIV-1 disease history in french adolescents and young adults infected in the perinatal period: the ANRS-EP38-IMMIP study.\",\n",
      "        \"authors\": \"Blanche S; Scott-Algara D; Le Chenadec J; Didier C; Montange T; Avettand-Fenoel V; Rouzioux C; M\\u00e9lard A; Viard JP; Dollfus C; Bouallag N; Warszawski J; Buseyne F\",\n",
      "        \"doi\": \"10.1093/cid/cit729\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Blanche S, et al. Naive T lymphocytes and recent thymic emigrants are associated with HIV-1 disease history in french adolescents and young adults infected in the perinatal period: the ANRS-EP38-IMMIP study. Naive T lymphocytes and recent thymic emigrants are associated with HIV-1 disease history in french adolescents and young adults infected in the perinatal period: the ANRS-EP38-IMMIP study. 2014; 58:573-87. doi: 10.1093/cid/cit729\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19194272\",\n",
      "        \"title\": \"Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants.\",\n",
      "        \"authors\": \"Goetghebuer T; Haelterman E; Le Chenadec J; Dollfus C; Gibb D; Judd A; Green H; Galli L; Ramos JT; Giaquinto C; Warszawski J; Levy J; European Infant Collaboration group\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e328326ca37\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Goetghebuer T, et al. Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. 2009; 23:597-604. doi: 10.1097/QAD.0b013e328326ca37\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22198788\",\n",
      "        \"title\": \"Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation.\",\n",
      "        \"authors\": \"Goetghebuer T; Le Chenadec J; Haelterman E; Galli L; Dollfus C; Thorne C; Judd A; Keiser O; Ramos JT; Levy J; Warszawski J; European Infant Collaboration Group\",\n",
      "        \"doi\": \"10.1093/cid/cir950\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Goetghebuer T, et al. Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation. Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation. 2012; 54:878-81. doi: 10.1093/cid/cir950\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20536367\",\n",
      "        \"title\": \"Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10).\",\n",
      "        \"authors\": \"Dollfus C; Le Chenadec J; Faye A; Blanche S; Briand N; Rouzioux C; Warszawski J\",\n",
      "        \"doi\": \"10.1086/653674\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Dollfus C, et al. Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10). Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10). 2010; 51:214-24. doi: 10.1086/653674\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26762993\",\n",
      "        \"title\": \"HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report.\",\n",
      "        \"authors\": \"Frange P; Faye A; Avettand-Feno\\u00ebl V; Bellaton E; Descamps D; Angin M; David A; Caillat-Zucman S; Peytavin G; Dollfus C; Le Chenadec J; Warszawski J; Rouzioux C; S\\u00e1ez-Ciri\\u00f3n A; ANRS EPF-CO10 Pediatric Cohort and the ANRS EP47 VISCONTI study group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(15)00232-5\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Case Reports\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Frange P, et al. HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report. HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report. 2016; 3:e49-54. doi: 10.1016/S2352-3018(15)00232-5\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24945880\",\n",
      "        \"title\": \"Interruption of cART in clinical practice is associated with an increase in the long-term risk of subsequent immunosuppression in HIV-1-infected children.\",\n",
      "        \"authors\": \"Aupiais C; Faye A; Le Chenadec J; Rouzioux C; Bouallag N; Laurent C; Blanche S; Dollfus C; Warszawski J; ANRS EPF-CO10 French Pediatric Cohort\",\n",
      "        \"doi\": \"10.1097/INF.0000000000000450\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Aupiais C, et al. Interruption of cART in clinical practice is associated with an increase in the long-term risk of subsequent immunosuppression in HIV-1-infected children. Interruption of cART in clinical practice is associated with an increase in the long-term risk of subsequent immunosuppression in HIV-1-infected children. 2014; 33:1237-45. doi: 10.1097/INF.0000000000000450\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21511330\",\n",
      "        \"title\": \"Risk of triple-class virological failure in children with HIV: a retrospective cohort study.\",\n",
      "        \"authors\": \"Pursuing Later Treatment Options II (PLATO II) project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE); Castro H; Judd A; Gibb DM; Butler K; Lodwick RK; van Sighem A; Ramos JT; Warsawski J; Thorne C; Noguera-Julian A; Obel N; Costagliola D; Tookey PA; Colin C; Kjaer J; Grarup J; Chene G; Phillips A\",\n",
      "        \"doi\": \"10.1016/S0140-6736(11)60208-0\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Pursuing Later Treatment Options II (PLATO II) project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE), et al. Risk of triple-class virological failure in children with HIV: a retrospective cohort study. Risk of triple-class virological failure in children with HIV: a retrospective cohort study. 2011; 377:1580-7. doi: 10.1016/S0140-6736(11)60208-0\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18614870\",\n",
      "        \"title\": \"Response to combination antiretroviral therapy: variation by age.\",\n",
      "        \"authors\": \"Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group; Sabin CA; Smith CJ; d'Arminio Monforte A; Battegay M; Gabiano C; Galli L; Geelen S; Gibb D; Guiguet M; Judd A; Leport C; Dabis F; Pantazis N; Porter K; Raffi F; Thorne C; Torti C; Walker S; Warszawski J; Wintergerst U; Chene G; Lundgren J\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e3282f88d02\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group, et al. Response to combination antiretroviral therapy: variation by age. Response to combination antiretroviral therapy: variation by age. 2008; 22:1463-73. doi: 10.1097/QAD.0b013e3282f88d02\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24705410\",\n",
      "        \"title\": \"Low birth weight in perinatally HIV-exposed uninfected infants: observations in urban settings in Cameroon.\",\n",
      "        \"authors\": \"Sofeu CL; Warszawski J; Ateba Ndongo F; Penda IC; Tetang Ndiang S; Guemkam G; Makwet N; Owona F; Kfutwah A; Tchendjou P; Texier G; Tchuente M; Faye A; Tejiokem MC; ANRS-PEDIACAM Study Group\",\n",
      "        \"doi\": \"10.1371/journal.pone.0093554\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Sofeu CL, et al. Low birth weight in perinatally HIV-exposed uninfected infants: observations in urban settings in Cameroon. Low birth weight in perinatally HIV-exposed uninfected infants: observations in urban settings in Cameroon. 2014; 9:e93554. doi: 10.1371/journal.pone.0093554\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03071458\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02886416\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01899196\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00944541\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02160119\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00158496\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"16956918\",\n",
      "        \"title\": \"Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt.\",\n",
      "        \"authors\": \"Marzouk D; Sass J; Bakr I; El Hosseiny M; Abdel-Hamid M; Rekacewicz C; Chaturvedi N; Mohamed MK; Fontanet A\",\n",
      "        \"doi\": \"10.1136/gut.2006.091983\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Marzouk D, et al. Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. 2007; 56:1105-10. doi: 10.1136/gut.2006.091983\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16434426\",\n",
      "        \"title\": \"Higher clearance of hepatitis C virus infection in females compared with males.\",\n",
      "        \"authors\": \"Bakr I; Rekacewicz C; El Hosseiny M; Ismail S; El Daly M; El-Kafrawy S; Esmat G; Hamid MA; Mohamed MK; Fontanet A\",\n",
      "        \"doi\": \"10.1136/gut.2005.078147\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bakr I, et al. Higher clearance of hepatitis C virus infection in females compared with males. Higher clearance of hepatitis C virus infection in females compared with males. 2006; 55:1183-7. doi: 10.1136/gut.2005.078147\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16019104\",\n",
      "        \"title\": \"Changing pattern of hepatitis C virus spread in rural areas of Egypt.\",\n",
      "        \"authors\": \"Arafa N; El Hoseiny M; Rekacewicz C; Bakr I; El-Kafrawy S; El Daly M; Aoun S; Marzouk D; Mohamed MK; Fontanet A\",\n",
      "        \"doi\": \"10.1016/j.jhep.2005.03.021\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Arafa N, et al. Changing pattern of hepatitis C virus spread in rural areas of Egypt. Changing pattern of hepatitis C virus spread in rural areas of Egypt. 2005; 43:418-24. doi: 10.1016/j.jhep.2005.03.021\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16847958\",\n",
      "        \"title\": \"HCV-related morbidity in a rural community of Egypt.\",\n",
      "        \"authors\": \"Mohamed MK; Bakr I; El-Hoseiny M; Arafa N; Hassan A; Ismail S; Anwar M; Attala M; Rekacewicz C; Zalata K; Abdel-Hamid M; Esmat G; Fontanet A\",\n",
      "        \"doi\": \"10.1002/jmv.20679\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mohamed MK, et al. HCV-related morbidity in a rural community of Egypt. HCV-related morbidity in a rural community of Egypt. 2006; 78:1185-9. doi: 10.1002/jmv.20679\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02192658\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26846895\",\n",
      "        \"title\": \"HandiVIH--A population-based survey to understand the vulnerability of people with disabilities to HIV and other sexual and reproductive health problems in Cameroon: protocol and methodological considerations.\",\n",
      "        \"authors\": \"De Beaudrap P; Pasquier E; Tchoumkeu A; Touko A; Essomba F; Brus A; Desgr\\u00e9es du Lo\\u00fb A; Aderemi TJ; Hanass-Hancock J; Eide AH; Mont D; Mac-Seing M; Beninguisse G\",\n",
      "        \"doi\": \"10.1136/bmjopen-2015-008934\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"De Beaudrap P, et al. HandiVIH--A population-based survey to understand the vulnerability of people with disabilities to HIV and other sexual and reproductive health problems in Cameroon: protocol and methodological considerations. HandiVIH--A population-based survey to understand the vulnerability of people with disabilities to HIV and other sexual and reproductive health problems in Cameroon: protocol and methodological considerations. 2016; 6:e008934. doi: 10.1136/bmjopen-2015-008934\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00383734\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"23432777\",\n",
      "        \"title\": \"Polylactic acid vs. polyacrylamide hydrogel for treatment of facial lipoatrophy: a randomized controlled trial [Agence Nationale de Recherches sur le SIDA et les H\\u00e9patites Virales (ANRS) 132 SMILE].\",\n",
      "        \"authors\": \"Lafaurie M; Dolivo M; Girard PM; May T; Bouchaud O; Carbonnel E; Madelaine I; Loze B; Porcher R; Molina JM; ANRS 132 SMILE study group\",\n",
      "        \"doi\": \"10.1111/hiv.12021\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Lafaurie M, et al. Polylactic acid vs. polyacrylamide hydrogel for treatment of facial lipoatrophy: a randomized controlled trial [Agence Nationale de Recherches sur le SIDA et les H\\u00e9patites Virales (ANRS) 132 SMILE]. Polylactic acid vs. polyacrylamide hydrogel for treatment of facial lipoatrophy: a randomized controlled trial [Agence Nationale de Recherches sur le SIDA et les H\\u00e9patites Virales (ANRS) 132 SMILE]. 2013; 14:410-20. doi: 10.1111/hiv.12021\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02051413\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03109067\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02073604\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01490489\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"19602057\",\n",
      "        \"title\": \"Role of EG-VEGF in human placentation: Physiological and pathological implications.\",\n",
      "        \"authors\": \"Hoffmann P; Saoudi Y; Benharouga M; Graham CH; Schaal JP; Mazouni C; Feige JJ; Alfaidy N\",\n",
      "        \"doi\": \"10.1111/j.1582-4934.2008.00554.x\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hoffmann P, et al. Role of EG-VEGF in human placentation: Physiological and pathological implications. Role of EG-VEGF in human placentation: Physiological and pathological implications. 2009; 13:2224-2235. doi: 10.1111/j.1582-4934.2008.00554.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16384869\",\n",
      "        \"title\": \"Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy.\",\n",
      "        \"authors\": \"Hoffmann P; Feige JJ; Alfaidy N\",\n",
      "        \"doi\": \"10.1210/en.2005-0912\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hoffmann P, et al. Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy. Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy. 2006; 147:1675-84. doi: 10.1210/en.2005-0912\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17531315\",\n",
      "        \"title\": \"Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation.\",\n",
      "        \"authors\": \"Hoffmann P; Feige JJ; Alfaidy N\",\n",
      "        \"doi\": \"10.1016/j.placenta.2007.03.008\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hoffmann P, et al. Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation. Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation. 2007; 28:1049-58. doi: 10.1016/j.placenta.2007.03.008\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01335529\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"27077673\",\n",
      "        \"title\": \"Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study.\",\n",
      "        \"authors\": \"Poizot-Martin I; Bellissant E; Garraffo R; Colson P; Piroth L; Solas C; Renault A; Bourli\\u00e8re M; Halfon P; Ghosn J; Alric L; Naqvi A; Carrieri P; Molina JM; ANRS HC27 BOCEPREVIH Study Group\",\n",
      "        \"doi\": \"10.1080/15284336.2015.1135553\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Poizot-Martin I, et al. Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study. Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study. 2016; 17:63-71. doi: 10.1080/15284336.2015.1135553\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00545194\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"11236117\",\n",
      "        \"title\": \"In vivo controlled release of PGE2 from a vaginal insert (0.8 mm, 10 mg) during induction of labour.\",\n",
      "        \"authors\": \"Lyren\\u00e4s S; Clason I; Ulmsten U\",\n",
      "        \"doi\": \"10.1111/j.1471-0528.2001.00039.x\",\n",
      "        \"year\": \"2001\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Lyren\\u00e4s S, et al. In vivo controlled release of PGE2 from a vaginal insert (0.8 mm, 10 mg) during induction of labour. In vivo controlled release of PGE2 from a vaginal insert (0.8 mm, 10 mg) during induction of labour. 2001; 108:169-78. doi: 10.1111/j.1471-0528.2001.00039.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17071427\",\n",
      "        \"title\": \"Induction of labour at term with vaginal prostaglandins preparations: a randomised controlled trial of Prostin vs Propess.\",\n",
      "        \"authors\": \"El-Shawarby SA; Connell RJ\",\n",
      "        \"doi\": \"10.1080/01443610600903362\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"El-Shawarby SA and Connell RJ. Induction of labour at term with vaginal prostaglandins preparations: a randomised controlled trial of Prostin vs Propess. Induction of labour at term with vaginal prostaglandins preparations: a randomised controlled trial of Prostin vs Propess. 2006; 26:627-30. doi: 10.1080/01443610600903362\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16553177\",\n",
      "        \"title\": \"Randomized study on removable PGE2 vaginal insert versus PGE2 cervical gel for cervical priming and labor induction in low-Bishop-score pregnancy.\",\n",
      "        \"authors\": \"Strobelt N; Meregalli V; Ratti M; Mariani S; Zani G; Morana S\",\n",
      "        \"doi\": \"10.1080/00016340500523685\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Strobelt N, et al. Randomized study on removable PGE2 vaginal insert versus PGE2 cervical gel for cervical priming and labor induction in low-Bishop-score pregnancy. Randomized study on removable PGE2 vaginal insert versus PGE2 cervical gel for cervical priming and labor induction in low-Bishop-score pregnancy. 2006; 85:302-5. doi: 10.1080/00016340500523685\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03298360\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01508494\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00573001\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00236340\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"11438952\",\n",
      "        \"title\": \"Rapid and radical amniodrainage in the treatment of severe twin-twin transfusion syndrome.\",\n",
      "        \"authors\": \"Jauniaux E; Holmes A; Hyett J; Yates R; Rodeck C\",\n",
      "        \"doi\": \"10.1002/pd.96\",\n",
      "        \"year\": \"2001\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Jauniaux E, et al. Rapid and radical amniodrainage in the treatment of severe twin-twin transfusion syndrome. Rapid and radical amniodrainage in the treatment of severe twin-twin transfusion syndrome. 2001; 21:471-6. doi: 10.1002/pd.96\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"7970458\",\n",
      "        \"title\": \"Large-volume therapeutic amniocentesis in the treatment of hydramnios.\",\n",
      "        \"authors\": \"Elliott JP; Sawyer AT; Radin TG; Strong RE\",\n",
      "        \"doi\": null,\n",
      "        \"year\": \"1994\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Elliott JP, et al. Large-volume therapeutic amniocentesis in the treatment of hydramnios. Large-volume therapeutic amniocentesis in the treatment of hydramnios. 1994; 84:1025-7.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"9464739\",\n",
      "        \"title\": \"Therapeutic amniocentesis using a vacuum bottle aspiration system.\",\n",
      "        \"authors\": \"Dolinger MB; Donnenfeld AE\",\n",
      "        \"doi\": \"10.1016/s0029-7844(97)00584-x\",\n",
      "        \"year\": \"1998\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Dolinger MB and Donnenfeld AE. Therapeutic amniocentesis using a vacuum bottle aspiration system. Therapeutic amniocentesis using a vacuum bottle aspiration system. 1998; 91:143-4. doi: 10.1016/s0029-7844(97)00584-x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"14770396\",\n",
      "        \"title\": \"Procedure-related complications of rapid amniodrainage in the treatment of polyhydramnios.\",\n",
      "        \"authors\": \"Leung WC; Jouannic JM; Hyett J; Rodeck C; Jauniaux E\",\n",
      "        \"doi\": \"10.1002/uog.972\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Leung WC, et al. Procedure-related complications of rapid amniodrainage in the treatment of polyhydramnios. Procedure-related complications of rapid amniodrainage in the treatment of polyhydramnios. 2004; 23:154-8. doi: 10.1002/uog.972\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02542891\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"34874888\",\n",
      "        \"title\": \"Examining the Theoretical Framework of Behavioral Activation for Major Depressive Disorder: Smartphone-Based Ecological Momentary Assessment Study.\",\n",
      "        \"authors\": \"van Genugten CR; Schuurmans J; Hoogendoorn AW; Araya R; Andersson G; Ba\\u00f1os R; Botella C; Cerga Pashoja A; Cieslak R; Ebert DD; Garc\\u00eda-Palacios A; Hazo JB; Herrero R; Holtzmann J; Kemmeren L; Kleiboer A; Krieger T; Smoktunowicz E; Titzler I; Topooco N; Urech A; Smit JH; Riper H\",\n",
      "        \"doi\": \"10.2196/32007\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"van Genugten CR, et al. Examining the Theoretical Framework of Behavioral Activation for Major Depressive Disorder: Smartphone-Based Ecological Momentary Assessment Study. Examining the Theoretical Framework of Behavioral Activation for Major Depressive Disorder: Smartphone-Based Ecological Momentary Assessment Study. 2021; 8:e32007. doi: 10.2196/32007\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27488181\",\n",
      "        \"title\": \"European COMPARative Effectiveness research on blended Depression treatment versus treatment-as-usual (E-COMPARED): study protocol for a randomized controlled, non-inferiority trial in eight European countries.\",\n",
      "        \"authors\": \"Kleiboer A; Smit J; Bosmans J; Ruwaard J; Andersson G; Topooco N; Berger T; Krieger T; Botella C; Ba\\u00f1os R; Chevreul K; Araya R; Cerga-Pashoja A; Cie\\u015blak R; Rogala A; Vis C; Draisma S; van Schaik A; Kemmeren L; Ebert D; Berking M; Funk B; Cuijpers P; Riper H\",\n",
      "        \"doi\": \"10.1186/s13063-016-1511-1\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Equivalence Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Pragmatic Clinical Trial\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Kleiboer A, et al. European COMPARative Effectiveness research on blended Depression treatment versus treatment-as-usual (E-COMPARED): study protocol for a randomized controlled, non-inferiority trial in eight European countries. European COMPARative Effectiveness research on blended Depression treatment versus treatment-as-usual (E-COMPARED): study protocol for a randomized controlled, non-inferiority trial in eight European countries. 2016; 17:387. doi: 10.1186/s13063-016-1511-1\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03671291\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01066962\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"33794182\",\n",
      "        \"title\": \"Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial.\",\n",
      "        \"authors\": \"Esteban-Cantos A; Rodr\\u00edguez-Centeno J; Barruz P; Alejos B; Saiz-Medrano G; Nevado J; Martin A; Gay\\u00e1 F; De Miguel R; Bernardino JI; Montejano R; Mena-Garay B; Cadi\\u00f1anos J; Florence E; Mulcahy F; Banhegyi D; Antinori A; Pozniak A; Wallet C; Raffi F; Rod\\u00e9s B; Arribas JR; NEAT001/ANRS143 Study Group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(21)00006-0\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Esteban-Cantos A, et al. Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial. Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial. 2021; 8:e197-e205. doi: 10.1016/S2352-3018(21)00006-0\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30365452\",\n",
      "        \"title\": \"Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial.\",\n",
      "        \"authors\": \"Ammassari A; St\\u00f6hr W; Antinori A; Molina JM; Schwimmer C; Domingo P; Thalme A; Di Pietro M; Wallet C; Pozniak A; Richert L; Raffi F; NEAT001/ANRS143 Trial Study Group\",\n",
      "        \"doi\": \"10.1097/QAI.0000000000001834\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Ammassari A, et al. Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial. Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial. 2018; 79:481-490. doi: 10.1097/QAI.0000000000001834\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26520926\",\n",
      "        \"title\": \"Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial.\",\n",
      "        \"authors\": \"Bernardino JI; Mocroft A; Mallon PW; Wallet C; Gerstoft J; Russell C; Reiss P; Katlama C; De Wit S; Richert L; Babiker A; Bu\\u00f1o A; Castagna A; Girard PM; Chene G; Raffi F; Arribas JR; NEAT001/ANRS143 Study Group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(15)00181-2\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bernardino JI, et al. Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial. Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial. 2015; 2:e464-73. doi: 10.1016/S2352-3018(15)00181-2\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25103176\",\n",
      "        \"title\": \"Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial.\",\n",
      "        \"authors\": \"Raffi F; Babiker AG; Richert L; Molina JM; George EC; Antinori A; Arribas JR; Grarup J; Hudson F; Schwimmer C; Saillard J; Wallet C; Jansson PO; Allavena C; Van Leeuwen R; Delfraissy JF; Vella S; Ch\\u00eane G; Pozniak A; NEAT001/ANRS143 Study Group\",\n",
      "        \"doi\": \"10.1016/S0140-6736(14)61170-3\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Raffi F, et al. Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial. Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial. 2014; 384:1942-51. doi: 10.1016/S0140-6736(14)61170-3\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01703962\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"37668523\",\n",
      "        \"title\": \"Neurochemical Differences between 1p/19q Codeleted and Noncodeleted IDH-mutant Gliomas by in Vivo MR Spectroscopy.\",\n",
      "        \"authors\": \"Branzoli F; Liserre R; Deelchand DK; Poliani PL; Bielle F; Nichelli L; Sanson M; Leh\\u00e9ricy S; Marja\\u0144ska M\",\n",
      "        \"doi\": \"10.1148/radiol.223255\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Research Support, N.I.H., Extramural\"\n",
      "        ],\n",
      "        \"citation\": \"Branzoli F, et al. Neurochemical Differences between 1p/19q Codeleted and Noncodeleted IDH-mutant Gliomas by in Vivo MR Spectroscopy. Neurochemical Differences between 1p/19q Codeleted and Noncodeleted IDH-mutant Gliomas by in Vivo MR Spectroscopy. 2023; 308:e223255. doi: 10.1148/radiol.223255\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03642704\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01086904\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01127204\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"28483965\",\n",
      "        \"title\": \"Pharmacokinetics of Efavirenz at a High Dose of 25 Milligrams per Kilogram per Day in Children 2 to 3 Years Old.\",\n",
      "        \"authors\": \"Pressiat C; Amorissani-Folquet M; Yonaba C; Treluyer JM; Dahourou DL; Eboua F; Blanche S; Mea-Assande V; Bouazza N; Foissac F; Malateste K; Ouedraogo S; Lui G; Leroy V; Hirt D\",\n",
      "        \"doi\": \"10.1128/AAC.00297-17\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Pressiat C, et al. Pharmacokinetics of Efavirenz at a High Dose of 25 Milligrams per Kilogram per Day in Children 2 to 3 Years Old. Pharmacokinetics of Efavirenz at a High Dose of 25 Milligrams per Kilogram per Day in Children 2 to 3 Years Old. 2017; 61:(unknown pages). doi: 10.1128/AAC.00297-17\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31334298\",\n",
      "        \"title\": \"Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus.\",\n",
      "        \"authors\": \"Desmonde S; Frank SC; Coovadia A; Dahourou DL; Hou T; Abrams EJ; Amorissani-Folquet M; Walensky RP; Strehlau R; Penazzato M; Freedberg KA; Kuhn L; Leroy V; Ciaranello AL\",\n",
      "        \"doi\": \"10.1093/ofid/ofz276\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Desmonde S, et al. Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus. Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus. 2019; 6:ofz276. doi: 10.1093/ofid/ofz276\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28800382\",\n",
      "        \"title\": \"Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines.\",\n",
      "        \"authors\": \"Pressiat C; Mea-Assande V; Yonaba C; Treluyer JM; Dahourou DL; Amorissani-Folquet M; Blanche S; Eboua F; Ye D; Lui G; Malateste K; Zheng Y; Leroy V; Hirt D; MONOD Study Group\",\n",
      "        \"doi\": \"10.1111/bcp.13397\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Pressiat C, et al. Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines. Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines. 2017; 83:2729-2740. doi: 10.1111/bcp.13397\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28453240\",\n",
      "        \"title\": \"Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort.\",\n",
      "        \"authors\": \"Amani-Bosse C; Dahourou DL; Malateste K; Amorissani-Folquet M; Coulibaly M; Dattez S; Emieme A; Barry M; Rouzioux C; N'gbeche S; Yonaba C; Timit\\u00e9-Konan M; Mea V; Ou\\u00e9draogo S; Blanche S; Meda N; Seguin-Devaux C; Leroy V\",\n",
      "        \"doi\": \"10.7448/IAS.20.01.21362\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Amani-Bosse C, et al. Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort. Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort. 2017; 20:21362. doi: 10.7448/IAS.20.01.21362\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34723858\",\n",
      "        \"title\": \"High nevirapine levels in breast milk and consequences in HIV-infected child when initiated on antiretroviral therapy.\",\n",
      "        \"authors\": \"Pressiat C; Toni TD; Treluyer JM; Yonaba C; Dahourou DL; Malateste K; Seguin-Devaux C; Leroy V; Hirt D; MONOD ANRS Study Group\",\n",
      "        \"doi\": \"10.1097/QAD.0000000000003043\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Letter\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Pressiat C, et al. High nevirapine levels in breast milk and consequences in HIV-infected child when initiated on antiretroviral therapy. High nevirapine levels in breast milk and consequences in HIV-infected child when initiated on antiretroviral therapy. 2021; 35:2409-2410. doi: 10.1097/QAD.0000000000003043\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27015798\",\n",
      "        \"title\": \"Missed opportunities of inclusion in a cohort of HIV-infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013.\",\n",
      "        \"authors\": \"Dahourou DL; Amorissani-Folquet M; Coulibaly M; Avit-Edi D; Meda N; Timite-Konan M; Arendt V; Ye D; Amani-Bosse C; Salamon R; Lepage P; Leroy V; Monod Anrs 12206 Study Group\",\n",
      "        \"doi\": \"10.7448/IAS.19.1.20601\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Dahourou DL, et al. Missed opportunities of inclusion in a cohort of HIV-infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013. Missed opportunities of inclusion in a cohort of HIV-infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013. 2016; 19:20601. doi: 10.7448/IAS.19.1.20601\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28434406\",\n",
      "        \"title\": \"Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and C\\u00f4te d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.\",\n",
      "        \"authors\": \"Dahourou DL; Amorissani-Folquet M; Malateste K; Amani-Bosse C; Coulibaly M; Seguin-Devaux C; Toni T; Ou\\u00e9draogo R; Blanche S; Yonaba C; Eboua F; Lepage P; Avit D; Ou\\u00e9draogo S; Van de Perre P; N'Gbeche S; Kalmogho A; Salamon R; Meda N; Timit\\u00e9-Konan M; Leroy V; MONOD Study Group\",\n",
      "        \"doi\": \"10.1186/s12916-017-0842-4\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Dahourou DL, et al. Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and C\\u00f4te d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial. Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and C\\u00f4te d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial. 2017; 15:85. doi: 10.1186/s12916-017-0842-4\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01771562\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"27881690\",\n",
      "        \"title\": \"Acceptability of Outpatient Ready-To-Use Food-Based Protocols in HIV-Infected Senegalese Children and Adolescents Within the MAGGSEN Cohort Study.\",\n",
      "        \"authors\": \"Cames C; Varloteaux M; Have NN; Diom AB; Msellati P; Mbaye N; Mbodj H; Sy Signate H; Diack A; ANRS 12279 MAGGSEN Cohort Study Group\",\n",
      "        \"doi\": \"10.1177/0379572116679053\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Cames C, et al. Acceptability of Outpatient Ready-To-Use Food-Based Protocols in HIV-Infected Senegalese Children and Adolescents Within the MAGGSEN Cohort Study. Acceptability of Outpatient Ready-To-Use Food-Based Protocols in HIV-Infected Senegalese Children and Adolescents Within the MAGGSEN Cohort Study. 2017; 38:27-36. doi: 10.1177/0379572116679053\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30081838\",\n",
      "        \"title\": \"Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort Study.\",\n",
      "        \"authors\": \"Cames C; Pascal L; Ba A; Mbodj H; Ouattara B; Diallo NF; Msellati P; Mbaye N; Sy Signate H; Blanche S; Diack A; MAGGSEN Cohort Study Group\",\n",
      "        \"doi\": \"10.1186/s12879-018-3282-7\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Cames C, et al. Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort Study. Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort Study. 2018; 18:374. doi: 10.1186/s12879-018-3282-7\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00196612\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"15717256\",\n",
      "        \"title\": \"Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HIV-1-infected adults with viral suppression receiving a protease inhibitor-based regimen: a randomized trial.\",\n",
      "        \"authors\": \"Molina JM; Journot V; Morand-Joubert L; Y\\u00e9ni P; Rozenbaum W; Rancinan C; Fournier S; Morlat P; Palmer P; Dupont B; Goujard C; Dellamonica P; Collin F; Poizot-Martin I; Chene G; ALIZE (Agence Nationale de Recherches sur le SIDA 099) Study Team\",\n",
      "        \"doi\": \"10.1086/428091\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Molina JM, et al. Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HIV-1-infected adults with viral suppression receiving a protease inhibitor-based regimen: a randomized trial. Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HIV-1-infected adults with viral suppression receiving a protease inhibitor-based regimen: a randomized trial. 2005; 191:830-9. doi: 10.1086/428091\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01226446\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"25987791\",\n",
      "        \"title\": \"Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study.\",\n",
      "        \"authors\": \"Terrier B; Lapidus N; Pol S; Serfaty L; Ratziu V; Asselah T; Thibault V; Souberbielle JC; Carrat F; Cacoub P\",\n",
      "        \"doi\": \"10.3748/wjg.v21.i18.5647\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\"\n",
      "        ],\n",
      "        \"citation\": \"Terrier B, et al. Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study. Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study. 2015; 21:5647-53. doi: 10.3748/wjg.v21.i18.5647\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02496312\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"19533496\",\n",
      "        \"title\": \"Apathy after acquired brain impairment: a systematic review of non-pharmacological interventions.\",\n",
      "        \"authors\": \"Lane-Brown AT; Tate RL\",\n",
      "        \"doi\": \"10.1080/09602010902949207\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\",\n",
      "          \"Systematic Review\"\n",
      "        ],\n",
      "        \"citation\": \"Lane-Brown AT and Tate RL. Apathy after acquired brain impairment: a systematic review of non-pharmacological interventions. Apathy after acquired brain impairment: a systematic review of non-pharmacological interventions. 2009; 19:481-516. doi: 10.1080/09602010902949207\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16207933\",\n",
      "        \"title\": \"Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits.\",\n",
      "        \"authors\": \"Levy R; Dubois B\",\n",
      "        \"doi\": \"10.1093/cercor/bhj043\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Levy R and Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. 2006; 16:916-28. doi: 10.1093/cercor/bhj043\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"10941190\",\n",
      "        \"title\": \"Negative symptoms: the 'pathology' of motivation and goal-directed behaviour.\",\n",
      "        \"authors\": \"Brown RG; Pluck G\",\n",
      "        \"doi\": \"10.1016/s0166-2236(00)01626-x\",\n",
      "        \"year\": \"2000\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Brown RG and Pluck G. Negative symptoms: the 'pathology' of motivation and goal-directed behaviour. Negative symptoms: the 'pathology' of motivation and goal-directed behaviour. 2000; 23:412-7. doi: 10.1016/s0166-2236(00)01626-x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"12461757\",\n",
      "        \"title\": \"The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment.\",\n",
      "        \"authors\": \"Robert PH; Clairet S; Benoit M; Koutaich J; Bertogliati C; Tible O; Caci H; Borg M; Brocker P; Bedoucha P\",\n",
      "        \"doi\": \"10.1002/gps.755\",\n",
      "        \"year\": \"2002\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Validation Study\"\n",
      "        ],\n",
      "        \"citation\": \"Robert PH, et al. The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. 2002; 17:1099-105. doi: 10.1002/gps.755\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"10678322\",\n",
      "        \"title\": \"Group differences in the relationship between apathy and depression.\",\n",
      "        \"authors\": \"Marin RS; Firinciogullari S; Biedrzycki RC\",\n",
      "        \"doi\": \"10.1097/00005053-199404000-00008\",\n",
      "        \"year\": \"1994\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, U.S. Gov't, P.H.S.\"\n",
      "        ],\n",
      "        \"citation\": \"Marin RS, et al. Group differences in the relationship between apathy and depression. Group differences in the relationship between apathy and depression. 1994; 182:235-9. doi: 10.1097/00005053-199404000-00008\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"1821241\",\n",
      "        \"title\": \"Apathy: a neuropsychiatric syndrome.\",\n",
      "        \"authors\": \"Marin RS\",\n",
      "        \"doi\": \"10.1176/jnp.3.3.243\",\n",
      "        \"year\": \"1991\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, U.S. Gov't, P.H.S.\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Marin RS. Apathy: a neuropsychiatric syndrome. Apathy: a neuropsychiatric syndrome. 1991; 3:243-54. doi: 10.1176/jnp.3.3.243\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16421064\",\n",
      "        \"title\": \"Reduced daytime activity in patients with acquired brain damage and apathy: a study with ambulatory actigraphy.\",\n",
      "        \"authors\": \"M\\u00fcller U; Czymmek J; Th\\u00f6ne-Otto A; Von Cramon DY\",\n",
      "        \"doi\": \"10.1080/02699050500443467\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"M\\u00fcller U, et al. Reduced daytime activity in patients with acquired brain damage and apathy: a study with ambulatory actigraphy. Reduced daytime activity in patients with acquired brain damage and apathy: a study with ambulatory actigraphy. 2006; 20:157-60. doi: 10.1080/02699050500443467\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19933975\",\n",
      "        \"title\": \"Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study.\",\n",
      "        \"authors\": \"Le Jeune F; Drapier D; Bourguignon A; P\\u00e9ron J; Mesbah H; Drapier S; Sauleau P; Haegelen C; Travers D; Garin E; Malbert CH; Millet B; V\\u00e9rin M\",\n",
      "        \"doi\": \"10.1212/WNL.0b013e3181c34b34\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Le Jeune F, et al. Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. 2009; 73:1746-51. doi: 10.1212/WNL.0b013e3181c34b34\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19713543\",\n",
      "        \"title\": \"A longitudinal view of apathy and its impact after stroke.\",\n",
      "        \"authors\": \"Mayo NE; Fellows LK; Scott SC; Cameron J; Wood-Dauphinee S\",\n",
      "        \"doi\": \"10.1161/STROKEAHA.109.554410\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mayo NE, et al. A longitudinal view of apathy and its impact after stroke. A longitudinal view of apathy and its impact after stroke. 2009; 40:3299-307. doi: 10.1161/STROKEAHA.109.554410\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15897497\",\n",
      "        \"title\": \"Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?\",\n",
      "        \"authors\": \"Czernecki V; Pillon B; Houeto JL; Welter ML; Mesnage V; Agid Y; Dubois B\",\n",
      "        \"doi\": \"10.1136/jnnp.2003.033258\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Czernecki V, et al. Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?. Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?. 2005; 76:775-9. doi: 10.1136/jnnp.2003.033258\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18307266\",\n",
      "        \"title\": \"The Lille Apathy Rating Scale: validation of a caregiver-based version.\",\n",
      "        \"authors\": \"Dujardin K; Sockeel P; Delliaux M; Dest\\u00e9e A; Defebvre L\",\n",
      "        \"doi\": \"10.1002/mds.21968\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Dujardin K, et al. The Lille Apathy Rating Scale: validation of a caregiver-based version. The Lille Apathy Rating Scale: validation of a caregiver-based version. 2008; 23:845-9. doi: 10.1002/mds.21968\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"10436334\",\n",
      "        \"title\": \"The clinical picture of frontotemporal dementia: diagnosis and follow-up.\",\n",
      "        \"authors\": \"Pasquier F; Lebert F; Lavenu I; Guillaume B\",\n",
      "        \"doi\": \"10.1159/000051206\",\n",
      "        \"year\": \"1999\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Pasquier F, et al. The clinical picture of frontotemporal dementia: diagnosis and follow-up. The clinical picture of frontotemporal dementia: diagnosis and follow-up. 1999; 10 Suppl 1:10-4. doi: 10.1159/000051206\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17131230\",\n",
      "        \"title\": \"Apathy and the basal ganglia.\",\n",
      "        \"authors\": \"Levy R; Czernecki V\",\n",
      "        \"doi\": \"10.1007/s00415-006-7012-5\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Levy R and Czernecki V. Apathy and the basal ganglia. Apathy and the basal ganglia. 2006; 253 Suppl 7:VII54-61. doi: 10.1007/s00415-006-7012-5\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17027767\",\n",
      "        \"title\": \"Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's disease.\",\n",
      "        \"authors\": \"Winograd-Gurvich C; Fitzgerald PB; Georgiou-Karistianis N; Bradshaw JL; White OB\",\n",
      "        \"doi\": \"10.1016/j.brainresbull.2006.06.007\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Winograd-Gurvich C, et al. Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's disease. Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's disease. 2006; 70:312-21. doi: 10.1016/j.brainresbull.2006.06.007\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21895376\",\n",
      "        \"title\": \"The SEA (Social cognition and Emotional Assessment): a clinical neuropsychological tool for early diagnosis of frontal variant of frontotemporal lobar degeneration.\",\n",
      "        \"authors\": \"Funkiewiez A; Bertoux M; de Souza LC; L\\u00e9vy R; Dubois B\",\n",
      "        \"doi\": \"10.1037/a0025318\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Funkiewiez A, et al. The SEA (Social cognition and Emotional Assessment): a clinical neuropsychological tool for early diagnosis of frontal variant of frontotemporal lobar degeneration. The SEA (Social cognition and Emotional Assessment): a clinical neuropsychological tool for early diagnosis of frontal variant of frontotemporal lobar degeneration. 2012; 26:81-90. doi: 10.1037/a0025318\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04133012\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01100281\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01647295\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00424814\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"25838291\",\n",
      "        \"title\": \"In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.\",\n",
      "        \"authors\": \"Sibiude J; Le Chenadec J; Bonnet D; Tubiana R; Faye A; Dollfus C; Mandelbrot L; Delmas S; Lelong N; Khoshnood B; Warszawski J; Blanche S; French National Agency for Research on AIDS and Viral Hepatitis French Perinatal Cohort/Protease Inhibitor Monotherapy Evaluation Trial\",\n",
      "        \"doi\": \"10.1093/cid/civ260\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Observational Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Sibiude J, et al. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial. 2015; 61:270-80. doi: 10.1093/cid/civ260\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23766338\",\n",
      "        \"title\": \"Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial.\",\n",
      "        \"authors\": \"Tubiana R; Mandelbrot L; Le Chenadec J; Delmas S; Rouzioux C; Hirt D; Treluyer JM; Ekoukou D; Bui E; Chaix ML; Blanche S; Warszawski J; ANRS 135 PRIMEVA (Protease Inhibitor Monotherapy Evaluation) Study Group\",\n",
      "        \"doi\": \"10.1093/cid/cit390\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Tubiana R, et al. Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial. Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial. 2013; 57:891-902. doi: 10.1093/cid/cit390\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02488395\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"6774653\",\n",
      "        \"title\": \"Visual-motor function of the primate superior colliculus.\",\n",
      "        \"authors\": \"Wurtz RH; Albano JE\",\n",
      "        \"doi\": \"10.1146/annurev.ne.03.030180.001201\",\n",
      "        \"year\": \"1980\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Wurtz RH and Albano JE. Visual-motor function of the primate superior colliculus. Visual-motor function of the primate superior colliculus. 1980; 3:189-226. doi: 10.1146/annurev.ne.03.030180.001201\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23916713\",\n",
      "        \"title\": \"Enhanced visual responses in the superior colliculus and subthalamic nucleus in an animal model of Parkinson's disease.\",\n",
      "        \"authors\": \"Rolland M; Carcenac C; Overton PG; Savasta M; Coizet V\",\n",
      "        \"doi\": \"10.1016/j.neuroscience.2013.07.047\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Rolland M, et al. Enhanced visual responses in the superior colliculus and subthalamic nucleus in an animal model of Parkinson's disease. Enhanced visual responses in the superior colliculus and subthalamic nucleus in an animal model of Parkinson's disease. 2013; 252:277-88. doi: 10.1016/j.neuroscience.2013.07.047\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22639796\",\n",
      "        \"title\": \"Linking visual response properties in the superior colliculus to saccade behavior.\",\n",
      "        \"authors\": \"Marino RA; Levy R; Boehnke S; White BJ; Itti L; Munoz DP\",\n",
      "        \"doi\": \"10.1111/j.1460-9568.2012.08079.x\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Marino RA, et al. Linking visual response properties in the superior colliculus to saccade behavior. Linking visual response properties in the superior colliculus to saccade behavior. 2012; 35:1738-52. doi: 10.1111/j.1460-9568.2012.08079.x\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00658346\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"31063537\",\n",
      "        \"title\": \"Comparative Immunovirological and Clinical Responses to Antiretroviral Therapy Between HIV-1 Group O and HIV-1 Group M Infected Patients.\",\n",
      "        \"authors\": \"Kouanfack C; Unal G; Schaeffer L; Kfutwah A; Aghokeng A; Mougnutou R; Tchemgui-Noumsi N; Alessandri-Gradt E; Delaporte E; Simon F; Vray M; Plantier JC; ANRS 12168 DynaMO Study\",\n",
      "        \"doi\": \"10.1093/cid/ciz371\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kouanfack C, et al. Comparative Immunovirological and Clinical Responses to Antiretroviral Therapy Between HIV-1 Group O and HIV-1 Group M Infected Patients. Comparative Immunovirological and Clinical Responses to Antiretroviral Therapy Between HIV-1 Group O and HIV-1 Group M Infected Patients. 2020; 70:1471-1477. doi: 10.1093/cid/ciz371\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01188512\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"24793938\",\n",
      "        \"title\": \"B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial.\",\n",
      "        \"authors\": \"Jahnmatz M; Amu S; Ljungman M; Wehlin L; Chiodi F; Mielcarek N; Locht C; Thorstensson R\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2014.04.048\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Jahnmatz M, et al. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial. 2014; 32:3350-6. doi: 10.1016/j.vaccine.2014.04.048\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24421886\",\n",
      "        \"title\": \"A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers.\",\n",
      "        \"authors\": \"Thorstensson R; Trollfors B; Al-Tawil N; Jahnmatz M; Bergstr\\u00f6m J; Ljungman M; T\\u00f6rner A; Wehlin L; Van Broekhoven A; Bosman F; Debrie AS; Mielcarek N; Locht C\",\n",
      "        \"doi\": \"10.1371/journal.pone.0083449\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Thorstensson R, et al. A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. 2014; 9:e83449. doi: 10.1371/journal.pone.0083449\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20184606\",\n",
      "        \"title\": \"Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model.\",\n",
      "        \"authors\": \"Kavanagh H; Noone C; Cahill E; English K; Locht C; Mahon BP\",\n",
      "        \"doi\": \"10.1111/j.1365-2222.2010.03459.x\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kavanagh H, et al. Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model. Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model. 2010; 40:933-41. doi: 10.1111/j.1365-2222.2010.03459.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24261996\",\n",
      "        \"title\": \"Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism.\",\n",
      "        \"authors\": \"Schnoeller C; Roux X; Sawant D; Raze D; Olszewska W; Locht C; Openshaw PJ\",\n",
      "        \"doi\": \"10.1164/rccm.201307-1227OC\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Evaluation Study\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Schnoeller C, et al. Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism. Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism. 2014; 189:194-202. doi: 10.1164/rccm.201307-1227OC\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19625486\",\n",
      "        \"title\": \"A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice.\",\n",
      "        \"authors\": \"Skerry CM; Cassidy JP; English K; Feunou-Feunou P; Locht C; Mahon BP\",\n",
      "        \"doi\": \"10.1128/CVI.00082-09\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Skerry CM, et al. A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice. A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice. 2009; 16:1344-51. doi: 10.1128/CVI.00082-09\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16839199\",\n",
      "        \"title\": \"Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough.\",\n",
      "        \"authors\": \"Mielcarek N; Debrie AS; Raze D; Bertout J; Rouanet C; Younes AB; Creusy C; Engle J; Goldman WE; Locht C\",\n",
      "        \"doi\": \"10.1371/journal.ppat.0020065\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mielcarek N, et al. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. 2006; 2:e65. doi: 10.1371/journal.ppat.0020065\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18762220\",\n",
      "        \"title\": \"Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1.\",\n",
      "        \"authors\": \"Feunou PF; Ismaili J; Debrie AS; Huot L; Hot D; Raze D; Lemoine Y; Locht C\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2008.08.018\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Feunou PF, et al. Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1. Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1. 2008; 26:5722-7. doi: 10.1016/j.vaccine.2008.08.018\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20107007\",\n",
      "        \"title\": \"Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice.\",\n",
      "        \"authors\": \"Mielcarek N; Debrie AS; Mahieux S; Locht C\",\n",
      "        \"doi\": \"10.1128/CVI.00322-09\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mielcarek N, et al. Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice. Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice. 2010; 17:317-24. doi: 10.1128/CVI.00322-09\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04945655\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"35332045\",\n",
      "        \"title\": \"Impact of a school-based and primary care-based multicomponent intervention on HPV vaccination coverage among French adolescents: a cluster randomised controlled trial protocol (the PrevHPV study).\",\n",
      "        \"authors\": \"Bocquier A; Michel M; Giraudeau B; Bonnay S; Gagneux-Brunon A; Gauchet A; Gilberg S; Le Duc-Banaszuk AS; Mueller JE; Chevreul K; Thilly N; PrevHPV Study group\",\n",
      "        \"doi\": \"10.1136/bmjopen-2021-057943\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial Protocol\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bocquier A, et al. Impact of a school-based and primary care-based multicomponent intervention on HPV vaccination coverage among French adolescents: a cluster randomised controlled trial protocol (the PrevHPV study). Impact of a school-based and primary care-based multicomponent intervention on HPV vaccination coverage among French adolescents: a cluster randomised controlled trial protocol (the PrevHPV study). 2022; 12:e057943. doi: 10.1136/bmjopen-2021-057943\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01942655\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01332955\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"25139963\",\n",
      "        \"title\": \"Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial.\",\n",
      "        \"authors\": \"Cotte L; Braun J; Lascoux-Combe C; Vincent C; Valantin MA; Sogni P; Lacombe K; Neau D; Aumaitre H; Batisse D; de Truchis P; Gervais A; Michelet C; Morlat P; Vittecoq D; Rosa I; Bertucci I; Chevaliez S; Aboulker JP; Molina JM; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) HC26 Study Group\",\n",
      "        \"doi\": \"10.1093/cid/ciu659\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Cotte L, et al. Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial. Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial. 2014; 59:1768-76. doi: 10.1093/cid/ciu659\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01552044\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02592174\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"31755936\",\n",
      "        \"title\": \"Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55-70 Study.\",\n",
      "        \"authors\": \"Makinson A; Dubois J; Eymard-Duvernay S; Leclercq P; Zaegel-Faucher O; Bernard L; Vassallo M; Barbuat C; G\\u00e9ny C; Thouvenot E; Costagliola D; Ozguler A; Zins M; Simony M; Reynes J; Berr C\",\n",
      "        \"doi\": \"10.1093/cid/ciz670\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Makinson A, et al. Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55-70 Study. Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55-70 Study. 2020; 70:2641-2648. doi: 10.1093/cid/ciz670\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02100774\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"21957063\",\n",
      "        \"title\": \"Genetic variations involved in interindividual variability in carotenoid status.\",\n",
      "        \"authors\": \"Borel P\",\n",
      "        \"doi\": \"10.1002/mnfr.201100322\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Borel P. Genetic variations involved in interindividual variability in carotenoid status. Genetic variations involved in interindividual variability in carotenoid status. 2012; 56:228-40. doi: 10.1002/mnfr.201100322\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24808487\",\n",
      "        \"title\": \"Interindividual variability of lutein bioavailability in healthy men: characterization, genetic variants involved, and relation with fasting plasma lutein concentration.\",\n",
      "        \"authors\": \"Borel P; Desmarchelier C; Nowicki M; Bott R; Morange S; Lesavre N\",\n",
      "        \"doi\": \"10.3945/ajcn.114.085720\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Borel P, et al. Interindividual variability of lutein bioavailability in healthy men: characterization, genetic variants involved, and relation with fasting plasma lutein concentration. Interindividual variability of lutein bioavailability in healthy men: characterization, genetic variants involved, and relation with fasting plasma lutein concentration. 2014; 100:168-75. doi: 10.3945/ajcn.114.085720\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26063065\",\n",
      "        \"title\": \"A Combination of Single-Nucleotide Polymorphisms Is Associated with Interindividual Variability in Dietary \\u03b2-Carotene Bioavailability in Healthy Men.\",\n",
      "        \"authors\": \"Borel P; Desmarchelier C; Nowicki M; Bott R\",\n",
      "        \"doi\": \"10.3945/jn.115.212837\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Borel P, et al. A Combination of Single-Nucleotide Polymorphisms Is Associated with Interindividual Variability in Dietary \\u03b2-Carotene Bioavailability in Healthy Men. A Combination of Single-Nucleotide Polymorphisms Is Associated with Interindividual Variability in Dietary \\u03b2-Carotene Bioavailability in Healthy Men. 2015; 145:1740-7. doi: 10.3945/jn.115.212837\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27798339\",\n",
      "        \"title\": \"A Combination of Single-Nucleotide Polymorphisms Is Associated with Interindividual Variability in Cholecalciferol Bioavailability in Healthy Men.\",\n",
      "        \"authors\": \"Desmarchelier C; Borel P; Goncalves A; Kopec R; Nowicki M; Morange S; Lesavre N; Portugal H; Reboul E\",\n",
      "        \"doi\": \"10.3945/jn.116.237115\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Desmarchelier C, et al. A Combination of Single-Nucleotide Polymorphisms Is Associated with Interindividual Variability in Cholecalciferol Bioavailability in Healthy Men. A Combination of Single-Nucleotide Polymorphisms Is Associated with Interindividual Variability in Cholecalciferol Bioavailability in Healthy Men. 2016; 146:2421-2428. doi: 10.3945/jn.116.237115\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00490074\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01882062\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"25568297\",\n",
      "        \"title\": \"Triheptanoin improves brain energy metabolism in patients with Huntington disease.\",\n",
      "        \"authors\": \"Adanyeguh IM; Rinaldi D; Henry PG; Caillet S; Valabregue R; Durr A; Mochel F\",\n",
      "        \"doi\": \"10.1212/WNL.0000000000001214\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Adanyeguh IM, et al. Triheptanoin improves brain energy metabolism in patients with Huntington disease. Triheptanoin improves brain energy metabolism in patients with Huntington disease. 2015; 84:490-5. doi: 10.1212/WNL.0000000000001214\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01525472\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02650427\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01473472\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"28747274\",\n",
      "        \"title\": \"Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.\",\n",
      "        \"authors\": \"Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Dor\\u00e9 V; Meyer L; ANRS IPERGAY Study Group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(17)30089-9\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Molina JM, et al. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. 2017; 4:e402-e410. doi: 10.1016/S2352-3018(17)30089-9\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26624850\",\n",
      "        \"title\": \"On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.\",\n",
      "        \"authors\": \"Molina JM; Capitant C; Spire B; Pialoux G; Cotte L; Charreau I; Tremblay C; Le Gall JM; Cua E; Pasquet A; Raffi F; Pintado C; Chidiac C; Chas J; Charbonneau P; Delaugerre C; Suzan-Monti M; Loze B; Fonsart J; Peytavin G; Cheret A; Timsit J; Girard G; Lorente N; Pr\\u00e9au M; Rooney JF; Wainberg MA; Thompson D; Rozenbaum W; Dor\\u00e9 V; Marchand L; Simon MC; Etien N; Aboulker JP; Meyer L; Delfraissy JF; ANRS IPERGAY Study Group\",\n",
      "        \"doi\": \"10.1056/NEJMoa1506273\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Molina JM, et al. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. 2015; 373:2237-46. doi: 10.1056/NEJMoa1506273\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29229440\",\n",
      "        \"title\": \"Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.\",\n",
      "        \"authors\": \"Molina JM; Charreau I; Chidiac C; Pialoux G; Cua E; Delaugerre C; Capitant C; Rojas-Castro D; Fonsart J; Bercot B; B\\u00e9b\\u00e9ar C; Cotte L; Robineau O; Raffi F; Charbonneau P; Aslan A; Chas J; Niedbalski L; Spire B; Sagaon-Teyssier L; Carette D; Mestre SL; Dor\\u00e9 V; Meyer L; ANRS IPERGAY Study Group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(17)30725-9\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Molina JM, et al. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. 2018; 18:308-317. doi: 10.1016/S1473-3099(17)30725-9\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"36601747\",\n",
      "        \"title\": \"Hepatitis A and B vaccine uptake and immunisation among men who have sex with men seeking PrEP: a substudy of the ANRS IPERGAY trial.\",\n",
      "        \"authors\": \"Le Turnier P; Charreau I; Gabassi A; Carette D; Cotte L; Pialoux G; Tremblay C; Spire B; Chaix ML; Meyer L; Capitant C; Delaugerre C; Raffi F; Molina JM; ANRS IPERGAY study group\",\n",
      "        \"doi\": \"10.1136/sextrans-2022-055634\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Letter\"\n",
      "        ],\n",
      "        \"citation\": \"Le Turnier P, et al. Hepatitis A and B vaccine uptake and immunisation among men who have sex with men seeking PrEP: a substudy of the ANRS IPERGAY trial. Hepatitis A and B vaccine uptake and immunisation among men who have sex with men seeking PrEP: a substudy of the ANRS IPERGAY trial. 2023; 99:140-142. doi: 10.1136/sextrans-2022-055634\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31784343\",\n",
      "        \"title\": \"On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.\",\n",
      "        \"authors\": \"Antoni G; Tremblay C; Delaugerre C; Charreau I; Cua E; Rojas Castro D; Raffi F; Chas J; Huleux T; Spire B; Capitant C; Cotte L; Meyer L; Molina JM; ANRS IPERGAY study group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(19)30341-8\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Antoni G, et al. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial. 2020; 7:e113-e120. doi: 10.1016/S2352-3018(19)30341-8\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02267304\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04780191\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"32232101\",\n",
      "        \"title\": \"Non-invasive treatment of patients with upper extremity spasticity following stroke using paired trans-spinal and peripheral direct current stimulation.\",\n",
      "        \"authors\": \"Paget-Blanc A; Chang JL; Saul M; Lin R; Ahmed Z; Volpe BT\",\n",
      "        \"doi\": \"10.1186/s42234-019-0028-9\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Paget-Blanc A, et al. Non-invasive treatment of patients with upper extremity spasticity following stroke using paired trans-spinal and peripheral direct current stimulation. Non-invasive treatment of patients with upper extremity spasticity following stroke using paired trans-spinal and peripheral direct current stimulation. 2019; 5:11. doi: 10.1186/s42234-019-0028-9\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00495326\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"24663014\",\n",
      "        \"title\": \"Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment.\",\n",
      "        \"authors\": \"Bhatt NB; Barau C; Amin A; Baudin E; Meggi B; Silva C; Furlan V; Grinsztejn B; Barrail-Tran A; Bonnet M; Taburet AM; ANRS 12146-CARINEMO Study Group\",\n",
      "        \"doi\": \"10.1128/AAC.02379-13\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bhatt NB, et al. Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment. Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment. 2014; 58:3182-90. doi: 10.1128/AAC.02379-13\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23433590\",\n",
      "        \"title\": \"Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial.\",\n",
      "        \"authors\": \"Bonnet M; Bhatt N; Baudin E; Silva C; Michon C; Taburet AM; Ciaffi L; Sobry A; Bastos R; Nunes E; Rouzioux C; Jani I; Calmy A; CARINEMO study group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(13)70007-0\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bonnet M, et al. Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial. Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial. 2013; 13:303-12. doi: 10.1016/S1473-3099(13)70007-0\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03459157\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"34048794\",\n",
      "        \"title\": \"HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study.\",\n",
      "        \"authors\": \"Laurent C; Demb\\u00e9l\\u00e9 Keita B; Yaya I; Le Guicher G; Sagaon-Teyssier L; Agboyibor MK; Coulibaly A; Traor\\u00e9 I; Malan JB; De Baetselier I; Eubanks A; Riegel L; Rojas Castro D; Fay\\u00e9-Kett\\u00e9 H; Kon\\u00e9 A; Diand\\u00e9 S; Dagnra CA; Serrano L; Diallo F; Mensah E; Dah TTE; Anoma C; Vuylsteke B; Spire B; CohMSM-PrEP Study Group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(21)00005-9\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Laurent C, et al. HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study. HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study. 2021; 8:e420-e428. doi: 10.1016/S2352-3018(21)00005-9\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01620957\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00339157\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"21173013\",\n",
      "        \"title\": \"A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial).\",\n",
      "        \"authors\": \"Quartier P; Allantaz F; Cimaz R; Pillet P; Messiaen C; Bardin C; Bossuyt X; Boutten A; Bienvenu J; Duquesne A; Richer O; Chaussabel D; Mogenet A; Banchereau J; Treluyer JM; Landais P; Pascual V\",\n",
      "        \"doi\": \"10.1136/ard.2010.134254\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Quartier P, et al. A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). 2011; 70:747-54. doi: 10.1136/ard.2010.134254\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01555450\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29909873\",\n",
      "        \"title\": \"Cost-Effectiveness Analysis of a Navigation Program for Colorectal Cancer Screening to Reduce Social Health Inequalities: A French Cluster Randomized Controlled Trial.\",\n",
      "        \"authors\": \"De Mil R; Guillaume E; Guittet L; Dejardin O; Bouvier V; Pornet C; Christophe V; Notari A; Delattre-Massy H; De Seze C; Peng J; Launoy G; Berchi C\",\n",
      "        \"doi\": \"10.1016/j.jval.2017.09.020\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"De Mil R, et al. Cost-Effectiveness Analysis of a Navigation Program for Colorectal Cancer Screening to Reduce Social Health Inequalities: A French Cluster Randomized Controlled Trial. Cost-Effectiveness Analysis of a Navigation Program for Colorectal Cancer Screening to Reduce Social Health Inequalities: A French Cluster Randomized Controlled Trial. 2018; 21:685-691. doi: 10.1016/j.jval.2017.09.020\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28823681\",\n",
      "        \"title\": \"Patient navigation to reduce social inequalities in colorectal cancer screening participation: A cluster randomized controlled trial.\",\n",
      "        \"authors\": \"Guillaume E; Dejardin O; Bouvier V; De Mil R; Berchi C; Pornet C; Christophe V; Notari A; Delattre Massy H; De Seze C; Peng J; Guittet L; Launoy G\",\n",
      "        \"doi\": \"10.1016/j.ypmed.2017.08.012\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Guillaume E, et al. Patient navigation to reduce social inequalities in colorectal cancer screening participation: A cluster randomized controlled trial. Patient navigation to reduce social inequalities in colorectal cancer screening participation: A cluster randomized controlled trial. 2017; 103:76-83. doi: 10.1016/j.ypmed.2017.08.012\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21256688\",\n",
      "        \"title\": \"[Social inequalities in health from observational studies to intervention: can the patient navigator reduce social inequalities in cancer patients?].\",\n",
      "        \"authors\": \"Dejardin O; Berchi C; Mignon A; Pornet C; Guillaume E; Guittet L; Bouvier V; Sailly M; Salinas A; Christophe V; Launoy G\",\n",
      "        \"doi\": \"10.1016/j.respe.2010.10.008\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"English Abstract\",\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Dejardin O, et al. [Social inequalities in health from observational studies to intervention: can the patient navigator reduce social inequalities in cancer patients?]. [Social inequalities in health from observational studies to intervention: can the patient navigator reduce social inequalities in cancer patients?]. 2011; 59:45-51. doi: 10.1016/j.respe.2010.10.008\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01348308\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"32040959\",\n",
      "        \"title\": \"Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial.\",\n",
      "        \"authors\": \"L\\u00e9vy Y; Leli\\u00e8vre JD; Assoumou L; Aznar E; Pulido F; Tambussi G; Crespo M; Meybeck A; Molina JM; Delaugerre C; Izopet J; Peytavin G; Cardon F; Diallo A; Lancar R; B\\u00e9niguel L; Costagliola D\",\n",
      "        \"doi\": \"10.7326/M19-2133\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"L\\u00e9vy Y, et al. Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial. Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial. 2020; 172:297-305. doi: 10.7326/M19-2133\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01696708\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"25568297\",\n",
      "        \"title\": \"Triheptanoin improves brain energy metabolism in patients with Huntington disease.\",\n",
      "        \"authors\": \"Adanyeguh IM; Rinaldi D; Henry PG; Caillet S; Valabregue R; Durr A; Mochel F\",\n",
      "        \"doi\": \"10.1212/WNL.0000000000001214\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Adanyeguh IM, et al. Triheptanoin improves brain energy metabolism in patients with Huntington disease. Triheptanoin improves brain energy metabolism in patients with Huntington disease. 2015; 84:490-5. doi: 10.1212/WNL.0000000000001214\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01509508\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29199100\",\n",
      "        \"title\": \"Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial.\",\n",
      "        \"authors\": \"Iwuji CC; Orne-Gliemann J; Larmarange J; Balestre E; Thiebaut R; Tanser F; Okesola N; Makowa T; Dreyer J; Herbst K; McGrath N; B\\u00e4rnighausen T; Boyer S; De Oliveira T; Rekacewicz C; Bazin B; Newell ML; Pillay D; Dabis F; ANRS 12249 TasP Study Group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(17)30205-9\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase IV\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Iwuji CC, et al. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. 2018; 5:e116-e125. doi: 10.1016/S2352-3018(17)30205-9\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25880823\",\n",
      "        \"title\": \"Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal.\",\n",
      "        \"authors\": \"Orne-Gliemann J; Larmarange J; Boyer S; Iwuji C; McGrath N; B\\u00e4rnighausen T; Zuma T; Dray-Spira R; Spire B; Rochat T; Lert F; Imrie J; ANRS 12249 TasP Group\",\n",
      "        \"doi\": \"10.1186/s12889-015-1344-y\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Orne-Gliemann J, et al. Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal. Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal. 2015; 15:209. doi: 10.1186/s12889-015-1344-y\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23880306\",\n",
      "        \"title\": \"Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial.\",\n",
      "        \"authors\": \"Iwuji CC; Orne-Gliemann J; Tanser F; Boyer S; Lessells RJ; Lert F; Imrie J; B\\u00e4rnighausen T; Rekacewicz C; Bazin B; Newell ML; Dabis F; ANRS 12249 TasP Study Group\",\n",
      "        \"doi\": \"10.1186/1745-6215-14-230\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Iwuji CC, et al. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial. 2013; 14:230. doi: 10.1186/1745-6215-14-230\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27504637\",\n",
      "        \"title\": \"Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial.\",\n",
      "        \"authors\": \"Iwuji CC; Orne-Gliemann J; Larmarange J; Okesola N; Tanser F; Thiebaut R; Rekacewicz C; Newell ML; Dabis F; ANRS 12249 TasP trial group\",\n",
      "        \"doi\": \"10.1371/journal.pmed.1002107\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Iwuji CC, et al. Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial. Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial. 2016; 13:e1002107. doi: 10.1371/journal.pmed.1002107\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30027600\",\n",
      "        \"title\": \"The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa).\",\n",
      "        \"authors\": \"Larmarange J; Diallo MH; McGrath N; Iwuji C; Plazy M; Thi\\u00e9baut R; Tanser F; B\\u00e4rnighausen T; Pillay D; Dabis F; Orne-Gliemann J; ANRS 12249 TasP Study Group\",\n",
      "        \"doi\": \"10.1002/jia2.25128\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Larmarange J, et al. The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa). The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa). 2018; 21 Suppl 4:e25128. doi: 10.1002/jia2.25128\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28329393\",\n",
      "        \"title\": \"Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis.\",\n",
      "        \"authors\": \"Collier D; Iwuji C; Derache A; de Oliveira T; Okesola N; Calmy A; Dabis F; Pillay D; Gupta RK; French National Agency for AIDS and Viral Hepatitis Research (ANRS) 12249 Treatment as Prevention (TasP) Study Group\",\n",
      "        \"doi\": \"10.1093/cid/cix015\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Collier D, et al. Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis. Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis. 2017; 64:1006-1016. doi: 10.1093/cid/cix015\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30412926\",\n",
      "        \"title\": \"\\\"If you are here at the clinic, you do not know how many people need help in the community\\\": Perspectives of home-based HIV services from health care workers in rural KwaZulu-Natal, South Africa in the era of universal test-and-treat.\",\n",
      "        \"authors\": \"Perriat D; Plazy M; Gumede D; Boyer S; Pillay D; Dabis F; Seeley J; Orne-Gliemann J; ANRS 12249 TasP Study Group\",\n",
      "        \"doi\": \"10.1371/journal.pone.0202473\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Perriat D, et al. \\\"If you are here at the clinic, you do not know how many people need help in the community\\\": Perspectives of home-based HIV services from health care workers in rural KwaZulu-Natal, South Africa in the era of universal test-and-treat. \\\"If you are here at the clinic, you do not know how many people need help in the community\\\": Perspectives of home-based HIV services from health care workers in rural KwaZulu-Natal, South Africa in the era of universal test-and-treat. 2018; 13:e0202473. doi: 10.1371/journal.pone.0202473\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30321314\",\n",
      "        \"title\": \"Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial.\",\n",
      "        \"authors\": \"Derache A; Iwuji CC; Baisley K; Danaviah S; Marcelin AG; Calvez V; de Oliveira T; Dabis F; Porter K; Pillay D\",\n",
      "        \"doi\": \"10.1093/cid/ciy881\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Derache A, et al. Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial. Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial. 2019; 69:207-214. doi: 10.1093/cid/ciy881\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31637821\",\n",
      "        \"title\": \"Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa.\",\n",
      "        \"authors\": \"Larmarange J; Diallo MH; McGrath N; Iwuji C; Plazy M; Thi\\u00e9baut R; Tanser F; B\\u00e4rnighausen T; Orne-Gliemann J; Pillay D; Dabis F; ANRS 12249 TasP Study Group\",\n",
      "        \"doi\": \"10.1002/jia2.25402\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Larmarange J, et al. Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa. Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa. 2019; 22:e25402. doi: 10.1002/jia2.25402\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32970730\",\n",
      "        \"title\": \"Test but not treat: Community members' experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa.\",\n",
      "        \"authors\": \"Iwuji C; Chimukuche RS; Zuma T; Plazy M; Larmarange J; Orne-Gliemann J; Siedner M; Shahmanesh M; Seeley J\",\n",
      "        \"doi\": \"10.1371/journal.pone.0239513\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Iwuji C, et al. Test but not treat: Community members' experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa. Test but not treat: Community members' experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa. 2020; 15:e0239513. doi: 10.1371/journal.pone.0239513\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29890048\",\n",
      "        \"title\": \"Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial.\",\n",
      "        \"authors\": \"Iwuji C; McGrath N; Calmy A; Dabis F; Pillay D; Newell ML; Baisley K; Porter K\",\n",
      "        \"doi\": \"10.1002/jia2.25112\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Iwuji C, et al. Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial. Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial. 2018; 21:e25112. doi: 10.1002/jia2.25112\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01874808\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02126384\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03150290\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03519503\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"21602695\",\n",
      "        \"title\": \"Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children.\",\n",
      "        \"authors\": \"Heidari S; Mofenson L; Cotton MF; Marlink R; Cahn P; Katabira E\",\n",
      "        \"doi\": \"10.1097/QAI.0b013e318221c56a\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Heidari S, et al. Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children. Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children. 2011; 57:290-6. doi: 10.1097/QAI.0b013e318221c56a\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26603917\",\n",
      "        \"title\": \"Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial.\",\n",
      "        \"authors\": \"Nagot N; Kankasa C; Tumwine JK; Meda N; Hofmeyr GJ; Vallo R; Mwiya M; Kwagala M; Traore H; Sunday A; Singata M; Siuluta C; Some E; Rutagwera D; Neboua D; Ndeezi G; Jackson D; Mar\\u00e9chal V; Neveu D; Engebretsen IMS; Lombard C; Blanche S; Sommerfelt H; Rekacewicz C; Tyllesk\\u00e4r T; Van de Perre P; ANRS 12174 Trial Group\",\n",
      "        \"doi\": \"10.1016/S0140-6736(15)00984-8\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nagot N, et al. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. 2016; 387:566-573. doi: 10.1016/S0140-6736(15)00984-8\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22814853\",\n",
      "        \"title\": \"HIV-1 reservoirs in breast milk and challenges to elimination of breast-feeding transmission of HIV-1.\",\n",
      "        \"authors\": \"Van de Perre P; Rubbo PA; Viljoen J; Nagot N; Tyllesk\\u00e4r T; Lepage P; Vendrell JP; Tuaillon E\",\n",
      "        \"doi\": \"10.1126/scitranslmed.3003327\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Van de Perre P, et al. HIV-1 reservoirs in breast milk and challenges to elimination of breast-feeding transmission of HIV-1. HIV-1 reservoirs in breast milk and challenges to elimination of breast-feeding transmission of HIV-1. 2012; 4:143sr3. doi: 10.1126/scitranslmed.3003327\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00465790\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00122603\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"19420019\",\n",
      "        \"title\": \"Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.\",\n",
      "        \"authors\": \"Landman R; Capitant C; Descamps D; Chazallon C; Peytavin G; Katlama C; Pialoux G; Bentata M; Brun-V\\u00e9zinet F; Aboulker JP; Y\\u00e9ni P; ANRS 127 Study Group\",\n",
      "        \"doi\": \"10.1093/jac/dkp146\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Landman R, et al. Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study. Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study. 2009; 64:118-25. doi: 10.1093/jac/dkp146\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02314208\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00121121\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"17712402\",\n",
      "        \"title\": \"Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial.\",\n",
      "        \"authors\": \"Launay O; Durier C; Desaint C; Silbermann B; Jackson A; Pialoux G; Bonnet B; Poizot-Martin I; Gonzalez-Canali G; Cuzin L; Figuereido S; Surenaud M; Ben Hamouda N; Gahery H; Choppin J; Salmon D; Gu\\u00e9rin C; Bourgault Villada I; Guillet JG; ANRS VAC16 Study Group\",\n",
      "        \"doi\": \"10.1371/journal.pone.0000725\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Launay O, et al. Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial. Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial. 2007; 2:e725. doi: 10.1371/journal.pone.0000725\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01432821\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"2271377\",\n",
      "        \"title\": \"Apomorphine-induced blinking and yawning in healthy volunteers.\",\n",
      "        \"authors\": \"Blin O; Masson G; Azulay JP; Fondarai J; Serratrice G\",\n",
      "        \"doi\": \"10.1111/j.1365-2125.1990.tb03848.x\",\n",
      "        \"year\": \"1990\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Blin O, et al. Apomorphine-induced blinking and yawning in healthy volunteers. Apomorphine-induced blinking and yawning in healthy volunteers. 1990; 30:769-73. doi: 10.1111/j.1365-2125.1990.tb03848.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15249613\",\n",
      "        \"title\": \"PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy.\",\n",
      "        \"authors\": \"Biraben A; Semah F; Ribeiro MJ; Douaud G; Remy P; Depaulis A\",\n",
      "        \"doi\": \"10.1212/01.wnl.0000132840.40838.13\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Biraben A, et al. PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy. PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy. 2004; 63:73-7. doi: 10.1212/01.wnl.0000132840.40838.13\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15777732\",\n",
      "        \"title\": \"Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids.\",\n",
      "        \"authors\": \"Ahmad S; Fowler LJ; Whitton PS\",\n",
      "        \"doi\": \"10.1016/j.eplepsyres.2005.02.002\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Ahmad S, et al. Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids. Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids. 2005; 63:141-9. doi: 10.1016/j.eplepsyres.2005.02.002\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"12914551\",\n",
      "        \"title\": \"Pharmacokinetic-pharmacodynamic study of apomorphine's effect on growth hormone secretion in healthy subjects.\",\n",
      "        \"authors\": \"Aymard G; Berlin I; de Brettes B; Diquet B\",\n",
      "        \"doi\": \"10.1046/j.1472-8206.2003.00152.x\",\n",
      "        \"year\": \"2003\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Aymard G, et al. Pharmacokinetic-pharmacodynamic study of apomorphine's effect on growth hormone secretion in healthy subjects. Pharmacokinetic-pharmacodynamic study of apomorphine's effect on growth hormone secretion in healthy subjects. 2003; 17:473-81. doi: 10.1046/j.1472-8206.2003.00152.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15037514\",\n",
      "        \"title\": \"Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5-hydroxytryptamine and dopamine in the hippocampus of the freely moving rat.\",\n",
      "        \"authors\": \"Ahmad S; Fowler LJ; Whitton PS\",\n",
      "        \"doi\": \"10.1038/sj.bjp.0705737\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Ahmad S, et al. Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5-hydroxytryptamine and dopamine in the hippocampus of the freely moving rat. Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5-hydroxytryptamine and dopamine in the hippocampus of the freely moving rat. 2004; 142:136-42. doi: 10.1038/sj.bjp.0705737\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02071784\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02738502\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26709605\",\n",
      "        \"title\": \"Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials.\",\n",
      "        \"authors\": \"Arribas JR; Girard PM; Paton N; Winston A; Marcelin AG; Elbirt D; Hill A; Hadacek MB\",\n",
      "        \"doi\": \"10.1111/hiv.12348\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Meta-Analysis\"\n",
      "        ],\n",
      "        \"citation\": \"Arribas JR, et al. Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials. Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials. 2016; 17:358-67. doi: 10.1111/hiv.12348\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26197844\",\n",
      "        \"title\": \"No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.\",\n",
      "        \"authors\": \"Mandelbrot L; Tubiana R; Le Chenadec J; Dollfus C; Faye A; Pannier E; Matheron S; Khuong MA; Garrait V; Reliquet V; Devidas A; Berrebi A; Allisy C; Elleau C; Arvieux C; Rouzioux C; Warszawski J; Blanche S; ANRS-EPF Study Group\",\n",
      "        \"doi\": \"10.1093/cid/civ578\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mandelbrot L, et al. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception. 2015; 61:1715-25. doi: 10.1093/cid/civ578\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26854809\",\n",
      "        \"title\": \"Risk of cancer in children exposed to didanosine in utero.\",\n",
      "        \"authors\": \"Hleyhel M; Goujon S; Delteil C; Vasiljevic A; Luzi S; Stephan JL; Reliquet V; Jannier S; Tubiana R; Dollfus C; Faye A; Mandelbrot L; Clavel J; Warszawski J; Blanche S; ANRS French Perinatal Cohort Study Group\",\n",
      "        \"doi\": \"10.1097/QAD.0000000000001051\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hleyhel M, et al. Risk of cancer in children exposed to didanosine in utero. Risk of cancer in children exposed to didanosine in utero. 2016; 30:1245-56. doi: 10.1097/QAD.0000000000001051\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22160145\",\n",
      "        \"title\": \"Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study.\",\n",
      "        \"authors\": \"Valantin MA; Lambert-Niclot S; Flandre P; Morand-Joubert L; Cabi\\u00e8 A; Meynard JL; Ponscarme D; Ajana F; Slama L; Curjol A; Cuzin L; Schneider L; Taburet AM; Marcelin AG; Katlama C; MONOI ANRS 136 Study Group\",\n",
      "        \"doi\": \"10.1093/jac/dkr504\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Valantin MA, et al. Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study. Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study. 2012; 67:691-5. doi: 10.1093/jac/dkr504\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23559464\",\n",
      "        \"title\": \"Genotoxic signature in cord blood cells of newborns exposed in utero to a Zidovudine-based antiretroviral combination.\",\n",
      "        \"authors\": \"Andr\\u00e9-Schmutz I; Dal-Cortivo L; Six E; Kaltenbach S; Cocchiarella F; Le Chenadec J; Cagnard N; Cordier AG; Benachi A; Mandelbrot L; Azria E; Bouallag N; Luce S; Ternaux B; Reimann C; Revy P; Radford-Weiss I; Leschi C; Recchia A; Mavilio F; Cavazzana M; Blanche S\",\n",
      "        \"doi\": \"10.1093/infdis/jit149\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Andr\\u00e9-Schmutz I, et al. Genotoxic signature in cord blood cells of newborns exposed in utero to a Zidovudine-based antiretroviral combination. Genotoxic signature in cord blood cells of newborns exposed in utero to a Zidovudine-based antiretroviral combination. 2013; 208:235-43. doi: 10.1093/infdis/jit149\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22848481\",\n",
      "        \"title\": \"Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks.\",\n",
      "        \"authors\": \"Lambert-Niclot S; Flandre P; Valantin MA; Soulie C; Fourati S; Wirden M; Sayon S; Pakianather S; Bocket L; Masquelier B; Dos Santos G; Katlama C; Calvez V; Marcelin AG\",\n",
      "        \"doi\": \"10.1371/journal.pone.0041390\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Lambert-Niclot S, et al. Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks. Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks. 2012; 7:e41390. doi: 10.1371/journal.pone.0041390\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23766338\",\n",
      "        \"title\": \"Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial.\",\n",
      "        \"authors\": \"Tubiana R; Mandelbrot L; Le Chenadec J; Delmas S; Rouzioux C; Hirt D; Treluyer JM; Ekoukou D; Bui E; Chaix ML; Blanche S; Warszawski J; ANRS 135 PRIMEVA (Protease Inhibitor Monotherapy Evaluation) Study Group\",\n",
      "        \"doi\": \"10.1093/cid/cit390\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Tubiana R, et al. Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial. Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial. 2013; 57:891-902. doi: 10.1093/cid/cit390\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02992184\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29615488\",\n",
      "        \"title\": \"Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus.\",\n",
      "        \"authors\": \"Llibre A; Shimakawa Y; Mottez E; Ainsworth S; Buivan TP; Firth R; Harrison E; Rosenberg AR; Meritet JF; Fontanet A; Castan P; Madej\\u00f3n A; Laverick M; Glass A; Viana R; Pol S; McClure CP; Irving WL; Miele G; Albert ML; Duffy D\",\n",
      "        \"doi\": \"10.1136/gutjnl-2017-315783\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Validation Study\"\n",
      "        ],\n",
      "        \"citation\": \"Llibre A, et al. Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus. Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus. 2018; 67:2017-2024. doi: 10.1136/gutjnl-2017-315783\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01514890\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"24704719\",\n",
      "        \"title\": \"Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.\",\n",
      "        \"authors\": \"H\\u00e9zode C; Fontaine H; Dorival C; Zoulim F; Larrey D; Canva V; De Ledinghen V; Poynard T; Samuel D; Bourliere M; Alric L; Raabe JJ; Zarski JP; Marcellin P; Riachi G; Bernard PH; Loustaud-Ratti V; Chazouilleres O; Abergel A; Guyader D; Metivier S; Tran A; Di Martino V; Causse X; Dao T; Lucidarme D; Portal I; Cacoub P; Gournay J; Grando-Lemaire V; Hillon P; Attali P; Fontanges T; Rosa I; Petrov-Sanchez V; Barthe Y; Pawlotsky JM; Pol S; Carrat F; Bronowicki JP; CUPIC Study Group\",\n",
      "        \"doi\": \"10.1053/j.gastro.2014.03.051\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\"\n",
      "        ],\n",
      "        \"citation\": \"H\\u00e9zode C, et al. Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis. Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis. 2014; 147:132-142.e4. doi: 10.1053/j.gastro.2014.03.051\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25556540\",\n",
      "        \"title\": \"Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy.\",\n",
      "        \"authors\": \"Sultanik P; Mallet V; Lagaye S; Casrouge A; Dorival C; Barthe Y; Fontaine H; H\\u00e9zode C; Mottez E; Bronowicki JP; Carrat F; Theodorou I; Abel L; Gayat E; Fontanet A; Pol S; Albert ML; ANRS CO20-CUPIC\",\n",
      "        \"doi\": \"10.1111/liv.12759\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Sultanik P, et al. Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy. Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy. 2015; 35:1833-44. doi: 10.1111/liv.12759\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23669289\",\n",
      "        \"title\": \"Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.\",\n",
      "        \"authors\": \"H\\u00e9zode C; Fontaine H; Dorival C; Larrey D; Zoulim F; Canva V; de Ledinghen V; Poynard T; Samuel D; Bourli\\u00e8re M; Zarski JP; Raabe JJ; Alric L; Marcellin P; Riachi G; Bernard PH; Loustaud-Ratti V; M\\u00e9tivier S; Tran A; Serfaty L; Abergel A; Causse X; Di Martino V; Guyader D; Lucidarme D; Grando-Lemaire V; Hillon P; Feray C; Dao T; Cacoub P; Rosa I; Attali P; Petrov-Sanchez V; Barthe Y; Pawlotsky JM; Pol S; Carrat F; Bronowicki JP; CUPIC Study Group\",\n",
      "        \"doi\": \"10.1016/j.jhep.2013.04.035\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"H\\u00e9zode C, et al. Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890. Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890. 2013; 59:434-41. doi: 10.1016/j.jhep.2013.04.035\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02212379\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"31269208\",\n",
      "        \"title\": \"Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study.\",\n",
      "        \"authors\": \"Katlama C; Assoumou L; Valantin MA; Souli\\u00e9 C; Martinez E; B\\u00e9niguel L; Bouchaud O; Raffi F; Molina JM; Fellahi S; Peytavin G; Marcelin AG; Kolta S; Capeau J; Gibowski S; Cardon F; Reynes J; Costagliola D; members of the ANRS 163 ETRAL study\",\n",
      "        \"doi\": \"10.1093/jac/dkz224\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Katlama C, et al. Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study. Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study. 2019; 74:2742-2751. doi: 10.1093/jac/dkz224\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03652090\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00196664\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03335995\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"32026446\",\n",
      "        \"title\": \"Outcomes of Acute Stroke Patients Requiring Mechanical Ventilation: Study Protocol for the SPICE Multicenter Prospective Observational Study.\",\n",
      "        \"authors\": \"Sonneville R; Mazighi M; Bresson D; Crassard I; Crozier S; de Montmollin E; Degos V; Faugeras F; Gayat E; Josse L; Lamy C; Magalhaes E; Maldjian A; Ruckly S; Servan J; Vassel P; Vigu\\u00e9 B; Timsit JF; Woimant F; SPICE investigators\",\n",
      "        \"doi\": \"10.1007/s12028-019-00907-0\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Sonneville R, et al. Outcomes of Acute Stroke Patients Requiring Mechanical Ventilation: Study Protocol for the SPICE Multicenter Prospective Observational Study. Outcomes of Acute Stroke Patients Requiring Mechanical Ventilation: Study Protocol for the SPICE Multicenter Prospective Observational Study. 2020; 32:624-629. doi: 10.1007/s12028-019-00907-0\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"37497675\",\n",
      "        \"title\": \"One-Year Outcomes in Patients With Acute Stroke Requiring Mechanical Ventilation.\",\n",
      "        \"authors\": \"Sonneville R; Mazighi M; Collet M; Gayat E; Degos V; Duranteau J; Gr\\u00e9goire C; Sharshar T; Naim G; Cortier D; Jost PH; Foucrier A; Bagate F; de Montmollin E; Papin G; Magalhaes E; Guidet B; Ben Hadj Salem O; Benghanem S; le Guennec L; Delpierre E; Legriel S; Megarbane B; Toumert K; Tran M; Geri G; Monchi M; Bodiguel E; Mariotte E; Demoule A; Zarka J; Diehl JL; Roux D; Barr\\u00e9 E; Tanaka S; Osman D; Pasquier P; Lamara F; Crassard I; Boursin P; Ruckly S; Staiquly Q; Timsit JF; Woimant F; SPICE Investigators\",\n",
      "        \"doi\": \"10.1161/STROKEAHA.123.042910\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Multicenter Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Sonneville R, et al. One-Year Outcomes in Patients With Acute Stroke Requiring Mechanical Ventilation. One-Year Outcomes in Patients With Acute Stroke Requiring Mechanical Ventilation. 2023; 54:2328-2337. doi: 10.1161/STROKEAHA.123.042910\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00946595\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"30968368\",\n",
      "        \"title\": \"Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM).\",\n",
      "        \"authors\": \"Garay OU; Nishimwe ML; Bousmah MA; Janah A; Girard PM; Ch\\u00eane G; Moinot L; Sagaon-Teyssier L; Meynard JL; Spire B; Boyer S\",\n",
      "        \"doi\": \"10.1007/s41669-019-0130-7\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Garay OU, et al. Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM). Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM). 2019; 3:505-515. doi: 10.1007/s41669-019-0130-7\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29767684\",\n",
      "        \"title\": \"Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies.\",\n",
      "        \"authors\": \"Lambert-Niclot S; Grude M; Meynard JL; Marcelin AG; Valantin MA; Flandre P; Izopet J; Moinot L; Bouteloup V; Calvez V; Katlama C; Girard PM; Morand-Joubert L\",\n",
      "        \"doi\": \"10.1093/cid/ciy382\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Lambert-Niclot S, et al. Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies. Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies. 2018; 67:1883-1889. doi: 10.1093/cid/ciy382\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02469350\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29636105\",\n",
      "        \"title\": \"The feasibility and positive effects of a customised videogame rehabilitation programme for freezing of gait and falls in Parkinson's disease patients: a pilot study.\",\n",
      "        \"authors\": \"Nuic D; Vinti M; Karachi C; Foulon P; Van Hamme A; Welter ML\",\n",
      "        \"doi\": \"10.1186/s12984-018-0375-x\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nuic D, et al. The feasibility and positive effects of a customised videogame rehabilitation programme for freezing of gait and falls in Parkinson's disease patients: a pilot study. The feasibility and positive effects of a customised videogame rehabilitation programme for freezing of gait and falls in Parkinson's disease patients: a pilot study. 2018; 15:31. doi: 10.1186/s12984-018-0375-x\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01546181\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"30010022\",\n",
      "        \"title\": \"Adaptive optics ophthalmoscopy: Application to age-related macular degeneration and vascular diseases.\",\n",
      "        \"authors\": \"Paques M; Meimon S; Rossant F; Rosenbaum D; Mrejen S; Sennlaub F; Grieve K\",\n",
      "        \"doi\": \"10.1016/j.preteyeres.2018.07.001\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Paques M, et al. Adaptive optics ophthalmoscopy: Application to age-related macular degeneration and vascular diseases. Adaptive optics ophthalmoscopy: Application to age-related macular degeneration and vascular diseases. 2018; 66:1-16. doi: 10.1016/j.preteyeres.2018.07.001\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28900746\",\n",
      "        \"title\": \"Electrophysiological features and multimodal imaging in ritonavir-related maculopathy.\",\n",
      "        \"authors\": \"Faure C; Paques M; Audo I\",\n",
      "        \"doi\": \"10.1007/s10633-017-9612-z\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Case Reports\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Faure C, et al. Electrophysiological features and multimodal imaging in ritonavir-related maculopathy. Electrophysiological features and multimodal imaging in ritonavir-related maculopathy. 2017; 135:241-248. doi: 10.1007/s10633-017-9612-z\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27065002\",\n",
      "        \"title\": \"Effects of age, blood pressure and antihypertensive treatments on retinal arterioles remodeling assessed by adaptive optics.\",\n",
      "        \"authors\": \"Rosenbaum D; Mattina A; Koch E; Rossant F; Gallo A; Kachenoura N; Paques M; Redheuil A; Girerd X\",\n",
      "        \"doi\": \"10.1097/HJH.0000000000000894\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Rosenbaum D, et al. Effects of age, blood pressure and antihypertensive treatments on retinal arterioles remodeling assessed by adaptive optics. Effects of age, blood pressure and antihypertensive treatments on retinal arterioles remodeling assessed by adaptive optics. 2016; 34:1115-22. doi: 10.1097/HJH.0000000000000894\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30947025\",\n",
      "        \"title\": \"Vision loss after chemotherapy: an irinotecan-induced retinopathy.\",\n",
      "        \"authors\": \"Boil\\u00e8ve A; Jozwiak M; Malka D; Boige V; Le Roy F; Paques M; Ducreux M\",\n",
      "        \"doi\": \"10.1016/j.ejca.2019.02.015\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Case Reports\",\n",
      "          \"Letter\"\n",
      "        ],\n",
      "        \"citation\": \"Boil\\u00e8ve A, et al. Vision loss after chemotherapy: an irinotecan-induced retinopathy. Vision loss after chemotherapy: an irinotecan-induced retinopathy. 2019; 112:80-82. doi: 10.1016/j.ejca.2019.02.015\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26523388\",\n",
      "        \"title\": \"The Negative Cone Mosaic: A New Manifestation of the Optical Stiles-Crawford Effect in Normal Eyes.\",\n",
      "        \"authors\": \"Miloudi C; Rossant F; Bloch I; Chaumette C; Leseigneur A; Sahel JA; Meimon S; Mrejen S; Paques M\",\n",
      "        \"doi\": \"10.1167/iovs.15-17022\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Miloudi C, et al. The Negative Cone Mosaic: A New Manifestation of the Optical Stiles-Crawford Effect in Normal Eyes. The Negative Cone Mosaic: A New Manifestation of the Optical Stiles-Crawford Effect in Normal Eyes. 2015; 56:7043-50. doi: 10.1167/iovs.15-17022\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26418443\",\n",
      "        \"title\": \"CONE DENSITY LOSS ON ADAPTIVE OPTICS IN EARLY MACULAR TELANGIECTASIA TYPE 2.\",\n",
      "        \"authors\": \"Jacob J; Krivosic V; Paques M; Tadayoni R; Gaudric A\",\n",
      "        \"doi\": \"10.1097/IAE.0000000000000737\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Jacob J, et al. CONE DENSITY LOSS ON ADAPTIVE OPTICS IN EARLY MACULAR TELANGIECTASIA TYPE 2. CONE DENSITY LOSS ON ADAPTIVE OPTICS IN EARLY MACULAR TELANGIECTASIA TYPE 2. 2016; 36:545-51. doi: 10.1097/IAE.0000000000000737\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23620431\",\n",
      "        \"title\": \"Adaptive optics imaging of geographic atrophy.\",\n",
      "        \"authors\": \"Gocho K; Sarda V; Falah S; Sahel JA; Sennlaub F; Benchaboune M; Ullern M; Paques M\",\n",
      "        \"doi\": \"10.1167/iovs.12-10672\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Controlled Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Gocho K, et al. Adaptive optics imaging of geographic atrophy. Adaptive optics imaging of geographic atrophy. 2013; 54:3673-80. doi: 10.1167/iovs.12-10672\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25997175\",\n",
      "        \"title\": \"Venous Nicking Without Arteriovenous Contact: The Role of the Arteriolar Microenvironment in Arteriovenous Nickings.\",\n",
      "        \"authors\": \"Paques M; Brolly A; Benesty J; Lerm\\u00e9 N; Koch E; Rossant F; Bloch I; Girmens JF\",\n",
      "        \"doi\": \"10.1001/jamaophthalmol.2015.1132\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Paques M, et al. Venous Nicking Without Arteriovenous Contact: The Role of the Arteriolar Microenvironment in Arteriovenous Nickings. Venous Nicking Without Arteriovenous Contact: The Role of the Arteriolar Microenvironment in Arteriovenous Nickings. 2015; 133:947-50. doi: 10.1001/jamaophthalmol.2015.1132\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24576889\",\n",
      "        \"title\": \"Retinal vasculitis imaging by adaptive optics.\",\n",
      "        \"authors\": \"Errera MH; Coisy S; Fardeau C; Sahel JA; Kallel S; Westcott M; Bodaghi B; Paques M\",\n",
      "        \"doi\": \"10.1016/j.ophtha.2013.12.036\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Errera MH, et al. Retinal vasculitis imaging by adaptive optics. Retinal vasculitis imaging by adaptive optics. 2014; 121:1311-2.e2. doi: 10.1016/j.ophtha.2013.12.036\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24337723\",\n",
      "        \"title\": \"Functional and high resolution retinal imaging assessment in a case of ocular siderosis.\",\n",
      "        \"authors\": \"Faure C; Gocho K; Le Mer Y; Sahel JA; Paques M; Audo I\",\n",
      "        \"doi\": \"10.1007/s10633-013-9421-y\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Case Reports\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Faure C, et al. Functional and high resolution retinal imaging assessment in a case of ocular siderosis. Functional and high resolution retinal imaging assessment in a case of ocular siderosis. 2014; 128:69-75. doi: 10.1007/s10633-013-9421-y\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27009576\",\n",
      "        \"title\": \"Relationships between retinal arteriole anatomy and aortic geometry and function and peripheral resistance in hypertensives.\",\n",
      "        \"authors\": \"Rosenbaum D; Kachenoura N; Koch E; Paques M; Cluzel P; Redheuil A; Girerd X\",\n",
      "        \"doi\": \"10.1038/hr.2016.26\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Rosenbaum D, et al. Relationships between retinal arteriole anatomy and aortic geometry and function and peripheral resistance in hypertensives. Relationships between retinal arteriole anatomy and aortic geometry and function and peripheral resistance in hypertensives. 2016; 39:536-42. doi: 10.1038/hr.2016.26\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31568064\",\n",
      "        \"title\": \"IN VIVO OBSERVATION OF RETINAL VASCULAR DEPOSITS USING ADAPTIVE OPTICS IMAGING IN FABRY DISEASE.\",\n",
      "        \"authors\": \"Sodi A; Germain DP; Bacherini D; Finocchio L; Pacini B; Marziali E; Lenzetti C; Tanini I; Koraichi F; Coriat C; Nencini P; Olivotto I; Virgili G; Rizzo S; Paques M\",\n",
      "        \"doi\": \"10.1097/IAE.0000000000002648\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\"\n",
      "        ],\n",
      "        \"citation\": \"Sodi A, et al. IN VIVO OBSERVATION OF RETINAL VASCULAR DEPOSITS USING ADAPTIVE OPTICS IMAGING IN FABRY DISEASE. IN VIVO OBSERVATION OF RETINAL VASCULAR DEPOSITS USING ADAPTIVE OPTICS IMAGING IN FABRY DISEASE. 2020; 40:1623-1629. doi: 10.1097/IAE.0000000000002648\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24406779\",\n",
      "        \"title\": \"Morphometric analysis of small arteries in the human retina using adaptive optics imaging: relationship with blood pressure and focal vascular changes.\",\n",
      "        \"authors\": \"Koch E; Rosenbaum D; Brolly A; Sahel JA; Chaumet-Riffaud P; Girerd X; Rossant F; Paques M\",\n",
      "        \"doi\": \"10.1097/HJH.0000000000000095\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Koch E, et al. Morphometric analysis of small arteries in the human retina using adaptive optics imaging: relationship with blood pressure and focal vascular changes. Morphometric analysis of small arteries in the human retina using adaptive optics imaging: relationship with blood pressure and focal vascular changes. 2014; 32:890-8. doi: 10.1097/HJH.0000000000000095\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29369084\",\n",
      "        \"title\": \"DIRECTIONAL VARIABILITY OF FUNDUS REFLECTANCE IN ACUTE MACULAR NEURORETINOPATHY: EVIDENCE FOR A CONTRIBUTION OF THE STILES-CRAWFORD EFFECT.\",\n",
      "        \"authors\": \"Bottin C; Grieve K; Rossant F; Pedinielli A; Mrejen S; Paques M\",\n",
      "        \"doi\": \"10.1097/ICB.0000000000000701\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Case Reports\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Bottin C, et al. DIRECTIONAL VARIABILITY OF FUNDUS REFLECTANCE IN ACUTE MACULAR NEURORETINOPATHY: EVIDENCE FOR A CONTRIBUTION OF THE STILES-CRAWFORD EFFECT. DIRECTIONAL VARIABILITY OF FUNDUS REFLECTANCE IN ACUTE MACULAR NEURORETINOPATHY: EVIDENCE FOR A CONTRIBUTION OF THE STILES-CRAWFORD EFFECT. 2018; 12 Suppl 1:S19-S24. doi: 10.1097/ICB.0000000000000701\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25077537\",\n",
      "        \"title\": \"High-resolution imaging of gunn's dots.\",\n",
      "        \"authors\": \"Paques M; Miloudi C; Kulcsar C; Leseigneur A; Chaumette C; Koch E\",\n",
      "        \"doi\": \"10.1097/IAE.0000000000000269\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Paques M, et al. High-resolution imaging of gunn's dots. High-resolution imaging of gunn's dots. 2015; 35:120-4. doi: 10.1097/IAE.0000000000000269\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26344727\",\n",
      "        \"title\": \"Functional and high-resolution retinal imaging monitoring photoreceptor damage in acute macular neuroretinopathy.\",\n",
      "        \"authors\": \"Audo I; Gocho K; Rossant F; Mohand-Sa\\u00efd S; Loquin K; Bloch I; Sahel JA; Paques M\",\n",
      "        \"doi\": \"10.1007/s00417-015-3136-6\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Case Reports\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Audo I, et al. Functional and high-resolution retinal imaging monitoring photoreceptor damage in acute macular neuroretinopathy. Functional and high-resolution retinal imaging monitoring photoreceptor damage in acute macular neuroretinopathy. 2016; 254:855-64. doi: 10.1007/s00417-015-3136-6\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31972545\",\n",
      "        \"title\": \"IGF-1 is an independent predictor of retinal arterioles remodeling in subjects with uncontrolled acromegaly.\",\n",
      "        \"authors\": \"Gallo A; Chaigneau E; Jublanc C; Rosenbaum D; Mattina A; Paques M; Rossant F; Girerd X; Leban M; Bruckert E\",\n",
      "        \"doi\": \"10.1530/EJE-19-0390\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Gallo A, et al. IGF-1 is an independent predictor of retinal arterioles remodeling in subjects with uncontrolled acromegaly. IGF-1 is an independent predictor of retinal arterioles remodeling in subjects with uncontrolled acromegaly. 2020; 182:375-383. doi: 10.1530/EJE-19-0390\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31922497\",\n",
      "        \"title\": \"ATTENUATION OUTER RETINAL BANDS ON OPTICAL COHERENCE TOMOGRAPHY FOLLOWING MACULAR EDEMA: A Possible Manifestation of Photoreceptor Misalignment.\",\n",
      "        \"authors\": \"Paques M; Rossant F; Finocchio L; Grieve K; Sahel JA; Pedinielli A; Mrejen S\",\n",
      "        \"doi\": \"10.1097/IAE.0000000000002738\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Paques M, et al. ATTENUATION OUTER RETINAL BANDS ON OPTICAL COHERENCE TOMOGRAPHY FOLLOWING MACULAR EDEMA: A Possible Manifestation of Photoreceptor Misalignment. ATTENUATION OUTER RETINAL BANDS ON OPTICAL COHERENCE TOMOGRAPHY FOLLOWING MACULAR EDEMA: A Possible Manifestation of Photoreceptor Misalignment. 2020; 40:2232-2239. doi: 10.1097/IAE.0000000000002738\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31573376\",\n",
      "        \"title\": \"High-Resolution Imaging of Retinal Vasculitis by Flood Illumination Adaptive Optics Ophthalmoscopy: A Follow-up Study.\",\n",
      "        \"authors\": \"Errera MH; Laguarrigue M; Rossant F; Koch E; Chaumette C; Fardeau C; Westcott M; Sahel JA; Bodaghi B; Benesty J; Paques M\",\n",
      "        \"doi\": \"10.1080/09273948.2019.1646773\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Errera MH, et al. High-Resolution Imaging of Retinal Vasculitis by Flood Illumination Adaptive Optics Ophthalmoscopy: A Follow-up Study. High-Resolution Imaging of Retinal Vasculitis by Flood Illumination Adaptive Optics Ophthalmoscopy: A Follow-up Study. 2020; 28:1171-1180. doi: 10.1080/09273948.2019.1646773\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25284764\",\n",
      "        \"title\": \"Meaning of visualizing retinal cone mosaic on adaptive optics images.\",\n",
      "        \"authors\": \"Jacob J; Paques M; Krivosic V; Dupas B; Couturier A; Kulcsar C; Tadayoni R; Massin P; Gaudric A\",\n",
      "        \"doi\": \"10.1016/j.ajo.2014.09.043\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Case Reports\",\n",
      "          \"Journal Article\",\n",
      "          \"Observational Study\"\n",
      "        ],\n",
      "        \"citation\": \"Jacob J, et al. Meaning of visualizing retinal cone mosaic on adaptive optics images. Meaning of visualizing retinal cone mosaic on adaptive optics images. 2015; 159:118-23.e1. doi: 10.1016/j.ajo.2014.09.043\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00122538\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"23719348\",\n",
      "        \"title\": \"A novel pharmacokinetic approach to predict virologic failure in HIV-1-infected paediatric patients.\",\n",
      "        \"authors\": \"Bouazza N; Tr\\u00e9luyer JM; Msellati P; Van de Perre P; Diagbouga S; Nacro B; Hien H; Zoure E; Rouet F; Ouiminga A; Blanche S; Hirt D; Urien S\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32835caad1\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bouazza N, et al. A novel pharmacokinetic approach to predict virologic failure in HIV-1-infected paediatric patients. A novel pharmacokinetic approach to predict virologic failure in HIV-1-infected paediatric patients. 2013; 27:761-8. doi: 10.1097/QAD.0b013e32835caad1\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20516271\",\n",
      "        \"title\": \"Is the recommended once-daily dose of lamivudine optimal in West African HIV-infected children?\",\n",
      "        \"authors\": \"Bouazza N; Hirt D; Bardin C; Diagbouga S; Nacro B; Hien H; Zoure E; Rouet F; Ouiminga A; Blanche S; Van De Perre P; Tr\\u00e9luyer JM; Msellati P; Urien S\",\n",
      "        \"doi\": \"10.1128/AAC.00306-10\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Bouazza N, et al. Is the recommended once-daily dose of lamivudine optimal in West African HIV-infected children?. Is the recommended once-daily dose of lamivudine optimal in West African HIV-infected children?. 2010; 54:3280-6. doi: 10.1128/AAC.00306-10\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21857286\",\n",
      "        \"title\": \"Short-term virological efficacy, immune reconstitution, tolerance, and adherence of once-daily dosing of didanosine, lamivudine, and efavirenz in HIV-1-infected African children: ANRS 12103 Burkiname.\",\n",
      "        \"authors\": \"Barro M; Some J; Foulongne V; Diasso Y; Zour\\u00e9 E; Hien H; Fran\\u00e7ois R; Michel S; Drabo A; Tamboura H; Ouiminga A; Diagbouga S; Hien A; Yam\\u00e9ogo S; Van De Perre P; Nacro B; Msellati P\",\n",
      "        \"doi\": \"10.1097/QAI.0b013e31821fd64f\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Barro M, et al. Short-term virological efficacy, immune reconstitution, tolerance, and adherence of once-daily dosing of didanosine, lamivudine, and efavirenz in HIV-1-infected African children: ANRS 12103 Burkiname. Short-term virological efficacy, immune reconstitution, tolerance, and adherence of once-daily dosing of didanosine, lamivudine, and efavirenz in HIV-1-infected African children: ANRS 12103 Burkiname. 2011; 57 Suppl 1:S44-9. doi: 10.1097/QAI.0b013e31821fd64f\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01426243\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"30096071\",\n",
      "        \"title\": \"Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients.\",\n",
      "        \"authors\": \"Colin de Verdiere N; Durier C; Samri A; Meiffredy V; Launay O; Matheron S; Mercier-Delarue S; Even S; Aboulker JP; Molina JM; Autran B; Simon F; ANRS EP46 NOVAA Group\",\n",
      "        \"doi\": \"10.1097/QAD.0000000000001963\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Colin de Verdiere N, et al. Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients. Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients. 2018; 32:2291-2299. doi: 10.1097/QAD.0000000000001963\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26314624\",\n",
      "        \"title\": \"Molecular characterization of the 17D-204 yellow fever vaccine.\",\n",
      "        \"authors\": \"Salmona M; Gazaignes S; Mercier-Delarue S; Garnier F; Korimbocus J; Colin de Verdi\\u00e8re N; LeGoff J; Roques P; Simon F\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2015.08.055\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Salmona M, et al. Molecular characterization of the 17D-204 yellow fever vaccine. Molecular characterization of the 17D-204 yellow fever vaccine. 2015; 33:5432-5436. doi: 10.1016/j.vaccine.2015.08.055\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04824638\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02113943\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00299143\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03870438\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"38484756\",\n",
      "        \"title\": \"Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial.\",\n",
      "        \"authors\": \"Kankasa C; Mennecier A; Sakana BLD; Mol\\u00e8s JP; Mwiya M; Chunda-Liyoka C; D'Ottavi M; Tassembedo S; Wilfred-Tonga MM; Fao P; Rutagwera D; Matoka B; Kania D; Taofiki OA; Tyllesk\\u00e4r T; Van de Perre P; Nagot N; PROMISE-EPI Trial Group\",\n",
      "        \"doi\": \"10.1016/S0140-6736(23)02464-9\",\n",
      "        \"year\": \"2024\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Kankasa C, et al. Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial. Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial. 2024; (unknown volume):(unknown pages). doi: 10.1016/S0140-6736(23)02464-9\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33872801\",\n",
      "        \"title\": \"Design and challenges of a large HIV prevention clinical study on mother-to-child transmission: ANRS 12397 PROMISE-EPI study in Zambia and Burkina Faso.\",\n",
      "        \"authors\": \"Mennecier A; Kankasa C; Fao P; Moles JP; Eymard-Duvernay S; Mwiya M; Kania D; Chunda-Liyoka C; Sakana L; Rutagwera D; Tassembedo S; Wilfred-Tonga MM; Mosqueira B; Tyllesk\\u00e4r T; Nagot N; Van de Perre P; ANRS 12397 Study group\",\n",
      "        \"doi\": \"10.1016/j.cct.2021.106402\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial Protocol\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mennecier A, et al. Design and challenges of a large HIV prevention clinical study on mother-to-child transmission: ANRS 12397 PROMISE-EPI study in Zambia and Burkina Faso. Design and challenges of a large HIV prevention clinical study on mother-to-child transmission: ANRS 12397 PROMISE-EPI study in Zambia and Burkina Faso. 2021; 105:106402. doi: 10.1016/j.cct.2021.106402\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26603917\",\n",
      "        \"title\": \"Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial.\",\n",
      "        \"authors\": \"Nagot N; Kankasa C; Tumwine JK; Meda N; Hofmeyr GJ; Vallo R; Mwiya M; Kwagala M; Traore H; Sunday A; Singata M; Siuluta C; Some E; Rutagwera D; Neboua D; Ndeezi G; Jackson D; Mar\\u00e9chal V; Neveu D; Engebretsen IMS; Lombard C; Blanche S; Sommerfelt H; Rekacewicz C; Tyllesk\\u00e4r T; Van de Perre P; ANRS 12174 Trial Group\",\n",
      "        \"doi\": \"10.1016/S0140-6736(15)00984-8\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nagot N, et al. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. 2016; 387:566-573. doi: 10.1016/S0140-6736(15)00984-8\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01605890\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29590335\",\n",
      "        \"title\": \"First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2).\",\n",
      "        \"authors\": \"Matheron S; Descamps D; Gallien S; Besseghir A; Sellier P; Blum L; Mortier E; Charpentier C; Tubiana R; Damond F; Peytavin G; Ponscarme D; Collin F; Brun-Vezinet F; Chene G; France REcherche Nord&Sud Sida-Hiv H\\u00e9patites (ANRS) 159 HIV-2 Trial Study Group\",\n",
      "        \"doi\": \"10.1093/cid/ciy245\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Matheron S, et al. First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2). First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2). 2018; 67:1161-1167. doi: 10.1093/cid/ciy245\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00391638\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02323308\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02384967\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29905808\",\n",
      "        \"title\": \"Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100\\u2009mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study.\",\n",
      "        \"authors\": \"L\\u00ea MP; Chaix ML; Chevret S; Bertrand J; Raffi F; Gallien S; El Abbassi EMB; Katlama C; Delobel P; Yazdanpanah Y; Saillard J; Molina JM; Peytavin G; ANRS 165 DARULIGHT Study Group\",\n",
      "        \"doi\": \"10.1093/jac/dky193\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"L\\u00ea MP, et al. Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100\\u2009mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study. Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100\\u2009mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study. 2018; 73:2120-2128. doi: 10.1093/jac/dky193\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00988767\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"15382173\",\n",
      "        \"title\": \"Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers.\",\n",
      "        \"authors\": \"Mancini-Bourgine M; Fontaine H; Scott-Algara D; Pol S; Br\\u00e9chot C; Michel ML\",\n",
      "        \"doi\": \"10.1002/hep.20408\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mancini-Bourgine M, et al. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers. 2004; 40:874-82. doi: 10.1002/hep.20408\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16310901\",\n",
      "        \"title\": \"Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers.\",\n",
      "        \"authors\": \"Mancini-Bourgine M; Fontaine H; Br\\u00e9chot C; Pol S; Michel ML\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2005.08.013\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mancini-Bourgine M, et al. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. 2006; 24:4482-9. doi: 10.1016/j.vaccine.2005.08.013\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20090916\",\n",
      "        \"title\": \"Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination.\",\n",
      "        \"authors\": \"Scott-Algara D; Mancini-Bourgine M; Fontaine H; Pol S; Michel ML\",\n",
      "        \"doi\": \"10.1371/journal.pone.0008761\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Scott-Algara D, et al. Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination. Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination. 2010; 5:e8761. doi: 10.1371/journal.pone.0008761\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00323804\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04849767\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"34916316\",\n",
      "        \"title\": \"Living conditions, HIV and gender affirmation care pathways of transgender people living with HIV in France: a nationwide, comprehensive, cross-sectional, community-based research protocol (ANRS Trans&HIV).\",\n",
      "        \"authors\": \"Mora M; Rincon G; Bourrelly M; Maradan G; Freire Maresca A; Michard F; Rouveix E; Pannetier J; Leriche D; Alain T; Yazdanpanah Y; Michels D; Spire B\",\n",
      "        \"doi\": \"10.1136/bmjopen-2021-052691\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mora M, et al. Living conditions, HIV and gender affirmation care pathways of transgender people living with HIV in France: a nationwide, comprehensive, cross-sectional, community-based research protocol (ANRS Trans&HIV). Living conditions, HIV and gender affirmation care pathways of transgender people living with HIV in France: a nationwide, comprehensive, cross-sectional, community-based research protocol (ANRS Trans&HIV). 2021; 11:e052691. doi: 10.1136/bmjopen-2021-052691\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03047967\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00120367\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"21738597\",\n",
      "        \"title\": \"Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy.\",\n",
      "        \"authors\": \"Gasnault J; Costagliola D; Hendel-Chavez H; Dulioust A; Pakianather S; Mazet AA; de Goer de Herve MG; Lancar R; Lascaux AS; Porte L; Delfraissy JF; Taoufik Y; ANRS 125 Trial Team\",\n",
      "        \"doi\": \"10.1371/journal.pone.0020967\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Gasnault J, et al. Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy. Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy. 2011; 6:e20967. doi: 10.1371/journal.pone.0020967\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01038401\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04484740\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03078439\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"38408861\",\n",
      "        \"title\": \"Birth weight and head circumference discordance and outcome in preterms: results from the EPIPAGE-2 cohort.\",\n",
      "        \"authors\": \"Guellec I; Brunet A; Lapillonne A; Taine M; Torchin H; Favrais G; Gascoin G; Simon L; Heude B; Scherdel P; Kayem G; Delorme P; Jarreau PH; Ancel PY\",\n",
      "        \"doi\": \"10.1136/archdischild-2023-326336\",\n",
      "        \"year\": \"2024\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Guellec I, et al. Birth weight and head circumference discordance and outcome in preterms: results from the EPIPAGE-2 cohort. Birth weight and head circumference discordance and outcome in preterms: results from the EPIPAGE-2 cohort. 2024; (unknown volume):(unknown pages). doi: 10.1136/archdischild-2023-326336\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00148863\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"23190183\",\n",
      "        \"title\": \"Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI).\",\n",
      "        \"authors\": \"Couzigou P; P\\u00e9rusat S; Bourli\\u00e8re M; Trimoulet P; Poynard T; Leroy V; Marcellin P; Foucher J; Bronowicki JP; Ch\\u00eane G; ANRS HC16 GAMMATRI Trial Group\",\n",
      "        \"doi\": \"10.1111/jgh.12060\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Couzigou P, et al. Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI). Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI). 2013; 28:329-34. doi: 10.1111/jgh.12060\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01548586\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"11723286\",\n",
      "        \"title\": \"Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans.\",\n",
      "        \"authors\": \"Nitsche MA; Paulus W\",\n",
      "        \"doi\": \"10.1212/wnl.57.10.1899\",\n",
      "        \"year\": \"2001\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nitsche MA and Paulus W. Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. 2001; 57:1899-901. doi: 10.1212/wnl.57.10.1899\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16002441\",\n",
      "        \"title\": \"Modulating parameters of excitability during and after transcranial direct current stimulation of the human motor cortex.\",\n",
      "        \"authors\": \"Nitsche MA; Seeber A; Frommann K; Klein CC; Rochford C; Nitsche MS; Fricke K; Liebetanz D; Lang N; Antal A; Paulus W; Tergau F\",\n",
      "        \"doi\": \"10.1113/jphysiol.2005.092429\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nitsche MA, et al. Modulating parameters of excitability during and after transcranial direct current stimulation of the human motor cortex. Modulating parameters of excitability during and after transcranial direct current stimulation of the human motor cortex. 2005; 568:291-303. doi: 10.1113/jphysiol.2005.092429\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"8756819\",\n",
      "        \"title\": \"Impairment of central motor conduction to the diaphragm in stroke.\",\n",
      "        \"authors\": \"Similowski T; Catala M; Rancurel G; Derenne JP\",\n",
      "        \"doi\": \"10.1164/ajrccm.154.2.8756819\",\n",
      "        \"year\": \"1996\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Similowski T, et al. Impairment of central motor conduction to the diaphragm in stroke. Impairment of central motor conduction to the diaphragm in stroke. 1996; 154:436-41. doi: 10.1164/ajrccm.154.2.8756819\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15634731\",\n",
      "        \"title\": \"Effects of non-invasive cortical stimulation on skilled motor function in chronic stroke.\",\n",
      "        \"authors\": \"Hummel F; Celnik P; Giraux P; Floel A; Wu WH; Gerloff C; Cohen LG\",\n",
      "        \"doi\": \"10.1093/brain/awh369\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Controlled Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hummel F, et al. Effects of non-invasive cortical stimulation on skilled motor function in chronic stroke. Effects of non-invasive cortical stimulation on skilled motor function in chronic stroke. 2005; 128:490-9. doi: 10.1093/brain/awh369\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20161639\",\n",
      "        \"title\": \"Focal and bi-directional modulation of lower limb motor cortex using anodal transcranial direct current stimulation.\",\n",
      "        \"authors\": \"Madhavan S; Stinear JW\",\n",
      "        \"doi\": \"10.1016/j.brs.2009.06.005\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Madhavan S and Stinear JW. Focal and bi-directional modulation of lower limb motor cortex using anodal transcranial direct current stimulation. Focal and bi-directional modulation of lower limb motor cortex using anodal transcranial direct current stimulation. 2010; 3:42. doi: 10.1016/j.brs.2009.06.005\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22085959\",\n",
      "        \"title\": \"Transcranial direct current stimulation--update 2011.\",\n",
      "        \"authors\": \"Nitsche MA; Paulus W\",\n",
      "        \"doi\": \"10.3233/RNN-2011-0618\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Historical Article\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Nitsche MA and Paulus W. Transcranial direct current stimulation--update 2011. Transcranial direct current stimulation--update 2011. 2011; 29:463-92. doi: 10.3233/RNN-2011-0618\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"10990547\",\n",
      "        \"title\": \"Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation.\",\n",
      "        \"authors\": \"Nitsche MA; Paulus W\",\n",
      "        \"doi\": \"10.1111/j.1469-7793.2000.t01-1-00633.x\",\n",
      "        \"year\": \"2000\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nitsche MA and Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. 2000; 527 Pt 3:633-9. doi: 10.1111/j.1469-7793.2000.t01-1-00633.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19805746\",\n",
      "        \"title\": \"Impact of transcranial direct current stimulation on spinal network excitability in humans.\",\n",
      "        \"authors\": \"Roche N; Lackmy A; Achache V; Bussel B; Katz R\",\n",
      "        \"doi\": \"10.1113/jphysiol.2009.177550\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Roche N, et al. Impact of transcranial direct current stimulation on spinal network excitability in humans. Impact of transcranial direct current stimulation on spinal network excitability in humans. 2009; 587:5653-64. doi: 10.1113/jphysiol.2009.177550\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15272049\",\n",
      "        \"title\": \"Demonstration of a second rapidly conducting cortico-diaphragmatic pathway in humans.\",\n",
      "        \"authors\": \"Sharshar T; Hopkinson NS; Jonville S; Prigent H; Carlier R; Dayer MJ; Swallow EB; Lofaso F; Moxham J; Polkey MI\",\n",
      "        \"doi\": \"10.1113/jphysiol.2004.061150\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Sharshar T, et al. Demonstration of a second rapidly conducting cortico-diaphragmatic pathway in humans. Demonstration of a second rapidly conducting cortico-diaphragmatic pathway in humans. 2004; 560:897-908. doi: 10.1113/jphysiol.2004.061150\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00302822\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00196625\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"15456093\",\n",
      "        \"title\": \"Salvage therapy with amprenavir, lopinavir and ritonavir 200 mg/d or 400 mg/d in HIV-infected patients in virological failure.\",\n",
      "        \"authors\": \"Raguin G; Ch\\u00eane G; Morand-Joubert L; Taburet AM; Droz C; Le Tiec C; Clavel F; Girard PM; Puzzle 1 Study Group\",\n",
      "        \"doi\": null,\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Raguin G, et al. Salvage therapy with amprenavir, lopinavir and ritonavir 200 mg/d or 400 mg/d in HIV-infected patients in virological failure. Salvage therapy with amprenavir, lopinavir and ritonavir 200 mg/d or 400 mg/d in HIV-infected patients in virological failure. 2004; 9:615-25.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15060509\",\n",
      "        \"title\": \"Interactions between amprenavir and the lopinavir-ritonavir combination in heavily pretreated patients infected with human immunodeficiency virus.\",\n",
      "        \"authors\": \"Taburet AM; Raguin G; Le Tiec C; Droz C; Barrail A; Vincent I; Morand-Joubert L; Ch\\u00eane G; Clavel F; Girard PM\",\n",
      "        \"doi\": \"10.1016/j.clpt.2003.12.013\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Taburet AM, et al. Interactions between amprenavir and the lopinavir-ritonavir combination in heavily pretreated patients infected with human immunodeficiency virus. Interactions between amprenavir and the lopinavir-ritonavir combination in heavily pretreated patients infected with human immunodeficiency virus. 2004; 75:310-23. doi: 10.1016/j.clpt.2003.12.013\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01188525\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00670839\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26257021\",\n",
      "        \"title\": \"Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.\",\n",
      "        \"authors\": \"Rey D; Piroth L; Wendling MJ; Miailhes P; Michel ML; Dufour C; Haour G; Sogni P; Rohel A; Ajana F; Billaud E; Molina JM; Launay O; Carrat F; ANRS HB04 B-BOOST study group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(15)00220-0\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Rey D, et al. Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial. Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial. 2015; 15:1283-91. doi: 10.1016/S1473-3099(15)00220-0\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00158522\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"15977225\",\n",
      "        \"title\": \"Surveillance of acute hepatitis C in Cairo, Egypt.\",\n",
      "        \"authors\": \"El Gaafary MM; Rekacewicz C; Abdel-Rahman AG; Allam MF; El Hosseiny M; Hamid MA; Colombani F; Sultan Y; El-Aidy S; Fontanet A; Mohamed MK\",\n",
      "        \"doi\": \"10.1002/jmv.20392\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"El Gaafary MM, et al. Surveillance of acute hepatitis C in Cairo, Egypt. Surveillance of acute hepatitis C in Cairo, Egypt. 2005; 76:520-5. doi: 10.1002/jmv.20392\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16434426\",\n",
      "        \"title\": \"Higher clearance of hepatitis C virus infection in females compared with males.\",\n",
      "        \"authors\": \"Bakr I; Rekacewicz C; El Hosseiny M; Ismail S; El Daly M; El-Kafrawy S; Esmat G; Hamid MA; Mohamed MK; Fontanet A\",\n",
      "        \"doi\": \"10.1136/gut.2005.078147\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bakr I, et al. Higher clearance of hepatitis C virus infection in females compared with males. Higher clearance of hepatitis C virus infection in females compared with males. 2006; 55:1183-7. doi: 10.1136/gut.2005.078147\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00196586\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04808986\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02626286\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"33753460\",\n",
      "        \"title\": \"Decrease in incidence of sexually transmitted infections symptoms in men who have sex with men enrolled in a quarterly HIV prevention and care programme in West Africa (CohMSM ANRS 12324-Expertise France).\",\n",
      "        \"authors\": \"Yaya I; Diallo F; Kouam\\u00e9 MJ; Agboyibor MK; Traor\\u00e9 I; Coulibaly A; Maiga K; Mora M; Palvadeau P; Dah ETT; Mensah E; Anoma C; Demb\\u00e9l\\u00e9 Keita B; Spire B; Laurent C; CohMSM Study Group\",\n",
      "        \"doi\": \"10.1136/sextrans-2020-054755\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Yaya I, et al. Decrease in incidence of sexually transmitted infections symptoms in men who have sex with men enrolled in a quarterly HIV prevention and care programme in West Africa (CohMSM ANRS 12324-Expertise France). Decrease in incidence of sexually transmitted infections symptoms in men who have sex with men enrolled in a quarterly HIV prevention and care programme in West Africa (CohMSM ANRS 12324-Expertise France). 2022; 98:85-94. doi: 10.1136/sextrans-2020-054755\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34352834\",\n",
      "        \"title\": \"Rapid antiretroviral therapy initiation and its effect on treatment response in MSM in West Africa.\",\n",
      "        \"authors\": \"Dah TTE; Yaya I; Mensah E; Coulibaly A; Kouam\\u00e9 JM; Traor\\u00e9 I; Mora M; Palvadeau P; Anoma C; Keita BD; Spire B; Laurent C; CohMSM Study Group\",\n",
      "        \"doi\": \"10.1097/QAD.0000000000003046\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Dah TTE, et al. Rapid antiretroviral therapy initiation and its effect on treatment response in MSM in West Africa. Rapid antiretroviral therapy initiation and its effect on treatment response in MSM in West Africa. 2021; 35:2201-2210. doi: 10.1097/QAD.0000000000003046\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34022820\",\n",
      "        \"title\": \"Adherence to quarterly HIV prevention services and its impact on HIV incidence in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France).\",\n",
      "        \"authors\": \"Dah TTE; Yaya I; Sagaon-Teyssier L; Coulibaly A; Kouam\\u00e9 MJ; Agboyibor MK; Maiga K; Traor\\u00e9 I; Mora M; Palvadeau P; Rojas-Castro D; Diallo F; Mensah E; Anoma C; Keita BD; Spire B; Laurent C; CohMSM Study Group\",\n",
      "        \"doi\": \"10.1186/s12889-021-10994-4\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Dah TTE, et al. Adherence to quarterly HIV prevention services and its impact on HIV incidence in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France). Adherence to quarterly HIV prevention services and its impact on HIV incidence in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France). 2021; 21:972. doi: 10.1186/s12889-021-10994-4\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01207986\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03537196\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"20041309\",\n",
      "        \"title\": \"Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection.\",\n",
      "        \"authors\": \"Clatts MC; Col\\u00f3n-L\\u00f3pez V; Giang LM; Goldsamt LA\",\n",
      "        \"doi\": \"10.1007/s11524-009-9417-9\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Clatts MC, et al. Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection. Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection. 2010; 87:278-291. doi: 10.1007/s11524-009-9417-9\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27667367\",\n",
      "        \"title\": \"EASL Recommendations on Treatment of Hepatitis C 2016.\",\n",
      "        \"authors\": \"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu\",\n",
      "        \"doi\": \"10.1016/j.jhep.2016.09.001\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Practice Guideline\"\n",
      "        ],\n",
      "        \"citation\": \"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL Recommendations on Treatment of Hepatitis C 2016. EASL Recommendations on Treatment of Hepatitis C 2016. 2017; 66:153-194. doi: 10.1016/j.jhep.2016.09.001\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22098550\",\n",
      "        \"title\": \"Liver disease in Viet Nam: screening, surveillance, management and education: a 5-year plan and call to action.\",\n",
      "        \"authors\": \"Gish RG; Bui TD; Nguyen CT; Nguyen DT; Tran HV; Tran DM; Trinh HN; International Group for Liver Health in Viet Nam\",\n",
      "        \"doi\": \"10.1111/j.1440-1746.2011.06974.x\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Gish RG, et al. Liver disease in Viet Nam: screening, surveillance, management and education: a 5-year plan and call to action. Liver disease in Viet Nam: screening, surveillance, management and education: a 5-year plan and call to action. 2012; 27:238-47. doi: 10.1111/j.1440-1746.2011.06974.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27178119\",\n",
      "        \"title\": \"Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.\",\n",
      "        \"authors\": \"Des Jarlais D; Duong HT; Pham Minh K; Khuat OH; Nham TT; Arasteh K; Feelemyer J; Heckathorn DD; Peries M; Moles JP; Laureillard D; Nagot N; (The Drive Study Team)\",\n",
      "        \"doi\": \"10.1080/09540121.2016.1178698\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Des Jarlais D, et al. Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions. 2016; 28:1312-5. doi: 10.1080/09540121.2016.1178698\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25920094\",\n",
      "        \"title\": \"From non-A, non-B hepatitis to hepatitis C virus cure.\",\n",
      "        \"authors\": \"Pawlotsky JM; Feld JJ; Zeuzem S; Hoofnagle JH\",\n",
      "        \"doi\": \"10.1016/j.jhep.2015.02.006\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Pawlotsky JM, et al. From non-A, non-B hepatitis to hepatitis C virus cure. From non-A, non-B hepatitis to hepatitis C virus cure. 2015; 62:S87-99. doi: 10.1016/j.jhep.2015.02.006\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27427455\",\n",
      "        \"title\": \"The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.\",\n",
      "        \"authors\": \"Altice FL; Azbel L; Stone J; Brooks-Pollock E; Smyrnov P; Dvoriak S; Taxman FS; El-Bassel N; Martin NK; Booth R; St\\u00f6ver H; Dolan K; Vickerman P\",\n",
      "        \"doi\": \"10.1016/S0140-6736(16)30856-X\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, U.S. Gov't, Non-P.H.S.\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Altice FL, et al. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. 2016; 388:1228-48. doi: 10.1016/S0140-6736(16)30856-X\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22564041\",\n",
      "        \"title\": \"Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings.\",\n",
      "        \"authors\": \"Vickerman P; Martin N; Turner K; Hickman M\",\n",
      "        \"doi\": \"10.1111/j.1360-0443.2012.03932.x\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Vickerman P, et al. Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings. Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings. 2012; 107:1984-95. doi: 10.1111/j.1360-0443.2012.03932.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27148964\",\n",
      "        \"title\": \"High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262).\",\n",
      "        \"authors\": \"Nguyen Truong T; Laureillard D; Lacombe K; Duong Thi H; Pham Thi Hanh P; Truong Thi Xuan L; Chu Thi N; Luong Que A; Vu Hai V; Nagot N; Tuaillon E; Dominguez S; Lemoine M\",\n",
      "        \"doi\": \"10.1371/journal.pone.0153744\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nguyen Truong T, et al. High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262). High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262). 2016; 11:e0153744. doi: 10.1371/journal.pone.0153744\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27349488\",\n",
      "        \"title\": \"Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals.\",\n",
      "        \"authors\": \"Conti F; Buonfiglioli F; Scuteri A; Crespi C; Bolondi L; Caraceni P; Foschi FG; Lenzi M; Mazzella G; Verucchi G; Andreone P; Brillanti S\",\n",
      "        \"doi\": \"10.1016/j.jhep.2016.06.015\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Conti F, et al. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. 2016; 65:727-733. doi: 10.1016/j.jhep.2016.06.015\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33208326\",\n",
      "        \"title\": \"Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C).\",\n",
      "        \"authors\": \"Rapoud D; Quillet C; Pham Minh K; Vu Hai V; Nguyen Thanh B; Nham Thi Tuyet T; Tran Thi H; Mol\\u00e8s JP; Vallo R; Michel L; Feelemyer J; Weiss L; Lemoine M; Vickerman P; Fraser H; Duong Thi H; Khuat Thi Hai O; Des Jarlais D; Nagot N; Laureillard D; DRIVE-C Study Group\",\n",
      "        \"doi\": \"10.1136/bmjopen-2020-039234\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Rapoud D, et al. Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C). Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C). 2020; 10:e039234. doi: 10.1136/bmjopen-2020-039234\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20196807\",\n",
      "        \"title\": \"Vietnamese community screening for hepatitis B virus and hepatitis C virus.\",\n",
      "        \"authors\": \"Kallman JB; Tran S; Arsalla A; Haddad D; Stepanova M; Fang Y; Wrobel VJ; Srishord M; Younossi ZM\",\n",
      "        \"doi\": \"10.1111/j.1365-2893.2010.01278.x\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kallman JB, et al. Vietnamese community screening for hepatitis B virus and hepatitis C virus. Vietnamese community screening for hepatitis B virus and hepatitis C virus. 2011; 18:70-6. doi: 10.1111/j.1365-2893.2010.01278.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23884064\",\n",
      "        \"title\": \"Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy.\",\n",
      "        \"authors\": \"Martin NK; Hickman M; Hutchinson SJ; Goldberg DJ; Vickerman P\",\n",
      "        \"doi\": \"10.1093/cid/cit296\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Martin NK, et al. Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. 2013; 57 Suppl 2:S39-45. doi: 10.1093/cid/cit296\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23728143\",\n",
      "        \"title\": \"Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements.\",\n",
      "        \"authors\": \"Grebely J; Matthews GV; Lloyd AR; Dore GJ\",\n",
      "        \"doi\": \"10.1093/cid/cit377\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Grebely J, et al. Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements. Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements. 2013; 57:1014-20. doi: 10.1093/cid/cit377\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25086286\",\n",
      "        \"title\": \"Global epidemiology and genotype distribution of the hepatitis C virus infection.\",\n",
      "        \"authors\": \"Gower E; Estes C; Blach S; Razavi-Shearer K; Razavi H\",\n",
      "        \"doi\": \"10.1016/j.jhep.2014.07.027\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Gower E, et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. Global epidemiology and genotype distribution of the hepatitis C virus infection. 2014; 61:S45-57. doi: 10.1016/j.jhep.2014.07.027\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23553643\",\n",
      "        \"title\": \"Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals.\",\n",
      "        \"authors\": \"Martin NK; Vickerman P; Grebely J; Hellard M; Hutchinson SJ; Lima VD; Foster GR; Dillon JF; Goldberg DJ; Dore GJ; Hickman M\",\n",
      "        \"doi\": \"10.1002/hep.26431\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Martin NK, et al. Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. 2013; 58:1598-609. doi: 10.1002/hep.26431\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19839502\",\n",
      "        \"title\": \"High prevalence of Hepatitis C virus genotype 6 in Vietnam.\",\n",
      "        \"authors\": \"Pham DA; Leuangwutiwong P; Jittmittraphap A; Luplertlop N; Bach HK; Akkarathamrongsin S; Theamboonlers A; Poovorawan Y\",\n",
      "        \"doi\": null,\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Pham DA, et al. High prevalence of Hepatitis C virus genotype 6 in Vietnam. High prevalence of Hepatitis C virus genotype 6 in Vietnam. 2009; 27:153-60.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20572071\",\n",
      "        \"title\": \"Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam.\",\n",
      "        \"authors\": \"Tanimoto T; Nguyen HC; Ishizaki A; Chung PT; Hoang TT; Nguyen VT; Kageyama S; Oka S; Pham VT; Ichimura H\",\n",
      "        \"doi\": \"10.1002/jmv.21787\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Tanimoto T, et al. Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam. Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam. 2010; 82:1355-63. doi: 10.1002/jmv.21787\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23675659\",\n",
      "        \"title\": \"Current and future therapies for hepatitis C virus infection.\",\n",
      "        \"authors\": \"Liang TJ; Ghany MG\",\n",
      "        \"doi\": \"10.1056/NEJMra1213651\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Liang TJ and Ghany MG. Current and future therapies for hepatitis C virus infection. Current and future therapies for hepatitis C virus infection. 2013; 368:1907-17. doi: 10.1056/NEJMra1213651\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25245939\",\n",
      "        \"title\": \"Prevention, treatment and care of hepatitis C virus infection among people who inject drugs.\",\n",
      "        \"authors\": \"Bruggmann P; Grebely J\",\n",
      "        \"doi\": \"10.1016/j.drugpo.2014.08.014\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bruggmann P and Grebely J. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs. 2015; 26 Suppl 1:S22-6. doi: 10.1016/j.drugpo.2014.08.014\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23172780\",\n",
      "        \"title\": \"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.\",\n",
      "        \"authors\": \"Mohd Hanafiah K; Groeger J; Flaxman AD; Wiersma ST\",\n",
      "        \"doi\": \"10.1002/hep.26141\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Meta-Analysis\",\n",
      "          \"Review\",\n",
      "          \"Systematic Review\"\n",
      "        ],\n",
      "        \"citation\": \"Mohd Hanafiah K, et al. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. 2013; 57:1333-42. doi: 10.1002/hep.26141\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26298331\",\n",
      "        \"title\": \"Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis.\",\n",
      "        \"authors\": \"Smith DJ; Combellick J; Jordan AE; Hagan H\",\n",
      "        \"doi\": \"10.1016/j.drugpo.2015.07.004\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Meta-Analysis\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Review\",\n",
      "          \"Systematic Review\"\n",
      "        ],\n",
      "        \"citation\": \"Smith DJ, et al. Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis. Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis. 2015; 26:911-21. doi: 10.1016/j.drugpo.2015.07.004\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22828983\",\n",
      "        \"title\": \"Epidemiology, responses, and way forward: the silent epidemic of viral hepatitis and HIV coinfection in Vietnam.\",\n",
      "        \"authors\": \"Sereno L; Mesquita F; Kato M; Jacka D; Nguyen TT; Nguyen TN\",\n",
      "        \"doi\": \"10.1177/1545109712453939\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Sereno L, et al. Epidemiology, responses, and way forward: the silent epidemic of viral hepatitis and HIV coinfection in Vietnam. Epidemiology, responses, and way forward: the silent epidemic of viral hepatitis and HIV coinfection in Vietnam. 2012; 11:311-20. doi: 10.1177/1545109712453939\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04684758\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00121758\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"20625264\",\n",
      "        \"title\": \"Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial.\",\n",
      "        \"authors\": \"Salmon-C\\u00e9ron D; Durier C; Desaint C; Cuzin L; Surenaud M; Hamouda NB; Leli\\u00e8vre JD; Bonnet B; Pialoux G; Poizot-Martin I; Aboulker JP; L\\u00e9vy Y; Launay O; ANRS VAC18 trial group\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32833ce566\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Salmon-C\\u00e9ron D, et al. Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial. Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial. 2010; 24:2211-23. doi: 10.1097/QAD.0b013e32833ce566\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23759749\",\n",
      "        \"title\": \"Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers.\",\n",
      "        \"authors\": \"Richert L; Hue S; Hocini H; Raimbault M; Lacabaratz C; Surenaud M; Wiedemann A; Tisserand P; Durier C; Salmon D; Leli\\u00e8vre JD; Ch\\u00eane G; Thi\\u00e9baut R; L\\u00e9vy Y; ANRS Vaccine Network/Vaccine Research Institute\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32835f5b60\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Richert L, et al. Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers. Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers. 2013; 27:1421-31. doi: 10.1097/QAD.0b013e32835f5b60\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02527096\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00158457\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00136630\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"16055926\",\n",
      "        \"title\": \"Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases.\",\n",
      "        \"authors\": \"Depienne C; Tallaksen C; Lephay JY; Bricka B; Poea-Guyon S; Fontaine B; Labauge P; Brice A; Durr A\",\n",
      "        \"doi\": \"10.1136/jmg.2005.035311\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Letter\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Depienne C, et al. Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases. Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases. 2006; 43:259-65. doi: 10.1136/jmg.2005.035311\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15365159\",\n",
      "        \"title\": \"Mutations in the FGF14 gene are not a major cause of spinocerebellar ataxia in Caucasians.\",\n",
      "        \"authors\": \"Stevanin G; Durr A; Dussert C; Penet C; Brice A\",\n",
      "        \"doi\": \"10.1212/01.wnl.0000137020.30604.1e\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Stevanin G, et al. Mutations in the FGF14 gene are not a major cause of spinocerebellar ataxia in Caucasians. Mutations in the FGF14 gene are not a major cause of spinocerebellar ataxia in Caucasians. 2004; 63:936. doi: 10.1212/01.wnl.0000137020.30604.1e\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17605047\",\n",
      "        \"title\": \"A novel locus for autosomal dominant \\\"uncomplicated\\\" hereditary spastic paraplegia maps to chromosome 8p21.1-q13.3.\",\n",
      "        \"authors\": \"Hanein S; D\\u00fcrr A; Ribai P; Forlani S; Leutenegger AL; Nelson I; Babron MC; Elleuch N; Depienne C; Charon C; Brice A; Stevanin G\",\n",
      "        \"doi\": \"10.1007/s00439-007-0396-1\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hanein S, et al. A novel locus for autosomal dominant \\\"uncomplicated\\\" hereditary spastic paraplegia maps to chromosome 8p21.1-q13.3. A novel locus for autosomal dominant \\\"uncomplicated\\\" hereditary spastic paraplegia maps to chromosome 8p21.1-q13.3. 2007; 122:261-73. doi: 10.1007/s00439-007-0396-1\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16501573\",\n",
      "        \"title\": \"Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes.\",\n",
      "        \"authors\": \"Waters MF; Minassian NA; Stevanin G; Figueroa KP; Bannister JP; Nolte D; Mock AF; Evidente VG; Fee DB; M\\u00fcller U; D\\u00fcrr A; Brice A; Papazian DM; Pulst SM\",\n",
      "        \"doi\": \"10.1038/ng1758\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Waters MF, et al. Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes. Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes. 2006; 38:447-51. doi: 10.1038/ng1758\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15313841\",\n",
      "        \"title\": \"Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14.\",\n",
      "        \"authors\": \"Stevanin G; Hahn V; Lohmann E; Bouslam N; Gouttard M; Soumphonphakdy C; Welter ML; Ollagnon-Roman E; Lemainque A; Ruberg M; Brice A; Durr A\",\n",
      "        \"doi\": \"10.1001/archneur.61.8.1242\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Stevanin G, et al. Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14. Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14. 2004; 61:1242-8. doi: 10.1001/archneur.61.8.1242\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17597328\",\n",
      "        \"title\": \"A de novo SPAST mutation leading to somatic mosaicism is associated with a later age at onset in HSP.\",\n",
      "        \"authors\": \"Depienne C; Fedirko E; Faucheux JM; Forlani S; Bricka B; Goizet C; Lesourd S; Stevanin G; Ruberg M; Durr A; Brice A\",\n",
      "        \"doi\": \"10.1007/s10048-007-0090-4\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Case Reports\",\n",
      "          \"Letter\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Depienne C, et al. A de novo SPAST mutation leading to somatic mosaicism is associated with a later age at onset in HSP. A de novo SPAST mutation leading to somatic mosaicism is associated with a later age at onset in HSP. 2007; 8:231-3. doi: 10.1007/s10048-007-0090-4\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22491195\",\n",
      "        \"title\": \"Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegia.\",\n",
      "        \"authors\": \"Tezenas du Montcel S; Charles P; Goizet C; Marelli C; Ribai P; Vincitorio C; Anheim M; Guyant-Mar\\u00e9chal L; Le Bayon A; Vandenberghe N; Tchikviladz\\u00e9 M; Devos D; Le Ber I; N'Guyen K; Cazeneuve C; Tallaksen C; Brice A; Durr A\",\n",
      "        \"doi\": \"10.1001/archneurol.2011.2713\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Tezenas du Montcel S, et al. Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegia. Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegia. 2012; 69:500-8. doi: 10.1001/archneurol.2011.2713\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24780882\",\n",
      "        \"title\": \"Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6.\",\n",
      "        \"authors\": \"Tezenas du Montcel S; Durr A; Rakowicz M; Nanetti L; Charles P; Sulek A; Mariotti C; Rola R; Schols L; Bauer P; Dufaure-Gar\\u00e9 I; Jacobi H; Forlani S; Schmitz-H\\u00fcbsch T; Filla A; Timmann D; van de Warrenburg BP; Marelli C; Kang JS; Giunti P; Cook A; Baliko L; Melegh B; Boesch S; Szymanski S; Berciano J; Infante J; Buerk K; Masciullo M; Di Fabio R; Depondt C; Ratka S; Stevanin G; Klockgether T; Brice A; Golmard JL\",\n",
      "        \"doi\": \"10.1136/jmedgenet-2013-102200\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Tezenas du Montcel S, et al. Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6. Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6. 2014; 51:479-86. doi: 10.1136/jmedgenet-2013-102200\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18378516\",\n",
      "        \"title\": \"Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment.\",\n",
      "        \"authors\": \"du Montcel ST; Charles P; Ribai P; Goizet C; Le Bayon A; Labauge P; Guyant-Mar\\u00e9chal L; Forlani S; Jauffret C; Vandenberghe N; N'guyen K; Le Ber I; Devos D; Vincitorio CM; Manto MU; Tison F; Hannequin D; Ruberg M; Brice A; Durr A\",\n",
      "        \"doi\": \"10.1093/brain/awn059\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Validation Study\"\n",
      "        ],\n",
      "        \"citation\": \"du Montcel ST, et al. Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment. Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment. 2008; 131:1352-61. doi: 10.1093/brain/awn059\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17098887\",\n",
      "        \"title\": \"Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia.\",\n",
      "        \"authors\": \"Depienne C; Fedirko E; Forlani S; Cazeneuve C; Riba\\u00ef P; Feki I; Tallaksen C; Nguyen K; Stankoff B; Ruberg M; Stevanin G; Durr A; Brice A\",\n",
      "        \"doi\": \"10.1136/jmg.2006.046425\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Letter\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Depienne C, et al. Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia. Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia. 2007; 44:281-4. doi: 10.1136/jmg.2006.046425\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16193476\",\n",
      "        \"title\": \"New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14.\",\n",
      "        \"authors\": \"Klebe S; Durr A; Rentschler A; Hahn-Barma V; Abele M; Bouslam N; Sch\\u00f6ls L; Jedynak P; Forlani S; Denis E; Dussert C; Agid Y; Bauer P; Globas C; W\\u00fcllner U; Brice A; Riess O; Stevanin G\",\n",
      "        \"doi\": \"10.1002/ana.20628\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Klebe S, et al. New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14. New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14. 2005; 58:720-9. doi: 10.1002/ana.20628\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18853458\",\n",
      "        \"title\": \"Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10.\",\n",
      "        \"authors\": \"Goizet C; Boukhris A; Mundwiller E; Tallaksen C; Forlani S; Toutain A; Carriere N; Paquis V; Depienne C; Durr A; Stevanin G; Brice A\",\n",
      "        \"doi\": \"10.1002/humu.20920\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Goizet C, et al. Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. 2009; 30:E376-85. doi: 10.1002/humu.20920\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17957230\",\n",
      "        \"title\": \"Mental deficiency in three families with SPG4 spastic paraplegia.\",\n",
      "        \"authors\": \"Riba\\u00ef P; Depienne C; Fedirko E; Jothy AC; Viveweger C; Hahn-Barma V; Brice A; Durr A\",\n",
      "        \"doi\": \"10.1038/sj.ejhg.5201922\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Riba\\u00ef P, et al. Mental deficiency in three families with SPG4 spastic paraplegia. Mental deficiency in three families with SPG4 spastic paraplegia. 2008; 16:97-104. doi: 10.1038/sj.ejhg.5201922\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01579435\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02057796\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"36883573\",\n",
      "        \"title\": \"High performance of systematic combined urine LAM test and sputum Xpert MTB/RIF\\u00ae for tuberculosis screening in severely immunosuppressed ambulatory adults with HIV.\",\n",
      "        \"authors\": \"Bonnet M; Gabillard D; Domoua S; Muzoora C; Messou E; Sovannarith S; Nguyen DB; Badje A; Juchet S; Bunnet D; Borand L; Natukunda N; Tran TH; Anglaret X; Laureillard D; Blanc FX; STATIS ANRS 12290 Trial Team\",\n",
      "        \"doi\": \"10.1093/cid/ciad125\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Bonnet M, et al. High performance of systematic combined urine LAM test and sputum Xpert MTB/RIF\\u00ae for tuberculosis screening in severely immunosuppressed ambulatory adults with HIV. High performance of systematic combined urine LAM test and sputum Xpert MTB/RIF\\u00ae for tuberculosis screening in severely immunosuppressed ambulatory adults with HIV. 2023; (unknown volume):(unknown pages). doi: 10.1093/cid/ciad125\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32558469\",\n",
      "        \"title\": \"Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults.\",\n",
      "        \"authors\": \"Blanc FX; Badje AD; Bonnet M; Gabillard D; Messou E; Muzoora C; Samreth S; Nguyen BD; Borand L; Domergue A; Rapoud D; Natukunda N; Thai S; Juchet S; Eholi\\u00e9 SP; Lawn SD; Domoua SK; Anglaret X; Laureillard D; STATIS ANRS 12290 Trial Team\",\n",
      "        \"doi\": \"10.1056/NEJMoa1910708\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Blanc FX, et al. Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults. Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults. 2020; 382:2397-2410. doi: 10.1056/NEJMoa1910708\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01713335\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02073630\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT05040048\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03446430\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01094899\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03193099\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03831906\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"36395782\",\n",
      "        \"title\": \"Effect of systematic tuberculosis detection on mortality in young children with severe pneumonia in countries with high incidence of tuberculosis: a stepped-wedge cluster-randomised trial.\",\n",
      "        \"authors\": \"Marcy O; Wobudeya E; Font H; Vessi\\u00e8re A; Chabala C; Khosa C; Taguebue JV; Moh R; Mwanga-Amumpaire J; Lounnas M; Mulenga V; Mavale S; Chilundo J; Rego D; Nduna B; Shankalala P; Chirwa U; De Lauzanne A; Dim B; Tiogouo Ngouana E; Folquet Amorrissani M; Cisse L; Amon Tanoh Dick F; Komena EA; Kwedi Nolna S; Businge G; Natukunda N; Cumbe S; Mbekeka P; Kim A; Kheang C; Pol S; Maleche-Obimbo E; Seddon JA; Mao TE; Graham SM; Delacourt C; Borand L; Bonnet M; TB-Speed Pneumonia Study Group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(22)00668-5\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Marcy O, et al. Effect of systematic tuberculosis detection on mortality in young children with severe pneumonia in countries with high incidence of tuberculosis: a stepped-wedge cluster-randomised trial. Effect of systematic tuberculosis detection on mortality in young children with severe pneumonia in countries with high incidence of tuberculosis: a stepped-wedge cluster-randomised trial. 2023; 23:341-351. doi: 10.1016/S1473-3099(22)00668-5\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32853411\",\n",
      "        \"title\": \"Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.\",\n",
      "        \"authors\": \"Kay AW; Gonz\\u00e1lez Fern\\u00e1ndez L; Takwoingi Y; Eisenhut M; Detjen AK; Steingart KR; Mandalakas AM\",\n",
      "        \"doi\": \"10.1002/14651858.CD013359.pub2\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Meta-Analysis\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Systematic Review\"\n",
      "        ],\n",
      "        \"citation\": \"Kay AW, et al. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children. 2020; 8:CD013359. doi: 10.1002/14651858.CD013359.pub2\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33743621\",\n",
      "        \"title\": \"Impact of systematic early tuberculosis detection using Xpert MTB/RIF Ultra in children with severe pneumonia in high tuberculosis burden countries (TB-Speed pneumonia): a stepped wedge cluster randomized trial.\",\n",
      "        \"authors\": \"Vessi\\u00e8re A; Font H; Gabillard D; Adonis-Koffi L; Borand L; Chabala C; Khosa C; Mavale S; Moh R; Mulenga V; Mwanga-Amumpere J; Taguebue JV; Eang MT; Delacourt C; Seddon JA; Lounnas M; Godreuil S; Wobudeya E; Bonnet M; Marcy O\",\n",
      "        \"doi\": \"10.1186/s12887-021-02576-5\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Vessi\\u00e8re A, et al. Impact of systematic early tuberculosis detection using Xpert MTB/RIF Ultra in children with severe pneumonia in high tuberculosis burden countries (TB-Speed pneumonia): a stepped wedge cluster randomized trial. Impact of systematic early tuberculosis detection using Xpert MTB/RIF Ultra in children with severe pneumonia in high tuberculosis burden countries (TB-Speed pneumonia): a stepped wedge cluster randomized trial. 2021; 21:136. doi: 10.1186/s12887-021-02576-5\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00148824\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"20210645\",\n",
      "        \"title\": \"Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults.\",\n",
      "        \"authors\": \"Rabian C; Tsch\\u00f6pe I; Lesprit P; Katlama C; Molina JM; Meynard JL; Delfraissy JF; Ch\\u00eane G; L\\u00e9vy Y; ANRS 114 Pneumovac Study Group\",\n",
      "        \"doi\": \"10.1086/651418\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Rabian C, et al. Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults. Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults. 2010; 50:1174-83. doi: 10.1086/651418\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00901524\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"24905490\",\n",
      "        \"title\": \"Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection.\",\n",
      "        \"authors\": \"Laird ME; Mohsen A; Duffy D; Mamdouh R; LeFouler L; Casrouge A; El-Daly M; Rafik M; Abdel-Hamid M; Soulier A; Pawlotsky JM; H\\u00e9zode C; Rosa I; Renard P; Mohamed MK; Bonnard P; Izopet J; Mallet V; Pol S; Albert ML; Fontanet A\",\n",
      "        \"doi\": \"10.1016/j.jhep.2014.05.040\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Laird ME, et al. Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection. Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection. 2014; 61:770-6. doi: 10.1016/j.jhep.2014.05.040\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00870649\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"30532268\",\n",
      "        \"title\": \"Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: A phase 3 randomized, controlled trial in Senegalese children.\",\n",
      "        \"authors\": \"Riveau G; Schacht AM; Dompnier JP; Deplanque D; Seck M; Waucquier N; Senghor S; Delcroix-Genete D; Hermann E; Idris-Khodja N; Levy-Marchal C; Capron M; Capron A\",\n",
      "        \"doi\": \"10.1371/journal.pntd.0006968\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Riveau G, et al. Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: A phase 3 randomized, controlled trial in Senegalese children. Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: A phase 3 randomized, controlled trial in Senegalese children. 2018; 12:e0006968. doi: 10.1371/journal.pntd.0006968\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01207349\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"22030240\",\n",
      "        \"title\": \"Quarterly individual outpatients lifestyle counseling after initial inpatients education on type 2 diabetes: the REDIA Prev-2 randomized controlled trial in Reunion Island.\",\n",
      "        \"authors\": \"Debussche X; Rollot O; Le Pommelet C; Fianu A; Le Moullec N; R\\u00e9gnier C; Boyer MC; Cogne M; Bakiri F; Schwager JC; Favier F\",\n",
      "        \"doi\": \"10.1016/j.diabet.2011.07.002\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Debussche X, et al. Quarterly individual outpatients lifestyle counseling after initial inpatients education on type 2 diabetes: the REDIA Prev-2 randomized controlled trial in Reunion Island. Quarterly individual outpatients lifestyle counseling after initial inpatients education on type 2 diabetes: the REDIA Prev-2 randomized controlled trial in Reunion Island. 2012; 38:46-53. doi: 10.1016/j.diabet.2011.07.002\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01531036\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"20505064\",\n",
      "        \"title\": \"Breast lesions: quantitative elastography with supersonic shear imaging--preliminary results.\",\n",
      "        \"authors\": \"Athanasiou A; Tardivon A; Tanter M; Sigal-Zafrani B; Bercoff J; Deffieux T; Gennisson JL; Fink M; Neuenschwander S\",\n",
      "        \"doi\": \"10.1148/radiol.10090385\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Athanasiou A, et al. Breast lesions: quantitative elastography with supersonic shear imaging--preliminary results. Breast lesions: quantitative elastography with supersonic shear imaging--preliminary results. 2010; 256:297-303. doi: 10.1148/radiol.10090385\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00651066\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"24465443\",\n",
      "        \"title\": \"Randomised pharmacokinetic trial of rifabutin with lopinavir/ritonavir-antiretroviral therapy in patients with HIV-associated tuberculosis in Vietnam.\",\n",
      "        \"authors\": \"Lan NT; Thu NT; Barrail-Tran A; Duc NH; Lan NN; Laureillard D; Lien TT; Borand L; Quillet C; Connolly C; Lagarde D; Pym A; Lienhardt C; Dung NH; Taburet AM; Harries AD\",\n",
      "        \"doi\": \"10.1371/journal.pone.0084866\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Lan NT, et al. Randomised pharmacokinetic trial of rifabutin with lopinavir/ritonavir-antiretroviral therapy in patients with HIV-associated tuberculosis in Vietnam. Randomised pharmacokinetic trial of rifabutin with lopinavir/ritonavir-antiretroviral therapy in patients with HIV-associated tuberculosis in Vietnam. 2014; 9:e84866. doi: 10.1371/journal.pone.0084866\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02081066\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01164436\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01038999\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"23285253\",\n",
      "        \"title\": \"HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 \\\"aging\\\" study.\",\n",
      "        \"authors\": \"Perrin S; Cremer J; Faucher O; Reynes J; Dellamonica P; Micallef J; Solas C; Lacarelle B; Stretti C; Kaspi E; Robaglia-Schlupp A; Nicolino-Brunet C; Tamalet C; L\\u00e9vy N; Poizot-Martin I; Cau P; Roll P\",\n",
      "        \"doi\": \"10.1371/journal.pone.0053035\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Controlled Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Perrin S, et al. HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 \\\"aging\\\" study. HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 \\\"aging\\\" study. 2012; 7:e53035. doi: 10.1371/journal.pone.0053035\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22829920\",\n",
      "        \"title\": \"HIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: the ANRS EP45 \\\"Aging\\\" study.\",\n",
      "        \"authors\": \"Perrin S; Cremer J; Roll P; Faucher O; M\\u00e9nard A; Reynes J; Dellamonica P; Naqvi A; Micallef J; Jouve E; Tamalet C; Solas C; Pissier C; Arnoux I; Nicolino-Brunet C; Espinosa L; L\\u00e9vy N; Kaspi E; Robaglia-Schlupp A; Poizot-Martin I; Cau P\",\n",
      "        \"doi\": \"10.1371/journal.pone.0041129\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Perrin S, et al. HIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: the ANRS EP45 \\\"Aging\\\" study. HIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: the ANRS EP45 \\\"Aging\\\" study. 2012; 7:e41129. doi: 10.1371/journal.pone.0041129\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00604149\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01569399\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01917175\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01592175\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01271842\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"22948576\",\n",
      "        \"title\": \"Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS.\",\n",
      "        \"authors\": \"Luyt CE; Combes A; Becquemin MH; Beigelman-Aubry C; Hatem S; Brun AL; Zraik N; Carrat F; Grenier PA; Richard JM; Mercat A; Brochard L; Brun-Buisson C; Chastre J; REVA Study Group\",\n",
      "        \"doi\": \"10.1378/chest.11-2196\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Luyt CE, et al. Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS. Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS. 2012; 142:583-592. doi: 10.1378/chest.11-2196\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00265642\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01008813\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00158470\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04265742\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04631224\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01493934\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02978924\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00226434\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"22010913\",\n",
      "        \"title\": \"Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.\",\n",
      "        \"authors\": \"Blanc FX; Sok T; Laureillard D; Borand L; Rekacewicz C; Nerrienet E; Madec Y; Marcy O; Chan S; Prak N; Kim C; Lak KK; Hak C; Dim B; Sin CI; Sun S; Guillard B; Sar B; Vong S; Fernandez M; Fox L; Delfraissy JF; Goldfeld AE; CAMELIA (ANRS 1295\\u2013CIPRA KH001) Study Team\",\n",
      "        \"doi\": \"10.1056/NEJMoa1013911\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Blanc FX, et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. 2011; 365:1471-81. doi: 10.1056/NEJMoa1013911\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24759827\",\n",
      "        \"title\": \"Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial.\",\n",
      "        \"authors\": \"Marcy O; Laureillard D; Madec Y; Chan S; Mayaud C; Borand L; Prak N; Kim C; Lak KK; Hak C; Dim B; Sok T; Delfraissy JF; Goldfeld AE; Blanc FX; CAMELIA (ANRS 1295-CIPRA KH001) Study Team\",\n",
      "        \"doi\": \"10.1093/cid/ciu283\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Marcy O, et al. Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial. Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial. 2014; 59:435-45. doi: 10.1093/cid/ciu283\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24096631\",\n",
      "        \"title\": \"Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial.\",\n",
      "        \"authors\": \"Laureillard D; Marcy O; Madec Y; Chea S; Chan S; Borand L; Fernandez M; Prak N; Kim C; Dim B; Nerrienet E; Sok T; Delfraissy JF; Goldfeld AE; Blanc FX; CAMELIA (ANRS 1295 \\u2013 CIPRA KH001) Study Team\",\n",
      "        \"doi\": \"10.1097/01.aids.0000432456.14099.c7\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Laureillard D, et al. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial. 2013; 27:2577-86. doi: 10.1097/01.aids.0000432456.14099.c7\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17624825\",\n",
      "        \"title\": \"Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials.\",\n",
      "        \"authors\": \"Blanc FX; Havlir DV; Onyebujoh PC; Thim S; Goldfeld AE; Delfraissy JF\",\n",
      "        \"doi\": \"10.1086/518658\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Research Support, U.S. Gov't, P.H.S.\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Blanc FX, et al. Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials. Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials. 2007; 196 Suppl 1:S46-51. doi: 10.1086/518658\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23237982\",\n",
      "        \"title\": \"Plasma concentrations of efavirenz with a 600 mg standard dose in Cambodian HIV-infected adults treated for tuberculosis with a body weight above 50 kg.\",\n",
      "        \"authors\": \"Borand L; Laureillard D; Madec Y; Chou M; Pheng P; Marcy O; Sok T; Goldfeld AE; Taburet AM; Blanc FX; CAMELIA ANRS 1295-CIPRA KH001 Study Team\",\n",
      "        \"doi\": \"10.3851/IMP2483\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Borand L, et al. Plasma concentrations of efavirenz with a 600 mg standard dose in Cambodian HIV-infected adults treated for tuberculosis with a body weight above 50 kg. Plasma concentrations of efavirenz with a 600 mg standard dose in Cambodian HIV-infected adults treated for tuberculosis with a body weight above 50 kg. 2013; 18:419-23. doi: 10.3851/IMP2483\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24608960\",\n",
      "        \"title\": \"Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial).\",\n",
      "        \"authors\": \"Borand L; Madec Y; Laureillard D; Chou M; Marcy O; Pheng P; Prak N; Kim C; Lak KK; Hak C; Dim B; Nerrienet E; Fontanet A; Sok T; Goldfeld AE; Blanc FX; Taburet AM\",\n",
      "        \"doi\": \"10.1371/journal.pone.0090350\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Borand L, et al. Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial). Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial). 2014; 9:e90350. doi: 10.1371/journal.pone.0090350\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04392388\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"34293141\",\n",
      "        \"title\": \"Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study.\",\n",
      "        \"authors\": \"Carrat F; de Lamballerie X; Rahib D; Blanch\\u00e9 H; Lapidus N; Artaud F; Kab S; Renuy A; Szabo de Edelenyi F; Meyer L; Lydi\\u00e9 N; Charles MA; Ancel PY; Jusot F; Rouquette A; Priet S; Saba Villarroel PM; Fouri\\u00e9 T; Lusivika-Nzinga C; Nicol J; Legot S; Druesne-Pecollo N; Esseddik Y; Lai C; Gagliolo JM; Deleuze JF; Bajos N; Severi G; Touvier M; Zins M;  for the SAPRIS and SAPRIS-SERO study groups\",\n",
      "        \"doi\": \"10.1093/ije/dyab110\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Carrat F, et al. Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study. Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study. 2021; 50:1458-1472. doi: 10.1093/ije/dyab110\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00928187\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"31273686\",\n",
      "        \"title\": \"Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa.\",\n",
      "        \"authors\": \"Boyer S; Nishimwe ML; Sagaon-Teyssier L; March L; Koulla-Shiro S; Bousmah MQ; Toby R; Mpoudi-Etame MP; Ngom Gueye NF; Sawadogo A; Kouanfack C; Ciaffi L; Spire B; Delaporte E; 2-Lady Group\",\n",
      "        \"doi\": \"10.1007/s41669-019-0157-9\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Boyer S, et al. Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa. Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa. 2020; 4:45-60. doi: 10.1007/s41669-019-0157-9\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00640887\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26482301\",\n",
      "        \"title\": \"Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis.\",\n",
      "        \"authors\": \"Hennig S; Naiker S; Reddy T; Egan D; Kellerman T; Wiesner L; Owen A; McIlleron H; Pym A\",\n",
      "        \"doi\": \"10.1128/AAC.01195-15\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hennig S, et al. Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis. Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis. 2016; 60:617-20. doi: 10.1128/AAC.01195-15\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25406657\",\n",
      "        \"title\": \"Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy.\",\n",
      "        \"authors\": \"Naiker S; Connolly C; Wiesner L; Kellerman T; Reddy T; Harries A; McIlleron H; Lienhardt C; Pym A\",\n",
      "        \"doi\": \"10.1186/2050-6511-15-61\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Naiker S, et al. Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy. Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy. 2014; 15:61. doi: 10.1186/2050-6511-15-61\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01952587\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01089387\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"25974235\",\n",
      "        \"title\": \"Mesenchymal stem cell therapy for the treatment of erectile dysfunction.\",\n",
      "        \"authors\": \"Khera M; Albersen M; Mulhall JP\",\n",
      "        \"doi\": \"10.1111/jsm.12871\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Khera M, et al. Mesenchymal stem cell therapy for the treatment of erectile dysfunction. Mesenchymal stem cell therapy for the treatment of erectile dysfunction. 2015; 12:1105-6. doi: 10.1111/jsm.12871\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28753830\",\n",
      "        \"title\": \"Intracavernous Injections of Bone Marrow Mononucleated Cells for Postradical Prostatectomy Erectile Dysfunction: Final Results of the INSTIN Clinical Trial.\",\n",
      "        \"authors\": \"Yiou R; Hamidou L; Birebent B; Bitari D; Le Corvoisier P; Contremoulins I; Rodriguez AM; Augustin D; Roudot-Thoraval F; de la Taille A; Rouard H\",\n",
      "        \"doi\": \"10.1016/j.euf.2017.06.009\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Letter\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Yiou R, et al. Intracavernous Injections of Bone Marrow Mononucleated Cells for Postradical Prostatectomy Erectile Dysfunction: Final Results of the INSTIN Clinical Trial. Intracavernous Injections of Bone Marrow Mononucleated Cells for Postradical Prostatectomy Erectile Dysfunction: Final Results of the INSTIN Clinical Trial. 2017; 3:643-645. doi: 10.1016/j.euf.2017.06.009\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26439886\",\n",
      "        \"title\": \"Safety of Intracavernous Bone Marrow-Mononuclear Cells for Postradical Prostatectomy Erectile Dysfunction: An Open Dose-Escalation Pilot Study.\",\n",
      "        \"authors\": \"Yiou R; Hamidou L; Birebent B; Bitari D; Lecorvoisier P; Contremoulins I; Khodari M; Rodriguez AM; Augustin D; Roudot-Thoraval F; de la Taille A; Rouard H\",\n",
      "        \"doi\": \"10.1016/j.eururo.2015.09.026\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Yiou R, et al. Safety of Intracavernous Bone Marrow-Mononuclear Cells for Postradical Prostatectomy Erectile Dysfunction: An Open Dose-Escalation Pilot Study. Safety of Intracavernous Bone Marrow-Mononuclear Cells for Postradical Prostatectomy Erectile Dysfunction: An Open Dose-Escalation Pilot Study. 2016; 69:988-91. doi: 10.1016/j.eururo.2015.09.026\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02833961\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"36318030\",\n",
      "        \"title\": \"Longitudinal Monitoring of Microstructural Alterations in Cerebral Ischemia with in Vivo Diffusion-weighted MR Spectroscopy.\",\n",
      "        \"authors\": \"Genovese G; Diaz-Fernandez B; Lejeune FX; Ronen I; Marja\\u0144ska M; Yahia-Cherif L; Leh\\u00e9ricy S; Branzoli F; Rosso C\",\n",
      "        \"doi\": \"10.1148/radiol.220430\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Research Support, N.I.H., Extramural\"\n",
      "        ],\n",
      "        \"citation\": \"Genovese G, et al. Longitudinal Monitoring of Microstructural Alterations in Cerebral Ischemia with in Vivo Diffusion-weighted MR Spectroscopy. Longitudinal Monitoring of Microstructural Alterations in Cerebral Ischemia with in Vivo Diffusion-weighted MR Spectroscopy. 2023; 306:e220430. doi: 10.1148/radiol.220430\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02453061\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"31381524\",\n",
      "        \"title\": \"Huntington's Disease Clinical Trials Corner: June 2019.\",\n",
      "        \"authors\": \"Rodrigues FB; Ferreira JJ; Wild EJ\",\n",
      "        \"doi\": \"10.3233/JHD-199003\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Rodrigues FB, et al. Huntington's Disease Clinical Trials Corner: June 2019. Huntington's Disease Clinical Trials Corner: June 2019. 2019; 8:363-371. doi: 10.3233/JHD-199003\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01494961\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"23343912\",\n",
      "        \"title\": \"Increasing HIV testing among male partners.\",\n",
      "        \"authors\": \"Orne-Gliemann J; Balestre E; Tchendjou P; Miric M; Darak S; Butsashvili M; Perez-Then E; Eboko F; Plazy M; Kulkarni S; Desgr\\u00e9es du Lo\\u00fb A; Dabis F; Prenahtest ANRS 12127 Study Group\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32835f1d8c\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Orne-Gliemann J, et al. Increasing HIV testing among male partners. Increasing HIV testing among male partners. 2013; 27:1167-77. doi: 10.1097/QAD.0b013e32835f1d8c\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29178852\",\n",
      "        \"title\": \"Couples HIV counselling and couple relationships in India, Georgia and the Dominican Republic.\",\n",
      "        \"authors\": \"Tiendrebeogo T; Plazy M; Darak S; Miric M; Perez-Then E; Butsashvili M; Tchendjou P; Dabis F; Orne-Gliemann J\",\n",
      "        \"doi\": \"10.1186/s12889-017-4901-8\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Tiendrebeogo T, et al. Couples HIV counselling and couple relationships in India, Georgia and the Dominican Republic. Couples HIV counselling and couple relationships in India, Georgia and the Dominican Republic. 2017; 17:901. doi: 10.1186/s12889-017-4901-8\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21857289\",\n",
      "        \"title\": \"Factors associated with history of HIV testing among pregnant women and their partners in Cameroon: baseline data from a Behavioral Intervention Trial (ANRS 12127 Prenahtest).\",\n",
      "        \"authors\": \"Tchendjou PT; Koki PN; Eboko F; Malateste K; Essounga AN; Amassana D; Mossus T; Tejiokem M; Boisier P; Orne-Gliemann J\",\n",
      "        \"doi\": \"10.1097/QAI.0b013e31821ec6e2\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Tchendjou PT, et al. Factors associated with history of HIV testing among pregnant women and their partners in Cameroon: baseline data from a Behavioral Intervention Trial (ANRS 12127 Prenahtest). Factors associated with history of HIV testing among pregnant women and their partners in Cameroon: baseline data from a Behavioral Intervention Trial (ANRS 12127 Prenahtest). 2011; 57 Suppl 1:S9-15. doi: 10.1097/QAI.0b013e31821ec6e2\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20403152\",\n",
      "        \"title\": \"Couple-oriented prenatal HIV counseling for HIV primary prevention: an acceptability study.\",\n",
      "        \"authors\": \"Orne-Gliemann J; Tchendjou PT; Miric M; Gadgil M; Butsashvili M; Eboko F; Perez-Then E; Darak S; Kulkarni S; Kamkamidze G; Balestre E; du Lo\\u00fb AD; Dabis F\",\n",
      "        \"doi\": \"10.1186/1471-2458-10-197\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Evaluation Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Orne-Gliemann J, et al. Couple-oriented prenatal HIV counseling for HIV primary prevention: an acceptability study. Couple-oriented prenatal HIV counseling for HIV primary prevention: an acceptability study. 2010; 10:197. doi: 10.1186/1471-2458-10-197\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34329355\",\n",
      "        \"title\": \"Couple oriented counselling improves male partner involvement in sexual and reproductive health of a couple: Evidence from the ANRS PRENAHTEST randomized trial.\",\n",
      "        \"authors\": \"Kengne-Nde C; Tejiokem MC; Orne-Gliemann J; Melingui B; Koki Ndombo P; Essounga NA; Bissek AC; Cauchemez S; Tchendjou PT\",\n",
      "        \"doi\": \"10.1371/journal.pone.0255330\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kengne-Nde C, et al. Couple oriented counselling improves male partner involvement in sexual and reproductive health of a couple: Evidence from the ANRS PRENAHTEST randomized trial. Couple oriented counselling improves male partner involvement in sexual and reproductive health of a couple: Evidence from the ANRS PRENAHTEST randomized trial. 2021; 16:e0255330. doi: 10.1371/journal.pone.0255330\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00301561\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"35248123\",\n",
      "        \"title\": \"Non-inferiority test for a continuous variable with a flexible margin in an active controlled trial: an application to the \\\"Stratall ANRS 12110 / ESTHER\\\" trial.\",\n",
      "        \"authors\": \"Sandie AB; Molinari N; Wanjoya A; Kouanfack C; Laurent C; Tchatchueng-Mbougua JB\",\n",
      "        \"doi\": \"10.1186/s13063-022-06118-x\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Sandie AB, et al. Non-inferiority test for a continuous variable with a flexible margin in an active controlled trial: an application to the \\\"Stratall ANRS 12110 / ESTHER\\\" trial. Non-inferiority test for a continuous variable with a flexible margin in an active controlled trial: an application to the \\\"Stratall ANRS 12110 / ESTHER\\\" trial. 2022; 23:202. doi: 10.1186/s13063-022-06118-x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21831714\",\n",
      "        \"title\": \"Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial.\",\n",
      "        \"authors\": \"Laurent C; Kouanfack C; Laborde-Balen G; Aghokeng AF; Mbougua JB; Boyer S; Carrieri MP; Mben JM; Dontsop M; Kaz\\u00e9 S; Molinari N; Bourgeois A; Mpoudi-Ngol\\u00e9 E; Spire B; Koulla-Shiro S; Delaporte E; Stratall ANRS 12110/ESTHER study group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(11)70168-2\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Laurent C, et al. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial. 2011; 11:825-33. doi: 10.1016/S1473-3099(11)70168-2\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01167283\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02150993\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01075061\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02014883\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26536893\",\n",
      "        \"title\": \"Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency.\",\n",
      "        \"authors\": \"Mochel F; Hainque E; Gras D; Adanyeguh IM; Caillet S; H\\u00e9ron B; Roubertie A; Kaphan E; Valabregue R; Rinaldi D; Vuillaumier S; Schiffmann R; Ottolenghi C; Hogrel JY; Servais L; Roze E\",\n",
      "        \"doi\": \"10.1136/jnnp-2015-311475\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mochel F, et al. Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency. Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency. 2016; 87:550-3. doi: 10.1136/jnnp-2015-311475\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00158483\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"19530940\",\n",
      "        \"title\": \"Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial.\",\n",
      "        \"authors\": \"Mayaud P; Legoff J; Weiss HA; Gr\\u00e9senguet G; Nzambi K; Bouhlal H; Frost E; P\\u00e9pin J; Malkin JE; Hayes RJ; Mabey DC; B\\u00e9lec L; ANRS 1212 Study Group\",\n",
      "        \"doi\": \"10.1086/599991\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mayaud P, et al. Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial. Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial. 2009; 200:216-26. doi: 10.1086/599991\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16455895\",\n",
      "        \"title\": \"Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV.\",\n",
      "        \"authors\": \"Legoff J; Bouhlal H; Gr\\u00e9senguet G; Weiss H; Khonde N; Hocini H; D\\u00e9sir\\u00e9 N; Si-Mohamed A; de Dieu Longo J; Chemin C; Frost E; P\\u00e9pin J; Malkin JE; Mayaud P; B\\u00e9lec L\",\n",
      "        \"doi\": \"10.1128/JCM.44.2.423-432.2006\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Evaluation Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Legoff J, et al. Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV. Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV. 2006; 44:423-32. doi: 10.1128/JCM.44.2.423-432.2006\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18385443\",\n",
      "        \"title\": \"Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2.\",\n",
      "        \"authors\": \"LeGoff J; Mayaud P; Gresenguet G; Weiss HA; Nzambi K; Frost E; Pepin J; Belec L; ANRS 12-12 Study Group\",\n",
      "        \"doi\": \"10.1128/JCM.02332-07\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Evaluation Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"LeGoff J, et al. Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2. Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2. 2008; 46:1914-8. doi: 10.1128/JCM.02332-07\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02481453\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"24975859\",\n",
      "        \"title\": \"Evaluation and construction of diagnostic criteria for inclusion body myositis.\",\n",
      "        \"authors\": \"Lloyd TE; Mammen AL; Amato AA; Weiss MD; Needham M; Greenberg SA\",\n",
      "        \"doi\": \"10.1212/WNL.0000000000000642\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Lloyd TE, et al. Evaluation and construction of diagnostic criteria for inclusion body myositis. Evaluation and construction of diagnostic criteria for inclusion body myositis. 2014; 83:426-33. doi: 10.1212/WNL.0000000000000642\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20413309\",\n",
      "        \"title\": \"International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009.\",\n",
      "        \"authors\": \"Benveniste O; Hilton-Jones D\",\n",
      "        \"doi\": \"10.1016/j.nmd.2010.03.014\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Congress\"\n",
      "        ],\n",
      "        \"citation\": \"Benveniste O and Hilton-Jones D. International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009. International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009. 2010; 20:414-21. doi: 10.1016/j.nmd.2010.03.014\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"38273639\",\n",
      "        \"title\": \"Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial.\",\n",
      "        \"authors\": \"Benveniste O; Hogrel JY; Belin L; Annoussamy M; Bachasson D; Rigolet A; Laforet P; Dzangu\\u00e9-Tchoupou G; Salem JE; Nguyen LS; Stojkovic T; Zahr N; Hervier B; Landon-Cardinal O; Behin A; Guilloux E; Reyngoudt H; Amelin D; Uruha A; Mariampillai K; Marty B; Eymard B; Hulot JS; Greenberg SA; Carlier PG; Allenbach Y\",\n",
      "        \"doi\": \"10.1016/S2665-9913(20)30280-0\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Benveniste O, et al. Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial. Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial. 2021; 3:e40-e48. doi: 10.1016/S2665-9913(20)30280-0\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02329054\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"27046271\",\n",
      "        \"title\": \"Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.\",\n",
      "        \"authors\": \"Sissoko D; Laouenan C; Folkesson E; M'Lebing AB; Beavogui AH; Baize S; Camara AM; Maes P; Shepherd S; Danel C; Carazo S; Conde MN; Gala JL; Colin G; Savini H; Bore JA; Le Marcis F; Koundouno FR; Petitjean F; Lamah MC; Diederich S; Tounkara A; Poelart G; Berbain E; Dindart JM; Duraffour S; Lefevre A; Leno T; Peyrouset O; Irenge L; Bangoura N; Palich R; Hinzmann J; Kraus A; Barry TS; Berette S; Bongono A; Camara MS; Munoz VC; Doumbouya L; Harouna S; Kighoma PM; Koundouno FR; Lolamou R; Loua CM; Massala V; Moumouni K; Provost C; Samake N; Sekou C; Soumah A; Arnould I; Komano MS; Gustin L; Berutto C; Camara D; Camara FS; Colpaert J; Delamou L; Jansson L; Kourouma E; Loua M; Malme K; Manfrin E; Maomou A; Milinouno A; Ombelet S; Sidiboun AY; Verreckt I; Yombouno P; Bocquin A; Carbonnelle C; Carmoi T; Frange P; Mely S; Nguyen VK; Pannetier D; Taburet AM; Treluyer JM; Kolie J; Moh R; Gonzalez MC; Kuisma E; Liedigk B; Ngabo D; Rudolf M; Thom R; Kerber R; Gabriel M; Di Caro A; W\\u00f6lfel R; Badir J; Bentahir M; Deccache Y; Dumont C; Durant JF; El Bakkouri K; Uwamahoro MG; Smits B; Toufik N; Van Cauwenberghe S; Ezzedine K; D'Ortenzio E; Pizarro L; Etienne A; Guedj J; Fizet A; de Sainte Fare EB; Murgue B; Tran-Minh T; Rapp C; Piguet P; Poncin M; Draguez B; Duverger TA; Barbe S; Baret G; Defourny I; Carroll M; Raoul H; Augier A; Eholie SP; Yazdanpanah Y; Levy-Marchal C; Antierrens A; Van Herp M; G\\u00fcnther S; de Lamballerie X; Ke\\u00efta S; Mentre F; Anglaret X; Malvy D; JIKI Study Group\",\n",
      "        \"doi\": \"10.1371/journal.pmed.1002009\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Published Erratum\"\n",
      "        ],\n",
      "        \"citation\": \"Sissoko D, et al. Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. 2016; 13:e1002009. doi: 10.1371/journal.pmed.1002009\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26930627\",\n",
      "        \"title\": \"Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.\",\n",
      "        \"authors\": \"Sissoko D; Laouenan C; Folkesson E; M'Lebing AB; Beavogui AH; Baize S; Camara AM; Maes P; Shepherd S; Danel C; Carazo S; Conde MN; Gala JL; Colin G; Savini H; Bore JA; Le Marcis F; Koundouno FR; Petitjean F; Lamah MC; Diederich S; Tounkara A; Poelart G; Berbain E; Dindart JM; Duraffour S; Lefevre A; Leno T; Peyrouset O; Irenge L; Bangoura N; Palich R; Hinzmann J; Kraus A; Barry TS; Berette S; Bongono A; Camara MS; Chanfreau Munoz V; Doumbouya L; Souley Harouna; Kighoma PM; Koundouno FR; R\\u00e9n\\u00e9 Lolamou; Loua CM; Massala V; Moumouni K; Provost C; Samake N; Sekou C; Soumah A; Arnould I; Komano MS; Gustin L; Berutto C; Camara D; Camara FS; Colpaert J; Delamou L; Jansson L; Kourouma E; Loua M; Malme K; Manfrin E; Maomou A; Milinouno A; Ombelet S; Sidiboun AY; Verreckt I; Yombouno P; Bocquin A; Carbonnelle C; Carmoi T; Frange P; Mely S; Nguyen VK; Pannetier D; Taburet AM; Treluyer JM; Kolie J; Moh R; Gonzalez MC; Kuisma E; Liedigk B; Ngabo D; Rudolf M; Thom R; Kerber R; Gabriel M; Di Caro A; W\\u00f6lfel R; Badir J; Bentahir M; Deccache Y; Dumont C; Durant JF; El Bakkouri K; Gasasira Uwamahoro M; Smits B; Toufik N; Van Cauwenberghe S; Ezzedine K; D'Ortenzio E; Pizarro L; Etienne A; Guedj J; Fizet A; Barte de Sainte Fare E; Murgue B; Tran-Minh T; Rapp C; Piguet P; Poncin M; Draguez B; Allaford Duverger T; Barbe S; Baret G; Defourny I; Carroll M; Raoul H; Augier A; Eholie SP; Yazdanpanah Y; Levy-Marchal C; Antierrens A; Van Herp M; G\\u00fcnther S; de Lamballerie X; Ke\\u00efta S; Mentre F; Anglaret X; Malvy D; JIKI Study Group\",\n",
      "        \"doi\": \"10.1371/journal.pmed.1001967\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Sissoko D, et al. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. 2016; 13:e1001967. doi: 10.1371/journal.pmed.1001967\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25435054\",\n",
      "        \"title\": \"Dose regimen of favipiravir for Ebola virus disease.\",\n",
      "        \"authors\": \"Mentr\\u00e9 F; Taburet AM; Guedj J; Anglaret X; Ke\\u00efta S; de Lamballerie X; Malvy D\",\n",
      "        \"doi\": \"10.1016/S1473-3099(14)71047-3\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Letter\"\n",
      "        ],\n",
      "        \"citation\": \"Mentr\\u00e9 F, et al. Dose regimen of favipiravir for Ebola virus disease. Dose regimen of favipiravir for Ebola virus disease. 2015; 15:150-1. doi: 10.1016/S1473-3099(14)71047-3\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28231247\",\n",
      "        \"title\": \"Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted.\",\n",
      "        \"authors\": \"Nguyen TH; Guedj J; Anglaret X; Laou\\u00e9nan C; Madelain V; Taburet AM; Baize S; Sissoko D; Pastorino B; Rodallec A; Piorkowski G; Carazo S; Conde MN; Gala JL; Bore JA; Carbonnelle C; Jacquot F; Raoul H; Malvy D; de Lamballerie X; Mentr\\u00e9 F; JIKI study group\",\n",
      "        \"doi\": \"10.1371/journal.pntd.0005389\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nguyen TH, et al. Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted. Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted. 2017; 11:e0005389. doi: 10.1371/journal.pntd.0005389\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02027233\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02093754\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03324633\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"23461846\",\n",
      "        \"title\": \"Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions.\",\n",
      "        \"authors\": \"Winnock M; Bani-Sadr F; Pambrun E; Loko MA; Carrieri P; Neau D; Morlat P; Marchou B; Dabis F; Salmon D; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) CO13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1111/hiv.12023\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Winnock M, et al. Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions. Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions. 2013; 14:430-6. doi: 10.1111/hiv.12023\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27073179\",\n",
      "        \"title\": \"No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort).\",\n",
      "        \"authors\": \"Marcellin F; Lions C; Rosenthal E; Roux P; Sogni P; Wittkop L; Protopopescu C; Spire B; Salmon-Ceron D; Dabis F; Carrieri MP; HEPAVIH ANRS CO13 Study Group*\",\n",
      "        \"doi\": \"10.1111/dar.12398\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Marcellin F, et al. No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort). No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort). 2017; 36:227-238. doi: 10.1111/dar.12398\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22409788\",\n",
      "        \"title\": \"Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France).\",\n",
      "        \"authors\": \"Salmon-Ceron D; Cohen J; Winnock M; Roux P; Sadr FB; Rosenthal E; Martin IP; Loko MA; Mora M; Sogni P; Spire B; Dabis F; Carrieri MP; HEPAVIH group\",\n",
      "        \"doi\": \"10.1186/1472-6963-12-59\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Salmon-Ceron D, et al. Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France). Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France). 2012; 12:59. doi: 10.1186/1472-6963-12-59\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20493576\",\n",
      "        \"title\": \"Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.\",\n",
      "        \"authors\": \"Cal\\u00e8s P; Halfon P; Batisse D; Carrat F; Perr\\u00e9 P; Penaranda G; Guyader D; d'Alteroche L; Fouchard-Hubert I; Michelet C; Veillon P; Lambert J; Weiss L; Salmon D; Cacoub P\",\n",
      "        \"doi\": \"10.1016/j.jhep.2010.03.007\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Cal\\u00e8s P, et al. Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection. Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection. 2010; 53:238-44. doi: 10.1016/j.jhep.2010.03.007\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20969743\",\n",
      "        \"title\": \"The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010.\",\n",
      "        \"authors\": \"Loko MA; Salmon D; Carrieri P; Winnock M; Mora M; Merchadou L; Gillet S; Pambrun E; Delaune J; Valantin MA; Poizot-Martin I; Neau D; Bonnard P; Rosenthal E; Barange K; Morlat P; Lacombe K; Gervais A; Rouges F; See AB; Lascoux-Combe C; Vittecoq D; Goujard C; Duvivier C; Spire B; Izopet J; Sogni P; Serfaty L; Benhamou Y; Bani-Sadr F; Dabis F; ANRS CO 13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1186/1471-2334-10-303\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Loko MA, et al. The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010. The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010. 2010; 10:303. doi: 10.1186/1471-2334-10-303\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24499953\",\n",
      "        \"title\": \"Correlates of HIV sustained viral suppression in HIV/hepatitis C virus coinfected patients: possible role of the hepatitis C virus sustained viral response.\",\n",
      "        \"authors\": \"Bani-Sadr F; Loko MA; Pambrun E; Winnock M; Carrieri P; Gilbert C; Duvivier C; Bouchaud O; Gervais A; Dabis F; Salmon D; ANRS CO 13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1097/QAD.0000000000000218\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bani-Sadr F, et al. Correlates of HIV sustained viral suppression in HIV/hepatitis C virus coinfected patients: possible role of the hepatitis C virus sustained viral response. Correlates of HIV sustained viral suppression in HIV/hepatitis C virus coinfected patients: possible role of the hepatitis C virus sustained viral response. 2014; 28:1155-60. doi: 10.1097/QAD.0000000000000218\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23421419\",\n",
      "        \"title\": \"Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort).\",\n",
      "        \"authors\": \"Marcellin F; Lions C; Winnock M; Salmon D; Durant J; Spire B; Mora M; Loko MA; Dabis F; Dominguez S; Roux P; Carrieri MP; ANRS CO13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1111/add.12149\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Marcellin F, et al. Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort). Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort). 2013; 108:1250-8. doi: 10.1111/add.12149\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22781224\",\n",
      "        \"title\": \"Ribavirin and abacavir drug interaction in HIV-HCV coinfected patients: fact or fiction?\",\n",
      "        \"authors\": \"Solas C; Pambrun E; Winnock M; Salmon D; Poizot-Martin I; Dominguez S; Bani-Sadr F; Izopet J; Garraffo R; Peytavin G; ANRS CO-13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32835763a4\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Solas C, et al. Ribavirin and abacavir drug interaction in HIV-HCV coinfected patients: fact or fiction?. Ribavirin and abacavir drug interaction in HIV-HCV coinfected patients: fact or fiction?. 2012; 26:2193-9. doi: 10.1097/QAD.0b013e32835763a4\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25015913\",\n",
      "        \"title\": \"High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort.\",\n",
      "        \"authors\": \"Marcellin F; Roux P; Loko MA; Lions C; Caumont-Prim A; Dabis F; Salmon-Ceron D; Spire B; Carrieri MP; HEPAVIH (ANRS CO13) Study Group\",\n",
      "        \"doi\": \"10.1093/cid/ciu525\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Letter\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Comment\"\n",
      "        ],\n",
      "        \"citation\": \"Marcellin F, et al. High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort. High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort. 2014; 59:1190-2. doi: 10.1093/cid/ciu525\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21920402\",\n",
      "        \"title\": \"Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination.\",\n",
      "        \"authors\": \"Winnock M; Bani-Sadr F; Pambrun E; Loko MA; Lascoux-Combe C; Garipuy D; Rosenthal E; Carrieri P; Dabis F; Salmon D\",\n",
      "        \"doi\": \"10.1016/j.vaccine.2011.08.125\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Winnock M, et al. Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination. Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination. 2011; 29:8656-60. doi: 10.1016/j.vaccine.2011.08.125\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26528903\",\n",
      "        \"title\": \"HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patients.\",\n",
      "        \"authors\": \"Salmon D; Bani-Sadr F; Gilbert C; Rosenthal E; Valantin MA; Simon A; Neau D; Morlat P; Loko MA; Wittkop L; Dabis F; ANRS CO13HEPAVIH study group\",\n",
      "        \"doi\": \"10.1016/j.jcv.2015.10.010\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Observational Study\"\n",
      "        ],\n",
      "        \"citation\": \"Salmon D, et al. HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patients. HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patients. 2015; 73:32-35. doi: 10.1016/j.jcv.2015.10.010\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28942916\",\n",
      "        \"title\": \"Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients.\",\n",
      "        \"authors\": \"Carrieri MP; Protopopescu C; Marcellin F; Rosellini S; Wittkop L; Esterle L; Zucman D; Raffi F; Rosenthal E; Poizot-Martin I; Salmon-Ceron D; Dabis F; Spire B; ANRS CO13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1016/j.jhep.2017.08.005\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Carrieri MP, et al. Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients. Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients. 2017; 67:1157-1167. doi: 10.1016/j.jhep.2017.08.005\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26372388\",\n",
      "        \"title\": \"Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients.\",\n",
      "        \"authors\": \"ANRS CO13 HEPAVIH Cohort\",\n",
      "        \"doi\": \"10.1097/QAD.0000000000000787\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"ANRS CO13 HEPAVIH Cohort. Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients. Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients. 2015; 29:1821-30. doi: 10.1097/QAD.0000000000000787\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23052829\",\n",
      "        \"title\": \"Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort.\",\n",
      "        \"authors\": \"Loko MA; Bani-Sadr F; Valantin MA; Lascoux-Combe C; Fontaine H; Bonnard P; Gervais A; Bouchaud O; Garipuy D; Quertainmont Y; Vittecoq D; Tehrani MS; Winnock M; Dabis F; Salmon D; ANRS CO 13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.3851/IMP2419\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Loko MA, et al. Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort. Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort. 2012; 17:1335-43. doi: 10.3851/IMP2419\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22173166\",\n",
      "        \"title\": \"Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH.\",\n",
      "        \"authors\": \"Salmon D; Bani-Sadr F; Loko MA; Stitou H; Gervais A; Durant J; Rosenthal E; Quertainmont Y; Barange K; Vittecoq D; Shoai-Tehrani M; Alvarez M; Winnock M; Trinchet JC; Dabis F; Sogni P\",\n",
      "        \"doi\": \"10.1016/j.jhep.2011.11.009\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Salmon D, et al. Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH. Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH. 2012; 56:862-8. doi: 10.1016/j.jhep.2011.11.009\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22535683\",\n",
      "        \"title\": \"Elevated coffee consumption and reduced risk of insulin resistance in HIV-HCV coinfected patients (HEPAVIH ANRS CO-13).\",\n",
      "        \"authors\": \"Carrieri MP; Sogni P; Cohen J; Loko MA; Winnock M; Spire B; HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1002/hep.25813\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Letter\",\n",
      "          \"Comment\"\n",
      "        ],\n",
      "        \"citation\": \"Carrieri MP, et al. Elevated coffee consumption and reduced risk of insulin resistance in HIV-HCV coinfected patients (HEPAVIH ANRS CO-13). Elevated coffee consumption and reduced risk of insulin resistance in HIV-HCV coinfected patients (HEPAVIH ANRS CO-13). 2012; 56:2010. doi: 10.1002/hep.25813\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27317796\",\n",
      "        \"title\": \"All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort.\",\n",
      "        \"authors\": \"Sogni P; Gilbert C; Lacombe K; Piroth L; Rosenthal E; Miailhes P; Gervais A; Esterle L; Chas J; Poizot-Martin I; Dominguez S; Simon A; Morlat P; Neau D; Zucman D; Bouchaud O; Lascoux-Combe C; Bani-Sadr F; Alric L; Goujard C; Vittecoq D; Billaud E; Auma\\u00eetre H; Bou\\u00e9 F; Valantin MA; Dabis F; Salmon D; Wittkop L\",\n",
      "        \"doi\": \"10.1093/cid/ciw379\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Sogni P, et al. All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort. All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort. 2016; 63:763-770. doi: 10.1093/cid/ciw379\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20876416\",\n",
      "        \"title\": \"Chocolate intake, depression, and clinical progression in HIV-HCV coinfected patients: still more questions than answers.\",\n",
      "        \"authors\": \"Carrieri MP; Cohen J; Winnock M; Salmon D\",\n",
      "        \"doi\": \"10.1001/archinternmed.2010.330\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Comment\",\n",
      "          \"Letter\"\n",
      "        ],\n",
      "        \"citation\": \"Carrieri MP, et al. Chocolate intake, depression, and clinical progression in HIV-HCV coinfected patients: still more questions than answers. Chocolate intake, depression, and clinical progression in HIV-HCV coinfected patients: still more questions than answers. 2010; 170:1607; author reply 1608-9. doi: 10.1001/archinternmed.2010.330\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21888878\",\n",
      "        \"title\": \"Coffee consumption and reduced self-reported side effects in HIV-HCV co-infected patients during PEG-IFN and ribavirin treatment: results from ANRS CO13 HEPAVIH.\",\n",
      "        \"authors\": \"Carrieri MP; Cohen J; Salmon-Ceron D; Winnock M\",\n",
      "        \"doi\": \"10.1016/j.jhep.2011.08.005\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Letter\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Carrieri MP, et al. Coffee consumption and reduced self-reported side effects in HIV-HCV co-infected patients during PEG-IFN and ribavirin treatment: results from ANRS CO13 HEPAVIH. Coffee consumption and reduced self-reported side effects in HIV-HCV co-infected patients during PEG-IFN and ribavirin treatment: results from ANRS CO13 HEPAVIH. 2012; 56:745-7. doi: 10.1016/j.jhep.2011.08.005\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27339598\",\n",
      "        \"title\": \"A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients.\",\n",
      "        \"authors\": \"Ulveling D; Le Clerc S; Cobat A; Labib T; Noirel J; Laville V; Coulonges C; Carpentier W; Nalpas B; Heim MH; Poynard T; Cerny A; Pol S; Bochud PY; Dabis F; Theodorou I; L\\u00e9vy Y; Salmon D; Abel L; Dominguez S; Zagury JF; HEPAVIH ANRS CO13 Cohort Study Group; Swiss Hepatitis C Cohort Study Group; French ANRS HC EP 26 Genoscan Study Group\",\n",
      "        \"doi\": \"10.1002/hep.28695\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Ulveling D, et al. A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients. A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients. 2016; 64:1462-1472. doi: 10.1002/hep.28695\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23978720\",\n",
      "        \"title\": \"Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.\",\n",
      "        \"authors\": \"Carrieri MP; Lions C; Sogni P; Winnock M; Roux P; Mora M; Bonnard P; Salmon D; Dabis F; Spire B; ANRS CO13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1016/j.jhep.2013.08.014\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Carrieri MP, et al. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study. 2014; 60:46-53. doi: 10.1016/j.jhep.2013.08.014\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27177169\",\n",
      "        \"title\": \"Short article: Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort).\",\n",
      "        \"authors\": \"Marcellin F; Protopopescu C; Poizot-Martin I; Miailhes P; Esterle L; Wittkop L; Spire B; Bocquier A; Salmon-Ceron D; Dabis F; Carrieri MP; HEPAVIH ANRS CO13 Study Group\",\n",
      "        \"doi\": \"10.1097/MEG.0000000000000664\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Observational Study\"\n",
      "        ],\n",
      "        \"citation\": \"Marcellin F, et al. Short article: Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort). Short article: Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort). 2016; 28:1003-7. doi: 10.1097/MEG.0000000000000664\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28418984\",\n",
      "        \"title\": \"Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH).\",\n",
      "        \"authors\": \"Marcellin F; Protopopescu C; Esterle L; Wittkop L; Piroth L; Aumaitre H; Bouchaud O; Goujard C; Vittecoq D; Dabis F; Salmon-Ceron D; Spire B; Roux P; Carrieri MP; ANRS CO13-HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1097/MEG.0000000000000883\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Marcellin F, et al. Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH). Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH). 2017; 29:786-791. doi: 10.1097/MEG.0000000000000883\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25778750\",\n",
      "        \"title\": \"Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH).\",\n",
      "        \"authors\": \"Carrieri MP; Serfaty L; Vilotitch A; Winnock M; Poizot-Martin I; Loko MA; Lions C; Lascoux-Combe C; Roux P; Salmon-Ceron D; Spire B; Dabis F; ANRS CO13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1093/cid/civ217\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Carrieri MP, et al. Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH). Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH). 2015; 61:40-8. doi: 10.1093/cid/civ217\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28430385\",\n",
      "        \"title\": \"Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort.\",\n",
      "        \"authors\": \"Knight R; Roux P; Vilotitch A; Marcellin F; Rosenthal E; Esterle L; Bou\\u00e9 F; Rey D; Piroth L; Dominguez S; Sogni P; Salmon-Ceron D; Spire B; Carrieri MP; ANRS CO13-HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1111/add.13851\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Knight R, et al. Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort. Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort. 2017; 112:1669-1679. doi: 10.1111/add.13851\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22285372\",\n",
      "        \"title\": \"Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: should the same test be applied to all samples?\",\n",
      "        \"authors\": \"Trimoulet P; Merchadou L; Winnock M; Loko MA; Fleury H; Salmon D; Dabis F; Neau D; ANRS CO 13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1016/j.jviromet.2012.01.006\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Trimoulet P, et al. Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: should the same test be applied to all samples?. Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: should the same test be applied to all samples?. 2012; 181:131-3. doi: 10.1016/j.jviromet.2012.01.006\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21239121\",\n",
      "        \"title\": \"Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician.\",\n",
      "        \"authors\": \"Roux P; Cohen J; Lascoux-Combe C; Sogni P; Winnock M; Salmon-Ceron D; Spire B; Dabis F; Carrieri MP; ANRS-CO13-HEPAVIH study group\",\n",
      "        \"doi\": \"10.1016/j.drugalcdep.2010.09.025\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Roux P, et al. Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician. Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician. 2011; 116:228-32. doi: 10.1016/j.drugalcdep.2010.09.025\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28235612\",\n",
      "        \"title\": \"Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort.\",\n",
      "        \"authors\": \"Piroth L; Wittkop L; Lacombe K; Rosenthal E; Gilbert C; Miailhes P; Carrieri P; Chas J; Poizot-Martin I; Gervais A; Dominguez S; Neau D; Zucman D; Billaud E; Morlat P; Aumaitre H; Lascoux-Combe C; Simon A; Bouchaud O; Teicher E; Bani-Sadr F; Alric L; Vittecoq D; Bou\\u00e9 F; Duvivier C; Valantin MA; Esterle L; Dabis F; Sogni P; Salmon D; ANRS CO13 HEPAVIH study group\",\n",
      "        \"doi\": \"10.1016/j.jhep.2017.02.012\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Piroth L, et al. Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort. Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort. 2017; 67:23-31. doi: 10.1016/j.jhep.2017.02.012\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32798585\",\n",
      "        \"title\": \"Increased mortality in HIV/HCV-coinfected compared to\\u00a0HCV-monoinfected patients in the DAA era due to non-liver-related death.\",\n",
      "        \"authors\": \"Chalouni M; Pol S; Sogni P; Fontaine H; Lacombe K; Marc-Lacombe J; Esterle L; Dorival C; Bourli\\u00e8re M; Bani-Sadr F; de Ledinghen V; Zucman D; Larrey D; Salmon D; Carrat F; Wittkop L; ANRS CO13 HEPAVIH and ANRS CO22 HEPATHER cohort study groups\",\n",
      "        \"doi\": \"10.1016/j.jhep.2020.08.008\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Chalouni M, et al. Increased mortality in HIV/HCV-coinfected compared to\\u00a0HCV-monoinfected patients in the DAA era due to non-liver-related death. Increased mortality in HIV/HCV-coinfected compared to\\u00a0HCV-monoinfected patients in the DAA era due to non-liver-related death. 2021; 74:37-47. doi: 10.1016/j.jhep.2020.08.008\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23226258\",\n",
      "        \"title\": \"HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients.\",\n",
      "        \"authors\": \"Abravanel F; Raymond S; Pambrun E; Winnock M; Bonnard P; Sogni P; Trimoulet P; Dabis F; Salmon-Ceron D; Izopet J; ANRS CO13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1371/journal.pone.0050289\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Abravanel F, et al. HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients. HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients. 2012; 7:e50289. doi: 10.1371/journal.pone.0050289\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34212476\",\n",
      "        \"title\": \"Risk of severe clinical events after sustained virological response following direct-acting antiviral therapy in HIV and hepatitis C virus coinfected participants.\",\n",
      "        \"authors\": \"Chalouni M; Wittkop L; Bani-Sadr F; Lacombe K; Esterle L; Gilbert C; Miailhes P; Zucman D; Valantin MA; Br\\u00e9gigeon-Ronot S; Morlat P; Billaud E; Piroth L; Naqvi A; Sogni P; Salmon D; ANRS CO13 HEPAVIH Cohort Study Group\",\n",
      "        \"doi\": \"10.1111/hiv.13127\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Chalouni M, et al. Risk of severe clinical events after sustained virological response following direct-acting antiviral therapy in HIV and hepatitis C virus coinfected participants. Risk of severe clinical events after sustained virological response following direct-acting antiviral therapy in HIV and hepatitis C virus coinfected participants. 2021; 22:791-804. doi: 10.1111/hiv.13127\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21692942\",\n",
      "        \"title\": \"Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients.\",\n",
      "        \"authors\": \"Loko MA; Bani-Sadr F; Winnock M; Lacombe K; Carrieri P; Neau D; Morlat P; Serfaty L; Dabis F; Salmon D; ANRS CO 13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1111/j.1365-2893.2010.01417.x\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Loko MA, et al. Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients. Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients. 2011; 18:e307-14. doi: 10.1111/j.1365-2893.2010.01417.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28780609\",\n",
      "        \"title\": \"Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort).\",\n",
      "        \"authors\": \"Yaya I; Roux P; Marcellin F; Salmon-Ceron D; Carrieri MP\",\n",
      "        \"doi\": \"10.1007/s10620-017-4703-y\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Letter\",\n",
      "          \"Comment\"\n",
      "        ],\n",
      "        \"citation\": \"Yaya I, et al. Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort). Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort). 2017; 62:2943-2944. doi: 10.1007/s10620-017-4703-y\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30570526\",\n",
      "        \"title\": \"Nadir CD4 Is Negatively Associated With Antinuclear Antibody Detection in HCV/HIV-Coinfected Patients.\",\n",
      "        \"authors\": \"Poizot-Martin I; Rosenthal E; Gilbert C; Cano CE; Simon A; Lascoux-Combe C; Alric L; Gervais A; Neau D; Esterle L; Salmon D; Sogni P; Wittkop L; ANRS CO13 HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1097/QAI.0000000000001940\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Poizot-Martin I, et al. Nadir CD4 Is Negatively Associated With Antinuclear Antibody Detection in HCV/HIV-Coinfected Patients. Nadir CD4 Is Negatively Associated With Antinuclear Antibody Detection in HCV/HIV-Coinfected Patients. 2019; 80:461-466. doi: 10.1097/QAI.0000000000001940\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24580042\",\n",
      "        \"title\": \"Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort.\",\n",
      "        \"authors\": \"Marcellin F; Roux P; Winnock M; Lions C; Dabis F; Salmon-Ceron D; Loko MA; Spire B; Carrieri MP\",\n",
      "        \"doi\": \"10.1586/17474124.2014.888949\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Marcellin F, et al. Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort. Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort. 2014; 8:351-8. doi: 10.1586/17474124.2014.888949\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21819472\",\n",
      "        \"title\": \"Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.\",\n",
      "        \"authors\": \"Roux P; Fugon L; Winnock M; Salmon-C\\u00e9ron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP; ANRS-CO-13-HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.1111/j.1360-0443.2011.03608.x\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Roux P, et al. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users. 2012; 107:152-9. doi: 10.1111/j.1360-0443.2011.03608.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24166726\",\n",
      "        \"title\": \"Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort.\",\n",
      "        \"authors\": \"Roux P; Lions C; Cohen J; Winnock M; Salmon-C\\u00e9ron D; Bani-Sadr F; Sogni P; Spire B; Dabis F; Carrieri MP; ANRS-CO13-HEPAVIH Study Group\",\n",
      "        \"doi\": \"10.3851/IMP2699\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Roux P, et al. Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort. Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort. 2014; 19:171-8. doi: 10.3851/IMP2699\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04842851\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04409405\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"38043556\",\n",
      "        \"title\": \"Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of Ebola virus disease in the Democratic Republic of the Congo: an observational cohort study.\",\n",
      "        \"authors\": \"Nkuba-Ndaye A; Dilu-Keti A; Tovar-Sanchez T; Diallo MSK; Mukadi-Bamuleka D; Kitenge R; Formenty P; Legand A; Edidi-Atani F; Thaurignac G; Pelloquin R; Mbala-Kingebeni P; Toure A; Ayouba A; Muyembe-Tamfum JJ; Delaporte E; Peeters M; Ahuka-Mundeke S; Les Vainqueurs d\\u2019Ebola Study Group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(23)00552-2\",\n",
      "        \"year\": \"2024\",\n",
      "        \"publication_types\": [\n",
      "          \"Observational Study\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Nkuba-Ndaye A, et al. Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of Ebola virus disease in the Democratic Republic of the Congo: an observational cohort study. Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of Ebola virus disease in the Democratic Republic of the Congo: an observational cohort study. 2024; 24:266-274. doi: 10.1016/S1473-3099(23)00552-2\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00158405\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"16152755\",\n",
      "        \"title\": \"Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in C\\u00f4te d'Ivoire.\",\n",
      "        \"authors\": \"Moh R; Danel C; Sorho S; Sauvageot D; Anzian A; Minga A; Gomis OB; Konga C; Inwoley A; Gabillard D; Bissagnene E; Salamon R; Anglaret X\",\n",
      "        \"doi\": \"10.1177/135965350501000510\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Moh R, et al. Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in C\\u00f4te d'Ivoire. Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in C\\u00f4te d'Ivoire. 2005; 10:615-24. doi: 10.1177/135965350501000510\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16782488\",\n",
      "        \"title\": \"CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial.\",\n",
      "        \"authors\": \"Danel C; Moh R; Minga A; Anzian A; Ba-Gomis O; Kanga C; Nzunetu G; Gabillard D; Rouet F; Sorho S; Chaix ML; Eholi\\u00e9 S; Menan H; Sauvageot D; Bissagnene E; Salamon R; Anglaret X; Trivacan ANRS 1269 trial group\",\n",
      "        \"doi\": \"10.1016/S0140-6736(06)68887-9\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Danel C, et al. CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial. CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial. 2006; 367:1981-9. doi: 10.1016/S0140-6736(06)68887-9\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18986246\",\n",
      "        \"title\": \"Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults.\",\n",
      "        \"authors\": \"Danel C; Moh R; Chaix ML; Gabillard D; Gnokoro J; Diby CJ; Toni T; Dohoun L; Rouzioux C; Bissagnene E; Salamon R; Anglaret X; Trivacan ANRS 1269 Trial Group\",\n",
      "        \"doi\": \"10.1086/595298\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Danel C, et al. Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults. Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults. 2009; 199:66-76. doi: 10.1086/595298\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02960698\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02931097\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00657397\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"27048152\",\n",
      "        \"title\": \"Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study).\",\n",
      "        \"authors\": \"Roux P; Lions C; Vilotitch A; Michel L; Mora M; Maradan G; Marcellin F; Spire B; Morel A; Carrieri PM; ANRS Methaville study group\",\n",
      "        \"doi\": \"10.1186/s12954-016-0100-7\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Roux P, et al. Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study). Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study). 2016; 13:12. doi: 10.1186/s12954-016-0100-7\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27770695\",\n",
      "        \"title\": \"Decrease in self-reported offences and incarceration rates during methadone treatment: A comparison between patients switching from buprenorphine to methadone and maintenance treatment incident users (ANRS-Methaville trial).\",\n",
      "        \"authors\": \"Carrieri P; Vilotitch A; Nordmann S; Lions C; Michel L; Mora M; Morel A; Maradan G; Spire B; Roux P; Methaville Study Group\",\n",
      "        \"doi\": \"10.1016/j.drugpo.2016.08.005\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Carrieri P, et al. Decrease in self-reported offences and incarceration rates during methadone treatment: A comparison between patients switching from buprenorphine to methadone and maintenance treatment incident users (ANRS-Methaville trial). Decrease in self-reported offences and incarceration rates during methadone treatment: A comparison between patients switching from buprenorphine to methadone and maintenance treatment incident users (ANRS-Methaville trial). 2017; 39:86-91. doi: 10.1016/j.drugpo.2016.08.005\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22741944\",\n",
      "        \"title\": \"Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial.\",\n",
      "        \"authors\": \"Roux P; Michel L; Cohen J; Mora M; Morel A; Aubertin JF; Desenclos JC; Spire B; Carrieri PM; ANRS Methaville Study Group\",\n",
      "        \"doi\": \"10.1186/1471-2458-12-488\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Roux P, et al. Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial. Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial. 2012; 12:488. doi: 10.1186/1471-2458-12-488\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24268548\",\n",
      "        \"title\": \"Predictors of non-prescribed opioid use after one year of methadone treatment: an attributable-risk approach (ANRS-Methaville trial).\",\n",
      "        \"authors\": \"Lions C; Carrieri MP; Michel L; Mora M; Marcellin F; Morel A; Spire B; Roux P; Methaville Study Group\",\n",
      "        \"doi\": \"10.1016/j.drugalcdep.2013.10.018\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Lions C, et al. Predictors of non-prescribed opioid use after one year of methadone treatment: an attributable-risk approach (ANRS-Methaville trial). Predictors of non-prescribed opioid use after one year of methadone treatment: an attributable-risk approach (ANRS-Methaville trial). 2014; 135:1-8. doi: 10.1016/j.drugalcdep.2013.10.018\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25209306\",\n",
      "        \"title\": \"Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions.\",\n",
      "        \"authors\": \"Roux P; Lions C; Michel L; Mora M; Daulou\\u00e8de JP; Marcellin F; Spire B; Morel A; Carrieri PM; ANRS Methaville study group\",\n",
      "        \"doi\": \"10.1186/1747-597X-9-37\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Roux P, et al. Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions. Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions. 2014; 9:37. doi: 10.1186/1747-597X-9-37\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25393311\",\n",
      "        \"title\": \"Methadone induction in primary care for opioid dependence: a pragmatic randomized trial (ANRS Methaville).\",\n",
      "        \"authors\": \"Carrieri PM; Michel L; Lions C; Cohen J; Vray M; Mora M; Marcellin F; Spire B; Morel A; Roux P; Methaville Study Group\",\n",
      "        \"doi\": \"10.1371/journal.pone.0112328\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Pragmatic Clinical Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Carrieri PM, et al. Methadone induction in primary care for opioid dependence: a pragmatic randomized trial (ANRS Methaville). Methadone induction in primary care for opioid dependence: a pragmatic randomized trial (ANRS Methaville). 2014; 9:e112328. doi: 10.1371/journal.pone.0112328\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00421551\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"22848481\",\n",
      "        \"title\": \"Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks.\",\n",
      "        \"authors\": \"Lambert-Niclot S; Flandre P; Valantin MA; Soulie C; Fourati S; Wirden M; Sayon S; Pakianather S; Bocket L; Masquelier B; Dos Santos G; Katlama C; Calvez V; Marcelin AG\",\n",
      "        \"doi\": \"10.1371/journal.pone.0041390\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Lambert-Niclot S, et al. Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks. Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks. 2012; 7:e41390. doi: 10.1371/journal.pone.0041390\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20802297\",\n",
      "        \"title\": \"Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136.\",\n",
      "        \"authors\": \"Katlama C; Valantin MA; Algarte-Genin M; Duvivier C; Lambert-Niclot S; Girard PM; Molina JM; Hoen B; Pakianather S; Peytavin G; Marcelin AG; Flandre P\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32833dec20\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Katlama C, et al. Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136. Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136. 2010; 24:2365-74. doi: 10.1097/QAD.0b013e32833dec20\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29767684\",\n",
      "        \"title\": \"Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies.\",\n",
      "        \"authors\": \"Lambert-Niclot S; Grude M; Meynard JL; Marcelin AG; Valantin MA; Flandre P; Izopet J; Moinot L; Bouteloup V; Calvez V; Katlama C; Girard PM; Morand-Joubert L\",\n",
      "        \"doi\": \"10.1093/cid/ciy382\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Lambert-Niclot S, et al. Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies. Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies. 2018; 67:1883-1889. doi: 10.1093/cid/ciy382\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00623051\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00116454\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03954054\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"35012570\",\n",
      "        \"title\": \"Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER).\",\n",
      "        \"authors\": \"Antwerpes S; Costa M; Coste M; Bureau M; Maradan G; Cutarella C; Leloutre J; Riccobono-Soulier O; Hedoire S; Frot E; Vernier F; Vassas-Goyard S; Barr\\u00e9 T; Casanova D; Carrieri P\",\n",
      "        \"doi\": \"10.1186/s12954-021-00587-0\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Antwerpes S, et al. Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER). Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER). 2022; 19:2. doi: 10.1186/s12954-021-00587-0\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02976298\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02101398\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT05472051\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00495651\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26193126\",\n",
      "        \"title\": \"A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.\",\n",
      "        \"authors\": \"TEMPRANO ANRS 12136 Study Group; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakp\\u00e9 JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouam\\u00e9 A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidib\\u00e9 B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouam\\u00e9 E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundz\\u00e9 S; Hawerlander D; Ani A; Demb\\u00e9l\\u00e9 F; Kon\\u00e9 F; Gu\\u00e9hi C; Kanga C; Koule S; S\\u00e9ri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleou\\u00e9 G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semd\\u00e9 C; Kouame A; Massumbuko JM; Ch\\u00eane G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholi\\u00e9 SP; Anglaret X\",\n",
      "        \"doi\": \"10.1056/NEJMoa1507198\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"TEMPRANO ANRS 12136 Study Group, et al. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. 2015; 373:808-22. doi: 10.1056/NEJMoa1507198\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29297443\",\n",
      "        \"title\": \"Screening for active tuberculosis before isoniazid preventive therapy among HIV-infected West African adults.\",\n",
      "        \"authors\": \"Moh R; Badj\\u00e9 A; N'takp\\u00e9 JB; Kouam\\u00e9 GM; Gabillard D; Ouassa T; Ouattara E; Le Carrou J; Bohoussou F; Messou E; Eholi\\u00e9 S; Anglaret X; Danel C\",\n",
      "        \"doi\": \"10.5588/ijtld.17.0016\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Moh R, et al. Screening for active tuberculosis before isoniazid preventive therapy among HIV-infected West African adults. Screening for active tuberculosis before isoniazid preventive therapy among HIV-infected West African adults. 2017; 21:1237-1244. doi: 10.5588/ijtld.17.0016\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29020361\",\n",
      "        \"title\": \"Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.\",\n",
      "        \"authors\": \"Kouam\\u00e9 GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emi\\u00e8me A; Maylin S; Chekaraou MA; Eholi\\u00e9 SP; Zoulim F; Lacombe K; Anglaret X; Danel C; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) 12136 Temprano and ANRS 12240 VarBVA Study Groups\",\n",
      "        \"doi\": \"10.1093/cid/cix747\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kouam\\u00e9 GM, et al. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication. 2018; 66:112-120. doi: 10.1093/cid/cix747\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23639243\",\n",
      "        \"title\": \"Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts.\",\n",
      "        \"authors\": \"Ouattara E; Danel C; Moh R; Gabillard D; Peytavin G; Konan R; Carrou JL; Bohoussou F; Eholie SP; Anglaret X\",\n",
      "        \"doi\": \"10.7448/IAS.16.1.18059\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Ouattara E, et al. Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts. Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts. 2013; 16:18059. doi: 10.7448/IAS.16.1.18059\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25330161\",\n",
      "        \"title\": \"Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in C\\u00f4te d'Ivoire, West Africa.\",\n",
      "        \"authors\": \"Danel C; Kabran M; Inwoley A; Badje A; Herrmann JL; Moh R; Lecarrou J; Gabillard D; Ntakpe JB; Deschamps N; Ouattara E; Perronne C; Eholie S; Anglaret X\",\n",
      "        \"doi\": \"10.1371/journal.pone.0107245\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Danel C, et al. Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in C\\u00f4te d'Ivoire, West Africa. Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in C\\u00f4te d'Ivoire, West Africa. 2014; 9:e107245. doi: 10.1371/journal.pone.0107245\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24985779\",\n",
      "        \"title\": \"Decrease in sexual risk behaviours after early initiation of antiretroviral therapy: a 24-month prospective study in C\\u00f4te d'Ivoire.\",\n",
      "        \"authors\": \"Jean K; Gabillard D; Moh R; Danel C; Desgr\\u00e9es-du-Lo\\u00fb A; N'takpe JB; Le Carrou J; Badj\\u00e9 A; Eholi\\u00e9 S; Lert F; Anglaret X; Dray-Spira R\",\n",
      "        \"doi\": \"10.7448/IAS.17.1.18977\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Jean K, et al. Decrease in sexual risk behaviours after early initiation of antiretroviral therapy: a 24-month prospective study in C\\u00f4te d'Ivoire. Decrease in sexual risk behaviours after early initiation of antiretroviral therapy: a 24-month prospective study in C\\u00f4te d'Ivoire. 2014; 17:18977. doi: 10.7448/IAS.17.1.18977\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35093007\",\n",
      "        \"title\": \"Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adults.\",\n",
      "        \"authors\": \"Moh DR; Ntakp\\u00e9 JB; Gabillard D; Yayo-Emieme AA; Badj\\u00e9 A; Kouame GM; d'Aquin TT; Danel C; Anglaret X; Eholi\\u00e9 SP\",\n",
      "        \"doi\": \"10.1186/s12879-022-07082-2\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Moh DR, et al. Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adults. Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adults. 2022; 22:100. doi: 10.1186/s12879-022-07082-2\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01693861\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00272428\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"28033414\",\n",
      "        \"title\": \"Effect of Multimorbidity on Health-Related Quality of Life in Adults Aged 55 Years or Older: Results from the SU.VI.MAX 2 Cohort.\",\n",
      "        \"authors\": \"Walker V; Perret-Guillaume C; Kesse-Guyot E; Agrinier N; Hercberg S; Galan P; Assmann KE; Brian\\u00e7on S; Rotonda C\",\n",
      "        \"doi\": \"10.1371/journal.pone.0169282\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Walker V, et al. Effect of Multimorbidity on Health-Related Quality of Life in Adults Aged 55 Years or Older: Results from the SU.VI.MAX 2 Cohort. Effect of Multimorbidity on Health-Related Quality of Life in Adults Aged 55 Years or Older: Results from the SU.VI.MAX 2 Cohort. 2016; 11:e0169282. doi: 10.1371/journal.pone.0169282\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31164347\",\n",
      "        \"title\": \"Plasma Metabolomic Signatures Associated with Long-term Breast Cancer Risk in the SU.VI.MAX Prospective Cohort.\",\n",
      "        \"authors\": \"L\\u00e9cuyer L; Dalle C; Lyan B; Demidem A; Rossary A; Vasson MP; Petera M; Lagree M; Ferreira T; Centeno D; Galan P; Hercberg S; Deschasaux M; Partula V; Srour B; Latino-Martel P; Kesse-Guyot E; Druesne-Pecollo N; Durand S; Pujos-Guillot E; Touvier M\",\n",
      "        \"doi\": \"10.1158/1055-9965.EPI-19-0154\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"L\\u00e9cuyer L, et al. Plasma Metabolomic Signatures Associated with Long-term Breast Cancer Risk in the SU.VI.MAX Prospective Cohort. Plasma Metabolomic Signatures Associated with Long-term Breast Cancer Risk in the SU.VI.MAX Prospective Cohort. 2019; 28:1300-1307. doi: 10.1158/1055-9965.EPI-19-0154\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26409628\",\n",
      "        \"title\": \"Are different vascular risk scores calculated at midlife uniformly associated with subsequent poor cognitive performance?\",\n",
      "        \"authors\": \"Kesse-Guyot E; Lassale C; Assmann KE; Andreeva VA; Julia C; Blacher J; Fezeu L; Hercberg S; Galan P\",\n",
      "        \"doi\": \"10.1016/j.atherosclerosis.2015.09.023\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. Are different vascular risk scores calculated at midlife uniformly associated with subsequent poor cognitive performance?. Are different vascular risk scores calculated at midlife uniformly associated with subsequent poor cognitive performance?. 2015; 243:286-92. doi: 10.1016/j.atherosclerosis.2015.09.023\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28356432\",\n",
      "        \"title\": \"The Inflammatory Potential of the Diet Is Associated with Depressive Symptoms in Different Subgroups of the General Population.\",\n",
      "        \"authors\": \"Adjibade M; Andreeva VA; Lemogne C; Touvier M; Shivappa N; H\\u00e9bert JR; Wirth MD; Hercberg S; Galan P; Julia C; Assmann KE; Kesse-Guyot E\",\n",
      "        \"doi\": \"10.3945/jn.116.245167\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Adjibade M, et al. The Inflammatory Potential of the Diet Is Associated with Depressive Symptoms in Different Subgroups of the General Population. The Inflammatory Potential of the Diet Is Associated with Depressive Symptoms in Different Subgroups of the General Population. 2017; 147:879-887. doi: 10.3945/jn.116.245167\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22633793\",\n",
      "        \"title\": \"Adherence to Mediterranean diet reduces the risk of metabolic syndrome: a 6-year prospective study.\",\n",
      "        \"authors\": \"Kesse-Guyot E; Ahluwalia N; Lassale C; Hercberg S; Fezeu L; Lairon D\",\n",
      "        \"doi\": \"10.1016/j.numecd.2012.02.005\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. Adherence to Mediterranean diet reduces the risk of metabolic syndrome: a 6-year prospective study. Adherence to Mediterranean diet reduces the risk of metabolic syndrome: a 6-year prospective study. 2013; 23:677-83. doi: 10.1016/j.numecd.2012.02.005\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30517725\",\n",
      "        \"title\": \"Unsaturated Fatty Acid Intakes During Midlife Are Positively Associated with Later Cognitive Function in Older Adults with Modulating Effects of Antioxidant Supplementation.\",\n",
      "        \"authors\": \"Assmann KE; Adjibade M; Hercberg S; Galan P; Kesse-Guyot E\",\n",
      "        \"doi\": \"10.1093/jn/nxy206\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Assmann KE, et al. Unsaturated Fatty Acid Intakes During Midlife Are Positively Associated with Later Cognitive Function in Older Adults with Modulating Effects of Antioxidant Supplementation. Unsaturated Fatty Acid Intakes During Midlife Are Positively Associated with Later Cognitive Function in Older Adults with Modulating Effects of Antioxidant Supplementation. 2018; 148:1938-1945. doi: 10.1093/jn/nxy206\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28494135\",\n",
      "        \"title\": \"Prospective association between body mass index at midlife and healthy aging among French adults.\",\n",
      "        \"authors\": \"Ruhunuhewa I; Adjibade M; Andreeva VA; Galan P; Hercberg S; Assmann KE; Kesse-Guyot E\",\n",
      "        \"doi\": \"10.1002/oby.21853\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Ruhunuhewa I, et al. Prospective association between body mass index at midlife and healthy aging among French adults. Prospective association between body mass index at midlife and healthy aging among French adults. 2017; 25:1254-1262. doi: 10.1002/oby.21853\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22378736\",\n",
      "        \"title\": \"Modulation of the association between plasma intercellular adhesion molecule-1 and cancer risk by n-3 PUFA intake: a nested case-control study.\",\n",
      "        \"authors\": \"Touvier M; Kesse-Guyot E; Andreeva VA; Fezeu L; Charnaux N; Sutton A; Druesne-Pecollo N; Hercberg S; Galan P; Zelek L; Latino-Martel P; Czernichow S\",\n",
      "        \"doi\": \"10.3945/ajcn.111.027805\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Touvier M, et al. Modulation of the association between plasma intercellular adhesion molecule-1 and cancer risk by n-3 PUFA intake: a nested case-control study. Modulation of the association between plasma intercellular adhesion molecule-1 and cancer risk by n-3 PUFA intake: a nested case-control study. 2012; 95:944-50. doi: 10.3945/ajcn.111.027805\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29546305\",\n",
      "        \"title\": \"The Inflammatory Potential of the Diet at Midlife Is Associated with Later Healthy Aging in French Adults.\",\n",
      "        \"authors\": \"Assmann KE; Adjibade M; Shivappa N; H\\u00e9bert JR; Wirth MD; Touvier M; Akbaraly T; Hercberg S; Galan P; Julia C; Kesse-Guyot E\",\n",
      "        \"doi\": \"10.1093/jn/nxx061\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Assmann KE, et al. The Inflammatory Potential of the Diet at Midlife Is Associated with Later Healthy Aging in French Adults. The Inflammatory Potential of the Diet at Midlife Is Associated with Later Healthy Aging in French Adults. 2018; 148:437-444. doi: 10.1093/jn/nxx061\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20176858\",\n",
      "        \"title\": \"Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndrome.\",\n",
      "        \"authors\": \"Phillips CM; Goumidi L; Bertrais S; Field MR; Cupples LA; Ordovas JM; Defoort C; Lovegrove JA; Drevon CA; Gibney MJ; Blaak EE; Kiec-Wilk B; Karlstrom B; Lopez-Miranda J; McManus R; Hercberg S; Lairon D; Planells R; Roche HM\",\n",
      "        \"doi\": \"10.1194/jlr.M003046\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Phillips CM, et al. Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndrome. Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndrome. 2010; 51:1793-800. doi: 10.1194/jlr.M003046\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25994566\",\n",
      "        \"title\": \"Prospective association between alcohol intake and hormone-dependent cancer risk: modulation by dietary fiber intake.\",\n",
      "        \"authors\": \"Chhim AS; Fassier P; Latino-Martel P; Druesne-Pecollo N; Zelek L; Duverger L; Hercberg S; Galan P; Deschasaux M; Touvier M\",\n",
      "        \"doi\": \"10.3945/ajcn.114.098418\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Chhim AS, et al. Prospective association between alcohol intake and hormone-dependent cancer risk: modulation by dietary fiber intake. Prospective association between alcohol intake and hormone-dependent cancer risk: modulation by dietary fiber intake. 2015; 102:182-9. doi: 10.3945/ajcn.114.098418\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27000099\",\n",
      "        \"title\": \"Prospective association between a dietary quality index based on a nutrient profiling system and cardiovascular disease risk.\",\n",
      "        \"authors\": \"Adriouch S; Julia C; Kesse-Guyot E; M\\u00e9jean C; Ducrot P; P\\u00e9neau S; Donnenfeld M; Deschasaux M; Menai M; Hercberg S; Touvier M; Fezeu LK\",\n",
      "        \"doi\": \"10.1177/2047487316640659\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Adriouch S, et al. Prospective association between a dietary quality index based on a nutrient profiling system and cardiovascular disease risk. Prospective association between a dietary quality index based on a nutrient profiling system and cardiovascular disease risk. 2016; 23:1669-76. doi: 10.1177/2047487316640659\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26962176\",\n",
      "        \"title\": \"The Dietary Inflammatory Index Is Associated with Prostate Cancer Risk in French Middle-Aged Adults in a Prospective Study.\",\n",
      "        \"authors\": \"Graffouill\\u00e8re L; Deschasaux M; Mariotti F; Neufcourt L; Shivappa N; H\\u00e9bert JR; Wirth MD; Latino-Martel P; Hercberg S; Galan P; Julia C; Kesse-Guyot E; Touvier M\",\n",
      "        \"doi\": \"10.3945/jn.115.225623\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Graffouill\\u00e8re L, et al. The Dietary Inflammatory Index Is Associated with Prostate Cancer Risk in French Middle-Aged Adults in a Prospective Study. The Dietary Inflammatory Index Is Associated with Prostate Cancer Risk in French Middle-Aged Adults in a Prospective Study. 2016; 146:785-791. doi: 10.3945/jn.115.225623\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21490142\",\n",
      "        \"title\": \"Dietary intake of 337 polyphenols in French adults.\",\n",
      "        \"authors\": \"P\\u00e9rez-Jim\\u00e9nez J; Fezeu L; Touvier M; Arnault N; Manach C; Hercberg S; Galan P; Scalbert A\",\n",
      "        \"doi\": \"10.3945/ajcn.110.007096\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"P\\u00e9rez-Jim\\u00e9nez J, et al. Dietary intake of 337 polyphenols in French adults. Dietary intake of 337 polyphenols in French adults. 2011; 93:1220-8. doi: 10.3945/ajcn.110.007096\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21106918\",\n",
      "        \"title\": \"Adherence to nutritional recommendations and subsequent cognitive performance: findings from the prospective Supplementation with Antioxidant Vitamins and Minerals 2 (SU.VI.MAX 2) study.\",\n",
      "        \"authors\": \"Kesse-Guyot E; Amieva H; Castetbon K; Henegar A; Ferry M; Jeandel C; Hercberg S; Galan P; SU.VI.MAX 2 Research Group\",\n",
      "        \"doi\": \"10.3945/ajcn.2010.29761\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. Adherence to nutritional recommendations and subsequent cognitive performance: findings from the prospective Supplementation with Antioxidant Vitamins and Minerals 2 (SU.VI.MAX 2) study. Adherence to nutritional recommendations and subsequent cognitive performance: findings from the prospective Supplementation with Antioxidant Vitamins and Minerals 2 (SU.VI.MAX 2) study. 2011; 93:200-10. doi: 10.3945/ajcn.2010.29761\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25651444\",\n",
      "        \"title\": \"Overall and abdominal adiposity in midlife and subsequent cognitive function.\",\n",
      "        \"authors\": \"Kesse-Guyot E; Andreeva VA; Touvier M; Jeandel C; Ferry M; Hercberg S; Galan P; SU.VI.MAX 2 Research Group\",\n",
      "        \"doi\": \"10.1007/s12603-014-0508-2\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. Overall and abdominal adiposity in midlife and subsequent cognitive function. Overall and abdominal adiposity in midlife and subsequent cognitive function. 2015; 19:183-9. doi: 10.1007/s12603-014-0508-2\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26817718\",\n",
      "        \"title\": \"Weight Status and Alcohol Intake Modify the Association between Vitamin D and Breast Cancer Risk.\",\n",
      "        \"authors\": \"Deschasaux M; Souberbielle JC; Latino-Martel P; Sutton A; Charnaux N; Druesne-Pecollo N; Galan P; Hercberg S; Le Clerc S; Kesse-Guyot E; Ezzedine K; Touvier M\",\n",
      "        \"doi\": \"10.3945/jn.115.221481\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Deschasaux M, et al. Weight Status and Alcohol Intake Modify the Association between Vitamin D and Breast Cancer Risk. Weight Status and Alcohol Intake Modify the Association between Vitamin D and Breast Cancer Risk. 2016; 146:576-85. doi: 10.3945/jn.115.221481\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24089418\",\n",
      "        \"title\": \"Midlife iron status is inversely associated with subsequent cognitive performance, particularly in perimenopausal women.\",\n",
      "        \"authors\": \"Andreeva VA; Galan P; Arnaud J; Julia C; Hercberg S; Kesse-Guyot E\",\n",
      "        \"doi\": \"10.3945/jn.113.177089\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Andreeva VA, et al. Midlife iron status is inversely associated with subsequent cognitive performance, particularly in perimenopausal women. Midlife iron status is inversely associated with subsequent cognitive performance, particularly in perimenopausal women. 2013; 143:1974-81. doi: 10.3945/jn.113.177089\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20431391\",\n",
      "        \"title\": \"Associations between dietary patterns and arterial stiffness, carotid artery intima-media thickness and atherosclerosis.\",\n",
      "        \"authors\": \"Kesse-Guyot E; Vergnaud AC; Fezeu L; Zureik M; Blacher J; P\\u00e9neau S; Hercberg S; Galan P; Czernichow S\",\n",
      "        \"doi\": \"10.1097/HJR.0b013e32833a197f\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. Associations between dietary patterns and arterial stiffness, carotid artery intima-media thickness and atherosclerosis. Associations between dietary patterns and arterial stiffness, carotid artery intima-media thickness and atherosclerosis. 2010; 17:718-24. doi: 10.1097/HJR.0b013e32833a197f\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23284983\",\n",
      "        \"title\": \"Alcohol consumption in midlife and cognitive performance assessed 13 years later in the SU.VI.MAX 2 cohort.\",\n",
      "        \"authors\": \"Kesse-Guyot E; Andreeva VA; Jeandel C; Ferry M; Touvier M; Hercberg S; Galan P\",\n",
      "        \"doi\": \"10.1371/journal.pone.0052311\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. Alcohol consumption in midlife and cognitive performance assessed 13 years later in the SU.VI.MAX 2 cohort. Alcohol consumption in midlife and cognitive performance assessed 13 years later in the SU.VI.MAX 2 cohort. 2012; 7:e52311. doi: 10.1371/journal.pone.0052311\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26156743\",\n",
      "        \"title\": \"Prospective association between dietary folate intake and skin cancer risk: results from the Suppl\\u00e9mentation en Vitamines et Min\\u00e9raux Antioxydants cohort.\",\n",
      "        \"authors\": \"Donnenfeld M; Deschasaux M; Latino-Martel P; Diallo A; Galan P; Hercberg S; Ezzedine K; Touvier M\",\n",
      "        \"doi\": \"10.3945/ajcn.115.109041\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Donnenfeld M, et al. Prospective association between dietary folate intake and skin cancer risk: results from the Suppl\\u00e9mentation en Vitamines et Min\\u00e9raux Antioxydants cohort. Prospective association between dietary folate intake and skin cancer risk: results from the Suppl\\u00e9mentation en Vitamines et Min\\u00e9raux Antioxydants cohort. 2015; 102:471-8. doi: 10.3945/ajcn.115.109041\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21775560\",\n",
      "        \"title\": \"French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial.\",\n",
      "        \"authors\": \"Kesse-Guyot E; Fezeu L; Jeandel C; Ferry M; Andreeva V; Amieva H; Hercberg S; Galan P\",\n",
      "        \"doi\": \"10.3945/ajcn.110.007815\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial. French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial. 2011; 94:892-9. doi: 10.3945/ajcn.110.007815\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26447153\",\n",
      "        \"title\": \"Prospective associations between vitamin D status, vitamin D-related gene polymorphisms, and risk of tobacco-related cancers.\",\n",
      "        \"authors\": \"Deschasaux M; Souberbielle JC; Latino-Martel P; Sutton A; Charnaux N; Druesne-Pecollo N; Galan P; Hercberg S; Le Clerc S; Kesse-Guyot E; Ezzedine K; Touvier M\",\n",
      "        \"doi\": \"10.3945/ajcn.115.110510\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Deschasaux M, et al. Prospective associations between vitamin D status, vitamin D-related gene polymorphisms, and risk of tobacco-related cancers. Prospective associations between vitamin D status, vitamin D-related gene polymorphisms, and risk of tobacco-related cancers. 2015; 102:1207-15. doi: 10.3945/ajcn.115.110510\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24027184\",\n",
      "        \"title\": \"Intakes of PUFAs were inversely associated with plasma C-reactive protein 12 years later in a middle-aged population with vitamin E intake as an effect modifier.\",\n",
      "        \"authors\": \"Julia C; Touvier M; Meunier N; Papet I; Galan P; Hercberg S; Kesse-Guyot E\",\n",
      "        \"doi\": \"10.3945/jn.113.180943\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Julia C, et al. Intakes of PUFAs were inversely associated with plasma C-reactive protein 12 years later in a middle-aged population with vitamin E intake as an effect modifier. Intakes of PUFAs were inversely associated with plasma C-reactive protein 12 years later in a middle-aged population with vitamin E intake as an effect modifier. 2013; 143:1760-6. doi: 10.3945/jn.113.180943\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20605091\",\n",
      "        \"title\": \"Incidence of skin cancers during 5-year follow-up after stopping antioxidant vitamins and mineral supplementation.\",\n",
      "        \"authors\": \"Ezzedine K; Latreille J; Kesse-Guyot E; Galan P; Hercberg S; Guinot C; Malvy D\",\n",
      "        \"doi\": \"10.1016/j.ejca.2010.06.008\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Ezzedine K, et al. Incidence of skin cancers during 5-year follow-up after stopping antioxidant vitamins and mineral supplementation. Incidence of skin cancers during 5-year follow-up after stopping antioxidant vitamins and mineral supplementation. 2010; 46:3316-22. doi: 10.1016/j.ejca.2010.06.008\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29649036\",\n",
      "        \"title\": \"Association Between Alexithymia and Risk of Incident Cardiovascular Diseases in the SUppl\\u00e9mentation en VItamines et Min\\u00e9raux AntioXydants (SU.VI.MAX) Cohort.\",\n",
      "        \"authors\": \"Wiernik E; Lemogne C; Fezeu L; Arnault N; Hercberg S; Kesse-Guyot E; Galan P\",\n",
      "        \"doi\": \"10.1097/PSY.0000000000000592\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Wiernik E, et al. Association Between Alexithymia and Risk of Incident Cardiovascular Diseases in the SUppl\\u00e9mentation en VItamines et Min\\u00e9raux AntioXydants (SU.VI.MAX) Cohort. Association Between Alexithymia and Risk of Incident Cardiovascular Diseases in the SUppl\\u00e9mentation en VItamines et Min\\u00e9raux AntioXydants (SU.VI.MAX) Cohort. 2018; 80:460-467. doi: 10.1097/PSY.0000000000000592\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19491388\",\n",
      "        \"title\": \"Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults.\",\n",
      "        \"authors\": \"Czernichow S; Vergnaud AC; Galan P; Arnaud J; Favier A; Faure H; Huxley R; Hercberg S; Ahluwalia N\",\n",
      "        \"doi\": \"10.3945/ajcn.2009.27635\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Czernichow S, et al. Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults. Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults. 2009; 90:329-35. doi: 10.3945/ajcn.2009.27635\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26812508\",\n",
      "        \"title\": \"Consumption of Dairy Products and Cognitive Functioning: Findings from the SU.VI.MAX 2 Study.\",\n",
      "        \"authors\": \"Kesse-Guyot E; Assmann KE; Andreeva VA; Ferry M; Hercberg S; Galan P; SU.VI.MAX 2 Research Group\",\n",
      "        \"doi\": \"10.1007/s12603-015-0593-x\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. Consumption of Dairy Products and Cognitive Functioning: Findings from the SU.VI.MAX 2 Study. Consumption of Dairy Products and Cognitive Functioning: Findings from the SU.VI.MAX 2 Study. 2016; 20:128-37. doi: 10.1007/s12603-015-0593-x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23283500\",\n",
      "        \"title\": \"Mediterranean diet and cognitive function: a French study.\",\n",
      "        \"authors\": \"Kesse-Guyot E; Andreeva VA; Lassale C; Ferry M; Jeandel C; Hercberg S; Galan P; SU.VI.MAX 2 Research Group\",\n",
      "        \"doi\": \"10.3945/ajcn.112.047993\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. Mediterranean diet and cognitive function: a French study. Mediterranean diet and cognitive function: a French study. 2013; 97:369-76. doi: 10.3945/ajcn.112.047993\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19828715\",\n",
      "        \"title\": \"Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome.\",\n",
      "        \"authors\": \"Phillips CM; Goumidi L; Bertrais S; Ferguson JF; Field MR; Kelly ED; Peloso GM; Cupples LA; Shen J; Ordovas JM; McManus R; Hercberg S; Portugal H; Lairon D; Planells R; Roche HM\",\n",
      "        \"doi\": \"10.3945/ajcn.2009.28101\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Phillips CM, et al. Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome. Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome. 2009; 90:1665-73. doi: 10.3945/ajcn.2009.28101\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23082222\",\n",
      "        \"title\": \"Cross-sectional and longitudinal associations of different sedentary behaviors with cognitive performance in older adults.\",\n",
      "        \"authors\": \"Kesse-Guyot E; Charreire H; Andreeva VA; Touvier M; Hercberg S; Galan P; Oppert JM\",\n",
      "        \"doi\": \"10.1371/journal.pone.0047831\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. Cross-sectional and longitudinal associations of different sedentary behaviors with cognitive performance in older adults. Cross-sectional and longitudinal associations of different sedentary behaviors with cognitive performance in older adults. 2012; 7:e47831. doi: 10.1371/journal.pone.0047831\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31927670\",\n",
      "        \"title\": \"Untargeted plasma metabolomic profiles associated with overall diet in women from the SU.VI.MAX cohort.\",\n",
      "        \"authors\": \"L\\u00e9cuyer L; Dalle C; Micheau P; P\\u00e9t\\u00e9ra M; Centeno D; Lyan B; Lagree M; Galan P; Hercberg S; Rossary A; Demidem A; Vasson MP; Partula V; Deschasaux M; Srour B; Latino-Martel P; Druesne-Pecollo N; Kesse-Guyot E; Durand S; Pujos-Guillot E; Manach C; Touvier M\",\n",
      "        \"doi\": \"10.1007/s00394-020-02177-5\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"L\\u00e9cuyer L, et al. Untargeted plasma metabolomic profiles associated with overall diet in women from the SU.VI.MAX cohort. Untargeted plasma metabolomic profiles associated with overall diet in women from the SU.VI.MAX cohort. 2020; 59:3425-3439. doi: 10.1007/s00394-020-02177-5\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26864363\",\n",
      "        \"title\": \"Prospective association between the Dietary Inflammatory Index and mortality: modulation by antioxidant supplementation in the SU.VI.MAX randomized controlled trial.\",\n",
      "        \"authors\": \"Graffouill\\u00e8re L; Deschasaux M; Mariotti F; Neufcourt L; Shivappa N; H\\u00e9bert JR; Wirth MD; Latino-Martel P; Hercberg S; Galan P; Julia C; Kesse-Guyot E; Touvier M\",\n",
      "        \"doi\": \"10.3945/ajcn.115.126243\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Graffouill\\u00e8re L, et al. Prospective association between the Dietary Inflammatory Index and mortality: modulation by antioxidant supplementation in the SU.VI.MAX randomized controlled trial. Prospective association between the Dietary Inflammatory Index and mortality: modulation by antioxidant supplementation in the SU.VI.MAX randomized controlled trial. 2016; 103:878-85. doi: 10.3945/ajcn.115.126243\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24527713\",\n",
      "        \"title\": \"Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values.\",\n",
      "        \"authors\": \"Touvier M; Deschasaux M; Montourcy M; Sutton A; Charnaux N; Kesse-Guyot E; Fezeu LK; Latino-Martel P; Druesne-Pecollo N; Malvy D; Galan P; Hercberg S; Ezzedine K; Souberbielle JC\",\n",
      "        \"doi\": \"10.1210/jc.2013-3349\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Touvier M, et al. Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values. Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values. 2014; 99:1196-203. doi: 10.1210/jc.2013-3349\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24553693\",\n",
      "        \"title\": \"Dietary total and insoluble fiber intakes are inversely associated with prostate cancer risk.\",\n",
      "        \"authors\": \"Deschasaux M; Pouchieu C; His M; Hercberg S; Latino-Martel P; Touvier M\",\n",
      "        \"doi\": \"10.3945/jn.113.189670\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Deschasaux M, et al. Dietary total and insoluble fiber intakes are inversely associated with prostate cancer risk. Dietary total and insoluble fiber intakes are inversely associated with prostate cancer risk. 2014; 144:504-10. doi: 10.3945/jn.113.189670\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22158670\",\n",
      "        \"title\": \"Long-term antioxidant supplementation has no effect on health-related quality of life: the randomized, double-blind, placebo-controlled, primary prevention SU.VI.MAX trial.\",\n",
      "        \"authors\": \"Brian\\u00e7on S; Boini S; Bertrais S; Guillemin F; Galan P; Hercberg S\",\n",
      "        \"doi\": \"10.1093/ije/dyr161\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Brian\\u00e7on S, et al. Long-term antioxidant supplementation has no effect on health-related quality of life: the randomized, double-blind, placebo-controlled, primary prevention SU.VI.MAX trial. Long-term antioxidant supplementation has no effect on health-related quality of life: the randomized, double-blind, placebo-controlled, primary prevention SU.VI.MAX trial. 2011; 40:1605-16. doi: 10.1093/ije/dyr161\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21955649\",\n",
      "        \"title\": \"Fruit and vegetable intake and cognitive function in the SU.VI.MAX 2 prospective study.\",\n",
      "        \"authors\": \"P\\u00e9neau S; Galan P; Jeandel C; Ferry M; Andreeva V; Hercberg S; Kesse-Guyot E; SU.VI.MAX 2 Research Group\",\n",
      "        \"doi\": \"10.3945/ajcn.111.014712\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"P\\u00e9neau S, et al. Fruit and vegetable intake and cognitive function in the SU.VI.MAX 2 prospective study. Fruit and vegetable intake and cognitive function in the SU.VI.MAX 2 prospective study. 2011; 94:1295-303. doi: 10.3945/ajcn.111.014712\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"33738534\",\n",
      "        \"title\": \"The inflammatory potential of the diet is prospectively associated with subjective hearing loss.\",\n",
      "        \"authors\": \"Andreeva VA; P\\u00e9neau S; Julia C; Shivappa N; H\\u00e9bert JR; Wirth MD; Touvier M; Hercberg S; Galan P; Kesse-Guyot E\",\n",
      "        \"doi\": \"10.1007/s00394-021-02531-1\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Andreeva VA, et al. The inflammatory potential of the diet is prospectively associated with subjective hearing loss. The inflammatory potential of the diet is prospectively associated with subjective hearing loss. 2021; 60:3669-3678. doi: 10.1007/s00394-021-02531-1\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27055851\",\n",
      "        \"title\": \"Long-term association between the dietary inflammatory index and cognitive functioning: findings from the SU.VI.MAX study.\",\n",
      "        \"authors\": \"Kesse-Guyot E; Assmann KE; Andreeva VA; Touvier M; Neufcourt L; Shivappa N; H\\u00e9bert JR; Wirth MD; Hercberg S; Galan P; Julia C\",\n",
      "        \"doi\": \"10.1007/s00394-016-1211-3\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Observational Study\"\n",
      "        ],\n",
      "        \"citation\": \"Kesse-Guyot E, et al. Long-term association between the dietary inflammatory index and cognitive functioning: findings from the SU.VI.MAX study. Long-term association between the dietary inflammatory index and cognitive functioning: findings from the SU.VI.MAX study. 2017; 56:1647-1655. doi: 10.1007/s00394-016-1211-3\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"15557412\",\n",
      "        \"title\": \"The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals.\",\n",
      "        \"authors\": \"Hercberg S; Galan P; Preziosi P; Bertrais S; Mennen L; Malvy D; Roussel AM; Favier A; Brian\\u00e7on S\",\n",
      "        \"doi\": \"10.1001/archinte.164.21.2335\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hercberg S, et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. 2004; 164:2335-42. doi: 10.1001/archinte.164.21.2335\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02052271\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01534728\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01492985\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"33568510\",\n",
      "        \"title\": \"A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial.\",\n",
      "        \"authors\": \"L\\u00e9vy Y; Lacabaratz C; Lhomme E; Wiedemann A; Bauduin C; Fenwick C; Foucat E; Surenaud M; Guillaumat L; Boilet V; Rieux V; Bouchaud O; Girard PM; Molina JM; Morlat P; Hocqueloux L; Richert L; Pantaleo G; Leli\\u00e8vre JD; Thi\\u00e9baut R\",\n",
      "        \"doi\": \"10.1128/JVI.02165-20\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"L\\u00e9vy Y, et al. A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial. A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial. 2021; 95:(unknown pages). doi: 10.1128/JVI.02165-20\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00120185\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"19508157\",\n",
      "        \"title\": \"Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119).\",\n",
      "        \"authors\": \"Molina JM; Levy Y; Fournier I; Hamonic S; Bentata M; Beck-Wirth G; Gougeon ML; Venet A; Madelaine I; Sereni D; Jeanblanc F; Boulet T; Simon F; Aboulker JP; Agence Nationale de Recherches sur le SIDA et les H\\u00e9patites Virales (ANRS) 119 Interstart Study Team\",\n",
      "        \"doi\": \"10.1086/599989\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Molina JM, et al. Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119). Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119). 2009; 200:206-15. doi: 10.1086/599989\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01463956\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00334256\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"19104016\",\n",
      "        \"title\": \"Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates.\",\n",
      "        \"authors\": \"Hirt D; Urien S; Rey E; Arriv\\u00e9 E; Ekou\\u00e9vi DK; Coffi\\u00e9 P; Leang SK; Lalsab S; Avit D; Nerrienet E; McIntyre J; Blanche S; Dabis F; Tr\\u00e9luyer JM\",\n",
      "        \"doi\": \"10.1128/AAC.00860-08\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hirt D, et al. Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates. 2009; 53:1067-73. doi: 10.1128/AAC.00860-08\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19307941\",\n",
      "        \"title\": \"Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1.\",\n",
      "        \"authors\": \"TEmAA ANRS 12109 Study group; Arriv\\u00e9 E; Chaix ML; Nerrienet E; Blanche S; Rouzioux C; Coffie PA; Kruy Leang S; McIntyre J; Avit D; Srey VH; Gray G; N'Dri-Yoman T; Diallo A; Ekou\\u00e9vi DK; Dabis F\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32832949d5\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"TEmAA ANRS 12109 Study group, et al. Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1. Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1. 2009; 23:825-33. doi: 10.1097/QAD.0b013e32832949d5\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18987623\",\n",
      "        \"title\": \"Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109).\",\n",
      "        \"authors\": \"Hirt D; Urien S; Ekou\\u00e9vi DK; Rey E; Arriv\\u00e9 E; Blanche S; Amani-Bosse C; Nerrienet E; Gray G; Kone M; Leang SK; McIntyre J; Dabis F; Tr\\u00e9luyer JM; ANRS 12109\",\n",
      "        \"doi\": \"10.1038/clpt.2008.201\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hirt D, et al. Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109). Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109). 2009; 85:182-9. doi: 10.1038/clpt.2008.201\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00822315\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"24726095\",\n",
      "        \"title\": \"Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial.\",\n",
      "        \"authors\": \"Grinsztejn B; De Castro N; Arnold V; Veloso VG; Morgado M; Pilotto JH; Brites C; Madruga JV; Barcellos NT; Santos BR; Vorsatz C; Fagard C; Santini-Oliveira M; Patey O; Delaugerre C; Ch\\u00eane G; Molina JM; ANRS 12 180 Reflate TB study group\",\n",
      "        \"doi\": \"10.1016/S1473-3099(14)70711-X\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Grinsztejn B, et al. Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial. Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial. 2014; 14:459-67. doi: 10.1016/S1473-3099(14)70711-X\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04120415\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02567071\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01331811\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"26908804\",\n",
      "        \"title\": \"Performance of Xpert MTB/RIF and Alternative Specimen Collection Methods for the Diagnosis of Tuberculosis in HIV-Infected Children.\",\n",
      "        \"authors\": \"Marcy O; Ung V; Goyet S; Borand L; Msellati P; Tejiokem M; Nguyen Thi NL; Nacro B; Cheng S; Eyangoh S; Pham TH; Ouedraogo AS; Tarantola A; Godreuil S; Blanche S; Delacourt C\",\n",
      "        \"doi\": \"10.1093/cid/ciw036\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Marcy O, et al. Performance of Xpert MTB/RIF and Alternative Specimen Collection Methods for the Diagnosis of Tuberculosis in HIV-Infected Children. Performance of Xpert MTB/RIF and Alternative Specimen Collection Methods for the Diagnosis of Tuberculosis in HIV-Infected Children. 2016; 62:1161-1168. doi: 10.1093/cid/ciw036\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29174612\",\n",
      "        \"title\": \"Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study.\",\n",
      "        \"authors\": \"Marcy O; Tejiokem M; Msellati P; Truong Huu K; Do Chau V; Tran Ngoc D; Nacro B; Ateba-Ndongo F; Tetang-Ndiang S; Ung V; Dim B; Neou L; Berteloot L; Borand L; Delacourt C; Blanche S; ANRS 12229 PAANTHER 01 Study Group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(17)30206-0\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Marcy O, et al. Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study. Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study. 2018; 5:e87-e95. doi: 10.1016/S2352-3018(17)30206-0\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"30689814\",\n",
      "        \"title\": \"Isolation of Nontuberculous Mycobacteria in Southeast Asian and African Human Immunodeficiency Virus-infected Children With Suspected Tuberculosis.\",\n",
      "        \"authors\": \"Borand L; de Lauzanne A; Nguyen NL; Cheng S; Pham TH; Eyangoh S; Ouedraogo AS; Ung V; Msellati P; Tejiokem M; Nacro B; Inghammar M; Dim B; Delacourt C; Godreuil S; Blanche S; Marcy O; Pediatric Asian African Network for Tuberculosis and HIV Research (PAANTHER) Study Group\",\n",
      "        \"doi\": \"10.1093/cid/ciy897\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Borand L, et al. Isolation of Nontuberculous Mycobacteria in Southeast Asian and African Human Immunodeficiency Virus-infected Children With Suspected Tuberculosis. Isolation of Nontuberculous Mycobacteria in Southeast Asian and African Human Immunodeficiency Virus-infected Children With Suspected Tuberculosis. 2019; 68:1750-1753. doi: 10.1093/cid/ciy897\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31455612\",\n",
      "        \"title\": \"A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis.\",\n",
      "        \"authors\": \"Marcy O; Borand L; Ung V; Msellati P; Tejiokem M; Huu KT; Do Chau V; Ngoc Tran D; Ateba-Ndongo F; Tetang-Ndiang S; Nacro B; Sanogo B; Neou L; Goyet S; Dim B; Pean P; Quillet C; Fournier I; Berteloot L; Carcelain G; Godreuil S; Blanche S; Delacourt C; ANRS 12229 PAANTHER 01 STUDY GROUP\",\n",
      "        \"doi\": \"10.1542/peds.2018-2065\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Marcy O, et al. A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis. A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis. 2019; 144:(unknown pages). doi: 10.1542/peds.2018-2065\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02214511\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01698411\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04288128\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"38419144\",\n",
      "        \"title\": \"Digital Gait Measures Capture 1-Year Progression in Early-Stage Spinocerebellar Ataxia Type 2.\",\n",
      "        \"authors\": \"Seemann J; Daghsen L; Cazier M; Lamy JC; Welter ML; Giese MA; Synofzik M; Durr A; Ilg W; Coarelli G\",\n",
      "        \"doi\": \"10.1002/mds.29757\",\n",
      "        \"year\": \"2024\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Seemann J, et al. Digital Gait Measures Capture 1-Year Progression in Early-Stage Spinocerebellar Ataxia Type 2. Digital Gait Measures Capture 1-Year Progression in Early-Stage Spinocerebellar Ataxia Type 2. 2024; (unknown volume):(unknown pages). doi: 10.1002/mds.29757\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"38421662\",\n",
      "        \"title\": \"ATXN7-Related Cone-Rod Dystrophy: The Integrated Functional Evaluation of the Cerebellum (CERMOI) Study.\",\n",
      "        \"authors\": \"Nassisi M; Coarelli G; Blanchard B; Dubec-Fleury C; Drine K; Kitic N; Sancho S; Hilab R; Tezenas du Montcel S; Junge C; Lane R; Arnold HM; Durr A; Audo I\",\n",
      "        \"doi\": \"10.1001/jamaophthalmol.2024.0001\",\n",
      "        \"year\": \"2024\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Nassisi M, et al. ATXN7-Related Cone-Rod Dystrophy: The Integrated Functional Evaluation of the Cerebellum (CERMOI) Study. ATXN7-Related Cone-Rod Dystrophy: The Integrated Functional Evaluation of the Cerebellum (CERMOI) Study. 2024; (unknown volume):(unknown pages). doi: 10.1001/jamaophthalmol.2024.0001\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02157311\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29186458\",\n",
      "        \"title\": \"Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial.\",\n",
      "        \"authors\": \"de Truchis P; Assoumou L; Landman R; Mathez D; Le D\\u00fb D; Bellet J; Amat K; Katlama C; Gras G; Bouchaud O; Duracinsky M; Abe E; Alvarez JC; Izopet J; Saillard J; Melchior JC; Leibowitch J; Costagliola D; Girard PM; Perronne C; ANRS 162-4D Study Group\",\n",
      "        \"doi\": \"10.1093/jac/dkx434\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"de Truchis P, et al. Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial. Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial. 2018; 73:738-747. doi: 10.1093/jac/dkx434\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02082171\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00918307\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29329763\",\n",
      "        \"title\": \"Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial.\",\n",
      "        \"authors\": \"Merci\\u00e9 P; Arsandaux J; Katlama C; Ferret S; Beuscart A; Spadone C; Duvivier C; Reynes J; Wirth N; Moinot L; B\\u00e9nard A; Zucman D; Duval X; Molina JM; Spire B; Fagard C; Ch\\u00eane G; ANRS 144 Inter-ACTIV study group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(18)30002-X\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Merci\\u00e9 P, et al. Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial. Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial. 2018; 5:e126-e135. doi: 10.1016/S2352-3018(18)30002-X\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34611902\",\n",
      "        \"title\": \"Interventions for preventing weight gain after smoking cessation.\",\n",
      "        \"authors\": \"Hartmann-Boyce J; Theodoulou A; Farley A; Hajek P; Lycett D; Jones LL; Kudlek L; Heath L; Hajizadeh A; Schenkels M; Aveyard P\",\n",
      "        \"doi\": \"10.1002/14651858.CD006219.pub4\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Meta-Analysis\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\",\n",
      "          \"Systematic Review\"\n",
      "        ],\n",
      "        \"citation\": \"Hartmann-Boyce J, et al. Interventions for preventing weight gain after smoking cessation. Interventions for preventing weight gain after smoking cessation. 2021; 10:CD006219. doi: 10.1002/14651858.CD006219.pub4\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT05090956\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02346409\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00196599\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"15012649\",\n",
      "        \"title\": \"Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial).\",\n",
      "        \"authors\": \"Molina JM; Peytavin G; Perusat S; Lascoux-Combes C; Sereni D; Rozenbaum W; Chene G\",\n",
      "        \"doi\": \"10.1111/j.1468-1293.2004.00194.x\",\n",
      "        \"year\": \"2004\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Molina JM, et al. Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial). Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial). 2004; 5:99-104. doi: 10.1111/j.1468-1293.2004.00194.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"10915095\",\n",
      "        \"title\": \"Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients.\",\n",
      "        \"authors\": \"Molina JM; Ferchal F; Rancinan C; Raffi F; Rozenbaum W; Sereni D; Morlat P; Journot V; Decazes JM; Ch\\u00eane G\",\n",
      "        \"doi\": \"10.1086/315711\",\n",
      "        \"year\": \"2000\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Molina JM, et al. Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients. Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients. 2000; 182:599-602. doi: 10.1086/315711\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02102737\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00454337\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"19995925\",\n",
      "        \"title\": \"High concentration of raltegravir in semen of HIV-infected men: results from a substudy of the EASIER-ANRS 138 trial.\",\n",
      "        \"authors\": \"Barau C; Delaugerre C; Braun J; de Castro N; Furlan V; Charreau I; G\\u00e9rard L; Lascoux-Combe C; Molina JM; Taburet AM\",\n",
      "        \"doi\": \"10.1128/AAC.01261-09\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Barau C, et al. High concentration of raltegravir in semen of HIV-infected men: results from a substudy of the EASIER-ANRS 138 trial. High concentration of raltegravir in semen of HIV-infected men: results from a substudy of the EASIER-ANRS 138 trial. 2010; 54:937-9. doi: 10.1128/AAC.01261-09\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21326075\",\n",
      "        \"title\": \"Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia.\",\n",
      "        \"authors\": \"Gallien S; Delaugerre C; Charreau I; Braun J; Boulet T; Barrail-Tran A; de Castro N; Molina JM; Kuritzkes DR\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e3283445834\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Gallien S, et al. Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia. Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia. 2011; 25:665-9. doi: 10.1097/QAD.0b013e3283445834\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22416781\",\n",
      "        \"title\": \"Comparison of resistance mutation patterns in historical plasma HIV RNA genotypes with those in current proviral HIV DNA genotypes among extensively treated patients with suppressed replication.\",\n",
      "        \"authors\": \"Delaugerre C; Braun J; Charreau I; Delarue S; Nere ML; de Castro N; May T; Marchou B; Simon F; Molina JM; Aboulker JP; ANRS 138-EASIER study group\",\n",
      "        \"doi\": \"10.1111/j.1468-1293.2012.01002.x\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Delaugerre C, et al. Comparison of resistance mutation patterns in historical plasma HIV RNA genotypes with those in current proviral HIV DNA genotypes among extensively treated patients with suppressed replication. Comparison of resistance mutation patterns in historical plasma HIV RNA genotypes with those in current proviral HIV DNA genotypes among extensively treated patients with suppressed replication. 2012; 13:517-25. doi: 10.1111/j.1468-1293.2012.01002.x\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21576452\",\n",
      "        \"title\": \"Switch from enfuvirtide to raltegravir lowers plasma concentrations of darunavir and tipranavir: a pharmacokinetic substudy of the EASIER-ANRS 138 trial.\",\n",
      "        \"authors\": \"Goldwirt L; Braun J; de Castro N; Charreau I; Barrail-Tran A; Delaugerre C; Raffi F; Lascoux-Combe C; Aboulker JP; Taburet AM; Molina JM\",\n",
      "        \"doi\": \"10.1128/AAC.01827-10\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Goldwirt L, et al. Switch from enfuvirtide to raltegravir lowers plasma concentrations of darunavir and tipranavir: a pharmacokinetic substudy of the EASIER-ANRS 138 trial. Switch from enfuvirtide to raltegravir lowers plasma concentrations of darunavir and tipranavir: a pharmacokinetic substudy of the EASIER-ANRS 138 trial. 2011; 55:3613-5. doi: 10.1128/AAC.01827-10\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27042193\",\n",
      "        \"title\": \"Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial.\",\n",
      "        \"authors\": \"de Castro N; Braun J; Charreau I; Lafeuillade A; Viard JP; Allavena C; Aboulker JP; Molina JM; EASIER ANRS 138 study group\",\n",
      "        \"doi\": \"10.1186/s12981-016-0101-3\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"de Castro N, et al. Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial. Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial. 2016; 13:17. doi: 10.1186/s12981-016-0101-3\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21126958\",\n",
      "        \"title\": \"Impact on health-related quality of life of a switch from enfuvirtide to raltegravir among multidrug-resistant HIV-1-infected patients: a randomized open-label trial (EASIER-ANRS 138).\",\n",
      "        \"authors\": \"Boulet T; Pavie J; Charreau I; Braun J; Reynes J; Morlat P; Piroth L; Spire B; Molina JM; Aboulker JP; Easier-Anrs 138 Study Group\",\n",
      "        \"doi\": \"10.1310/hct1105-283\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Boulet T, et al. Impact on health-related quality of life of a switch from enfuvirtide to raltegravir among multidrug-resistant HIV-1-infected patients: a randomized open-label trial (EASIER-ANRS 138). Impact on health-related quality of life of a switch from enfuvirtide to raltegravir among multidrug-resistant HIV-1-infected patients: a randomized open-label trial (EASIER-ANRS 138). 2010; 11:283-93. doi: 10.1310/hct1105-283\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21712241\",\n",
      "        \"title\": \"Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial.\",\n",
      "        \"authors\": \"Gallien S; Braun J; Delaugerre C; Charreau I; Reynes J; Jeanblanc F; Verdon R; de Truchis P; May T; Madelaine-Chambrin I; Aboulker JP; Molina JM; EASIER ANRS 138 Study Group\",\n",
      "        \"doi\": \"10.1093/jac/dkr269\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Gallien S, et al. Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial. Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial. 2011; 66:2099-106. doi: 10.1093/jac/dkr269\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"19757993\",\n",
      "        \"title\": \"Switch from enfuvirtide to raltegravir in virologically suppressed multidrug-resistant HIV-1-infected patients: a randomized open-label trial.\",\n",
      "        \"authors\": \"De Castro N; Braun J; Charreau I; Pialoux G; Cotte L; Katlama C; Raffi F; Weiss L; Meynard JL; Yazdanpanah Y; Delaugerre C; Madelaine-Chambrin I; Aboulker JP; Molina JM; EASIER ANRS 138 study group\",\n",
      "        \"doi\": \"10.1086/605674\",\n",
      "        \"year\": \"2009\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"De Castro N, et al. Switch from enfuvirtide to raltegravir in virologically suppressed multidrug-resistant HIV-1-infected patients: a randomized open-label trial. Switch from enfuvirtide to raltegravir in virologically suppressed multidrug-resistant HIV-1-infected patients: a randomized open-label trial. 2009; 49:1259-67. doi: 10.1086/605674\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20683319\",\n",
      "        \"title\": \"Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimen.\",\n",
      "        \"authors\": \"Delaugerre C; Charreau I; Braun J; N\\u00e9r\\u00e9 ML; de Castro N; Yeni P; Ghosn J; Aboulker JP; Molina JM; Simon F; ANRS 138 study group\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32833d214c\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Delaugerre C, et al. Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimen. Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimen. 2010; 24:2391-5. doi: 10.1097/QAD.0b013e32833d214c\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02656407\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"25955583\",\n",
      "        \"title\": \"Spatiotemporal Clutter Filtering of Ultrafast Ultrasound Data Highly Increases Doppler and fUltrasound Sensitivity.\",\n",
      "        \"authors\": \"Demen\\u00e9 C; Deffieux T; Pernot M; Osmanski BF; Biran V; Gennisson JL; Sieu LA; Bergel A; Franqui S; Correas JM; Cohen I; Baud O; Tanter M\",\n",
      "        \"doi\": \"10.1109/TMI.2015.2428634\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Demen\\u00e9 C, et al. Spatiotemporal Clutter Filtering of Ultrafast Ultrasound Data Highly Increases Doppler and fUltrasound Sensitivity. Spatiotemporal Clutter Filtering of Ultrafast Ultrasound Data Highly Increases Doppler and fUltrasound Sensitivity. 2015; 34:2271-85. doi: 10.1109/TMI.2015.2428634\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00158509\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"18593294\",\n",
      "        \"title\": \"Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels.\",\n",
      "        \"authors\": \"Nagot N; Ouedraogo A; Konate I; Weiss HA; Foulongne V; Defer MC; Sanon A; Becquart P; Segondy M; Sawadogo A; Van de Perre P; Mayaud P; ANRS 1285 Study Group\",\n",
      "        \"doi\": \"10.1086/589621\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nagot N, et al. Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels. Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels. 2008; 198:241-9. doi: 10.1086/589621\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17314338\",\n",
      "        \"title\": \"Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus.\",\n",
      "        \"authors\": \"Nagot N; Ou\\u00e9draogo A; Foulongne V; Konat\\u00e9 I; Weiss HA; Vergne L; Defer MC; Djagbar\\u00e9 D; Sanon A; Andonaba JB; Becquart P; Segondy M; Vallo R; Sawadogo A; Van de Perre P; Mayaud P; ANRS 1285 Study Group\",\n",
      "        \"doi\": \"10.1056/NEJMoa062607\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nagot N, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. 2007; 356:790-9. doi: 10.1056/NEJMoa062607\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16044019\",\n",
      "        \"title\": \"Longitudinal assessment of HIV-1 and HSV-2 shedding in the genital tract of West African women.\",\n",
      "        \"authors\": \"Nagot N; Foulongne V; Becquart P; Mayaud P; Konate I; Ouedraogo A; Defer MC; Weiss H; Van de Perre P; Segondy M\",\n",
      "        \"doi\": null,\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Evaluation Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Nagot N, et al. Longitudinal assessment of HIV-1 and HSV-2 shedding in the genital tract of West African women. Longitudinal assessment of HIV-1 and HSV-2 shedding in the genital tract of West African women. 2005; 39:632-4.\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18596069\",\n",
      "        \"title\": \"Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women.\",\n",
      "        \"authors\": \"Mayaud P; Nagot N; Konat\\u00e9 I; Ouedraogo A; Weiss HA; Foulongne V; Defer MC; Sawadogo A; Segondy M; Van de Perre P; ANRS 1285 Study Group\",\n",
      "        \"doi\": \"10.1136/sti.2008.030692\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Mayaud P, et al. Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women. Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women. 2008; 84:332-7. doi: 10.1136/sti.2008.030692\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02038842\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01725542\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"25977266\",\n",
      "        \"title\": \"High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH Study.\",\n",
      "        \"authors\": \"Piroth L; Paniez H; Taburet AM; Vincent C; Rosenthal E; Lacombe K; Billaud E; Rey D; Zucman D; Bailly F; Bronowicki JP; Simony M; Diallo A; Izopet J; Aboulker JP; Meyer L; Molina JM; ANRS HC30 QUADRIH Study Group\",\n",
      "        \"doi\": \"10.1093/cid/civ381\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Piroth L, et al. High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH Study. High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH Study. 2015; 61:817-25. doi: 10.1093/cid/civ381\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT06260319\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01842919\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02906137\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01192737\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02647632\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29077864\",\n",
      "        \"title\": \"Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study.\",\n",
      "        \"authors\": \"de L\\u00e9dinghen V; Laforest C; H\\u00e9zode C; Pol S; Renault A; Alric L; Larrey D; M\\u00e9tivier S; Tran A; J\\u00e9z\\u00e9quel C; Samuel D; Zoulim F; Tual C; Pailh\\u00e9 A; Gibowski S; Bourli\\u00e8re M; Bellissant E; Pawlotsky JM\",\n",
      "        \"doi\": \"10.1093/cid/cix916\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"de L\\u00e9dinghen V, et al. Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study. Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study. 2018; 66:1013-1018. doi: 10.1093/cid/cix916\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01065207\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02542800\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01089400\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"24646009\",\n",
      "        \"title\": \"Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.\",\n",
      "        \"authors\": \"Guihot A; Luyt CE; Parrot A; Rousset D; Cavaillon JM; Boutolleau D; Fitting C; Pajanirassa P; Mallet A; Fartoukh M; Agut H; Musset L; Zoorob R; Kirilovksy A; Combadi\\u00e8re B; van der Werf S; Autran B; Carcelain G; FluBAL Study Group\",\n",
      "        \"doi\": \"10.1164/rccm.201311-2071OC\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Guihot A, et al. Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection. Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection. 2014; 189:1240-9. doi: 10.1164/rccm.201311-2071OC\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00574652\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"22129253\",\n",
      "        \"title\": \"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.\",\n",
      "        \"authors\": \"Saadoun D; Rosenzwajg M; Joly F; Six A; Carrat F; Thibault V; Sene D; Cacoub P; Klatzmann D\",\n",
      "        \"doi\": \"10.1056/NEJMoa1105143\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Saadoun D, et al. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. 2011; 365:2067-77. doi: 10.1056/NEJMoa1105143\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01905059\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"16249701\",\n",
      "        \"title\": \"Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study).\",\n",
      "        \"authors\": \"Arribas JR; Pulido F; Delgado R; Lorenzo A; Miralles P; Arranz A; Gonz\\u00e1lez-Garc\\u00eda JJ; Cepeda C; Herv\\u00e1s R; Pa\\u00f1o JR; Gaya F; Carcas A; Montes ML; Costa JR; Pe\\u00f1a JM\",\n",
      "        \"doi\": \"10.1097/01.qai.0000180077.59159.f4\",\n",
      "        \"year\": \"2005\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Arribas JR, et al. Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study). Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study). 2005; 40:280-7. doi: 10.1097/01.qai.0000180077.59159.f4\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20010070\",\n",
      "        \"title\": \"The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml.\",\n",
      "        \"authors\": \"Arribas JR; Horban A; Gerstoft J; F\\u00e4tkenheuer G; Nelson M; Clumeck N; Pulido F; Hill A; van Delft Y; Stark T; Moecklinghoff C\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e3283348944\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase III\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Arribas JR, et al. The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml. The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml. 2010; 24:223-30. doi: 10.1097/QAD.0b013e3283348944\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"28566227\",\n",
      "        \"title\": \"Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.\",\n",
      "        \"authors\": \"Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E; MOBIDIP study group\",\n",
      "        \"doi\": \"10.1016/S2352-3018(17)30069-3\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Equivalence Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Ciaffi L, et al. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial. 2017; 4:e384-e392. doi: 10.1016/S2352-3018(17)30069-3\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23075703\",\n",
      "        \"title\": \"A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: the HIV STAR study.\",\n",
      "        \"authors\": \"Bunupuradah T; Chetchotisakd P; Ananworanich J; Munsakul W; Jirajariyavej S; Kantipong P; Prasithsirikul W; Sungkanuparph S; Bowonwatanuwong C; Klinbuayaem V; Kerr SJ; Sophonphan J; Bhakeecheep S; Hirschel B; Ruxrungtham K; HIV STAR Study Group\",\n",
      "        \"doi\": \"10.3851/IMP2443\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Bunupuradah T, et al. A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: the HIV STAR study. A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: the HIV STAR study. 2012; 17:1351-61. doi: 10.3851/IMP2443\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21886816\",\n",
      "        \"title\": \"Pilot, randomized study assessing safety, tolerability and efficacy of simplified LPV/r maintenance therapy in HIV patients on the 1 PI-based regimen.\",\n",
      "        \"authors\": \"Cahn P; Montaner J; Junod P; Patterson P; Krolewiecki A; Andrade-Villanueva J; Cassetti I; Sierra-Madero J; Casir\\u00f3 AD; Bortolozzi R; Lupo SH; Longo N; Rampakakis E; Ackad N; Sampalis JS\",\n",
      "        \"doi\": \"10.1371/journal.pone.0023726\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Cahn P, et al. Pilot, randomized study assessing safety, tolerability and efficacy of simplified LPV/r maintenance therapy in HIV patients on the 1 PI-based regimen. Pilot, randomized study assessing safety, tolerability and efficacy of simplified LPV/r maintenance therapy in HIV patients on the 1 PI-based regimen. 2011; 6:e23726. doi: 10.1371/journal.pone.0023726\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20802298\",\n",
      "        \"title\": \"Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir.\",\n",
      "        \"authors\": \"Gutmann C; Cusini A; G\\u00fcnthard HF; Fux C; Hirschel B; Decosterd LA; Cavassini M; Yerly S; Vernazza PL; Swiss HIV Cohort Study (SHCS)\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32833db9a1\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Gutmann C, et al. Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir. Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir. 2010; 24:2347-54. doi: 10.1097/QAD.0b013e32833db9a1\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"20802297\",\n",
      "        \"title\": \"Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136.\",\n",
      "        \"authors\": \"Katlama C; Valantin MA; Algarte-Genin M; Duvivier C; Lambert-Niclot S; Girard PM; Molina JM; Hoen B; Pakianather S; Peytavin G; Marcelin AG; Flandre P\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32833dec20\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Katlama C, et al. Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136. Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136. 2010; 24:2365-74. doi: 10.1097/QAD.0b013e32833dec20\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22814125\",\n",
      "        \"title\": \"Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA).\",\n",
      "        \"authors\": \"Gilks CF; Walker AS; Dunn DT; Gibb DM; Kikaire B; Reid A; Musana H; Mambule I; Kasirye R; Robertson V; Ssali F; Spyer M; Pillay D; Yirrell D; Kaleebu P; DART Virology Group and Trial Team\",\n",
      "        \"doi\": \"10.3851/IMP2253\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Gilks CF, et al. Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA). Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA). 2012; 17:1363-73. doi: 10.3851/IMP2253\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16549962\",\n",
      "        \"title\": \"Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study).\",\n",
      "        \"authors\": \"Castagna A; Danise A; Menzo S; Galli L; Gianotti N; Carini E; Boeri E; Galli A; Cernuschi M; Hasson H; Clementi M; Lazzarin A\",\n",
      "        \"doi\": \"10.1097/01.aids.0000218542.08845.b2\",\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Castagna A, et al. Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study). Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study). 2006; 20:795-803. doi: 10.1097/01.aids.0000218542.08845.b2\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"21811554\",\n",
      "        \"title\": \"Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis.\",\n",
      "        \"authors\": \"Mathis S; Khanlari B; Pulido F; Schechter M; Negredo E; Nelson M; Vernazza P; Cahn P; Meynard JL; Arribas J; Bucher HC\",\n",
      "        \"doi\": \"10.1371/journal.pone.0022003\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Meta-Analysis\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Mathis S, et al. Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis. Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis. 2011; 6:e22003. doi: 10.1371/journal.pone.0022003\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18097218\",\n",
      "        \"title\": \"Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV.\",\n",
      "        \"authors\": \"Pulido F; Arribas JR; Delgado R; Cabrero E; Gonz\\u00e1lez-Garc\\u00eda J; P\\u00e9rez-Elias MJ; Arranz A; Portilla J; Pasquau J; Iribarren JA; Rubio R; Norton M; OK04 Study Group\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e3282f4243b\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Classical Article\",\n",
      "          \"Comparative Study\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Pulido F, et al. Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV. Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV. 2008; 22:F1-9. doi: 10.1097/QAD.0b013e3282f4243b\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22441252\",\n",
      "        \"title\": \"Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings.\",\n",
      "        \"authors\": \"Bartlett JA; Ribaudo HJ; Wallis CL; Aga E; Katzenstein DA; Stevens WS; Norton MR; Klingman KL; Hosseinipour MC; Crump JA; Supparatpinyo K; Badal-Faesen S; Kallungal BA; Kumarasamy N\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e328353b066\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Research Support, U.S. Gov't, P.H.S.\"\n",
      "        ],\n",
      "        \"citation\": \"Bartlett JA, et al. Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings. Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings. 2012; 26:1345-54. doi: 10.1097/QAD.0b013e328353b066\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"17545707\",\n",
      "        \"title\": \"The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial.\",\n",
      "        \"authors\": \"Vernazza P; Daneel S; Schiffer V; Decosterd L; Fierz W; Klimkait T; Hoffmann M; Hirschel B\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32814e6b1c\",\n",
      "        \"year\": \"2007\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Vernazza P, et al. The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial. The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial. 2007; 21:1309-15. doi: 10.1097/QAD.0b013e32814e6b1c\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"18540803\",\n",
      "        \"title\": \"A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy.\",\n",
      "        \"authors\": \"Cameron DW; da Silva BA; Arribas JR; Myers RA; Bellos NC; Gilmore N; King MS; Bernstein BM; Brun SC; Hanna GJ\",\n",
      "        \"doi\": \"10.1086/589622\",\n",
      "        \"year\": \"2008\",\n",
      "        \"publication_types\": [\n",
      "          \"Controlled Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Cameron DW, et al. A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy. A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy. 2008; 198:234-40. doi: 10.1086/589622\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02125500\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01413152\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02236832\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00115609\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT04396288\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00445575\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01024400\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"22147712\",\n",
      "        \"title\": \"Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial.\",\n",
      "        \"authors\": \"Tsatsaris V; Capitant C; Schmitz T; Chazallon C; Bulifon S; Riethmuller D; Picone O; Poulain P; Lewin F; Lain\\u00e9 F; Jacqz-Aigrain E; Aboulker JP; Launay O; Inserm C09-33 PREFLUVAC (Immunogenicity and Safety of an Inactivated Nonadjuvanted A[H1N1v] Influenza Vaccine in Pregnant Women) Study Group\",\n",
      "        \"doi\": \"10.7326/0003-4819-155-11-201112060-00005\",\n",
      "        \"year\": \"2011\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Tsatsaris V, et al. Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial. Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial. 2011; 155:733-41. doi: 10.7326/0003-4819-155-11-201112060-00005\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01779752\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03215732\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"37143029\",\n",
      "        \"title\": \"Hepatitis B prevention and treatment needs in women in Senegal (ANRS 12356 AmBASS survey).\",\n",
      "        \"authors\": \"Djaogol T; P\\u00e9ri\\u00e8res L; Marcellin F; Diouf A; Carrieri MP; Diallo A; Boyer S; ANRS 12356 AmBASS Study Group\",\n",
      "        \"doi\": \"10.1186/s12889-023-15710-y\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Djaogol T, et al. Hepatitis B prevention and treatment needs in women in Senegal (ANRS 12356 AmBASS survey). Hepatitis B prevention and treatment needs in women in Senegal (ANRS 12356 AmBASS survey). 2023; 23:825. doi: 10.1186/s12889-023-15710-y\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"31320358\",\n",
      "        \"title\": \"Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356).\",\n",
      "        \"authors\": \"Coste M; De S\\u00e8ze M; Diallo A; Carrieri MP; Marcellin F; Boyer S; ANRS 12356 AmBASS Study Group\",\n",
      "        \"doi\": \"10.1136/bmjopen-2019-030211\",\n",
      "        \"year\": \"2019\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Coste M, et al. Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356). Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356). 2019; 9:e030211. doi: 10.1136/bmjopen-2019-030211\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03005652\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"33873195\",\n",
      "        \"title\": \"Effects of a Mindfulness-Based Intervention versus Health Self-Management on Subclinical Anxiety in Older Adults with Subjective Cognitive Decline: The SCD-Well Randomized Superiority Trial.\",\n",
      "        \"authors\": \"Marchant NL; Barnhofer T; Coueron R; Wirth M; Lutz A; Arenaza-Urquijo EM; Collette F; Poisnel G; Demnitz-King H; Schild AK; Coll-Padros N; Delphin-Combe F; Whitfield T; Schlosser M; Gonneaud J; Asselineau J; Walker Z; Krolak-Salmon P; Molinuevo JL; Frison E; Ch\\u00e9telat G; Jessen F; Klimecki OM; The\\u00a0Medit-Ageing\\u00a0Research\\u00a0Group\",\n",
      "        \"doi\": \"10.1159/000515669\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Marchant NL, et al. Effects of a Mindfulness-Based Intervention versus Health Self-Management on Subclinical Anxiety in Older Adults with Subjective Cognitive Decline: The SCD-Well Randomized Superiority Trial. Effects of a Mindfulness-Based Intervention versus Health Self-Management on Subclinical Anxiety in Older Adults with Subjective Cognitive Decline: The SCD-Well Randomized Superiority Trial. 2021; 90:341-350. doi: 10.1159/000515669\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"38100477\",\n",
      "        \"title\": \"Effects of a mindfulness-based intervention and a health self-management programme on psychological well-being in older adults with subjective cognitive decline: Secondary analyses from the SCD-Well randomised clinical trial.\",\n",
      "        \"authors\": \"Schlosser M; Demnitz-King H; Barnhofer T; Collette F; Gonneaud J; Ch\\u00e9telat G; Jessen F; Kliegel M; Klimecki OM; Lutz A; Marchant NL; Medit-Ageing Research Group\",\n",
      "        \"doi\": \"10.1371/journal.pone.0295175\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Schlosser M, et al. Effects of a mindfulness-based intervention and a health self-management programme on psychological well-being in older adults with subjective cognitive decline: Secondary analyses from the SCD-Well randomised clinical trial. Effects of a mindfulness-based intervention and a health self-management programme on psychological well-being in older adults with subjective cognitive decline: Secondary analyses from the SCD-Well randomised clinical trial. 2023; 18:e0295175. doi: 10.1371/journal.pone.0295175\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35853750\",\n",
      "        \"title\": \"Association of Self-reflection With Cognition and Brain Health in Cognitively Unimpaired Older Adults.\",\n",
      "        \"authors\": \"Demnitz-King H; Gonneaud J; Klimecki OM; Chocat A; Collette F; Dautricourt S; Jessen F; Krolak-Salmon P; Lutz A; Morse RM; Molinuevo JL; Poisnel G; Touron E; Wirth M; Walker Z; Ch\\u00e9telat G; Marchant NL; Medit-Ageing Research Group\",\n",
      "        \"doi\": \"10.1212/WNL.0000000000200951\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Demnitz-King H, et al. Association of Self-reflection With Cognition and Brain Health in Cognitively Unimpaired Older Adults. Association of Self-reflection With Cognition and Brain Health in Cognitively Unimpaired Older Adults. 2022; 99:e1422-e1431. doi: 10.1212/WNL.0000000000200951\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"36068621\",\n",
      "        \"title\": \"Effects of a mindfulness-based versus a health self-management intervention on objective cognitive performance in older adults with subjective cognitive decline (SCD): a secondary analysis of the SCD-Well randomized controlled trial.\",\n",
      "        \"authors\": \"Whitfield T; Demnitz-King H; Schlosser M; Barnhofer T; Frison E; Coll-Padros N; Dautricourt S; Requier F; Delarue M; Gonneaud J; Klimecki OM; Lutz A; Paly L; Salmon E; Schild AK; Walker Z; Jessen F; Ch\\u00e9telat G; Collette F; Wirth M; Marchant NL; Medit-Ageing Research Group\",\n",
      "        \"doi\": \"10.1186/s13195-022-01057-w\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Whitfield T, et al. Effects of a mindfulness-based versus a health self-management intervention on objective cognitive performance in older adults with subjective cognitive decline (SCD): a secondary analysis of the SCD-Well randomized controlled trial. Effects of a mindfulness-based versus a health self-management intervention on objective cognitive performance in older adults with subjective cognitive decline (SCD): a secondary analysis of the SCD-Well randomized controlled trial. 2022; 14:125. doi: 10.1186/s13195-022-01057-w\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02916732\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"33657112\",\n",
      "        \"title\": \"Reassessment of the risk of birth defects due to Zika virus in Guadeloupe, 2016.\",\n",
      "        \"authors\": \"Funk AL; Hoen B; Vingdassalom I; Ryan C; Kadhel P; Schepers K; Gaete S; Tressi\\u00e8res B; Fontanet A\",\n",
      "        \"doi\": \"10.1371/journal.pntd.0009048\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Funk AL, et al. Reassessment of the risk of birth defects due to Zika virus in Guadeloupe, 2016. Reassessment of the risk of birth defects due to Zika virus in Guadeloupe, 2016. 2021; 15:e0009048. doi: 10.1371/journal.pntd.0009048\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29539287\",\n",
      "        \"title\": \"Pregnancy Outcomes after ZIKV Infection in French Territories in the Americas.\",\n",
      "        \"authors\": \"Hoen B; Schaub B; Funk AL; Ardillon V; Boullard M; Cabi\\u00e9 A; Callier C; Carles G; Cassadou S; C\\u00e9saire R; Douine M; Herrmann-Storck C; Kadhel P; Laou\\u00e9nan C; Madec Y; Monthieux A; Nacher M; Najioullah F; Rousset D; Ryan C; Schepers K; Stegmann-Planchard S; Tressi\\u00e8res B; Volum\\u00e9nie JL; Yassinguezo S; Janky E; Fontanet A\",\n",
      "        \"doi\": \"10.1056/NEJMoa1709481\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Hoen B, et al. Pregnancy Outcomes after ZIKV Infection in French Territories in the Americas. Pregnancy Outcomes after ZIKV Infection in French Territories in the Americas. 2018; 378:985-994. doi: 10.1056/NEJMoa1709481\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01311752\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01269632\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01495897\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00463983\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"22379151\",\n",
      "        \"title\": \"Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study.\",\n",
      "        \"authors\": \"Crestani B; Chapron J; Wallaert B; Bergot E; Delaval P; Israel-Biet D; Lacronique J; Monnet I; Reynaud-Gaubert M; Tazi A; Lebtahi R; Debray MP; Brauner M; Dehoux M; Dornic Q; Aubier M; Mentr\\u00e9 F; Duval X\",\n",
      "        \"doi\": \"10.1183/09031936.00113011\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase II\",\n",
      "          \"Letter\",\n",
      "          \"Multicenter Study\"\n",
      "        ],\n",
      "        \"citation\": \"Crestani B, et al. Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study. Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study. 2012; 39:772-5. doi: 10.1183/09031936.00113011\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"16883006\",\n",
      "        \"title\": \"Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis.\",\n",
      "        \"authors\": \"Lebtahi R; Moreau S; Marchand-Adam S; Debray MP; Brauner M; Soler P; Marchal J; Raguin O; Gruaz-Guyon A; Reubi JC; Le Guludec D; Crestani B\",\n",
      "        \"doi\": null,\n",
      "        \"year\": \"2006\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Lebtahi R, et al. Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis. Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis. 2006; 47:1281-7.\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT03137797\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"24465584\",\n",
      "        \"title\": \"Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaboration.\",\n",
      "        \"authors\": \"Boufassa F; Lechenadec J; Meyer L; Costagliola D; Hunt PW; Pereyra F; Deeks S; Pancino G; Taulera O; Lichterfeld M; Delobel P; Saez-Cirion A; Lambotte O; ANRS CO18 HIV Controllers Cohort; Cascade Collaboration in Eurocoord; SCOPE Cohort; International HIV Controllers Study\",\n",
      "        \"doi\": \"10.1371/journal.pone.0085516\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, N.I.H., Extramural\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Boufassa F, et al. Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaboration. Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaboration. 2014; 9:e85516. doi: 10.1371/journal.pone.0085516\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"26636578\",\n",
      "        \"title\": \"Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities.\",\n",
      "        \"authors\": \"Ghislain M; Bastard JP; Meyer L; Capeau J; Fellahi S; G\\u00e9rard L; May T; Simon A; Vigouroux C; Goujard C; ANRS-COPANA Cohort Study Group\",\n",
      "        \"doi\": \"10.1371/journal.pone.0144317\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Ghislain M, et al. Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities. Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities. 2015; 10:e0144317. doi: 10.1371/journal.pone.0144317\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22267473\",\n",
      "        \"title\": \"Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort.\",\n",
      "        \"authors\": \"Boufassa F; Goujard C; Viard JP; Carlier R; Lefebvre B; Yeni P; Bouchaud O; Capeau J; Meyer L; Vigouroux C; ANRS COPANA Cohort Study Group\",\n",
      "        \"doi\": \"10.3851/IMP1916\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Boufassa F, et al. Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort. Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort. 2012; 17:91-100. doi: 10.3851/IMP1916\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23079802\",\n",
      "        \"title\": \"Does pregnancy affect the early response to cART?\",\n",
      "        \"authors\": \"Rachas A; Warszawski J; Le Chenadec J; Legeai C; Teglas JP; Goujard C; Rouzioux C; Mandelbrot L; Tubiana R; Meyer L\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32835ac8bc\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Rachas A, et al. Does pregnancy affect the early response to cART?. Does pregnancy affect the early response to cART?. 2013; 27:357-67. doi: 10.1097/QAD.0b013e32835ac8bc\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"23936509\",\n",
      "        \"title\": \"Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts.\",\n",
      "        \"authors\": \"Krastinova E; Seng R; Yeni P; Viard JP; Vittecoq D; Lascoux-Combe C; Fourn E; Pahlavan G; Delfraissy JF; Goujard C; Meyer L; ANRS PRIMO and COPANA Cohorts\",\n",
      "        \"doi\": \"10.1371/journal.pone.0071473\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Krastinova E, et al. Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts. Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts. 2013; 8:e71473. doi: 10.1371/journal.pone.0071473\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24058636\",\n",
      "        \"title\": \"Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 \\u00abCOPANA\\u00bb cohort study.\",\n",
      "        \"authors\": \"Legeai C; Vigouroux C; Souberbielle JC; Bouchaud O; Boufassa F; Bastard JP; Carlier R; Capeau J; Goujard C; Meyer L; Viard JP; ANRS-COPANA Cohort Study Group\",\n",
      "        \"doi\": \"10.1371/journal.pone.0074868\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Legeai C, et al. Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 \\u00abCOPANA\\u00bb cohort study. Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 \\u00abCOPANA\\u00bb cohort study. 2013; 8:e74868. doi: 10.1371/journal.pone.0074868\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"27509048\",\n",
      "        \"title\": \"Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset.\",\n",
      "        \"authors\": \"Ploquin MJ; Madec Y; Casrouge A; Huot N; Passaes C; L\\u00e9curoux C; Essat A; Boufassa F; Jacquelin B; Jochems SP; Petitjean G; Angin M; G\\u00e4rtner K; Garcia-Tellez T; No\\u00ebl N; Booiman T; Boeser-Nunnink BD; Roques P; Saez-Cirion A; Vaslin B; Dereudre-Bosquet N; Barr\\u00e9-Sinoussi F; Ghislain M; Rouzioux C; Lambotte O; Albert ML; Goujard C; Kootstra N; Meyer L; M\\u00fcller-Trutwin MC\",\n",
      "        \"doi\": \"10.1371/journal.ppat.1005774\",\n",
      "        \"year\": \"2016\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Ploquin MJ, et al. Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset. Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset. 2016; 12:e1005774. doi: 10.1371/journal.ppat.1005774\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"25573889\",\n",
      "        \"title\": \"Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART.\",\n",
      "        \"authors\": \"El Khoury P; Ghislain M; Villard EF; Le Goff W; Lascoux-Combe C; Yeni P; Meyer L; Vigouroux C; Goujard C; Guerin M\",\n",
      "        \"doi\": \"10.1194/jlr.M054510\",\n",
      "        \"year\": \"2015\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"El Khoury P, et al. Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART. Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART. 2015; 56:692-702. doi: 10.1194/jlr.M054510\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"22008658\",\n",
      "        \"title\": \"Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use.\",\n",
      "        \"authors\": \"Dray-Spira R; Legeai C; Le Den M; Bou\\u00e9 F; Lascoux-Combe C; Simon A; May T; Goujard C; Meyer L; ANRS-COPANA Cohort Study Group\",\n",
      "        \"doi\": \"10.1097/QAD.0b013e32834dcf61\",\n",
      "        \"year\": \"2012\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Dray-Spira R, et al. Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use. Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use. 2012; 26:207-15. doi: 10.1097/QAD.0b013e32834dcf61\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01037777\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"23707147\",\n",
      "        \"title\": \"Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.\",\n",
      "        \"authors\": \"Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Sch\\u00f6ls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; B\\u00fcrk K; Peltz A; Schulz JB; Dufaure-Gar\\u00e9 I; Klockgether T\",\n",
      "        \"doi\": \"10.1016/S1474-4422(13)70104-2\",\n",
      "        \"year\": \"2013\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Jacobi H, et al. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data. 2013; 12:650-8. doi: 10.1016/S1474-4422(13)70104-2\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"24780882\",\n",
      "        \"title\": \"Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6.\",\n",
      "        \"authors\": \"Tezenas du Montcel S; Durr A; Rakowicz M; Nanetti L; Charles P; Sulek A; Mariotti C; Rola R; Schols L; Bauer P; Dufaure-Gar\\u00e9 I; Jacobi H; Forlani S; Schmitz-H\\u00fcbsch T; Filla A; Timmann D; van de Warrenburg BP; Marelli C; Kang JS; Giunti P; Cook A; Baliko L; Melegh B; Boesch S; Szymanski S; Berciano J; Infante J; Buerk K; Masciullo M; Di Fabio R; Depondt C; Ratka S; Stevanin G; Klockgether T; Brice A; Golmard JL\",\n",
      "        \"doi\": \"10.1136/jmedgenet-2013-102200\",\n",
      "        \"year\": \"2014\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Tezenas du Montcel S, et al. Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6. Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6. 2014; 51:479-86. doi: 10.1136/jmedgenet-2013-102200\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32822634\",\n",
      "        \"title\": \"Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.\",\n",
      "        \"authors\": \"Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Sch\\u00f6ls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; B\\u00fcrk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T\",\n",
      "        \"doi\": \"10.1016/S1474-4422(20)30235-0\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Observational Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Jacobi H, et al. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study. 2020; 19:738-747. doi: 10.1016/S1474-4422(20)30235-0\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35264424\",\n",
      "        \"title\": \"Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1.\",\n",
      "        \"authors\": \"Wilke C; Mengel D; Sch\\u00f6ls L; Hengel H; Rakowicz M; Klockgether T; Durr A; Filla A; Melegh B; Sch\\u00fcle R; Reetz K; Jacobi H; Synofzik M\",\n",
      "        \"doi\": \"10.1212/WNL.0000000000200257\",\n",
      "        \"year\": \"2022\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Wilke C, et al. Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1. Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1. 2022; 98:e1985-e1996. doi: 10.1212/WNL.0000000000200257\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01842477\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02721745\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02408354\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"28969699\",\n",
      "        \"title\": \"A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood.\",\n",
      "        \"authors\": \"Hainque E; Caillet S; Leroy S; Flamand-Roze C; Adanyeguh I; Charbonnier-Beaupel F; Retail M; Le Toullec B; Atencio M; Rivaud-P\\u00e9choux S; Brochard V; Habarou F; Ottolenghi C; Cormier F; M\\u00e9neret A; Ruiz M; Doulazmi M; Roubergue A; Corvol JC; Vidailhet M; Mochel F; Roze E\",\n",
      "        \"doi\": \"10.1186/s13023-017-0713-2\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\"\n",
      "        ],\n",
      "        \"citation\": \"Hainque E, et al. A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood. A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood. 2017; 12:160. doi: 10.1186/s13023-017-0713-2\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01688453\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"29696179\",\n",
      "        \"title\": \"Reducing social inequalities in access to overweight and obesity care management for adolescents: The PRALIMAP-IN\\u00c8S trial protocol and inclusion data analysis.\",\n",
      "        \"authors\": \"Legrand K; Lecomte E; Langlois J; Muller L; Saez L; Quinet MH; B\\u00f6hme P; Spitz E; Omorou AY; Brian\\u00e7on S; PRALIMAP-IN\\u00c8S trial group\",\n",
      "        \"doi\": \"10.1016/j.conctc.2017.05.010\",\n",
      "        \"year\": \"2017\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Legrand K, et al. Reducing social inequalities in access to overweight and obesity care management for adolescents: The PRALIMAP-IN\\u00c8S trial protocol and inclusion data analysis. Reducing social inequalities in access to overweight and obesity care management for adolescents: The PRALIMAP-IN\\u00c8S trial protocol and inclusion data analysis. 2017; 7:141-157. doi: 10.1016/j.conctc.2017.05.010\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32097754\",\n",
      "        \"title\": \"Physical activity rather than sedentary behaviour is socially determined in French adolescents with overweight and obesity.\",\n",
      "        \"authors\": \"Omorou AY; Manneville F; Langlois J; Legrand K; B\\u00f6hme P; Muller L; Guillemin F; Brian\\u00e7on S; Lecomte E; PRALIMAP-IN\\u00c8S Trial Group\",\n",
      "        \"doi\": \"10.1016/j.ypmed.2020.106043\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Omorou AY, et al. Physical activity rather than sedentary behaviour is socially determined in French adolescents with overweight and obesity. Physical activity rather than sedentary behaviour is socially determined in French adolescents with overweight and obesity. 2020; 134:106043. doi: 10.1016/j.ypmed.2020.106043\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"34087324\",\n",
      "        \"title\": \"Sociodemographic and psychological characteristics associated with discrepancy between body satisfaction and weight change among adolescents.\",\n",
      "        \"authors\": \"Manneville F; Omorou AY; Legrand K; Lecomte E; Rydberg JA; Brian\\u00e7on S; Guillemin F; PRALIMAP Trial Group\",\n",
      "        \"doi\": \"10.1016/j.ypmed.2021.106668\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Manneville F, et al. Sociodemographic and psychological characteristics associated with discrepancy between body satisfaction and weight change among adolescents. Sociodemographic and psychological characteristics associated with discrepancy between body satisfaction and weight change among adolescents. 2021; 150:106668. doi: 10.1016/j.ypmed.2021.106668\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29776897\",\n",
      "        \"title\": \"Reach and Acceptability of a Mobile Reminder Strategy and Facebook Group Intervention for Weight Management in Less Advantaged Adolescents: Insights From the PRALIMAP-IN\\u00c8S Trial.\",\n",
      "        \"authors\": \"Saez L; Langlois J; Legrand K; Quinet MH; Lecomte E; Omorou AY; Brian\\u00e7on S; PRALIMAP-IN\\u00c8S Trial Group\",\n",
      "        \"doi\": \"10.2196/mhealth.7657\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\"\n",
      "        ],\n",
      "        \"citation\": \"Saez L, et al. Reach and Acceptability of a Mobile Reminder Strategy and Facebook Group Intervention for Weight Management in Less Advantaged Adolescents: Insights From the PRALIMAP-IN\\u00c8S Trial. Reach and Acceptability of a Mobile Reminder Strategy and Facebook Group Intervention for Weight Management in Less Advantaged Adolescents: Insights From the PRALIMAP-IN\\u00c8S Trial. 2018; 6:e110. doi: 10.2196/mhealth.7657\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"35272723\",\n",
      "        \"title\": \"Behavioural risk patterns in adolescents with excess weight participating in the PRALIMAP-IN\\u00c8S trial.\",\n",
      "        \"authors\": \"Julia C; Omorou A; Lecomte E; Langlois J; Touvier M; Hercberg S; Brian\\u00e7on S; Kesse-Guyot E; Guillemin F; PRALIMAP-IN\\u00c8S Trial Group\",\n",
      "        \"doi\": \"10.1017/S136898002200057X\",\n",
      "        \"year\": \"2023\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Julia C, et al. Behavioural risk patterns in adolescents with excess weight participating in the PRALIMAP-IN\\u00c8S trial. Behavioural risk patterns in adolescents with excess weight participating in the PRALIMAP-IN\\u00c8S trial. 2023; 26:96-105. doi: 10.1017/S136898002200057X\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"29934380\",\n",
      "        \"title\": \"Using facilitator-receiver peer dyads matched according to socioeconomic status to promote behaviour change in overweight adolescents: a feasibility study.\",\n",
      "        \"authors\": \"Saez L; Legrand K; Alleyrat C; Ramisasoa S; Langlois J; Muller L; Omorou AY; De Lavenne R; Kivits J; Lecomte E; Brian\\u00e7on S; PRALIMAP-IN\\u00c8S Trial Group\",\n",
      "        \"doi\": \"10.1136/bmjopen-2017-019731\",\n",
      "        \"year\": \"2018\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Saez L, et al. Using facilitator-receiver peer dyads matched according to socioeconomic status to promote behaviour change in overweight adolescents: a feasibility study. Using facilitator-receiver peer dyads matched according to socioeconomic status to promote behaviour change in overweight adolescents: a feasibility study. 2018; 8:e019731. doi: 10.1136/bmjopen-2017-019731\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02172677\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT01880151\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02658253\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"33717176\",\n",
      "        \"title\": \"Progress and Insights Toward an Effective Placental Malaria Vaccine.\",\n",
      "        \"authors\": \"Gamain B; Ch\\u00eane A; Viebig NK; Tuikue Ndam N; Nielsen MA\",\n",
      "        \"doi\": \"10.3389/fimmu.2021.634508\",\n",
      "        \"year\": \"2021\",\n",
      "        \"publication_types\": [\n",
      "          \"Journal Article\",\n",
      "          \"Research Support, Non-U.S. Gov't\",\n",
      "          \"Review\"\n",
      "        ],\n",
      "        \"citation\": \"Gamain B, et al. Progress and Insights Toward an Effective Placental Malaria Vaccine. Progress and Insights Toward an Effective Placental Malaria Vaccine. 2021; 12:634508. doi: 10.3389/fimmu.2021.634508\"\n",
      "      },\n",
      "      {\n",
      "        \"pmid\": \"32032566\",\n",
      "        \"title\": \"PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study.\",\n",
      "        \"authors\": \"Sirima SB; Richert L; Ch\\u00eane A; Konate AT; Campion C; Dechavanne S; Semblat JP; Benhamouda N; Bahuaud M; Loulergue P; Ou\\u00e9draogo A; N\\u00e9bi\\u00e9 I; Kabore M; Kargougou D; Barry A; Ouattara SM; Boilet V; Allais F; Roguet G; Havelange N; Lopez-Perez E; Kuppers A; Konat\\u00e9 E; Roussillon C; Kant\\u00e9 M; Belarbi L; Diarra A; Henry N; Soulama I; Ou\\u00e9draogo A; Esperou H; Leroy O; Batteux F; Tartour E; Viebig NK; Thiebaut R; Launay O; Gamain B\",\n",
      "        \"doi\": \"10.1016/S1473-3099(19)30739-X\",\n",
      "        \"year\": \"2020\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial, Phase I\",\n",
      "          \"Journal Article\",\n",
      "          \"Randomized Controlled Trial\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Sirima SB, et al. PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study. PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study. 2020; 20:585-597. doi: 10.1016/S1473-3099(19)30739-X\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT02027051\",\n",
      "    \"publications\": []\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00118677\",\n",
      "    \"publications\": [\n",
      "      {\n",
      "        \"pmid\": \"20657770\",\n",
      "        \"title\": \"Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy.\",\n",
      "        \"authors\": \"Weiss L; Piketty C; Assoumou L; Didier C; Caccavelli L; Donkova-Petrini V; Levy Y; Girard PM; Burgard M; Viard JP; Rouzioux C; Costagliola D; ANRS 116 SALTO study group\",\n",
      "        \"doi\": \"10.1371/journal.pone.0011659\",\n",
      "        \"year\": \"2010\",\n",
      "        \"publication_types\": [\n",
      "          \"Clinical Trial\",\n",
      "          \"Journal Article\",\n",
      "          \"Multicenter Study\",\n",
      "          \"Research Support, Non-U.S. Gov't\"\n",
      "        ],\n",
      "        \"citation\": \"Weiss L, et al. Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy. Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy. 2010; 5:e11659. doi: 10.1371/journal.pone.0011659\"\n",
      "      }\n",
      "    ]\n",
      "  },\n",
      "  {\n",
      "    \"NCTId\": \"NCT00647205\",\n",
      "    \"publications\": []\n",
      "  }\n",
      "]\n"
     ]
    }
   ],
   "source": [
    "print(json.dumps(total_publications_list, indent=2))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "e319963c-1e2c-4dde-aae6-c86f161be7ba",
   "metadata": {},
   "outputs": [],
   "source": [
    "# The number of NCTId didn't change\n",
    "assert len(total_publications_list) == len(studies_list)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "22ec89f9-6196-4a75-b71f-ef5b6aad595d",
   "metadata": {},
   "source": [
    "### Import dans Pandas"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "eef6d4fe-795d-447a-8184-61e8f6522c0d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>publications</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02014727</td>\n",
       "      <td>[{'pmid': '28947345', 'title': 'Safety and imm...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT00117494</td>\n",
       "      <td>[{'pmid': '22739396', 'title': 'Effects of ros...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT00536627</td>\n",
       "      <td>[{'pmid': '24394187', 'title': 'Immunological ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT01033760</td>\n",
       "      <td>[{'pmid': '25701561', 'title': 'Intensive five...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT05349162</td>\n",
       "      <td>[{'pmid': '36735263', 'title': 'Epicardial vs....</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>284</th>\n",
       "      <td>NCT01880151</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>285</th>\n",
       "      <td>NCT02658253</td>\n",
       "      <td>[{'pmid': '33717176', 'title': 'Progress and I...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>286</th>\n",
       "      <td>NCT02027051</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>287</th>\n",
       "      <td>NCT00118677</td>\n",
       "      <td>[{'pmid': '20657770', 'title': 'Relationship b...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>288</th>\n",
       "      <td>NCT00647205</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>289 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                       publications\n",
       "0    NCT02014727  [{'pmid': '28947345', 'title': 'Safety and imm...\n",
       "1    NCT00117494  [{'pmid': '22739396', 'title': 'Effects of ros...\n",
       "2    NCT00536627  [{'pmid': '24394187', 'title': 'Immunological ...\n",
       "3    NCT01033760  [{'pmid': '25701561', 'title': 'Intensive five...\n",
       "4    NCT05349162  [{'pmid': '36735263', 'title': 'Epicardial vs....\n",
       "..           ...                                                ...\n",
       "284  NCT01880151                                                 []\n",
       "285  NCT02658253  [{'pmid': '33717176', 'title': 'Progress and I...\n",
       "286  NCT02027051                                                 []\n",
       "287  NCT00118677  [{'pmid': '20657770', 'title': 'Relationship b...\n",
       "288  NCT00647205                                                 []\n",
       "\n",
       "[289 rows x 2 columns]"
      ]
     },
     "execution_count": 60,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_pubmed = pd.DataFrame.from_records(total_publications_list)\n",
    "df_pubmed"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c8f8e322-5468-427d-951a-52769f39d215",
   "metadata": {},
   "source": [
    "#### On \"explose\" la colonne \"publications\":\n",
    "\n",
    "Pour chaque NCTId, la colonne 'publications' contient potentiellement une liste de plusieurs publications.  \n",
    "Si par exemple, on a 3 publications, on veut se retrouver avec 3 lignes, chacune indexée par le même NCTId et contenant une unique publication.  \n",
    "\n",
    "*Avant*:  \n",
    "**`NCTId    Reference`**  \n",
    "`NCT0001, [Pub1, Pub2, Pub3]`   \n",
    "\n",
    "*Après*:  \n",
    "**`NCTId    Reference`**  \n",
    "`NCT0001,   Pub1`  \n",
    "`NCT0001,   Pub2`  \n",
    "`NCT0001,   Pub3`   "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "id": "2d2b41c7-a86c-40d8-804a-dc5fe197aca1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>publications</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02014727</td>\n",
       "      <td>{'pmid': '28947345', 'title': 'Safety and immu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT00117494</td>\n",
       "      <td>{'pmid': '22739396', 'title': 'Effects of rosu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT00117494</td>\n",
       "      <td>{'pmid': '22318219', 'title': 'Determinants of...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00536627</td>\n",
       "      <td>{'pmid': '24394187', 'title': 'Immunological a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT00536627</td>\n",
       "      <td>{'pmid': '15382173', 'title': 'Induction or ex...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>701</th>\n",
       "      <td>NCT02658253</td>\n",
       "      <td>{'pmid': '33717176', 'title': 'Progress and In...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>702</th>\n",
       "      <td>NCT02658253</td>\n",
       "      <td>{'pmid': '32032566', 'title': 'PRIMVAC vaccine...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>703</th>\n",
       "      <td>NCT02027051</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>704</th>\n",
       "      <td>NCT00118677</td>\n",
       "      <td>{'pmid': '20657770', 'title': 'Relationship be...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>705</th>\n",
       "      <td>NCT00647205</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>706 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                       publications\n",
       "0    NCT02014727  {'pmid': '28947345', 'title': 'Safety and immu...\n",
       "1    NCT00117494  {'pmid': '22739396', 'title': 'Effects of rosu...\n",
       "2    NCT00117494  {'pmid': '22318219', 'title': 'Determinants of...\n",
       "3    NCT00536627  {'pmid': '24394187', 'title': 'Immunological a...\n",
       "4    NCT00536627  {'pmid': '15382173', 'title': 'Induction or ex...\n",
       "..           ...                                                ...\n",
       "701  NCT02658253  {'pmid': '33717176', 'title': 'Progress and In...\n",
       "702  NCT02658253  {'pmid': '32032566', 'title': 'PRIMVAC vaccine...\n",
       "703  NCT02027051                                                NaN\n",
       "704  NCT00118677  {'pmid': '20657770', 'title': 'Relationship be...\n",
       "705  NCT00647205                                                NaN\n",
       "\n",
       "[706 rows x 2 columns]"
      ]
     },
     "execution_count": 61,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_pubmed = df_pubmed.explode('publications', ignore_index=True)\n",
    "df_pubmed"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f9457360-7404-4027-a392-4f0f72e765fa",
   "metadata": {},
   "source": [
    "On vérifie que l'on a retrouvé plus de publications avec PubMed + CT que CT tout seul:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "id": "9439fcc7-84f2-4cbe-ace4-b278cf26bac9",
   "metadata": {},
   "outputs": [],
   "source": [
    "assert len(df_pubmed) >= len(df_ct)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6d4bd8f4-3e7b-4845-8016-ce08f3d86aa3",
   "metadata": {},
   "source": [
    "Pour chaque NCTId, la colonne 'publications' contient maintenant un dictionnaire de la forme:  \n",
    "`{  \n",
    "\"pmid\": \"17545707\",  \n",
    "\"title\": \"Haematological ...\",  \n",
    "\"authors\": \"Smith DJ; ...\",  \n",
    "}`\n",
    "\n",
    "Dont on veut extraire de nouvelles colonnes en utilant les clés du dictionnaire:  \n",
    "**`pmid      title                 authors`**  \n",
    "`17545707, \"Haematological ...\", \"Smith DJ; ...\"`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "id": "de0d46f5-ad8f-47ba-9cb2-900c74ceda72",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pmid</th>\n",
       "      <th>title</th>\n",
       "      <th>authors</th>\n",
       "      <th>doi</th>\n",
       "      <th>year</th>\n",
       "      <th>publication_types</th>\n",
       "      <th>citation</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>28947345</td>\n",
       "      <td>Safety and immunogenicity of a recombinant Pla...</td>\n",
       "      <td>Sirima SB; Durier C; Kara L; Houard S; Gansane...</td>\n",
       "      <td>10.1016/j.vaccine.2017.09.027</td>\n",
       "      <td>2017</td>\n",
       "      <td>[Clinical Trial, Phase I, Journal Article, Ran...</td>\n",
       "      <td>Sirima SB, et al. Safety and immunogenicity of...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>22739396</td>\n",
       "      <td>Effects of rosuvastatin versus pravastatin on ...</td>\n",
       "      <td>Bittar R; Giral P; Aslangul E; Assoumou L; Val...</td>\n",
       "      <td>10.1097/QAD.0b013e328357063c</td>\n",
       "      <td>2012</td>\n",
       "      <td>[Comparative Study, Journal Article, Multicent...</td>\n",
       "      <td>Bittar R, et al. Effects of rosuvastatin versu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>22318219</td>\n",
       "      <td>Determinants of low-density lipoprotein partic...</td>\n",
       "      <td>Bittar R; Giral P; Aslangul E; Assoumou L; Val...</td>\n",
       "      <td>10.3851/IMP2065</td>\n",
       "      <td>2012</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "      <td>Bittar R, et al. Determinants of low-density l...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>24394187</td>\n",
       "      <td>Immunological and antiviral responses after th...</td>\n",
       "      <td>Godon O; Fontaine H; Kahi S; Meritet JF; Scott...</td>\n",
       "      <td>10.1038/mt.2013.274</td>\n",
       "      <td>2014</td>\n",
       "      <td>[Clinical Trial, Phase I, Clinical Trial, Phas...</td>\n",
       "      <td>Godon O, et al. Immunological and antiviral re...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>15382173</td>\n",
       "      <td>Induction or expansion of T-cell responses by ...</td>\n",
       "      <td>Mancini-Bourgine M; Fontaine H; Scott-Algara D...</td>\n",
       "      <td>10.1002/hep.20408</td>\n",
       "      <td>2004</td>\n",
       "      <td>[Clinical Trial, Clinical Trial, Phase I, Jour...</td>\n",
       "      <td>Mancini-Bourgine M, et al. Induction or expans...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>701</th>\n",
       "      <td>33717176</td>\n",
       "      <td>Progress and Insights Toward an Effective Plac...</td>\n",
       "      <td>Gamain B; Chêne A; Viebig NK; Tuikue Ndam N; N...</td>\n",
       "      <td>10.3389/fimmu.2021.634508</td>\n",
       "      <td>2021</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "      <td>Gamain B, et al. Progress and Insights Toward ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>702</th>\n",
       "      <td>32032566</td>\n",
       "      <td>PRIMVAC vaccine adjuvanted with Alhydrogel or ...</td>\n",
       "      <td>Sirima SB; Richert L; Chêne A; Konate AT; Camp...</td>\n",
       "      <td>10.1016/S1473-3099(19)30739-X</td>\n",
       "      <td>2020</td>\n",
       "      <td>[Clinical Trial, Phase I, Journal Article, Ran...</td>\n",
       "      <td>Sirima SB, et al. PRIMVAC vaccine adjuvanted w...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>703</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>704</th>\n",
       "      <td>20657770</td>\n",
       "      <td>Relationship between regulatory T cells and im...</td>\n",
       "      <td>Weiss L; Piketty C; Assoumou L; Didier C; Cacc...</td>\n",
       "      <td>10.1371/journal.pone.0011659</td>\n",
       "      <td>2010</td>\n",
       "      <td>[Clinical Trial, Journal Article, Multicenter ...</td>\n",
       "      <td>Weiss L, et al. Relationship between regulator...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>705</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>706 rows × 7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "         pmid                                              title  \\\n",
       "0    28947345  Safety and immunogenicity of a recombinant Pla...   \n",
       "1    22739396  Effects of rosuvastatin versus pravastatin on ...   \n",
       "2    22318219  Determinants of low-density lipoprotein partic...   \n",
       "3    24394187  Immunological and antiviral responses after th...   \n",
       "4    15382173  Induction or expansion of T-cell responses by ...   \n",
       "..        ...                                                ...   \n",
       "701  33717176  Progress and Insights Toward an Effective Plac...   \n",
       "702  32032566  PRIMVAC vaccine adjuvanted with Alhydrogel or ...   \n",
       "703       NaN                                                NaN   \n",
       "704  20657770  Relationship between regulatory T cells and im...   \n",
       "705       NaN                                                NaN   \n",
       "\n",
       "                                               authors  \\\n",
       "0    Sirima SB; Durier C; Kara L; Houard S; Gansane...   \n",
       "1    Bittar R; Giral P; Aslangul E; Assoumou L; Val...   \n",
       "2    Bittar R; Giral P; Aslangul E; Assoumou L; Val...   \n",
       "3    Godon O; Fontaine H; Kahi S; Meritet JF; Scott...   \n",
       "4    Mancini-Bourgine M; Fontaine H; Scott-Algara D...   \n",
       "..                                                 ...   \n",
       "701  Gamain B; Chêne A; Viebig NK; Tuikue Ndam N; N...   \n",
       "702  Sirima SB; Richert L; Chêne A; Konate AT; Camp...   \n",
       "703                                                NaN   \n",
       "704  Weiss L; Piketty C; Assoumou L; Didier C; Cacc...   \n",
       "705                                                NaN   \n",
       "\n",
       "                               doi  year  \\\n",
       "0    10.1016/j.vaccine.2017.09.027  2017   \n",
       "1     10.1097/QAD.0b013e328357063c  2012   \n",
       "2                  10.3851/IMP2065  2012   \n",
       "3              10.1038/mt.2013.274  2014   \n",
       "4                10.1002/hep.20408  2004   \n",
       "..                             ...   ...   \n",
       "701      10.3389/fimmu.2021.634508  2021   \n",
       "702  10.1016/S1473-3099(19)30739-X  2020   \n",
       "703                            NaN   NaN   \n",
       "704   10.1371/journal.pone.0011659  2010   \n",
       "705                            NaN   NaN   \n",
       "\n",
       "                                     publication_types  \\\n",
       "0    [Clinical Trial, Phase I, Journal Article, Ran...   \n",
       "1    [Comparative Study, Journal Article, Multicent...   \n",
       "2    [Journal Article, Research Support, Non-U.S. G...   \n",
       "3    [Clinical Trial, Phase I, Clinical Trial, Phas...   \n",
       "4    [Clinical Trial, Clinical Trial, Phase I, Jour...   \n",
       "..                                                 ...   \n",
       "701  [Journal Article, Research Support, Non-U.S. G...   \n",
       "702  [Clinical Trial, Phase I, Journal Article, Ran...   \n",
       "703                                                NaN   \n",
       "704  [Clinical Trial, Journal Article, Multicenter ...   \n",
       "705                                                NaN   \n",
       "\n",
       "                                              citation  \n",
       "0    Sirima SB, et al. Safety and immunogenicity of...  \n",
       "1    Bittar R, et al. Effects of rosuvastatin versu...  \n",
       "2    Bittar R, et al. Determinants of low-density l...  \n",
       "3    Godon O, et al. Immunological and antiviral re...  \n",
       "4    Mancini-Bourgine M, et al. Induction or expans...  \n",
       "..                                                 ...  \n",
       "701  Gamain B, et al. Progress and Insights Toward ...  \n",
       "702  Sirima SB, et al. PRIMVAC vaccine adjuvanted w...  \n",
       "703                                                NaN  \n",
       "704  Weiss L, et al. Relationship between regulator...  \n",
       "705                                                NaN  \n",
       "\n",
       "[706 rows x 7 columns]"
      ]
     },
     "execution_count": 63,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_pubmed_publications = pd.json_normalize(df_pubmed.pop('publications'))\n",
    "df_pubmed_publications"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7d9d8656-c1b0-459b-aebb-7846b57288a6",
   "metadata": {},
   "source": [
    "On réassemble la dataFrame complète:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "id": "cce27392-459f-45e0-b262-300df63184b2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>pmid</th>\n",
       "      <th>title</th>\n",
       "      <th>authors</th>\n",
       "      <th>doi</th>\n",
       "      <th>year</th>\n",
       "      <th>publication_types</th>\n",
       "      <th>citation</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02014727</td>\n",
       "      <td>28947345</td>\n",
       "      <td>Safety and immunogenicity of a recombinant Pla...</td>\n",
       "      <td>Sirima SB; Durier C; Kara L; Houard S; Gansane...</td>\n",
       "      <td>10.1016/j.vaccine.2017.09.027</td>\n",
       "      <td>2017</td>\n",
       "      <td>[Clinical Trial, Phase I, Journal Article, Ran...</td>\n",
       "      <td>Sirima SB, et al. Safety and immunogenicity of...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT00117494</td>\n",
       "      <td>22739396</td>\n",
       "      <td>Effects of rosuvastatin versus pravastatin on ...</td>\n",
       "      <td>Bittar R; Giral P; Aslangul E; Assoumou L; Val...</td>\n",
       "      <td>10.1097/QAD.0b013e328357063c</td>\n",
       "      <td>2012</td>\n",
       "      <td>[Comparative Study, Journal Article, Multicent...</td>\n",
       "      <td>Bittar R, et al. Effects of rosuvastatin versu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT00117494</td>\n",
       "      <td>22318219</td>\n",
       "      <td>Determinants of low-density lipoprotein partic...</td>\n",
       "      <td>Bittar R; Giral P; Aslangul E; Assoumou L; Val...</td>\n",
       "      <td>10.3851/IMP2065</td>\n",
       "      <td>2012</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "      <td>Bittar R, et al. Determinants of low-density l...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00536627</td>\n",
       "      <td>24394187</td>\n",
       "      <td>Immunological and antiviral responses after th...</td>\n",
       "      <td>Godon O; Fontaine H; Kahi S; Meritet JF; Scott...</td>\n",
       "      <td>10.1038/mt.2013.274</td>\n",
       "      <td>2014</td>\n",
       "      <td>[Clinical Trial, Phase I, Clinical Trial, Phas...</td>\n",
       "      <td>Godon O, et al. Immunological and antiviral re...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT00536627</td>\n",
       "      <td>15382173</td>\n",
       "      <td>Induction or expansion of T-cell responses by ...</td>\n",
       "      <td>Mancini-Bourgine M; Fontaine H; Scott-Algara D...</td>\n",
       "      <td>10.1002/hep.20408</td>\n",
       "      <td>2004</td>\n",
       "      <td>[Clinical Trial, Clinical Trial, Phase I, Jour...</td>\n",
       "      <td>Mancini-Bourgine M, et al. Induction or expans...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>701</th>\n",
       "      <td>NCT02658253</td>\n",
       "      <td>33717176</td>\n",
       "      <td>Progress and Insights Toward an Effective Plac...</td>\n",
       "      <td>Gamain B; Chêne A; Viebig NK; Tuikue Ndam N; N...</td>\n",
       "      <td>10.3389/fimmu.2021.634508</td>\n",
       "      <td>2021</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "      <td>Gamain B, et al. Progress and Insights Toward ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>702</th>\n",
       "      <td>NCT02658253</td>\n",
       "      <td>32032566</td>\n",
       "      <td>PRIMVAC vaccine adjuvanted with Alhydrogel or ...</td>\n",
       "      <td>Sirima SB; Richert L; Chêne A; Konate AT; Camp...</td>\n",
       "      <td>10.1016/S1473-3099(19)30739-X</td>\n",
       "      <td>2020</td>\n",
       "      <td>[Clinical Trial, Phase I, Journal Article, Ran...</td>\n",
       "      <td>Sirima SB, et al. PRIMVAC vaccine adjuvanted w...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>703</th>\n",
       "      <td>NCT02027051</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>704</th>\n",
       "      <td>NCT00118677</td>\n",
       "      <td>20657770</td>\n",
       "      <td>Relationship between regulatory T cells and im...</td>\n",
       "      <td>Weiss L; Piketty C; Assoumou L; Didier C; Cacc...</td>\n",
       "      <td>10.1371/journal.pone.0011659</td>\n",
       "      <td>2010</td>\n",
       "      <td>[Clinical Trial, Journal Article, Multicenter ...</td>\n",
       "      <td>Weiss L, et al. Relationship between regulator...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>705</th>\n",
       "      <td>NCT00647205</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>706 rows × 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId      pmid                                              title  \\\n",
       "0    NCT02014727  28947345  Safety and immunogenicity of a recombinant Pla...   \n",
       "1    NCT00117494  22739396  Effects of rosuvastatin versus pravastatin on ...   \n",
       "2    NCT00117494  22318219  Determinants of low-density lipoprotein partic...   \n",
       "3    NCT00536627  24394187  Immunological and antiviral responses after th...   \n",
       "4    NCT00536627  15382173  Induction or expansion of T-cell responses by ...   \n",
       "..           ...       ...                                                ...   \n",
       "701  NCT02658253  33717176  Progress and Insights Toward an Effective Plac...   \n",
       "702  NCT02658253  32032566  PRIMVAC vaccine adjuvanted with Alhydrogel or ...   \n",
       "703  NCT02027051       NaN                                                NaN   \n",
       "704  NCT00118677  20657770  Relationship between regulatory T cells and im...   \n",
       "705  NCT00647205       NaN                                                NaN   \n",
       "\n",
       "                                               authors  \\\n",
       "0    Sirima SB; Durier C; Kara L; Houard S; Gansane...   \n",
       "1    Bittar R; Giral P; Aslangul E; Assoumou L; Val...   \n",
       "2    Bittar R; Giral P; Aslangul E; Assoumou L; Val...   \n",
       "3    Godon O; Fontaine H; Kahi S; Meritet JF; Scott...   \n",
       "4    Mancini-Bourgine M; Fontaine H; Scott-Algara D...   \n",
       "..                                                 ...   \n",
       "701  Gamain B; Chêne A; Viebig NK; Tuikue Ndam N; N...   \n",
       "702  Sirima SB; Richert L; Chêne A; Konate AT; Camp...   \n",
       "703                                                NaN   \n",
       "704  Weiss L; Piketty C; Assoumou L; Didier C; Cacc...   \n",
       "705                                                NaN   \n",
       "\n",
       "                               doi  year  \\\n",
       "0    10.1016/j.vaccine.2017.09.027  2017   \n",
       "1     10.1097/QAD.0b013e328357063c  2012   \n",
       "2                  10.3851/IMP2065  2012   \n",
       "3              10.1038/mt.2013.274  2014   \n",
       "4                10.1002/hep.20408  2004   \n",
       "..                             ...   ...   \n",
       "701      10.3389/fimmu.2021.634508  2021   \n",
       "702  10.1016/S1473-3099(19)30739-X  2020   \n",
       "703                            NaN   NaN   \n",
       "704   10.1371/journal.pone.0011659  2010   \n",
       "705                            NaN   NaN   \n",
       "\n",
       "                                     publication_types  \\\n",
       "0    [Clinical Trial, Phase I, Journal Article, Ran...   \n",
       "1    [Comparative Study, Journal Article, Multicent...   \n",
       "2    [Journal Article, Research Support, Non-U.S. G...   \n",
       "3    [Clinical Trial, Phase I, Clinical Trial, Phas...   \n",
       "4    [Clinical Trial, Clinical Trial, Phase I, Jour...   \n",
       "..                                                 ...   \n",
       "701  [Journal Article, Research Support, Non-U.S. G...   \n",
       "702  [Clinical Trial, Phase I, Journal Article, Ran...   \n",
       "703                                                NaN   \n",
       "704  [Clinical Trial, Journal Article, Multicenter ...   \n",
       "705                                                NaN   \n",
       "\n",
       "                                              citation  \n",
       "0    Sirima SB, et al. Safety and immunogenicity of...  \n",
       "1    Bittar R, et al. Effects of rosuvastatin versu...  \n",
       "2    Bittar R, et al. Determinants of low-density l...  \n",
       "3    Godon O, et al. Immunological and antiviral re...  \n",
       "4    Mancini-Bourgine M, et al. Induction or expans...  \n",
       "..                                                 ...  \n",
       "701  Gamain B, et al. Progress and Insights Toward ...  \n",
       "702  Sirima SB, et al. PRIMVAC vaccine adjuvanted w...  \n",
       "703                                                NaN  \n",
       "704  Weiss L, et al. Relationship between regulator...  \n",
       "705                                                NaN  \n",
       "\n",
       "[706 rows x 8 columns]"
      ]
     },
     "execution_count": 64,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_pubmed = df_pubmed.join(df_pubmed_publications)\n",
    "df_pubmed"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cb881be8-1255-4040-bad6-6e2952e20a06",
   "metadata": {},
   "source": [
    "### Jointure des DataFrame de CT et Pubmed:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "id": "f4df0c6f-686a-4553-b2c4-de58040349af",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>StartDate</th>\n",
       "      <th>CompletionDate</th>\n",
       "      <th>pmid</th>\n",
       "      <th>type</th>\n",
       "      <th>citation_x</th>\n",
       "      <th>title</th>\n",
       "      <th>authors</th>\n",
       "      <th>doi</th>\n",
       "      <th>year</th>\n",
       "      <th>publication_types</th>\n",
       "      <th>citation_y</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02014727</td>\n",
       "      <td>Safety and Immunogenicity of Recombinant Pichi...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>EVI Industries, Inc. | BPRC | Recherche Cliniq...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2013-12-18</td>\n",
       "      <td>2014-01</td>\n",
       "      <td>2015-07</td>\n",
       "      <td>28947345</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Sirima SB, Durier C, Kara L, Houard S, Gansane...</td>\n",
       "      <td>Safety and immunogenicity of a recombinant Pla...</td>\n",
       "      <td>Sirima SB; Durier C; Kara L; Houard S; Gansane...</td>\n",
       "      <td>10.1016/j.vaccine.2017.09.027</td>\n",
       "      <td>2017</td>\n",
       "      <td>[Clinical Trial, Phase I, Journal Article, Ran...</td>\n",
       "      <td>Sirima SB, et al. Safety and immunogenicity of...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT00117494</td>\n",
       "      <td>Rosuvastatin Versus Pravastatin in HIV Patient...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-07-07</td>\n",
       "      <td>2005-10</td>\n",
       "      <td>2007-06</td>\n",
       "      <td>22739396</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Bittar R, Giral P, Aslangul E, Assoumou L, Val...</td>\n",
       "      <td>Effects of rosuvastatin versus pravastatin on ...</td>\n",
       "      <td>Bittar R; Giral P; Aslangul E; Assoumou L; Val...</td>\n",
       "      <td>10.1097/QAD.0b013e328357063c</td>\n",
       "      <td>2012</td>\n",
       "      <td>[Comparative Study, Journal Article, Multicent...</td>\n",
       "      <td>Bittar R, et al. Effects of rosuvastatin versu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT00117494</td>\n",
       "      <td>Rosuvastatin Versus Pravastatin in HIV Patient...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-07-07</td>\n",
       "      <td>2005-10</td>\n",
       "      <td>2007-06</td>\n",
       "      <td>22318219</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Bittar R, Giral P, Aslangul E, Assoumou L, Val...</td>\n",
       "      <td>Determinants of low-density lipoprotein partic...</td>\n",
       "      <td>Bittar R; Giral P; Aslangul E; Assoumou L; Val...</td>\n",
       "      <td>10.3851/IMP2065</td>\n",
       "      <td>2012</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "      <td>Bittar R, et al. Determinants of low-density l...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00536627</td>\n",
       "      <td>Efficacy and Tolerance of Naked DNA Vaccine in...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2007-09-28</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>2010-11</td>\n",
       "      <td>24394187</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Godon O, Fontaine H, Kahi S, Meritet JF, Scott...</td>\n",
       "      <td>Immunological and antiviral responses after th...</td>\n",
       "      <td>Godon O; Fontaine H; Kahi S; Meritet JF; Scott...</td>\n",
       "      <td>10.1038/mt.2013.274</td>\n",
       "      <td>2014</td>\n",
       "      <td>[Clinical Trial, Phase I, Clinical Trial, Phas...</td>\n",
       "      <td>Godon O, et al. Immunological and antiviral re...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT00536627</td>\n",
       "      <td>Efficacy and Tolerance of Naked DNA Vaccine in...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2007-09-28</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>2010-11</td>\n",
       "      <td>15382173</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Mancini-Bourgine M, Fontaine H, Scott-Algara D...</td>\n",
       "      <td>Induction or expansion of T-cell responses by ...</td>\n",
       "      <td>Mancini-Bourgine M; Fontaine H; Scott-Algara D...</td>\n",
       "      <td>10.1002/hep.20408</td>\n",
       "      <td>2004</td>\n",
       "      <td>[Clinical Trial, Clinical Trial, Phase I, Jour...</td>\n",
       "      <td>Mancini-Bourgine M, et al. Induction or expans...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>701</th>\n",
       "      <td>NCT02658253</td>\n",
       "      <td>Trial to Evaluate the Safety and Immunogenicit...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>EVI Industries, Inc. | Recherche Clinique Pari...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-01-18</td>\n",
       "      <td>2016-01</td>\n",
       "      <td>2019-02-21</td>\n",
       "      <td>33717176</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Gamain B, Chene A, Viebig NK, Tuikue Ndam N, N...</td>\n",
       "      <td>Progress and Insights Toward an Effective Plac...</td>\n",
       "      <td>Gamain B; Chêne A; Viebig NK; Tuikue Ndam N; N...</td>\n",
       "      <td>10.3389/fimmu.2021.634508</td>\n",
       "      <td>2021</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "      <td>Gamain B, et al. Progress and Insights Toward ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>702</th>\n",
       "      <td>NCT02658253</td>\n",
       "      <td>Trial to Evaluate the Safety and Immunogenicit...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>EVI Industries, Inc. | Recherche Clinique Pari...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-01-18</td>\n",
       "      <td>2016-01</td>\n",
       "      <td>2019-02-21</td>\n",
       "      <td>32032566</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Sirima SB, Richert L, Chene A, Konate AT, Camp...</td>\n",
       "      <td>PRIMVAC vaccine adjuvanted with Alhydrogel or ...</td>\n",
       "      <td>Sirima SB; Richert L; Chêne A; Konate AT; Camp...</td>\n",
       "      <td>10.1016/S1473-3099(19)30739-X</td>\n",
       "      <td>2020</td>\n",
       "      <td>[Clinical Trial, Phase I, Journal Article, Ran...</td>\n",
       "      <td>Sirima SB, et al. PRIMVAC vaccine adjuvanted w...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>703</th>\n",
       "      <td>NCT02027051</td>\n",
       "      <td>Etude génétique Des Arméniens</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2014-01-03</td>\n",
       "      <td>2014-01</td>\n",
       "      <td>2017-01</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>704</th>\n",
       "      <td>NCT00118677</td>\n",
       "      <td>Long-Term Supervised Treatment Interruption in...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-07-12</td>\n",
       "      <td>2003-02</td>\n",
       "      <td>2007-05</td>\n",
       "      <td>20657770</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Weiss L, Piketty C, Assoumou L, Didier C, Cacc...</td>\n",
       "      <td>Relationship between regulatory T cells and im...</td>\n",
       "      <td>Weiss L; Piketty C; Assoumou L; Didier C; Cacc...</td>\n",
       "      <td>10.1371/journal.pone.0011659</td>\n",
       "      <td>2010</td>\n",
       "      <td>[Clinical Trial, Journal Article, Multicenter ...</td>\n",
       "      <td>Weiss L, et al. Relationship between regulator...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>705</th>\n",
       "      <td>NCT00647205</td>\n",
       "      <td>Evaluation of 2 Interferon γ Assays in the Dia...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2008-03-31</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>2010-11</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>706 rows × 19 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                         BriefTitle  \\\n",
       "0    NCT02014727  Safety and Immunogenicity of Recombinant Pichi...   \n",
       "1    NCT00117494  Rosuvastatin Versus Pravastatin in HIV Patient...   \n",
       "2    NCT00117494  Rosuvastatin Versus Pravastatin in HIV Patient...   \n",
       "3    NCT00536627  Efficacy and Tolerance of Naked DNA Vaccine in...   \n",
       "4    NCT00536627  Efficacy and Tolerance of Naked DNA Vaccine in...   \n",
       "..           ...                                                ...   \n",
       "701  NCT02658253  Trial to Evaluate the Safety and Immunogenicit...   \n",
       "702  NCT02658253  Trial to Evaluate the Safety and Immunogenicit...   \n",
       "703  NCT02027051                      Etude génétique Des Arméniens   \n",
       "704  NCT00118677  Long-Term Supervised Treatment Interruption in...   \n",
       "705  NCT00647205  Evaluation of 2 Interferon γ Assays in the Dia...   \n",
       "\n",
       "                                       LeadSponsorName  \\\n",
       "0    Institut National de la Santé Et de la Recherc...   \n",
       "1    French National Agency for Research on AIDS an...   \n",
       "2    French National Agency for Research on AIDS an...   \n",
       "3    French National Agency for Research on AIDS an...   \n",
       "4    French National Agency for Research on AIDS an...   \n",
       "..                                                 ...   \n",
       "701  Institut National de la Santé Et de la Recherc...   \n",
       "702  Institut National de la Santé Et de la Recherc...   \n",
       "703  Institut National de la Santé Et de la Recherc...   \n",
       "704  French National Agency for Research on AIDS an...   \n",
       "705  French National Agency for Research on AIDS an...   \n",
       "\n",
       "                                      CollaboratorName OverallStatus  \\\n",
       "0    EVI Industries, Inc. | BPRC | Recherche Cliniq...     COMPLETED   \n",
       "1                                                 <NA>     COMPLETED   \n",
       "2                                                 <NA>     COMPLETED   \n",
       "3                                                 <NA>     COMPLETED   \n",
       "4                                                 <NA>     COMPLETED   \n",
       "..                                                 ...           ...   \n",
       "701  EVI Industries, Inc. | Recherche Clinique Pari...     COMPLETED   \n",
       "702  EVI Industries, Inc. | Recherche Clinique Pari...     COMPLETED   \n",
       "703                                               <NA>     COMPLETED   \n",
       "704                                               <NA>     COMPLETED   \n",
       "705                                               <NA>     COMPLETED   \n",
       "\n",
       "          StudyType  HasResults StudyFirstPostDate StartDate CompletionDate  \\\n",
       "0    INTERVENTIONAL       False         2013-12-18   2014-01        2015-07   \n",
       "1    INTERVENTIONAL       False         2005-07-07   2005-10        2007-06   \n",
       "2    INTERVENTIONAL       False         2005-07-07   2005-10        2007-06   \n",
       "3    INTERVENTIONAL       False         2007-09-28   2008-01        2010-11   \n",
       "4    INTERVENTIONAL       False         2007-09-28   2008-01        2010-11   \n",
       "..              ...         ...                ...       ...            ...   \n",
       "701  INTERVENTIONAL       False         2016-01-18   2016-01     2019-02-21   \n",
       "702  INTERVENTIONAL       False         2016-01-18   2016-01     2019-02-21   \n",
       "703   OBSERVATIONAL       False         2014-01-03   2014-01        2017-01   \n",
       "704  INTERVENTIONAL       False         2005-07-12   2003-02        2007-05   \n",
       "705  INTERVENTIONAL       False         2008-03-31   2008-01        2010-11   \n",
       "\n",
       "         pmid        type                                         citation_x  \\\n",
       "0    28947345     DERIVED  Sirima SB, Durier C, Kara L, Houard S, Gansane...   \n",
       "1    22739396     DERIVED  Bittar R, Giral P, Aslangul E, Assoumou L, Val...   \n",
       "2    22318219     DERIVED  Bittar R, Giral P, Aslangul E, Assoumou L, Val...   \n",
       "3    24394187     DERIVED  Godon O, Fontaine H, Kahi S, Meritet JF, Scott...   \n",
       "4    15382173  BACKGROUND  Mancini-Bourgine M, Fontaine H, Scott-Algara D...   \n",
       "..        ...         ...                                                ...   \n",
       "701  33717176     DERIVED  Gamain B, Chene A, Viebig NK, Tuikue Ndam N, N...   \n",
       "702  32032566     DERIVED  Sirima SB, Richert L, Chene A, Konate AT, Camp...   \n",
       "703      <NA>        <NA>                                               <NA>   \n",
       "704  20657770     DERIVED  Weiss L, Piketty C, Assoumou L, Didier C, Cacc...   \n",
       "705      <NA>        <NA>                                               <NA>   \n",
       "\n",
       "                                                 title  \\\n",
       "0    Safety and immunogenicity of a recombinant Pla...   \n",
       "1    Effects of rosuvastatin versus pravastatin on ...   \n",
       "2    Determinants of low-density lipoprotein partic...   \n",
       "3    Immunological and antiviral responses after th...   \n",
       "4    Induction or expansion of T-cell responses by ...   \n",
       "..                                                 ...   \n",
       "701  Progress and Insights Toward an Effective Plac...   \n",
       "702  PRIMVAC vaccine adjuvanted with Alhydrogel or ...   \n",
       "703                                                NaN   \n",
       "704  Relationship between regulatory T cells and im...   \n",
       "705                                                NaN   \n",
       "\n",
       "                                               authors  \\\n",
       "0    Sirima SB; Durier C; Kara L; Houard S; Gansane...   \n",
       "1    Bittar R; Giral P; Aslangul E; Assoumou L; Val...   \n",
       "2    Bittar R; Giral P; Aslangul E; Assoumou L; Val...   \n",
       "3    Godon O; Fontaine H; Kahi S; Meritet JF; Scott...   \n",
       "4    Mancini-Bourgine M; Fontaine H; Scott-Algara D...   \n",
       "..                                                 ...   \n",
       "701  Gamain B; Chêne A; Viebig NK; Tuikue Ndam N; N...   \n",
       "702  Sirima SB; Richert L; Chêne A; Konate AT; Camp...   \n",
       "703                                                NaN   \n",
       "704  Weiss L; Piketty C; Assoumou L; Didier C; Cacc...   \n",
       "705                                                NaN   \n",
       "\n",
       "                               doi  year  \\\n",
       "0    10.1016/j.vaccine.2017.09.027  2017   \n",
       "1     10.1097/QAD.0b013e328357063c  2012   \n",
       "2                  10.3851/IMP2065  2012   \n",
       "3              10.1038/mt.2013.274  2014   \n",
       "4                10.1002/hep.20408  2004   \n",
       "..                             ...   ...   \n",
       "701      10.3389/fimmu.2021.634508  2021   \n",
       "702  10.1016/S1473-3099(19)30739-X  2020   \n",
       "703                            NaN   NaN   \n",
       "704   10.1371/journal.pone.0011659  2010   \n",
       "705                            NaN   NaN   \n",
       "\n",
       "                                     publication_types  \\\n",
       "0    [Clinical Trial, Phase I, Journal Article, Ran...   \n",
       "1    [Comparative Study, Journal Article, Multicent...   \n",
       "2    [Journal Article, Research Support, Non-U.S. G...   \n",
       "3    [Clinical Trial, Phase I, Clinical Trial, Phas...   \n",
       "4    [Clinical Trial, Clinical Trial, Phase I, Jour...   \n",
       "..                                                 ...   \n",
       "701  [Journal Article, Research Support, Non-U.S. G...   \n",
       "702  [Clinical Trial, Phase I, Journal Article, Ran...   \n",
       "703                                                NaN   \n",
       "704  [Clinical Trial, Journal Article, Multicenter ...   \n",
       "705                                                NaN   \n",
       "\n",
       "                                            citation_y  \n",
       "0    Sirima SB, et al. Safety and immunogenicity of...  \n",
       "1    Bittar R, et al. Effects of rosuvastatin versu...  \n",
       "2    Bittar R, et al. Determinants of low-density l...  \n",
       "3    Godon O, et al. Immunological and antiviral re...  \n",
       "4    Mancini-Bourgine M, et al. Induction or expans...  \n",
       "..                                                 ...  \n",
       "701  Gamain B, et al. Progress and Insights Toward ...  \n",
       "702  Sirima SB, et al. PRIMVAC vaccine adjuvanted w...  \n",
       "703                                                NaN  \n",
       "704  Weiss L, et al. Relationship between regulator...  \n",
       "705                                                NaN  \n",
       "\n",
       "[706 rows x 19 columns]"
      ]
     },
     "execution_count": 65,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_final = df_ct.merge(df_pubmed, on=['NCTId', 'pmid'], how='right')\n",
    "df_final"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f4de1f05-1852-441a-801f-0af220d03f0d",
   "metadata": {},
   "source": [
    "Suppression des colonnes 'citation':"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "663a60db-5ccb-4fdd-873a-4d4bc82a3033",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_final.drop(['citation_x', 'citation_y'], axis=1, inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "id": "a9dad762-522c-4483-b9b8-01ff3033beb2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>StartDate</th>\n",
       "      <th>CompletionDate</th>\n",
       "      <th>pmid</th>\n",
       "      <th>type</th>\n",
       "      <th>title</th>\n",
       "      <th>authors</th>\n",
       "      <th>doi</th>\n",
       "      <th>year</th>\n",
       "      <th>publication_types</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02014727</td>\n",
       "      <td>Safety and Immunogenicity of Recombinant Pichi...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>EVI Industries, Inc. | BPRC | Recherche Cliniq...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2013-12-18</td>\n",
       "      <td>2014-01</td>\n",
       "      <td>2015-07</td>\n",
       "      <td>28947345</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Safety and immunogenicity of a recombinant Pla...</td>\n",
       "      <td>Sirima SB; Durier C; Kara L; Houard S; Gansane...</td>\n",
       "      <td>10.1016/j.vaccine.2017.09.027</td>\n",
       "      <td>2017</td>\n",
       "      <td>[Clinical Trial, Phase I, Journal Article, Ran...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT00117494</td>\n",
       "      <td>Rosuvastatin Versus Pravastatin in HIV Patient...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-07-07</td>\n",
       "      <td>2005-10</td>\n",
       "      <td>2007-06</td>\n",
       "      <td>22739396</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Effects of rosuvastatin versus pravastatin on ...</td>\n",
       "      <td>Bittar R; Giral P; Aslangul E; Assoumou L; Val...</td>\n",
       "      <td>10.1097/QAD.0b013e328357063c</td>\n",
       "      <td>2012</td>\n",
       "      <td>[Comparative Study, Journal Article, Multicent...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT00117494</td>\n",
       "      <td>Rosuvastatin Versus Pravastatin in HIV Patient...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-07-07</td>\n",
       "      <td>2005-10</td>\n",
       "      <td>2007-06</td>\n",
       "      <td>22318219</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Determinants of low-density lipoprotein partic...</td>\n",
       "      <td>Bittar R; Giral P; Aslangul E; Assoumou L; Val...</td>\n",
       "      <td>10.3851/IMP2065</td>\n",
       "      <td>2012</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00536627</td>\n",
       "      <td>Efficacy and Tolerance of Naked DNA Vaccine in...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2007-09-28</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>2010-11</td>\n",
       "      <td>24394187</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Immunological and antiviral responses after th...</td>\n",
       "      <td>Godon O; Fontaine H; Kahi S; Meritet JF; Scott...</td>\n",
       "      <td>10.1038/mt.2013.274</td>\n",
       "      <td>2014</td>\n",
       "      <td>[Clinical Trial, Phase I, Clinical Trial, Phas...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT00536627</td>\n",
       "      <td>Efficacy and Tolerance of Naked DNA Vaccine in...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2007-09-28</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>2010-11</td>\n",
       "      <td>15382173</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Induction or expansion of T-cell responses by ...</td>\n",
       "      <td>Mancini-Bourgine M; Fontaine H; Scott-Algara D...</td>\n",
       "      <td>10.1002/hep.20408</td>\n",
       "      <td>2004</td>\n",
       "      <td>[Clinical Trial, Clinical Trial, Phase I, Jour...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>701</th>\n",
       "      <td>NCT02658253</td>\n",
       "      <td>Trial to Evaluate the Safety and Immunogenicit...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>EVI Industries, Inc. | Recherche Clinique Pari...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-01-18</td>\n",
       "      <td>2016-01</td>\n",
       "      <td>2019-02-21</td>\n",
       "      <td>33717176</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Progress and Insights Toward an Effective Plac...</td>\n",
       "      <td>Gamain B; Chêne A; Viebig NK; Tuikue Ndam N; N...</td>\n",
       "      <td>10.3389/fimmu.2021.634508</td>\n",
       "      <td>2021</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>702</th>\n",
       "      <td>NCT02658253</td>\n",
       "      <td>Trial to Evaluate the Safety and Immunogenicit...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>EVI Industries, Inc. | Recherche Clinique Pari...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-01-18</td>\n",
       "      <td>2016-01</td>\n",
       "      <td>2019-02-21</td>\n",
       "      <td>32032566</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>PRIMVAC vaccine adjuvanted with Alhydrogel or ...</td>\n",
       "      <td>Sirima SB; Richert L; Chêne A; Konate AT; Camp...</td>\n",
       "      <td>10.1016/S1473-3099(19)30739-X</td>\n",
       "      <td>2020</td>\n",
       "      <td>[Clinical Trial, Phase I, Journal Article, Ran...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>703</th>\n",
       "      <td>NCT02027051</td>\n",
       "      <td>Etude génétique Des Arméniens</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2014-01-03</td>\n",
       "      <td>2014-01</td>\n",
       "      <td>2017-01</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>704</th>\n",
       "      <td>NCT00118677</td>\n",
       "      <td>Long-Term Supervised Treatment Interruption in...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2005-07-12</td>\n",
       "      <td>2003-02</td>\n",
       "      <td>2007-05</td>\n",
       "      <td>20657770</td>\n",
       "      <td>DERIVED</td>\n",
       "      <td>Relationship between regulatory T cells and im...</td>\n",
       "      <td>Weiss L; Piketty C; Assoumou L; Didier C; Cacc...</td>\n",
       "      <td>10.1371/journal.pone.0011659</td>\n",
       "      <td>2010</td>\n",
       "      <td>[Clinical Trial, Journal Article, Multicenter ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>705</th>\n",
       "      <td>NCT00647205</td>\n",
       "      <td>Evaluation of 2 Interferon γ Assays in the Dia...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2008-03-31</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>2010-11</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>706 rows × 17 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                         BriefTitle  \\\n",
       "0    NCT02014727  Safety and Immunogenicity of Recombinant Pichi...   \n",
       "1    NCT00117494  Rosuvastatin Versus Pravastatin in HIV Patient...   \n",
       "2    NCT00117494  Rosuvastatin Versus Pravastatin in HIV Patient...   \n",
       "3    NCT00536627  Efficacy and Tolerance of Naked DNA Vaccine in...   \n",
       "4    NCT00536627  Efficacy and Tolerance of Naked DNA Vaccine in...   \n",
       "..           ...                                                ...   \n",
       "701  NCT02658253  Trial to Evaluate the Safety and Immunogenicit...   \n",
       "702  NCT02658253  Trial to Evaluate the Safety and Immunogenicit...   \n",
       "703  NCT02027051                      Etude génétique Des Arméniens   \n",
       "704  NCT00118677  Long-Term Supervised Treatment Interruption in...   \n",
       "705  NCT00647205  Evaluation of 2 Interferon γ Assays in the Dia...   \n",
       "\n",
       "                                       LeadSponsorName  \\\n",
       "0    Institut National de la Santé Et de la Recherc...   \n",
       "1    French National Agency for Research on AIDS an...   \n",
       "2    French National Agency for Research on AIDS an...   \n",
       "3    French National Agency for Research on AIDS an...   \n",
       "4    French National Agency for Research on AIDS an...   \n",
       "..                                                 ...   \n",
       "701  Institut National de la Santé Et de la Recherc...   \n",
       "702  Institut National de la Santé Et de la Recherc...   \n",
       "703  Institut National de la Santé Et de la Recherc...   \n",
       "704  French National Agency for Research on AIDS an...   \n",
       "705  French National Agency for Research on AIDS an...   \n",
       "\n",
       "                                      CollaboratorName OverallStatus  \\\n",
       "0    EVI Industries, Inc. | BPRC | Recherche Cliniq...     COMPLETED   \n",
       "1                                                 <NA>     COMPLETED   \n",
       "2                                                 <NA>     COMPLETED   \n",
       "3                                                 <NA>     COMPLETED   \n",
       "4                                                 <NA>     COMPLETED   \n",
       "..                                                 ...           ...   \n",
       "701  EVI Industries, Inc. | Recherche Clinique Pari...     COMPLETED   \n",
       "702  EVI Industries, Inc. | Recherche Clinique Pari...     COMPLETED   \n",
       "703                                               <NA>     COMPLETED   \n",
       "704                                               <NA>     COMPLETED   \n",
       "705                                               <NA>     COMPLETED   \n",
       "\n",
       "          StudyType  HasResults StudyFirstPostDate StartDate CompletionDate  \\\n",
       "0    INTERVENTIONAL       False         2013-12-18   2014-01        2015-07   \n",
       "1    INTERVENTIONAL       False         2005-07-07   2005-10        2007-06   \n",
       "2    INTERVENTIONAL       False         2005-07-07   2005-10        2007-06   \n",
       "3    INTERVENTIONAL       False         2007-09-28   2008-01        2010-11   \n",
       "4    INTERVENTIONAL       False         2007-09-28   2008-01        2010-11   \n",
       "..              ...         ...                ...       ...            ...   \n",
       "701  INTERVENTIONAL       False         2016-01-18   2016-01     2019-02-21   \n",
       "702  INTERVENTIONAL       False         2016-01-18   2016-01     2019-02-21   \n",
       "703   OBSERVATIONAL       False         2014-01-03   2014-01        2017-01   \n",
       "704  INTERVENTIONAL       False         2005-07-12   2003-02        2007-05   \n",
       "705  INTERVENTIONAL       False         2008-03-31   2008-01        2010-11   \n",
       "\n",
       "         pmid        type                                              title  \\\n",
       "0    28947345     DERIVED  Safety and immunogenicity of a recombinant Pla...   \n",
       "1    22739396     DERIVED  Effects of rosuvastatin versus pravastatin on ...   \n",
       "2    22318219     DERIVED  Determinants of low-density lipoprotein partic...   \n",
       "3    24394187     DERIVED  Immunological and antiviral responses after th...   \n",
       "4    15382173  BACKGROUND  Induction or expansion of T-cell responses by ...   \n",
       "..        ...         ...                                                ...   \n",
       "701  33717176     DERIVED  Progress and Insights Toward an Effective Plac...   \n",
       "702  32032566     DERIVED  PRIMVAC vaccine adjuvanted with Alhydrogel or ...   \n",
       "703      <NA>        <NA>                                                NaN   \n",
       "704  20657770     DERIVED  Relationship between regulatory T cells and im...   \n",
       "705      <NA>        <NA>                                                NaN   \n",
       "\n",
       "                                               authors  \\\n",
       "0    Sirima SB; Durier C; Kara L; Houard S; Gansane...   \n",
       "1    Bittar R; Giral P; Aslangul E; Assoumou L; Val...   \n",
       "2    Bittar R; Giral P; Aslangul E; Assoumou L; Val...   \n",
       "3    Godon O; Fontaine H; Kahi S; Meritet JF; Scott...   \n",
       "4    Mancini-Bourgine M; Fontaine H; Scott-Algara D...   \n",
       "..                                                 ...   \n",
       "701  Gamain B; Chêne A; Viebig NK; Tuikue Ndam N; N...   \n",
       "702  Sirima SB; Richert L; Chêne A; Konate AT; Camp...   \n",
       "703                                                NaN   \n",
       "704  Weiss L; Piketty C; Assoumou L; Didier C; Cacc...   \n",
       "705                                                NaN   \n",
       "\n",
       "                               doi  year  \\\n",
       "0    10.1016/j.vaccine.2017.09.027  2017   \n",
       "1     10.1097/QAD.0b013e328357063c  2012   \n",
       "2                  10.3851/IMP2065  2012   \n",
       "3              10.1038/mt.2013.274  2014   \n",
       "4                10.1002/hep.20408  2004   \n",
       "..                             ...   ...   \n",
       "701      10.3389/fimmu.2021.634508  2021   \n",
       "702  10.1016/S1473-3099(19)30739-X  2020   \n",
       "703                            NaN   NaN   \n",
       "704   10.1371/journal.pone.0011659  2010   \n",
       "705                            NaN   NaN   \n",
       "\n",
       "                                     publication_types  \n",
       "0    [Clinical Trial, Phase I, Journal Article, Ran...  \n",
       "1    [Comparative Study, Journal Article, Multicent...  \n",
       "2    [Journal Article, Research Support, Non-U.S. G...  \n",
       "3    [Clinical Trial, Phase I, Clinical Trial, Phas...  \n",
       "4    [Clinical Trial, Clinical Trial, Phase I, Jour...  \n",
       "..                                                 ...  \n",
       "701  [Journal Article, Research Support, Non-U.S. G...  \n",
       "702  [Clinical Trial, Phase I, Journal Article, Ran...  \n",
       "703                                                NaN  \n",
       "704  [Clinical Trial, Journal Article, Multicenter ...  \n",
       "705                                                NaN  \n",
       "\n",
       "[706 rows x 17 columns]"
      ]
     },
     "execution_count": 67,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_final"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7d497973-5788-41e4-a541-c326b32ffb83",
   "metadata": {},
   "source": [
    "Les nouveaux PMIDs trouvés via Pubmed, n'ont aucune des infos associées avec CT présentes: BriefTitle, LeadSponsorName, etc ...\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "id": "e83f92d2-39b0-4653-8ab5-9766b16f4da4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>StartDate</th>\n",
       "      <th>CompletionDate</th>\n",
       "      <th>pmid</th>\n",
       "      <th>type</th>\n",
       "      <th>title</th>\n",
       "      <th>authors</th>\n",
       "      <th>doi</th>\n",
       "      <th>year</th>\n",
       "      <th>publication_types</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>NCT05349162</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>36735263</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Epicardial vs. transvenous implantable cardiov...</td>\n",
       "      <td>Le Bos PA; Pontailler M; Maltret A; Kraiche D;...</td>\n",
       "      <td>10.1093/europace/euad015</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Clinical Trial, Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>37851566</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Improvements in Patient-Reported Outcomes Foll...</td>\n",
       "      <td>Bousmah MA; Protopopescu C; Mpoudi-Etame M; Om...</td>\n",
       "      <td>10.1097/QAI.0000000000003273</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Randomized Controlled Trial, Journal Article,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38156046</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Durability of the Efficacy and Safety of Dolut...</td>\n",
       "      <td>Mpoudi-Etame M; Tovar Sanchez T; Bousmah MA; O...</td>\n",
       "      <td>10.1093/ofid/ofad582</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>NCT01453192</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>30688008</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Low incidence of acute rejection within 6 mont...</td>\n",
       "      <td>Matignon M; Lelièvre JD; Lahiani A; Abbassi K;...</td>\n",
       "      <td>10.1111/hiv.12700</td>\n",
       "      <td>2019</td>\n",
       "      <td>[Journal Article, Multicenter Study, Research ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>NCT04315948</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>36695483</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Remdesivir for the treatment of COVID-19.</td>\n",
       "      <td>Grundeis F; Ansems K; Dahms K; Thieme V; Metze...</td>\n",
       "      <td>10.1002/14651858.CD014962.pub2</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article, Review, Research Support, No...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>NCT05311865</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>37795682</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>A randomised controlled trial to study the tra...</td>\n",
       "      <td>Luong Nguyen LB; Goupil de Bouillé J; Menant L...</td>\n",
       "      <td>10.1093/cid/ciad603</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>NCT05311865</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>36438274</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Transmission of SARS-CoV-2 during indoor clubb...</td>\n",
       "      <td>Goupil de Bouillé J; Luong Nguyen LB; Crépey P...</td>\n",
       "      <td>10.3389/fpubh.2022.981213</td>\n",
       "      <td>2022</td>\n",
       "      <td>[Clinical Trial Protocol, Journal Article, Res...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>NCT00640263</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>34425825</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>The prevalence and socio-behavioural and clini...</td>\n",
       "      <td>Birungi N; Fadnes LT; Engebretsen IMS; Tumwine...</td>\n",
       "      <td>10.1186/s12955-021-01844-3</td>\n",
       "      <td>2021</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>129</th>\n",
       "      <td>NCT01801618</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>29662875</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Positive Virological Outcomes of HIV-Infected ...</td>\n",
       "      <td>Ségéral O; Nerrienet E; Neth S; Spire B; Khol ...</td>\n",
       "      <td>10.3389/fpubh.2018.00063</td>\n",
       "      <td>2018</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>130</th>\n",
       "      <td>NCT02405013</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>36686592</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Patient-reported outcomes with direct-acting a...</td>\n",
       "      <td>Marcellin F; Mourad A; Lemoine M; Kouanfack C;...</td>\n",
       "      <td>10.1016/j.jhepr.2022.100665</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>179</th>\n",
       "      <td>NCT01703962</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>37668523</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Neurochemical Differences between 1p/19q Codel...</td>\n",
       "      <td>Branzoli F; Liserre R; Deelchand DK; Poliani P...</td>\n",
       "      <td>10.1148/radiol.223255</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article, Observational Study, Researc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>241</th>\n",
       "      <td>NCT01473472</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>36601747</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Hepatitis A and B vaccine uptake and immunisat...</td>\n",
       "      <td>Le Turnier P; Charreau I; Gabassi A; Carette D...</td>\n",
       "      <td>10.1136/sextrans-2022-055634</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Clinical Trial, Research Support, Non-U.S. Go...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>293</th>\n",
       "      <td>NCT02212379</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>31269208</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Dual therapy combining raltegravir with etravi...</td>\n",
       "      <td>Katlama C; Assoumou L; Valantin MA; Soulié C; ...</td>\n",
       "      <td>10.1093/jac/dkz224</td>\n",
       "      <td>2019</td>\n",
       "      <td>[Journal Article, Multicenter Study, Research ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>297</th>\n",
       "      <td>NCT03335995</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>37497675</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>One-Year Outcomes in Patients With Acute Strok...</td>\n",
       "      <td>Sonneville R; Mazighi M; Collet M; Gayat E; De...</td>\n",
       "      <td>10.1161/STROKEAHA.123.042910</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Multicenter Study, Journal Article, Research ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>325</th>\n",
       "      <td>NCT01426243</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>26314624</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Molecular characterization of the 17D-204 yell...</td>\n",
       "      <td>Salmona M; Gazaignes S; Mercier-Delarue S; Gar...</td>\n",
       "      <td>10.1016/j.vaccine.2015.08.055</td>\n",
       "      <td>2015</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>329</th>\n",
       "      <td>NCT03870438</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38484756</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Optimised prevention of postnatal HIV transmis...</td>\n",
       "      <td>Kankasa C; Mennecier A; Sakana BLD; Molès JP; ...</td>\n",
       "      <td>10.1016/S0140-6736(23)02464-9</td>\n",
       "      <td>2024</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>345</th>\n",
       "      <td>NCT03078439</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38408861</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Birth weight and head circumference discordanc...</td>\n",
       "      <td>Guellec I; Brunet A; Lapillonne A; Taine M; To...</td>\n",
       "      <td>10.1136/archdischild-2023-326336</td>\n",
       "      <td>2024</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>410</th>\n",
       "      <td>NCT02057796</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>36883573</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>High performance of systematic combined urine ...</td>\n",
       "      <td>Bonnet M; Gabillard D; Domoua S; Muzoora C; Me...</td>\n",
       "      <td>10.1093/cid/ciad125</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>449</th>\n",
       "      <td>NCT04392388</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>34293141</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Antibody status and cumulative incidence of SA...</td>\n",
       "      <td>Carrat F; de Lamballerie X; Rahib D; Blanché H...</td>\n",
       "      <td>10.1093/ije/dyab110</td>\n",
       "      <td>2021</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>456</th>\n",
       "      <td>NCT01089387</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>26439886</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Safety of Intracavernous Bone Marrow-Mononucle...</td>\n",
       "      <td>Yiou R; Hamidou L; Birebent B; Bitari D; Lecor...</td>\n",
       "      <td>10.1016/j.eururo.2015.09.026</td>\n",
       "      <td>2016</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>457</th>\n",
       "      <td>NCT02833961</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>36318030</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Longitudinal Monitoring of Microstructural Alt...</td>\n",
       "      <td>Genovese G; Diaz-Fernandez B; Lejeune FX; Rone...</td>\n",
       "      <td>10.1148/radiol.220430</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>475</th>\n",
       "      <td>NCT02481453</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38273639</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Sirolimus for treatment of patients with inclu...</td>\n",
       "      <td>Benveniste O; Hogrel JY; Belin L; Annoussamy M...</td>\n",
       "      <td>10.1016/S2665-9913(20)30280-0</td>\n",
       "      <td>2021</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>520</th>\n",
       "      <td>NCT04409405</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38043556</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Effect of anti-Ebola virus monoclonal antibodi...</td>\n",
       "      <td>Nkuba-Ndaye A; Dilu-Keti A; Tovar-Sanchez T; D...</td>\n",
       "      <td>10.1016/S1473-3099(23)00552-2</td>\n",
       "      <td>2024</td>\n",
       "      <td>[Observational Study, Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>606</th>\n",
       "      <td>NCT04288128</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38419144</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Digital Gait Measures Capture 1-Year Progressi...</td>\n",
       "      <td>Seemann J; Daghsen L; Cazier M; Lamy JC; Welte...</td>\n",
       "      <td>10.1002/mds.29757</td>\n",
       "      <td>2024</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>607</th>\n",
       "      <td>NCT04288128</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38421662</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>ATXN7-Related Cone-Rod Dystrophy: The Integrat...</td>\n",
       "      <td>Nassisi M; Coarelli G; Blanchard B; Dubec-Fleu...</td>\n",
       "      <td>10.1001/jamaophthalmol.2024.0001</td>\n",
       "      <td>2024</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>664</th>\n",
       "      <td>NCT03215732</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>37143029</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Hepatitis B prevention and treatment needs in ...</td>\n",
       "      <td>Djaogol T; Périères L; Marcellin F; Diouf A; C...</td>\n",
       "      <td>10.1186/s12889-023-15710-y</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>667</th>\n",
       "      <td>NCT03005652</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38100477</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Effects of a mindfulness-based intervention an...</td>\n",
       "      <td>Schlosser M; Demnitz-King H; Barnhofer T; Coll...</td>\n",
       "      <td>10.1371/journal.pone.0295175</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Randomized Controlled Trial, Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>697</th>\n",
       "      <td>NCT01688453</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>35272723</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Behavioural risk patterns in adolescents with ...</td>\n",
       "      <td>Julia C; Omorou A; Lecomte E; Langlois J; Touv...</td>\n",
       "      <td>10.1017/S136898002200057X</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId BriefTitle LeadSponsorName CollaboratorName OverallStatus  \\\n",
       "9    NCT05349162       <NA>            <NA>             <NA>          <NA>   \n",
       "11   NCT02777229       <NA>            <NA>             <NA>          <NA>   \n",
       "14   NCT02777229       <NA>            <NA>             <NA>          <NA>   \n",
       "24   NCT01453192       <NA>            <NA>             <NA>          <NA>   \n",
       "60   NCT04315948       <NA>            <NA>             <NA>          <NA>   \n",
       "74   NCT05311865       <NA>            <NA>             <NA>          <NA>   \n",
       "75   NCT05311865       <NA>            <NA>             <NA>          <NA>   \n",
       "103  NCT00640263       <NA>            <NA>             <NA>          <NA>   \n",
       "129  NCT01801618       <NA>            <NA>             <NA>          <NA>   \n",
       "130  NCT02405013       <NA>            <NA>             <NA>          <NA>   \n",
       "179  NCT01703962       <NA>            <NA>             <NA>          <NA>   \n",
       "241  NCT01473472       <NA>            <NA>             <NA>          <NA>   \n",
       "293  NCT02212379       <NA>            <NA>             <NA>          <NA>   \n",
       "297  NCT03335995       <NA>            <NA>             <NA>          <NA>   \n",
       "325  NCT01426243       <NA>            <NA>             <NA>          <NA>   \n",
       "329  NCT03870438       <NA>            <NA>             <NA>          <NA>   \n",
       "345  NCT03078439       <NA>            <NA>             <NA>          <NA>   \n",
       "410  NCT02057796       <NA>            <NA>             <NA>          <NA>   \n",
       "449  NCT04392388       <NA>            <NA>             <NA>          <NA>   \n",
       "456  NCT01089387       <NA>            <NA>             <NA>          <NA>   \n",
       "457  NCT02833961       <NA>            <NA>             <NA>          <NA>   \n",
       "475  NCT02481453       <NA>            <NA>             <NA>          <NA>   \n",
       "520  NCT04409405       <NA>            <NA>             <NA>          <NA>   \n",
       "606  NCT04288128       <NA>            <NA>             <NA>          <NA>   \n",
       "607  NCT04288128       <NA>            <NA>             <NA>          <NA>   \n",
       "664  NCT03215732       <NA>            <NA>             <NA>          <NA>   \n",
       "667  NCT03005652       <NA>            <NA>             <NA>          <NA>   \n",
       "697  NCT01688453       <NA>            <NA>             <NA>          <NA>   \n",
       "\n",
       "    StudyType  HasResults StudyFirstPostDate StartDate CompletionDate  \\\n",
       "9        <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "11       <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "14       <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "24       <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "60       <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "74       <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "75       <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "103      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "129      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "130      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "179      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "241      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "293      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "297      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "325      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "329      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "345      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "410      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "449      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "456      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "457      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "475      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "520      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "606      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "607      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "664      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "667      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "697      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "\n",
       "         pmid  type                                              title  \\\n",
       "9    36735263  <NA>  Epicardial vs. transvenous implantable cardiov...   \n",
       "11   37851566  <NA>  Improvements in Patient-Reported Outcomes Foll...   \n",
       "14   38156046  <NA>  Durability of the Efficacy and Safety of Dolut...   \n",
       "24   30688008  <NA>  Low incidence of acute rejection within 6 mont...   \n",
       "60   36695483  <NA>          Remdesivir for the treatment of COVID-19.   \n",
       "74   37795682  <NA>  A randomised controlled trial to study the tra...   \n",
       "75   36438274  <NA>  Transmission of SARS-CoV-2 during indoor clubb...   \n",
       "103  34425825  <NA>  The prevalence and socio-behavioural and clini...   \n",
       "129  29662875  <NA>  Positive Virological Outcomes of HIV-Infected ...   \n",
       "130  36686592  <NA>  Patient-reported outcomes with direct-acting a...   \n",
       "179  37668523  <NA>  Neurochemical Differences between 1p/19q Codel...   \n",
       "241  36601747  <NA>  Hepatitis A and B vaccine uptake and immunisat...   \n",
       "293  31269208  <NA>  Dual therapy combining raltegravir with etravi...   \n",
       "297  37497675  <NA>  One-Year Outcomes in Patients With Acute Strok...   \n",
       "325  26314624  <NA>  Molecular characterization of the 17D-204 yell...   \n",
       "329  38484756  <NA>  Optimised prevention of postnatal HIV transmis...   \n",
       "345  38408861  <NA>  Birth weight and head circumference discordanc...   \n",
       "410  36883573  <NA>  High performance of systematic combined urine ...   \n",
       "449  34293141  <NA>  Antibody status and cumulative incidence of SA...   \n",
       "456  26439886  <NA>  Safety of Intracavernous Bone Marrow-Mononucle...   \n",
       "457  36318030  <NA>  Longitudinal Monitoring of Microstructural Alt...   \n",
       "475  38273639  <NA>  Sirolimus for treatment of patients with inclu...   \n",
       "520  38043556  <NA>  Effect of anti-Ebola virus monoclonal antibodi...   \n",
       "606  38419144  <NA>  Digital Gait Measures Capture 1-Year Progressi...   \n",
       "607  38421662  <NA>  ATXN7-Related Cone-Rod Dystrophy: The Integrat...   \n",
       "664  37143029  <NA>  Hepatitis B prevention and treatment needs in ...   \n",
       "667  38100477  <NA>  Effects of a mindfulness-based intervention an...   \n",
       "697  35272723  <NA>  Behavioural risk patterns in adolescents with ...   \n",
       "\n",
       "                                               authors  \\\n",
       "9    Le Bos PA; Pontailler M; Maltret A; Kraiche D;...   \n",
       "11   Bousmah MA; Protopopescu C; Mpoudi-Etame M; Om...   \n",
       "14   Mpoudi-Etame M; Tovar Sanchez T; Bousmah MA; O...   \n",
       "24   Matignon M; Lelièvre JD; Lahiani A; Abbassi K;...   \n",
       "60   Grundeis F; Ansems K; Dahms K; Thieme V; Metze...   \n",
       "74   Luong Nguyen LB; Goupil de Bouillé J; Menant L...   \n",
       "75   Goupil de Bouillé J; Luong Nguyen LB; Crépey P...   \n",
       "103  Birungi N; Fadnes LT; Engebretsen IMS; Tumwine...   \n",
       "129  Ségéral O; Nerrienet E; Neth S; Spire B; Khol ...   \n",
       "130  Marcellin F; Mourad A; Lemoine M; Kouanfack C;...   \n",
       "179  Branzoli F; Liserre R; Deelchand DK; Poliani P...   \n",
       "241  Le Turnier P; Charreau I; Gabassi A; Carette D...   \n",
       "293  Katlama C; Assoumou L; Valantin MA; Soulié C; ...   \n",
       "297  Sonneville R; Mazighi M; Collet M; Gayat E; De...   \n",
       "325  Salmona M; Gazaignes S; Mercier-Delarue S; Gar...   \n",
       "329  Kankasa C; Mennecier A; Sakana BLD; Molès JP; ...   \n",
       "345  Guellec I; Brunet A; Lapillonne A; Taine M; To...   \n",
       "410  Bonnet M; Gabillard D; Domoua S; Muzoora C; Me...   \n",
       "449  Carrat F; de Lamballerie X; Rahib D; Blanché H...   \n",
       "456  Yiou R; Hamidou L; Birebent B; Bitari D; Lecor...   \n",
       "457  Genovese G; Diaz-Fernandez B; Lejeune FX; Rone...   \n",
       "475  Benveniste O; Hogrel JY; Belin L; Annoussamy M...   \n",
       "520  Nkuba-Ndaye A; Dilu-Keti A; Tovar-Sanchez T; D...   \n",
       "606  Seemann J; Daghsen L; Cazier M; Lamy JC; Welte...   \n",
       "607  Nassisi M; Coarelli G; Blanchard B; Dubec-Fleu...   \n",
       "664  Djaogol T; Périères L; Marcellin F; Diouf A; C...   \n",
       "667  Schlosser M; Demnitz-King H; Barnhofer T; Coll...   \n",
       "697  Julia C; Omorou A; Lecomte E; Langlois J; Touv...   \n",
       "\n",
       "                                  doi  year  \\\n",
       "9            10.1093/europace/euad015  2023   \n",
       "11       10.1097/QAI.0000000000003273  2023   \n",
       "14               10.1093/ofid/ofad582  2023   \n",
       "24                  10.1111/hiv.12700  2019   \n",
       "60     10.1002/14651858.CD014962.pub2  2023   \n",
       "74                10.1093/cid/ciad603  2023   \n",
       "75          10.3389/fpubh.2022.981213  2022   \n",
       "103        10.1186/s12955-021-01844-3  2021   \n",
       "129          10.3389/fpubh.2018.00063  2018   \n",
       "130       10.1016/j.jhepr.2022.100665  2023   \n",
       "179             10.1148/radiol.223255  2023   \n",
       "241      10.1136/sextrans-2022-055634  2023   \n",
       "293                10.1093/jac/dkz224  2019   \n",
       "297      10.1161/STROKEAHA.123.042910  2023   \n",
       "325     10.1016/j.vaccine.2015.08.055  2015   \n",
       "329     10.1016/S0140-6736(23)02464-9  2024   \n",
       "345  10.1136/archdischild-2023-326336  2024   \n",
       "410               10.1093/cid/ciad125  2023   \n",
       "449               10.1093/ije/dyab110  2021   \n",
       "456      10.1016/j.eururo.2015.09.026  2016   \n",
       "457             10.1148/radiol.220430  2023   \n",
       "475     10.1016/S2665-9913(20)30280-0  2021   \n",
       "520     10.1016/S1473-3099(23)00552-2  2024   \n",
       "606                 10.1002/mds.29757  2024   \n",
       "607  10.1001/jamaophthalmol.2024.0001  2024   \n",
       "664        10.1186/s12889-023-15710-y  2023   \n",
       "667      10.1371/journal.pone.0295175  2023   \n",
       "697         10.1017/S136898002200057X  2023   \n",
       "\n",
       "                                     publication_types  \n",
       "9                    [Clinical Trial, Journal Article]  \n",
       "11   [Randomized Controlled Trial, Journal Article,...  \n",
       "14                                   [Journal Article]  \n",
       "24   [Journal Article, Multicenter Study, Research ...  \n",
       "60   [Journal Article, Review, Research Support, No...  \n",
       "74                                   [Journal Article]  \n",
       "75   [Clinical Trial Protocol, Journal Article, Res...  \n",
       "103                                  [Journal Article]  \n",
       "129                                  [Journal Article]  \n",
       "130                                  [Journal Article]  \n",
       "179  [Journal Article, Observational Study, Researc...  \n",
       "241  [Clinical Trial, Research Support, Non-U.S. Go...  \n",
       "293  [Journal Article, Multicenter Study, Research ...  \n",
       "297  [Multicenter Study, Journal Article, Research ...  \n",
       "325  [Journal Article, Research Support, Non-U.S. G...  \n",
       "329                                  [Journal Article]  \n",
       "345                                  [Journal Article]  \n",
       "410                                  [Journal Article]  \n",
       "449                                  [Journal Article]  \n",
       "456  [Journal Article, Research Support, Non-U.S. G...  \n",
       "457  [Journal Article, Research Support, Non-U.S. G...  \n",
       "475                                  [Journal Article]  \n",
       "520             [Observational Study, Journal Article]  \n",
       "606                                  [Journal Article]  \n",
       "607                                  [Journal Article]  \n",
       "664  [Journal Article, Research Support, Non-U.S. G...  \n",
       "667     [Randomized Controlled Trial, Journal Article]  \n",
       "697  [Journal Article, Research Support, Non-U.S. G...  "
      ]
     },
     "execution_count": 68,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Index of empty rows we need to fill\n",
    "index_empty_rows = df_final.loc[:, 'BriefTitle'].isna()\n",
    "\n",
    "df_final[index_empty_rows]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2d9866a6",
   "metadata": {},
   "source": [
    "On rajoute un type 'PUBMED' pour les PMIDs issues de PubMed uniquement:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "id": "05507df2",
   "metadata": {},
   "outputs": [],
   "source": [
    "# We add a 'PUBMED' type to the PMIDs extracted from Pubmed exclusively\n",
    "df_final.loc[index_empty_rows, 'type'] = 'PUBMED'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "id": "50ec3c16",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>StartDate</th>\n",
       "      <th>CompletionDate</th>\n",
       "      <th>pmid</th>\n",
       "      <th>type</th>\n",
       "      <th>title</th>\n",
       "      <th>authors</th>\n",
       "      <th>doi</th>\n",
       "      <th>year</th>\n",
       "      <th>publication_types</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>NCT05349162</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>36735263</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Epicardial vs. transvenous implantable cardiov...</td>\n",
       "      <td>Le Bos PA; Pontailler M; Maltret A; Kraiche D;...</td>\n",
       "      <td>10.1093/europace/euad015</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Clinical Trial, Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>37851566</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Improvements in Patient-Reported Outcomes Foll...</td>\n",
       "      <td>Bousmah MA; Protopopescu C; Mpoudi-Etame M; Om...</td>\n",
       "      <td>10.1097/QAI.0000000000003273</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Randomized Controlled Trial, Journal Article,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38156046</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Durability of the Efficacy and Safety of Dolut...</td>\n",
       "      <td>Mpoudi-Etame M; Tovar Sanchez T; Bousmah MA; O...</td>\n",
       "      <td>10.1093/ofid/ofad582</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>NCT01453192</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>30688008</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Low incidence of acute rejection within 6 mont...</td>\n",
       "      <td>Matignon M; Lelièvre JD; Lahiani A; Abbassi K;...</td>\n",
       "      <td>10.1111/hiv.12700</td>\n",
       "      <td>2019</td>\n",
       "      <td>[Journal Article, Multicenter Study, Research ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>NCT04315948</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>36695483</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Remdesivir for the treatment of COVID-19.</td>\n",
       "      <td>Grundeis F; Ansems K; Dahms K; Thieme V; Metze...</td>\n",
       "      <td>10.1002/14651858.CD014962.pub2</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article, Review, Research Support, No...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>NCT05311865</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>37795682</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>A randomised controlled trial to study the tra...</td>\n",
       "      <td>Luong Nguyen LB; Goupil de Bouillé J; Menant L...</td>\n",
       "      <td>10.1093/cid/ciad603</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>NCT05311865</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>36438274</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Transmission of SARS-CoV-2 during indoor clubb...</td>\n",
       "      <td>Goupil de Bouillé J; Luong Nguyen LB; Crépey P...</td>\n",
       "      <td>10.3389/fpubh.2022.981213</td>\n",
       "      <td>2022</td>\n",
       "      <td>[Clinical Trial Protocol, Journal Article, Res...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>NCT00640263</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>34425825</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>The prevalence and socio-behavioural and clini...</td>\n",
       "      <td>Birungi N; Fadnes LT; Engebretsen IMS; Tumwine...</td>\n",
       "      <td>10.1186/s12955-021-01844-3</td>\n",
       "      <td>2021</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>129</th>\n",
       "      <td>NCT01801618</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>29662875</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Positive Virological Outcomes of HIV-Infected ...</td>\n",
       "      <td>Ségéral O; Nerrienet E; Neth S; Spire B; Khol ...</td>\n",
       "      <td>10.3389/fpubh.2018.00063</td>\n",
       "      <td>2018</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>130</th>\n",
       "      <td>NCT02405013</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>36686592</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Patient-reported outcomes with direct-acting a...</td>\n",
       "      <td>Marcellin F; Mourad A; Lemoine M; Kouanfack C;...</td>\n",
       "      <td>10.1016/j.jhepr.2022.100665</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>179</th>\n",
       "      <td>NCT01703962</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>37668523</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Neurochemical Differences between 1p/19q Codel...</td>\n",
       "      <td>Branzoli F; Liserre R; Deelchand DK; Poliani P...</td>\n",
       "      <td>10.1148/radiol.223255</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article, Observational Study, Researc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>241</th>\n",
       "      <td>NCT01473472</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>36601747</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Hepatitis A and B vaccine uptake and immunisat...</td>\n",
       "      <td>Le Turnier P; Charreau I; Gabassi A; Carette D...</td>\n",
       "      <td>10.1136/sextrans-2022-055634</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Clinical Trial, Research Support, Non-U.S. Go...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>293</th>\n",
       "      <td>NCT02212379</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>31269208</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Dual therapy combining raltegravir with etravi...</td>\n",
       "      <td>Katlama C; Assoumou L; Valantin MA; Soulié C; ...</td>\n",
       "      <td>10.1093/jac/dkz224</td>\n",
       "      <td>2019</td>\n",
       "      <td>[Journal Article, Multicenter Study, Research ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>297</th>\n",
       "      <td>NCT03335995</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>37497675</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>One-Year Outcomes in Patients With Acute Strok...</td>\n",
       "      <td>Sonneville R; Mazighi M; Collet M; Gayat E; De...</td>\n",
       "      <td>10.1161/STROKEAHA.123.042910</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Multicenter Study, Journal Article, Research ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>325</th>\n",
       "      <td>NCT01426243</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>26314624</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Molecular characterization of the 17D-204 yell...</td>\n",
       "      <td>Salmona M; Gazaignes S; Mercier-Delarue S; Gar...</td>\n",
       "      <td>10.1016/j.vaccine.2015.08.055</td>\n",
       "      <td>2015</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>329</th>\n",
       "      <td>NCT03870438</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38484756</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Optimised prevention of postnatal HIV transmis...</td>\n",
       "      <td>Kankasa C; Mennecier A; Sakana BLD; Molès JP; ...</td>\n",
       "      <td>10.1016/S0140-6736(23)02464-9</td>\n",
       "      <td>2024</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>345</th>\n",
       "      <td>NCT03078439</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38408861</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Birth weight and head circumference discordanc...</td>\n",
       "      <td>Guellec I; Brunet A; Lapillonne A; Taine M; To...</td>\n",
       "      <td>10.1136/archdischild-2023-326336</td>\n",
       "      <td>2024</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>410</th>\n",
       "      <td>NCT02057796</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>36883573</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>High performance of systematic combined urine ...</td>\n",
       "      <td>Bonnet M; Gabillard D; Domoua S; Muzoora C; Me...</td>\n",
       "      <td>10.1093/cid/ciad125</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>449</th>\n",
       "      <td>NCT04392388</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>34293141</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Antibody status and cumulative incidence of SA...</td>\n",
       "      <td>Carrat F; de Lamballerie X; Rahib D; Blanché H...</td>\n",
       "      <td>10.1093/ije/dyab110</td>\n",
       "      <td>2021</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>456</th>\n",
       "      <td>NCT01089387</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>26439886</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Safety of Intracavernous Bone Marrow-Mononucle...</td>\n",
       "      <td>Yiou R; Hamidou L; Birebent B; Bitari D; Lecor...</td>\n",
       "      <td>10.1016/j.eururo.2015.09.026</td>\n",
       "      <td>2016</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>457</th>\n",
       "      <td>NCT02833961</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>36318030</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Longitudinal Monitoring of Microstructural Alt...</td>\n",
       "      <td>Genovese G; Diaz-Fernandez B; Lejeune FX; Rone...</td>\n",
       "      <td>10.1148/radiol.220430</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>475</th>\n",
       "      <td>NCT02481453</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38273639</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Sirolimus for treatment of patients with inclu...</td>\n",
       "      <td>Benveniste O; Hogrel JY; Belin L; Annoussamy M...</td>\n",
       "      <td>10.1016/S2665-9913(20)30280-0</td>\n",
       "      <td>2021</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>520</th>\n",
       "      <td>NCT04409405</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38043556</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Effect of anti-Ebola virus monoclonal antibodi...</td>\n",
       "      <td>Nkuba-Ndaye A; Dilu-Keti A; Tovar-Sanchez T; D...</td>\n",
       "      <td>10.1016/S1473-3099(23)00552-2</td>\n",
       "      <td>2024</td>\n",
       "      <td>[Observational Study, Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>606</th>\n",
       "      <td>NCT04288128</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38419144</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Digital Gait Measures Capture 1-Year Progressi...</td>\n",
       "      <td>Seemann J; Daghsen L; Cazier M; Lamy JC; Welte...</td>\n",
       "      <td>10.1002/mds.29757</td>\n",
       "      <td>2024</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>607</th>\n",
       "      <td>NCT04288128</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38421662</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>ATXN7-Related Cone-Rod Dystrophy: The Integrat...</td>\n",
       "      <td>Nassisi M; Coarelli G; Blanchard B; Dubec-Fleu...</td>\n",
       "      <td>10.1001/jamaophthalmol.2024.0001</td>\n",
       "      <td>2024</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>664</th>\n",
       "      <td>NCT03215732</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>37143029</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Hepatitis B prevention and treatment needs in ...</td>\n",
       "      <td>Djaogol T; Périères L; Marcellin F; Diouf A; C...</td>\n",
       "      <td>10.1186/s12889-023-15710-y</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>667</th>\n",
       "      <td>NCT03005652</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>38100477</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Effects of a mindfulness-based intervention an...</td>\n",
       "      <td>Schlosser M; Demnitz-King H; Barnhofer T; Coll...</td>\n",
       "      <td>10.1371/journal.pone.0295175</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Randomized Controlled Trial, Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>697</th>\n",
       "      <td>NCT01688453</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>35272723</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Behavioural risk patterns in adolescents with ...</td>\n",
       "      <td>Julia C; Omorou A; Lecomte E; Langlois J; Touv...</td>\n",
       "      <td>10.1017/S136898002200057X</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId BriefTitle LeadSponsorName CollaboratorName OverallStatus  \\\n",
       "9    NCT05349162       <NA>            <NA>             <NA>          <NA>   \n",
       "11   NCT02777229       <NA>            <NA>             <NA>          <NA>   \n",
       "14   NCT02777229       <NA>            <NA>             <NA>          <NA>   \n",
       "24   NCT01453192       <NA>            <NA>             <NA>          <NA>   \n",
       "60   NCT04315948       <NA>            <NA>             <NA>          <NA>   \n",
       "74   NCT05311865       <NA>            <NA>             <NA>          <NA>   \n",
       "75   NCT05311865       <NA>            <NA>             <NA>          <NA>   \n",
       "103  NCT00640263       <NA>            <NA>             <NA>          <NA>   \n",
       "129  NCT01801618       <NA>            <NA>             <NA>          <NA>   \n",
       "130  NCT02405013       <NA>            <NA>             <NA>          <NA>   \n",
       "179  NCT01703962       <NA>            <NA>             <NA>          <NA>   \n",
       "241  NCT01473472       <NA>            <NA>             <NA>          <NA>   \n",
       "293  NCT02212379       <NA>            <NA>             <NA>          <NA>   \n",
       "297  NCT03335995       <NA>            <NA>             <NA>          <NA>   \n",
       "325  NCT01426243       <NA>            <NA>             <NA>          <NA>   \n",
       "329  NCT03870438       <NA>            <NA>             <NA>          <NA>   \n",
       "345  NCT03078439       <NA>            <NA>             <NA>          <NA>   \n",
       "410  NCT02057796       <NA>            <NA>             <NA>          <NA>   \n",
       "449  NCT04392388       <NA>            <NA>             <NA>          <NA>   \n",
       "456  NCT01089387       <NA>            <NA>             <NA>          <NA>   \n",
       "457  NCT02833961       <NA>            <NA>             <NA>          <NA>   \n",
       "475  NCT02481453       <NA>            <NA>             <NA>          <NA>   \n",
       "520  NCT04409405       <NA>            <NA>             <NA>          <NA>   \n",
       "606  NCT04288128       <NA>            <NA>             <NA>          <NA>   \n",
       "607  NCT04288128       <NA>            <NA>             <NA>          <NA>   \n",
       "664  NCT03215732       <NA>            <NA>             <NA>          <NA>   \n",
       "667  NCT03005652       <NA>            <NA>             <NA>          <NA>   \n",
       "697  NCT01688453       <NA>            <NA>             <NA>          <NA>   \n",
       "\n",
       "    StudyType  HasResults StudyFirstPostDate StartDate CompletionDate  \\\n",
       "9        <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "11       <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "14       <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "24       <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "60       <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "74       <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "75       <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "103      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "129      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "130      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "179      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "241      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "293      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "297      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "325      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "329      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "345      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "410      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "449      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "456      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "457      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "475      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "520      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "606      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "607      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "664      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "667      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "697      <NA>        <NA>               <NA>      <NA>           <NA>   \n",
       "\n",
       "         pmid    type                                              title  \\\n",
       "9    36735263  PUBMED  Epicardial vs. transvenous implantable cardiov...   \n",
       "11   37851566  PUBMED  Improvements in Patient-Reported Outcomes Foll...   \n",
       "14   38156046  PUBMED  Durability of the Efficacy and Safety of Dolut...   \n",
       "24   30688008  PUBMED  Low incidence of acute rejection within 6 mont...   \n",
       "60   36695483  PUBMED          Remdesivir for the treatment of COVID-19.   \n",
       "74   37795682  PUBMED  A randomised controlled trial to study the tra...   \n",
       "75   36438274  PUBMED  Transmission of SARS-CoV-2 during indoor clubb...   \n",
       "103  34425825  PUBMED  The prevalence and socio-behavioural and clini...   \n",
       "129  29662875  PUBMED  Positive Virological Outcomes of HIV-Infected ...   \n",
       "130  36686592  PUBMED  Patient-reported outcomes with direct-acting a...   \n",
       "179  37668523  PUBMED  Neurochemical Differences between 1p/19q Codel...   \n",
       "241  36601747  PUBMED  Hepatitis A and B vaccine uptake and immunisat...   \n",
       "293  31269208  PUBMED  Dual therapy combining raltegravir with etravi...   \n",
       "297  37497675  PUBMED  One-Year Outcomes in Patients With Acute Strok...   \n",
       "325  26314624  PUBMED  Molecular characterization of the 17D-204 yell...   \n",
       "329  38484756  PUBMED  Optimised prevention of postnatal HIV transmis...   \n",
       "345  38408861  PUBMED  Birth weight and head circumference discordanc...   \n",
       "410  36883573  PUBMED  High performance of systematic combined urine ...   \n",
       "449  34293141  PUBMED  Antibody status and cumulative incidence of SA...   \n",
       "456  26439886  PUBMED  Safety of Intracavernous Bone Marrow-Mononucle...   \n",
       "457  36318030  PUBMED  Longitudinal Monitoring of Microstructural Alt...   \n",
       "475  38273639  PUBMED  Sirolimus for treatment of patients with inclu...   \n",
       "520  38043556  PUBMED  Effect of anti-Ebola virus monoclonal antibodi...   \n",
       "606  38419144  PUBMED  Digital Gait Measures Capture 1-Year Progressi...   \n",
       "607  38421662  PUBMED  ATXN7-Related Cone-Rod Dystrophy: The Integrat...   \n",
       "664  37143029  PUBMED  Hepatitis B prevention and treatment needs in ...   \n",
       "667  38100477  PUBMED  Effects of a mindfulness-based intervention an...   \n",
       "697  35272723  PUBMED  Behavioural risk patterns in adolescents with ...   \n",
       "\n",
       "                                               authors  \\\n",
       "9    Le Bos PA; Pontailler M; Maltret A; Kraiche D;...   \n",
       "11   Bousmah MA; Protopopescu C; Mpoudi-Etame M; Om...   \n",
       "14   Mpoudi-Etame M; Tovar Sanchez T; Bousmah MA; O...   \n",
       "24   Matignon M; Lelièvre JD; Lahiani A; Abbassi K;...   \n",
       "60   Grundeis F; Ansems K; Dahms K; Thieme V; Metze...   \n",
       "74   Luong Nguyen LB; Goupil de Bouillé J; Menant L...   \n",
       "75   Goupil de Bouillé J; Luong Nguyen LB; Crépey P...   \n",
       "103  Birungi N; Fadnes LT; Engebretsen IMS; Tumwine...   \n",
       "129  Ségéral O; Nerrienet E; Neth S; Spire B; Khol ...   \n",
       "130  Marcellin F; Mourad A; Lemoine M; Kouanfack C;...   \n",
       "179  Branzoli F; Liserre R; Deelchand DK; Poliani P...   \n",
       "241  Le Turnier P; Charreau I; Gabassi A; Carette D...   \n",
       "293  Katlama C; Assoumou L; Valantin MA; Soulié C; ...   \n",
       "297  Sonneville R; Mazighi M; Collet M; Gayat E; De...   \n",
       "325  Salmona M; Gazaignes S; Mercier-Delarue S; Gar...   \n",
       "329  Kankasa C; Mennecier A; Sakana BLD; Molès JP; ...   \n",
       "345  Guellec I; Brunet A; Lapillonne A; Taine M; To...   \n",
       "410  Bonnet M; Gabillard D; Domoua S; Muzoora C; Me...   \n",
       "449  Carrat F; de Lamballerie X; Rahib D; Blanché H...   \n",
       "456  Yiou R; Hamidou L; Birebent B; Bitari D; Lecor...   \n",
       "457  Genovese G; Diaz-Fernandez B; Lejeune FX; Rone...   \n",
       "475  Benveniste O; Hogrel JY; Belin L; Annoussamy M...   \n",
       "520  Nkuba-Ndaye A; Dilu-Keti A; Tovar-Sanchez T; D...   \n",
       "606  Seemann J; Daghsen L; Cazier M; Lamy JC; Welte...   \n",
       "607  Nassisi M; Coarelli G; Blanchard B; Dubec-Fleu...   \n",
       "664  Djaogol T; Périères L; Marcellin F; Diouf A; C...   \n",
       "667  Schlosser M; Demnitz-King H; Barnhofer T; Coll...   \n",
       "697  Julia C; Omorou A; Lecomte E; Langlois J; Touv...   \n",
       "\n",
       "                                  doi  year  \\\n",
       "9            10.1093/europace/euad015  2023   \n",
       "11       10.1097/QAI.0000000000003273  2023   \n",
       "14               10.1093/ofid/ofad582  2023   \n",
       "24                  10.1111/hiv.12700  2019   \n",
       "60     10.1002/14651858.CD014962.pub2  2023   \n",
       "74                10.1093/cid/ciad603  2023   \n",
       "75          10.3389/fpubh.2022.981213  2022   \n",
       "103        10.1186/s12955-021-01844-3  2021   \n",
       "129          10.3389/fpubh.2018.00063  2018   \n",
       "130       10.1016/j.jhepr.2022.100665  2023   \n",
       "179             10.1148/radiol.223255  2023   \n",
       "241      10.1136/sextrans-2022-055634  2023   \n",
       "293                10.1093/jac/dkz224  2019   \n",
       "297      10.1161/STROKEAHA.123.042910  2023   \n",
       "325     10.1016/j.vaccine.2015.08.055  2015   \n",
       "329     10.1016/S0140-6736(23)02464-9  2024   \n",
       "345  10.1136/archdischild-2023-326336  2024   \n",
       "410               10.1093/cid/ciad125  2023   \n",
       "449               10.1093/ije/dyab110  2021   \n",
       "456      10.1016/j.eururo.2015.09.026  2016   \n",
       "457             10.1148/radiol.220430  2023   \n",
       "475     10.1016/S2665-9913(20)30280-0  2021   \n",
       "520     10.1016/S1473-3099(23)00552-2  2024   \n",
       "606                 10.1002/mds.29757  2024   \n",
       "607  10.1001/jamaophthalmol.2024.0001  2024   \n",
       "664        10.1186/s12889-023-15710-y  2023   \n",
       "667      10.1371/journal.pone.0295175  2023   \n",
       "697         10.1017/S136898002200057X  2023   \n",
       "\n",
       "                                     publication_types  \n",
       "9                    [Clinical Trial, Journal Article]  \n",
       "11   [Randomized Controlled Trial, Journal Article,...  \n",
       "14                                   [Journal Article]  \n",
       "24   [Journal Article, Multicenter Study, Research ...  \n",
       "60   [Journal Article, Review, Research Support, No...  \n",
       "74                                   [Journal Article]  \n",
       "75   [Clinical Trial Protocol, Journal Article, Res...  \n",
       "103                                  [Journal Article]  \n",
       "129                                  [Journal Article]  \n",
       "130                                  [Journal Article]  \n",
       "179  [Journal Article, Observational Study, Researc...  \n",
       "241  [Clinical Trial, Research Support, Non-U.S. Go...  \n",
       "293  [Journal Article, Multicenter Study, Research ...  \n",
       "297  [Multicenter Study, Journal Article, Research ...  \n",
       "325  [Journal Article, Research Support, Non-U.S. G...  \n",
       "329                                  [Journal Article]  \n",
       "345                                  [Journal Article]  \n",
       "410                                  [Journal Article]  \n",
       "449                                  [Journal Article]  \n",
       "456  [Journal Article, Research Support, Non-U.S. G...  \n",
       "457  [Journal Article, Research Support, Non-U.S. G...  \n",
       "475                                  [Journal Article]  \n",
       "520             [Observational Study, Journal Article]  \n",
       "606                                  [Journal Article]  \n",
       "607                                  [Journal Article]  \n",
       "664  [Journal Article, Research Support, Non-U.S. G...  \n",
       "667     [Randomized Controlled Trial, Journal Article]  \n",
       "697  [Journal Article, Research Support, Non-U.S. G...  "
      ]
     },
     "execution_count": 70,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_final[index_empty_rows]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fc08104a-116a-4a29-9212-2e5b60fbee3f",
   "metadata": {},
   "source": [
    "On va remplir ces colonnes avec les infos contenus dans la DataFrame CT:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "id": "e2bb2823",
   "metadata": {},
   "outputs": [],
   "source": [
    "# NCTIds of empty rows\n",
    "NCTIds_empty_rows = df_final.loc[index_empty_rows, 'NCTId']\n",
    "NCTIds_empty_rows\n",
    "\n",
    "# Columns we wish to copy\n",
    "columns_to_copy = [\n",
    "    'BriefTitle',\n",
    "    'LeadSponsorName',\n",
    "    'CollaboratorName',\n",
    "    'OverallStatus',\n",
    "    'StudyType',\n",
    "    'HasResults',\n",
    "    'StudyFirstPostDate',\n",
    "    'StartDate',\n",
    "    'CompletionDate',\n",
    "]\n",
    "\n",
    "# We copy the missing values from the CT dataframe\n",
    "for index, nctid in NCTIds_empty_rows.items():\n",
    "    # For an NCTId, we look in the CT dataframe for the first row with this NCTDId\n",
    "    # and copy the missings columns\n",
    "    df_final.loc[index, columns_to_copy] = df_ct.loc[\n",
    "        df_ct.loc[:, 'NCTId'] == nctid, columns_to_copy\n",
    "    ].iloc[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "id": "cce5605e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTId</th>\n",
       "      <th>BriefTitle</th>\n",
       "      <th>LeadSponsorName</th>\n",
       "      <th>CollaboratorName</th>\n",
       "      <th>OverallStatus</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>HasResults</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>StartDate</th>\n",
       "      <th>CompletionDate</th>\n",
       "      <th>pmid</th>\n",
       "      <th>type</th>\n",
       "      <th>title</th>\n",
       "      <th>authors</th>\n",
       "      <th>doi</th>\n",
       "      <th>year</th>\n",
       "      <th>publication_types</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>NCT05349162</td>\n",
       "      <td>Epicardial vs. Transvenous ICDs in Children</td>\n",
       "      <td>Paris Cardiovascular Research Center (Inserm U...</td>\n",
       "      <td>Hôpital Necker-Enfants Malades</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2022-04-27</td>\n",
       "      <td>2003-01-01</td>\n",
       "      <td>2022-04-01</td>\n",
       "      <td>36735263</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Epicardial vs. transvenous implantable cardiov...</td>\n",
       "      <td>Le Bos PA; Pontailler M; Maltret A; Kraiche D;...</td>\n",
       "      <td>10.1093/europace/euad015</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Clinical Trial, Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>Efficacy and Safety of a Dolutegravir-based Re...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Institut de Recherche pour le Developpement | ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-05-19</td>\n",
       "      <td>2016-07</td>\n",
       "      <td>2021-07</td>\n",
       "      <td>37851566</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Improvements in Patient-Reported Outcomes Foll...</td>\n",
       "      <td>Bousmah MA; Protopopescu C; Mpoudi-Etame M; Om...</td>\n",
       "      <td>10.1097/QAI.0000000000003273</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Randomized Controlled Trial, Journal Article,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>NCT02777229</td>\n",
       "      <td>Efficacy and Safety of a Dolutegravir-based Re...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Institut de Recherche pour le Developpement | ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-05-19</td>\n",
       "      <td>2016-07</td>\n",
       "      <td>2021-07</td>\n",
       "      <td>38156046</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Durability of the Efficacy and Safety of Dolut...</td>\n",
       "      <td>Mpoudi-Etame M; Tovar Sanchez T; Bousmah MA; O...</td>\n",
       "      <td>10.1093/ofid/ofad582</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>NCT01453192</td>\n",
       "      <td>Renal Transplantation and Raltegravir in HIV-I...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Merck Sharp &amp; Dohme LLC</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2011-10-17</td>\n",
       "      <td>2011-12</td>\n",
       "      <td>2015-11</td>\n",
       "      <td>30688008</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Low incidence of acute rejection within 6 mont...</td>\n",
       "      <td>Matignon M; Lelièvre JD; Lahiani A; Abbassi K;...</td>\n",
       "      <td>10.1111/hiv.12700</td>\n",
       "      <td>2019</td>\n",
       "      <td>[Journal Article, Multicenter Study, Research ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>NCT04315948</td>\n",
       "      <td>Trial of Treatments for COVID-19 in Hospitaliz...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2020-03-20</td>\n",
       "      <td>2020-03-22</td>\n",
       "      <td>2023-09-25</td>\n",
       "      <td>36695483</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Remdesivir for the treatment of COVID-19.</td>\n",
       "      <td>Grundeis F; Ansems K; Dahms K; Thieme V; Metze...</td>\n",
       "      <td>10.1002/14651858.CD014962.pub2</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article, Review, Research Support, No...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>NCT05311865</td>\n",
       "      <td>Transmission of Covid-19 During Clubbing Event...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Cerballiance | Kappa Santé</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2022-04-05</td>\n",
       "      <td>2021-09-04</td>\n",
       "      <td>2022-02-26</td>\n",
       "      <td>37795682</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>A randomised controlled trial to study the tra...</td>\n",
       "      <td>Luong Nguyen LB; Goupil de Bouillé J; Menant L...</td>\n",
       "      <td>10.1093/cid/ciad603</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>NCT05311865</td>\n",
       "      <td>Transmission of Covid-19 During Clubbing Event...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Cerballiance | Kappa Santé</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2022-04-05</td>\n",
       "      <td>2021-09-04</td>\n",
       "      <td>2022-02-26</td>\n",
       "      <td>36438274</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Transmission of SARS-CoV-2 during indoor clubb...</td>\n",
       "      <td>Goupil de Bouillé J; Luong Nguyen LB; Crépey P...</td>\n",
       "      <td>10.3389/fpubh.2022.981213</td>\n",
       "      <td>2022</td>\n",
       "      <td>[Clinical Trial Protocol, Journal Article, Res...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>NCT00640263</td>\n",
       "      <td>Comparison of Efficacy and Safety of Infant Pe...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>European and Developing Countries Clinical Tri...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2008-03-21</td>\n",
       "      <td>2009-12</td>\n",
       "      <td>2014-02</td>\n",
       "      <td>34425825</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>The prevalence and socio-behavioural and clini...</td>\n",
       "      <td>Birungi N; Fadnes LT; Engebretsen IMS; Tumwine...</td>\n",
       "      <td>10.1186/s12955-021-01844-3</td>\n",
       "      <td>2021</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>129</th>\n",
       "      <td>NCT01801618</td>\n",
       "      <td>National Evaluation of PI-based 2nd Line Effic...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2013-03-01</td>\n",
       "      <td>2013-02</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>29662875</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Positive Virological Outcomes of HIV-Infected ...</td>\n",
       "      <td>Ségéral O; Nerrienet E; Neth S; Spire B; Khol ...</td>\n",
       "      <td>10.3389/fpubh.2018.00063</td>\n",
       "      <td>2018</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>130</th>\n",
       "      <td>NCT02405013</td>\n",
       "      <td>Feasibility, Tolerance and Efficacy of Interfe...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2015-04-01</td>\n",
       "      <td>2015-10</td>\n",
       "      <td>2017-11</td>\n",
       "      <td>36686592</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Patient-reported outcomes with direct-acting a...</td>\n",
       "      <td>Marcellin F; Mourad A; Lemoine M; Kouanfack C;...</td>\n",
       "      <td>10.1016/j.jhepr.2022.100665</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>179</th>\n",
       "      <td>NCT01703962</td>\n",
       "      <td>Non Invasive IDentification of Gliomas With ID...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2012-10-11</td>\n",
       "      <td>2012-03-14</td>\n",
       "      <td>2014-03-20</td>\n",
       "      <td>37668523</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Neurochemical Differences between 1p/19q Codel...</td>\n",
       "      <td>Branzoli F; Liserre R; Deelchand DK; Poliani P...</td>\n",
       "      <td>10.1148/radiol.223255</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article, Observational Study, Researc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>241</th>\n",
       "      <td>NCT01473472</td>\n",
       "      <td>On Demand Antiretroviral Pre-exposure Prophyla...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2011-11-17</td>\n",
       "      <td>2012-01</td>\n",
       "      <td>2016-12-15</td>\n",
       "      <td>36601747</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Hepatitis A and B vaccine uptake and immunisat...</td>\n",
       "      <td>Le Turnier P; Charreau I; Gabassi A; Carette D...</td>\n",
       "      <td>10.1136/sextrans-2022-055634</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Clinical Trial, Research Support, Non-U.S. Go...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>293</th>\n",
       "      <td>NCT02212379</td>\n",
       "      <td>Capacity of the Dual Combination Raltegravir/E...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Merck Sharp &amp; Dohme LLC | Janssen-Cilag Ltd.</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>True</td>\n",
       "      <td>2014-08-08</td>\n",
       "      <td>2015-01</td>\n",
       "      <td>2018-04</td>\n",
       "      <td>31269208</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Dual therapy combining raltegravir with etravi...</td>\n",
       "      <td>Katlama C; Assoumou L; Valantin MA; Soulié C; ...</td>\n",
       "      <td>10.1093/jac/dkz224</td>\n",
       "      <td>2019</td>\n",
       "      <td>[Journal Article, Multicenter Study, Research ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>297</th>\n",
       "      <td>NCT03335995</td>\n",
       "      <td>Stroke Prognosis in Intensive CarE</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2017-11-08</td>\n",
       "      <td>2017-10-18</td>\n",
       "      <td>2020-11-18</td>\n",
       "      <td>37497675</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>One-Year Outcomes in Patients With Acute Strok...</td>\n",
       "      <td>Sonneville R; Mazighi M; Collet M; Gayat E; De...</td>\n",
       "      <td>10.1161/STROKEAHA.123.042910</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Multicenter Study, Journal Article, Research ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>325</th>\n",
       "      <td>NCT01426243</td>\n",
       "      <td>The Yellow Fever Vaccine Immunity in HIV Infec...</td>\n",
       "      <td>French National Agency for Research on AIDS an...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2011-08-31</td>\n",
       "      <td>2011-07</td>\n",
       "      <td>2017-12</td>\n",
       "      <td>26314624</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Molecular characterization of the 17D-204 yell...</td>\n",
       "      <td>Salmona M; Gazaignes S; Mercier-Delarue S; Gar...</td>\n",
       "      <td>10.1016/j.vaccine.2015.08.055</td>\n",
       "      <td>2015</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>329</th>\n",
       "      <td>NCT03870438</td>\n",
       "      <td>Prevention of Mother-to-child Transmission of ...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>University Teaching Hospital, Lusaka, Zambia |...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2019-03-12</td>\n",
       "      <td>2019-12-14</td>\n",
       "      <td>2022-10-31</td>\n",
       "      <td>38484756</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Optimised prevention of postnatal HIV transmis...</td>\n",
       "      <td>Kankasa C; Mennecier A; Sakana BLD; Molès JP; ...</td>\n",
       "      <td>10.1016/S0140-6736(23)02464-9</td>\n",
       "      <td>2024</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>345</th>\n",
       "      <td>NCT03078439</td>\n",
       "      <td>EPIPAGE2 Cohort Study Follow up at Five and a ...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2017-03-13</td>\n",
       "      <td>2016-09-02</td>\n",
       "      <td>2018-01-08</td>\n",
       "      <td>38408861</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Birth weight and head circumference discordanc...</td>\n",
       "      <td>Guellec I; Brunet A; Lapillonne A; Taine M; To...</td>\n",
       "      <td>10.1136/archdischild-2023-326336</td>\n",
       "      <td>2024</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>410</th>\n",
       "      <td>NCT02057796</td>\n",
       "      <td>Systematic Empirical vs. Test-guided Anti-TB T...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2014-02-07</td>\n",
       "      <td>2014-09</td>\n",
       "      <td>2018-04</td>\n",
       "      <td>36883573</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>High performance of systematic combined urine ...</td>\n",
       "      <td>Bonnet M; Gabillard D; Domoua S; Muzoora C; Me...</td>\n",
       "      <td>10.1093/cid/ciad125</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>449</th>\n",
       "      <td>NCT04392388</td>\n",
       "      <td>Health, Perception, Practices, Relations and S...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2020-05-18</td>\n",
       "      <td>2020-05-01</td>\n",
       "      <td>2023-04-11</td>\n",
       "      <td>34293141</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Antibody status and cumulative incidence of SA...</td>\n",
       "      <td>Carrat F; de Lamballerie X; Rahib D; Blanché H...</td>\n",
       "      <td>10.1093/ije/dyab110</td>\n",
       "      <td>2021</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>456</th>\n",
       "      <td>NCT01089387</td>\n",
       "      <td>Intracavernous Bone Marrow Stem-cell Injection...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2010-03-18</td>\n",
       "      <td>2010-05</td>\n",
       "      <td>2015-03</td>\n",
       "      <td>26439886</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Safety of Intracavernous Bone Marrow-Mononucle...</td>\n",
       "      <td>Yiou R; Hamidou L; Birebent B; Bitari D; Lecor...</td>\n",
       "      <td>10.1016/j.eururo.2015.09.026</td>\n",
       "      <td>2016</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>457</th>\n",
       "      <td>NCT02833961</td>\n",
       "      <td>Diffusion Spectroscopy in Stroke</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-07-14</td>\n",
       "      <td>2016-07-28</td>\n",
       "      <td>2019-10-25</td>\n",
       "      <td>36318030</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Longitudinal Monitoring of Microstructural Alt...</td>\n",
       "      <td>Genovese G; Diaz-Fernandez B; Lejeune FX; Rone...</td>\n",
       "      <td>10.1148/radiol.220430</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>475</th>\n",
       "      <td>NCT02481453</td>\n",
       "      <td>Rapamycine vs Placebo for the Treatment of Inc...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2015-06-25</td>\n",
       "      <td>2015-07-15</td>\n",
       "      <td>2018-01-22</td>\n",
       "      <td>38273639</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Sirolimus for treatment of patients with inclu...</td>\n",
       "      <td>Benveniste O; Hogrel JY; Belin L; Annoussamy M...</td>\n",
       "      <td>10.1016/S2665-9913(20)30280-0</td>\n",
       "      <td>2021</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>520</th>\n",
       "      <td>NCT04409405</td>\n",
       "      <td>Evaluation and Support to EVD Cured Patients a...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>Institut National de Recherche Biomédicale. Ki...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2020-06-01</td>\n",
       "      <td>2020-04-16</td>\n",
       "      <td>2021-10-18</td>\n",
       "      <td>38043556</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Effect of anti-Ebola virus monoclonal antibodi...</td>\n",
       "      <td>Nkuba-Ndaye A; Dilu-Keti A; Tovar-Sanchez T; D...</td>\n",
       "      <td>10.1016/S1473-3099(23)00552-2</td>\n",
       "      <td>2024</td>\n",
       "      <td>[Observational Study, Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>606</th>\n",
       "      <td>NCT04288128</td>\n",
       "      <td>Integrated Functional Evaluation of the Cerebe...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>Biogen | Ionis Pharmaceuticals, Inc.</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2020-02-28</td>\n",
       "      <td>2020-05-28</td>\n",
       "      <td>2022-06-01</td>\n",
       "      <td>38419144</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Digital Gait Measures Capture 1-Year Progressi...</td>\n",
       "      <td>Seemann J; Daghsen L; Cazier M; Lamy JC; Welte...</td>\n",
       "      <td>10.1002/mds.29757</td>\n",
       "      <td>2024</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>607</th>\n",
       "      <td>NCT04288128</td>\n",
       "      <td>Integrated Functional Evaluation of the Cerebe...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>Biogen | Ionis Pharmaceuticals, Inc.</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2020-02-28</td>\n",
       "      <td>2020-05-28</td>\n",
       "      <td>2022-06-01</td>\n",
       "      <td>38421662</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>ATXN7-Related Cone-Rod Dystrophy: The Integrat...</td>\n",
       "      <td>Nassisi M; Coarelli G; Blanchard B; Dubec-Fleu...</td>\n",
       "      <td>10.1001/jamaophthalmol.2024.0001</td>\n",
       "      <td>2024</td>\n",
       "      <td>[Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>664</th>\n",
       "      <td>NCT03215732</td>\n",
       "      <td>Cross Sectional Survey on the Burden and Impac...</td>\n",
       "      <td>ANRS, Emerging Infectious Diseases</td>\n",
       "      <td>Institute of Research for Development, France</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2017-07-12</td>\n",
       "      <td>2017-10-19</td>\n",
       "      <td>2019-07-31</td>\n",
       "      <td>37143029</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Hepatitis B prevention and treatment needs in ...</td>\n",
       "      <td>Djaogol T; Périères L; Marcellin F; Diouf A; C...</td>\n",
       "      <td>10.1186/s12889-023-15710-y</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>667</th>\n",
       "      <td>NCT03005652</td>\n",
       "      <td>Effects Of An 8-Weeks Mindfulness-based Interv...</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2016-12-29</td>\n",
       "      <td>2017-04-21</td>\n",
       "      <td>2018-09-18</td>\n",
       "      <td>38100477</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Effects of a mindfulness-based intervention an...</td>\n",
       "      <td>Schlosser M; Demnitz-King H; Barnhofer T; Coll...</td>\n",
       "      <td>10.1371/journal.pone.0295175</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Randomized Controlled Trial, Journal Article]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>697</th>\n",
       "      <td>NCT01688453</td>\n",
       "      <td>Overweight Management and Social Inequalities</td>\n",
       "      <td>Institut National de la Santé Et de la Recherc...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>False</td>\n",
       "      <td>2012-09-19</td>\n",
       "      <td>2012-04</td>\n",
       "      <td>2015-11</td>\n",
       "      <td>35272723</td>\n",
       "      <td>PUBMED</td>\n",
       "      <td>Behavioural risk patterns in adolescents with ...</td>\n",
       "      <td>Julia C; Omorou A; Lecomte E; Langlois J; Touv...</td>\n",
       "      <td>10.1017/S136898002200057X</td>\n",
       "      <td>2023</td>\n",
       "      <td>[Journal Article, Research Support, Non-U.S. G...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           NCTId                                         BriefTitle  \\\n",
       "9    NCT05349162        Epicardial vs. Transvenous ICDs in Children   \n",
       "11   NCT02777229  Efficacy and Safety of a Dolutegravir-based Re...   \n",
       "14   NCT02777229  Efficacy and Safety of a Dolutegravir-based Re...   \n",
       "24   NCT01453192  Renal Transplantation and Raltegravir in HIV-I...   \n",
       "60   NCT04315948  Trial of Treatments for COVID-19 in Hospitaliz...   \n",
       "74   NCT05311865  Transmission of Covid-19 During Clubbing Event...   \n",
       "75   NCT05311865  Transmission of Covid-19 During Clubbing Event...   \n",
       "103  NCT00640263  Comparison of Efficacy and Safety of Infant Pe...   \n",
       "129  NCT01801618  National Evaluation of PI-based 2nd Line Effic...   \n",
       "130  NCT02405013  Feasibility, Tolerance and Efficacy of Interfe...   \n",
       "179  NCT01703962  Non Invasive IDentification of Gliomas With ID...   \n",
       "241  NCT01473472  On Demand Antiretroviral Pre-exposure Prophyla...   \n",
       "293  NCT02212379  Capacity of the Dual Combination Raltegravir/E...   \n",
       "297  NCT03335995                 Stroke Prognosis in Intensive CarE   \n",
       "325  NCT01426243  The Yellow Fever Vaccine Immunity in HIV Infec...   \n",
       "329  NCT03870438  Prevention of Mother-to-child Transmission of ...   \n",
       "345  NCT03078439  EPIPAGE2 Cohort Study Follow up at Five and a ...   \n",
       "410  NCT02057796  Systematic Empirical vs. Test-guided Anti-TB T...   \n",
       "449  NCT04392388  Health, Perception, Practices, Relations and S...   \n",
       "456  NCT01089387  Intracavernous Bone Marrow Stem-cell Injection...   \n",
       "457  NCT02833961                   Diffusion Spectroscopy in Stroke   \n",
       "475  NCT02481453  Rapamycine vs Placebo for the Treatment of Inc...   \n",
       "520  NCT04409405  Evaluation and Support to EVD Cured Patients a...   \n",
       "606  NCT04288128  Integrated Functional Evaluation of the Cerebe...   \n",
       "607  NCT04288128  Integrated Functional Evaluation of the Cerebe...   \n",
       "664  NCT03215732  Cross Sectional Survey on the Burden and Impac...   \n",
       "667  NCT03005652  Effects Of An 8-Weeks Mindfulness-based Interv...   \n",
       "697  NCT01688453      Overweight Management and Social Inequalities   \n",
       "\n",
       "                                       LeadSponsorName  \\\n",
       "9    Paris Cardiovascular Research Center (Inserm U...   \n",
       "11                  ANRS, Emerging Infectious Diseases   \n",
       "14                  ANRS, Emerging Infectious Diseases   \n",
       "24                  ANRS, Emerging Infectious Diseases   \n",
       "60   Institut National de la Santé Et de la Recherc...   \n",
       "74                  ANRS, Emerging Infectious Diseases   \n",
       "75                  ANRS, Emerging Infectious Diseases   \n",
       "103  French National Agency for Research on AIDS an...   \n",
       "129                 ANRS, Emerging Infectious Diseases   \n",
       "130                 ANRS, Emerging Infectious Diseases   \n",
       "179  Institut National de la Santé Et de la Recherc...   \n",
       "241                 ANRS, Emerging Infectious Diseases   \n",
       "293                 ANRS, Emerging Infectious Diseases   \n",
       "297  Institut National de la Santé Et de la Recherc...   \n",
       "325  French National Agency for Research on AIDS an...   \n",
       "329                 ANRS, Emerging Infectious Diseases   \n",
       "345  Institut National de la Santé Et de la Recherc...   \n",
       "410                 ANRS, Emerging Infectious Diseases   \n",
       "449  Institut National de la Santé Et de la Recherc...   \n",
       "456  Institut National de la Santé Et de la Recherc...   \n",
       "457  Institut National de la Santé Et de la Recherc...   \n",
       "475  Institut National de la Santé Et de la Recherc...   \n",
       "520  Institut National de la Santé Et de la Recherc...   \n",
       "606  Institut National de la Santé Et de la Recherc...   \n",
       "607  Institut National de la Santé Et de la Recherc...   \n",
       "664                 ANRS, Emerging Infectious Diseases   \n",
       "667  Institut National de la Santé Et de la Recherc...   \n",
       "697  Institut National de la Santé Et de la Recherc...   \n",
       "\n",
       "                                      CollaboratorName OverallStatus  \\\n",
       "9                       Hôpital Necker-Enfants Malades     COMPLETED   \n",
       "11   Institut de Recherche pour le Developpement | ...     COMPLETED   \n",
       "14   Institut de Recherche pour le Developpement | ...     COMPLETED   \n",
       "24                             Merck Sharp & Dohme LLC     COMPLETED   \n",
       "60                                                <NA>     COMPLETED   \n",
       "74                          Cerballiance | Kappa Santé     COMPLETED   \n",
       "75                          Cerballiance | Kappa Santé     COMPLETED   \n",
       "103  European and Developing Countries Clinical Tri...     COMPLETED   \n",
       "129                                               <NA>     COMPLETED   \n",
       "130                                               <NA>     COMPLETED   \n",
       "179                                               <NA>     COMPLETED   \n",
       "241                                               <NA>     COMPLETED   \n",
       "293       Merck Sharp & Dohme LLC | Janssen-Cilag Ltd.     COMPLETED   \n",
       "297                                               <NA>     COMPLETED   \n",
       "325                                               <NA>     COMPLETED   \n",
       "329  University Teaching Hospital, Lusaka, Zambia |...     COMPLETED   \n",
       "345                                               <NA>     COMPLETED   \n",
       "410                                               <NA>     COMPLETED   \n",
       "449                                               <NA>     COMPLETED   \n",
       "456                                               <NA>     COMPLETED   \n",
       "457                                               <NA>     COMPLETED   \n",
       "475                                               <NA>     COMPLETED   \n",
       "520  Institut National de Recherche Biomédicale. Ki...     COMPLETED   \n",
       "606               Biogen | Ionis Pharmaceuticals, Inc.     COMPLETED   \n",
       "607               Biogen | Ionis Pharmaceuticals, Inc.     COMPLETED   \n",
       "664      Institute of Research for Development, France     COMPLETED   \n",
       "667                                               <NA>     COMPLETED   \n",
       "697                                               <NA>     COMPLETED   \n",
       "\n",
       "          StudyType  HasResults StudyFirstPostDate   StartDate CompletionDate  \\\n",
       "9     OBSERVATIONAL       False         2022-04-27  2003-01-01     2022-04-01   \n",
       "11   INTERVENTIONAL       False         2016-05-19     2016-07        2021-07   \n",
       "14   INTERVENTIONAL       False         2016-05-19     2016-07        2021-07   \n",
       "24   INTERVENTIONAL       False         2011-10-17     2011-12        2015-11   \n",
       "60   INTERVENTIONAL       False         2020-03-20  2020-03-22     2023-09-25   \n",
       "74   INTERVENTIONAL       False         2022-04-05  2021-09-04     2022-02-26   \n",
       "75   INTERVENTIONAL       False         2022-04-05  2021-09-04     2022-02-26   \n",
       "103  INTERVENTIONAL       False         2008-03-21     2009-12        2014-02   \n",
       "129   OBSERVATIONAL       False         2013-03-01     2013-02        2014-12   \n",
       "130  INTERVENTIONAL       False         2015-04-01     2015-10        2017-11   \n",
       "179   OBSERVATIONAL       False         2012-10-11  2012-03-14     2014-03-20   \n",
       "241  INTERVENTIONAL       False         2011-11-17     2012-01     2016-12-15   \n",
       "293  INTERVENTIONAL        True         2014-08-08     2015-01        2018-04   \n",
       "297   OBSERVATIONAL       False         2017-11-08  2017-10-18     2020-11-18   \n",
       "325  INTERVENTIONAL       False         2011-08-31     2011-07        2017-12   \n",
       "329  INTERVENTIONAL       False         2019-03-12  2019-12-14     2022-10-31   \n",
       "345   OBSERVATIONAL       False         2017-03-13  2016-09-02     2018-01-08   \n",
       "410  INTERVENTIONAL       False         2014-02-07     2014-09        2018-04   \n",
       "449   OBSERVATIONAL       False         2020-05-18  2020-05-01     2023-04-11   \n",
       "456  INTERVENTIONAL       False         2010-03-18     2010-05        2015-03   \n",
       "457  INTERVENTIONAL       False         2016-07-14  2016-07-28     2019-10-25   \n",
       "475  INTERVENTIONAL       False         2015-06-25  2015-07-15     2018-01-22   \n",
       "520   OBSERVATIONAL       False         2020-06-01  2020-04-16     2021-10-18   \n",
       "606   OBSERVATIONAL       False         2020-02-28  2020-05-28     2022-06-01   \n",
       "607   OBSERVATIONAL       False         2020-02-28  2020-05-28     2022-06-01   \n",
       "664   OBSERVATIONAL       False         2017-07-12  2017-10-19     2019-07-31   \n",
       "667  INTERVENTIONAL       False         2016-12-29  2017-04-21     2018-09-18   \n",
       "697  INTERVENTIONAL       False         2012-09-19     2012-04        2015-11   \n",
       "\n",
       "         pmid    type                                              title  \\\n",
       "9    36735263  PUBMED  Epicardial vs. transvenous implantable cardiov...   \n",
       "11   37851566  PUBMED  Improvements in Patient-Reported Outcomes Foll...   \n",
       "14   38156046  PUBMED  Durability of the Efficacy and Safety of Dolut...   \n",
       "24   30688008  PUBMED  Low incidence of acute rejection within 6 mont...   \n",
       "60   36695483  PUBMED          Remdesivir for the treatment of COVID-19.   \n",
       "74   37795682  PUBMED  A randomised controlled trial to study the tra...   \n",
       "75   36438274  PUBMED  Transmission of SARS-CoV-2 during indoor clubb...   \n",
       "103  34425825  PUBMED  The prevalence and socio-behavioural and clini...   \n",
       "129  29662875  PUBMED  Positive Virological Outcomes of HIV-Infected ...   \n",
       "130  36686592  PUBMED  Patient-reported outcomes with direct-acting a...   \n",
       "179  37668523  PUBMED  Neurochemical Differences between 1p/19q Codel...   \n",
       "241  36601747  PUBMED  Hepatitis A and B vaccine uptake and immunisat...   \n",
       "293  31269208  PUBMED  Dual therapy combining raltegravir with etravi...   \n",
       "297  37497675  PUBMED  One-Year Outcomes in Patients With Acute Strok...   \n",
       "325  26314624  PUBMED  Molecular characterization of the 17D-204 yell...   \n",
       "329  38484756  PUBMED  Optimised prevention of postnatal HIV transmis...   \n",
       "345  38408861  PUBMED  Birth weight and head circumference discordanc...   \n",
       "410  36883573  PUBMED  High performance of systematic combined urine ...   \n",
       "449  34293141  PUBMED  Antibody status and cumulative incidence of SA...   \n",
       "456  26439886  PUBMED  Safety of Intracavernous Bone Marrow-Mononucle...   \n",
       "457  36318030  PUBMED  Longitudinal Monitoring of Microstructural Alt...   \n",
       "475  38273639  PUBMED  Sirolimus for treatment of patients with inclu...   \n",
       "520  38043556  PUBMED  Effect of anti-Ebola virus monoclonal antibodi...   \n",
       "606  38419144  PUBMED  Digital Gait Measures Capture 1-Year Progressi...   \n",
       "607  38421662  PUBMED  ATXN7-Related Cone-Rod Dystrophy: The Integrat...   \n",
       "664  37143029  PUBMED  Hepatitis B prevention and treatment needs in ...   \n",
       "667  38100477  PUBMED  Effects of a mindfulness-based intervention an...   \n",
       "697  35272723  PUBMED  Behavioural risk patterns in adolescents with ...   \n",
       "\n",
       "                                               authors  \\\n",
       "9    Le Bos PA; Pontailler M; Maltret A; Kraiche D;...   \n",
       "11   Bousmah MA; Protopopescu C; Mpoudi-Etame M; Om...   \n",
       "14   Mpoudi-Etame M; Tovar Sanchez T; Bousmah MA; O...   \n",
       "24   Matignon M; Lelièvre JD; Lahiani A; Abbassi K;...   \n",
       "60   Grundeis F; Ansems K; Dahms K; Thieme V; Metze...   \n",
       "74   Luong Nguyen LB; Goupil de Bouillé J; Menant L...   \n",
       "75   Goupil de Bouillé J; Luong Nguyen LB; Crépey P...   \n",
       "103  Birungi N; Fadnes LT; Engebretsen IMS; Tumwine...   \n",
       "129  Ségéral O; Nerrienet E; Neth S; Spire B; Khol ...   \n",
       "130  Marcellin F; Mourad A; Lemoine M; Kouanfack C;...   \n",
       "179  Branzoli F; Liserre R; Deelchand DK; Poliani P...   \n",
       "241  Le Turnier P; Charreau I; Gabassi A; Carette D...   \n",
       "293  Katlama C; Assoumou L; Valantin MA; Soulié C; ...   \n",
       "297  Sonneville R; Mazighi M; Collet M; Gayat E; De...   \n",
       "325  Salmona M; Gazaignes S; Mercier-Delarue S; Gar...   \n",
       "329  Kankasa C; Mennecier A; Sakana BLD; Molès JP; ...   \n",
       "345  Guellec I; Brunet A; Lapillonne A; Taine M; To...   \n",
       "410  Bonnet M; Gabillard D; Domoua S; Muzoora C; Me...   \n",
       "449  Carrat F; de Lamballerie X; Rahib D; Blanché H...   \n",
       "456  Yiou R; Hamidou L; Birebent B; Bitari D; Lecor...   \n",
       "457  Genovese G; Diaz-Fernandez B; Lejeune FX; Rone...   \n",
       "475  Benveniste O; Hogrel JY; Belin L; Annoussamy M...   \n",
       "520  Nkuba-Ndaye A; Dilu-Keti A; Tovar-Sanchez T; D...   \n",
       "606  Seemann J; Daghsen L; Cazier M; Lamy JC; Welte...   \n",
       "607  Nassisi M; Coarelli G; Blanchard B; Dubec-Fleu...   \n",
       "664  Djaogol T; Périères L; Marcellin F; Diouf A; C...   \n",
       "667  Schlosser M; Demnitz-King H; Barnhofer T; Coll...   \n",
       "697  Julia C; Omorou A; Lecomte E; Langlois J; Touv...   \n",
       "\n",
       "                                  doi  year  \\\n",
       "9            10.1093/europace/euad015  2023   \n",
       "11       10.1097/QAI.0000000000003273  2023   \n",
       "14               10.1093/ofid/ofad582  2023   \n",
       "24                  10.1111/hiv.12700  2019   \n",
       "60     10.1002/14651858.CD014962.pub2  2023   \n",
       "74                10.1093/cid/ciad603  2023   \n",
       "75          10.3389/fpubh.2022.981213  2022   \n",
       "103        10.1186/s12955-021-01844-3  2021   \n",
       "129          10.3389/fpubh.2018.00063  2018   \n",
       "130       10.1016/j.jhepr.2022.100665  2023   \n",
       "179             10.1148/radiol.223255  2023   \n",
       "241      10.1136/sextrans-2022-055634  2023   \n",
       "293                10.1093/jac/dkz224  2019   \n",
       "297      10.1161/STROKEAHA.123.042910  2023   \n",
       "325     10.1016/j.vaccine.2015.08.055  2015   \n",
       "329     10.1016/S0140-6736(23)02464-9  2024   \n",
       "345  10.1136/archdischild-2023-326336  2024   \n",
       "410               10.1093/cid/ciad125  2023   \n",
       "449               10.1093/ije/dyab110  2021   \n",
       "456      10.1016/j.eururo.2015.09.026  2016   \n",
       "457             10.1148/radiol.220430  2023   \n",
       "475     10.1016/S2665-9913(20)30280-0  2021   \n",
       "520     10.1016/S1473-3099(23)00552-2  2024   \n",
       "606                 10.1002/mds.29757  2024   \n",
       "607  10.1001/jamaophthalmol.2024.0001  2024   \n",
       "664        10.1186/s12889-023-15710-y  2023   \n",
       "667      10.1371/journal.pone.0295175  2023   \n",
       "697         10.1017/S136898002200057X  2023   \n",
       "\n",
       "                                     publication_types  \n",
       "9                    [Clinical Trial, Journal Article]  \n",
       "11   [Randomized Controlled Trial, Journal Article,...  \n",
       "14                                   [Journal Article]  \n",
       "24   [Journal Article, Multicenter Study, Research ...  \n",
       "60   [Journal Article, Review, Research Support, No...  \n",
       "74                                   [Journal Article]  \n",
       "75   [Clinical Trial Protocol, Journal Article, Res...  \n",
       "103                                  [Journal Article]  \n",
       "129                                  [Journal Article]  \n",
       "130                                  [Journal Article]  \n",
       "179  [Journal Article, Observational Study, Researc...  \n",
       "241  [Clinical Trial, Research Support, Non-U.S. Go...  \n",
       "293  [Journal Article, Multicenter Study, Research ...  \n",
       "297  [Multicenter Study, Journal Article, Research ...  \n",
       "325  [Journal Article, Research Support, Non-U.S. G...  \n",
       "329                                  [Journal Article]  \n",
       "345                                  [Journal Article]  \n",
       "410                                  [Journal Article]  \n",
       "449                                  [Journal Article]  \n",
       "456  [Journal Article, Research Support, Non-U.S. G...  \n",
       "457  [Journal Article, Research Support, Non-U.S. G...  \n",
       "475                                  [Journal Article]  \n",
       "520             [Observational Study, Journal Article]  \n",
       "606                                  [Journal Article]  \n",
       "607                                  [Journal Article]  \n",
       "664  [Journal Article, Research Support, Non-U.S. G...  \n",
       "667     [Randomized Controlled Trial, Journal Article]  \n",
       "697  [Journal Article, Research Support, Non-U.S. G...  "
      ]
     },
     "execution_count": 72,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_final[index_empty_rows]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d5132e99-076f-46b6-9007-fa34d0abef35",
   "metadata": {},
   "source": [
    "### Resultat final:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "id": "d31b1848-6436-4ac9-a8bd-bd3d63558aa3",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 706 entries, 0 to 705\n",
      "Data columns (total 17 columns):\n",
      " #   Column              Non-Null Count  Dtype   \n",
      "---  ------              --------------  -----   \n",
      " 0   NCTId               706 non-null    object  \n",
      " 1   BriefTitle          706 non-null    string  \n",
      " 2   LeadSponsorName     706 non-null    string  \n",
      " 3   CollaboratorName    357 non-null    string  \n",
      " 4   OverallStatus       706 non-null    category\n",
      " 5   StudyType           706 non-null    category\n",
      " 6   HasResults          706 non-null    boolean \n",
      " 7   StudyFirstPostDate  706 non-null    string  \n",
      " 8   StartDate           706 non-null    string  \n",
      " 9   CompletionDate      705 non-null    string  \n",
      " 10  pmid                568 non-null    object  \n",
      " 11  type                568 non-null    string  \n",
      " 12  title               568 non-null    object  \n",
      " 13  authors             568 non-null    object  \n",
      " 14  doi                 563 non-null    object  \n",
      " 15  year                568 non-null    object  \n",
      " 16  publication_types   568 non-null    object  \n",
      "dtypes: boolean(1), category(2), object(7), string(7)\n",
      "memory usage: 80.3+ KB\n"
     ]
    }
   ],
   "source": [
    "df_final.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "id": "8debbfa2-f680-45e1-b62b-0b2c09fa4026",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 706 entries, 0 to 705\n",
      "Data columns (total 17 columns):\n",
      " #   Column              Non-Null Count  Dtype   \n",
      "---  ------              --------------  -----   \n",
      " 0   NCTId               706 non-null    string  \n",
      " 1   BriefTitle          706 non-null    string  \n",
      " 2   LeadSponsorName     706 non-null    string  \n",
      " 3   CollaboratorName    357 non-null    string  \n",
      " 4   OverallStatus       706 non-null    category\n",
      " 5   StudyType           706 non-null    category\n",
      " 6   HasResults          706 non-null    boolean \n",
      " 7   StudyFirstPostDate  706 non-null    string  \n",
      " 8   StartDate           706 non-null    string  \n",
      " 9   CompletionDate      705 non-null    string  \n",
      " 10  pmid                568 non-null    string  \n",
      " 11  type                568 non-null    string  \n",
      " 12  title               568 non-null    string  \n",
      " 13  authors             568 non-null    string  \n",
      " 14  doi                 563 non-null    string  \n",
      " 15  year                568 non-null    string  \n",
      " 16  publication_types   568 non-null    object  \n",
      "dtypes: boolean(1), category(2), object(1), string(13)\n",
      "memory usage: 80.3+ KB\n"
     ]
    }
   ],
   "source": [
    "df_final = df_final.convert_dtypes()\n",
    "# df_final = df_final.astype({\"OverallStatus\" : 'category', \"StudyType\" : 'category'})\n",
    "df_final.info()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "52dafbcd-284c-4aa4-81f5-e2f6506a8105",
   "metadata": {},
   "source": [
    "### Export en CSV: "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "id": "062a8821-b680-4e5a-823e-256adda183e0",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_final.to_csv(\n",
    "    'Data/outputs/extract_df_final.csv',\n",
    "    sep=';',\n",
    "    index=False,\n",
    "    encoding='utf-8-sig',\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "fb7433f5",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "49f4e637-25ae-4ddf-871a-1d93e4f8b3dc",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
